"\"{\\\"index\\\": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256, 257, 258, 259, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 306, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 328, 329, 330, 331, 332, 333, 334, 335, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 355, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 374, 375, 376, 377, 378, 379, 380, 381, 382, 383, 384, 385, 386, 387, 388, 389, 390, 391, 392, 393, 394, 395, 396, 397, 398, 399, 400, 401, 402, 403, 404, 405, 406, 407, 408, 409, 410, 411, 412, 413, 414, 415, 416, 417, 418, 419, 420, 421, 422, 423, 424, 425, 426, 427, 428, 429, 430, 431, 432, 433, 434, 435, 436, 437, 438, 439, 440, 441, 442, 443, 444, 445, 446, 447, 448, 449, 450, 451, 452, 453, 454, 455, 456, 457, 458, 459, 460, 461, 462, 463, 464, 465, 466, 467, 468, 469, 470, 471, 472, 473, 474, 475, 476, 477, 478, 479, 480, 481, 482, 483, 484, 485, 486, 487, 488, 489, 490, 491, 492, 493, 494, 495, 496, 497, 498, 499, 500, 501, 502, 503, 504, 505, 506, 507, 508, 509, 510, 511, 512, 513, 514, 515, 516, 517, 518, 519, 520, 521, 522, 523, 524, 525, 526, 527, 528, 529, 530, 531, 532, 533, 534, 535, 536, 537, 538, 539, 540, 541, 542, 543, 544, 545, 546, 547, 548, 549, 550, 551, 552, 553, 554, 555, 556, 557, 558, 559, 560, 561, 562, 563, 564, 565, 566, 567, 568, 569, 570, 571, 572, 573, 574, 575, 576, 577, 578, 579, 580, 581, 582, 583, 584, 585, 586, 587, 588, 589, 590, 591, 592, 593, 594, 595, 596, 597, 598, 599, 600, 601, 602, 603, 604, 605, 606, 607, 608, 609, 610, 611, 612, 613, 614, 615, 616, 617, 618, 619, 620, 621, 622, 623, 624, 625, 626, 627, 628, 629, 630, 631, 632, 633, 634, 635, 636, 637, 638, 639, 640, 641, 642, 643, 644, 645, 646, 647, 648, 649, 650, 651, 652, 653, 654, 655, 656, 657, 658, 659, 660, 661, 662, 663, 664, 665, 666, 667, 668, 669, 670, 671, 672, 673, 674, 675, 676, 677, 678, 679, 680, 681, 682, 683, 684, 685, 686, 687, 688, 689, 690, 691, 692, 693, 694, 695, 696, 697, 698, 699, 700, 701, 702, 703, 704, 705, 706, 707, 708, 709, 710, 711, 712, 713, 714, 715, 716, 717, 718, 719, 720, 721, 722, 723, 724, 725, 726, 727, 728, 729, 730, 731, 732, 733, 734, 735, 736, 737, 738, 739, 740, 741, 742, 743, 744, 745, 746, 747, 748, 749, 750, 751, 752, 753, 754, 755, 756, 757, 758, 759, 760, 761, 762, 763, 764, 765, 766, 767, 768, 769, 770, 771, 772, 773, 774, 775, 776, 777, 778, 779, 780, 781, 782, 783, 784, 785, 786, 787, 788, 789, 790, 791, 792, 793, 794, 795, 796, 797, 798, 799, 800, 801, 802, 803, 804, 805, 806, 807, 808, 809, 810, 811, 812, 813, 814, 815, 816, 817, 818, 819, 820, 821, 822, 823, 824, 825, 826, 827, 828, 829, 830, 831, 832, 833, 834, 835, 836, 837, 838, 839, 840, 841, 842, 843, 844, 845, 846, 847, 848, 849, 850, 851, 852, 853, 854, 855, 856, 857, 858, 859, 860, 861, 862, 863, 864, 865, 866, 867, 868, 869, 870, 871, 872, 873, 874, 875, 876, 877, 878, 879, 880, 881, 882, 883, 884, 885, 886, 887, 888, 889, 890, 891, 892, 893, 894, 895, 896, 897, 898, 899, 900, 901, 902, 903, 904, 905, 906, 907, 908, 909, 910, 911, 912, 913, 914, 915, 916, 917, 918, 919, 920, 921, 922, 923, 924, 925, 926, 927, 928, 929, 930, 931, 932, 933, 934, 935, 936, 937, 938, 939, 940, 941, 942, 943, 944, 945, 946, 947, 948, 949, 950, 951, 952, 953, 954, 955, 956, 957, 958, 959, 960, 961, 962, 963, 964, 965, 966, 967, 968, 969, 970, 971, 972, 973, 974, 975, 976, 977, 978, 979, 980, 981, 982, 983, 984, 985, 986, 987, 988, 989, 990, 991, 992, 993, 994, 995, 996, 997, 998, 999, 1000, 1001, 1002, 1003, 1004, 1005, 1006, 1007, 1008, 1009, 1010, 1011, 1012, 1013, 1014, 1015, 1016, 1017, 1018, 1019, 1020, 1021, 1022, 1023, 1024, 1025, 1026, 1027, 1028, 1029, 1030, 1031, 1032, 1033, 1034, 1035, 1036, 1037, 1038, 1039, 1040, 1041, 1042, 1043, 1044, 1045, 1046, 1047, 1048, 1049, 1050, 1051, 1052, 1053, 1054, 1055, 1056, 1057, 1058, 1059, 1060, 1061, 1062, 1063, 1064, 1065, 1066, 1067, 1068, 1069, 1070, 1071, 1072, 1073, 1074, 1075, 1076, 1077, 1078, 1079, 1080, 1081, 1082, 1083, 1084, 1085, 1086, 1087, 1088, 1089, 1090, 1091, 1092, 1093, 1094, 1095, 1096, 1097, 1098, 1099, 1100, 1101, 1102, 1103, 1104, 1105, 1106, 1107, 1108, 1109, 1110, 1111, 1112, 1113, 1114, 1115, 1116, 1117, 1118, 1119, 1120, 1121, 1122, 1123, 1124, 1125, 1126, 1127, 1128, 1129, 1130, 1131, 1132, 1133, 1134, 1135, 1136, 1137, 1138, 1139, 1140, 1141, 1142, 1143, 1144, 1145, 1146, 1147, 1148, 1149, 1150, 1151, 1152, 1153, 1154, 1155, 1156, 1157, 1158, 1159, 1160, 1161, 1162, 1163, 1164, 1165, 1166, 1167, 1168, 1169, 1170, 1171, 1172, 1173, 1174, 1175, 1176, 1177, 1178, 1179, 1180, 1181, 1182, 1183, 1184, 1185, 1186, 1187, 1188, 1189, 1190, 1191, 1192, 1193, 1194, 1195, 1196, 1197, 1198, 1199, 1200, 1201, 1202, 1203, 1204, 1205, 1206, 1207, 1208, 1209, 1210, 1211, 1212, 1213, 1214, 1215, 1216, 1217, 1218, 1219, 1220, 1221, 1222, 1223, 1224, 1225, 1226, 1227, 1228, 1229, 1230, 1231, 1232, 1233, 1234, 1235, 1236, 1237, 1238, 1239, 1240, 1241, 1242, 1243, 1244, 1245, 1246, 1247, 1248, 1249, 1250, 1251, 1252, 1253, 1254, 1255, 1256, 1257, 1258, 1259, 1260, 1261, 1262, 1263, 1264, 1265, 1266, 1267, 1268, 1269, 1270, 1271, 1272, 1273, 1274, 1275, 1276, 1277, 1278, 1279, 1280, 1281, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1289, 1290, 1291, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 1299, 1300, 1301, 1302, 1303, 1304, 1305, 1306, 1307, 1308, 1309, 1310, 1311, 1312, 1313, 1314, 1315, 1316, 1317, 1318, 1319, 1320, 1321, 1322, 1323, 1324, 1325, 1326, 1327, 1328, 1329, 1330, 1331, 1332, 1333, 1334, 1335, 1336, 1337, 1338, 1339, 1340, 1341, 1342, 1343, 1344, 1345, 1346, 1347, 1348, 1349, 1350, 1351, 1352, 1353, 1354, 1355, 1356, 1357, 1358, 1359, 1360, 1361, 1362, 1363, 1364, 1365, 1366, 1367, 1368, 1369, 1370, 1371, 1372, 1373, 1374, 1375, 1376, 1377, 1378, 1379, 1380, 1381, 1382, 1383, 1384, 1385, 1386, 1387, 1388, 1389, 1390, 1391, 1392, 1393, 1394, 1395, 1396, 1397, 1398, 1399, 1400, 1401, 1402, 1403, 1404, 1405, 1406, 1407, 1408, 1409, 1410, 1411, 1412, 1413, 1414, 1415, 1416, 1417, 1418, 1419, 1420, 1421, 1422, 1423, 1424, 1425, 1426, 1427, 1428, 1429, 1430, 1431, 1432, 1433, 1434, 1435, 1436, 1437, 1438, 1439, 1440, 1441, 1442, 1443, 1444, 1445, 1446, 1447, 1448, 1449, 1450, 1451, 1452, 1453, 1454, 1455, 1456, 1457, 1458, 1459, 1460, 1461, 1462, 1463, 1464, 1465, 1466, 1467, 1468, 1469, 1470, 1471, 1472, 1473, 1474, 1475, 1476, 1477, 1478, 1479, 1480, 1481, 1482, 1483, 1484, 1485, 1486, 1487, 1488, 1489, 1490, 1491, 1492, 1493, 1494, 1495, 1496, 1497, 1498, 1499, 1500, 1501, 1502, 1503, 1504, 1505, 1506, 1507, 1508, 1509, 1510, 1511, 1512, 1513, 1514, 1515, 1516, 1517, 1518, 1519, 1520, 1521, 1522, 1523, 1524, 1525, 1526, 1527, 1528, 1529, 1530, 1531, 1532, 1533, 1534, 1535, 1536, 1537, 1538, 1539, 1540, 1541, 1542, 1543, 1544, 1545, 1546, 1547, 1548, 1549, 1550, 1551, 1552, 1553, 1554, 1555, 1556, 1557, 1558, 1559, 1560, 1561, 1562, 1563, 1564, 1565, 1566, 1567, 1568, 1569, 1570, 1571, 1572, 1573, 1574, 1575, 1576, 1577, 1578, 1579, 1580, 1581, 1582, 1583, 1584, 1585, 1586, 1587, 1588, 1589, 1590, 1591, 1592, 1593, 1594, 1595, 1596, 1597, 1598, 1599, 1600, 1601, 1602, 1603, 1604, 1605, 1606, 1607, 1608, 1609, 1610, 1611, 1612, 1613, 1614, 1615, 1616, 1617, 1618, 1619, 1620, 1621, 1622, 1623, 1624, 1625, 1626, 1627, 1628, 1629, 1630, 1631, 1632, 1633, 1634, 1635, 1636, 1637, 1638, 1639, 1640, 1641, 1642, 1643, 1644, 1645, 1646, 1647, 1648, 1649, 1650, 1651, 1652, 1653, 1654, 1655, 1656, 1657, 1658, 1659, 1660, 1661, 1662, 1663, 1664, 1665, 1666, 1667, 1668, 1669, 1670, 1671, 1672, 1673, 1674, 1675, 1676, 1677, 1678, 1679, 1680, 1681, 1682, 1683, 1684, 1685, 1686, 1687, 1688, 1689, 1690, 1691, 1692, 1693, 1694, 1695, 1696, 1697, 1698, 1699, 1700, 1701, 1702, 1703, 1704, 1705, 1706, 1707, 1708, 1709, 1710, 1711, 1712, 1713, 1714, 1715, 1716, 1717, 1718, 1719, 1720, 1721, 1722, 1723, 1724, 1725, 1726, 1727, 1728, 1729, 1730, 1731, 1732, 1733, 1734, 1735, 1736, 1737, 1738, 1739, 1740, 1741, 1742, 1743, 1744, 1745, 1746, 1747, 1748, 1749, 1750, 1751, 1752, 1753, 1754, 1755, 1756, 1757, 1758, 1759, 1760, 1761, 1762, 1763, 1764, 1765, 1766, 1767, 1768, 1769, 1770, 1771, 1772, 1773, 1774, 1775, 1776, 1777, 1778, 1779, 1780, 1781, 1782, 1783, 1784, 1785, 1786, 1787, 1788, 1789, 1790, 1791, 1792, 1793, 1794, 1795, 1796, 1797, 1798, 1799, 1800, 1801, 1802, 1803, 1804, 1805, 1806, 1807, 1808, 1809, 1810, 1811, 1812, 1813, 1814, 1815, 1816, 1817, 1818, 1819, 1820, 1821, 1822, 1823, 1824, 1825, 1826, 1827, 1828, 1829, 1830, 1831, 1832, 1833, 1834, 1835, 1836, 1837, 1838, 1839, 1840, 1841, 1842, 1843, 1844, 1845, 1846, 1847, 1848, 1849, 1850, 1851, 1852, 1853, 1854, 1855, 1856, 1857, 1858, 1859, 1860, 1861, 1862, 1863, 1864, 1865, 1866, 1867, 1868, 1869, 1870, 1871, 1872, 1873, 1874, 1875, 1876, 1877, 1878, 1879, 1880, 1881, 1882, 1883, 1884, 1885, 1886, 1887, 1888, 1889, 1890, 1891, 1892, 1893, 1894, 1895, 1896, 1897, 1898, 1899, 1900, 1901, 1902, 1903, 1904, 1905, 1906, 1907, 1908, 1909, 1910, 1911, 1912, 1913, 1914, 1915, 1916, 1917, 1918, 1919, 1920, 1921, 1922, 1923, 1924, 1925, 1926, 1927, 1928, 1929, 1930, 1931, 1932, 1933, 1934, 1935, 1936, 1937, 1938, 1939, 1940, 1941, 1942, 1943, 1944, 1945, 1946, 1947, 1948, 1949, 1950, 1951, 1952, 1953, 1954, 1955, 1956, 1957, 1958, 1959, 1960, 1961, 1962, 1963, 1964, 1965, 1966, 1967, 1968, 1969, 1970, 1971, 1972, 1973, 1974, 1975, 1976, 1977, 1978, 1979, 1980, 1981, 1982, 1983, 1984, 1985, 1986, 1987, 1988, 1989, 1990, 1991, 1992, 1993, 1994, 1995, 1996, 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025, 2026, 2027, 2028, 2029, 2030, 2031, 2032, 2033, 2034, 2035, 2036, 2037, 2038, 2039, 2040, 2041, 2042, 2043, 2044, 2045, 2046, 2047, 2048, 2049, 2050, 2051, 2052, 2053, 2054, 2055, 2056, 2057, 2058, 2059, 2060, 2061, 2062, 2063, 2064, 2065, 2066, 2067, 2068, 2069, 2070, 2071, 2072, 2073, 2074, 2075, 2076, 2077, 2078, 2079, 2080, 2081, 2082, 2083, 2084, 2085, 2086, 2087, 2088, 2089, 2090, 2091, 2092, 2093, 2094, 2095, 2096, 2097, 2098, 2099, 2100, 2101, 2102, 2103, 2104, 2105, 2106, 2107, 2108, 2109, 2110, 2111, 2112, 2113, 2114, 2115, 2116, 2117, 2118, 2119, 2120, 2121, 2122, 2123, 2124, 2125, 2126, 2127, 2128, 2129, 2130, 2131, 2132, 2133, 2134, 2135, 2136, 2137, 2138, 2139, 2140, 2141, 2142, 2143, 2144, 2145, 2146, 2147, 2148, 2149, 2150, 2151, 2152, 2153, 2154, 2155, 2156, 2157, 2158, 2159, 2160, 2161, 2162, 2163, 2164, 2165, 2166, 2167, 2168, 2169, 2170, 2171, 2172, 2173, 2174, 2175, 2176, 2177, 2178, 2179, 2180, 2181, 2182, 2183, 2184, 2185, 2186, 2187, 2188, 2189, 2190, 2191, 2192, 2193, 2194, 2195, 2196, 2197, 2198, 2199, 2200, 2201, 2202, 2203, 2204, 2205, 2206, 2207, 2208, 2209, 2210, 2211, 2212, 2213, 2214, 2215, 2216, 2217, 2218, 2219, 2220, 2221, 2222, 2223, 2224, 2225, 2226, 2227, 2228, 2229, 2230, 2231, 2232, 2233, 2234, 2235, 2236, 2237, 2238, 2239, 2240, 2241, 2242, 2243, 2244, 2245, 2246, 2247, 2248, 2249, 2250, 2251, 2252, 2253, 2254, 2255, 2256, 2257, 2258, 2259, 2260, 2261, 2262, 2263, 2264, 2265, 2266, 2267, 2268, 2269, 2270, 2271, 2272, 2273, 2274, 2275, 2276, 2277, 2278, 2279, 2280, 2281, 2282, 2283, 2284, 2285, 2286, 2287, 2288, 2289, 2290, 2291, 2292, 2293, 2294, 2295, 2296, 2297, 2298, 2299, 2300, 2301, 2302, 2303, 2304, 2305, 2306, 2307, 2308, 2309, 2310, 2311, 2312, 2313, 2314, 2315, 2316, 2317, 2318, 2319, 2320, 2321, 2322, 2323, 2324, 2325, 2326, 2327, 2328, 2329, 2330, 2331, 2332, 2333, 2334, 2335, 2336, 2337, 2338, 2339, 2340, 2341, 2342, 2343, 2344, 2345, 2346, 2347, 2348, 2349, 2350, 2351, 2352, 2353, 2354, 2355, 2356, 2357, 2358, 2359, 2360, 2361, 2362, 2363, 2364, 2365, 2366, 2367, 2368, 2369, 2370, 2371, 2372, 2373, 2374, 2375, 2376, 2377, 2378, 2379, 2380, 2381, 2382, 2383, 2384, 2385, 2386, 2387, 2388, 2389, 2390, 2391, 2392, 2393, 2394, 2395, 2396, 2397, 2398, 2399, 2400, 2401, 2402, 2403, 2404, 2405, 2406, 2407, 2408, 2409, 2410, 2411, 2412, 2413, 2414, 2415, 2416, 2417, 2418, 2419, 2420, 2421, 2422, 2423, 2424, 2425, 2426, 2427, 2428, 2429, 2430, 2431, 2432, 2433, 2434, 2435, 2436, 2437, 2438, 2439, 2440, 2441, 2442, 2443, 2444, 2445, 2446, 2447, 2448, 2449, 2450, 2451, 2452, 2453, 2454, 2455, 2456, 2457, 2458, 2459, 2460, 2461, 2462, 2463, 2464, 2465, 2466, 2467, 2468, 2469, 2470, 2471, 2472, 2473, 2474, 2475, 2476, 2477, 2478, 2479, 2480, 2481, 2482, 2483, 2484, 2485, 2486, 2487, 2488, 2489, 2490, 2491, 2492, 2493, 2494, 2495, 2496, 2497, 2498, 2499, 2500, 2501, 2502, 2503, 2504, 2505, 2506, 2507, 2508, 2509, 2510, 2511, 2512, 2513, 2514, 2515, 2516, 2517, 2518, 2519, 2520, 2521, 2522, 2523, 2524, 2525, 2526, 2527, 2528, 2529, 2530, 2531, 2532, 2533, 2534, 2535, 2536, 2537, 2538, 2539, 2540, 2541, 2542, 2543, 2544, 2545, 2546, 2547, 2548, 2549, 2550, 2551, 2552, 2553, 2554, 2555, 2556, 2557, 2558, 2559, 2560, 2561, 2562, 2563, 2564, 2565, 2566, 2567, 2568, 2569, 2570, 2571, 2572, 2573, 2574, 2575, 2576, 2577, 2578, 2579, 2580, 2581, 2582, 2583, 2584, 2585, 2586, 2587, 2588, 2589, 2590, 2591, 2592, 2593, 2594, 2595, 2596, 2597, 2598, 2599, 2600, 2601, 2602, 2603, 2604, 2605, 2606, 2607, 2608, 2609, 2610, 2611, 2612, 2613, 2614, 2615, 2616, 2617, 2618, 2619, 2620, 2621, 2622, 2623, 2624, 2625, 2626, 2627, 2628, 2629, 2630, 2631, 2632, 2633, 2634, 2635, 2636, 2637, 2638, 2639, 2640, 2641, 2642, 2643, 2644, 2645, 2646, 2647, 2648, 2649, 2650, 2651, 2652, 2653, 2654, 2655, 2656, 2657, 2658, 2659, 2660, 2661, 2662, 2663, 2664, 2665, 2666, 2667, 2668, 2669, 2670, 2671, 2672, 2673, 2674, 2675, 2676, 2677, 2678, 2679, 2680, 2681, 2682, 2683, 2684, 2685, 2686, 2687, 2688, 2689, 2690, 2691, 2692, 2693, 2694, 2695, 2696, 2697, 2698, 2699, 2700, 2701, 2702, 2703, 2704, 2705, 2706, 2707, 2708, 2709, 2710, 2711], \\\"columns\\\": [\\\"section_level\\\", \\\"CPT_section\\\", \\\"type\\\", \\\"content\\\", \\\"font_info\\\", \\\"level_1_CPT_section\\\", \\\"file_section\\\", \\\"file_section_num\\\", \\\"file_section_level\\\", \\\"seq_num\\\", \\\"qc_change_type\\\"], \\\"data\\\": [[\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"TITLE PAGE\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 32, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"19266fb8-e935-411c-a5b7-e23e9e132874\\\", \\\"childbox\\\": \\\"ca1c56c2-426f-4404-9aa4-09261c55c735\\\", \\\"subtext\\\": \\\"811f588d-1e1a-47bc-a2ab-de1812542db1\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 32, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 1, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Protocol Title:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9e0ca227-3fc8-428e-9225-843978f73e12\\\", \\\"childbox\\\": \\\"3b2b6d36-40ca-43be-ba43-a08f405b30eb\\\", \\\"subtext\\\": \\\"27b46720-1dae-442b-a036-ee15dd1f3712\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 2, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A phase IIIB, randomized, controlled, observer-blind study to evaluate safety and immunogenicity of ~REDACTED~ meningococcal ABCWY ~REDACTED~ when administered in healthy adolescents and adults, previously primed with meningococcal ACWY ~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9e0ca227-3fc8-428e-9225-843978f73e12\\\", \\\"childbox\\\": \\\"3b2b6d36-40ca-43be-ba43-a08f405b30eb\\\", \\\"subtext\\\": \\\"939b3a06-bea5-476f-b850-10316d75396a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 3, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9e0ca227-3fc8-428e-9225-843978f73e12\\\", \\\"childbox\\\": \\\"3b2b6d36-40ca-43be-ba43-a08f405b30eb\\\", \\\"subtext\\\": \\\"76e6f066-c4dc-40ec-8e96-e0d89793ddd4\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 4, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Protocol Number:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d600d8c8-4270-4ed7-9c51-ad8be24fc390\\\", \\\"childbox\\\": \\\"2e3a4b60-d8aa-4f92-8645-eee2e84181c8\\\", \\\"subtext\\\": \\\"351a8e9e-90b7-4bf6-bd96-7f86adcefa62\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 5, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"213171 (MENABCWY-019)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d600d8c8-4270-4ed7-9c51-ad8be24fc390\\\", \\\"childbox\\\": \\\"2e3a4b60-d8aa-4f92-8645-eee2e84181c8\\\", \\\"subtext\\\": \\\"2b8ac9ae-0bd5-457e-9ce5-ed224a73c883\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 6, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d600d8c8-4270-4ed7-9c51-ad8be24fc390\\\", \\\"childbox\\\": \\\"2e3a4b60-d8aa-4f92-8645-eee2e84181c8\\\", \\\"subtext\\\": \\\"5a2a263c-073d-4213-b91b-c4e16b606840\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 7, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Amendment Number:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"828d48de-f0d1-4c39-8571-50d267f0f2ac\\\", \\\"childbox\\\": \\\"ecdf2500-5cd1-4557-ada0-5dd5ae2d7faa\\\", \\\"subtext\\\": \\\"3e573769-5d65-436a-82a3-f08570e0735b\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 8, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"828d48de-f0d1-4c39-8571-50d267f0f2ac\\\", \\\"childbox\\\": \\\"ecdf2500-5cd1-4557-ada0-5dd5ae2d7faa\\\", \\\"subtext\\\": \\\"c9f25ddd-0de3-45e5-8360-2b09bed9ea51\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 9, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"828d48de-f0d1-4c39-8571-50d267f0f2ac\\\", \\\"childbox\\\": \\\"ecdf2500-5cd1-4557-ada0-5dd5ae2d7faa\\\", \\\"subtext\\\": \\\"0b667875-aaa2-4b15-b991-3cc91fd0e099\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 10, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Product:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a4567cb4-a650-458b-baba-df6e010b236d\\\", \\\"childbox\\\": \\\"9b027893-688c-4705-8fd1-1a8bced6ef86\\\", \\\"subtext\\\": \\\"a90f8b99-c710-4eca-9dde-13353e69b7e4\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 11, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~ ~REDACTED~ combined Meningococcal Groups A, B, C, W, and Y ~REDACTED~ (~REDACTED~)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a4567cb4-a650-458b-baba-df6e010b236d\\\", \\\"childbox\\\": \\\"9b027893-688c-4705-8fd1-1a8bced6ef86\\\", \\\"subtext\\\": \\\"2fd82c1e-9910-4424-957a-7eeb98e2a447\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 12, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a4567cb4-a650-458b-baba-df6e010b236d\\\", \\\"childbox\\\": \\\"9b027893-688c-4705-8fd1-1a8bced6ef86\\\", \\\"subtext\\\": \\\"289a8bbc-a45c-4777-aa4f-4701b063014f\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 13, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Short Title:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4379f5f7-4ffb-4f71-ab88-93d6bbb18db8\\\", \\\"childbox\\\": \\\"85fc94b1-d306-493b-9790-8599f1717a34\\\", \\\"subtext\\\": \\\"f3184558-b443-4490-9156-48c5bf43e8a5\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 14, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Immunogenicity and safety study of ~REDACTED~ MenABCWY ~REDACTED~ in healthy adolescents and adults previously primed with MenACWY ~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4379f5f7-4ffb-4f71-ab88-93d6bbb18db8\\\", \\\"childbox\\\": \\\"85fc94b1-d306-493b-9790-8599f1717a34\\\", \\\"subtext\\\": \\\"bab4a759-3c0b-4f93-8f83-50ae498feab2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 15, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4379f5f7-4ffb-4f71-ab88-93d6bbb18db8\\\", \\\"childbox\\\": \\\"85fc94b1-d306-493b-9790-8599f1717a34\\\", \\\"subtext\\\": \\\"455090c4-7cce-4d0e-8bdc-adfa34102ff0\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 16, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Study Phase:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dbe4c1f1-300f-419f-8958-32e8296597b9\\\", \\\"childbox\\\": \\\"d5a5afa0-fef9-454f-89bc-d06e71ed093c\\\", \\\"subtext\\\": \\\"d19810ae-830b-4646-9437-63408842bb37\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 17, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"IIIB\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dbe4c1f1-300f-419f-8958-32e8296597b9\\\", \\\"childbox\\\": \\\"d5a5afa0-fef9-454f-89bc-d06e71ed093c\\\", \\\"subtext\\\": \\\"dec01215-9dd9-4bd4-9cae-cb374637dcbb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 18, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dbe4c1f1-300f-419f-8958-32e8296597b9\\\", \\\"childbox\\\": \\\"d5a5afa0-fef9-454f-89bc-d06e71ed093c\\\", \\\"subtext\\\": \\\"4a0986d5-4f09-4256-88f2-5345e4991462\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 19, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Sponsor Name:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1158a197-f4ad-4f92-9de3-93d73a3e99dc\\\", \\\"childbox\\\": \\\"96b9aa07-f8cf-483e-a4fa-d49c1c44b2a7\\\", \\\"subtext\\\": \\\"b9f2f0d7-b758-46f9-96cd-8416869b2c8b\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 20, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1158a197-f4ad-4f92-9de3-93d73a3e99dc\\\", \\\"childbox\\\": \\\"96b9aa07-f8cf-483e-a4fa-d49c1c44b2a7\\\", \\\"subtext\\\": \\\"6e00dece-5da3-4d00-8e01-b9eb83058c83\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 21, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1158a197-f4ad-4f92-9de3-93d73a3e99dc\\\", \\\"childbox\\\": \\\"96b9aa07-f8cf-483e-a4fa-d49c1c44b2a7\\\", \\\"subtext\\\": \\\"64d0fffc-aa02-407c-8bb9-262839cc1bd2\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 22, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Legal Registered Address:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cb2dfdb9-78fa-405f-827d-d49b8d38c8e4\\\", \\\"childbox\\\": \\\"7e7fd15a-29fe-4d38-ab12-67fe68e918d0\\\", \\\"subtext\\\": \\\"418d442a-c090-4cad-8b10-3d5eb6d462c0\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 23, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Rue de l\\\\u2019Institut, 89, ~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cb2dfdb9-78fa-405f-827d-d49b8d38c8e4\\\", \\\"childbox\\\": \\\"7e7fd15a-29fe-4d38-ab12-67fe68e918d0\\\", \\\"subtext\\\": \\\"1920f171-419f-492a-9cb7-632ce0aa60b1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 24, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cb2dfdb9-78fa-405f-827d-d49b8d38c8e4\\\", \\\"childbox\\\": \\\"7e7fd15a-29fe-4d38-ab12-67fe68e918d0\\\", \\\"subtext\\\": \\\"e646b84e-62f7-4496-85e8-4832fd761fe7\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 25, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"IND Number:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb7d8921-e266-4349-b802-656f3b30f508\\\", \\\"childbox\\\": \\\"cee90665-07a2-4005-a22d-c2028d7c87a5\\\", \\\"subtext\\\": \\\"c30bdda8-9887-4e81-8a49-a72f948e6bbc\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 26, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"BB-IND-014605\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb7d8921-e266-4349-b802-656f3b30f508\\\", \\\"childbox\\\": \\\"cee90665-07a2-4005-a22d-c2028d7c87a5\\\", \\\"subtext\\\": \\\"c14dfdb7-5044-4d59-8929-77af83c38a0e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 27, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb7d8921-e266-4349-b802-656f3b30f508\\\", \\\"childbox\\\": \\\"cee90665-07a2-4005-a22d-c2028d7c87a5\\\", \\\"subtext\\\": \\\"cd0ca890-1c27-4a85-a7fa-ad559fb17ca0\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 28, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"EudraCT Number:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb64d204-bced-4ec9-b15c-b877d2502c65\\\", \\\"childbox\\\": \\\"abad5a36-5270-46f3-9e35-340f3f31166b\\\", \\\"subtext\\\": \\\"7306561b-bab2-4d66-88a9-bb09d8bfe480\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 29, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2019-004982-42\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb64d204-bced-4ec9-b15c-b877d2502c65\\\", \\\"childbox\\\": \\\"abad5a36-5270-46f3-9e35-340f3f31166b\\\", \\\"subtext\\\": \\\"7af66bc6-0502-46c1-ad2a-83bde5618948\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 30, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb64d204-bced-4ec9-b15c-b877d2502c65\\\", \\\"childbox\\\": \\\"abad5a36-5270-46f3-9e35-340f3f31166b\\\", \\\"subtext\\\": \\\"bcbd8fa3-3b2d-473c-8dc5-c615025322d8\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 31, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Date of Protocol:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2ce92512-ea0b-491c-95e3-ebf021d58fb0\\\", \\\"childbox\\\": \\\"fa8667a4-a88c-4edf-8bb3-bd9d93ad1701\\\", \\\"subtext\\\": \\\"53a58d8f-c12f-433b-b665-e0c9c8c4dcec\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 32, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"12 February 2021\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2ce92512-ea0b-491c-95e3-ebf021d58fb0\\\", \\\"childbox\\\": \\\"fa8667a4-a88c-4edf-8bb3-bd9d93ad1701\\\", \\\"subtext\\\": \\\"28fa2ff7-75ff-4ca9-9ffc-aabe27ca7503\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 33, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2ce92512-ea0b-491c-95e3-ebf021d58fb0\\\", \\\"childbox\\\": \\\"fa8667a4-a88c-4edf-8bb3-bd9d93ad1701\\\", \\\"subtext\\\": \\\"3e575ca5-969e-4f05-93a3-70f807c78a35\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 34, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"238f49b2-cc21-4dcf-866d-9dc5ce9de9d3\\\", \\\"childbox\\\": \\\"aba907bc-1e26-4430-8e0c-c2beb78476a4\\\", \\\"subtext\\\": \\\"4ab8fdce-4019-471e-8a4a-04827fc48340\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 35, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7411997d-6def-4b85-9b68-70e464b6623a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 36, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"caf8cffe-575b-4e94-a5ff-5bf06cadef77\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"TITLE PAGE\\\", \\\"\\\", \\\"1\\\", 37, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Sponsor Signatory:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c63036ee-21df-4cfb-887d-4c93327125d3\\\", \\\"childbox\\\": \\\"3b91244e-e17a-4eb1-8369-1ef0b89d2e8c\\\", \\\"subtext\\\": \\\"c6ca630e-1be8-48f2-b767-a79ce6f55846\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 38, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b050920b-b655-43ed-94e3-6c4c465f2ddd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 39, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74985775-620c-449f-9228-f4b238cf322e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 40, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"I have read this protocol in its entirety and agree to conduct the study accordingly:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"45eb5059-5f48-4bcd-93ae-08da1ee3ba6a\\\", \\\"childbox\\\": \\\"b50cf01e-d378-4fbd-8467-48270a19f688\\\", \\\"subtext\\\": \\\"bc84b6c2-062a-4791-b808-52d4870cecc4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 41, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6af26ff4-8b89-4ee3-84fc-f982bbb42af0\\\", \\\"childbox\\\": \\\"8de1f404-2bf8-4d70-aad7-4c9e1b6e28a6\\\", \\\"subtext\\\": \\\"d84e625a-d719-464a-bf11-4c99e6e5c837\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 42, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bd178f9d-36c9-41c9-a0a6-e457021984b6\\\", \\\"childbox\\\": \\\"0a5946f0-8f67-44c1-87a1-9a3f029d3bda\\\", \\\"subtext\\\": \\\"ba16a23c-966f-4894-8dbc-9b41a730766c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Lucida Console\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 43, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"da2dc4f7-f470-4167-afe7-8e6dc28273b8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 44, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"57cb013d-5fd1-4ff5-85c6-905bfe9db871\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 45, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"13f6ec04-f061-400b-ab09-0eb63b80f036\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 46, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d79d3812-b962-403b-b693-9a0c96373d5b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 47, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"09465fc4-6ece-4202-aaa8-1c565068eb37\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 48, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f2808adc-f77d-42bb-98e5-87c929d0d79f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 49, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"439c901d-7a27-45a7-86cc-588112b3c035\\\", \\\"childbox\\\": \\\"a87467d9-5c44-4d8a-a729-b2c10ff9a9b1\\\", \\\"subtext\\\": \\\"741472ab-d4b9-4d52-a77e-d332ab8ce539\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 50, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"439c901d-7a27-45a7-86cc-588112b3c035\\\", \\\"childbox\\\": \\\"4cb36f49-f7a2-4dd2-8878-ae55b42c8239\\\", \\\"subtext\\\": \\\"54b9a265-d574-4d1e-ba74-f374520caf88\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 51, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"439c901d-7a27-45a7-86cc-588112b3c035\\\", \\\"childbox\\\": \\\"6ff976c4-3b07-42b4-9cb6-84226c3ebcc7\\\", \\\"subtext\\\": \\\"da7a8db9-73f6-4bdc-ad6e-7fdad0d17ad9\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 52, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Date\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 34, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"439c901d-7a27-45a7-86cc-588112b3c035\\\", \\\"childbox\\\": \\\"4839fa24-34ee-43c9-8de6-3c98b312f171\\\", \\\"subtext\\\": \\\"4e61f354-cf7b-453b-84d4-1eb92a9a9d91\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 34, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"superscript\\\"}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 53, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Clinical and Epidemiology R&D Project Lead\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d243fc73-f63c-4d06-9b39-77a275c9e941\\\", \\\"childbox\\\": \\\"86ad589b-0099-45a7-9df7-930d84ca47a0\\\", \\\"subtext\\\": \\\"70c789c9-cc49-4e70-8b0d-3d1e78faf190\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 54, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2c9e551b-97cc-40a2-8eea-dae4b9579459\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 55, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"33544c85-5261-46cd-8e38-5439290482f7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 56, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5c41cc0a-601c-451c-90c5-b61234a9c319\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 57, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eacdeadd-3895-4eed-9e6e-7534445f3255\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 58, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"32ecb212-e762-4b78-9bcb-ef4e614186d0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 59, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the study reference manual for Medical Monitor name and contact information.\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7fbd56c6-0a5e-41db-9eed-0f9224b28ca0\\\", \\\"childbox\\\": \\\"bc7259fa-d5e2-4ff4-8dd0-931358fc4461\\\", \\\"subtext\\\": \\\"de42bb9d-9ebd-4949-a7df-dd27cc5fa52e\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 60, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b79f66e5-bd57-4772-80a8-386283b0657a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 61, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7a804e72-d2f3-496f-a6df-302abe9b1b21\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Sponsor Signatory:\\\", \\\"\\\", \\\"1\\\", 62, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"PROTOCOL AMENDMENT SUMMARY OF CHANGES\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading1\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"26643d47-0bcc-422c-938e-3db86c673868\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"PROTOCOL AMENDMENT SUMMARY OF CHANGES\\\", \\\"\\\", \\\"1\\\", 63, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Table 1\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"842e4a5a-a07a-448f-873c-a1c7f43b62f4\\\", \\\"childbox\\\": \\\"ce17f9f1-deca-46f7-b4b7-96b945e1abf7\\\", \\\"subtext\\\": \\\"8fd97863-064d-46dc-ab60-cd6386e2f118\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Document History\\\", \\\"Table 1\\\", \\\"1\\\", 64, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"842e4a5a-a07a-448f-873c-a1c7f43b62f4\\\", \\\"childbox\\\": \\\"9e47cd6d-6eb4-436e-919d-abfc2ec38b88\\\", \\\"subtext\\\": \\\"2f409b50-cb03-4d6d-aadd-da94385b2fd7\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Document History\\\", \\\"Table 1\\\", \\\"1\\\", 65, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Document History\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"842e4a5a-a07a-448f-873c-a1c7f43b62f4\\\", \\\"childbox\\\": \\\"41f5975f-4c37-49f2-b1df-f957bec3fc47\\\", \\\"subtext\\\": \\\"2f409b50-cb03-4d6d-aadd-da94385b2fd7\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Document History\\\", \\\"Table 1\\\", \\\"1\\\", 66, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Document</td>\\\\n      <td>Date</td>\\\\n      <td>Substantial</td>\\\\n      <td>Region</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Amendment 2</td>\\\\n      <td>12 Feb 2021</td>\\\\n      <td>Yes</td>\\\\n      <td>Global</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Amendment 1</td>\\\\n      <td>31 Aug 2020</td>\\\\n      <td>No</td>\\\\n      <td>Global</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Original Protocol</td>\\\\n      <td>04 Jun 2020</td>\\\\n      <td>-</td>\\\\n      <td>-</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"2\\\", \\\"TableIndex\\\": \\\"1\\\", \\\"TableName\\\": \\\"Table 1 Document History\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"c4e5450a-a91a-4e6a-b1e4-feadd27387cb\\\", \\\"childbox\\\": \\\"7d19407d-a084-44aa-a11f-0a0f162408fe\\\", \\\"subtext\\\": \\\"24644f9e-1fd3-4246-b54a-46be571a9693\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Document History\\\", \\\"Table 1\\\", \\\"1\\\", 67, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"66ede389-4e74-4290-ab0a-fe71de38f3c4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Document History\\\", \\\"Table 1\\\", \\\"1\\\", 68, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Amendment 2 \\\\u2013 12 February 2021\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9af2f0a3-bc52-4a6c-bbb7-d63193e40b5b\\\", \\\"childbox\\\": \\\"2a6b8441-607b-45f2-802e-6e372a8915c9\\\", \\\"subtext\\\": \\\"722ecb87-ea98-4d43-a41e-a1b2382f6ffb\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Document History\\\", \\\"Table 1\\\", \\\"1\\\", 69, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This amendment is considered substantial based on the criteria set forth in Article 10(a) of Directive 2001/20/EC of the European Parliament and the Council of the ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"06b8f190-e325-4099-b796-e37e08e2a944\\\", \\\"childbox\\\": \\\"d413f17d-3977-475c-92b9-8f558f676cca\\\", \\\"subtext\\\": \\\"71b7a934-f381-46f9-a224-a3a1d30a5ba0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Document History\\\", \\\"Table 1\\\", \\\"1\\\", 70, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Overall Rationale for Amendment 2:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aed59fd0-b554-4fef-b647-af5ac8faf60a\\\", \\\"childbox\\\": \\\"ac3a482f-222e-48d7-9ff7-d18621867845\\\", \\\"subtext\\\": \\\"54613de1-d3fc-48b0-acc0-dfe8be90b776\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Document History\\\", \\\"Table 1\\\", \\\"1\\\", 71, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aed59fd0-b554-4fef-b647-af5ac8faf60a\\\", \\\"childbox\\\": \\\"ac3a482f-222e-48d7-9ff7-d18621867845\\\", \\\"subtext\\\": \\\"72850d5e-014e-438a-9f50-1eefb2c7d551\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Document History\\\", \\\"Table 1\\\", \\\"1\\\", 72, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The primary goal of this amendment is to promote one of the secondary endpoints to co-primary, which will allow to evaluate ~REDACTED~ immunogenicity at 1 month after both the first and the second MenABCWY vaccinations (0,6-months).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"64f2ade1-58db-4afb-ad97-aacd970ee7f2\\\", \\\"childbox\\\": \\\"12279efc-be83-4d8a-9a51-a9847eeaebb5\\\", \\\"subtext\\\": \\\"fbfa3024-44cb-4578-b30f-9834c3057c80\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Document History\\\", \\\"Table 1\\\", \\\"1\\\", 73, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Also, considering that some of the study interventions are combination products constituted of a device and biologic product (pre-filled syringes), the amended protocol provides instructions for collection of safety information related to the use of medical devices.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"64f2ade1-58db-4afb-ad97-aacd970ee7f2\\\", \\\"childbox\\\": \\\"4f54bf37-9d94-487f-b8a9-06b408b39a38\\\", \\\"subtext\\\": \\\"a15f2fc3-db3b-46b3-9ea9-87de19248b3f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Document History\\\", \\\"Table 1\\\", \\\"1\\\", 74, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1689611b-2abc-414d-879a-842395fefe04\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Document History\\\", \\\"Table 1\\\", \\\"1\\\", 75, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d534a560-7d7f-4417-a3c6-a50840dac805\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Document History\\\", \\\"Table 1\\\", \\\"1\\\", 76, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a205ebff-26ad-47c0-8745-c1e5777e1cb5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Document History\\\", \\\"Table 1\\\", \\\"1\\\", 77, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Table 2\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"59ce353b-0b70-4bcd-9fc6-b0c1fc3828b1\\\", \\\"childbox\\\": \\\"f7a8e179-a0fc-465e-ac71-64521cd7f282\\\", \\\"subtext\\\": \\\"c2c8dc2f-64b4-4f39-93b0-196e64af7883\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 78, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"59ce353b-0b70-4bcd-9fc6-b0c1fc3828b1\\\", \\\"childbox\\\": \\\"eaac353e-c605-4acc-9c37-b8330d442124\\\", \\\"subtext\\\": \\\"9c06dc9b-5ad8-4ba3-8b2c-82c24f6f1648\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 79, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Description of Changes in Amendment 2\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"59ce353b-0b70-4bcd-9fc6-b0c1fc3828b1\\\", \\\"childbox\\\": \\\"3a92d764-3128-46a9-bbdd-e4b41504751e\\\", \\\"subtext\\\": \\\"9c06dc9b-5ad8-4ba3-8b2c-82c24f6f1648\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 80, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c7f8386d-7d9f-4f2b-af5f-3cb9453be7cd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 81, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n      <th>5.0</th>\\\\n      <th>6.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Section # and Name</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Brief Rationale</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Substantial Changes</td>\\\\n      <td>Substantial Changes</td>\\\\n      <td>Substantial Changes</td>\\\\n      <td>Substantial Changes</td>\\\\n      <td>Substantial Changes</td>\\\\n      <td>Substantial Changes</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>1.1  Synopsis</td>\\\\n      <td>The following secondary endpoint was promoted to co-primary and labeled \\\\u201cFamily 1\\\\u201d: Objectives Endpoints Immunological non-inferiority: MenABCWY vs. MenACWY (Family 1): To demonstrate the immunological non-inferiority of the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with a MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, as measured by the percentages of participants achieving a 4-fold rise in hSBA titers against N. meningitidis serogroups A, C, W, and Y, at 1 month after the second MenABCWY vaccination (0,6-months) and 1 month after the MenACWY vaccination (single dose).  The percentages of participants with a 4-fold rise in hSBA titers against N. meningitidis serogroups A, C, W, and Y at 1 month after the second vaccination for the ABCWY group (Day 211, Month 7), and 1 month after the single MenACWY vaccination for the ACWY group (Day 31, Month 1) relative to baseline (Day 1, Month 0).  The original primary endpoint was changed to co-primary and was labeled \\\\u201cFamily 2\\\\u201d: Objectives   Endpoints</td>\\\\n      <td>The following secondary endpoint was promoted to co-primary and labeled \\\\u201cFamily 1\\\\u201d: Objectives Endpoints Immunological non-inferiority: MenABCWY vs. MenACWY (Family 1): To demonstrate the immunological non-inferiority of the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with a MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, as measured by the percentages of participants achieving a 4-fold rise in hSBA titers against N. meningitidis serogroups A, C, W, and Y, at 1 month after the second MenABCWY vaccination (0,6-months) and 1 month after the MenACWY vaccination (single dose).  The percentages of participants with a 4-fold rise in hSBA titers against N. meningitidis serogroups A, C, W, and Y at 1 month after the second vaccination for the ABCWY group (Day 211, Month 7), and 1 month after the single MenACWY vaccination for the ACWY group (Day 31, Month 1) relative to baseline (Day 1, Month 0).  The original primary endpoint was changed to co-primary and was labeled \\\\u201cFamily 2\\\\u201d: Objectives   Endpoints</td>\\\\n      <td>The following secondary endpoint was promoted to co-primary and labeled \\\\u201cFamily 1\\\\u201d: Objectives Endpoints Immunological non-inferiority: MenABCWY vs. MenACWY (Family 1): To demonstrate the immunological non-inferiority of the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with a MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, as measured by the percentages of participants achieving a 4-fold rise in hSBA titers against N. meningitidis serogroups A, C, W, and Y, at 1 month after the second MenABCWY vaccination (0,6-months) and 1 month after the MenACWY vaccination (single dose).  The percentages of participants with a 4-fold rise in hSBA titers against N. meningitidis serogroups A, C, W, and Y at 1 month after the second vaccination for the ABCWY group (Day 211, Month 7), and 1 month after the single MenACWY vaccination for the ACWY group (Day 31, Month 1) relative to baseline (Day 1, Month 0).  The original primary endpoint was changed to co-primary and was labeled \\\\u201cFamily 2\\\\u201d: Objectives   Endpoints</td>\\\\n      <td>The following secondary endpoint was promoted to co-primary and labeled \\\\u201cFamily 1\\\\u201d: Objectives Endpoints Immunological non-inferiority: MenABCWY vs. MenACWY (Family 1): To demonstrate the immunological non-inferiority of the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with a MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, as measured by the percentages of participants achieving a 4-fold rise in hSBA titers against N. meningitidis serogroups A, C, W, and Y, at 1 month after the second MenABCWY vaccination (0,6-months) and 1 month after the MenACWY vaccination (single dose).  The percentages of participants with a 4-fold rise in hSBA titers against N. meningitidis serogroups A, C, W, and Y at 1 month after the second vaccination for the ABCWY group (Day 211, Month 7), and 1 month after the single MenACWY vaccination for the ACWY group (Day 31, Month 1) relative to baseline (Day 1, Month 0).  The original primary endpoint was changed to co-primary and was labeled \\\\u201cFamily 2\\\\u201d: Objectives   Endpoints</td>\\\\n      <td>To promote one of the secondary endpoints to coprimary, which will allow to evaluate <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> immunogenicity at 1 month after both the first and the second MenABCWY vaccinations (0, 6-months)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>Immunological non-inferiority: MenABCWY vs. MenACWY  (Family 2)  To demonstrate the immunological non-inferiority of the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with a MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, as measured by the percentages of participants achieving a 4-fold rise in hSBA titers against N. meningitidis serogroups A, C, W, and Y, at 1 month after the first MenABCWY vaccination (0,6-months) and 1 month after the MenACWY vaccination (single dose).</td>\\\\n      <td>The percentages of participants with a 4-fold rise in hSBA titers against N. meningitidis serogroups A, C, W, and Y at 1 month after the first vaccination for the ABCWY group (Day 31, Month 1), and 1 month after the single dose of MenACWY vaccination for the ACWY group (Day 31, Month 1), relative to baseline (Day 1, Month 0).</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>1.3 Schedule of Activities</td>\\\\n      <td>In the footnote for Table 3 (formerly Table 1 in the original protocol) \\\\u201cSchedule of Activities\\\\u201d, the following footnotes were added:</td>\\\\n      <td>In the footnote for Table 3 (formerly Table 1 in the original protocol) \\\\u201cSchedule of Activities\\\\u201d, the following footnotes were added:</td>\\\\n      <td>In the footnote for Table 3 (formerly Table 1 in the original protocol) \\\\u201cSchedule of Activities\\\\u201d, the following footnotes were added:</td>\\\\n      <td>In the footnote for Table 3 (formerly Table 1 in the original protocol) \\\\u201cSchedule of Activities\\\\u201d, the following footnotes were added:</td>\\\\n      <td>To allow additional</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"3\\\", \\\"TableIndex\\\": \\\"2\\\", \\\"TableName\\\": \\\"Table 2 Description of Changes in Amendment 2\\\", \\\"Header\\\": [0, 1, 2]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"51cbb7d1-85f7-48c8-966f-da1133f647ab\\\", \\\"childbox\\\": \\\"1d2ab399-3caa-4c72-9841-cd21af2fbaca\\\", \\\"subtext\\\": \\\"6007ef63-e76f-48b1-9b07-fb93732c2cc7\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 82, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n      <th>5.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Objectives</td>\\\\n      <td>Endpoints</td>\\\\n      <td>Endpoints</td>\\\\n      <td>Endpoints</td>\\\\n      <td>Endpoints</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td></td>\\\\n      <td>The percentages of participants with a 4-fold rise in hSBA titers against N. meningitidis serogroups A, C, W, and Y at 1 month after the second vaccination for the ABCWY group (Day 211, Month 7), and 1 month after the single MenACWY vaccination for the ACWY group (Day 31, Month 1) relative to baseline (Day 1, Month 0).</td>\\\\n      <td>Immunological non-inferiority: MenABCWY vs. MenACWY (Family 1): To demonstrate the immunological non-inferiority of the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with a MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, as measured by the percentages of participants achieving a 4-fold rise in hSBA titers against N. meningitidis serogroups A, C, W, and Y, at 1 month after the second MenABCWY vaccination (0,6-months) and 1 month after the MenACWY vaccination (single dose).</td>\\\\n      <td>Immunological non-inferiority: MenABCWY vs. MenACWY (Family 1): To demonstrate the immunological non-inferiority of the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with a MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, as measured by the percentages of participants achieving a 4-fold rise in hSBA titers against N. meningitidis serogroups A, C, W, and Y, at 1 month after the second MenABCWY vaccination (0,6-months) and 1 month after the MenACWY vaccination (single dose).</td>\\\\n      <td>Immunological non-inferiority: MenABCWY vs. MenACWY (Family 1): To demonstrate the immunological non-inferiority of the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with a MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, as measured by the percentages of participants achieving a 4-fold rise in hSBA titers against N. meningitidis serogroups A, C, W, and Y, at 1 month after the second MenABCWY vaccination (0,6-months) and 1 month after the MenACWY vaccination (single dose).</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"3\\\", \\\"TableIndex\\\": \\\"3\\\", \\\"TableName\\\": \\\"Table 2 Description of Changes in Amendment 2\\\", \\\"Header\\\": [0, 1]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"45734e60-86e6-4250-98ea-da3fbd7a760a\\\", \\\"childbox\\\": \\\"2e13cde0-f1ad-4c3c-a363-9e740589b342\\\", \\\"subtext\\\": \\\"fab8a6c1-6771-47ce-9e18-7fdefe722493\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 83, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ec58e828-5da6-4ffa-b0fe-5147911223ed\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 84, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"401b50fb-e635-4ffe-a2f4-3740defd3ac6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 85, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f809e204-c702-4c64-b422-46f7e27d7b6c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 86, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b8d11edc-dfd0-4dc7-ba1a-dedf77c397aa\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 87, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ffc4191c-9e15-4291-9459-6155e59335e0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 88, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"269e4bad-10ba-418e-90e1-9a2174fef9c4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 89, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fed1a201-74f9-4e74-b620-c48a616e6450\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 90, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n      <th>5.0</th>\\\\n      <th>6.0</th>\\\\n      <th>7.0</th>\\\\n      <th>8.0</th>\\\\n      <th>9.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Section # and Name</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Brief Rationale</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td></td>\\\\n      <td><sup>1</sup>   Home visits are always allowed if deemed suitable and are conducted according to local regulations.</td>\\\\n      <td><sup>1</sup>   Home visits are always allowed if deemed suitable and are conducted according to local regulations.</td>\\\\n      <td><sup>1</sup>   Home visits are always allowed if deemed suitable and are conducted according to local regulations.</td>\\\\n      <td><sup>1</sup>   Home visits are always allowed if deemed suitable and are conducted according to local regulations.</td>\\\\n      <td><sup>1</sup>   Home visits are always allowed if deemed suitable and are conducted according to local regulations.</td>\\\\n      <td><sup>1</sup>   Home visits are always allowed if deemed suitable and are conducted according to local regulations.</td>\\\\n      <td><sup>1</sup>   Home visits are always allowed if deemed suitable and are conducted according to local regulations.</td>\\\\n      <td>flexibility to perform study visits.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td></td>\\\\n      <td><sup>9</sup> <sup></sup> Frequency or urine pregnancy tests can be established at the site according to local regulations. Numbering of the footnotes shifted accordingly. The cross-reference to the footnote 1 was added to the row \\\\u201cDays post-vaccination\\\\u201d The cross-reference to the footnote 9 was added to the row \\\\u201cUrine pregnancy test for females of childbearing potential\\\\u201d</td>\\\\n      <td><sup>9</sup> <sup></sup> Frequency or urine pregnancy tests can be established at the site according to local regulations. Numbering of the footnotes shifted accordingly. The cross-reference to the footnote 1 was added to the row \\\\u201cDays post-vaccination\\\\u201d The cross-reference to the footnote 9 was added to the row \\\\u201cUrine pregnancy test for females of childbearing potential\\\\u201d</td>\\\\n      <td><sup>9</sup> <sup></sup> Frequency or urine pregnancy tests can be established at the site according to local regulations. Numbering of the footnotes shifted accordingly. The cross-reference to the footnote 1 was added to the row \\\\u201cDays post-vaccination\\\\u201d The cross-reference to the footnote 9 was added to the row \\\\u201cUrine pregnancy test for females of childbearing potential\\\\u201d</td>\\\\n      <td><sup>9</sup> <sup></sup> Frequency or urine pregnancy tests can be established at the site according to local regulations. Numbering of the footnotes shifted accordingly. The cross-reference to the footnote 1 was added to the row \\\\u201cDays post-vaccination\\\\u201d The cross-reference to the footnote 9 was added to the row \\\\u201cUrine pregnancy test for females of childbearing potential\\\\u201d</td>\\\\n      <td><sup>9</sup> <sup></sup> Frequency or urine pregnancy tests can be established at the site according to local regulations. Numbering of the footnotes shifted accordingly. The cross-reference to the footnote 1 was added to the row \\\\u201cDays post-vaccination\\\\u201d The cross-reference to the footnote 9 was added to the row \\\\u201cUrine pregnancy test for females of childbearing potential\\\\u201d</td>\\\\n      <td><sup>9</sup> <sup></sup> Frequency or urine pregnancy tests can be established at the site according to local regulations. Numbering of the footnotes shifted accordingly. The cross-reference to the footnote 1 was added to the row \\\\u201cDays post-vaccination\\\\u201d The cross-reference to the footnote 9 was added to the row \\\\u201cUrine pregnancy test for females of childbearing potential\\\\u201d</td>\\\\n      <td><sup>9</sup> <sup></sup> Frequency or urine pregnancy tests can be established at the site according to local regulations. Numbering of the footnotes shifted accordingly. The cross-reference to the footnote 1 was added to the row \\\\u201cDays post-vaccination\\\\u201d The cross-reference to the footnote 9 was added to the row \\\\u201cUrine pregnancy test for females of childbearing potential\\\\u201d</td>\\\\n      <td>To reflect local requirements on pregnancy testing.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>3.0 OBJECTIVES AND ENDPOINTS</td>\\\\n      <td>Table 6 \\\\u201cStudy Objectives and Endpoints\\\\u201d was revised to reflect the changes made in the same table in Synopsis.</td>\\\\n      <td>Table 6 \\\\u201cStudy Objectives and Endpoints\\\\u201d was revised to reflect the changes made in the same table in Synopsis.</td>\\\\n      <td>Table 6 \\\\u201cStudy Objectives and Endpoints\\\\u201d was revised to reflect the changes made in the same table in Synopsis.</td>\\\\n      <td>Table 6 \\\\u201cStudy Objectives and Endpoints\\\\u201d was revised to reflect the changes made in the same table in Synopsis.</td>\\\\n      <td>Table 6 \\\\u201cStudy Objectives and Endpoints\\\\u201d was revised to reflect the changes made in the same table in Synopsis.</td>\\\\n      <td>Table 6 \\\\u201cStudy Objectives and Endpoints\\\\u201d was revised to reflect the changes made in the same table in Synopsis.</td>\\\\n      <td>Table 6 \\\\u201cStudy Objectives and Endpoints\\\\u201d was revised to reflect the changes made in the same table in Synopsis.</td>\\\\n      <td>For consistency.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>5.1 Inclusion Criteria</td>\\\\n      <td>The following text was revised as follows ( the new text is bold ): 4. Previous vaccination with 1 dose of MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> at an age of 10 years or older, with an interval of at least 4 years and not more than 6 years (intended as up to 6 years and 364 days) between the previous MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and enrollment (informed consent and assent [as applicable]) into this study.</td>\\\\n      <td>The following text was revised as follows ( the new text is bold ): 4. Previous vaccination with 1 dose of MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> at an age of 10 years or older, with an interval of at least 4 years and not more than 6 years (intended as up to 6 years and 364 days) between the previous MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and enrollment (informed consent and assent [as applicable]) into this study.</td>\\\\n      <td>The following text was revised as follows ( the new text is bold ): 4. Previous vaccination with 1 dose of MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> at an age of 10 years or older, with an interval of at least 4 years and not more than 6 years (intended as up to 6 years and 364 days) between the previous MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and enrollment (informed consent and assent [as applicable]) into this study.</td>\\\\n      <td>The following text was revised as follows ( the new text is bold ): 4. Previous vaccination with 1 dose of MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> at an age of 10 years or older, with an interval of at least 4 years and not more than 6 years (intended as up to 6 years and 364 days) between the previous MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and enrollment (informed consent and assent [as applicable]) into this study.</td>\\\\n      <td>The following text was revised as follows ( the new text is bold ): 4. Previous vaccination with 1 dose of MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> at an age of 10 years or older, with an interval of at least 4 years and not more than 6 years (intended as up to 6 years and 364 days) between the previous MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and enrollment (informed consent and assent [as applicable]) into this study.</td>\\\\n      <td>The following text was revised as follows ( the new text is bold ): 4. Previous vaccination with 1 dose of MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> at an age of 10 years or older, with an interval of at least 4 years and not more than 6 years (intended as up to 6 years and 364 days) between the previous MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and enrollment (informed consent and assent [as applicable]) into this study.</td>\\\\n      <td>The following text was revised as follows ( the new text is bold ): 4. Previous vaccination with 1 dose of MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> at an age of 10 years or older, with an interval of at least 4 years and not more than 6 years (intended as up to 6 years and 364 days) between the previous MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and enrollment (informed consent and assent [as applicable]) into this study.</td>\\\\n      <td>For clarity.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td></td>\\\\n      <td>The following sentence was added: Frequency or urine pregnancy tests can be established at the site according to local regulations.</td>\\\\n      <td>The following sentence was added: Frequency or urine pregnancy tests can be established at the site according to local regulations.</td>\\\\n      <td>The following sentence was added: Frequency or urine pregnancy tests can be established at the site according to local regulations.</td>\\\\n      <td>The following sentence was added: Frequency or urine pregnancy tests can be established at the site according to local regulations.</td>\\\\n      <td>The following sentence was added: Frequency or urine pregnancy tests can be established at the site according to local regulations.</td>\\\\n      <td>The following sentence was added: Frequency or urine pregnancy tests can be established at the site according to local regulations.</td>\\\\n      <td>The following sentence was added: Frequency or urine pregnancy tests can be established at the site according to local regulations.</td>\\\\n      <td>To incorporate local requirement on pregnancy testing.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td>5.2.1 Medical Conditions 5.2.2 Prior/Concomitant Therapy</td>\\\\n      <td>The exclusion criteria #7 and #14 were revised as follows (the new text is bold; the deleted text is crossed out) : <strike>For corticosteroids (oral/intravenous/intramuscular), with mean prednisone \\\\u226520 mg/day (for adult participants),</strike>  <strike>or \\\\u22650.5 mg/kg/day, or \\\\u226520 mg/day whichever is the maximum dose for pediatric participants, or equivalent.</strike>  For corticosteroids, this will mean prednisone equivalent \\\\u226520 mg/day for adult participants and \\\\u22650.5 mg/kg/day with maximum \\\\u226520 mg/day for pediatric participants.</td>\\\\n      <td>The exclusion criteria #7 and #14 were revised as follows (the new text is bold; the deleted text is crossed out) : <strike>For corticosteroids (oral/intravenous/intramuscular), with mean prednisone \\\\u226520 mg/day (for adult participants),</strike>  <strike>or \\\\u22650.5 mg/kg/day, or \\\\u226520 mg/day whichever is the maximum dose for pediatric participants, or equivalent.</strike>  For corticosteroids, this will mean prednisone equivalent \\\\u226520 mg/day for adult participants and \\\\u22650.5 mg/kg/day with maximum \\\\u226520 mg/day for pediatric participants.</td>\\\\n      <td>The exclusion criteria #7 and #14 were revised as follows (the new text is bold; the deleted text is crossed out) : <strike>For corticosteroids (oral/intravenous/intramuscular), with mean prednisone \\\\u226520 mg/day (for adult participants),</strike>  <strike>or \\\\u22650.5 mg/kg/day, or \\\\u226520 mg/day whichever is the maximum dose for pediatric participants, or equivalent.</strike>  For corticosteroids, this will mean prednisone equivalent \\\\u226520 mg/day for adult participants and \\\\u22650.5 mg/kg/day with maximum \\\\u226520 mg/day for pediatric participants.</td>\\\\n      <td>The exclusion criteria #7 and #14 were revised as follows (the new text is bold; the deleted text is crossed out) : <strike>For corticosteroids (oral/intravenous/intramuscular), with mean prednisone \\\\u226520 mg/day (for adult participants),</strike>  <strike>or \\\\u22650.5 mg/kg/day, or \\\\u226520 mg/day whichever is the maximum dose for pediatric participants, or equivalent.</strike>  For corticosteroids, this will mean prednisone equivalent \\\\u226520 mg/day for adult participants and \\\\u22650.5 mg/kg/day with maximum \\\\u226520 mg/day for pediatric participants.</td>\\\\n      <td>The exclusion criteria #7 and #14 were revised as follows (the new text is bold; the deleted text is crossed out) : <strike>For corticosteroids (oral/intravenous/intramuscular), with mean prednisone \\\\u226520 mg/day (for adult participants),</strike>  <strike>or \\\\u22650.5 mg/kg/day, or \\\\u226520 mg/day whichever is the maximum dose for pediatric participants, or equivalent.</strike>  For corticosteroids, this will mean prednisone equivalent \\\\u226520 mg/day for adult participants and \\\\u22650.5 mg/kg/day with maximum \\\\u226520 mg/day for pediatric participants.</td>\\\\n      <td>The exclusion criteria #7 and #14 were revised as follows (the new text is bold; the deleted text is crossed out) : <strike>For corticosteroids (oral/intravenous/intramuscular), with mean prednisone \\\\u226520 mg/day (for adult participants),</strike>  <strike>or \\\\u22650.5 mg/kg/day, or \\\\u226520 mg/day whichever is the maximum dose for pediatric participants, or equivalent.</strike>  For corticosteroids, this will mean prednisone equivalent \\\\u226520 mg/day for adult participants and \\\\u22650.5 mg/kg/day with maximum \\\\u226520 mg/day for pediatric participants.</td>\\\\n      <td>The exclusion criteria #7 and #14 were revised as follows (the new text is bold; the deleted text is crossed out) : <strike>For corticosteroids (oral/intravenous/intramuscular), with mean prednisone \\\\u226520 mg/day (for adult participants),</strike>  <strike>or \\\\u22650.5 mg/kg/day, or \\\\u226520 mg/day whichever is the maximum dose for pediatric participants, or equivalent.</strike>  For corticosteroids, this will mean prednisone equivalent \\\\u226520 mg/day for adult participants and \\\\u22650.5 mg/kg/day with maximum \\\\u226520 mg/day for pediatric participants.</td>\\\\n      <td>For clarity.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>7</th>\\\\n      <td>6.1 Study Interventions Administered</td>\\\\n      <td>In Table 8 (formerly Table 6) \\\\u201cStudy Interventions Administered\\\\u201d, the following rows (shown in bold) were added:</td>\\\\n      <td>In Table 8 (formerly Table 6) \\\\u201cStudy Interventions Administered\\\\u201d, the following rows (shown in bold) were added:</td>\\\\n      <td>In Table 8 (formerly Table 6) \\\\u201cStudy Interventions Administered\\\\u201d, the following rows (shown in bold) were added:</td>\\\\n      <td>In Table 8 (formerly Table 6) \\\\u201cStudy Interventions Administered\\\\u201d, the following rows (shown in bold) were added:</td>\\\\n      <td>In Table 8 (formerly Table 6) \\\\u201cStudy Interventions Administered\\\\u201d, the following rows (shown in bold) were added:</td>\\\\n      <td>In Table 8 (formerly Table 6) \\\\u201cStudy Interventions Administered\\\\u201d, the following rows (shown in bold) were added:</td>\\\\n      <td>In Table 8 (formerly Table 6) \\\\u201cStudy Interventions Administered\\\\u201d, the following rows (shown in bold) were added:</td>\\\\n      <td>The new row with \\\\u201cProduct type\\\\u201d was added to identify combination products.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>8</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>Study Intervention Name</td>\\\\n      <td>MenABCWY</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n      <td>Bexsero</td>\\\\n      <td>Placebo</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>9</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>Product type</td>\\\\n      <td>Combination</td>\\\\n      <td>Biological</td>\\\\n      <td>Combination</td>\\\\n      <td>Combination</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"3\\\", \\\"TableIndex\\\": \\\"4\\\", \\\"TableName\\\": \\\"Table 2 Description of Changes in Amendment 2\\\", \\\"Header\\\": [0, 3]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"d27efb6c-544b-4be9-819d-69a1dfa6b20b\\\", \\\"childbox\\\": \\\"e586c2fd-1ea1-4700-9247-324b1d5e2ee6\\\", \\\"subtext\\\": \\\"25ec6e99-36a2-4036-8982-cda1690aee69\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 91, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"99c1d64b-f99b-46d6-a9f1-ddbd86e84bfb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 92, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b92200ad-4cbd-462d-9dff-eb06d982306e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 93, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b3f7d793-0871-4880-aa98-cff70c63043b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 94, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a2edd06f-50e4-439c-bb70-2ef07f772ae0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 95, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0e4416f5-0bf7-47e9-abe7-550ee8aec595\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 96, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fc6c9101-6a1c-437f-bfa6-cf309b7347cb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 97, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e15fdda5-dbee-4449-b605-33f2c0184e2e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 98, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d48789a0-2328-4ff5-8e7b-52478924d222\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 99, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"848f3562-6a0c-44dd-b26d-241f1428434e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 100, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5c1d5e54-432d-4b68-8375-910443cc5d11\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 101, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1a3df690-03df-46ca-8cc2-860712b7073f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 102, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5e3c63bd-4817-46c8-84b0-f82ddaea8a59\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 103, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"32293df5-fca0-4924-adc7-2a170784b8e2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 104, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d41cf8e4-66b8-4191-ba97-e0d8683f4716\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 105, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n      <th>5.0</th>\\\\n      <th>6.0</th>\\\\n      <th>7.0</th>\\\\n      <th>8.0</th>\\\\n      <th>9.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Section # and Name</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Brief Rationale</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>Type</td>\\\\n      <td>Study</td>\\\\n      <td>Control</td>\\\\n      <td>Additional</td>\\\\n      <td>Additional</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>6.3.5.1  Blinding</td>\\\\n      <td>The following text was revised as follows (the new text is bold; the deleted text is crossed out) : <strike>The laboratory in charge of the sample testing will be blinded to the intervention assignment.</strike> <strike>Codes will be used</strike>  <strike>to link the participant and study (without any link to the intervention attributed to the participant) to each</strike>  <strike>sample.</strike>  The laboratory in charge of the laboratory testing will be blinded to the treatment, subject and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> number, and codes will be used to link the subject, <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and study (without any link to the treatment attributed to the subject) to each sample.</td>\\\\n      <td>The following text was revised as follows (the new text is bold; the deleted text is crossed out) : <strike>The laboratory in charge of the sample testing will be blinded to the intervention assignment.</strike> <strike>Codes will be used</strike>  <strike>to link the participant and study (without any link to the intervention attributed to the participant) to each</strike>  <strike>sample.</strike>  The laboratory in charge of the laboratory testing will be blinded to the treatment, subject and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> number, and codes will be used to link the subject, <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and study (without any link to the treatment attributed to the subject) to each sample.</td>\\\\n      <td>The following text was revised as follows (the new text is bold; the deleted text is crossed out) : <strike>The laboratory in charge of the sample testing will be blinded to the intervention assignment.</strike> <strike>Codes will be used</strike>  <strike>to link the participant and study (without any link to the intervention attributed to the participant) to each</strike>  <strike>sample.</strike>  The laboratory in charge of the laboratory testing will be blinded to the treatment, subject and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> number, and codes will be used to link the subject, <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and study (without any link to the treatment attributed to the subject) to each sample.</td>\\\\n      <td>The following text was revised as follows (the new text is bold; the deleted text is crossed out) : <strike>The laboratory in charge of the sample testing will be blinded to the intervention assignment.</strike> <strike>Codes will be used</strike>  <strike>to link the participant and study (without any link to the intervention attributed to the participant) to each</strike>  <strike>sample.</strike>  The laboratory in charge of the laboratory testing will be blinded to the treatment, subject and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> number, and codes will be used to link the subject, <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and study (without any link to the treatment attributed to the subject) to each sample.</td>\\\\n      <td>The following text was revised as follows (the new text is bold; the deleted text is crossed out) : <strike>The laboratory in charge of the sample testing will be blinded to the intervention assignment.</strike> <strike>Codes will be used</strike>  <strike>to link the participant and study (without any link to the intervention attributed to the participant) to each</strike>  <strike>sample.</strike>  The laboratory in charge of the laboratory testing will be blinded to the treatment, subject and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> number, and codes will be used to link the subject, <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and study (without any link to the treatment attributed to the subject) to each sample.</td>\\\\n      <td>The following text was revised as follows (the new text is bold; the deleted text is crossed out) : <strike>The laboratory in charge of the sample testing will be blinded to the intervention assignment.</strike> <strike>Codes will be used</strike>  <strike>to link the participant and study (without any link to the intervention attributed to the participant) to each</strike>  <strike>sample.</strike>  The laboratory in charge of the laboratory testing will be blinded to the treatment, subject and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> number, and codes will be used to link the subject, <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and study (without any link to the treatment attributed to the subject) to each sample.</td>\\\\n      <td>The following text was revised as follows (the new text is bold; the deleted text is crossed out) : <strike>The laboratory in charge of the sample testing will be blinded to the intervention assignment.</strike> <strike>Codes will be used</strike>  <strike>to link the participant and study (without any link to the intervention attributed to the participant) to each</strike>  <strike>sample.</strike>  The laboratory in charge of the laboratory testing will be blinded to the treatment, subject and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> number, and codes will be used to link the subject, <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and study (without any link to the treatment attributed to the subject) to each sample.</td>\\\\n      <td>For clarity.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>6.7 Criteria for Temporary Delay for Enrollment and/or Vaccination and/or Blood Sampling</td>\\\\n      <td>The following text was revised as follows (the new text is bold) : Under such circumstances, a participant may be considered eligible for study enrollment and/or vaccination after the appropriate window for delay described above, or as defined by local health authorities has passed and inclusion/exclusion criteria have been re-checked, and if the participant is confirmed to be eligible.</td>\\\\n      <td>The following text was revised as follows (the new text is bold) : Under such circumstances, a participant may be considered eligible for study enrollment and/or vaccination after the appropriate window for delay described above, or as defined by local health authorities has passed and inclusion/exclusion criteria have been re-checked, and if the participant is confirmed to be eligible.</td>\\\\n      <td>The following text was revised as follows (the new text is bold) : Under such circumstances, a participant may be considered eligible for study enrollment and/or vaccination after the appropriate window for delay described above, or as defined by local health authorities has passed and inclusion/exclusion criteria have been re-checked, and if the participant is confirmed to be eligible.</td>\\\\n      <td>The following text was revised as follows (the new text is bold) : Under such circumstances, a participant may be considered eligible for study enrollment and/or vaccination after the appropriate window for delay described above, or as defined by local health authorities has passed and inclusion/exclusion criteria have been re-checked, and if the participant is confirmed to be eligible.</td>\\\\n      <td>The following text was revised as follows (the new text is bold) : Under such circumstances, a participant may be considered eligible for study enrollment and/or vaccination after the appropriate window for delay described above, or as defined by local health authorities has passed and inclusion/exclusion criteria have been re-checked, and if the participant is confirmed to be eligible.</td>\\\\n      <td>The following text was revised as follows (the new text is bold) : Under such circumstances, a participant may be considered eligible for study enrollment and/or vaccination after the appropriate window for delay described above, or as defined by local health authorities has passed and inclusion/exclusion criteria have been re-checked, and if the participant is confirmed to be eligible.</td>\\\\n      <td>The following text was revised as follows (the new text is bold) : Under such circumstances, a participant may be considered eligible for study enrollment and/or vaccination after the appropriate window for delay described above, or as defined by local health authorities has passed and inclusion/exclusion criteria have been re-checked, and if the participant is confirmed to be eligible.</td>\\\\n      <td>For clarity.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>8.1.2 Laboratory Assays</td>\\\\n      <td>In the footnote for Table 10 (formerly Table 8) \\\\u201cLaboratory Assays\\\\u201d, the text was revised as follows (the added text is bold; the deleted text is crossed out) : <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Biologicals laboratory refers to the <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Sciences (CLS) in Rixensart <strike>Belgium;</strike> or <strike></strike> Wavre, Belgium <strike>or Marburg, Germany</strike> . CLS may delegate testing to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Research laboratories in Siena, Italy, or to Nexelis in Marburg, Germany, or to <strike>an</strike> other external laborator <strike>y</strike> ies .</td>\\\\n      <td>In the footnote for Table 10 (formerly Table 8) \\\\u201cLaboratory Assays\\\\u201d, the text was revised as follows (the added text is bold; the deleted text is crossed out) : <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Biologicals laboratory refers to the <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Sciences (CLS) in Rixensart <strike>Belgium;</strike> or <strike></strike> Wavre, Belgium <strike>or Marburg, Germany</strike> . CLS may delegate testing to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Research laboratories in Siena, Italy, or to Nexelis in Marburg, Germany, or to <strike>an</strike> other external laborator <strike>y</strike> ies .</td>\\\\n      <td>In the footnote for Table 10 (formerly Table 8) \\\\u201cLaboratory Assays\\\\u201d, the text was revised as follows (the added text is bold; the deleted text is crossed out) : <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Biologicals laboratory refers to the <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Sciences (CLS) in Rixensart <strike>Belgium;</strike> or <strike></strike> Wavre, Belgium <strike>or Marburg, Germany</strike> . CLS may delegate testing to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Research laboratories in Siena, Italy, or to Nexelis in Marburg, Germany, or to <strike>an</strike> other external laborator <strike>y</strike> ies .</td>\\\\n      <td>In the footnote for Table 10 (formerly Table 8) \\\\u201cLaboratory Assays\\\\u201d, the text was revised as follows (the added text is bold; the deleted text is crossed out) : <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Biologicals laboratory refers to the <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Sciences (CLS) in Rixensart <strike>Belgium;</strike> or <strike></strike> Wavre, Belgium <strike>or Marburg, Germany</strike> . CLS may delegate testing to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Research laboratories in Siena, Italy, or to Nexelis in Marburg, Germany, or to <strike>an</strike> other external laborator <strike>y</strike> ies .</td>\\\\n      <td>In the footnote for Table 10 (formerly Table 8) \\\\u201cLaboratory Assays\\\\u201d, the text was revised as follows (the added text is bold; the deleted text is crossed out) : <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Biologicals laboratory refers to the <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Sciences (CLS) in Rixensart <strike>Belgium;</strike> or <strike></strike> Wavre, Belgium <strike>or Marburg, Germany</strike> . CLS may delegate testing to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Research laboratories in Siena, Italy, or to Nexelis in Marburg, Germany, or to <strike>an</strike> other external laborator <strike>y</strike> ies .</td>\\\\n      <td>In the footnote for Table 10 (formerly Table 8) \\\\u201cLaboratory Assays\\\\u201d, the text was revised as follows (the added text is bold; the deleted text is crossed out) : <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Biologicals laboratory refers to the <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Sciences (CLS) in Rixensart <strike>Belgium;</strike> or <strike></strike> Wavre, Belgium <strike>or Marburg, Germany</strike> . CLS may delegate testing to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Research laboratories in Siena, Italy, or to Nexelis in Marburg, Germany, or to <strike>an</strike> other external laborator <strike>y</strike> ies .</td>\\\\n      <td>In the footnote for Table 10 (formerly Table 8) \\\\u201cLaboratory Assays\\\\u201d, the text was revised as follows (the added text is bold; the deleted text is crossed out) : <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Biologicals laboratory refers to the <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Sciences (CLS) in Rixensart <strike>Belgium;</strike> or <strike></strike> Wavre, Belgium <strike>or Marburg, Germany</strike> . CLS may delegate testing to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Research laboratories in Siena, Italy, or to Nexelis in Marburg, Germany, or to <strike>an</strike> other external laborator <strike>y</strike> ies .</td>\\\\n      <td>To reflect the fact that Nexelis acquired CLS in Germany.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>8.3.6.1 Time Period and Frequency for Collecting AE and SAE Information</td>\\\\n      <td>The following text was added:  Any solicited AE that has not resolved within 30 days post-vaccination and is reported during clinic visits or safety follow-up calls will be entered into the subject\\\\u2019s eCRF as an unsolicited AE. It will also be included in the subject\\\\u2019s source documents at the site by the investigator/site staff as a verbally reported event. It will not be included in the Subject eDiary. These AEs will be analyzed as unsolicited AEs (i.e., in the Unsolicited Safety Set).</td>\\\\n      <td>The following text was added:  Any solicited AE that has not resolved within 30 days post-vaccination and is reported during clinic visits or safety follow-up calls will be entered into the subject\\\\u2019s eCRF as an unsolicited AE. It will also be included in the subject\\\\u2019s source documents at the site by the investigator/site staff as a verbally reported event. It will not be included in the Subject eDiary. These AEs will be analyzed as unsolicited AEs (i.e., in the Unsolicited Safety Set).</td>\\\\n      <td>The following text was added:  Any solicited AE that has not resolved within 30 days post-vaccination and is reported during clinic visits or safety follow-up calls will be entered into the subject\\\\u2019s eCRF as an unsolicited AE. It will also be included in the subject\\\\u2019s source documents at the site by the investigator/site staff as a verbally reported event. It will not be included in the Subject eDiary. These AEs will be analyzed as unsolicited AEs (i.e., in the Unsolicited Safety Set).</td>\\\\n      <td>The following text was added:  Any solicited AE that has not resolved within 30 days post-vaccination and is reported during clinic visits or safety follow-up calls will be entered into the subject\\\\u2019s eCRF as an unsolicited AE. It will also be included in the subject\\\\u2019s source documents at the site by the investigator/site staff as a verbally reported event. It will not be included in the Subject eDiary. These AEs will be analyzed as unsolicited AEs (i.e., in the Unsolicited Safety Set).</td>\\\\n      <td>The following text was added:  Any solicited AE that has not resolved within 30 days post-vaccination and is reported during clinic visits or safety follow-up calls will be entered into the subject\\\\u2019s eCRF as an unsolicited AE. It will also be included in the subject\\\\u2019s source documents at the site by the investigator/site staff as a verbally reported event. It will not be included in the Subject eDiary. These AEs will be analyzed as unsolicited AEs (i.e., in the Unsolicited Safety Set).</td>\\\\n      <td>The following text was added:  Any solicited AE that has not resolved within 30 days post-vaccination and is reported during clinic visits or safety follow-up calls will be entered into the subject\\\\u2019s eCRF as an unsolicited AE. It will also be included in the subject\\\\u2019s source documents at the site by the investigator/site staff as a verbally reported event. It will not be included in the Subject eDiary. These AEs will be analyzed as unsolicited AEs (i.e., in the Unsolicited Safety Set).</td>\\\\n      <td>The following text was added:  Any solicited AE that has not resolved within 30 days post-vaccination and is reported during clinic visits or safety follow-up calls will be entered into the subject\\\\u2019s eCRF as an unsolicited AE. It will also be included in the subject\\\\u2019s source documents at the site by the investigator/site staff as a verbally reported event. It will not be included in the Subject eDiary. These AEs will be analyzed as unsolicited AEs (i.e., in the Unsolicited Safety Set).</td>\\\\n      <td>For clarity and to align with other MenABCWY protocols</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td>8.3.8 Medical Device Deficiencies</td>\\\\n      <td>The new section \\\\u201cMedical Device Deficiencies\\\\u201d was added, with the following subsections included ( only the</td>\\\\n      <td>The new section \\\\u201cMedical Device Deficiencies\\\\u201d was added, with the following subsections included ( only the</td>\\\\n      <td>The new section \\\\u201cMedical Device Deficiencies\\\\u201d was added, with the following subsections included ( only the</td>\\\\n      <td>The new section \\\\u201cMedical Device Deficiencies\\\\u201d was added, with the following subsections included ( only the</td>\\\\n      <td>The new section \\\\u201cMedical Device Deficiencies\\\\u201d was added, with the following subsections included ( only the</td>\\\\n      <td>The new section \\\\u201cMedical Device Deficiencies\\\\u201d was added, with the following subsections included ( only the</td>\\\\n      <td>The new section \\\\u201cMedical Device Deficiencies\\\\u201d was added, with the following subsections included ( only the</td>\\\\n      <td>Given that the study interventions</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"3\\\", \\\"TableIndex\\\": \\\"5\\\", \\\"TableName\\\": \\\"Table 2 Description of Changes in Amendment 2\\\", \\\"Header\\\": [0, 1, 3]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"3bf991ab-6158-43c9-a7b9-8c9ff3058fac\\\", \\\"childbox\\\": \\\"e4b65cc3-cb0e-43de-bd3f-7a74068fd085\\\", \\\"subtext\\\": \\\"74d6e4df-b03d-4f65-b294-75b204ccb185\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 106, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e7448bde-8ff4-430f-9f50-03b3d9b69020\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 107, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ae0938a3-10fd-4e1b-bccb-d2d165be699e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 108, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2f0484d7-7062-4d2b-a8bd-1e45b9f6b509\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 109, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"968f7039-3ccb-419d-9365-7c111f6ab17c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 110, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5b8def77-d46b-41a3-8be0-760366a34f8e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 111, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dba095d8-d4f5-4745-96ce-98ded08bf08d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 112, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1179ebcd-567e-4749-b054-a07c1b80cee0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 113, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"118903f3-b355-484f-9aee-696bb62295a1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 114, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e3522033-6fc7-4843-9ad9-f77fbf68d2f0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 115, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f2e7c274-0a83-435b-996b-3db3cdc4834c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 116, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"72af9382-964e-42c3-8f9a-0fb3276b4977\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 117, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7d3cec94-0d0f-46e6-a336-18dfbf7da081\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 118, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Section # and Name</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Brief Rationale</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td></td>\\\\n      <td>subsections headers are shown; see the content of these sections in the body of the protocol amendment ): 8.3.8.1  Detection, Follow-up and Prompt Reporting of Medical Device Deficiency 8.3.8.2  Regulatory Reporting of Medical Device Deficiency When Used as Combination Product</td>\\\\n      <td>(MenABCWY and Bexsero ) are combination products constituted of a device and biologic product (pre-filled syringes), the language regarding combination products, collection and reporting of safety events related to medical devices in accordance with the <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> guidelines, was added.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>9.1 Statistical Hypotheses</td>\\\\n      <td>The text was revised as follows (the added content is bold; the deleted text is crossed out): <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Immunogenicity Objective (Family 1)  The first co- primary immunogenicity objective is to demonstrate the immunological non inferiority (NI) of the antibody response to MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with MenACWY, as measured by percentage of participants with 4-fold rise in hSBA titer against each of the N. meningitidis serogroups A, C, W, and Y, at 1 month after the <strike>first</strike> second MenABCWY vaccination and 1 month after the MenACWY vaccination (single dose). This translates to the following hypotheses: H0:  (p1_MenABCWY(i) \\\\u2013 p1_MenACWY(i) \\\\u2264\\\\u221210% vs.  H1:  (p1_MenABCWY(i) \\\\u2013 p1_MenACWY(i) >\\\\u221210% Where  p1_MenABCWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for</td>\\\\n      <td>Statistical considerations were revised to accommodate additional analyses required in the study due to promotion of one of the secondary endpoints to co-primary. Identifiers</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"3\\\", \\\"TableIndex\\\": \\\"6\\\", \\\"TableName\\\": \\\"Table 2 Description of Changes in Amendment 2\\\", \\\"Header\\\": [0, 1, 2]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"1925cff7-6efe-4373-9737-0ad4f055e424\\\", \\\"childbox\\\": \\\"35bc9a90-5354-4abc-b55e-9ba0e0c29373\\\", \\\"subtext\\\": \\\"534c0db6-42ed-4f2f-85da-b577cb7f0a2d\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 119, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"df46e652-9dc4-463f-9475-6ecca6e8a861\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 120, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c5aadb2c-bbb6-4367-a2eb-9cc8990a6650\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 121, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n      <th>5.0</th>\\\\n      <th>6.0</th>\\\\n      <th>7.0</th>\\\\n      <th>8.0</th>\\\\n      <th>9.0</th>\\\\n      <th>11.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Section # and Name</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Brief Rationale</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td></td>\\\\n      <td>serogroups i=A, C, W, and Y, 1 month after the <strike>first</strike> second vaccination of MenABCWY group and p1_MenACWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group. NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y. <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>  <strike>Secondary</strike> Immunogenicity Objective (Family 2)  The second <strike>ary</strike>  co-primary immunogenicity objective is to demonstrate the immunological NI of the antibody response to MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with MenACWY, as measured by percentage of participants with 4-fold rise in hSBA titer against each of the N. meningitidis serogroups A, C, W, and Y, at 1 month after the <strike>second</strike> first MenABCWY vaccination and 1 month after the MenACWY vaccination (single dose). This translates to the following hypotheses: H0:  (p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) \\\\u2264\\\\u221210% vs.  H1:  (p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) >\\\\u221210% Where  p2_MenABCWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the <strike>second</strike>  first vaccination of MenABCWY group and p2_MenACWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group. NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y.</td>\\\\n      <td>serogroups i=A, C, W, and Y, 1 month after the <strike>first</strike> second vaccination of MenABCWY group and p1_MenACWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group. NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y. <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>  <strike>Secondary</strike> Immunogenicity Objective (Family 2)  The second <strike>ary</strike>  co-primary immunogenicity objective is to demonstrate the immunological NI of the antibody response to MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with MenACWY, as measured by percentage of participants with 4-fold rise in hSBA titer against each of the N. meningitidis serogroups A, C, W, and Y, at 1 month after the <strike>second</strike> first MenABCWY vaccination and 1 month after the MenACWY vaccination (single dose). This translates to the following hypotheses: H0:  (p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) \\\\u2264\\\\u221210% vs.  H1:  (p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) >\\\\u221210% Where  p2_MenABCWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the <strike>second</strike>  first vaccination of MenABCWY group and p2_MenACWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group. NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y.</td>\\\\n      <td>serogroups i=A, C, W, and Y, 1 month after the <strike>first</strike> second vaccination of MenABCWY group and p1_MenACWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group. NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y. <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>  <strike>Secondary</strike> Immunogenicity Objective (Family 2)  The second <strike>ary</strike>  co-primary immunogenicity objective is to demonstrate the immunological NI of the antibody response to MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with MenACWY, as measured by percentage of participants with 4-fold rise in hSBA titer against each of the N. meningitidis serogroups A, C, W, and Y, at 1 month after the <strike>second</strike> first MenABCWY vaccination and 1 month after the MenACWY vaccination (single dose). This translates to the following hypotheses: H0:  (p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) \\\\u2264\\\\u221210% vs.  H1:  (p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) >\\\\u221210% Where  p2_MenABCWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the <strike>second</strike>  first vaccination of MenABCWY group and p2_MenACWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group. NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y.</td>\\\\n      <td>serogroups i=A, C, W, and Y, 1 month after the <strike>first</strike> second vaccination of MenABCWY group and p1_MenACWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group. NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y. <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>  <strike>Secondary</strike> Immunogenicity Objective (Family 2)  The second <strike>ary</strike>  co-primary immunogenicity objective is to demonstrate the immunological NI of the antibody response to MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with MenACWY, as measured by percentage of participants with 4-fold rise in hSBA titer against each of the N. meningitidis serogroups A, C, W, and Y, at 1 month after the <strike>second</strike> first MenABCWY vaccination and 1 month after the MenACWY vaccination (single dose). This translates to the following hypotheses: H0:  (p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) \\\\u2264\\\\u221210% vs.  H1:  (p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) >\\\\u221210% Where  p2_MenABCWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the <strike>second</strike>  first vaccination of MenABCWY group and p2_MenACWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group. NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y.</td>\\\\n      <td>serogroups i=A, C, W, and Y, 1 month after the <strike>first</strike> second vaccination of MenABCWY group and p1_MenACWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group. NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y. <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>  <strike>Secondary</strike> Immunogenicity Objective (Family 2)  The second <strike>ary</strike>  co-primary immunogenicity objective is to demonstrate the immunological NI of the antibody response to MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with MenACWY, as measured by percentage of participants with 4-fold rise in hSBA titer against each of the N. meningitidis serogroups A, C, W, and Y, at 1 month after the <strike>second</strike> first MenABCWY vaccination and 1 month after the MenACWY vaccination (single dose). This translates to the following hypotheses: H0:  (p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) \\\\u2264\\\\u221210% vs.  H1:  (p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) >\\\\u221210% Where  p2_MenABCWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the <strike>second</strike>  first vaccination of MenABCWY group and p2_MenACWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group. NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y.</td>\\\\n      <td>serogroups i=A, C, W, and Y, 1 month after the <strike>first</strike> second vaccination of MenABCWY group and p1_MenACWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group. NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y. <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>  <strike>Secondary</strike> Immunogenicity Objective (Family 2)  The second <strike>ary</strike>  co-primary immunogenicity objective is to demonstrate the immunological NI of the antibody response to MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with MenACWY, as measured by percentage of participants with 4-fold rise in hSBA titer against each of the N. meningitidis serogroups A, C, W, and Y, at 1 month after the <strike>second</strike> first MenABCWY vaccination and 1 month after the MenACWY vaccination (single dose). This translates to the following hypotheses: H0:  (p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) \\\\u2264\\\\u221210% vs.  H1:  (p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) >\\\\u221210% Where  p2_MenABCWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the <strike>second</strike>  first vaccination of MenABCWY group and p2_MenACWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group. NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y.</td>\\\\n      <td>serogroups i=A, C, W, and Y, 1 month after the <strike>first</strike> second vaccination of MenABCWY group and p1_MenACWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group. NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y. <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>  <strike>Secondary</strike> Immunogenicity Objective (Family 2)  The second <strike>ary</strike>  co-primary immunogenicity objective is to demonstrate the immunological NI of the antibody response to MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with MenACWY, as measured by percentage of participants with 4-fold rise in hSBA titer against each of the N. meningitidis serogroups A, C, W, and Y, at 1 month after the <strike>second</strike> first MenABCWY vaccination and 1 month after the MenACWY vaccination (single dose). This translates to the following hypotheses: H0:  (p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) \\\\u2264\\\\u221210% vs.  H1:  (p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) >\\\\u221210% Where  p2_MenABCWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the <strike>second</strike>  first vaccination of MenABCWY group and p2_MenACWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group. NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y.</td>\\\\n      <td>serogroups i=A, C, W, and Y, 1 month after the <strike>first</strike> second vaccination of MenABCWY group and p1_MenACWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group. NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y. <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>  <strike>Secondary</strike> Immunogenicity Objective (Family 2)  The second <strike>ary</strike>  co-primary immunogenicity objective is to demonstrate the immunological NI of the antibody response to MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with MenACWY, as measured by percentage of participants with 4-fold rise in hSBA titer against each of the N. meningitidis serogroups A, C, W, and Y, at 1 month after the <strike>second</strike> first MenABCWY vaccination and 1 month after the MenACWY vaccination (single dose). This translates to the following hypotheses: H0:  (p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) \\\\u2264\\\\u221210% vs.  H1:  (p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) >\\\\u221210% Where  p2_MenABCWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the <strike>second</strike>  first vaccination of MenABCWY group and p2_MenACWY(i) denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group. NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y.</td>\\\\n      <td>\\\\u201cFamily 1\\\\u201d and \\\\u201cFamily 2\\\\u201d were added for referencing testing strategy for the 2 co-primary endpoints.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>9.2 Sample Size Determination</td>\\\\n      <td>The text was revised as follows (the added content is bold; the deleted text is crossed out): <strike>Table 14  Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of</strike>  <strike>MenABCWY Compared to MenACWY (Primary)</strike></td>\\\\n      <td>The text was revised as follows (the added content is bold; the deleted text is crossed out): <strike>Table 14  Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of</strike>  <strike>MenABCWY Compared to MenACWY (Primary)</strike></td>\\\\n      <td>The text was revised as follows (the added content is bold; the deleted text is crossed out): <strike>Table 14  Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of</strike>  <strike>MenABCWY Compared to MenACWY (Primary)</strike></td>\\\\n      <td>The text was revised as follows (the added content is bold; the deleted text is crossed out): <strike>Table 14  Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of</strike>  <strike>MenABCWY Compared to MenACWY (Primary)</strike></td>\\\\n      <td>The text was revised as follows (the added content is bold; the deleted text is crossed out): <strike>Table 14  Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of</strike>  <strike>MenABCWY Compared to MenACWY (Primary)</strike></td>\\\\n      <td>The text was revised as follows (the added content is bold; the deleted text is crossed out): <strike>Table 14  Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of</strike>  <strike>MenABCWY Compared to MenACWY (Primary)</strike></td>\\\\n      <td>The text was revised as follows (the added content is bold; the deleted text is crossed out): <strike>Table 14  Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of</strike>  <strike>MenABCWY Compared to MenACWY (Primary)</strike></td>\\\\n      <td>The text was revised as follows (the added content is bold; the deleted text is crossed out): <strike>Table 14  Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of</strike>  <strike>MenABCWY Compared to MenACWY (Primary)</strike></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td><strike>Serogroup</strike></td>\\\\n      <td><strike>4-fold Rate</strike>  <strike>MenACWY,</strike>  <strike>%</strike></td>\\\\n      <td><strike>4-fold Rate</strike>  <strike>MenABCW</strike> <strike>Y, %</strike></td>\\\\n      <td><strike>NI Margin,</strike>  <strike>%</strike></td>\\\\n      <td><strike>Actual</strike>  <strike>Margin, %</strike></td>\\\\n      <td><strike>Power, %</strike></td>\\\\n      <td><strike>n, Group</strike></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td><strike>A</strike></td>\\\\n      <td><strike>95</strike></td>\\\\n      <td><strike>91</strike></td>\\\\n      <td><strike>\\\\u221210</strike></td>\\\\n      <td><strike>\\\\u22124</strike></td>\\\\n      <td><strike>96.00</strike></td>\\\\n      <td><strike>542</strike></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td><strike>C</strike></td>\\\\n      <td><strike>95</strike></td>\\\\n      <td><strike>93</strike></td>\\\\n      <td><strike>\\\\u221210</strike></td>\\\\n      <td><strike>\\\\u22122</strike></td>\\\\n      <td><strike>99.95</strike></td>\\\\n      <td><strike>542</strike></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td><strike>W</strike></td>\\\\n      <td><strike>95</strike></td>\\\\n      <td><strike>91</strike></td>\\\\n      <td><strike>\\\\u221210</strike></td>\\\\n      <td><strike>\\\\u22124</strike></td>\\\\n      <td><strike>96.00</strike></td>\\\\n      <td><strike>542</strike></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>7</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td><strike>Y</strike></td>\\\\n      <td><strike>95</strike></td>\\\\n      <td><strike>93</strike></td>\\\\n      <td><strike>\\\\u221210</strike></td>\\\\n      <td><strike>\\\\u22122</strike></td>\\\\n      <td><strike>99.95</strike></td>\\\\n      <td><strike>542</strike></td>\\\\n      <td></td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"3\\\", \\\"TableIndex\\\": \\\"7\\\", \\\"TableName\\\": \\\"Table 2 Description of Changes in Amendment 2\\\", \\\"Header\\\": [0, 1, 2, 3]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"c0327c6b-712a-49bb-9ff9-f6571a85fdc8\\\", \\\"childbox\\\": \\\"22d7db04-57ce-4bdd-aabf-0ed4dfaccc42\\\", \\\"subtext\\\": \\\"25e6e486-ef6e-401b-8f80-4552e90fb5ad\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 122, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"48c60744-3452-470d-ad9a-c117c62b2b62\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 123, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"af64e899-03ff-4d7a-a010-8c9ba48a146e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 124, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"314a29dc-3309-4aa6-96a9-ada35bc0bf33\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 125, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"04a14081-b020-4c45-8dce-a371ae6cc014\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 126, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c28e0dee-a0a2-42b5-840f-3130527c58ba\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 127, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3b46e265-77cc-4e7f-a451-6de58296599f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 128, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d6ac5047-73ee-4f70-888f-3de0bd6696d9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 129, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"afd0edc7-aa57-400c-bd52-d9dcb006c757\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 130, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8d8ceddf-5b82-4d79-86a5-0b75bab21883\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 131, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ec94e917-2682-4eec-a214-ee49db1cc3e9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 132, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aadcbf1f-1296-41a8-b8f7-8c504a54ef0c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 133, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b1ee9d21-2c73-4289-aa59-2cd87d4ac718\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 134, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"57afe171-cfc3-4cf7-ab06-346933bda9a6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 135, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b88192a0-2335-4038-aeac-40d54b8a2e1e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 136, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e97560a8-a524-4868-ae85-6b6a4d17507d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 137, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f1fb3b6b-63f5-4158-acfc-90664645820b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 138, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b4efa367-f958-4967-8482-006ca9c230fe\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 139, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"35ef8a6e-7f30-4516-ba41-437d2fa7233d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 140, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c9e81206-2924-44ee-a67f-26a6fb1b2ea7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 141, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"13e95837-62d1-4906-a754-9a9724b50c62\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 142, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"84928511-25ba-411f-b5de-645e11062ca1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 143, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7b89eaaf-fc17-4451-8bee-d6ab26f3c150\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 144, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3533e839-c1f1-4c3e-9b56-e1cc970015a7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 145, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"161e8914-fe72-4049-8724-3f6bb28adfc5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 146, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7b2c9d21-a0ad-4c53-b34d-53781895da5f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 147, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5597a788-8d2f-4807-ba93-76c004050933\\\", \\\"childbox\\\": \\\"bcdb4163-39b9-47f8-b745-3f1e28c8a33c\\\", \\\"subtext\\\": \\\"615192d3-142d-4ade-8512-f2ce41d8823d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 148, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d468dfd3-8e6d-483f-bca5-7c3075e1066b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 149, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n      <th>5.0</th>\\\\n      <th>6.0</th>\\\\n      <th>7.0</th>\\\\n      <th>8.0</th>\\\\n      <th>9.0</th>\\\\n      <th>10.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Section # and Name</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Brief Rationale</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>Serogroup</td>\\\\n      <td>4-fold rate MenACWY</td>\\\\n      <td>4-fold rate MenABCWY</td>\\\\n      <td>NI margin</td>\\\\n      <td>Actual margin</td>\\\\n      <td>Power</td>\\\\n      <td>N ABCWY/ ACWY</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>Family 1: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 1: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 1: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 1: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 1: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 1: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 1: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>A</td>\\\\n      <td>95%</td>\\\\n      <td>95%</td>\\\\n      <td>-10%</td>\\\\n      <td>0%</td>\\\\n      <td>99.87%</td>\\\\n      <td>225</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>Family 2: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 2: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 2: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 2: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 2: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 2: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 2: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>A</td>\\\\n      <td>95%</td>\\\\n      <td>91%</td>\\\\n      <td>-10%</td>\\\\n      <td>-4%</td>\\\\n      <td>96.00%</td>\\\\n      <td>542</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>C</td>\\\\n      <td>95%</td>\\\\n      <td>93%</td>\\\\n      <td>-10%</td>\\\\n      <td>-2%</td>\\\\n      <td>99.95%</td>\\\\n      <td>542</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>7</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>W</td>\\\\n      <td>95%</td>\\\\n      <td>91%</td>\\\\n      <td>-10%</td>\\\\n      <td>-4%</td>\\\\n      <td>96.00%</td>\\\\n      <td>542</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>8</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>Y</td>\\\\n      <td>95%</td>\\\\n      <td>93%</td>\\\\n      <td>-10%</td>\\\\n      <td>-2%</td>\\\\n      <td>99.95%</td>\\\\n      <td>542</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>9</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>Global Power</td>\\\\n      <td>Global Power</td>\\\\n      <td>Global Power</td>\\\\n      <td>Global Power</td>\\\\n      <td>Global Power</td>\\\\n      <td>91.00%</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>10</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>n = number of participants; NI = non-inferiority  <strike>Considering that approximately 10% of the selected participants might withdraw or not be evaluable for the</strike>  <strike>immunogenicity objectives, the target sample size to be analyzed is 853 participants (603 and 250 participants</strike>  <strike>for ACWY and ABCWY respectively).</strike>  Considering that approximately 10% of the selected participants might withdraw or not be evaluable for the immunogenicity objectives, the target sample size to be analyzed will be 270 participants per group and 603 participants per group for the first co-primary and the second co-primary objectives respectively. Evaluable means all participants included in the set for the statistical analysis defined in Section 9.3. The sample size calculation was performed in PASS 12 (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 2013). The global power for all 4 strains across Family 1 and Family 2 is the product of individual powers.</td>\\\\n      <td>n = number of participants; NI = non-inferiority  <strike>Considering that approximately 10% of the selected participants might withdraw or not be evaluable for the</strike>  <strike>immunogenicity objectives, the target sample size to be analyzed is 853 participants (603 and 250 participants</strike>  <strike>for ACWY and ABCWY respectively).</strike>  Considering that approximately 10% of the selected participants might withdraw or not be evaluable for the immunogenicity objectives, the target sample size to be analyzed will be 270 participants per group and 603 participants per group for the first co-primary and the second co-primary objectives respectively. Evaluable means all participants included in the set for the statistical analysis defined in Section 9.3. The sample size calculation was performed in PASS 12 (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 2013). The global power for all 4 strains across Family 1 and Family 2 is the product of individual powers.</td>\\\\n      <td>n = number of participants; NI = non-inferiority  <strike>Considering that approximately 10% of the selected participants might withdraw or not be evaluable for the</strike>  <strike>immunogenicity objectives, the target sample size to be analyzed is 853 participants (603 and 250 participants</strike>  <strike>for ACWY and ABCWY respectively).</strike>  Considering that approximately 10% of the selected participants might withdraw or not be evaluable for the immunogenicity objectives, the target sample size to be analyzed will be 270 participants per group and 603 participants per group for the first co-primary and the second co-primary objectives respectively. Evaluable means all participants included in the set for the statistical analysis defined in Section 9.3. The sample size calculation was performed in PASS 12 (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 2013). The global power for all 4 strains across Family 1 and Family 2 is the product of individual powers.</td>\\\\n      <td>n = number of participants; NI = non-inferiority  <strike>Considering that approximately 10% of the selected participants might withdraw or not be evaluable for the</strike>  <strike>immunogenicity objectives, the target sample size to be analyzed is 853 participants (603 and 250 participants</strike>  <strike>for ACWY and ABCWY respectively).</strike>  Considering that approximately 10% of the selected participants might withdraw or not be evaluable for the immunogenicity objectives, the target sample size to be analyzed will be 270 participants per group and 603 participants per group for the first co-primary and the second co-primary objectives respectively. Evaluable means all participants included in the set for the statistical analysis defined in Section 9.3. The sample size calculation was performed in PASS 12 (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 2013). The global power for all 4 strains across Family 1 and Family 2 is the product of individual powers.</td>\\\\n      <td>n = number of participants; NI = non-inferiority  <strike>Considering that approximately 10% of the selected participants might withdraw or not be evaluable for the</strike>  <strike>immunogenicity objectives, the target sample size to be analyzed is 853 participants (603 and 250 participants</strike>  <strike>for ACWY and ABCWY respectively).</strike>  Considering that approximately 10% of the selected participants might withdraw or not be evaluable for the immunogenicity objectives, the target sample size to be analyzed will be 270 participants per group and 603 participants per group for the first co-primary and the second co-primary objectives respectively. Evaluable means all participants included in the set for the statistical analysis defined in Section 9.3. The sample size calculation was performed in PASS 12 (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 2013). The global power for all 4 strains across Family 1 and Family 2 is the product of individual powers.</td>\\\\n      <td>n = number of participants; NI = non-inferiority  <strike>Considering that approximately 10% of the selected participants might withdraw or not be evaluable for the</strike>  <strike>immunogenicity objectives, the target sample size to be analyzed is 853 participants (603 and 250 participants</strike>  <strike>for ACWY and ABCWY respectively).</strike>  Considering that approximately 10% of the selected participants might withdraw or not be evaluable for the immunogenicity objectives, the target sample size to be analyzed will be 270 participants per group and 603 participants per group for the first co-primary and the second co-primary objectives respectively. Evaluable means all participants included in the set for the statistical analysis defined in Section 9.3. The sample size calculation was performed in PASS 12 (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 2013). The global power for all 4 strains across Family 1 and Family 2 is the product of individual powers.</td>\\\\n      <td>n = number of participants; NI = non-inferiority  <strike>Considering that approximately 10% of the selected participants might withdraw or not be evaluable for the</strike>  <strike>immunogenicity objectives, the target sample size to be analyzed is 853 participants (603 and 250 participants</strike>  <strike>for ACWY and ABCWY respectively).</strike>  Considering that approximately 10% of the selected participants might withdraw or not be evaluable for the immunogenicity objectives, the target sample size to be analyzed will be 270 participants per group and 603 participants per group for the first co-primary and the second co-primary objectives respectively. Evaluable means all participants included in the set for the statistical analysis defined in Section 9.3. The sample size calculation was performed in PASS 12 (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 2013). The global power for all 4 strains across Family 1 and Family 2 is the product of individual powers.</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>11</th>\\\\n      <td>9.3 Populations for Analyses</td>\\\\n      <td>The text in the table was revised as follows: Participant who agreed/participant for whom parent(s)/LAR(s) agreed to participate in a clinical study after completion of the informed consent process <strike>who meet screening/eligibility criteria</strike> and randomized or received study intervention or undergone an invasive procedure.</td>\\\\n      <td>The text in the table was revised as follows: Participant who agreed/participant for whom parent(s)/LAR(s) agreed to participate in a clinical study after completion of the informed consent process <strike>who meet screening/eligibility criteria</strike> and randomized or received study intervention or undergone an invasive procedure.</td>\\\\n      <td>The text in the table was revised as follows: Participant who agreed/participant for whom parent(s)/LAR(s) agreed to participate in a clinical study after completion of the informed consent process <strike>who meet screening/eligibility criteria</strike> and randomized or received study intervention or undergone an invasive procedure.</td>\\\\n      <td>The text in the table was revised as follows: Participant who agreed/participant for whom parent(s)/LAR(s) agreed to participate in a clinical study after completion of the informed consent process <strike>who meet screening/eligibility criteria</strike> and randomized or received study intervention or undergone an invasive procedure.</td>\\\\n      <td>The text in the table was revised as follows: Participant who agreed/participant for whom parent(s)/LAR(s) agreed to participate in a clinical study after completion of the informed consent process <strike>who meet screening/eligibility criteria</strike> and randomized or received study intervention or undergone an invasive procedure.</td>\\\\n      <td>The text in the table was revised as follows: Participant who agreed/participant for whom parent(s)/LAR(s) agreed to participate in a clinical study after completion of the informed consent process <strike>who meet screening/eligibility criteria</strike> and randomized or received study intervention or undergone an invasive procedure.</td>\\\\n      <td>The text in the table was revised as follows: Participant who agreed/participant for whom parent(s)/LAR(s) agreed to participate in a clinical study after completion of the informed consent process <strike>who meet screening/eligibility criteria</strike> and randomized or received study intervention or undergone an invasive procedure.</td>\\\\n      <td>The text in the table was revised as follows: Participant who agreed/participant for whom parent(s)/LAR(s) agreed to participate in a clinical study after completion of the informed consent process <strike>who meet screening/eligibility criteria</strike> and randomized or received study intervention or undergone an invasive procedure.</td>\\\\n      <td></td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"3\\\", \\\"TableIndex\\\": \\\"8\\\", \\\"TableName\\\": \\\"Table 2 Description of Changes in Amendment 2\\\", \\\"Header\\\": [0, 1, 2, 3]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"ba8302dc-b2e2-4532-9667-f843dde787d0\\\", \\\"childbox\\\": \\\"ff7bd4d6-4809-4e14-b8c0-822091d935e9\\\", \\\"subtext\\\": \\\"00ac24c9-2521-458b-9d6e-b331381ce90a\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 150, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2686674b-b04d-4a85-ba94-0701a899a28a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 151, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f8c05533-b110-4ad7-b0d1-54e39159b244\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 152, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"db498973-ad40-4647-9f8b-52ab02b2b3c0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 153, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7370e851-257f-4be0-9fc7-2843ded574f5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 154, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b76585c1-6ac9-4568-bdf5-ee8ccde90dff\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 155, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"565b50b9-f993-498b-99c8-45ef673df8eb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 156, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0b245968-e381-4c52-9632-b397f31225e6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 157, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c951e470-ed1b-41be-bc91-ded9881db014\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 158, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"12290e84-5986-41aa-9500-91da1bedba5d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 159, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6d93db82-29a2-41c5-b122-de645d233df2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 160, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"faa91da1-905d-40d4-8012-743e50fbb350\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 161, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bf258818-5db0-4164-9d3b-cb2bafa2491d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 162, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"27a3e650-29b0-4102-bf67-1549a1143a08\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 163, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7e62f10d-a47a-43f9-8fdf-b882b337f21c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 164, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9a47a18b-4689-468f-8b85-0046f814615a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 165, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9d4da711-13b7-45ed-b95a-4ebe305dfcbc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 166, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4ddc4a9a-135f-4261-8db3-265f9f3d857a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 167, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6ac9ea7c-1e9c-4e66-9599-ab637431a12c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 168, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eef65988-70bd-4f0f-82bd-1d43ac26b4f5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 169, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9bf2075d-cedb-483f-b727-ed4c4582f5ba\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 170, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e1e8bea7-7e13-449e-969b-e9afe03ccfc8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 171, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e07e6b3a-6cd0-4a92-9516-eb26c44a8a63\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 172, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eaa6f302-d65e-48a9-8277-ee0068dea143\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 173, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c361fc97-cbd4-42a4-b788-d695f0642f9f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 174, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"236ab60a-2f7b-4bbe-9f41-4d16db4a7981\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 175, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"177bd1ed-bbcb-41f7-8bd8-32b10d618a0b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 176, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c049d8a5-86b2-43d2-80b5-e6ffd2df3353\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 177, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e6a3297b-b567-4527-8543-750b7be69956\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 178, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9c4ec8f7-2d2a-4d91-842a-4d500af9985e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 179, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8deeb4f7-4717-439a-a00f-fd42909937aa\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 180, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"90f38d4c-5296-4985-9ce6-7aeff86b4aea\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 181, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ad0aab57-f599-4447-9437-3cdc7ba1112f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 182, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dbd09b42-9c15-4ae5-b0c3-f7bdbb359f10\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 183, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"09dd9764-ef36-444a-b53b-86f9b8fa5c19\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 184, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e2709e53-5319-4672-ba73-f351b2a5f95e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 185, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ee338c73-0900-4581-b72b-fb1bad02bd0e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 186, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"949bbd74-aa6e-4d3b-9be5-2e65a0c12ab7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 187, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0c5e7ded-ff2a-4943-8d99-205a6ef7c22c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 188, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"918728e4-69eb-4512-9c0f-9ac42b754d95\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 189, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d9757751-c84b-481e-bc4a-cd4b4944a770\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 190, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bf9fcbb1-d414-439b-879d-d95c56655fbc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 191, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ada2039b-e02a-4846-8d57-cf0f253d49ec\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 192, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Section # and Name</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Brief Rationale</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>9.4.1 General Considerations</td>\\\\n      <td>The following bullet point list item was revised as follows (the added content is bold; the deleted text is crossed out) :  <strike>No multiplicity adjustment is foreseen as NI is considered achieved when the criterion is met for all 4</strike>  <strike>strains.</strike> <strike>This is applicable for both primary and secondary NI objectives.</strike> Fixed sequential testing with full alpha propagation in pre-ordered hypotheses families (Family 1 and Family 2, as defined in Section 9.1) will be applied.</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>9.4.3.1 Immunological Non-inferiority of MenABCWY vs. MenACWY</td>\\\\n      <td>The following text was revised as follows (the added content is bold; the deleted text is crossed out) : Statistical method  (Family 1) : For each of the serogroups A, C, W, and Y, the percentages of participants with 4-fold rise (refer to Section 9.4.1), and the corresponding exact 2-sided 95% CIs based on Clopper-Pearson method (Clopper and Pearson, 1934) will be calculated for each study group at 1 month after the <strike>first</strike> second vaccination. The standardized asymptotic CIs between group differences in percentages will be derived using the method of <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985). The following text was added:  Statistical method (Family 2) : For each of the serogroups A, C, W, and Y, the percentages of participants with 4-fold rise (refer to Section 9.4.1), and the corresponding exact 2-sided 95% CIs based on Clopper-Pearson method (Clopper and Pearson, 1934) will be calculated for each study group at 1 month after the first vaccination. The standardized asymptotic CIs between group differences in percentages will be derived using the method of <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985). NI criterion: Non-inferiority will be demonstrated if, the lower limit of 2-sided 95% CI for the percent difference in 4-fold rise in hSBA titers (p1_MenABCWY \\\\u2212 p1_MenACWY) is above \\\\u221210%, for each serogroup A, C, W, and Y.</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>9.4.4 Secondary Endpoints</td>\\\\n      <td>Section 9.4.4.1 \\\\u201cImmunological Non-Inferiority of MenABCWY vs. MenACWY\\\\u201d was deleted with all its content. Numbering of subsequent subsections in Section 9.4.4. shifted accordingly.</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>Appendix 1 Abbreviations and Glossary of Terms</td>\\\\n      <td>New abbreviations added: ADE SADE USADE New terms added: Combination product Medical device deficiency</td>\\\\n      <td>New terms added to support changes in the protocol text regarding combination products and device</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"3\\\", \\\"TableIndex\\\": \\\"9\\\", \\\"TableName\\\": \\\"Table 2 Description of Changes in Amendment 2\\\", \\\"Header\\\": [0, 1, 2, 3]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"cf52b708-47bd-47b4-b340-daf48265f2e2\\\", \\\"childbox\\\": \\\"adfe6e00-4707-4c06-9963-a37946307701\\\", \\\"subtext\\\": \\\"d26eb55e-700a-41ad-a64a-256d75393239\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 193, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"08c8ff81-149a-4612-9344-57d5cf37719b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 194, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8ff1c857-6203-4306-bea9-a12e4a1126ad\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 195, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"00b760f9-05ee-4e35-beef-1d4a2909369b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 196, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aa2f646d-a496-44dc-beba-f2630766a224\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 197, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ce9d9843-372e-4e74-906f-7271467dee32\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 198, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Section # and Name</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Brief Rationale</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>deficiencies.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td></td>\\\\n      <td>The following definitions were removed from the Glossary of Terms: Adverse event Adverse event of special interest</td>\\\\n      <td>Removed to avoid redundancy: both terms are defined in Appendix 4.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Appendix 2 Regulatory, Ethical, and Study Oversight Considerations</td>\\\\n      <td>In the subsection \\\\u201cInformed Consent and Assent Process\\\\u201d, the following text was added:  Re-consent must be obtained in accordance with local laws and regulations for participants who become legally emancipated during the study, i.e. reach the legal age of consent. The participant can provide consent by signing/witnessing/thumb printing an ICF, similar to that provided to the parent(s)/LAR(s) at study start, which summarizes the study and includes a consent statement and documents that the participant agrees to continue participating in the study.</td>\\\\n      <td>As an additional consideration for consent process applicable to the study population.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td></td>\\\\n      <td>The subheading \\\\u201c<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Start and Closure\\\\u201d was renamed to \\\\u201c<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> <strike>Start and</strike>  Closure\\\\u201d  In the subsection \\\\u201c<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Closure\\\\u201d, the following text was added.  An additional item in the list of reasons for study closure:   Total number of participants included earlier than expected  An addditional paragraph:  If the study is prematurely terminated or suspended, <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> shall promptly inform the investigators, the  IECs/IRBs, the regulatory authorities, for the reason for termination or suspension, as specified by the  applicable regulatory requirements. The investigator shall promptly inform the participants and should assure  appropriate participant therapy and/or follow-up.</td>\\\\n      <td>For clarity.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>Appendix 4 Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting</td>\\\\n      <td>In the section \\\\u201cPotential Immune-Mediated Diseases (pIMDs)\\\\u201d, the following text was removed: If pIMDs are the only AESIs collected during the study, this should be explicitly mentioned in this section and the term \\\\u201cAESI\\\\u201d can be replaced by \\\\u201cpIMD\\\\u201d throughout the document. Adapt the following list of pIMDs based on the discussion with the project Safety Physician if more disorders need to be considered.</td>\\\\n      <td>To correct the error as this text played administrative role and was not part of the content of the section.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td></td>\\\\n      <td>The table heading was revised as follows (the removed text is crossed out) :</td>\\\\n      <td>To correct the</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"3\\\", \\\"TableIndex\\\": \\\"10\\\", \\\"TableName\\\": \\\"Table 2 Description of Changes in Amendment 2\\\", \\\"Header\\\": [0, 2, 3]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"666c83c6-a553-43ee-9904-b28460080f46\\\", \\\"childbox\\\": \\\"2c25a876-ac82-4da6-8731-6ccb7136f04c\\\", \\\"subtext\\\": \\\"f687efa3-e663-4ec3-b530-c11e9da4bba8\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 199, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"db04c5d9-221b-4b35-bb92-5902e1482cac\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 200, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0516bb5e-14ef-4f9a-a438-dcbf8361aa81\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 201, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3b25abc0-7605-4cae-9831-e0c32146316c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 202, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"358acd04-8e25-4e5f-bc8f-53a92a0e4923\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 203, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bf348e8a-be29-4071-b1c9-b735abae9f15\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 204, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8bb5d772-3af6-4310-89ca-1fede7e1008c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 205, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8c062baf-581f-4339-9493-08281744f623\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 206, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Section # and Name</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Brief Rationale</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td></td>\\\\n      <td>Assessment of Intensity <strike>and Toxicity</strike></td>\\\\n      <td>error, as toxicity assessment methods are not described in the associated table.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td></td>\\\\n      <td>The following information was added (only the paragraph headers are shown; see the added content in the body of the appendix) : Definitions of Medical Device Adverse Events and Adverse Device Effects Definitions of a Medical Device SAE, Serious Adverse Device Effect, and Unexpected Serious Adverse Device Effect Recording and Reporting of Medical Device AE, ADEs, SADEs and USADE</td>\\\\n      <td>To provide instructions on identifying, recording, and reporting of device-related safety events</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Appendix 5 Contraceptive Guidance and Collection of Pregnancy Information</td>\\\\n      <td>In the table \\\\u201cHighly Effective Contraceptive Methods\\\\u201d, subheading \\\\u201cHighly Effective Contraceptive Methods That Are User Dependent\\\\u201d, the text was updated as follows (the added text is bold ) : Progestogen-only hormonal contraception associated with inhibition of ovulation Oral Injectable</td>\\\\n      <td>The oral contraception method was considered acceptable as discussed for V72_72 Phase III study. The oral contraception method will allow enrollment of more potential participants into the study.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td></td>\\\\n      <td>In the table \\\\u201cHighly Effective Contraceptive Methods\\\\u201d, subheading \\\\u201cHighly Effective Methods That Are User Independent\\\\u201d, the following item was aligned with other items on the list with an added bullet point:   Implantable progestogen-only hormonal contraception associated with inhibition of ovulation</td>\\\\n      <td>To correct the formatting error that affected accuracy on the content.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>Administrative Changes</td>\\\\n      <td>Administrative Changes</td>\\\\n      <td>Administrative Changes</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"3\\\", \\\"TableIndex\\\": \\\"11\\\", \\\"TableName\\\": \\\"Table 2 Description of Changes in Amendment 2\\\", \\\"Header\\\": [0, 2, 3]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"5ce63566-b418-4115-8d5a-121b541ea9fb\\\", \\\"childbox\\\": \\\"7ea7da86-8fb4-492c-8cd1-1b578af86f33\\\", \\\"subtext\\\": \\\"243f2868-82ae-417e-81d7-219f1064507b\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 207, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6dbe2362-bdd4-4858-bca2-e138401ccdfb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 208, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e2538dd0-bf47-4a80-96b8-6023f253dc01\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 209, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f6f4f02a-b6c4-47f8-9c08-186006864349\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 210, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"facdca7c-843f-4d74-91f9-57bd39165d75\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 211, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Section # and Name</td>\\\\n      <td>Description of Change</td>\\\\n      <td>Brief Rationale</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Title Page</td>\\\\n      <td>Original text: Amendment Number: Amendment 1 New Text: Amendment Number: 2 Original date: 31 August 2020 New date: 12 February 2021</td>\\\\n      <td>To reflect the change in the protocol version</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Page Headers</td>\\\\n      <td>Original text: Protocol 213171 (MENABCWY-019) \\\\u2013 Amendment 1 New text: Protocol 213171 (MENABCWY-019) \\\\u2013 Amendment 2</td>\\\\n      <td>To reflect the change in the protocol version</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Protocol Amendment Summary of Changes</td>\\\\n      <td>New section added</td>\\\\n      <td>To include relevant information regarding protocol history and summarize changes in the most recent protocol version</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>Appendix 7 Signature of Investigator</td>\\\\n      <td>Original text: VERSION: Amendment 1 New text: VERSION: Amendment 2</td>\\\\n      <td>To reflect the change in the protocol version</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>Additional administrative changes</td>\\\\n      <td>Page numbers, Table of Contents, Table of Tables were updated. Table numbering shifted. Relevant editorial changes were also made (e.g., internal cross-references, formatting).</td>\\\\n      <td>Updates were made according to the changes in the content of the document</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"3\\\", \\\"TableIndex\\\": \\\"12\\\", \\\"TableName\\\": \\\"Table 2 Description of Changes in Amendment 2\\\", \\\"Header\\\": [0, 3]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"c16984b5-87fd-4acc-afdb-a4f295db894e\\\", \\\"childbox\\\": \\\"43e364dd-aad2-499c-baf7-ccc9a87097fb\\\", \\\"subtext\\\": \\\"1607f75c-7b5b-4c91-ad3a-29f35e2a2644\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 212, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"69a4c8e8-1f6c-43a2-b8d3-b1c4e0830aae\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 213, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e304282e-0e12-4984-92e7-d122a73c8809\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Description of Changes in Amendment 2\\\", \\\"Table 2\\\", \\\"1\\\", 214, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"TABLE OF CONTENTS\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 32, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d155bf5c-66d8-418e-8ff5-2c8c26c0c260\\\", \\\"childbox\\\": \\\"c16a8fca-4bbe-4401-94fd-2c77e35a2d7b\\\", \\\"subtext\\\": \\\"5a7bc8f8-c1b5-45fc-bc76-931ae0f2da35\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 32, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 215, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"PROTOCOL AMENDMENT SUMMARY OF CHANGES 3\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68844215-8f2b-47fa-9204-b9228d501a90\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 216, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"TABLE OF TABLES 18\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d9b2a324-e72f-4f6b-a043-59e6a25e49ed\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 217, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"TABLE OF FIGURES 19\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"379bdac2-2621-4134-9a8c-3b200648b21b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 218, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1.0 PROTOCOL SUMMARY 20\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d46787ca-fb0e-4db4-a7e1-c68ec87b0ec1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 219, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1.1 Synopsis 20\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5991ea53-2321-4a26-bd08-c5cdea76f4fe\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 220, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1.2 Schema 24\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5d4afe5f-2f99-4d19-ac26-63361a0271d5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 221, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1.3 Schedule of Activities 26\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"339c3e24-07f2-4465-8165-ee7f41cd2ee3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 222, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2.0 INTRODUCTION 31\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"61188aae-f6f9-4d9c-9745-7c7ec34a2b5e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 223, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2.1 Study Rationale 31\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4d3e784e-abec-4020-a6db-8ba7413dcfcc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 224, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2.2 Background 32\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"405ed8cd-c169-4a18-af3a-4906c0ac15be\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 225, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2.3 Benefit/Risk Assessment 33\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dad074b0-53ad-44cf-8f46-7bd45d179f73\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 226, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"3.0 OBJECTIVES AND ENDPOINTS 34\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"be4b164e-9a74-47db-b1e7-c91a44dfbbe6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 227, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"4.0 STUD Y DESIGN 38\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"233bfe17-5b11-4b97-8147-c4e71befa6e9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 228, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"4.1 Overall Design 38\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ed6dfb38-a94a-4c57-8c8d-5a6616e26472\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 229, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"4.2 Scientific Rationale for Study Design 39\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d8c75ea8-1c32-40c3-b76f-d7b1895cd6ac\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 230, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"4.3 Justification for Dose 40\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7b4283db-0107-4eca-a764-c0e80eca6542\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 231, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"4.4 End of Study Definition 41\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"21454eff-c8e2-4509-85bc-54ac0668171b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 232, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"5.0 STUDY POPULATION 42\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"21d24680-a3f4-45b5-a051-04d2bb0c2996\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 233, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"5.1 Inclusion Cr iteria 42\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"32c8f50b-2a03-40db-89d0-fe0cc3489ba0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 234, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"5.2 Exclusion Criteria 43\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fc60e35e-6d2d-455a-8510-2cbb8758de4f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 235, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"5.2.1 Medical Conditions 43\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ea0200dc-1356-496b-a0ac-0e557504b195\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 236, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"5.2.2 Prior/Concomitant Therapy 44\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e495b37f-d4b7-47e9-81fa-de39d28d6867\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 237, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"5.2.3 Prior/Concurrent Clinical Study Experience 44\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a41c2b6a-4489-4590-bd2a-53bfd8cbdcde\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 238, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"5.2.4 Other Exclusions 44\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1f7c98ac-0bbf-44cb-9625-643911a2a7d7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 239, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"5.3 Lifestyle Considerations 45\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a5be8b97-4df6-426c-85b3-2cc5cc1bf72f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 240, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"5.4 Screen Failures 45\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6792c17f-bb1f-42f8-ae04-1014f1d67989\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 241, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6.0 STUDY INTERVENTION 46\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"af18108e-ab9c-4cae-b270-fe76fffd28cb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 242, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6.1 Study Inte rventions Administered 46\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e2dc9861-d5c4-4d2e-9ba4-8031b6ec93cb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 243, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6.2 Preparation/Handling/Storage/Accountability 50\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6addbc98-9ff9-419b-93d4-554872355c3e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 244, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6.3 Measures to Minimize Bias: Randomization and Blinding 50\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a1e0d310-c5b3-4bc8-93b7-39669c5a15de\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 245, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6.3.1 Participant Identification 50\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6157b77c-fa20-4bf5-9544-3f2bb4969027\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 246, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6.3.2 Randomization to Study Intervention 50\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"363fb0f9-7059-491d-b0c4-d7a93d199876\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 247, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6.3.3 Intervention Allocation to the Participant 51\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"529d4f08-b858-4ed8-8c25-499dfd5b2230\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 248, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6.3.4 Allocation of Participants to Assay Subsets 51\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f8d47e78-b4d1-4179-ad0e-f9be76f4843a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 249, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6.3.5 Blinding and Unblinding 52\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"017e31e8-752d-45e9-bd5d-8850426968a4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 250, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6.4 St udy Intervention Compliance 53\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b6fc5142-4be7-44cf-a1a7-63506564e208\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 251, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6.5 Concomitant Therapy 53\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"47ebbfc9-8231-424d-a180-4cdc0dd37564\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 252, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6.6 Dose Modification 54\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bc6d0975-b432-44e6-ac8a-912929589258\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 253, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6.7 Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f7f3f62f-738a-4eaa-a004-f3e93c02f436\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 254, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"and/or Blood Sampling 54\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"52740d6e-1c3e-499a-ad22-6db1fd5873ea\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 255, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6.8 Contraindications to Subsequent ~REDACTED~ Administration 55\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8aa425b9-9215-4052-8562-a44b1b661b96\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 256, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6.9 Intervention After the End of the Study 56\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b053e340-f719-483e-85fd-ce2da930ded6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF CONTENTS\\\", \\\"TABLE\\\", \\\"1\\\", 257, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"7.0 DISCONTINUATION OF STUDY INTERVENTION AND\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1ac6b011-f57d-469f-9900-ec5065005a4e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 258, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"PARTICIPANT DISCONTINUATION/WITHDRAWAL 57\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"abe93d26-acc6-4a8c-8f77-82450fb74092\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 259, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"7.1 Reasons for Discontinuation/Withdrawal 57\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"43fa65e6-7bf0-4495-bfdf-133113f82b80\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 260, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"7.2 Discontinuation of Study Intervention 57\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b0f2fb13-d91a-4980-909a-cd5a9bf08e89\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 261, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"7.3 Participant Discontinuation/Withdrawal from the Study 58\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"262a8200-1f0b-4adc-ab4d-a4fa1fa1aee2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 262, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"7.4 Lost to Follow-up 58\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8987a0a7-d186-468c-acec-07359863ba11\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 263, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.0 STUDY ASSE SSMENTS AND PROCEDURES 59\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"db28c84c-f9ae-4572-a593-369d348dda48\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 264, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.1 Immunogenicity Assessments 59\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"507b4f68-a63d-4aa2-95db-dae17e9e359a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 265, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.1.1 Biological Samples 60\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"33302951-242f-4ea0-9d9f-b6d09021d874\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 266, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.1.2 Laboratory Assays 60\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8e53624e-cf5a-4b28-8f1b-dae27b5df9d3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 267, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.1.3 Immunological Read-outs 62\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"19b01650-e7fc-411a-a2b3-1ad817003d42\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 268, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.1.4 Clinical Safety Laboratory Assessments 63\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9375c2c7-ef2f-4270-a2f4-22d4b5abaadf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 269, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.1.5 Immunological Correlates of Protection 63\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2044151f-3a34-4a04-9c38-705fb45dc2d5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 270, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.2 Collection of Demographic Data and Other Baseline\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cd87da9d-5aa8-46d7-9927-60e4cd59e49d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 271, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Characteristics 63\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"33567b19-d94b-4fe3-a120-deebc01af58c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 272, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.3 Safety Assessments 63\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d95122f8-559d-4b3f-8109-b0e39a4d5736\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 273, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.3.1 Medical History 64\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0fd619f4-c60c-4fc0-8dbe-8d4c9d237010\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 274, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.3.2 Physical Examination 64\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0ed0a8b6-d6a5-4d93-b35c-518ee4a8f83f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 275, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.3.3 Pregnancy Test 65\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e264ec43-508d-4347-9655-f37d8182e3eb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 276, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.3.4 Warnings and Precautions to Vaccination 65\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"250403d8-ec2c-401a-9176-7c57af8eabc4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 277, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.3.5 Pre-vaccination Body Temperature 65\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"be84b1c9-06f7-46be-ba89-f0c8d17aa7b4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 278, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.3.6 Adverse Events 66\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ac18bd90-8266-4098-8c13-f225b84b1fd3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 279, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.3.7 Treatment of Overdose 71\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"859a43e8-3830-45cd-abe9-d87ed3a4b547\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 280, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.3.8 Medical Device Deficiencies 71\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c884a330-922c-4f7f-bd40-673042a8443b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 281, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.4 Pharmacokinetics 72\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a9ffa69d-08cf-4ee7-9bf9-fc9d3f4eeabd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 282, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.5 Pharmacodynamics 72\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8e00ed34-0451-455d-ae5b-ceb27cd0d852\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 283, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.6 Genetics 72\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d6e362d0-e929-4caa-8e27-c8cf489e9555\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 284, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.7 Biomarkers 72\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4bf1abbb-cffd-4cae-b651-de3a5330fe64\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 285, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.8 Health Outcomes 72\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e50fc798-5b56-4736-a84c-282c965c33f6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 286, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.9 Study Procedures During Special Circumstances 72\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"328d5b9c-cd96-45ad-9a2b-615625a211c4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 287, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9.0 STATISTICAL CONSIDERATIONS 74\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"114468ed-e44d-4df9-a241-d103dbe0b6ba\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 288, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9.1 Statistical Hypotheses 74\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"84cfbd85-5d1f-446f-a713-e1d450361403\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 289, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9.2 Sample Size Determination 75\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c76deb78-592d-4bca-b601-d725dc6badfa\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 290, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9.3 Populations for Analyses 76\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e2f4e5de-4a64-4b86-ab9f-85b6a2c631bf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 291, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9.3.1 Cri teria for Elimination from Analysis 77\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e478eeb6-a219-4ab8-b0b1-1948928d986d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 292, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9.4 Statistical Analyses 77\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c9ff523c-d617-46d8-bf3e-b9aa3155355b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 293, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9.4.1 General Considerations 77\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9d2894ed-5777-4394-a443-1e62d4f54737\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 294, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.3.6.6 9.4.2 Participants Disposition 78\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f182a7fc-864a-4f5b-897c-5c22cf778fc6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 295, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9.4.3 Primary Endpoint(s) 78\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"37a63c39-e74c-4e0b-9dc6-2d44ac7dacbf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 296, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9.4.4 Secondary Endpoints 81\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9499afd0-85b7-4d77-9a40-b40b5c1bd45f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 297, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9.4.5 Tert iary Endpoints 82\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e33f3661-602e-4b9e-aa01-ab66ea83cf6d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 298, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9.4.6 Other Analyses 84\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a26b6b0d-c277-4b96-8ec3-2008e024cd94\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 299, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9.5 Interim Analyses 84\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"69691593-09ca-43e8-969c-8fc8f0d9186f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 300, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9.5.1 Sequence of Analyses 84\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"27509f79-9491-4f9b-9156-e1e457e65e8d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 301, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9.5.2 Statistical Consideration for Interim Analysis 84\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"63e698a5-5e27-4373-90d4-dfeed04d9b1a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 302, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9.6 Data Monitoring Committee 84\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7e412bd9-4007-40c6-8a5a-3b06fe19efa5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 303, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"10.0 R EFERENCES 85\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"03990ed1-2fdb-47df-a0d0-e220a453158d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 304, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"11.0 APPENDICES 86\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3a883da6-bf86-4598-8ce1-90aa2c7174db\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 305, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Appendix 1 Abbreviations and Glossary of Terms 87\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"32dbce52-b83f-43ed-9346-897ee92d7941\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 306, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Appendix 2 Regulatory, Ethical, and Study Oversight Considerations 94\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7cb102c0-113d-4629-ab35-f2bdb420ca5f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 307, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Regulatory and Ethical Considerations 94\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"57c799ae-5a97-4dd7-ac35-e7ae8a0e9674\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 308, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Financial Disclosure 94\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0b877a94-9c3c-4c50-9e02-46b0d93840b2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 309, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Informed Consent and Assent Process 95\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8dd4bb98-0158-4843-98cf-f0f7be99193d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 310, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Responsibilities of the Investigator and IRB/EC 95\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5a6e5d34-5b6b-4827-86d9-34f45c9840fa\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 311, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Administrativ e Structure 97\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2946562b-8cff-4da7-a889-f1aae443d3da\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 312, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Medical Monitor 97\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"edc82db7-c354-4d20-a56c-02a34cb25da2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 313, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Dissemination of Clinical Study Data 97\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"926c09e3-3103-4400-9c6a-f5c37d72f59b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 314, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Data Quality Assurance 98\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a67e77fe-8d71-4710-8770-72dcf466a781\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 315, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Source Document s 99\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d6311b2a-ca61-4e18-820b-7453f2de160a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 316, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~ Closure 99\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"15cf913e-d51c-4cd8-b869-d34acee5df58\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 317, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Publication Policy 99\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"45479d27-8270-49ee-a323-86232957b5f3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 318, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Appendix 3 Clinical Laboratory Tests 100\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"16d824a4-69d3-4b62-b2dd-1e251611e80c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 319, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~ Assessments 100\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8b647604-5340-4dcf-813c-4fe5684d8ca2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 320, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Laboratory Assays 100\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"643ba60b-c689-4a51-88eb-b91c50264766\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 321, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Appendix 4 Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting 102\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"11a48286-f357-4c80-8040-371a9cfbf5ed\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 322, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Appendix 5 Contraceptive Guidance and Collection of Pregnancy\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3ba8aa83-1882-4b9a-8f2c-205c3f8296ba\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 323, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Information 116\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74dcc567-9792-4782-b6dd-fec36afe448d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 324, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Appendix 6 Country-specific Requirements 119\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"02382ed1-e3f6-4baf-b220-24234bdd6672\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 325, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Appendix 7 Signature of Investigator 120\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"efc471c5-ec06-4c43-bc3a-5b15ac443e56\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 326, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3876fbd7-4b16-41e6-9672-8688ef08f3b9\\\", \\\"childbox\\\": \\\"7a634d25-43de-41bf-8d11-b26796eae693\\\", \\\"subtext\\\": \\\"e46caf91-b8a5-47b4-bd39-ff31ab3f4b2c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"DISCONTINUATION OF STUDY INTERVENTION AND\\\", \\\"7.0\\\", \\\"2\\\", 327, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"TABLE OF TABLES\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading1\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"31a4156c-8a3f-4d05-a735-2601cf2be7b7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"OF TABLES\\\", \\\"TABLE\\\", \\\"1\\\", 328, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Table 1</td>\\\\n      <td>Document History ..............................................................................................3</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Table 2</td>\\\\n      <td>Description of Changes in Amendment 2 ..........................................................4</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Table 3</td>\\\\n      <td>Schedule of Activities ......................................................................................26</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Table 4</td>\\\\n      <td>Intervals Between Study Visits ........................................................................29</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>Table 5</td>\\\\n      <td>Intervals Between Telephone Contacts ............................................................30</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>Table 6</td>\\\\n      <td>Study Objectives and Endpoints ......................................................................34</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td>Table 7</td>\\\\n      <td>Study Groups, Intervention, and Blinding Foreseen in the Study ...................39</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>7</th>\\\\n      <td>Table 8</td>\\\\n      <td>Study Interventions Administered ...................................................................47</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>8</th>\\\\n      <td>Table 9</td>\\\\n      <td>Biological Samples ..........................................................................................60</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>9</th>\\\\n      <td>Table 10</td>\\\\n      <td>Laboratory Assays ...........................................................................................61</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>10</th>\\\\n      <td>Table 11</td>\\\\n      <td>Immunological Read-outs ................................................................................62</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>11</th>\\\\n      <td>Table 12</td>\\\\n      <td>Timeframes for Collecting and Reporting of Safety Information ...................67</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>12</th>\\\\n      <td>Table 13</td>\\\\n      <td>Timeframes for Submitting SAEs, Pregnancies, and AESIs ...........................70</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>13</th>\\\\n      <td>Table 14</td>\\\\n      <td>Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary) ..........76</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>14</th>\\\\n      <td>Table 15</td>\\\\n      <td>Populations for Analyses .................................................................................77</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>15</th>\\\\n      <td>Table 16</td>\\\\n      <td>Study Administrative Structure........................................................................97</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>16</th>\\\\n      <td>Table 17</td>\\\\n      <td>List of Potential Immune-Mediated Diseases (pIMDs) .................................106</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"17\\\", \\\"TableIndex\\\": \\\"13\\\", \\\"TableName\\\": \\\"TABLE OF TABLES\\\", \\\"Header\\\": []}, {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"be30daa5-dc3a-430d-995f-341b5f43da9d\\\", \\\"childbox\\\": \\\"c0cc264c-d127-42ca-9a23-306cd7ea8c0f\\\", \\\"subtext\\\": \\\"6949cd8c-4f1c-464b-a43d-69e449e2f7a6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"OF TABLES\\\", \\\"TABLE\\\", \\\"1\\\", 329, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4e6ceaf5-6ba7-451a-a779-d4fccec48e02\\\", \\\"childbox\\\": \\\"a0083e26-d539-4ba5-9adb-f85df2a0eef4\\\", \\\"subtext\\\": \\\"663c20ac-4e5c-414f-bc22-a42470e5e4f4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"OF TABLES\\\", \\\"TABLE\\\", \\\"1\\\", 330, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"TABLE OF FIGURES\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading1\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1609a6a9-3720-4c65-8641-89fd2e1a2b6d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"OF FIGURES\\\", \\\"TABLE\\\", \\\"1\\\", 331, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Figure 1\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2027c835-a681-4d83-af62-8b660674861d\\\", \\\"childbox\\\": \\\"7538bb99-5701-4544-89bf-46660e901198\\\", \\\"subtext\\\": \\\"43199c5e-bb40-405d-a2c0-67b123ea2b44\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"OF FIGURES\\\", \\\"TABLE\\\", \\\"1\\\", 332, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2027c835-a681-4d83-af62-8b660674861d\\\", \\\"childbox\\\": \\\"7538bb99-5701-4544-89bf-46660e901198\\\", \\\"subtext\\\": \\\"e14f1e47-da78-4169-a637-90921a43df53\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Calibri\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"OF FIGURES\\\", \\\"TABLE\\\", \\\"1\\\", 333, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2027c835-a681-4d83-af62-8b660674861d\\\", \\\"childbox\\\": \\\"0ab43658-220e-4408-b0d1-16bdd6843615\\\", \\\"subtext\\\": \\\"c6a5d78b-595b-4843-9955-f198ae8486da\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Calibri\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"OF FIGURES\\\", \\\"TABLE\\\", \\\"1\\\", 334, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Study Design Overview ..................................................................................38\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2027c835-a681-4d83-af62-8b660674861d\\\", \\\"childbox\\\": \\\"9561e3f0-cd64-4470-b8e9-b04a90c648b4\\\", \\\"subtext\\\": \\\"e5649142-1c57-4b64-ae5c-c244235c7d2d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"OF FIGURES\\\", \\\"TABLE\\\", \\\"1\\\", 335, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2027c835-a681-4d83-af62-8b660674861d\\\", \\\"childbox\\\": \\\"9561e3f0-cd64-4470-b8e9-b04a90c648b4\\\", \\\"subtext\\\": \\\"ac579c25-c9d3-4546-80b4-86b8ad0d5806\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Calibri\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"OF FIGURES\\\", \\\"TABLE\\\", \\\"1\\\", 336, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"87e6d68a-a096-4a5f-a6c6-11b3fbba57a6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"OF FIGURES\\\", \\\"TABLE\\\", \\\"1\\\", 337, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d84df5df-6330-4576-bc04-c27e5b0697bb\\\", \\\"childbox\\\": \\\"dd106a9f-49c2-4caf-9c0a-d47f2692c2b6\\\", \\\"subtext\\\": \\\"7a9f2d56-f164-46cb-a940-f6c33e3cd2a0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"OF FIGURES\\\", \\\"TABLE\\\", \\\"1\\\", 338, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"1.0  PROTOCOL SUMMARY\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading1\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a6b35f66-bc91-44c9-a97f-21cebdca9734\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"PROTOCOL SUMMARY\\\", \\\"1.0\\\", \\\"2\\\", 339, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"1.1 Synopsis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"161b482d-00bd-4b26-85bf-acc58d8bfff0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 340, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Protocol Title\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"30e557f0-ca16-43d0-ad3e-a9066e3eb938\\\", \\\"childbox\\\": \\\"f0b10db9-b65a-430f-8028-035d70e9b5cf\\\", \\\"subtext\\\": \\\"c34be5d1-212a-4738-9fa7-f0c1b80fa6d3\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 341, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\": A phase IIIB, randomized, controlled, observer-blind study to evaluate safety and immunogenicity of ~REDACTED~ meningococcal ABCWY ~REDACTED~ when administered in healthy adolescents and adults, previously primed with meningococcal ACWY ~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"30e557f0-ca16-43d0-ad3e-a9066e3eb938\\\", \\\"childbox\\\": \\\"f0b10db9-b65a-430f-8028-035d70e9b5cf\\\", \\\"subtext\\\": \\\"385918ce-60ea-4ed0-946c-973b098a098b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 342, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Short Title:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8afe15c4-17bb-42b1-81ea-13645c10a690\\\", \\\"childbox\\\": \\\"0acef638-8835-477a-932c-812b0a731c38\\\", \\\"subtext\\\": \\\"517595eb-b06e-4296-91a5-4715f63492f7\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 343, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Immunogenicity and safety study of ~REDACTED~ MenABCWY ~REDACTED~ in healthy adolescents and adults previously primed with MenACWY ~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8afe15c4-17bb-42b1-81ea-13645c10a690\\\", \\\"childbox\\\": \\\"0acef638-8835-477a-932c-812b0a731c38\\\", \\\"subtext\\\": \\\"5b7f19be-28e3-4e29-a46e-125f15f94d31\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 344, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8afe15c4-17bb-42b1-81ea-13645c10a690\\\", \\\"childbox\\\": \\\"0acef638-8835-477a-932c-812b0a731c38\\\", \\\"subtext\\\": \\\"d5b6ab5b-9a26-4f92-b79f-8bc1fb81c777\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 345, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Rationale\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4cc7ac88-fcc5-492d-9889-7df795e9ae1f\\\", \\\"childbox\\\": \\\"8cffb0d1-d018-4d48-9159-6f6f37206286\\\", \\\"subtext\\\": \\\"7239808c-61f1-4a41-9e2b-f61dd92521bb\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 346, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\": ~REDACTED~ (~REDACTED~) is developing a combination ~REDACTED~ intended to protect against 5 of the most prevalent serogroups of\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4cc7ac88-fcc5-492d-9889-7df795e9ae1f\\\", \\\"childbox\\\": \\\"8cffb0d1-d018-4d48-9159-6f6f37206286\\\", \\\"subtext\\\": \\\"609f92a3-16af-4b8b-b283-c7fe24e1e950\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 347, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Neisseria meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4cc7ac88-fcc5-492d-9889-7df795e9ae1f\\\", \\\"childbox\\\": \\\"8cffb0d1-d018-4d48-9159-6f6f37206286\\\", \\\"subtext\\\": \\\"34641a09-aacb-4339-b494-5b76db32066b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 348, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4cc7ac88-fcc5-492d-9889-7df795e9ae1f\\\", \\\"childbox\\\": \\\"8cffb0d1-d018-4d48-9159-6f6f37206286\\\", \\\"subtext\\\": \\\"d706c946-a194-4bbd-ad0d-b9b307268d7d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 349, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4cc7ac88-fcc5-492d-9889-7df795e9ae1f\\\", \\\"childbox\\\": \\\"8cffb0d1-d018-4d48-9159-6f6f37206286\\\", \\\"subtext\\\": \\\"c548784b-1ab6-46c6-bd43-1d0873ac05cc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 350, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4cc7ac88-fcc5-492d-9889-7df795e9ae1f\\\", \\\"childbox\\\": \\\"5125d09e-35e1-42d9-bb43-386cac52fe4e\\\", \\\"subtext\\\": \\\"c548784b-1ab6-46c6-bd43-1d0873ac05cc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 351, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"), A, B, C, W, Y, in humans.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4cc7ac88-fcc5-492d-9889-7df795e9ae1f\\\", \\\"childbox\\\": \\\"5125d09e-35e1-42d9-bb43-386cac52fe4e\\\", \\\"subtext\\\": \\\"fa25099d-8554-42a8-b1d5-8a0c26aa2ed0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 352, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The availability of a pentavalent meningococcal ~REDACTED~ in a single administration would reduce the number of injections and could increase coverage for meningococcal disease caused by\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4cc7ac88-fcc5-492d-9889-7df795e9ae1f\\\", \\\"childbox\\\": \\\"57b0ef60-a1fb-4bd3-9799-28ec05a4999f\\\", \\\"subtext\\\": \\\"fa25099d-8554-42a8-b1d5-8a0c26aa2ed0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 353, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4cc7ac88-fcc5-492d-9889-7df795e9ae1f\\\", \\\"childbox\\\": \\\"57b0ef60-a1fb-4bd3-9799-28ec05a4999f\\\", \\\"subtext\\\": \\\"edc6a70d-c6d3-4098-a213-758e74db3971\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 354, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4cc7ac88-fcc5-492d-9889-7df795e9ae1f\\\", \\\"childbox\\\": \\\"bcf321a4-7a7d-4413-987e-fe89eafec861\\\", \\\"subtext\\\": \\\"edc6a70d-c6d3-4098-a213-758e74db3971\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 355, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"serogroups A, B, C, W, and Y worldwide.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4cc7ac88-fcc5-492d-9889-7df795e9ae1f\\\", \\\"childbox\\\": \\\"bcf321a4-7a7d-4413-987e-fe89eafec861\\\", \\\"subtext\\\": \\\"4802cffb-3c4f-4dc5-ae0a-a02b5d99ef41\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 356, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigational MenABCWY combination ~REDACTED~ is based upon 2 established ~REDACTED~ ~REDACTED~s, the quadrivalent meningococcal ACWY (MenACWY) conjugate ~REDACTED~ (\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e1114af1-349f-4b0a-805d-cd72e6a416fa\\\", \\\"childbox\\\": \\\"e22557d9-7dc4-4b46-867f-5d391aca22a5\\\", \\\"subtext\\\": \\\"d8d47084-9604-4c36-a8c4-b25d2dca4e7d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 357, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e1114af1-349f-4b0a-805d-cd72e6a416fa\\\", \\\"childbox\\\": \\\"e22557d9-7dc4-4b46-867f-5d391aca22a5\\\", \\\"subtext\\\": \\\"bad03bfe-e094-45c7-b7e8-8a1bcd5f1224\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 358, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\") and the multi-component recombinant meningococcal B (MenB) ~REDACTED~ (\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e1114af1-349f-4b0a-805d-cd72e6a416fa\\\", \\\"childbox\\\": \\\"e22557d9-7dc4-4b46-867f-5d391aca22a5\\\", \\\"subtext\\\": \\\"9b6ab3f6-19ca-4f3d-ab97-b1affb0c59fc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 359, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Bexsero\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e1114af1-349f-4b0a-805d-cd72e6a416fa\\\", \\\"childbox\\\": \\\"e22557d9-7dc4-4b46-867f-5d391aca22a5\\\", \\\"subtext\\\": \\\"9d2b623a-e0cf-4a22-a63c-01882bfd0892\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 360, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\").\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e1114af1-349f-4b0a-805d-cd72e6a416fa\\\", \\\"childbox\\\": \\\"e22557d9-7dc4-4b46-867f-5d391aca22a5\\\", \\\"subtext\\\": \\\"48951fbd-f22f-4546-9a28-604942b07110\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 361, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The United States (US) Advisory Committee on Immunization Practices (ACIP) recommends vaccination with a quadrivalent conjugated meningococcal ~REDACTED~ for adolescents at 11 to 12 years of age with a booster dose at 16 years of age, based on the data showing a robust immune response to a booster dose of MenACWY ~REDACTED~s in this age group.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4a5e906f-e9b7-4bbe-b92d-1df2011c3f64\\\", \\\"childbox\\\": \\\"d86b3509-29f1-469a-b2a6-b37354165b94\\\", \\\"subtext\\\": \\\"1aa05966-5364-4d1b-95c0-e73c7b19ef8d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 362, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The ACIP also recommends MenB vaccination in persons aged 10 years and older who are at increased risk for MenB disease and in adolescents and young adults aged 16 to 23 years not at increased risk based on shared clinical decision making.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4a5e906f-e9b7-4bbe-b92d-1df2011c3f64\\\", \\\"childbox\\\": \\\"06556c5a-3a5a-427b-bbac-de833e6fddea\\\", \\\"subtext\\\": \\\"726ba14e-bed3-40fc-a493-4cecd168ddaf\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 363, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Based on the current ACIP recommendations for a MenACWY booster dose at 16 years of age and for MenB vaccination at 16 to 23 years of age, there is a need to evaluate the response to the MenABCWY ~REDACTED~ in MenACWY-~REDACTED~ primed individuals.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"064cb4d1-fe44-44ca-9eeb-ecbb7220e594\\\", \\\"childbox\\\": \\\"4ee61bc5-0cb8-4e6f-97e0-1de715666114\\\", \\\"subtext\\\": \\\"a6c76d85-a71b-4a3b-8a9e-7159d8b009d7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 364, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In the context of the MenABCWY investigational ~REDACTED~ development, the MenACWY booster response has been evaluated in 2 phase II clinical studies (~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"064cb4d1-fe44-44ca-9eeb-ecbb7220e594\\\", \\\"childbox\\\": \\\"94e09522-783c-49e5-aa94-1c06ac3a737a\\\", \\\"subtext\\\": \\\"973d297a-cbb0-45d5-abd6-ecdb2d36435e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 365, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"064cb4d1-fe44-44ca-9eeb-ecbb7220e594\\\", \\\"childbox\\\": \\\"94e09522-783c-49e5-aa94-1c06ac3a737a\\\", \\\"subtext\\\": \\\"d2221889-7976-44b4-a995-775d07dae1c0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"single\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 366, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2018; ~REDACTED~, 2018).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"064cb4d1-fe44-44ca-9eeb-ecbb7220e594\\\", \\\"childbox\\\": \\\"94e09522-783c-49e5-aa94-1c06ac3a737a\\\", \\\"subtext\\\": \\\"e80f2fbb-5b8b-4e24-ba5b-f3af8416248f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 367, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Although the sample size of these studies was small, a robust anamnestic immune response against A, C, W, and Y serogroups was demonstrated at 1 month after the administration of the first dose of the MenABCWY ~REDACTED~ in participants previously primed with the ~REDACTED~ MenACWY ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"064cb4d1-fe44-44ca-9eeb-ecbb7220e594\\\", \\\"childbox\\\": \\\"ced6f14d-c503-4daf-9ab7-db2e42e30194\\\", \\\"subtext\\\": \\\"9ca2c2b0-f4f4-4cdf-ac6c-40bbc5b117e2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 368, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The main purpose of this phase IIIB clinical study is to assess the immunogenicity and safety of the MenABCWY ~REDACTED~ when administered as a booster in healthy adolescents and young adults, previously primed with a MenACWY ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"39e0d395-33c1-471a-8531-5d47da0b626d\\\", \\\"childbox\\\": \\\"df7f49bc-6a23-4fd1-821f-033b4f3b6b42\\\", \\\"subtext\\\": \\\"ecf148ec-9845-43c3-bfe1-b7bf0781f718\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 369, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Objectives and Endpoints:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8b5c2181-de19-4bf9-926a-17e672caa883\\\", \\\"childbox\\\": \\\"387a3d76-afb6-4601-8744-c03e528693e5\\\", \\\"subtext\\\": \\\"a10369ad-0d17-4291-9350-05c52b0edf10\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 370, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Objectives</td>\\\\n      <td>Endpoints</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Primary</td>\\\\n      <td>Primary</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Immunological non-inferiority: MenABCWY vs. MenACWY (Family 1) To demonstrate the immunological non-inferiority of the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with a MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, as measured by the percentages of participants achieving a 4-fold rise <sup>1</sup> in hSBA titers against N. meningitidis serogroups A, C, W, and Y, at 1 month after the second MenABCWY vaccination (0,6-months) and 1 month after the MenACWY vaccination (single dose).</td>\\\\n      <td>The percentages of participants with a 4-fold rise <sup>1</sup> in hSBA titers against N . meningitidis serogroups A, C, W, and Y at 1 month after the second vaccination for the ABCWY group (Day 211, Month 7), and 1 month after the single MenACWY vaccination for the ACWY group (Day 31, Month 1) relative to baseline (Day 1, Month 0).</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Immunological non-inferiority: MenABCWY vs. MenACWY  (Family 2)  To demonstrate the immunological non-inferiority of the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with a MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, as measured by the percentages of participants achieving a 4-fold rise <sup>1</sup> in hSBA titers against N. meningitidis serogroups A, C, W, and Y, at 1 month after the first MenABCWY vaccination (0,6-months) and 1 month after the MenACWY vaccination (single dose).</td>\\\\n      <td>The percentages of participants with a 4-fold rise <sup>1</sup> in hSBA titers against N . meningitidis serogroups A, C, W, and Y at 1 month after the first vaccination for the ABCWY group (Day 31, Month 1), and 1 month after the single dose of MenACWY vaccination for the ACWY group (Day 31, Month 1), relative to baseline (Day 1, Month 0).</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>Safety To evaluate the safety and reactogenicity of the MenABCWY and MenACWY vaccines.</td>\\\\n      <td>The frequencies and percentages of participants with solicited administration site events (i.e., injection site pain, erythema, swelling, induration) and solicited systemic events (i.e., fever [body temperature \\\\u226538.0\\\\u00b0C/100.4\\\\u00b0F], nausea, fatigue, myalgia, arthralgia, headache) during the 7 days (including the day of vaccination) following vaccination at Day 1, Month 0 (for the ABCWY and ACWY groups) and Day 181, Month 6 (for the ABCWY group). The frequencies and percentages of participants with any unsolicited AEs (including all SAEs, AEs leading to withdrawal, AESIs and medically attended AEs) during the 30 days (including the day of vaccination) following vaccination at Day 1, Month 0 (for the ABCWY and ACWY groups) and Day 181, Month 6 (for the ABCWY group). The percentages of participants with SAEs, AEs leading to withdrawal, AESIs and medically attended AEs throughout the study period (Month 0 to Month 12).</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>Secondary</td>\\\\n      <td>Secondary</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td>To assess <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to MenABCWY (0,6-month schedule) and MenACWY (single dose) vaccines against N. meningitidis serogroups A, C, W, and Y, at pre-vaccination and at 1 month after the first</td>\\\\n      <td>The percentages of participants with hSBA titers \\\\u2265Lower Limit of Quantitation (LLOQ) against serogroups A, C, W, and Y:</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"19\\\", \\\"TableIndex\\\": \\\"14\\\", \\\"TableName\\\": \\\"1.1 Synopsis\\\", \\\"Header\\\": [0, 1, 2]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"89d0eb07-9b41-4494-8939-2d9bf460581e\\\", \\\"childbox\\\": \\\"bfcc0298-3af5-432c-b513-5e6be62054cb\\\", \\\"subtext\\\": \\\"7f6e7896-40a5-4d1d-af56-6ae73f39bf83\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 371, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"460b0548-3e76-40ec-b768-f01b3bf5148f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 372, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Objectives</td>\\\\n      <td>Objectives</td>\\\\n      <td>Endpoints</td>\\\\n      <td>Endpoints</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>and last MenABCWY vaccinations and 1 month after the MenACWY vaccination.</td>\\\\n      <td>and last MenABCWY vaccinations and 1 month after the MenACWY vaccination.</td>\\\\n      <td>at baseline (Day 1, Month 0) and at 1 month after the first (Day 31, Month 1) and the last vaccination (Day 211, Month 7) for the ABCWY group, and at baseline (Day 1, Month 0) and 1 month after the single MenACWY vaccination for the ACWY group (Day 31, Month 1). The geometric mean titers (GMTs) against serogroups A, C, W, and Y: at baseline (Day 1, Month 0) and at 1 month after the first (Day 31, Month 1) and the last (Day 211, Month 7) vaccinations for the ABCWY group, and at baseline (Day 1, Month 0) and 1 month after the single MenACWY vaccination for the ACWY group (Day 31, Month 1). The geometric mean ratios (GMRs) against serogroups A, C, W, and Y: at 1 month after the first (Day 31, Month 1) and the last vaccination (Day 211, Month 7) for the ABCWY group as compared to baseline (Day 1, Month 0) and at 1 month after the MenACWY vaccination (Day 31, Month 1) for the ACWY group as compared to baseline (Day 1, Month 0).</td>\\\\n      <td>at baseline (Day 1, Month 0) and at 1 month after the first (Day 31, Month 1) and the last vaccination (Day 211, Month 7) for the ABCWY group, and at baseline (Day 1, Month 0) and 1 month after the single MenACWY vaccination for the ACWY group (Day 31, Month 1). The geometric mean titers (GMTs) against serogroups A, C, W, and Y: at baseline (Day 1, Month 0) and at 1 month after the first (Day 31, Month 1) and the last (Day 211, Month 7) vaccinations for the ABCWY group, and at baseline (Day 1, Month 0) and 1 month after the single MenACWY vaccination for the ACWY group (Day 31, Month 1). The geometric mean ratios (GMRs) against serogroups A, C, W, and Y: at 1 month after the first (Day 31, Month 1) and the last vaccination (Day 211, Month 7) for the ABCWY group as compared to baseline (Day 1, Month 0) and at 1 month after the MenACWY vaccination (Day 31, Month 1) for the ACWY group as compared to baseline (Day 1, Month 0).</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>To assess <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> (0,6-month schedule) against N. meningitidis serogroup B indicator strains, at pre-vaccination and at 1 month after the last MenABCWY vaccination.</td>\\\\n      <td>To assess <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> (0,6-month schedule) against N. meningitidis serogroup B indicator strains, at pre-vaccination and at 1 month after the last MenABCWY vaccination.</td>\\\\n      <td>The percentages of participants with hSBA titers \\\\u2265LLOQ for each and all serogroup B indicator strains at baseline (Day 1, Month 0) and at 1 month after the last vaccination (Day 211, Month 7) for the ABCWY group. The percentages of participants with 4-fold rise <sup>1</sup> in hSBA titers against each N. meningitidis serogroup B indicator strains at 1 month after the last vaccination (Day 211, Month 7) relative to baseline (Day 1, Month 0) for the ABCWY group. GMTs against each serogroup B indicator strains at baseline (Day 1, Month 0) and at 1 month after the last vaccination (Day 211, Month 7) for the ABCWY group. GMRs against each serogroup B indicator strains at 1 month after the last vaccination (Day 211, Month 7) as compared to the baseline (Day 1, Month 0) for the ABCWY group.</td>\\\\n      <td>The percentages of participants with hSBA titers \\\\u2265LLOQ for each and all serogroup B indicator strains at baseline (Day 1, Month 0) and at 1 month after the last vaccination (Day 211, Month 7) for the ABCWY group. The percentages of participants with 4-fold rise <sup>1</sup> in hSBA titers against each N. meningitidis serogroup B indicator strains at 1 month after the last vaccination (Day 211, Month 7) relative to baseline (Day 1, Month 0) for the ABCWY group. GMTs against each serogroup B indicator strains at baseline (Day 1, Month 0) and at 1 month after the last vaccination (Day 211, Month 7) for the ABCWY group. GMRs against each serogroup B indicator strains at 1 month after the last vaccination (Day 211, Month 7) as compared to the baseline (Day 1, Month 0) for the ABCWY group.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Tertiary <sup>2</sup></td>\\\\n      <td>Tertiary <sup>2</sup></td>\\\\n      <td>Tertiary <sup>2</sup></td>\\\\n      <td>Tertiary <sup>2</sup></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>To assess <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> (0,6-months schedule) against N. meningitidis serogroup B indicator strains, at 1 month after the first vaccination.</td>\\\\n      <td>To assess <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> (0,6-months schedule) against N. meningitidis serogroup B indicator strains, at 1 month after the first vaccination.</td>\\\\n      <td>The percentages of participants with hSBA titers \\\\u2265LLOQ for each serogroup B indicator strains at 1 month after the first vaccination (Day 31, Month 1 for the ABCWY group).</td>\\\\n      <td>The percentages of participants with hSBA titers \\\\u2265LLOQ for each serogroup B indicator strains at 1 month after the first vaccination (Day 31, Month 1 for the ABCWY group).</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>The percentages of participants with 4-fold rise <sup>1</sup> in hSBA titers against each N. meningitidis serogroup B indicator strains at 1 month after the first vaccination (Day 31, Month 1) relative to baseline (Day 1, Month 0) for the ABCWY group. GMTs against each serogroup B indicator strains at 1 month after the first vaccination (Day 31, Month 1) for the ABCWY group. GMRs against each serogroup B test strains at 1 month after first vaccination (Day 31, Month 1) as compared to baseline (Day 1, Month 0) for the ABCWY group.</td>\\\\n      <td>The percentages of participants with 4-fold rise <sup>1</sup> in hSBA titers against each N. meningitidis serogroup B indicator strains at 1 month after the first vaccination (Day 31, Month 1) relative to baseline (Day 1, Month 0) for the ABCWY group. GMTs against each serogroup B indicator strains at 1 month after the first vaccination (Day 31, Month 1) for the ABCWY group. GMRs against each serogroup B test strains at 1 month after first vaccination (Day 31, Month 1) as compared to baseline (Day 1, Month 0) for the ABCWY group.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td>To assess <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to MenABCWY (0,6-month schedule) and MenACWY (single dose) vaccines, as measured by Enzyme-Linked Immunosorbent Assay (ELISA) Geometric Mean Concentration (GMCs), against N. meningitidis serogroups A, C, W, and Y, at pre-vaccination (and at 1 month after the first and last MenABCWY vaccinations and 1 month after the MenACWY vaccination.</td>\\\\n      <td>To assess <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to MenABCWY (0,6-month schedule) and MenACWY (single dose) vaccines, as measured by Enzyme-Linked Immunosorbent Assay (ELISA) Geometric Mean Concentration (GMCs), against N. meningitidis serogroups A, C, W, and Y, at pre-vaccination (and at 1 month after the first and last MenABCWY vaccinations and 1 month after the MenACWY vaccination.</td>\\\\n      <td>The total IgG as measured by ELISA GMCs against serogroups A, C, W, and Y: at baseline (Day 1, Month 0) and at 1 month after the first (Day 31, Month 1) and the last vaccination (Day 211, Month 7) for the ABCWY group, and at baseline (Day 1, Month 0) and 1 month after the single MenACWY vaccination in the ACWY group (Day 31, Month 1).</td>\\\\n      <td>The total IgG as measured by ELISA GMCs against serogroups A, C, W, and Y: at baseline (Day 1, Month 0) and at 1 month after the first (Day 31, Month 1) and the last vaccination (Day 211, Month 7) for the ABCWY group, and at baseline (Day 1, Month 0) and 1 month after the single MenACWY vaccination in the ACWY group (Day 31, Month 1).</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"19\\\", \\\"TableIndex\\\": \\\"15\\\", \\\"TableName\\\": \\\"1.1 Synopsis\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"27a00c12-ead8-4613-b2bd-fb2de71bf3b2\\\", \\\"childbox\\\": \\\"14b4ef96-fe94-4fdc-af81-fd7cdd9b8c62\\\", \\\"subtext\\\": \\\"90afba72-4fc4-424e-8ff6-1fc640e7027f\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 373, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a06bd2ec-a722-4726-8196-e30bc95599fd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 374, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"AESI = adverse event of special interest; CI = confidence interval; ELISA = enzyme-linked immunosorbent assay; GMC = geometric mean concentration; GMT = geometric mean titer; GMR = geometric mean ratio; hSBA = human serum bactericidal assay; LLOQ = lower limit of quantitation;\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e7b6af71-e457-46cf-ae5f-049fdd3d290e\\\", \\\"childbox\\\": \\\"82909e3f-1225-4ce6-88b3-843869d4deea\\\", \\\"subtext\\\": \\\"286c1c8f-8e77-434b-92bd-1fb2297b8333\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 375, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e7b6af71-e457-46cf-ae5f-049fdd3d290e\\\", \\\"childbox\\\": \\\"82909e3f-1225-4ce6-88b3-843869d4deea\\\", \\\"subtext\\\": \\\"ffa60e95-f58c-42d5-961d-2d4b8d7ebe1e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 376, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e7b6af71-e457-46cf-ae5f-049fdd3d290e\\\", \\\"childbox\\\": \\\"58a73d2f-88df-4487-987b-f2eff7e261af\\\", \\\"subtext\\\": \\\"ffa60e95-f58c-42d5-961d-2d4b8d7ebe1e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 377, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"=\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e7b6af71-e457-46cf-ae5f-049fdd3d290e\\\", \\\"childbox\\\": \\\"58a73d2f-88df-4487-987b-f2eff7e261af\\\", \\\"subtext\\\": \\\"d1410c87-f5b6-4eb2-8936-1b583f5a4ca2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 378, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Neisseria meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e7b6af71-e457-46cf-ae5f-049fdd3d290e\\\", \\\"childbox\\\": \\\"58a73d2f-88df-4487-987b-f2eff7e261af\\\", \\\"subtext\\\": \\\"75dca529-9c28-4527-bce4-43ac468a50ed\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 379, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"; SAE = serious adverse event\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e7b6af71-e457-46cf-ae5f-049fdd3d290e\\\", \\\"childbox\\\": \\\"58a73d2f-88df-4487-987b-f2eff7e261af\\\", \\\"subtext\\\": \\\"9e0f6a01-a33d-4cdd-b27f-6479e8296e8b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 380, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1 Refer to Section 9.0 for the (seroresponse) definition of the 4-fold rise.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b8f9e943-50e8-4653-a089-b38b2c92e237\\\", \\\"childbox\\\": \\\"1e73c8b2-60d1-46ac-bd22-b1e8e6e90de2\\\", \\\"subtext\\\": \\\"5b47c92f-9148-49c3-9d96-9f7a2b8929aa\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 381, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2 Evaluation of the tertiary objective is participant to availability of samples and may or not be performed.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c9cc1ef3-459c-4222-a494-3004e3511702\\\", \\\"childbox\\\": \\\"b1553ad2-76e0-45ce-bb5f-79bf8783c6da\\\", \\\"subtext\\\": \\\"3b153102-09a4-4a37-b8ef-807a51d92860\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 382, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If the tertiary objective is evaluated, it may be assessed in a subset of participants using remaining serum after the primary and secondary analyses have been completed; no additional blood samples will be collected from participants.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c9cc1ef3-459c-4222-a494-3004e3511702\\\", \\\"childbox\\\": \\\"b9e7dc36-9b55-4063-8b6c-c99a4df34f1b\\\", \\\"subtext\\\": \\\"aa76497e-4f98-4695-8c0e-25480806e532\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 383, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Any outcome of exploratory testing in respect of the tertiary objective will be reported in an annex/addendum to the final clinical study report.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c9cc1ef3-459c-4222-a494-3004e3511702\\\", \\\"childbox\\\": \\\"5a3c5d09-5866-452d-92cd-af1ba7e83364\\\", \\\"subtext\\\": \\\"917e549e-e90a-43ae-99f1-7ebcd65e466e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 384, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Overall Design:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e7095263-a53a-4a67-9349-900917ec3536\\\", \\\"childbox\\\": \\\"d8eeed29-33e8-4b34-863c-8e5cb0c17d51\\\", \\\"subtext\\\": \\\"b22ceb7e-e79f-4496-a731-9174d717bbd0\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 385, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This is a phase IIIB, randomized, controlled, observer-blind, multi-centric study with 2 parallel study groups of healthy adolescents and young adults aged 15 to 25 years (i.e, 25 years + 364 days).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8be4b8d1-e6d6-4444-b7c7-c620222ee822\\\", \\\"childbox\\\": \\\"ab3966ec-d46b-48af-bbd2-b97dd0df32c1\\\", \\\"subtext\\\": \\\"10a0c46a-e253-4782-8cac-61b15bf70c74\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 386, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The participants will be randomized at a 1:1 ratio to the ABCWY or ACWY group using an Interactive Voice Response System randomization.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8be4b8d1-e6d6-4444-b7c7-c620222ee822\\\", \\\"childbox\\\": \\\"5bb0935f-a796-41a7-909f-0de1a405e325\\\", \\\"subtext\\\": \\\"10a0c46a-e253-4782-8cac-61b15bf70c74\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 387, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Number of Participants:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bb56ee92-ee28-4a38-8ce5-1c2ca55767f0\\\", \\\"childbox\\\": \\\"c9f8e059-6b56-4526-bae6-78c267c65034\\\", \\\"subtext\\\": \\\"7385ff22-a0cd-4190-94f0-3a1131c2ee46\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 388, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Approximately 1206 participants will be randomly assigned to study intervention or placebo for an estimated total of 1084 evaluable participants or 542 evaluable participants per study group.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"05e07cd1-2aef-4561-a204-6ad8f366bbad\\\", \\\"childbox\\\": \\\"9dae5c2c-cefa-4c2a-abd4-650cc922fc7d\\\", \\\"subtext\\\": \\\"6b82597a-2956-4f4a-a19a-88453d428bec\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 389, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For more information, see Section 9.0, Statistical Considerations, and Section 9.2, Sample Size Determination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4028bcbe-3d3d-4059-85c9-c042c159ba72\\\", \\\"childbox\\\": \\\"adff622b-deac-46a7-ab51-5520f1f8eb65\\\", \\\"subtext\\\": \\\"beeb7fa4-423f-40fd-9fe4-616744278ed2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 390, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Study Groups:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1932aa99-2e44-4262-aa13-a6737f16f590\\\", \\\"childbox\\\": \\\"5283032b-0d3b-4433-b076-5bd08410f73b\\\", \\\"subtext\\\": \\\"01b0c892-9d46-424d-ab16-d46e9aa0a05d\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 391, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ABCWY:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1469b610-bbb5-44b0-bc69-2080ba9acca3\\\", \\\"childbox\\\": \\\"33dcfdc7-3d27-485b-8ba4-e21fb35cb56d\\\", \\\"subtext\\\": \\\"8dceab32-056a-4de2-bcad-a08f4db2cc74\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 392, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"603 participants will receive 2 doses of the MenABCWY ~REDACTED~ at ~REDACTED~ 1 (Day 1) and ~REDACTED~ 3 (Day 181) (0,6-month schedule) and 1 dose of placebo at ~REDACTED~ 4 (Day 211).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1469b610-bbb5-44b0-bc69-2080ba9acca3\\\", \\\"childbox\\\": \\\"33dcfdc7-3d27-485b-8ba4-e21fb35cb56d\\\", \\\"subtext\\\": \\\"fea10d88-affd-48ca-8f85-63e4c9b77222\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 393, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ACWY:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"64dee032-7c59-4847-902e-d86fc80b9c55\\\", \\\"childbox\\\": \\\"a4e4e6db-3a5d-4e06-a905-76858a6ccc00\\\", \\\"subtext\\\": \\\"98814a09-cbf2-44dd-851e-f32fae870f2d\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 394, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"603 participants will receive 1 dose of MenACWY ~REDACTED~ at ~REDACTED~ 1 (Day 1) (single dose) and 2 doses of MenB ~REDACTED~ at ~REDACTED~ 3 (Day 181) and ~REDACTED~ 4 (Day 211).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"64dee032-7c59-4847-902e-d86fc80b9c55\\\", \\\"childbox\\\": \\\"a4e4e6db-3a5d-4e06-a905-76858a6ccc00\\\", \\\"subtext\\\": \\\"1c4a0098-f852-4aac-8af4-5f9dfe2c1659\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 395, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Duration:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dac4c755-ef15-4d4a-b909-9bd6ec0c07ff\\\", \\\"childbox\\\": \\\"dab5b097-6164-4de9-8e37-1c4aa8af328f\\\", \\\"subtext\\\": \\\"1db70d76-5a6c-4b31-8a46-ee895f437468\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 396, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The total duration of the study, per participant, will be approximately 12 months (4 visits), including 6 months of Extended Safety Follow-Up (ESFU) period after the last dose of investigational ~REDACTED~ (~REDACTED~ 3, Day 181).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dac4c755-ef15-4d4a-b909-9bd6ec0c07ff\\\", \\\"childbox\\\": \\\"dab5b097-6164-4de9-8e37-1c4aa8af328f\\\", \\\"subtext\\\": \\\"41c69c48-fbcf-4863-b853-f54f256e96d5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 397, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dac4c755-ef15-4d4a-b909-9bd6ec0c07ff\\\", \\\"childbox\\\": \\\"dab5b097-6164-4de9-8e37-1c4aa8af328f\\\", \\\"subtext\\\": \\\"19a78c5d-b9e6-4a9d-a07d-86db751fed35\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 398, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Statistical Methods:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1d891ee8-bdcb-4e5a-941e-4cffe7d117dc\\\", \\\"childbox\\\": \\\"3e1962dd-29c6-4871-a190-0537a97f0a71\\\", \\\"subtext\\\": \\\"1a6b1ca7-5c70-4dc5-b664-e926d339c2ea\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 399, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Immunological non-inferiority: MenABCWY vs. MenACWY\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"17e5aa28-21c0-4569-9340-85ee47577cb4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"single\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 400, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Non-inferiority will be demonstrated if, the lower limit of 2-sided 95% confidence interval (CI) for the percent difference in 4-fold rise in human serum bactericidal assay (hSBA) titers\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ac2f0502-6184-4e27-b473-afc4d4547924\\\", \\\"childbox\\\": \\\"f3e1af64-bffe-4ced-8dca-6d06237ef3ef\\\", \\\"subtext\\\": \\\"1bba8beb-abcd-49b0-94ee-b2bad62ef0d2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 401, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(p_MenABCWY \\\\u2212 p_MenACWY) is above \\\\u221210%, for each serogroup A, C, W, and Y.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"af2fdb8a-d370-48fa-9887-1402831db6ef\\\", \\\"childbox\\\": \\\"760d3960-3499-4340-9c72-b1374bc660f9\\\", \\\"subtext\\\": \\\"d98dc459-9d4f-4ab2-bacd-0f6541420781\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 402, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For each of the serogroups A, C, W, and Y, the percentages of participants with 4-fold rise and the corresponding exact 2-sided 95% CIs based on Clopper-Pearson method (Clopper and Pearson, 1934) will be calculated for each study group at time point of interest.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"af2fdb8a-d370-48fa-9887-1402831db6ef\\\", \\\"childbox\\\": \\\"0b85adb0-036c-478d-8f7d-cee6a4d1f2cb\\\", \\\"subtext\\\": \\\"d98dc459-9d4f-4ab2-bacd-0f6541420781\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 403, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The standardized asymptotic CIs between group differences in percentages will be derived using the method of ~REDACTED~ and ~REDACTED~ method (~REDACTED~, 1985).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"af2fdb8a-d370-48fa-9887-1402831db6ef\\\", \\\"childbox\\\": \\\"20855b45-fee1-494e-bb16-83441e13f3c4\\\", \\\"subtext\\\": \\\"6fa1a4a5-fda1-4ee2-b7c2-d92129d407d2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 404, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1afe3f8a-bd01-49f9-9c3c-7b83232feb13\\\", \\\"childbox\\\": \\\"634a476a-172e-410c-9200-c436264b978e\\\", \\\"subtext\\\": \\\"3e4a97f5-aa03-412f-b06e-ae3f24f5e239\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 405, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"4 serogroups.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"46ca2eee-0ad9-40a1-a994-eaa176a91f2c\\\", \\\"childbox\\\": \\\"1048c77c-600c-4888-9bcb-c6ace8f557e3\\\", \\\"subtext\\\": \\\"eca2ddfd-5cbb-4b71-a82f-5ecc691f3994\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 406, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The corresponding exact 2-sided 95% CIs based on Clopper-Pearson method will be calculated for each study group, each serogroup and at each time point (baseline/pre-vaccination, 1 month after first vaccination and 1 month after last vaccination).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"46ca2eee-0ad9-40a1-a994-eaa176a91f2c\\\", \\\"childbox\\\": \\\"4d4ae1ec-1f3f-453d-abe9-16bd0aff279e\\\", \\\"subtext\\\": \\\"eca2ddfd-5cbb-4b71-a82f-5ecc691f3994\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 407, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Geometric mean titers (GMTs) and Geometric mean ratios (GMRs) (post-vaccination/baseline titer), and their associated 2-sided 95% CIs will be computed for each study group, for each serogroup and at each time point.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"46ca2eee-0ad9-40a1-a994-eaa176a91f2c\\\", \\\"childbox\\\": \\\"a31239c5-af40-4e0c-9b3a-a08b6a963028\\\", \\\"subtext\\\": \\\"3efa2b1e-bc9a-4622-9a77-a17b667b02b0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 408, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Immune response to MenABCWY against Men B indicator stains\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"196dda91-34f0-4e43-94bf-65bf3531f0d7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"single\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 409, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Immune response of MenABCWY against each and all of the 4 Men B indicator strains\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"42bd986d-3b02-45bc-861f-a45f336fa7ba\\\", \\\"childbox\\\": \\\"681ceb03-2a06-4af2-985b-01123f601442\\\", \\\"subtext\\\": \\\"a7d5562c-b970-44bd-b777-c7ba98268808\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 410, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(M14459, M07-0241084, 96217 and NZ98/254) will be evaluated from the percentages of participants with hSBA titers \\\\u2265LLOQ and from the percentages of participants with 4-fold rise for each of the 4 Men B indicator strains.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7845c0be-b93c-44dc-939f-76ac152c01bb\\\", \\\"childbox\\\": \\\"3bfd6022-ffe2-4b4c-9571-1f6d170aa3e5\\\", \\\"subtext\\\": \\\"dd9e361b-ed3c-48e9-a20d-436abc484816\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 411, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The corresponding exact 2-sided 95% CIs based on Clopper-Pearson method will be calculated for each and all Men B indicator strains, at baseline/pre-vaccination and 1 month after last vaccination, and separately for 1 month after the first vaccination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7845c0be-b93c-44dc-939f-76ac152c01bb\\\", \\\"childbox\\\": \\\"eb7e48ce-996b-4c98-95bf-4c082d8cf9f4\\\", \\\"subtext\\\": \\\"dd9e361b-ed3c-48e9-a20d-436abc484816\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 412, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Geometric mean titers and GMRs (post-vaccination/baseline titer), and their associated 2-sided 95% CIs will be computed for each Men B indicator strain, at baseline/pre-vaccination and 1 month after last vaccination, and separately for 1 month after the first vaccination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5481f64b-4593-4c5e-b771-c9f816aefe17\\\", \\\"childbox\\\": \\\"9b3efefd-c612-4a70-8ce5-f83f0ec83220\\\", \\\"subtext\\\": \\\"a350d7e7-3f67-4b55-a45f-ba13d6042bcd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 413, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Safety\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7e3369aa-c924-4c4c-96ad-8cdddac8ff9d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"single\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 414, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The frequencies and percentages of participants will be presented for:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e72f55e1-7788-46e9-b4fd-76444dcf0141\\\", \\\"childbox\\\": \\\"bf7ddfc8-dadc-4458-abaf-40bfe4634c96\\\", \\\"subtext\\\": \\\"d8c2261d-2954-418e-bc76-7aa190b09628\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 415, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 solicited administration site and systemic adverse events (AEs) during the 7 days (including the day of vaccination) following each vaccination at Day 1 and Day 181\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c8258071-1215-40b2-8ab6-58b4dd3ef6c6\\\", \\\"childbox\\\": \\\"bfb3fd3e-f7d5-444c-8d94-9b3ec95a7522\\\", \\\"subtext\\\": \\\"eaac0067-e42f-4e32-a231-404d0308f220\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 416, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 unsolicited AEs during the 7 and the 30 days (including the day of vaccination) following vaccination at Day 1 and Day 181\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"91875070-4a78-4e02-a76e-a080afe3969f\\\", \\\"childbox\\\": \\\"57a8193e-03b2-4f16-8ff0-59f11b32991f\\\", \\\"subtext\\\": \\\"e9fea91b-b6ec-4496-a821-912360ca24f9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 417, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 serious AEs, AEs leading to withdrawal, AEs of special interest and medically attended AEs throughout the study period (Day 1 to Day 361)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0853cf25-629a-4ce0-bdbc-440d6e65053f\\\", \\\"childbox\\\": \\\"b62548df-2d20-4120-86dc-843b4fda772b\\\", \\\"subtext\\\": \\\"244f0b4f-d76a-4853-a687-7dd968bd7e30\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 418, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Data Monitoring Committee:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0853cf25-629a-4ce0-bdbc-440d6e65053f\\\", \\\"childbox\\\": \\\"b62548df-2d20-4120-86dc-843b4fda772b\\\", \\\"subtext\\\": \\\"e8a8dc43-cbca-4c7a-a5cb-58d24a2ade58\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 419, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"No.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0853cf25-629a-4ce0-bdbc-440d6e65053f\\\", \\\"childbox\\\": \\\"b62548df-2d20-4120-86dc-843b4fda772b\\\", \\\"subtext\\\": \\\"ba2ee688-5918-4c38-a2ac-75e7ff44b36b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 420, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"See Appendix 1, Glossary of Terms, for the definitions of randomization, Interactive Voice Response System, investigator, participants, evaluable participants, solicited and unsolicited AEs.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2368a4da-27ab-4aba-9c8f-90f0a33f971c\\\", \\\"childbox\\\": \\\"34bd1360-d4b6-412b-ae90-b396f394dd11\\\", \\\"subtext\\\": \\\"8f555528-7874-4a09-8d8c-ec74d9646cce\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Synopsis\\\", \\\"1.1\\\", \\\"2\\\", 421, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"1.2 Schema\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"411332b9-fe39-4a70-8cfe-06f4e25cff2a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Schema\\\", \\\"1.2\\\", \\\"2\\\", 422, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This is a phase IIIB, randomized, controlled, observer-blind, multi-centric study with 2 parallel groups (see Figure 1).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2be28c0f-6a17-4a70-bdd5-70f9fabdad0e\\\", \\\"childbox\\\": \\\"8367b656-01ac-4c34-be12-c68cdb686b90\\\", \\\"subtext\\\": \\\"13996a63-a1d9-4565-9b85-bd7852245710\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Schema\\\", \\\"1.2\\\", \\\"2\\\", 423, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A total of 1206 participants will be randomized in a 1:1 ratio as follows:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2be28c0f-6a17-4a70-bdd5-70f9fabdad0e\\\", \\\"childbox\\\": \\\"21767b66-a899-46c7-ac11-3f9e97afdb03\\\", \\\"subtext\\\": \\\"9f1ac77f-2e06-4099-ae64-bc6f61d31399\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Schema\\\", \\\"1.2\\\", \\\"2\\\", 424, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4cfe28ba-6385-4b6b-bb41-88cc44ae6d9d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schema\\\", \\\"1.2\\\", \\\"2\\\", 425, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ABCWY\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"faf663e2-827e-41c3-b311-b1e19dd50619\\\", \\\"childbox\\\": \\\"8a88661a-7a99-43b0-9e94-007f496b6004\\\", \\\"subtext\\\": \\\"b5dee53a-a2d8-4b14-a527-1bd76d491791\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Schema\\\", \\\"1.2\\\", \\\"2\\\", 426, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\": 603 participants will receive 2 doses of the MenABCWY ~REDACTED~ at Day 1 and Day 181 (0,6-months schedule) and 1 dose of placebo at Day 211.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"faf663e2-827e-41c3-b311-b1e19dd50619\\\", \\\"childbox\\\": \\\"8a88661a-7a99-43b0-9e94-007f496b6004\\\", \\\"subtext\\\": \\\"19b80d32-2370-4cb2-bf22-ed8816090f9d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Schema\\\", \\\"1.2\\\", \\\"2\\\", 427, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ACWY\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1a35c9cc-7387-4fc3-8d8c-b9518a837530\\\", \\\"childbox\\\": \\\"32041496-8e92-4a17-8020-3ee8f182569d\\\", \\\"subtext\\\": \\\"ed20aefd-cd63-4457-a6e2-09d9882f1eb7\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Schema\\\", \\\"1.2\\\", \\\"2\\\", 428, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\": 603 participants will receive 1 dose of MenACWY ~REDACTED~ at Day 1 (single dose) and 2 doses of MenB ~REDACTED~ at Day 181 and Day 211.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1a35c9cc-7387-4fc3-8d8c-b9518a837530\\\", \\\"childbox\\\": \\\"32041496-8e92-4a17-8020-3ee8f182569d\\\", \\\"subtext\\\": \\\"ccb39784-f3af-4f4e-9426-1bbd6fba90d1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Schema\\\", \\\"1.2\\\", \\\"2\\\", 429, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3f3cfd0a-8f98-478e-a0fb-b736cd25005e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schema\\\", \\\"1.2\\\", \\\"2\\\", 430, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8d670d8f-eea4-453b-8c1f-462356544924\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schema\\\", \\\"1.2\\\", \\\"2\\\", 431, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"1.3 Schedule of Activities\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"18616b36-9740-4bd0-a44e-f82cf9dd9420\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Schema\\\", \\\"1.2\\\", \\\"2\\\", 432, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Table 3 Schedule of Activities\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"118dde69-ef5b-4ac7-a781-ed3bd8223a8e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 433, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n      <th>5.0</th>\\\\n      <th>6.0</th>\\\\n      <th>7.0</th>\\\\n      <th>8.0</th>\\\\n      <th>9.0</th>\\\\n      <th>10.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Age</td>\\\\n      <td>15 to 25 Years (25 Years + 364 Days) at Study Start</td>\\\\n      <td>15 to 25 Years (25 Years + 364 Days) at Study Start</td>\\\\n      <td>15 to 25 Years (25 Years + 364 Days) at Study Start</td>\\\\n      <td>15 to 25 Years (25 Years + 364 Days) at Study Start</td>\\\\n      <td>15 to 25 Years (25 Years + 364 Days) at Study Start</td>\\\\n      <td>15 to 25 Years (25 Years + 364 Days) at Study Start</td>\\\\n      <td>15 to 25 Years (25 Years + 364 Days) at Study Start</td>\\\\n      <td>15 to 25 Years (25 Years + 364 Days) at Study Start</td>\\\\n      <td>15 to 25 Years (25 Years + 364 Days) at Study Start</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Type of contact</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n      <td>PC</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n      <td>PC</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n      <td>PC</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n      <td>PC</td>\\\\n      <td>PC</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/phone contact <sup>1</sup></td>\\\\n      <td>V1</td>\\\\n      <td>T1</td>\\\\n      <td>V2</td>\\\\n      <td>T2</td>\\\\n      <td>V3</td>\\\\n      <td>T3</td>\\\\n      <td>V4</td>\\\\n      <td>T4</td>\\\\n      <td>T5</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Time points</td>\\\\n      <td>D1 M0</td>\\\\n      <td>D15</td>\\\\n      <td>D31 M1</td>\\\\n      <td>D91 M3</td>\\\\n      <td>D181 M6</td>\\\\n      <td>D195</td>\\\\n      <td>D211 M7</td>\\\\n      <td>D271 M9</td>\\\\n      <td>D361 (ESFU)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> window (days)</td>\\\\n      <td>n/a</td>\\\\n      <td>(\\\\u22123/+3)</td>\\\\n      <td>(\\\\u22125/+14)</td>\\\\n      <td>(\\\\u22125/+14)</td>\\\\n      <td>(\\\\u22125/+14)</td>\\\\n      <td>(\\\\u22123 /+3)</td>\\\\n      <td>(\\\\u22125/+14)</td>\\\\n      <td>(\\\\u22125/+14)</td>\\\\n      <td>(\\\\u22127/+21)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>Days post-vaccination <sup>2</sup></td>\\\\n      <td>0</td>\\\\n      <td>14 post-vacc 1</td>\\\\n      <td>30 post-vacc 1</td>\\\\n      <td>90 post-vacc 1</td>\\\\n      <td>180 post-vacc 1</td>\\\\n      <td>14 post-vacc 2</td>\\\\n      <td>30 post-vacc 2</td>\\\\n      <td>90 post-vacc 2</td>\\\\n      <td>180 post-vacc 2</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td>Sampling time points</td>\\\\n      <td>pre-vacc</td>\\\\n      <td></td>\\\\n      <td>post-vacc 1</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>post-vacc 2</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>7</th>\\\\n      <td>Informed consent and Informed assent (as applicable) <sup>3</sup></td>\\\\n      <td>\\\\u25cf <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>8</th>\\\\n      <td>Check inclusion/exclusion criteria <sup>5</sup></td>\\\\n      <td>\\\\u25cf <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cb <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cb <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>9</th>\\\\n      <td>Collect demographic data</td>\\\\n      <td>\\\\u25cf <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>10</th>\\\\n      <td></td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>11</th>\\\\n      <td>Study group and treatment number allocation</td>\\\\n      <td>\\\\u25cb <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>12</th>\\\\n      <td>Treatment number allocation for subsequent doses</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cb</td>\\\\n      <td></td>\\\\n      <td>\\\\u25cb</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>13</th>\\\\n      <td>Recording of administered treatment number</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td></td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>14</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/Product administration</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td></td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>15</th>\\\\n      <td>Post-injection assessment (30 minutes) <sup>6, 11</sup></td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td></td>\\\\n      <td>\\\\u25cb</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>16</th>\\\\n      <td></td>\\\\n      <td>Laboratory assays</td>\\\\n      <td>Laboratory assays</td>\\\\n      <td>Laboratory assays</td>\\\\n      <td>Laboratory assays</td>\\\\n      <td>Laboratory assays</td>\\\\n      <td>Laboratory assays</td>\\\\n      <td>Laboratory assays</td>\\\\n      <td>Laboratory assays</td>\\\\n      <td>Laboratory assays</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>17</th>\\\\n      <td>Blood sampling (approximately 20 mL) <sup>7</sup></td>\\\\n      <td>\\\\u25cf <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cf <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cf <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>18</th>\\\\n      <td></td>\\\\n      <td>Safety assessments</td>\\\\n      <td>Safety assessments</td>\\\\n      <td>Safety assessments</td>\\\\n      <td>Safety assessments</td>\\\\n      <td>Safety assessments</td>\\\\n      <td>Safety assessments</td>\\\\n      <td>Safety assessments</td>\\\\n      <td>Safety assessments</td>\\\\n      <td>Safety assessments</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>19</th>\\\\n      <td>Medical history</td>\\\\n      <td>\\\\u25cf <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>20</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> window (days)</td>\\\\n      <td>n/a</td>\\\\n      <td>(\\\\u22123/+3)</td>\\\\n      <td>(\\\\u22125/+14)</td>\\\\n      <td>(\\\\u22125/+14)</td>\\\\n      <td>(\\\\u22125/+14)</td>\\\\n      <td>(\\\\u22123 /+3)</td>\\\\n      <td>(\\\\u22125/+14)</td>\\\\n      <td>(\\\\u22125/+14)</td>\\\\n      <td>(\\\\u22127/+21)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>21</th>\\\\n      <td>Days post-vaccination <sup>2</sup></td>\\\\n      <td>0</td>\\\\n      <td>14 post-vacc 1</td>\\\\n      <td>30 post-vacc 1</td>\\\\n      <td>90 post-vacc 1</td>\\\\n      <td>180 post-vacc 1</td>\\\\n      <td>14 post-vacc 2</td>\\\\n      <td>30 post-vacc 2</td>\\\\n      <td>90 post-vacc 2</td>\\\\n      <td>180 post-vacc 2</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>22</th>\\\\n      <td>Sampling time points</td>\\\\n      <td>pre-vacc</td>\\\\n      <td></td>\\\\n      <td>post-vacc 1</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>post-vacc 2</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>23</th>\\\\n      <td>General physical examination <sup>9</sup></td>\\\\n      <td>\\\\u25cb <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>24</th>\\\\n      <td>Symptom-directed physical examination</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cb</td>\\\\n      <td></td>\\\\n      <td>\\\\u25cb <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cb <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>25</th>\\\\n      <td>Urine pregnancy test for females of childbearing potential <sup>10</sup></td>\\\\n      <td>\\\\u25cf <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cf <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cf <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>26</th>\\\\n      <td>Check criteria for temporary delay for enrollment and vaccination and/or blood sampling</td>\\\\n      <td>\\\\u25cb <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cb</td>\\\\n      <td></td>\\\\n      <td>\\\\u25cb <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cb <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>27</th>\\\\n      <td>Check contraindications and warnings and precautions to vaccination</td>\\\\n      <td>\\\\u25cb <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cb <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cb <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>28</th>\\\\n      <td>Pre-vaccination body temperature <sup>11</sup></td>\\\\n      <td>\\\\u25cf <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cf <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cf <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>29</th>\\\\n      <td>Record any concomitant medication/vaccination</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>30</th>\\\\n      <td>Record any intercurrent medical conditions</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>31</th>\\\\n      <td>Training and distribution of eDiaries</td>\\\\n      <td>\\\\u25cb</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cb</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>32</th>\\\\n      <td>Recording of solicited events (Days 1-7 post-vaccination) in eDiary</td>\\\\n      <td>\\\\u00d7</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>\\\\u00d7</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>33</th>\\\\n      <td>Recording of unsolicited adverse events (Days 1-30 post-vaccination)</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td></td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>34</th>\\\\n      <td>Return and review of eDiaries</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cb</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cb</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>35</th>\\\\n      <td>Recording of any AEs leading to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/study withdrawal <sup>8</sup></td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>36</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> window (days)</td>\\\\n      <td>n/a</td>\\\\n      <td>(\\\\u22123/+3)</td>\\\\n      <td>(\\\\u22125/+14)</td>\\\\n      <td>(\\\\u22125/+14)</td>\\\\n      <td>(\\\\u22125/+14)</td>\\\\n      <td>(\\\\u22123 /+3)</td>\\\\n      <td>(\\\\u22125/+14)</td>\\\\n      <td>(\\\\u22125/+14)</td>\\\\n      <td>(\\\\u22127/+21)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>37</th>\\\\n      <td>Days post-vaccination <sup>1</sup></td>\\\\n      <td>0</td>\\\\n      <td>14 post-vacc 1</td>\\\\n      <td>30 post-vacc 1</td>\\\\n      <td>90 post-vacc 1</td>\\\\n      <td>180 post-vacc 1</td>\\\\n      <td>14 post-vacc 2</td>\\\\n      <td>30 post-vacc 2</td>\\\\n      <td>90 post-vacc 2</td>\\\\n      <td>180 post-vacc 2</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>38</th>\\\\n      <td>Sampling time points</td>\\\\n      <td>pre-vacc</td>\\\\n      <td></td>\\\\n      <td>post-vacc 1</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>post-vacc 2</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>39</th>\\\\n      <td>Recording of medically attended AEs</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>40</th>\\\\n      <td>Recording of SAEs</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>41</th>\\\\n      <td>Recording of AESIs</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>42</th>\\\\n      <td>Recording of SAEs related to study participation, or to a concurrent <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> medication/<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> <sup>12</sup></td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>43</th>\\\\n      <td>Recording of COVID-19 related AEs and SAEs <sup>13</sup></td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>44</th>\\\\n      <td>Recording of pregnancies</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n      <td>\\\\u25cf</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>45</th>\\\\n      <td>Study Conclusion <sup>12</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>\\\\u25cf</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"25\\\", \\\"TableIndex\\\": \\\"16\\\", \\\"TableName\\\": \\\"Table 3 Schedule of Activities\\\", \\\"Header\\\": [0, 1, 2, 3], \\\"FootnoteText_0\\\": \\\"1 study procedure that requires documentation in the individual eCRF. study procedure that does not require documentation in the individual eCRF. Documentation will be required in the source documents study procedure that requires documentation in the study eDiary AE = adverse event; AESI = adverse events of special interest; COVID-19 = coronavirus disease 2019; D = day; eCRF = electronic case report form; eDiary = participant diary (electronic diary); ESFU = extended safety follow-up; ~REDACTED~ = ~REDACTED~ Biologicals; M = month; PC = phone contact; post-vacc = post-vaccination; pre-vacc = pre-vaccination; T = telephone contact; SAE = serious adverse event; V = ~REDACTED~\\\", \\\"FootnoteText_1\\\": \\\"1 1 Home visits are always allowed if deemed suitable and are conducted according to local regulations.\\\", \\\"FootnoteText_2\\\": \\\"2 2 Days post-injection are included to keep track of the intercurrent days between vaccinations, they do not indicate Study Day\\\", \\\"FootnoteText_3\\\": \\\"3 3 Confirm consent form and informed assent form (if applicable) signed prior to any procedures.\\\", \\\"FootnoteText_4\\\": \\\"4 4 Procedure to be performed prior to any vaccination.\\\", \\\"FootnoteText_5\\\": \\\"5 5 Reminder: appropriate written documentation of the identity of the primary MenACWY vaccination and vaccination date to be provided prior to enrollment. Individuals for whom written documentation is not available may still be enrolled into the study.\\\", \\\"FootnoteText_6\\\": \\\"6 6 The participants must be observed closely for at least 30 minutes after the administration of the ~REDACTED~/product. Appropriate medical treatment must be readily available during the observation period in case of anaphylaxis and/or syncope.\\\", \\\"FootnoteText_7\\\": \\\"7 7 Insufficient blood volume may lead to test cancellation and jeopardize the statistical power. Hence, every effort must be done to collect blood volume as per protocol requirements.\\\", \\\"FootnoteText_8\\\": \\\"8 8 For information regarding participant discontinuation and withdrawal from the study refer to Section 7.3 .\\\", \\\"FootnoteText_9\\\": \\\"9 9 Physical examination must be performed by a qualified health care professional (refer to Appendix 1, Glossary of Terms) in accordance with local regulations and licensing requirements designated within the Site Responsibility Delegation Log.\\\", \\\"FootnoteText_10\\\": \\\"10 10 Frequency or urine pregnancy tests can be established at the site according to local regulations.\\\", \\\"FootnoteText_11\\\": \\\"11 11 Fever is defined as body temperature 38.0C/100.4F. The preferred location for measuring temperature in this study will be oral. In case any other route (other than oral) is used for measurement of body temperature/fever, it needs to be recorded in the participants eCRF.\\\", \\\"FootnoteText_12\\\": \\\"12 12 Recording of SAEs related to study participation, or to a concurrent ~REDACTED~ medication/~REDACTED~ begins from the time a participant/participants parent(s)/legally acceptable representative(s) signs the consent form and assent form (if applicable) to the end of the study.\\\", \\\"FootnoteText_13\\\": \\\"13 13 Diagnosis of coronavirus disease 2019 (COVID-19) should be made in accordance with the ~REDACTED~ case definitions. Cases should be reported as AEs or SAEs (refer to Appendix 4 for the definitions), and routine procedures for recording, evaluation, follow-up, and reporting of AEs, and SAEs should be followed in accordance with the protocol-defined time periods (refer to Table 12) . In addition, separate COVID-19 specific eCRF form(s) should be completed.\\\", \\\"FootnoteText_14\\\": \\\"14 14 Participants who terminate the study early are recommended to complete certain study-related procedures.\\\"}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"6cd93652-9c7c-43cd-810d-868f81bc196b\\\", \\\"childbox\\\": \\\"a5b9c87e-15a7-4113-86eb-a52fc109e858\\\", \\\"subtext\\\": \\\"15da3a72-b9f4-4205-95f1-5d9bf16b0fd2\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 434, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2b709556-09ed-41b6-beea-1d62721d7036\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 435, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f3c54953-39e7-4d26-a0f7-d36ad8275a3f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 436, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"19b4368f-0d76-447a-9a1d-ccec6c5ee9e8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 437, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5d9bd72a-c9e9-4648-9b90-4d9a9af295cd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 438, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"604a550c-7d53-4dc7-bfc9-30a5f35dec24\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 439, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9295e036-71e7-46f8-9844-ffe1c23b02dd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 440, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"85f2a8f1-02c7-4fd8-a738-fbab00d61f14\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 441, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"42b2aeaa-fc73-41bb-838d-eb5422639e5f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 442, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d59d4119-1dff-4824-8702-0a5b7e3e06d6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 443, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"431e0e48-5a9d-4f54-ae3e-749254e46b62\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 444, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"03cf6dcc-ba4b-400d-a428-8b987b7d6320\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 445, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"edacff28-0027-4ad0-ae73-c729d6b72056\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 446, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1d41bef9-b533-48c2-a19f-ff06f3bb4753\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 447, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aa1589cf-fe3b-431d-a081-7140289b720c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 448, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"77d1337a-4a9e-48bc-893b-88bfa91c5dd7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 449, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"882dcfad-2a7a-424b-b6da-87704b45e58b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 450, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"52d55ca2-92ab-4417-9789-b16bdf640889\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 451, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"151dd832-52bd-442c-971f-7fad3505865a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 452, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a96de969-5807-453e-bdc5-67d97f6aaba3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 453, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bc3e3763-251e-4f23-b742-2e80848b9e20\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 454, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fadf5be1-735f-45ab-866d-bd97902c766f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 455, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"34583ebb-3ca1-4787-ac17-9176ecd66867\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 456, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8118f2fc-c26a-4066-ba88-a8b1839909ef\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 457, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a6f480ae-4fca-4e9f-a678-546d90784022\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 458, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"138c4a51-fd2a-4a9f-88fb-5c572192df64\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 459, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"16e95fa5-0b58-4d64-a8ea-e79c0c8fe69d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 460, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f143e048-b576-45ad-b743-a05cbea30679\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 461, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4f631483-e5c1-4eff-9c29-536bb7e0396a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 462, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9d30288e-f52c-485b-99a9-29ca4943bec7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 463, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"76a2a5b7-ccbe-4332-b637-75da23975afc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 464, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"26343e22-dc3b-4b6e-938b-c11183e82565\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 465, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8487bc62-bf46-46b6-9344-0d4df9b257df\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 466, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"37391ff5-9646-4e1d-8ece-573ed86b67c6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 467, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"35b5f07a-a7ec-4fcd-8bca-1fae733037ea\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 468, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d8688b41-fba8-44da-8036-9fe557e26ed8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 469, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4f2a6a56-394d-43d8-b3d0-d1c4bd31c5f3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 470, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d95d93f9-eb90-4a08-82f6-0cef97b5f199\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 471, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"52420fb1-2e01-4a39-a9c9-d7a51194dbf9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 472, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"28537535-5678-4f88-a7cc-cf5dbcf7376a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 473, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"721dac6f-d96e-4f25-9ef6-e23ec9f29e18\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 474, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6ce2f882-5685-4517-8ad8-954ae3774aaf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 475, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3c39cd86-2298-4df6-8e56-d376030480e4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 476, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1796e333-efbb-4d93-b38f-27261516f2bd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 477, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0c573faf-059f-4cb1-8835-4ca6046b984d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 478, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2af08be7-3f45-4901-88f5-6d152c504dd3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 479, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"02c4bcff-6313-4807-951b-9a261b1acf93\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 480, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b9bed638-a8f3-4527-a8c8-b968ba2490ba\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 481, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b5021786-1456-4d64-ad11-9336ffc9c069\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 482, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5124314f-de99-4072-b416-c58644c8b0a5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 483, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dc8b1574-a557-4f5e-a0ad-bc3d946fcc31\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 484, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e0630ea8-879b-4e08-81cf-0e4832997812\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 485, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c40e2874-b2a0-4db2-8ca4-3bed8eaeb662\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 486, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"42f748f1-5e3a-473e-9864-9d9176d63107\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 487, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c286c732-5fd4-4388-990c-d3fece9ee9d9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 488, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8f185fd7-85c2-47ee-854c-cb0026ea6262\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 489, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6747795d-6a8a-4fc5-a98e-c6340e1bab7f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 490, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e12eb713-ebb6-41f0-876c-303a006feba6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 491, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"78b60429-a28b-40c4-87a8-c0b17bc5c345\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 492, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a05297e2-54ba-4402-86e1-b2915c9e2ce9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 493, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9755c5e2-4bca-4266-a998-0bfa122e7f86\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 494, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"af6350fb-f753-4ac6-8518-b69e256d5fbb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 495, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f72665e0-9968-45f7-a00b-8d3a3324c297\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 496, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b695197e-228a-4fea-aeb1-1077d8fbe4d7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 497, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"76396481-1fe4-4a76-8498-a1fc401cc77f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 498, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7e262770-5a55-4c27-aa57-898278db4bff\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 499, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f74c8e66-572b-45a2-95af-8ea99b05857d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 500, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d991e605-48a9-425d-a0ca-9a0ff925f4b0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 501, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cad361ed-c91f-4a65-87c3-61b0967abe9d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 502, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6e1ad1f0-01de-4059-a91b-7f05fd8d17ba\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 503, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"49953b49-4271-4a0d-bd7a-d870c18d64d7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 504, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"17506e5d-c9c0-4392-8e62-7cb76db2aaa1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 505, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6842dd0d-a15d-423f-85ee-47752d808963\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 506, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ab88339b-eba2-4dae-93e5-96bc46b0e68b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 507, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7d0b9c03-b9ba-434c-81b9-fc9e91bc885e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 508, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d80e183b-be91-4cdc-938d-0e634e80eb7c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 509, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"36814870-375c-4135-b87d-9eaefc6ee00c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 510, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d67d2ec3-0c0c-4b45-bdd4-d716e80a0610\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 511, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"70c1271b-72ff-418b-8ca5-6990cd7f8f36\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 512, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"23b5da05-03bb-44f4-977a-303634602c5c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 513, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"87a91574-998b-4c86-88a1-84be800324d3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 514, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bb855b3a-8d42-4f77-9481-25a430276ef8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 515, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"53854e8e-13d9-4511-9af1-37e6b8cf4167\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 516, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"bc02ba38-c749-449e-9260-9308b01f1d91\\\", \\\"childbox\\\": \\\"e4d2e2f3-1a70-49fe-a2dd-5f29a15659a6\\\", \\\"subtext\\\": \\\"b441f1ba-6bbd-4552-b103-3fb1229c026e\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 517, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"438fbfe1-7904-4999-86c2-41176b8cf7f2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 518, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e594c01d-d092-4059-819a-cc8f600b784d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 519, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"40c9e525-4586-4fb0-99ba-0e433a7d8371\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 520, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6e185039-3fc3-40bd-ad3c-ff359eda9460\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 521, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ef64a32-3c68-455b-8718-35b0c508df33\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 522, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8f354202-cdac-4539-b997-7b8b12a5a688\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 523, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"14c13ba5-e7da-4822-8121-7c1f1dfcc2b8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 524, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1fd739c9-a1a2-43c6-8c6d-0233bbf401e6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 525, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cceb81cc-cf9b-469e-a019-cf4b6cfe2f80\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 526, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d3054ffc-37f2-4756-b907-be91384f0ec7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 527, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c01f8ad5-5323-48fc-9374-1da8ec0862eb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 528, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c792c78d-d03b-4ece-9bc2-71a4d850fce2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 529, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fa05663e-a368-4b97-9183-f63a1c5d4886\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 530, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fcbd4c99-2655-4005-a683-e9419ab2ac59\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 531, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0d551074-b8c8-404e-84fc-5ae5602cb634\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 532, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3aa278f4-b7e4-4201-a349-0bdf2c88a199\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 533, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"33fc651a-5dca-4c81-9940-325687e3c6c8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 534, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f5de494b-cc51-4dca-b376-02415f6140b2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 535, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bfb32640-9a96-418c-a72e-e1fbf8ea0a66\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 536, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"833fdc0f-3fa9-4edb-9fc3-9f8e23570196\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 537, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dea79513-ea91-4fdf-9946-4b6fb05cc606\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 538, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f2c247c9-69c1-48c0-b59e-7c22867bbc5c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 539, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"20a2201c-7ace-4883-9161-39c5b37c8218\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 540, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6d36942f-e9df-48a5-a06e-1fe11b06543d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 541, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"02310511-47a7-49e0-94a7-f10ec9ec8019\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 542, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"55dfa758-d331-4459-8500-150953928946\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 543, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f46900aa-e606-41b4-87aa-a3dcb176058d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 544, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"654773e2-5519-4487-91e2-ccc939d36bc6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 545, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"45396981-91b8-42fd-a686-7da7a2ec9f0e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 546, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b781b55e-a89a-4284-aa0b-0c16c62ca826\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 547, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c32ff09d-5504-4544-b7d4-ed5a443296fc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 548, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f27c02db-5a03-4355-8f6d-01825383f887\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 549, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b3a08f39-a919-4a0f-8354-3ac61129a926\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 550, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b98ba85a-c7f5-4956-a56f-6f1ed5857ec1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 551, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b673f389-2105-44e8-96c0-ed8858b25541\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 552, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9f861801-79e3-41ce-a367-f2b9d61e9e88\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 553, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"baf86bc3-7912-47e1-a6d7-54d5fbb65951\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 554, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aed7c7d6-e3e8-4b11-abc3-b5cfc1b0b72e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 555, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fbdeb626-fec6-47e6-9e07-8a166f1757ae\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 556, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bc9c3531-d361-4d81-9cb7-4b7c9c075fd0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 557, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ed19fede-1ea2-47fd-9321-a4fd0ab43076\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 558, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b61b4fdb-b472-48c2-a11e-cc8db1b4a037\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 559, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0b2f4020-b782-499c-bb43-f284e48d5de4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 560, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c3972f36-2685-4068-a261-5f42de1c7af9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 561, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"62bc3c61-96af-4041-85fd-ab71fd430f53\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 562, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8d6a5acd-5eaa-46c0-863e-9e9f16680080\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 563, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0bab7d40-8c99-4759-b62a-485db0ab8227\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 564, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fa3bf2d8-f861-4e77-a056-3283c9cfb523\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 565, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9795174c-871e-40f0-8c66-95e76118833a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 566, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0afe0892-041b-45d8-a98b-bbc84602e266\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 567, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8cdf0f12-85d2-41af-a9bf-d12e8aadaa3a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 568, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c1fdd8d3-082d-47e5-b03a-ff66d01d44bb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 569, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"70933cac-796e-4c93-9066-773a8ca8c526\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 570, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6d9ede63-b987-4677-a73b-85d84e46c2c5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 571, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e0fe77be-5d69-4491-b433-6a283dd1e6ce\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 572, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5b46ed28-1ac2-4aa4-9c55-15c19cc17c38\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 573, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ba8595b3-cd3f-425e-9ac5-e9e839516424\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 574, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3d544d77-5cd5-422c-aab8-9eb9b6a98b18\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 575, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1427d194-78bb-4a1c-a6f8-81db0fa92b78\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 576, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a62c9b19-bbbd-4f26-aecd-b7a9922f12f1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 577, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0af545c5-9faa-468d-9a25-acdc9f1c0030\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 578, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3209c8a9-c93f-47e0-9990-764e84dd4896\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 579, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fcec8b11-9363-4eb1-93fa-ed1876cc2d61\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 580, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e10d6dc8-7673-4987-b75f-6b96f434c936\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 581, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9e4cb788-1604-4b15-ae20-d24cc553d12b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 582, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"405ce7ae-2a95-4396-9892-cde214463517\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 583, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a84e3db6-2059-4a8a-8aab-4e9efff0679a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 584, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3bce8178-505a-4c92-a61e-5b94fd4d0d7d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 585, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1efc0680-6410-4c3f-ba62-435645e24a75\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 586, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dddba567-12e9-48c2-9886-2404af0ec1ba\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 587, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bc136d4a-37bf-4497-b095-449ac80a5d22\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 588, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ba795b05-3caa-4500-ae8f-444a4e02e10f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 589, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d9040204-18ea-4bfb-9172-b4348b7113a1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 590, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"661c8d0a-5b15-44a6-8511-a9104ecdce2c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 591, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6c118e48-8409-4124-9fe0-963504016f5c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 592, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"463d6bd0-178e-4219-98e5-8ac37b8cc490\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 593, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b365bb79-767e-444e-a4d2-0c90a64b6d3a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 594, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cb22d2b4-ab90-4664-b396-41d8f304cd72\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 595, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0554c929-0650-4544-8a3c-6968f18a9292\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 596, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5df4e650-1a59-4d56-979b-7aa56e017bd1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 597, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5b6b7187-da2b-43a9-aebd-5a7094ebfb6d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 598, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c1c372a0-f7f6-40ef-a30d-60174f7571b5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 599, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f4d34d5a-2ae0-4786-88ce-e7be59579ecb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 600, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"180338e5-f459-4e5f-9742-fff76cd48da0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 601, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"07562868-8720-41a9-a288-5dec1de685f0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 602, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f97a9730-8850-448a-a96f-2b4a041ac3de\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 603, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"44ae60b1-5ace-4913-ba76-a9a1d9b61d26\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Schedule of Activities\\\", \\\"Table 3\\\", \\\"1\\\", 604, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Table 4 Intervals Between Study Visits\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f50d941a-36a9-4c80-91ba-37212f772036\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervals Between Study Visits\\\", \\\"Table 4\\\", \\\"1\\\", 605, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Interval</td>\\\\n      <td>Length of Interval</td>\\\\n      <td>Allowed Interval</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 1 to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 2</td>\\\\n      <td>30 days</td>\\\\n      <td>25 to 44 days (\\\\u22125 to +14 days)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 1 to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 3</td>\\\\n      <td>180 days</td>\\\\n      <td>175 to 194 days (\\\\u22125 to +14 days)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 3 to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 4</td>\\\\n      <td>30 days</td>\\\\n      <td>25 to 44 days (\\\\u22125 to +14 days)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 3 to last Telephone Contact (T5)</td>\\\\n      <td>180 days</td>\\\\n      <td>173 to 201 days (\\\\u22127 to +21 days)</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"28\\\", \\\"TableIndex\\\": \\\"18\\\", \\\"TableName\\\": \\\"Table 4 Intervals Between Study Visits\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"f8df71ce-d7d7-49a5-a650-dc93adc712fe\\\", \\\"childbox\\\": \\\"a4b7b319-8455-4b9b-9b00-e96ea3650cac\\\", \\\"subtext\\\": \\\"ce3c36b8-bed1-4e21-8aa5-a769f9d91cff\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervals Between Study Visits\\\", \\\"Table 4\\\", \\\"1\\\", 606, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"T = telephone contact\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d219bf16-fd59-4e5c-a75a-d1dc939e061b\\\", \\\"childbox\\\": \\\"e87f83f8-30d1-41db-818f-0616adb5360b\\\", \\\"subtext\\\": \\\"3f9167e6-db0f-49cb-8642-0eaeacbe152f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervals Between Study Visits\\\", \\\"Table 4\\\", \\\"1\\\", 607, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Table 5 Intervals Between Telephone Contacts\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"70391943-589b-4f29-aaba-029dc11d6bf0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervals Between Telephone Contacts\\\", \\\"Table 5\\\", \\\"1\\\", 608, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Interval</td>\\\\n      <td>Length of Interval</td>\\\\n      <td>Allowed Interval (Range)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 1 to Telephone contact T1</td>\\\\n      <td>14 days</td>\\\\n      <td>11 to 17 days (\\\\u22123 to +3 days)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 1 to Telephone contact T2</td>\\\\n      <td>90 days</td>\\\\n      <td>87 to 93 days (\\\\u22123 to +3 days)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 3 to Telephone contact T3</td>\\\\n      <td>14 days</td>\\\\n      <td>11 to 17 days (\\\\u22123 to +3 days)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 3 to Telephone contact T4</td>\\\\n      <td>90 days</td>\\\\n      <td>87 to 93 days (\\\\u22123 to +3 days)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 3 to Last Telephone contact (T5)</td>\\\\n      <td>180 days</td>\\\\n      <td>173 to 201 days (\\\\u22127 to +21 days)</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"29\\\", \\\"TableIndex\\\": \\\"19\\\", \\\"TableName\\\": \\\"Table 5 Intervals Between Telephone Contacts\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"2bd1b139-7acb-4d23-aacf-24a75a6ee327\\\", \\\"childbox\\\": \\\"42f2efa7-f3e0-4913-9568-a1cd00e32ce4\\\", \\\"subtext\\\": \\\"c2ceef6c-4ee2-4d74-b7ed-3c101390fff5\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervals Between Telephone Contacts\\\", \\\"Table 5\\\", \\\"1\\\", 609, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"T = telephone contact\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ec6e5b33-26ae-45b2-a20a-2bebc8ec9531\\\", \\\"childbox\\\": \\\"bdb9721f-3bb9-459c-bd2a-d61007317d81\\\", \\\"subtext\\\": \\\"1a8e065a-034c-42c9-b7e5-06be84158ae6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervals Between Telephone Contacts\\\", \\\"Table 5\\\", \\\"1\\\", 610, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9f0fe960-40eb-4669-9c64-8b3fa8e833c1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Intervals Between Telephone Contacts\\\", \\\"Table 5\\\", \\\"1\\\", 611, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"2.0  INTRODUCTION\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading1\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"239a5df5-57d8-40d8-b9c1-c0e43ad30031\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"INTRODUCTION\\\", \\\"2.0\\\", \\\"2\\\", 612, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"2.1 Study Rationale\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e5ce26ec-4c8b-48f5-ab8a-28d3d6d295aa\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 613, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Neisseria meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aebceb4a-6f23-4909-bbd5-8a96bbc0150a\\\", \\\"childbox\\\": \\\"92fd3414-ddf6-4c8b-9f2f-7cc00a561b88\\\", \\\"subtext\\\": \\\"aba8e4dc-b4bc-4149-8314-a6079f39a946\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 614, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aebceb4a-6f23-4909-bbd5-8a96bbc0150a\\\", \\\"childbox\\\": \\\"92fd3414-ddf6-4c8b-9f2f-7cc00a561b88\\\", \\\"subtext\\\": \\\"f7d792e4-e821-45ce-a742-5b7177e51de4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 615, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aebceb4a-6f23-4909-bbd5-8a96bbc0150a\\\", \\\"childbox\\\": \\\"92fd3414-ddf6-4c8b-9f2f-7cc00a561b88\\\", \\\"subtext\\\": \\\"3d4f856b-1fce-4ad3-83e8-f87aa98f5fc3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 616, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aebceb4a-6f23-4909-bbd5-8a96bbc0150a\\\", \\\"childbox\\\": \\\"03b12186-f6f8-4c3e-abe1-2ba277dd8aa7\\\", \\\"subtext\\\": \\\"3d4f856b-1fce-4ad3-83e8-f87aa98f5fc3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 617, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\")\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aebceb4a-6f23-4909-bbd5-8a96bbc0150a\\\", \\\"childbox\\\": \\\"03b12186-f6f8-4c3e-abe1-2ba277dd8aa7\\\", \\\"subtext\\\": \\\"e9bce7d9-321b-49ee-b4ed-4ff09c8f9354\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 618, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aebceb4a-6f23-4909-bbd5-8a96bbc0150a\\\", \\\"childbox\\\": \\\"03b12186-f6f8-4c3e-abe1-2ba277dd8aa7\\\", \\\"subtext\\\": \\\"44414e3d-5e03-4441-b94b-c26418c31cc6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 619, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"bacteria is a leading cause of invasive meningococcal disease (IMD) worldwide, capable of causing outbreaks and epidemics.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aebceb4a-6f23-4909-bbd5-8a96bbc0150a\\\", \\\"childbox\\\": \\\"03b12186-f6f8-4c3e-abe1-2ba277dd8aa7\\\", \\\"subtext\\\": \\\"bae47501-767d-4ef9-9b78-d09d955ab5f3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 620, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The best option for the control of IMD is the use of effective vaccines that would include all 5 of the most common serogroups of\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aebceb4a-6f23-4909-bbd5-8a96bbc0150a\\\", \\\"childbox\\\": \\\"c24ec46e-a737-4ca8-82ce-d0a7281f0ca6\\\", \\\"subtext\\\": \\\"bae47501-767d-4ef9-9b78-d09d955ab5f3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 621, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aebceb4a-6f23-4909-bbd5-8a96bbc0150a\\\", \\\"childbox\\\": \\\"c24ec46e-a737-4ca8-82ce-d0a7281f0ca6\\\", \\\"subtext\\\": \\\"a6302f14-539d-4ed7-b6b6-189fbe84065e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 622, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aebceb4a-6f23-4909-bbd5-8a96bbc0150a\\\", \\\"childbox\\\": \\\"f535b34a-acfa-4212-8b3b-9ac10404d648\\\", \\\"subtext\\\": \\\"93dbef03-698c-4a50-a346-63a433695bd4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 623, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\".\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aebceb4a-6f23-4909-bbd5-8a96bbc0150a\\\", \\\"childbox\\\": \\\"f535b34a-acfa-4212-8b3b-9ac10404d648\\\", \\\"subtext\\\": \\\"2ca27ccd-05ce-43d9-98b8-63a205e7b3c8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 624, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~ (~REDACTED~) is developing a combination ~REDACTED~ intended to protect against 5 of the most prevalent serogroups of\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bfc5c511-9b08-4085-a2b7-2c474138c0be\\\", \\\"childbox\\\": \\\"4bdb9a1d-2d4e-4978-bb04-70f7a1d962d6\\\", \\\"subtext\\\": \\\"d23c5217-a754-48f3-8077-ba356060ba4e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 625, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bfc5c511-9b08-4085-a2b7-2c474138c0be\\\", \\\"childbox\\\": \\\"4bdb9a1d-2d4e-4978-bb04-70f7a1d962d6\\\", \\\"subtext\\\": \\\"e6eb4526-d9ec-4f1d-b36d-b4c200823c1d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 626, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bfc5c511-9b08-4085-a2b7-2c474138c0be\\\", \\\"childbox\\\": \\\"338cceb1-2b63-4e73-8622-b1821cb01112\\\", \\\"subtext\\\": \\\"e6eb4526-d9ec-4f1d-b36d-b4c200823c1d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 627, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(A, B, C, W, and Y) in humans.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bfc5c511-9b08-4085-a2b7-2c474138c0be\\\", \\\"childbox\\\": \\\"338cceb1-2b63-4e73-8622-b1821cb01112\\\", \\\"subtext\\\": \\\"e794b875-350c-485a-b495-43923bbc6138\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 628, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The availability of a pentavalent meningococcal ~REDACTED~ in a single administration would reduce the number of injections and could increase coverage for meningococcal disease caused by\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bfc5c511-9b08-4085-a2b7-2c474138c0be\\\", \\\"childbox\\\": \\\"29d9490a-f5ce-4839-9380-b59c33f5fc2d\\\", \\\"subtext\\\": \\\"e794b875-350c-485a-b495-43923bbc6138\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 629, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bfc5c511-9b08-4085-a2b7-2c474138c0be\\\", \\\"childbox\\\": \\\"29d9490a-f5ce-4839-9380-b59c33f5fc2d\\\", \\\"subtext\\\": \\\"d706d9a4-b60a-4243-932d-b413ebc38cd6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 630, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bfc5c511-9b08-4085-a2b7-2c474138c0be\\\", \\\"childbox\\\": \\\"4afc1d92-cab9-40c9-b167-ec8edca55232\\\", \\\"subtext\\\": \\\"d706d9a4-b60a-4243-932d-b413ebc38cd6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 631, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"serogroups A, B, C, W, and Y worldwide.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bfc5c511-9b08-4085-a2b7-2c474138c0be\\\", \\\"childbox\\\": \\\"4afc1d92-cab9-40c9-b167-ec8edca55232\\\", \\\"subtext\\\": \\\"05eea1ee-a7d9-45b3-9cf8-1aca396a252f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 632, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigational meningococcal ABCWY (MenABCWY) combination ~REDACTED~ is based upon 2 established ~REDACTED~ ~REDACTED~s, the quadrivalent meningococcal ACWY (MenACWY) conjugate ~REDACTED~ (\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bfc5c511-9b08-4085-a2b7-2c474138c0be\\\", \\\"childbox\\\": \\\"f65f1d5d-67a8-492e-a4b8-0e56a07797de\\\", \\\"subtext\\\": \\\"05eea1ee-a7d9-45b3-9cf8-1aca396a252f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 633, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bfc5c511-9b08-4085-a2b7-2c474138c0be\\\", \\\"childbox\\\": \\\"f65f1d5d-67a8-492e-a4b8-0e56a07797de\\\", \\\"subtext\\\": \\\"8cfda32d-7df1-440a-8e45-6d22a7f8fb42\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 634, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\") and the multi-component recombinant meningococcal B (MenB) ~REDACTED~ (\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bfc5c511-9b08-4085-a2b7-2c474138c0be\\\", \\\"childbox\\\": \\\"f65f1d5d-67a8-492e-a4b8-0e56a07797de\\\", \\\"subtext\\\": \\\"d2915934-c0e9-4313-a1f0-f1963fad156c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 635, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Bexsero\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bfc5c511-9b08-4085-a2b7-2c474138c0be\\\", \\\"childbox\\\": \\\"f65f1d5d-67a8-492e-a4b8-0e56a07797de\\\", \\\"subtext\\\": \\\"209e2d26-6523-4c60-9663-1628a6d2ae94\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 636, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"), for which significant nonclinical and clinical data have been generated and used to support marketing authorizations in several jurisdictions.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bfc5c511-9b08-4085-a2b7-2c474138c0be\\\", \\\"childbox\\\": \\\"f65f1d5d-67a8-492e-a4b8-0e56a07797de\\\", \\\"subtext\\\": \\\"3af20294-4023-4e3e-9ba4-d4fa3bbfdaa1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 637, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Guidelines regarding meningococcal vaccination in different countries with overall low disease rates vary, but most countries recommend vaccination for defined \\\\u201cat risk\\\\u201d groups based on age, underlying host factors, and anticipated occupational and/or travel-related exposures.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1dce2db6-6e73-4e4b-8d43-a05daf272460\\\", \\\"childbox\\\": \\\"cee82e7b-1d15-4a31-a1ae-f67d99f1695d\\\", \\\"subtext\\\": \\\"d14af7d9-4159-4817-bfcc-c82e3471771f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 638, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In countries (such as Australia, Canada, the United Kingdom, and the United States), a booster dose of conjugate quadrivalent ACWY ~REDACTED~ is recommended every 5 years for persons at continued high risk (~REDACTED~ and ~REDACTED~, 2016).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1dce2db6-6e73-4e4b-8d43-a05daf272460\\\", \\\"childbox\\\": \\\"93b0d2d9-8256-4a30-a323-73d06da0f867\\\", \\\"subtext\\\": \\\"0b37d936-8d23-4c20-a769-2b514acb2592\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 639, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For example, the US Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination with a quadrivalent conjugated meningococcal ~REDACTED~ for adolescents at 11 to 12 years of age with a booster dose at 16 years of age, based on a substantial amount of data showing a robust immune response to a booster dose of MenACWY ~REDACTED~s in this age group.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1dce2db6-6e73-4e4b-8d43-a05daf272460\\\", \\\"childbox\\\": \\\"e7d076ca-99c7-4c81-9862-3505b487f2ed\\\", \\\"subtext\\\": \\\"8f6b235c-d007-4822-90b2-0a4d68fbdfbd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 640, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The ACIP also recommends MenB vaccination in individuals aged 10 years and older who are at increased risk for MenB disease and in adolescents and young adults aged 16 to 23 years regardless of an increased risk for MenB disease.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1dce2db6-6e73-4e4b-8d43-a05daf272460\\\", \\\"childbox\\\": \\\"1d93ea1a-be11-4b37-bfa7-79429edc0f14\\\", \\\"subtext\\\": \\\"5f703054-1a5b-4c83-974c-1e7f5dcfad42\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 641, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Based on the current ACIP recommendations for a MenACWY booster dose at 16 years of age and for MenB vaccination at 16 to 23 years of age, there is a need to evaluate the response to MenABCWY ~REDACTED~ in MenACWY ~REDACTED~-primed individuals.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"abc14b23-4964-40dc-99e6-a9f8f5f7b64d\\\", \\\"childbox\\\": \\\"77a2f6d3-d46f-4d0c-b1ac-e8c74c256eb2\\\", \\\"subtext\\\": \\\"ea44b220-6ab5-45eb-a7a3-82109165413f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 642, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In the context of the\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"abc14b23-4964-40dc-99e6-a9f8f5f7b64d\\\", \\\"childbox\\\": \\\"4e6d5506-4728-4fb2-9f6e-5a4936cf5825\\\", \\\"subtext\\\": \\\"c5b6c934-c63f-4eee-b5a2-ec0689343089\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 643, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"MenABCWY investigational ~REDACTED~ development, the MenACWY booster response was evaluated in 2 phase II clinical studies (~REDACTED~, 2018; ~REDACTED~, 2018).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3426d9bc-a24d-4427-b5cc-dc27a4e53947\\\", \\\"childbox\\\": \\\"c43eaf69-f654-4387-b142-e4cd9ad43ff9\\\", \\\"subtext\\\": \\\"5eb501d0-0208-49cc-b469-9cba3710a3f6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 644, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Although the sample size of these studies was small, a robust anamnestic immune response against MenA, MenC, MenW, and MenY serogroups was demonstrated at 1 month after the administration of the first dose of the MenABCWY ~REDACTED~ in participants previously primed with the ~REDACTED~ MenACWY ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3426d9bc-a24d-4427-b5cc-dc27a4e53947\\\", \\\"childbox\\\": \\\"f1ede0d5-7093-470c-8437-ba797cab6609\\\", \\\"subtext\\\": \\\"a967b90b-f9e8-4ffd-95a3-0aeb7e90fb5b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 645, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The main purpose of this phase IIIB clinical study is to assess the immunogenicity and safety of the MenABCWY ~REDACTED~ when administered as a booster in healthy adolescents and young adults, previously primed with a MenACWY ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4b45e5e2-7708-4ef2-86e1-99cafb3ff66d\\\", \\\"childbox\\\": \\\"baa51c04-a147-4ae2-961f-78193af176ab\\\", \\\"subtext\\\": \\\"9084f931-0a2f-481f-9736-d1394e3c5f6f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Rationale\\\", \\\"2.1\\\", \\\"2\\\", 646, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"2.2 Background\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"597d9610-0e48-4906-9eba-062d202e1e81\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 647, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N. meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"456ce620-c509-4da3-881c-2d920fb7653b\\\", \\\"childbox\\\": \\\"c9bef7a1-fc4a-4923-9e46-b201ce6ec15d\\\", \\\"subtext\\\": \\\"bffb8bda-3986-4577-9c80-f49836f5fc98\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 648, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"infections causing IMD are an important public health concern worldwide due to the substantial morbidity and mortality they cause, as well as the transmissibility of these infections.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"456ce620-c509-4da3-881c-2d920fb7653b\\\", \\\"childbox\\\": \\\"c9bef7a1-fc4a-4923-9e46-b201ce6ec15d\\\", \\\"subtext\\\": \\\"45bbfbda-f02f-44e0-947e-ef8640fc31d5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 649, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Invasive meningococcal disease occurs when, following an average incubation period of 4 days (range 2 to 10 days), the normally asymptomatically carried encapsulated gram-negative bacterium\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"251f86d4-4064-405f-ab5c-0d072a113624\\\", \\\"childbox\\\": \\\"9bfc1a63-2b77-42bc-b475-d97be2f35be8\\\", \\\"subtext\\\": \\\"71d28561-268b-40cb-9395-324789d820a0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 650, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"251f86d4-4064-405f-ab5c-0d072a113624\\\", \\\"childbox\\\": \\\"9bfc1a63-2b77-42bc-b475-d97be2f35be8\\\", \\\"subtext\\\": \\\"12c763ac-70d6-4e7c-bcec-954cee856877\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 651, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"251f86d4-4064-405f-ab5c-0d072a113624\\\", \\\"childbox\\\": \\\"5b5a5a87-ab5d-4a43-85af-32da1fc5db75\\\", \\\"subtext\\\": \\\"12c763ac-70d6-4e7c-bcec-954cee856877\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 652, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"enters the bloodstream and multiplies.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"251f86d4-4064-405f-ab5c-0d072a113624\\\", \\\"childbox\\\": \\\"5b5a5a87-ab5d-4a43-85af-32da1fc5db75\\\", \\\"subtext\\\": \\\"e9c21266-b7a9-4484-9f94-ca788cd54382\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 653, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If the bacteria cross the blood-brain barrier, meningitis occurs.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"251f86d4-4064-405f-ab5c-0d072a113624\\\", \\\"childbox\\\": \\\"32ef781d-3190-48b3-9a57-8687f0f35c57\\\", \\\"subtext\\\": \\\"e9c21266-b7a9-4484-9f94-ca788cd54382\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 654, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Sepsis and meningitis caused by\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"251f86d4-4064-405f-ab5c-0d072a113624\\\", \\\"childbox\\\": \\\"e66733a8-23c1-46ab-bb8d-d986942835fb\\\", \\\"subtext\\\": \\\"e9c21266-b7a9-4484-9f94-ca788cd54382\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 655, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"251f86d4-4064-405f-ab5c-0d072a113624\\\", \\\"childbox\\\": \\\"e66733a8-23c1-46ab-bb8d-d986942835fb\\\", \\\"subtext\\\": \\\"cead37da-697e-411c-af45-17a8f97a53b1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 656, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"251f86d4-4064-405f-ab5c-0d072a113624\\\", \\\"childbox\\\": \\\"bd1dc74a-ada5-4e73-a5e7-c8f78759c2e5\\\", \\\"subtext\\\": \\\"cead37da-697e-411c-af45-17a8f97a53b1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 657, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"are serious diseases that can be fatal or leave permanent sequelae.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"251f86d4-4064-405f-ab5c-0d072a113624\\\", \\\"childbox\\\": \\\"bd1dc74a-ada5-4e73-a5e7-c8f78759c2e5\\\", \\\"subtext\\\": \\\"1341f8f9-f9eb-430b-be6a-ec8baf848f76\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 658, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In ~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"251f86d4-4064-405f-ab5c-0d072a113624\\\", \\\"childbox\\\": \\\"c9bbe111-7419-492e-8c13-3b71767a5521\\\", \\\"subtext\\\": \\\"1341f8f9-f9eb-430b-be6a-ec8baf848f76\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 659, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(EU)/European Economic Area countries, despite the availability of advanced medical treatment and effective antibiotics, case-fatality rates are high at approximately 7% to 15%, with most cases caused by serogroup B (ECDC, 2016).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5fc8649a-6059-4c14-a20b-99dfd5a09228\\\", \\\"childbox\\\": \\\"74ef2a50-ae04-4fd8-b042-959acf50c659\\\", \\\"subtext\\\": \\\"0f367381-8f2f-4d21-8181-d5fbeafcf05d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 660, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Up to one-fifth of survivors suffer long-term sequelae, including mental retardation, hearing loss, and loss of limb use (~REDACTED~, 2001).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5fc8649a-6059-4c14-a20b-99dfd5a09228\\\", \\\"childbox\\\": \\\"e4149cb7-d0bc-43ba-b0ab-efb4b1c64495\\\", \\\"subtext\\\": \\\"d542de6d-b1c3-4b12-8b11-ab40658bbc03\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 661, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In the US, the overall case-fatality ratio remains at 10% to 15%, and 11% to 19% of survivors have long-term sequelae (~REDACTED~, 2013).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5fc8649a-6059-4c14-a20b-99dfd5a09228\\\", \\\"childbox\\\": \\\"91759463-3570-4a8a-8590-fca435ce1754\\\", \\\"subtext\\\": \\\"bcdc040e-5e21-478c-8dec-97de55fd481f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 662, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Rates of disease are highest in children younger than 1 year of age, followed by a second peak in adolescence (~REDACTED~, 2015).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5fc8649a-6059-4c14-a20b-99dfd5a09228\\\", \\\"childbox\\\": \\\"e6a22116-55a0-4ab5-8113-424bb3666996\\\", \\\"subtext\\\": \\\"043243fa-e536-4c48-810e-3e73a7eb6ec6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 663, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Reliable estimates of the global burden of disease are currently not available, as case definitions differ and surveillance data from many regions are incomplete (~REDACTED~, 2012).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f3e1768a-0a13-425b-8ba2-dc1129f8bc36\\\", \\\"childbox\\\": \\\"82a02bef-7625-45c1-a54e-316e19ac06e6\\\", \\\"subtext\\\": \\\"01c3db25-d621-4d04-835f-168c0d38deb7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 664, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The overall incidence of IMD in European countries ranges from approximately 0.1 to 2.4 cases per 100 000 populations (ECDC, 2016).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f3e1768a-0a13-425b-8ba2-dc1129f8bc36\\\", \\\"childbox\\\": \\\"e57722c8-3fe9-4867-9956-b79d1cd34b53\\\", \\\"subtext\\\": \\\"b55a2287-26ab-408f-88df-a0f6f2fefa35\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 665, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In the US, incidence is 0.1 cases per 100 000 population (CDC, 2018).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f3e1768a-0a13-425b-8ba2-dc1129f8bc36\\\", \\\"childbox\\\": \\\"3c212333-593d-4668-8177-4de6b16871c4\\\", \\\"subtext\\\": \\\"0132e62c-44e5-447d-a55c-ae7564407351\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 666, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~ MenACWY ~REDACTED~ is a meningococcal oligosaccharide conjugate ~REDACTED~ licensed for active immunization to prevent IMD caused by\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3e55c76e-70fc-4bcb-a58f-45ed5ccfe2de\\\", \\\"childbox\\\": \\\"37239ada-cef9-4f85-93ba-d5b9b16e114f\\\", \\\"subtext\\\": \\\"bca780cd-9cb1-4e87-bb6b-4d33ad88e683\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 667, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3e55c76e-70fc-4bcb-a58f-45ed5ccfe2de\\\", \\\"childbox\\\": \\\"37239ada-cef9-4f85-93ba-d5b9b16e114f\\\", \\\"subtext\\\": \\\"96d1738b-936e-4669-a8e8-ac3094bf5953\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 668, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3e55c76e-70fc-4bcb-a58f-45ed5ccfe2de\\\", \\\"childbox\\\": \\\"a338836f-e65b-429c-b419-da611586c98f\\\", \\\"subtext\\\": \\\"96d1738b-936e-4669-a8e8-ac3094bf5953\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 669, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"serogroups A, C, W-135, and Y.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3e55c76e-70fc-4bcb-a58f-45ed5ccfe2de\\\", \\\"childbox\\\": \\\"a338836f-e65b-429c-b419-da611586c98f\\\", \\\"subtext\\\": \\\"946411a0-a065-4206-91f9-e7086331884c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 670, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"It is approved for adolescents and adults in more than 60 countries; many of these countries have also approved its use in children.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3e55c76e-70fc-4bcb-a58f-45ed5ccfe2de\\\", \\\"childbox\\\": \\\"a5ee7456-8362-4739-8e76-01990391637a\\\", \\\"subtext\\\": \\\"946411a0-a065-4206-91f9-e7086331884c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 671, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In the EU, ~REDACTED~ is indicated for use in individuals 2 years of age and older, and in the US, in individuals 2 months to 55 years of age.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3e55c76e-70fc-4bcb-a58f-45ed5ccfe2de\\\", \\\"childbox\\\": \\\"180865b4-e4a0-4bb9-92f9-b5dd7b055c1c\\\", \\\"subtext\\\": \\\"95cd2595-0afe-414f-b049-ca57117750c5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 672, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A single booster dose of ~REDACTED~ MenACWY ~REDACTED~ (\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c187842e-aa3d-48ee-a6db-2c7d65aa71d3\\\", \\\"childbox\\\": \\\"25517a40-4b8f-4b2a-93e1-c535d64f04a4\\\", \\\"subtext\\\": \\\"0b4bfe7f-bfcf-4aed-94a8-8bc0f0984786\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 673, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c187842e-aa3d-48ee-a6db-2c7d65aa71d3\\\", \\\"childbox\\\": \\\"25517a40-4b8f-4b2a-93e1-c535d64f04a4\\\", \\\"subtext\\\": \\\"1adfe61e-380f-4674-98c9-addea4961d0d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 674, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\") has recently been approved by the US Federal Food and Drug Administration (~REDACTED~) for a boosting administration to individuals who are at continued risk for IMD if at least 4 years have elapsed since a prior dose of a meningococcal (serogroups A, C, W-135, Y) conjugate ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c187842e-aa3d-48ee-a6db-2c7d65aa71d3\\\", \\\"childbox\\\": \\\"25517a40-4b8f-4b2a-93e1-c535d64f04a4\\\", \\\"subtext\\\": \\\"93b756fc-70d4-491d-b4d5-c7945c0eeb9b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 675, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~ Biologicals\\\\u2019 MenB ~REDACTED~ (\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bcd733d3-4723-4348-971a-095074ddad6b\\\", \\\"childbox\\\": \\\"0a6d5edc-81ca-4b9d-8770-a7ac37d7d929\\\", \\\"subtext\\\": \\\"f0c1e9a5-c1c6-48b4-9234-a1896222fae7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 676, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Bexsero\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bcd733d3-4723-4348-971a-095074ddad6b\\\", \\\"childbox\\\": \\\"0a6d5edc-81ca-4b9d-8770-a7ac37d7d929\\\", \\\"subtext\\\": \\\"c3b72393-228d-4761-8c2a-cf4652a6b518\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 677, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\") is approved for use in the EU, US, and several other countries for active immunization to prevent IMD caused by\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bcd733d3-4723-4348-971a-095074ddad6b\\\", \\\"childbox\\\": \\\"0a6d5edc-81ca-4b9d-8770-a7ac37d7d929\\\", \\\"subtext\\\": \\\"6ef076a4-a759-4fe5-8b65-a25c5864138b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 678, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bcd733d3-4723-4348-971a-095074ddad6b\\\", \\\"childbox\\\": \\\"0a6d5edc-81ca-4b9d-8770-a7ac37d7d929\\\", \\\"subtext\\\": \\\"10f2ffa3-48fb-49fa-a9bd-99c7c2c2cbc0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 679, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bcd733d3-4723-4348-971a-095074ddad6b\\\", \\\"childbox\\\": \\\"eec2c0a5-7854-425e-bfd2-5eabfc2c90b5\\\", \\\"subtext\\\": \\\"10f2ffa3-48fb-49fa-a9bd-99c7c2c2cbc0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 680, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"serogroup B.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bcd733d3-4723-4348-971a-095074ddad6b\\\", \\\"childbox\\\": \\\"eec2c0a5-7854-425e-bfd2-5eabfc2c90b5\\\", \\\"subtext\\\": \\\"46f0a95c-0ebf-4705-a4a4-d9532c34b54f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 681, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In the EU, ~REDACTED~ is indicated for use in individuals 2 months of age and older; in the US, in individuals 10 to 25 years of age.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bcd733d3-4723-4348-971a-095074ddad6b\\\", \\\"childbox\\\": \\\"1c0cd99e-3d26-4a17-82bf-c31c8985026c\\\", \\\"subtext\\\": \\\"46f0a95c-0ebf-4705-a4a4-d9532c34b54f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 682, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Worldwide, MenB ~REDACTED~ is approved for use with different schedules depending on the country\\\\u2019s jurisdiction; dosage can vary between 2 to 4 doses per participant.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bcd733d3-4723-4348-971a-095074ddad6b\\\", \\\"childbox\\\": \\\"6b3eb8a0-ffaa-4efd-a703-92c0209d6267\\\", \\\"subtext\\\": \\\"729a0c5a-85f8-49d6-b289-9e94d849f637\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 683, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigational MenABCWY combination ~REDACTED~ is based upon the 2 aforementioned well-established ~REDACTED~ ~REDACTED~s, MenACWY and MenB.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8aaea5b1-7d80-4eea-9913-951d7e288190\\\", \\\"childbox\\\": \\\"a6623973-319a-4a08-a2b7-b4ac507a4fb3\\\", \\\"subtext\\\": \\\"ebd0c1eb-e223-40bc-a788-9e4850cab0d1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 684, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Both vaccines have been extensively tested in clinical trials in order to support marketing authorizations in several jurisdictions.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8aaea5b1-7d80-4eea-9913-951d7e288190\\\", \\\"childbox\\\": \\\"03604386-51bd-48fc-a2e5-55c17a4aead2\\\", \\\"subtext\\\": \\\"ebd0c1eb-e223-40bc-a788-9e4850cab0d1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 685, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the current Investigator\\\\u2019s Brochure (IB) for information regarding pre-clinical and clinical studies and epidemiological information of MenABCWY.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1a47aa08-8df1-4185-aafe-4cf31eb0e416\\\", \\\"childbox\\\": \\\"5e1fa863-da96-48a4-9950-81117dd19b3e\\\", \\\"subtext\\\": \\\"42adbaa5-ec3b-4a05-95a9-f413e4f7e44f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Background\\\", \\\"2.2\\\", \\\"2\\\", 686, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"2.3 Benefit/Risk Assessment\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b25b3c39-a80e-43d6-881a-37d5341358e0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 687, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Detailed information about the known and expected benefits and risks and reasonably expected adverse events (AEs) of MenABCWY can be found in the IB.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b170adae-6b06-45cc-9e60-9a6ac29f4a48\\\", \\\"childbox\\\": \\\"9b1b9611-d20a-403a-ab17-dbe1a8a2d344\\\", \\\"subtext\\\": \\\"536ee5a7-8a8f-4b58-8390-422352c0dfe7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 688, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the Product Information (PI) for information regarding the summary of potential risks and benefits of\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b170adae-6b06-45cc-9e60-9a6ac29f4a48\\\", \\\"childbox\\\": \\\"9df92cbc-59d2-4cd5-b9e0-e5b14abc3fec\\\", \\\"subtext\\\": \\\"536ee5a7-8a8f-4b58-8390-422352c0dfe7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 689, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Bexsero\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b170adae-6b06-45cc-9e60-9a6ac29f4a48\\\", \\\"childbox\\\": \\\"9df92cbc-59d2-4cd5-b9e0-e5b14abc3fec\\\", \\\"subtext\\\": \\\"3aecc8fa-babd-4a1c-a951-132cfea8b7c9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 690, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"and\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b170adae-6b06-45cc-9e60-9a6ac29f4a48\\\", \\\"childbox\\\": \\\"9df92cbc-59d2-4cd5-b9e0-e5b14abc3fec\\\", \\\"subtext\\\": \\\"d29880cb-1864-4e91-90ce-24fc477e0c56\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 691, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b170adae-6b06-45cc-9e60-9a6ac29f4a48\\\", \\\"childbox\\\": \\\"9df92cbc-59d2-4cd5-b9e0-e5b14abc3fec\\\", \\\"subtext\\\": \\\"b1a3ffa2-97f6-41e0-8d4c-7eda32ee6775\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 692, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\".\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b170adae-6b06-45cc-9e60-9a6ac29f4a48\\\", \\\"childbox\\\": \\\"9df92cbc-59d2-4cd5-b9e0-e5b14abc3fec\\\", \\\"subtext\\\": \\\"c591ddcb-413f-4a87-80fe-09f77933f41b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 693, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Benefit considerations include:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c1f554ac-4831-4bd6-be5e-10aa2d758436\\\", \\\"childbox\\\": \\\"246179ad-2170-4658-ba1c-1686164ecbc7\\\", \\\"subtext\\\": \\\"c38b64c8-dc57-41b1-80d5-ddca853185d6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 694, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Medical evaluations/assessments associated with this study (e.g., physical examinations).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ae15cc03-26e6-4814-b402-6fa2a8aff266\\\", \\\"childbox\\\": \\\"381090f9-5d1c-43cf-a9e2-fa179431dcaf\\\", \\\"subtext\\\": \\\"e592886e-a953-4bcd-baf7-976b23451371\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 695, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Contributing to the process of developing new therapies.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dfac7dc3-3f3a-4392-acf1-76699a4b1b8a\\\", \\\"childbox\\\": \\\"1f607a2f-12ce-4278-b08a-49ce283e1e25\\\", \\\"subtext\\\": \\\"fe8417eb-3cac-4eef-8ce3-1ec9e6c8a3ee\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 696, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Potential benefit of receiving the licensed\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"565c720e-ee70-492e-a1ac-f09e4cecad00\\\", \\\"childbox\\\": \\\"1654afba-c437-447e-b42c-f64536ea7591\\\", \\\"subtext\\\": \\\"6c968afd-e7ea-4791-bda5-825f97720e53\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 697, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Bexsero\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"565c720e-ee70-492e-a1ac-f09e4cecad00\\\", \\\"childbox\\\": \\\"1654afba-c437-447e-b42c-f64536ea7591\\\", \\\"subtext\\\": \\\"9c7c3761-8bf7-4cba-9461-b6a5e8c4d428\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 698, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"and\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"565c720e-ee70-492e-a1ac-f09e4cecad00\\\", \\\"childbox\\\": \\\"1654afba-c437-447e-b42c-f64536ea7591\\\", \\\"subtext\\\": \\\"d2a9289b-d61b-471c-960d-7b893a145a8f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 699, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"565c720e-ee70-492e-a1ac-f09e4cecad00\\\", \\\"childbox\\\": \\\"1654afba-c437-447e-b42c-f64536ea7591\\\", \\\"subtext\\\": \\\"6b565ec2-791e-476e-8831-6cea13da3c12\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 700, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"vaccines to help protect against meningococcal IMDs caused by\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"565c720e-ee70-492e-a1ac-f09e4cecad00\\\", \\\"childbox\\\": \\\"1654afba-c437-447e-b42c-f64536ea7591\\\", \\\"subtext\\\": \\\"8b9cef4b-e8cf-4074-8059-0cb46f48ee8c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 701, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"565c720e-ee70-492e-a1ac-f09e4cecad00\\\", \\\"childbox\\\": \\\"1654afba-c437-447e-b42c-f64536ea7591\\\", \\\"subtext\\\": \\\"d2c669fd-ebeb-40de-88f7-2eaf9cf99fd9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 702, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"565c720e-ee70-492e-a1ac-f09e4cecad00\\\", \\\"childbox\\\": \\\"f89ef946-fe79-4282-8d52-8c70c2d614b0\\\", \\\"subtext\\\": \\\"d2c669fd-ebeb-40de-88f7-2eaf9cf99fd9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 703, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"serogroups A, B, C, W, and Y.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"565c720e-ee70-492e-a1ac-f09e4cecad00\\\", \\\"childbox\\\": \\\"f89ef946-fe79-4282-8d52-8c70c2d614b0\\\", \\\"subtext\\\": \\\"abae4b65-8009-46c6-a714-fd53e2bca4a9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 704, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"No significant safety signals have been identified for MenABCWY.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"63124703-6deb-4fb4-8675-853eb794617c\\\", \\\"childbox\\\": \\\"873761e4-8618-4b93-8d62-4734653e2f8f\\\", \\\"subtext\\\": \\\"f0d1127b-3441-4d06-b72a-49fb849357b6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 705, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Cumulative safety data have not identified new important safety risks.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"63124703-6deb-4fb4-8675-853eb794617c\\\", \\\"childbox\\\": \\\"45225acf-30ea-4bd1-9ac1-93a2607a2661\\\", \\\"subtext\\\": \\\"f0d1127b-3441-4d06-b72a-49fb849357b6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 706, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The balance of anticipated benefits and apparent risks associated with MenABCWY continues to be acceptable following the ongoing systematic review of safety data.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"63124703-6deb-4fb4-8675-853eb794617c\\\", \\\"childbox\\\": \\\"f885eaa4-b251-4b67-870c-0f1a3cfe6366\\\", \\\"subtext\\\": \\\"282548e8-3b31-4c4f-8f3f-3e1ab5312916\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 707, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Taking into account the measures taken to minimize risk to participants in this study, the potential for risks identified in association with MenABCWY,\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"21a0c4d6-b886-4d01-bd95-9af51cf2ef03\\\", \\\"childbox\\\": \\\"37fa4eac-d65a-48eb-9b1d-df648b09cb42\\\", \\\"subtext\\\": \\\"2c794cf6-3b9f-4118-a359-52780b3a44ef\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 708, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Bexsero,\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"21a0c4d6-b886-4d01-bd95-9af51cf2ef03\\\", \\\"childbox\\\": \\\"37fa4eac-d65a-48eb-9b1d-df648b09cb42\\\", \\\"subtext\\\": \\\"46738bc0-22b7-4bd1-bb1d-9dace9a53d95\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 709, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"and\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"21a0c4d6-b886-4d01-bd95-9af51cf2ef03\\\", \\\"childbox\\\": \\\"37fa4eac-d65a-48eb-9b1d-df648b09cb42\\\", \\\"subtext\\\": \\\"e918bb3e-339d-471a-b425-cf3322d00e83\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 710, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"21a0c4d6-b886-4d01-bd95-9af51cf2ef03\\\", \\\"childbox\\\": \\\"37fa4eac-d65a-48eb-9b1d-df648b09cb42\\\", \\\"subtext\\\": \\\"10cea289-2c87-4f6c-9032-eb9538c07cad\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 711, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"are justified by the potential benefits that may be afforded to participants.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"21a0c4d6-b886-4d01-bd95-9af51cf2ef03\\\", \\\"childbox\\\": \\\"37fa4eac-d65a-48eb-9b1d-df648b09cb42\\\", \\\"subtext\\\": \\\"1df97ddf-a328-46d0-9b33-ddae3d68d560\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Benefit/Risk Assessment\\\", \\\"2.3\\\", \\\"2\\\", 712, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"3.0  OBJECTIVES AND ENDPOINTS\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading1\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fd284273-29ad-44dc-a26d-7d09cb22b42e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"OBJECTIVES AND ENDPOINTS\\\", \\\"3.0\\\", \\\"2\\\", 713, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Objectives and endpoints are presented in Table 6.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8b9cfce6-d9bc-4648-97a2-eaeb182721da\\\", \\\"childbox\\\": \\\"1646afb4-7bdf-41c6-8183-3ed5fa335447\\\", \\\"subtext\\\": \\\"ba1d2b2d-89cb-4442-a632-90791818d381\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"OBJECTIVES AND ENDPOINTS\\\", \\\"3.0\\\", \\\"2\\\", 714, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Table 6\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1c5e045e-a820-4cb1-9332-de1e025f4009\\\", \\\"childbox\\\": \\\"19eb3d1b-2585-410e-8ff2-365824dca829\\\", \\\"subtext\\\": \\\"06e9465c-ab8c-44c0-9ad9-a0c79ab6210c\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 715, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1c5e045e-a820-4cb1-9332-de1e025f4009\\\", \\\"childbox\\\": \\\"f401ef9d-f6b2-45db-a232-51a993b75ca0\\\", \\\"subtext\\\": \\\"07a8f348-c312-4f87-95ac-8f971c742fff\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 716, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Study Objectives and Endpoints\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1c5e045e-a820-4cb1-9332-de1e025f4009\\\", \\\"childbox\\\": \\\"1b1f0d9c-7ad3-4a89-9969-e7897d77cdd2\\\", \\\"subtext\\\": \\\"07a8f348-c312-4f87-95ac-8f971c742fff\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 717, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Objectives</td>\\\\n      <td>Endpoints</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Primary</td>\\\\n      <td>Primary</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Immunological non-inferiority: MenABCWY vs. MenACWY (Family 1) To demonstrate the immunological non-inferiority of the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with a MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, as measured by the percentages of participants achieving a 4-fold rise <sup>1</sup> in hSBA titers against N. meningitidis serogroups A, C, W, and Y, at 1 month after the second MenABCWY vaccination (0,6-months) and 1 month after the MenACWY vaccination (single dose).</td>\\\\n      <td>The percentages of participants with a 4-fold rise <sup>1</sup> in hSBA titers against N . meningitidis serogroups A, C, W, and Y at 1 month after the second vaccination for the ABCWY group (Day 211, Month 7), and 1 month after the single MenACWY vaccination for the ACWY group (Day 31, Month 1) relative to baseline (Day 1, Month 0).</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Immunological non-inferiority: MenABCWY vs. MenACWY  (Family 2)  To demonstrate the immunological non-inferiority of the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, compared to MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> given to healthy participants, previously primed with a MenACWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, as measured by the percentages of participants achieving a 4-fold rise <sup>1</sup> in hSBA titers against N. meningitidis serogroups A, C, W, and Y, at 1 month after the first MenABCWY vaccination (0,6-months) and 1 month after the MenACWY vaccination (single dose).</td>\\\\n      <td>The percentages of participants with a 4-fold rise <sup>1</sup> in hSBA titers against N . meningitidis serogroups A, C, W, and Y at 1 month after the first vaccination for the ABCWY group (Day 31, Month 1), and 1 month after the single dose of MenACWY vaccination for the ACWY group (Day 31, Month 1), relative to baseline (Day 1, Month 0).</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>Safety To evaluate the safety and reactogenicity of the MenABCWY and MenACWY vaccines.</td>\\\\n      <td>The frequencies and percentages of participants with solicited administration site events (i.e., injection site pain, erythema, swelling, induration) and solicited systemic events (i.e., fever [body temperature \\\\u226538.0\\\\u00b0C/100.4\\\\u00b0F], nausea, fatigue, myalgia, arthralgia, headache) during the 7 days (including the day of vaccination) following vaccination at Day 1, Month 0 (for the ABCWY and ACWY groups) and Day 181, Month 6 (for the ABCWY group). The frequencies and percentages of participants with any unsolicited AEs (including all SAEs, AEs leading to withdrawal, AESIs and medically attended AEs) during the 30 days (including the day of</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"33\\\", \\\"TableIndex\\\": \\\"20\\\", \\\"TableName\\\": \\\"Table 6 Study Objectives and Endpoints\\\", \\\"Header\\\": [0, 1, 2]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"be1efdd0-6abb-4f1c-809b-d17ecbb663f2\\\", \\\"childbox\\\": \\\"66ac28a4-7df6-498b-af53-b5f2cdc46b22\\\", \\\"subtext\\\": \\\"1822ac1c-cbbc-46bf-8886-1821ae73a54d\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 718, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"da5cb32c-7806-47bf-8878-e191f20971d1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 719, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Objectives</td>\\\\n      <td>Endpoints</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td></td>\\\\n      <td>vaccination) following vaccination at Day 1, Month 0 (for the ABCWY and ACWY groups) and Day 181, Month 6 (for the ABCWY group).   The percentages of participants with SAEs, AEs leading to withdrawal, AESIs and medically attended AEs throughout the study period (Month 0 to Month 12).</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Secondary</td>\\\\n      <td>Secondary</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>To assess <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to MenABCWY (0,6-month schedule) and MenACWY (single dose) vaccines against N. meningitidis serogroups A, C, W, and Y, at pre-vaccination and 1 month after the first and last MenABCWY vaccinations and 1 month after the MenACWY vaccination.</td>\\\\n      <td>The percentages of participants with hSBA titers \\\\u2265Lower Limit of Quantitation (LLOQ) against serogroups A, C, W, and Y: at baseline (Day 1, Month 0) and at 1 month after the first (Day 31, Month 1) and the last vaccination (Day 211, Month 7) for the ABCWY group, and at baseline (Day 1, Month 0) and 1 month after the single MenACWY vaccination for the ACWY group (Day 31, Month 1). The geometric mean titers (GMTs) against serogroups A, C, W, and Y: at baseline (Day 1, Month 0) and at 1 month after the first (Day 31, Month 1) and the last (Day 211, Month 7) vaccinations for the ABCWY group, and at baseline (Day 1, Month 0) and 1 month after the single MenACWY vaccination for the ACWY group (Day 31, Month 1). The geometric mean ratios (GMRs) against serogroups A, C, W, and Y: at 1 month after the first (Day 31, Month 1) and the last vaccination (Day 211, Month 7) for the ABCWY group as compared to baseline (Day 1, Month 0) and at 1 month after the MenACWY vaccination (Day 31, Month 1) for the ACWY group as compared to baseline (Day 1, Month 0).</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"33\\\", \\\"TableIndex\\\": \\\"21\\\", \\\"TableName\\\": \\\"Table 6 Study Objectives and Endpoints\\\", \\\"Header\\\": [0, 2]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"ed6d41a3-5cbd-4353-8b85-28e28243251c\\\", \\\"childbox\\\": \\\"1f7f492d-28d2-475e-b059-413048f889a8\\\", \\\"subtext\\\": \\\"7b73328b-1d02-4f74-8440-3d0c0041e281\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 720, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ba498e0d-d8ce-4ce3-93b1-e535029d0d28\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 721, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e1d9f04b-0798-4fb9-a418-02c5f4fe57dc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 722, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Objectives</td>\\\\n      <td>Objectives</td>\\\\n      <td>Endpoints</td>\\\\n      <td>Endpoints</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>To assess <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> (0,6-month schedule) against N. meningitidis serogroup B indicator strains, at pre-vaccination and at 1 month after the last MenABCWY vaccination.</td>\\\\n      <td>To assess <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> (0,6-month schedule) against N. meningitidis serogroup B indicator strains, at pre-vaccination and at 1 month after the last MenABCWY vaccination.</td>\\\\n      <td>The percentages of participants with hSBA titers \\\\u2265LLOQ for each and all serogroup B indicator strains at baseline (Day 1, Month 0) and at 1 month after the last vaccination (Day 211, Month 7) for the ABCWY group. The percentages of participants with 4-fold rise <sup>1</sup> in hSBA titers against each N. meningitidis serogroup B indicator strains at 1 month after the last vaccination (Day 211, Month 7) relative to baseline (Day 1, Month 0) for the ABCWY group. GMTs against each serogroup B indicator strains at baseline (Day 1, Month 0) and at 1 month after the last vaccination (Day 211, Month 7) for the ABCWY group. GMRs against each serogroup B indicator strains at 1 month after the last vaccination (Day 211, Month 7) as compared to the baseline (Day 1, Month 0) for the ABCWY group.</td>\\\\n      <td>The percentages of participants with hSBA titers \\\\u2265LLOQ for each and all serogroup B indicator strains at baseline (Day 1, Month 0) and at 1 month after the last vaccination (Day 211, Month 7) for the ABCWY group. The percentages of participants with 4-fold rise <sup>1</sup> in hSBA titers against each N. meningitidis serogroup B indicator strains at 1 month after the last vaccination (Day 211, Month 7) relative to baseline (Day 1, Month 0) for the ABCWY group. GMTs against each serogroup B indicator strains at baseline (Day 1, Month 0) and at 1 month after the last vaccination (Day 211, Month 7) for the ABCWY group. GMRs against each serogroup B indicator strains at 1 month after the last vaccination (Day 211, Month 7) as compared to the baseline (Day 1, Month 0) for the ABCWY group.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Tertiary <sup>2</sup></td>\\\\n      <td>Tertiary <sup>2</sup></td>\\\\n      <td>Tertiary <sup>2</sup></td>\\\\n      <td>Tertiary <sup>2</sup></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>To assess <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> (0,6-month schedule) against N. meningitidis serogroup B indicator strains, at 1 month after the first MenABCWY vaccination.</td>\\\\n      <td>To assess <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to the MenABCWY <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> (0,6-month schedule) against N. meningitidis serogroup B indicator strains, at 1 month after the first MenABCWY vaccination.</td>\\\\n      <td>The percentages of participants with hSBA titers \\\\u2265LLOQ for each serogroup B indicator strains at 1 month after the first vaccination (Day 31, Month 1 for the ABCWY group). The percentages of participants with 4-fold rise <sup>1</sup> in hSBA titers against each N. meningitidis serogroup B indicator strains at 1 month after the first vaccination (Day 31, Month 1) relative to baseline (Day 1, Month 0) for the ABCWY group. GMTs against each serogroup B indicator strains at 1 month after the first vaccination (Day 31, Month 1) for the ABCWY group. GMRs against each serogroup B test strains at 1 month after first vaccination (Day 31, Month 1) as compared to baseline (Day 1, Month 0) for the ABCWY group.</td>\\\\n      <td>The percentages of participants with hSBA titers \\\\u2265LLOQ for each serogroup B indicator strains at 1 month after the first vaccination (Day 31, Month 1 for the ABCWY group). The percentages of participants with 4-fold rise <sup>1</sup> in hSBA titers against each N. meningitidis serogroup B indicator strains at 1 month after the first vaccination (Day 31, Month 1) relative to baseline (Day 1, Month 0) for the ABCWY group. GMTs against each serogroup B indicator strains at 1 month after the first vaccination (Day 31, Month 1) for the ABCWY group. GMRs against each serogroup B test strains at 1 month after first vaccination (Day 31, Month 1) as compared to baseline (Day 1, Month 0) for the ABCWY group.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>To assess <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to MenABCWY (0,6-month schedule) and MenACWY (single dose) vaccines, as measured by Enzyme-Linked Immunosorbent Assay (ELISA) Geometric Mean Concentration (GMCs), against N. meningitidis serogroups A, C, W, and Y, at pre-vaccination and 1 month after the first and last MenABCWY</td>\\\\n      <td>To assess <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to MenABCWY (0,6-month schedule) and MenACWY (single dose) vaccines, as measured by Enzyme-Linked Immunosorbent Assay (ELISA) Geometric Mean Concentration (GMCs), against N. meningitidis serogroups A, C, W, and Y, at pre-vaccination and 1 month after the first and last MenABCWY</td>\\\\n      <td>The total IgG as measured by ELISA GMCs against serogroups A, C, W, and Y:   at baseline (Day 1, Month 0) and at 1 month after the first (Day 31, Month 1) and the last vaccination (Day 211, Month 7) for the ABCWY group, and</td>\\\\n      <td>The total IgG as measured by ELISA GMCs against serogroups A, C, W, and Y:   at baseline (Day 1, Month 0) and at 1 month after the first (Day 31, Month 1) and the last vaccination (Day 211, Month 7) for the ABCWY group, and</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>vaccinations and 1 month after the MenACWY vaccination.</td>\\\\n      <td>vaccinations and 1 month after the MenACWY vaccination.</td>\\\\n      <td>at baseline (Day 1, Month 0) and 1 month after the single MenACWY vaccination in the ACWY group (Day 31, Month 1).</td>\\\\n      <td>at baseline (Day 1, Month 0) and 1 month after the single MenACWY vaccination in the ACWY group (Day 31, Month 1).</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"33\\\", \\\"TableIndex\\\": \\\"22\\\", \\\"TableName\\\": \\\"Table 6 Study Objectives and Endpoints\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"aea3a36d-52d1-46b1-933e-ed5d5a3226bb\\\", \\\"childbox\\\": \\\"ad5cb404-8249-457e-ab30-e6151f4ecaf5\\\", \\\"subtext\\\": \\\"0277e028-f4b3-4db9-b6ed-c161c008d6e7\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 723, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"AESI = adverse event of special interest; CI = confidence interval; ELISA = enzyme-linked immunosorbent assay; GMC = geometric mean concentration; GMT = geometric mean titer; GMR = geometric mean ratio; hSBA = human serum bactericidal assay; LLOQ = lower limit of quantitation;\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f0791782-d68e-4b60-a89b-398a18409920\\\", \\\"childbox\\\": \\\"4a66c6c4-a38a-4b0e-9a25-117210bec554\\\", \\\"subtext\\\": \\\"6a3c71b6-a13c-4a65-85d8-c39bc3881d2f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 724, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f0791782-d68e-4b60-a89b-398a18409920\\\", \\\"childbox\\\": \\\"4a66c6c4-a38a-4b0e-9a25-117210bec554\\\", \\\"subtext\\\": \\\"e2046df7-d764-4361-8c8c-d7f4e858e6cd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 725, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f0791782-d68e-4b60-a89b-398a18409920\\\", \\\"childbox\\\": \\\"547277a6-9e34-4900-842f-7d6ba31f55fa\\\", \\\"subtext\\\": \\\"e2046df7-d764-4361-8c8c-d7f4e858e6cd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 726, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"=\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f0791782-d68e-4b60-a89b-398a18409920\\\", \\\"childbox\\\": \\\"547277a6-9e34-4900-842f-7d6ba31f55fa\\\", \\\"subtext\\\": \\\"8779c009-691c-4c15-a245-2721b2fd9809\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 727, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Neisseria meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f0791782-d68e-4b60-a89b-398a18409920\\\", \\\"childbox\\\": \\\"547277a6-9e34-4900-842f-7d6ba31f55fa\\\", \\\"subtext\\\": \\\"9118de54-00ec-4ba8-9830-990467f88a49\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 728, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"; SAE = serious adverse event\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f0791782-d68e-4b60-a89b-398a18409920\\\", \\\"childbox\\\": \\\"547277a6-9e34-4900-842f-7d6ba31f55fa\\\", \\\"subtext\\\": \\\"e9e5deee-979a-4aa0-9023-b1d5e06a6e24\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 729, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1 Refer to Section 9.0 for the (seroresponse) definition of the 4-fold rise.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7eae5926-2e41-4af9-b7ef-c39f49880e95\\\", \\\"childbox\\\": \\\"64047e4b-13b4-4568-9c8a-28774a39dc5e\\\", \\\"subtext\\\": \\\"b0ca63b0-a9eb-438f-8e60-417e3cf40a8e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 730, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2 Evaluation of the tertiary objective is participant to availability of samples and may or not be performed.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b99025f5-f8cf-45e3-a62f-65f96c20cd71\\\", \\\"childbox\\\": \\\"b5b00424-dd07-4bc7-a4b0-4652e1fcac8f\\\", \\\"subtext\\\": \\\"598c80c2-6133-472a-9f68-a4452995d8de\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 731, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If the tertiary objective is evaluated, it may be assessed in a subset of participants using remaining serum after the primary and secondary analyses have been completed; no additional blood samples will be collected from participants.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b99025f5-f8cf-45e3-a62f-65f96c20cd71\\\", \\\"childbox\\\": \\\"c611b835-cf4a-47dc-8840-bbe86f6b9411\\\", \\\"subtext\\\": \\\"598c80c2-6133-472a-9f68-a4452995d8de\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 732, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Any outcome of exploratory testing in respect of the tertiary objective will be reported in an annex/addendum to the final clinical study report.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b99025f5-f8cf-45e3-a62f-65f96c20cd71\\\", \\\"childbox\\\": \\\"162f07d0-514c-41b8-9838-466939b5d66c\\\", \\\"subtext\\\": \\\"8fc6f8d6-6b73-42d8-9c4c-1ad2f2a8773b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 733, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b99025f5-f8cf-45e3-a62f-65f96c20cd71\\\", \\\"childbox\\\": \\\"3305cdc4-6896-43c8-b27c-7aba78aab712\\\", \\\"subtext\\\": \\\"272698bb-8077-4796-a879-de69324a01b4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Objectives and Endpoints\\\", \\\"Table 6\\\", \\\"1\\\", 734, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"4.0  STUDY DESIGN\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading1\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8eb96f27-4b70-4134-b1c8-79d76dd3c502\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY DESIGN\\\", \\\"4.0\\\", \\\"2\\\", 735, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"4.1 Overall Design\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3a9917c6-afbd-40f4-9da3-e724c3956be0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Overall Design\\\", \\\"4.1\\\", \\\"2\\\", 736, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The study design diagram is provided in Figure 1.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"62950b1f-e810-4e0c-8c45-6dd2f0305d26\\\", \\\"childbox\\\": \\\"c4cf4fef-b3ec-4ae1-a47f-3280b0dffac0\\\", \\\"subtext\\\": \\\"4fd70b25-62f0-432f-8359-6b60c11294d8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Overall Design\\\", \\\"4.1\\\", \\\"2\\\", 737, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Figure 1 Study Design Overview\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ecc614db-5d9c-40b0-9d90-c2faee04a456\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 738, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"347164e8-82b8-4b3a-8332-758e651babf7\\\", \\\"childbox\\\": \\\"669ff644-660a-4538-ac85-f60473baaf56\\\", \\\"subtext\\\": \\\"5aee8a18-71a1-413f-8199-da095fcba5d5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 739, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"ACWY =\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"03e1607f-0a05-4213-9234-f6b0f056f546\\\", \\\"childbox\\\": \\\"aa06918a-7b01-4355-9777-6aea0223c46c\\\", \\\"subtext\\\": \\\"6ecf2d0d-6198-46e9-9ac9-f432100b01ea\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 740, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"03e1607f-0a05-4213-9234-f6b0f056f546\\\", \\\"childbox\\\": \\\"aa06918a-7b01-4355-9777-6aea0223c46c\\\", \\\"subtext\\\": \\\"9dc2341f-3585-4363-bea4-8e559e878649\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 741, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"; BS = blood sample; ESFU = extended safety follow-up; MenB =\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"03e1607f-0a05-4213-9234-f6b0f056f546\\\", \\\"childbox\\\": \\\"aa06918a-7b01-4355-9777-6aea0223c46c\\\", \\\"subtext\\\": \\\"2b71bf54-bae0-4b95-999d-811a3fd0873a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 742, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Bexsero\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"03e1607f-0a05-4213-9234-f6b0f056f546\\\", \\\"childbox\\\": \\\"aa06918a-7b01-4355-9777-6aea0223c46c\\\", \\\"subtext\\\": \\\"a6d758d2-d22e-403d-8db9-c80beb0a2376\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 743, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"; N = number of participants; T = telephone contact; V = ~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"03e1607f-0a05-4213-9234-f6b0f056f546\\\", \\\"childbox\\\": \\\"aa06918a-7b01-4355-9777-6aea0223c46c\\\", \\\"subtext\\\": \\\"4c74972c-82a9-4b5b-8e8f-31dbdb9a9206\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 744, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"a\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ce39f49a-9433-4053-849c-957b5628061d\\\", \\\"childbox\\\": \\\"22fa85dc-6954-4792-91e3-4a8bcc4c6e75\\\", \\\"subtext\\\": \\\"9e1518f7-e65c-4941-9153-9ed12c85c460\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"superscript\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 745, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Insufficient blood volume may lead to test cancellation and jeopardize the statistical power.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ce39f49a-9433-4053-849c-957b5628061d\\\", \\\"childbox\\\": \\\"22fa85dc-6954-4792-91e3-4a8bcc4c6e75\\\", \\\"subtext\\\": \\\"589f94a2-bdb2-4607-800f-371343125098\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 746, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Hence, every effort must be made to collect blood volume as per protocol requirements.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ce39f49a-9433-4053-849c-957b5628061d\\\", \\\"childbox\\\": \\\"e3273251-a54d-49f5-9050-3b5a0c323fb2\\\", \\\"subtext\\\": \\\"589f94a2-bdb2-4607-800f-371343125098\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 747, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"b\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ce39f49a-9433-4053-849c-957b5628061d\\\", \\\"childbox\\\": \\\"6c0fb6f5-b119-4d5b-bd60-397decc2db53\\\", \\\"subtext\\\": \\\"f87ccd34-4683-40ce-8699-2662c7c532b4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"superscript\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 748, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Bexsero\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ce39f49a-9433-4053-849c-957b5628061d\\\", \\\"childbox\\\": \\\"6c0fb6f5-b119-4d5b-bd60-397decc2db53\\\", \\\"subtext\\\": \\\"9390512b-cf16-4305-8c1a-f6ec4bcf9fcf\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 749, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"is given for compliance with standard of care.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ce39f49a-9433-4053-849c-957b5628061d\\\", \\\"childbox\\\": \\\"6c0fb6f5-b119-4d5b-bd60-397decc2db53\\\", \\\"subtext\\\": \\\"a69ef40e-3493-4e47-942d-5596976a3d12\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 750, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Protocol waivers or exemptions are not allowed except for immediate safety concerns.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65892008-b009-42bb-aed7-2f115e6d06d4\\\", \\\"childbox\\\": \\\"483d8962-571b-4d98-97f9-ff745ee38780\\\", \\\"subtext\\\": \\\"96ca4c9a-d21f-4392-9957-bacafb86bd87\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 751, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Therefore, adherence to the study design requirements, including those specified in the outline of study procedures (Section 1.3), are essential and required for study conduct.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65892008-b009-42bb-aed7-2f115e6d06d4\\\", \\\"childbox\\\": \\\"5af0f03d-4545-47e7-b53f-056bc55083f7\\\", \\\"subtext\\\": \\\"96ca4c9a-d21f-4392-9957-bacafb86bd87\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 752, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Type of study:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"528bf992-281e-47eb-a24a-5a4e4b565f49\\\", \\\"childbox\\\": \\\"ac08f6d2-1b04-438c-83c1-db997144e273\\\", \\\"subtext\\\": \\\"3cbd1451-f3aa-4d60-911b-7f504c2bd47e\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 753, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Self-contained.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"528bf992-281e-47eb-a24a-5a4e4b565f49\\\", \\\"childbox\\\": \\\"ac08f6d2-1b04-438c-83c1-db997144e273\\\", \\\"subtext\\\": \\\"a458ab31-5bda-4e9a-8a9d-2dbdeeecc84d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 754, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Experimental design:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"23788ac5-c5c1-4b9c-ae69-489dd20ae544\\\", \\\"childbox\\\": \\\"56fbefe9-df85-4fa2-a4fc-fac378a7726f\\\", \\\"subtext\\\": \\\"991877ee-c215-42d8-9043-e7f3dde3d15c\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 755, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Phase IIIB, randomized, controlled, observer-blind, multi-centric, study with 2 parallel study groups.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"23788ac5-c5c1-4b9c-ae69-489dd20ae544\\\", \\\"childbox\\\": \\\"56fbefe9-df85-4fa2-a4fc-fac378a7726f\\\", \\\"subtext\\\": \\\"1ff09a4b-d5df-4b71-af90-85518bb28f61\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 756, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Duration of the study:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5d16989c-7f48-41ff-9511-1eb0a477f49a\\\", \\\"childbox\\\": \\\"3246489e-9e21-4590-8ce4-c941db86a71f\\\", \\\"subtext\\\": \\\"0e616cfb-1bcc-4afd-86a3-f6e2b3583586\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 757, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The total duration of the study, per participant, will be approximately 12 months (4 visits), including the 6 months of Extended Safety Follow-Up (ESFU) period after the last dose of investigational ~REDACTED~ (~REDACTED~ 3, Day 181).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5d16989c-7f48-41ff-9511-1eb0a477f49a\\\", \\\"childbox\\\": \\\"3246489e-9e21-4590-8ce4-c941db86a71f\\\", \\\"subtext\\\": \\\"9695fb0b-362c-45f6-80ff-df3e059557f0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 758, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Primary completion date (PCD):\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"84fd34bd-6731-409c-ad74-7e7315ce033b\\\", \\\"childbox\\\": \\\"71df984f-85ce-43ae-a685-b3e3ad97260e\\\", \\\"subtext\\\": \\\"3bb77417-7a84-4512-8a0d-80740d5c3756\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 759, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Last Participant Last ~REDACTED~ (LSLV) (Day 361).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"84fd34bd-6731-409c-ad74-7e7315ce033b\\\", \\\"childbox\\\": \\\"71df984f-85ce-43ae-a685-b3e3ad97260e\\\", \\\"subtext\\\": \\\"bfcb415e-dd46-43cc-97f2-74203a50a54a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 760, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Blinding:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"514ef7ba-32dc-4826-ac1b-05ae6dee9f3e\\\", \\\"childbox\\\": \\\"90f966ac-421b-41f1-a7f2-d5c022a57f7a\\\", \\\"subtext\\\": \\\"d99ac359-5015-4aad-83b7-23c636241d23\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 761, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Observer-blind.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"514ef7ba-32dc-4826-ac1b-05ae6dee9f3e\\\", \\\"childbox\\\": \\\"90f966ac-421b-41f1-a7f2-d5c022a57f7a\\\", \\\"subtext\\\": \\\"fdf38817-84b0-4d2d-848d-6fd6383e743f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 762, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Section 6.3.5 for details.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"514ef7ba-32dc-4826-ac1b-05ae6dee9f3e\\\", \\\"childbox\\\": \\\"8e9b4831-f452-4c4f-9e50-1495b0966ea2\\\", \\\"subtext\\\": \\\"fdf38817-84b0-4d2d-848d-6fd6383e743f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 763, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Data collection:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bd55cd7d-a16d-4c47-bd40-9fd261e2ab16\\\", \\\"childbox\\\": \\\"4f032b11-7c25-47fb-bef4-dc4eb2ab740d\\\", \\\"subtext\\\": \\\"defbe665-964b-4fe1-b5c5-f516e79be52b\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 764, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Standardized electronic Case Report Form (eCRF).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bd55cd7d-a16d-4c47-bd40-9fd261e2ab16\\\", \\\"childbox\\\": \\\"4f032b11-7c25-47fb-bef4-dc4eb2ab740d\\\", \\\"subtext\\\": \\\"8b56dfb1-1f4b-4386-b437-fc04d9be4b7a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 765, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Solicited events will be collected using a Participant Diary (electronic diary [eDiary]).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bd55cd7d-a16d-4c47-bd40-9fd261e2ab16\\\", \\\"childbox\\\": \\\"edeca9db-8cf2-4da4-b84c-83fd2fba8c08\\\", \\\"subtext\\\": \\\"8b56dfb1-1f4b-4386-b437-fc04d9be4b7a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 766, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Safety monitoring:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5cc98f5f-b56e-4a25-a99e-39ace1bf90cb\\\", \\\"childbox\\\": \\\"4cb2cf82-bb55-4f9a-8aaf-6f37caf0b7f7\\\", \\\"subtext\\\": \\\"e15bedcc-47b7-4d7a-8256-93c77a9dce0b\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 767, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Regular safety follow-up will be done through telephone calls.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5cc98f5f-b56e-4a25-a99e-39ace1bf90cb\\\", \\\"childbox\\\": \\\"4cb2cf82-bb55-4f9a-8aaf-6f37caf0b7f7\\\", \\\"subtext\\\": \\\"5b50e174-b937-4f43-8e10-a94671e9dfbc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 768, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Safety follow-up calls are calls made to the participant by a qualified study center staff designated by the investigator on the site log.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5cc98f5f-b56e-4a25-a99e-39ace1bf90cb\\\", \\\"childbox\\\": \\\"f7ed5348-cc9f-493f-ab9c-96bf8bfc5eab\\\", \\\"subtext\\\": \\\"5b50e174-b937-4f43-8e10-a94671e9dfbc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 769, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"These calls will follow a script which will facilitate the collection of relevant safety information.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5cc98f5f-b56e-4a25-a99e-39ace1bf90cb\\\", \\\"childbox\\\": \\\"ff728ac4-bce7-4daa-9391-16b22138533f\\\", \\\"subtext\\\": \\\"5b50e174-b937-4f43-8e10-a94671e9dfbc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 770, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"There will also be ESFU phone call 6 months after the last dose of investigational ~REDACTED~ (~REDACTED~ 3, Day 181).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5cc98f5f-b56e-4a25-a99e-39ace1bf90cb\\\", \\\"childbox\\\": \\\"952f4091-5fd7-4568-94de-406bc9cd1fad\\\", \\\"subtext\\\": \\\"51cb8eef-1aba-4405-b9d4-ca4650184806\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 771, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This ESFU phone call will also mark the study conclusion.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5cc98f5f-b56e-4a25-a99e-39ace1bf90cb\\\", \\\"childbox\\\": \\\"84e107eb-6a7d-40d2-8faf-3142135f1791\\\", \\\"subtext\\\": \\\"51cb8eef-1aba-4405-b9d4-ca4650184806\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 772, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the Schedule of Events (SoA) (Table 3) and Section 8.3 for details on the safety follow-up.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5cc98f5f-b56e-4a25-a99e-39ace1bf90cb\\\", \\\"childbox\\\": \\\"330a2be3-04f3-4ab9-90e1-6c649885a5b2\\\", \\\"subtext\\\": \\\"51cb8eef-1aba-4405-b9d4-ca4650184806\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 773, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 End of study:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"800a2034-9f8b-4ede-820f-18632e145c90\\\", \\\"childbox\\\": \\\"ee7926b4-8ba8-4b58-904f-f9b5672804dc\\\", \\\"subtext\\\": \\\"28dca94a-711d-43bb-a1b5-175d02160fc7\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 774, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Section 4.4.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"800a2034-9f8b-4ede-820f-18632e145c90\\\", \\\"childbox\\\": \\\"ee7926b4-8ba8-4b58-904f-f9b5672804dc\\\", \\\"subtext\\\": \\\"1a6dd30b-d294-4c2b-bd04-e47fa11c9c6e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 775, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Study groups:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8154dbdd-8dd7-4f06-8439-8944ad4b3b63\\\", \\\"childbox\\\": \\\"0109bcc9-7a8b-4dcd-b871-7f842ed8a8b5\\\", \\\"subtext\\\": \\\"f6a04069-715c-41e3-b5b2-ad948b39118d\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 776, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8154dbdd-8dd7-4f06-8439-8944ad4b3b63\\\", \\\"childbox\\\": \\\"0109bcc9-7a8b-4dcd-b871-7f842ed8a8b5\\\", \\\"subtext\\\": \\\"100f9e1e-3207-43a7-a8ad-05288fb576aa\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 777, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d ABCWY:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74ea8460-9e17-4c18-a518-1fdd6903d080\\\", \\\"childbox\\\": \\\"d3095b27-7706-47d2-a97e-41d77850c732\\\", \\\"subtext\\\": \\\"ce8bb3b8-b050-4a67-99cc-c854b140c23d\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 778, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"603 participants will receive 2 doses of the MenABCWY ~REDACTED~ at ~REDACTED~ 1 (Day 1) and ~REDACTED~ 3 (Day 181) (0,6-month schedule) and 1 dose of placebo at ~REDACTED~ 4 (Day 211).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74ea8460-9e17-4c18-a518-1fdd6903d080\\\", \\\"childbox\\\": \\\"d3095b27-7706-47d2-a97e-41d77850c732\\\", \\\"subtext\\\": \\\"50072f5d-31be-4151-b7b7-3dd04af0cab7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 779, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d ACWY:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ed855ea6-2db8-4cdc-bc87-289f36e4bc10\\\", \\\"childbox\\\": \\\"ba2764dc-0210-4256-aa41-99e396866063\\\", \\\"subtext\\\": \\\"ba12c1e8-12e2-46fc-839d-06db54fc1ec5\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 780, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"603 participants will receive 1 dose of MenACWY ~REDACTED~ at ~REDACTED~ 1 (Day 1) (single dose) and 2 doses of MenB ~REDACTED~ at ~REDACTED~ 3 (Day 181) and ~REDACTED~ 4 (Day 211).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ed855ea6-2db8-4cdc-bc87-289f36e4bc10\\\", \\\"childbox\\\": \\\"ba2764dc-0210-4256-aa41-99e396866063\\\", \\\"subtext\\\": \\\"65e5c1d5-2851-4f52-9d03-1a0c7fa56913\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 781, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Study groups, intervention and blinding foreseen in the study are presented in Figure 1 and Table 7.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"141d7d17-6964-4c73-b6c1-70db3638b8d2\\\", \\\"childbox\\\": \\\"3dbec437-7766-47ff-a4c8-a58f6300e491\\\", \\\"subtext\\\": \\\"2f20aace-2f87-40b9-88ee-37bb2a234865\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 782, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"See Appendix 1, Glossary of Terms, for definitions of a self-contained study, PCD, solicited events, intervention, blinding, and a qualified health care professional.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0a88f42f-1f48-406e-b386-d092af10bfaf\\\", \\\"childbox\\\": \\\"4ffe8b4e-a0f1-450a-9313-ea22d7a28a96\\\", \\\"subtext\\\": \\\"6ff5cc6e-02ce-42de-ad17-3d921fa676a2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Figure 1  Study Design Overview\\\", \\\"\\\", \\\"1\\\", 783, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Table 7 Study Groups, Intervention, and Blinding Foreseen in the Study\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"25b97db4-8b41-48f1-83e1-192d073d0eef\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Groups, Intervention, and Blinding Foreseen in the Study\\\", \\\"Table 7\\\", \\\"1\\\", 784, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n      <th>5.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Study Group</td>\\\\n      <td>Number of Participants</td>\\\\n      <td>Age (Min to Max)</td>\\\\n      <td>Intervention</td>\\\\n      <td>Blinding</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>ABCWY</td>\\\\n      <td>603</td>\\\\n      <td>15 to 25 years (25 years + 364 days)</td>\\\\n      <td>MenABCWY</td>\\\\n      <td>V1 to T5: Observer-blind</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>Placebo</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>ACWY</td>\\\\n      <td>603</td>\\\\n      <td>15 to 25 years (25 years + 364 days)</td>\\\\n      <td>MenACWY</td>\\\\n      <td>V1 to T5: Observer-blind</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>MenB</td>\\\\n      <td></td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"38\\\", \\\"TableIndex\\\": \\\"23\\\", \\\"TableName\\\": \\\"Table 7 Study Groups, Intervention, and Blinding Foreseen in the Study\\\", \\\"Header\\\": [0, 3]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"e8e8f8c2-0855-441d-974b-da6cccd662db\\\", \\\"childbox\\\": \\\"6becadd8-5fd0-4270-b5c9-dcfda7031ddb\\\", \\\"subtext\\\": \\\"9b58590b-3c5c-428d-bf9e-7eaee585298c\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Groups, Intervention, and Blinding Foreseen in the Study\\\", \\\"Table 7\\\", \\\"1\\\", 785, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6a63d652-183e-4f35-aa02-689986dd91f8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Groups, Intervention, and Blinding Foreseen in the Study\\\", \\\"Table 7\\\", \\\"1\\\", 786, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3a11752d-6e28-42d6-895e-5c682964d2de\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Groups, Intervention, and Blinding Foreseen in the Study\\\", \\\"Table 7\\\", \\\"1\\\", 787, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e8cda5f7-cec8-4ee0-b1ff-363fc0f23c2a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Groups, Intervention, and Blinding Foreseen in the Study\\\", \\\"Table 7\\\", \\\"1\\\", 788, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0d7cf56e-95d8-4fd4-8c0e-ee83eded92a2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Groups, Intervention, and Blinding Foreseen in the Study\\\", \\\"Table 7\\\", \\\"1\\\", 789, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"09425fc6-7ec4-4635-9d0c-9297cc8db093\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Groups, Intervention, and Blinding Foreseen in the Study\\\", \\\"Table 7\\\", \\\"1\\\", 790, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"78408d15-434c-432b-ba8e-441515aedec8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Groups, Intervention, and Blinding Foreseen in the Study\\\", \\\"Table 7\\\", \\\"1\\\", 791, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8ce14b34-7671-48fb-8104-bc7e80a1820d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Groups, Intervention, and Blinding Foreseen in the Study\\\", \\\"Table 7\\\", \\\"1\\\", 792, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"afcbd25b-2d5d-4b6b-9d0d-820a320f5da3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Groups, Intervention, and Blinding Foreseen in the Study\\\", \\\"Table 7\\\", \\\"1\\\", 793, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"MenACWY =\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9a500d48-a681-48b2-ac07-b70e5f2d159a\\\", \\\"childbox\\\": \\\"216a0fcc-0889-4bef-8aa2-5b389aec102e\\\", \\\"subtext\\\": \\\"c84cbdb8-364c-43d1-86a1-7114989a39e6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Groups, Intervention, and Blinding Foreseen in the Study\\\", \\\"Table 7\\\", \\\"1\\\", 794, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9a500d48-a681-48b2-ac07-b70e5f2d159a\\\", \\\"childbox\\\": \\\"216a0fcc-0889-4bef-8aa2-5b389aec102e\\\", \\\"subtext\\\": \\\"127750a2-5a56-4895-b181-d3a825a093f2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Groups, Intervention, and Blinding Foreseen in the Study\\\", \\\"Table 7\\\", \\\"1\\\", 795, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"; MenB =\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9a500d48-a681-48b2-ac07-b70e5f2d159a\\\", \\\"childbox\\\": \\\"216a0fcc-0889-4bef-8aa2-5b389aec102e\\\", \\\"subtext\\\": \\\"1df22149-82d4-49f9-9e9c-8f2a8113edc8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Groups, Intervention, and Blinding Foreseen in the Study\\\", \\\"Table 7\\\", \\\"1\\\", 796, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Bexsero\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9a500d48-a681-48b2-ac07-b70e5f2d159a\\\", \\\"childbox\\\": \\\"216a0fcc-0889-4bef-8aa2-5b389aec102e\\\", \\\"subtext\\\": \\\"e289d605-7e2a-4b4c-ab3a-74b7d3b4ab6d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Groups, Intervention, and Blinding Foreseen in the Study\\\", \\\"Table 7\\\", \\\"1\\\", 797, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"; T = telephone contact; V = ~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9a500d48-a681-48b2-ac07-b70e5f2d159a\\\", \\\"childbox\\\": \\\"216a0fcc-0889-4bef-8aa2-5b389aec102e\\\", \\\"subtext\\\": \\\"e7639355-39d4-4d88-89d4-0d9b20348e45\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Groups, Intervention, and Blinding Foreseen in the Study\\\", \\\"Table 7\\\", \\\"1\\\", 798, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"4.2 Scientific Rationale for Study Design\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8676fbd6-daff-4d54-b4af-65f639b5da57\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 799, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The study is designed as a randomized, controlled, observer-blind study with 2 parallel groups.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"67d2e310-511c-4b67-97c9-e0dc04a2de47\\\", \\\"childbox\\\": \\\"d00ea532-b5a0-42cd-92ce-9ddfe2349cf1\\\", \\\"subtext\\\": \\\"c07846b5-a6f7-48d8-b85d-1c35b4323d90\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 800, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This study will evaluate the immunogenicity and safety of the MenABCWY ~REDACTED~ when administered as a booster in healthy adolescents and young adults, 15 through 25 years of age, previously primed with a MenACWY ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"67d2e310-511c-4b67-97c9-e0dc04a2de47\\\", \\\"childbox\\\": \\\"f8ce2f0c-ff81-49d6-a32c-d5ac56e9c8cd\\\", \\\"subtext\\\": \\\"c07846b5-a6f7-48d8-b85d-1c35b4323d90\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 801, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The currently licensed\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"67d2e310-511c-4b67-97c9-e0dc04a2de47\\\", \\\"childbox\\\": \\\"b2760bd1-94b5-4e9c-abb9-b2c1b84d717b\\\", \\\"subtext\\\": \\\"f9451aa6-ab4d-4906-a54e-c1535ea78cfc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 802, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"67d2e310-511c-4b67-97c9-e0dc04a2de47\\\", \\\"childbox\\\": \\\"b2760bd1-94b5-4e9c-abb9-b2c1b84d717b\\\", \\\"subtext\\\": \\\"18c72af5-4bbb-4a97-9869-9e107430e375\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 803, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(MenACWY) ~REDACTED~ will be used as comparator.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"67d2e310-511c-4b67-97c9-e0dc04a2de47\\\", \\\"childbox\\\": \\\"b2760bd1-94b5-4e9c-abb9-b2c1b84d717b\\\", \\\"subtext\\\": \\\"6893d591-33e7-42fb-8fab-570a09503293\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 804, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In order to let the participants in the ACWY group receive 2 doses of MenB ~REDACTED~ in line with ACIP recommendations, the participants in this group will receive vaccinations of MenB on ~REDACTED~ 3 (Day 181) and ~REDACTED~ 4 (Day 211).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"58b98786-eb17-4128-b120-e2b85924cb52\\\", \\\"childbox\\\": \\\"41c55f9f-1158-45f4-89ac-f9a97d60f0d6\\\", \\\"subtext\\\": \\\"12afe6c9-99f6-486f-956c-b3ae477c6f3e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 805, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"There are no study objectives related to the MenB ~REDACTED~, as it will be administered only to ensure standard of care.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"58b98786-eb17-4128-b120-e2b85924cb52\\\", \\\"childbox\\\": \\\"b33b5bc7-52a0-4a5d-8b6c-4e8210dbbf48\\\", \\\"subtext\\\": \\\"20125283-901f-4d97-b19b-df28090460bd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 806, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"However, to maintain the study blinding, solicited events (see Appendix 1, Glossary of Terms, for a definition of solicited events) during the 7 days (including the day of vaccination) after the first MenB vaccination will be collected and recorded through eDiary, and unsolicited AEs during the 30 days (including the day of vaccination) during interview with the participant/participant\\\\u2019s parent(s)/legally acceptable representative(s) (LAR[s]) at the next ~REDACTED~ (refer to the SoA [Table 3] and Section 8.3.6.1 for time and frequency on collection of AEs).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"58b98786-eb17-4128-b120-e2b85924cb52\\\", \\\"childbox\\\": \\\"80806f70-6dbe-4ef3-8a5f-299e55011d30\\\", \\\"subtext\\\": \\\"20125283-901f-4d97-b19b-df28090460bd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 807, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Although not part of the study objectives, solicited events and unsolicited AEs after the first MenB vaccination will be reported in the clinical study report (CSR).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"58b98786-eb17-4128-b120-e2b85924cb52\\\", \\\"childbox\\\": \\\"ccadadb1-0f69-46d9-9ff5-9b576657b01b\\\", \\\"subtext\\\": \\\"f0588654-48b3-4795-bd52-63b59742735c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 808, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For this study, a placebo (saline solution) will be administered in the ABCWY group at ~REDACTED~ 4 (Day 211) (Figure 1).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0d5f50bd-4169-4507-a322-25b1acc0b7c5\\\", \\\"childbox\\\": \\\"2f3fe2c6-d1fb-467a-a4ce-9ecda1a17143\\\", \\\"subtext\\\": \\\"172d317f-01b7-4520-bafd-c6e5dc3dcb6c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 809, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A placebo is the best available option to minimize the potential for reporting bias in collecting information about AEs and to ensure the same number of vaccinations are administered to participants assigned to either of the 2 study groups.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0d5f50bd-4169-4507-a322-25b1acc0b7c5\\\", \\\"childbox\\\": \\\"67a0ad1e-ab84-4f2d-9718-66291fed3177\\\", \\\"subtext\\\": \\\"d0e637e7-0522-402b-a8d3-b5be2526b94b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 810, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Blood will be taken from all participants at specified time points (~REDACTED~ 1, ~REDACTED~ 2, and ~REDACTED~ 4 [Figure 1]) (refer to Section 8.1 for details on immunogenicity assessments).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c7b98bd8-7e24-4570-a03e-e5b1f2020f5a\\\", \\\"childbox\\\": \\\"09f0773c-e447-446d-8bc7-778d01c04449\\\", \\\"subtext\\\": \\\"dbc4acb3-03fe-4980-9fea-36679a4ca926\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 811, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Insufficient blood volume may lead to test cancellation and jeopardize the statistical power.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c7b98bd8-7e24-4570-a03e-e5b1f2020f5a\\\", \\\"childbox\\\": \\\"c7540165-f2e5-4b6c-b41b-bbfb55437300\\\", \\\"subtext\\\": \\\"c2473405-9100-469a-9348-70327797782d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 812, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Hence, every effort must be done to collect blood volume as per protocol requirements.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c7b98bd8-7e24-4570-a03e-e5b1f2020f5a\\\", \\\"childbox\\\": \\\"a68ab849-d8e6-4742-8291-c8bac96ca902\\\", \\\"subtext\\\": \\\"05c948a0-f1fa-42d9-bfb9-c1190516cf01\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 813, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Blood samples will be taken from all participants irrespective of the testing status in order to maintain the study blind.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"18cd8836-f7c2-4ebd-8cda-ae20c0438395\\\", \\\"childbox\\\": \\\"9e9f9751-7575-4b0d-9b93-589cc08f58bc\\\", \\\"subtext\\\": \\\"d982ddac-27d1-4c21-899c-4a21e3871afa\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 814, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Section 8.1.1 for further details.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"18cd8836-f7c2-4ebd-8cda-ae20c0438395\\\", \\\"childbox\\\": \\\"ab750345-2913-4bb2-82fd-bc79c5731a9f\\\", \\\"subtext\\\": \\\"bd8d4c40-e753-42dc-b14a-aab629c8f315\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 815, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Given the aim of the study is to evaluate the MenABCWY booster response in healthy participants previously primed with MenACWY ~REDACTED~, eligible participants must have received a previous vaccination with a quadrivalent meningococcal conjugate ~REDACTED~ (MenACWY;\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cdaeabc1-6e2f-432c-88db-7bed727e7339\\\", \\\"childbox\\\": \\\"b16d9d3e-ea90-40b3-af99-34ef8770093f\\\", \\\"subtext\\\": \\\"884973da-f732-41b5-be08-d6c36d4216b2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 816, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cdaeabc1-6e2f-432c-88db-7bed727e7339\\\", \\\"childbox\\\": \\\"b16d9d3e-ea90-40b3-af99-34ef8770093f\\\", \\\"subtext\\\": \\\"5d4c9b0e-3049-4567-8f75-59fd4eb998a5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 817, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"or\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cdaeabc1-6e2f-432c-88db-7bed727e7339\\\", \\\"childbox\\\": \\\"b16d9d3e-ea90-40b3-af99-34ef8770093f\\\", \\\"subtext\\\": \\\"3b90526b-781d-44bf-b156-3ed7295a0a94\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 818, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Menactra\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cdaeabc1-6e2f-432c-88db-7bed727e7339\\\", \\\"childbox\\\": \\\"b16d9d3e-ea90-40b3-af99-34ef8770093f\\\", \\\"subtext\\\": \\\"13bd76e6-fc16-4d2f-b981-90084db561aa\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 819, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\") at least 4 years and not more than 6 years prior to study start.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cdaeabc1-6e2f-432c-88db-7bed727e7339\\\", \\\"childbox\\\": \\\"b16d9d3e-ea90-40b3-af99-34ef8770093f\\\", \\\"subtext\\\": \\\"be7e2309-452d-4eb4-bfc2-4bbfc9b9fbb5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Scientific Rationale for Study Design\\\", \\\"4.2\\\", \\\"2\\\", 820, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"4.3 Justification for Dose\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4841a4ed-a28e-427f-b466-92b8516c421c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Justification for Dose\\\", \\\"4.3\\\", \\\"2\\\", 821, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A number of different ~REDACTED~ formulations with different amounts of the MenB component of ~REDACTED~ were evaluated in MenABCWY phase I and II clinical studies.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e656de6a-d964-4301-bb59-3768a4c4b40c\\\", \\\"childbox\\\": \\\"6cb3884c-ec03-4562-9523-d42b4517d9b8\\\", \\\"subtext\\\": \\\"1e0fd6fa-770e-45df-ba7f-fe2aab29747a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Justification for Dose\\\", \\\"4.3\\\", \\\"2\\\", 822, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The MenABCWY formulation that included the same active ingredient composition for outer membrane vesicles (OMV) as\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e656de6a-d964-4301-bb59-3768a4c4b40c\\\", \\\"childbox\\\": \\\"46c2be66-d522-48c4-90c8-cceec2f0659a\\\", \\\"subtext\\\": \\\"26f412ec-4ebe-4c23-9db8-63a06ec83b27\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Justification for Dose\\\", \\\"4.3\\\", \\\"2\\\", 823, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Bexsero\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e656de6a-d964-4301-bb59-3768a4c4b40c\\\", \\\"childbox\\\": \\\"46c2be66-d522-48c4-90c8-cceec2f0659a\\\", \\\"subtext\\\": \\\"b09ca3a1-ae2a-451b-8d82-1208c4734abc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Justification for Dose\\\", \\\"4.3\\\", \\\"2\\\", 824, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"induced a higher immune response against serogroup B test strains with a comparable reactogenicity profile and no identified safety concerns.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e656de6a-d964-4301-bb59-3768a4c4b40c\\\", \\\"childbox\\\": \\\"46c2be66-d522-48c4-90c8-cceec2f0659a\\\", \\\"subtext\\\": \\\"fa037cb7-7426-4c6b-8f33-2d6982ad799d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Justification for Dose\\\", \\\"4.3\\\", \\\"2\\\", 825, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Therefore, the formulation with the same active ingredient composition as the MenB (\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e656de6a-d964-4301-bb59-3768a4c4b40c\\\", \\\"childbox\\\": \\\"8f4a7b31-e8d1-4b1c-af22-dcaa5ce6b4ed\\\", \\\"subtext\\\": \\\"9af4000e-e633-4725-81c5-e1b7da5a21ff\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Justification for Dose\\\", \\\"4.3\\\", \\\"2\\\", 826, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Bexsero\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e656de6a-d964-4301-bb59-3768a4c4b40c\\\", \\\"childbox\\\": \\\"8f4a7b31-e8d1-4b1c-af22-dcaa5ce6b4ed\\\", \\\"subtext\\\": \\\"54093ad5-b031-4fe6-94c4-75a6cc822f2b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Justification for Dose\\\", \\\"4.3\\\", \\\"2\\\", 827, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\") and MenACWY (\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e656de6a-d964-4301-bb59-3768a4c4b40c\\\", \\\"childbox\\\": \\\"8f4a7b31-e8d1-4b1c-af22-dcaa5ce6b4ed\\\", \\\"subtext\\\": \\\"294ccd72-640d-42cc-b0bc-3612f92f1bb9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Justification for Dose\\\", \\\"4.3\\\", \\\"2\\\", 828, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e656de6a-d964-4301-bb59-3768a4c4b40c\\\", \\\"childbox\\\": \\\"8f4a7b31-e8d1-4b1c-af22-dcaa5ce6b4ed\\\", \\\"subtext\\\": \\\"f32c658c-238e-436d-9a52-c687770b69a2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Justification for Dose\\\", \\\"4.3\\\", \\\"2\\\", 829, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\") ~REDACTED~s was chosen as the final formulation of the MenABCWY investigational ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e656de6a-d964-4301-bb59-3768a4c4b40c\\\", \\\"childbox\\\": \\\"8f4a7b31-e8d1-4b1c-af22-dcaa5ce6b4ed\\\", \\\"subtext\\\": \\\"0ce4bf44-9f9b-42be-b5b0-f9f4dc480378\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Justification for Dose\\\", \\\"4.3\\\", \\\"2\\\", 830, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The dosing schedule for MenB and MenACWY is based on approved schedules for those vaccines while it is not in major contradiction with vaccination schedules in other countries.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e656de6a-d964-4301-bb59-3768a4c4b40c\\\", \\\"childbox\\\": \\\"2c0e925c-a372-478c-a33b-2b8dcdaad647\\\", \\\"subtext\\\": \\\"0ce4bf44-9f9b-42be-b5b0-f9f4dc480378\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Justification for Dose\\\", \\\"4.3\\\", \\\"2\\\", 831, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The 0,6-month schedule for MenABCWY is based on the results of the completed phase II Study V102_15.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e656de6a-d964-4301-bb59-3768a4c4b40c\\\", \\\"childbox\\\": \\\"a7cd54ba-5f06-47ac-8ef0-567b1653c09d\\\", \\\"subtext\\\": \\\"1f8162ae-aab5-4990-966b-e8d47db7e571\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Justification for Dose\\\", \\\"4.3\\\", \\\"2\\\", 832, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"4.4 End of Study Definition\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2533cff0-d8ca-4cfc-9c5b-c999d12cc16c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"End of Study Definition\\\", \\\"4.4\\\", \\\"2\\\", 833, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A participant is considered to have completed the study if he/she returns or is available for the last scheduled contact as described in the protocol.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"01a8f67d-621a-4f0a-acd9-f8d5a9842b83\\\", \\\"childbox\\\": \\\"9dc90243-d180-485d-b020-ab2f18660071\\\", \\\"subtext\\\": \\\"26b809b3-5093-4968-94be-8a2055780a35\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"End of Study Definition\\\", \\\"4.4\\\", \\\"2\\\", 834, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"End of study (EoS): LSLV (Day 361) or last testing results released for the samples collected at ~REDACTED~ 4 (Day 211)*.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9794d91d-0678-443c-9722-b794830f59fe\\\", \\\"childbox\\\": \\\"164d2df5-2170-4349-a705-61b2f4a11c37\\\", \\\"subtext\\\": \\\"0810bd9e-c3e0-4546-a132-ec636c491af3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"End of Study Definition\\\", \\\"4.4\\\", \\\"2\\\", 835, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"*Note: In this case, EoS must be achieved no later than 8 months after LSLV.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"466d6990-9000-4ff0-9e6c-f96776e2786c\\\", \\\"childbox\\\": \\\"b21032e1-bd7a-4777-8994-83786a6109d0\\\", \\\"subtext\\\": \\\"d28d1329-e50b-4d46-8411-e015b86a01ed\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"End of Study Definition\\\", \\\"4.4\\\", \\\"2\\\", 836, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"466d6990-9000-4ff0-9e6c-f96776e2786c\\\", \\\"childbox\\\": \\\"c52dcc89-1542-4aaf-b99e-284780045b54\\\", \\\"subtext\\\": \\\"f374f16b-a1eb-41c5-94a0-17e952484ce6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"End of Study Definition\\\", \\\"4.4\\\", \\\"2\\\", 837, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"5.0  STUDY POPULATION\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading1\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"52557cbd-10ea-4741-90c8-e8016c1aabdc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY POPULATION\\\", \\\"5.0\\\", \\\"2\\\", 838, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Prospective approval of protocol deviations to recruitment and enrollment criteria, also known as protocol waivers or exemptions, is not permitted.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ff5bbcc6-ec3c-4cc6-be49-2d9fd62e4c60\\\", \\\"childbox\\\": \\\"24da4ec5-0d70-4c0b-89f8-7d4ccde40d4b\\\", \\\"subtext\\\": \\\"0e7c8cff-5b33-4523-8a1c-94baebacf4d7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY POPULATION\\\", \\\"5.0\\\", \\\"2\\\", 839, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"5.1 Inclusion Criteria\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9049f280-3870-493a-b532-36dd02bc3302\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 840, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Adherence to the criteria as specified in the protocol is essential.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"acab001a-2f9d-41d6-8761-01821d038763\\\", \\\"childbox\\\": \\\"256feec7-724e-4914-9988-0af3297dca54\\\", \\\"subtext\\\": \\\"ade50952-9af5-4c90-98a1-d22ac7016b16\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 841, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Inclusion criteria deviations are not allowed because they can jeopardise the scientific integrity or regulatory acceptability of the study or participant safety.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"acab001a-2f9d-41d6-8761-01821d038763\\\", \\\"childbox\\\": \\\"458aec69-f35b-441c-a872-3466de4e65f6\\\", \\\"subtext\\\": \\\"ade50952-9af5-4c90-98a1-d22ac7016b16\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 842, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"All participants must satisfy ALL of the following criteria at study entry:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d1b9ee70-e350-4f0e-bf1c-33fcb51a5ed2\\\", \\\"childbox\\\": \\\"208a8ff8-c97e-418a-b295-e84b26f0e22e\\\", \\\"subtext\\\": \\\"8d9ea570-0061-4296-962f-d32580602612\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 843, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1. Participants and/or participants\\\\u2019 parents/LARs, who, in the opinion of the investigator, can and will comply with the requirements of the protocol (e.g., completion of the eDiary, return for follow-up visits).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1d4565de-2733-454d-a44a-7350f01133e4\\\", \\\"childbox\\\": \\\"166c39bf-d55a-425d-a5ee-0f454a5ffbd8\\\", \\\"subtext\\\": \\\"1d8298e0-68ca-4538-bb5b-95df4bb26163\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 844, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2. Written or witnessed/thumb printed informed consent obtained from the participant/participant\\\\u2019s parent(s)/LAR(s) of the participant prior to performance of any study specific procedure.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7f36d10e-ad70-45e0-aad9-3f469ac806c3\\\", \\\"childbox\\\": \\\"20c76dcb-3f2e-443c-a02f-aca4a942f50e\\\", \\\"subtext\\\": \\\"cea0a621-905b-4a74-b79f-96df529a4e42\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 845, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"3. Written or witnessed/thumb printed informed assent obtained from participants below the legal age of consent prior to performance of any study specific procedure.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"db94018e-c265-4a2d-855f-60c5b67148b7\\\", \\\"childbox\\\": \\\"496c1978-9fd2-4b50-af48-143f089b9d9d\\\", \\\"subtext\\\": \\\"d7b32bec-0285-457d-909d-640a97f89aad\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 846, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"4. Previous vaccination with 1 dose of MenACWY ~REDACTED~ at an age of 10 years or older, with an interval of at least 4 years and not more than 6 years (intended as up to 6 years and 364 days) between the previous MenACWY ~REDACTED~ and enrollment (informed consent and assent [as applicable]) into this study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"16bf2da4-f926-4aff-aee4-30fb969e85da\\\", \\\"childbox\\\": \\\"ad739d3d-92ce-4c96-bd94-528185015994\\\", \\\"subtext\\\": \\\"5579a587-5e8e-49f6-aad7-54967ffccb61\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 847, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"5. A male or female between, and including, 15 and 25 years of age (i.e., 25 years + 364 days) at the time of the first vaccination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"86fcc97e-b8f0-44c0-84f8-c1ac2c83deae\\\", \\\"childbox\\\": \\\"a50526a6-6a57-4a8f-88b2-828110bd714e\\\", \\\"subtext\\\": \\\"3da0197c-d5f0-4501-8273-2d9db4d77bde\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 848, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6. Healthy participants as established by medical history, physical examination, and clinical judgment of the investigator before entering into the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"21375feb-4114-4085-9f97-e131494d7db3\\\", \\\"childbox\\\": \\\"51570ebc-bf76-4e3b-8ea6-c4dc3cae9113\\\", \\\"subtext\\\": \\\"f407206d-39e5-4070-b633-a1103a12b34c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 849, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"7. Female participants of non-childbearing potential may be enrolled in the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"69bc1116-dba2-4ead-8fe9-b99cf430c821\\\", \\\"childbox\\\": \\\"36f20251-528c-4526-8ffa-907c392a49bd\\\", \\\"subtext\\\": \\\"d60e04ae-7a2e-4475-aae9-5430db0b86cf\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 850, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Non-childbearing potential is defined as pre-menarche, current bilateral tubal ligation or occlusion, hysterectomy, bilateral ovariectomy, or post-menopause.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"69bc1116-dba2-4ead-8fe9-b99cf430c821\\\", \\\"childbox\\\": \\\"1d43b8b3-6fbd-4046-96b7-88195ef8a69b\\\", \\\"subtext\\\": \\\"0de05880-62ba-4004-835e-b85e8ee5c247\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 851, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"69bc1116-dba2-4ead-8fe9-b99cf430c821\\\", \\\"childbox\\\": \\\"1d43b8b3-6fbd-4046-96b7-88195ef8a69b\\\", \\\"subtext\\\": \\\"feb897d1-6dd2-48a5-a0c9-34e5970b3e1e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 852, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8. Female participants of childbearing potential may be enrolled in the study, if the participant:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4aa29f24-1d11-4c99-9e23-60732c3b1841\\\", \\\"childbox\\\": \\\"98490d68-4463-4114-b413-628b6f63c631\\\", \\\"subtext\\\": \\\"ba0b8f48-490e-4c1d-9b16-2245e57e39e4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 853, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d has practiced adequate contraception for 30 days prior to vaccination, and\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e2db0f14-9cd2-479b-bf82-86a79d492a58\\\", \\\"childbox\\\": \\\"6ef9300b-03ba-4e6a-8b43-6a3998e47129\\\", \\\"subtext\\\": \\\"035890c9-1428-42de-a283-bd98c3d1887c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 854, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d has a negative pregnancy test* on the day of vaccination, and\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"df7baf58-f8bc-45ac-ab66-f6be68c42987\\\", \\\"childbox\\\": \\\"c0fd639a-a4d6-406f-96ba-da0eccf9cdce\\\", \\\"subtext\\\": \\\"8d29f66e-eea7-430b-8d15-8007a1a9e660\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 855, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d has agreed to continue adequate contraception during the entire intervention period and for 30 days after completion of the vaccination series.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d43ce2ed-bc7a-4f10-93ed-5466c1c361b1\\\", \\\"childbox\\\": \\\"7b4e861f-f50c-45bd-b9db-2cd0e443434e\\\", \\\"subtext\\\": \\\"89d9fef1-3776-4146-a02f-fc5d6d16fd34\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 856, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"*\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5eb3fd9d-1838-4072-a0fe-155b9050c654\\\", \\\"childbox\\\": \\\"48eaf662-eb69-4f94-9dcf-7fe29a48b2b1\\\", \\\"subtext\\\": \\\"a3121d47-19b1-422a-8aa2-44e34740c43e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 857, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Note: Urine samples for pregnancy testing will be collected from female participants of childbearing potential at ~REDACTED~ 1, ~REDACTED~ 3, and ~REDACTED~ 4 prior to the vaccination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5eb3fd9d-1838-4072-a0fe-155b9050c654\\\", \\\"childbox\\\": \\\"48eaf662-eb69-4f94-9dcf-7fe29a48b2b1\\\", \\\"subtext\\\": \\\"0397f623-baf6-490f-baf2-9b63cfd2437c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 858, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Frequency or urine pregnancy tests can be established at the site according to local regulations.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5eb3fd9d-1838-4072-a0fe-155b9050c654\\\", \\\"childbox\\\": \\\"4c0e5621-8074-4903-bfdd-2a7b433649ac\\\", \\\"subtext\\\": \\\"31339367-7e91-428f-a1a6-de08637b0957\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 859, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5eb3fd9d-1838-4072-a0fe-155b9050c654\\\", \\\"childbox\\\": \\\"4c0e5621-8074-4903-bfdd-2a7b433649ac\\\", \\\"subtext\\\": \\\"9d541e4b-1e25-4c98-8703-1a879fd1938b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 860, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Appendix 5 for definitions of woman of childbearing potential and adequate contraception.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"43b22ade-a2e4-4b22-bdb9-ec097a573ea8\\\", \\\"childbox\\\": \\\"9716747c-71a5-4497-a454-1078c03cb38d\\\", \\\"subtext\\\": \\\"015876a2-9217-4ddb-832a-e0be01abd5b5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 861, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Appendix 1, Glossary of Terms, for definitions of the investigator, eligible participants, enrolled participants, and witness.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f77d98f2-05d8-44f9-a1b5-ee0038b1aec2\\\", \\\"childbox\\\": \\\"a0c65051-4344-47b4-895c-492f7d8dac0d\\\", \\\"subtext\\\": \\\"485d65ca-7196-4bc4-ba30-6b48bcea446a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Inclusion Criteria\\\", \\\"5.1\\\", \\\"2\\\", 862, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"5.2 Exclusion Criteria\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a0ee02e0-bd4d-4acd-a4be-33645f718f9a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Exclusion Criteria\\\", \\\"5.2\\\", \\\"2\\\", 863, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Adherence to criteria specified in the protocol is essential.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"607cf111-5f56-4848-8504-e1ba712b67e5\\\", \\\"childbox\\\": \\\"729a1c74-4ce1-448d-8846-10e9539a5d4b\\\", \\\"subtext\\\": \\\"4237d340-9839-4a02-a326-b87af0474e9a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Exclusion Criteria\\\", \\\"5.2\\\", \\\"2\\\", 864, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Exclusion criteria deviations are not allowed because they can potentially jeopardize the scientific integrity or regulatory acceptability of the study or safety of the participant.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"607cf111-5f56-4848-8504-e1ba712b67e5\\\", \\\"childbox\\\": \\\"30d3bf08-68d2-46c7-8122-8f06196d47be\\\", \\\"subtext\\\": \\\"4237d340-9839-4a02-a326-b87af0474e9a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Exclusion Criteria\\\", \\\"5.2\\\", \\\"2\\\", 865, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The following criteria should be checked at the time of study entry.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"77ff3fd6-12a3-49d0-bc5c-621079c0f6f0\\\", \\\"childbox\\\": \\\"56377774-1874-4ae2-af6c-784f986997d9\\\", \\\"subtext\\\": \\\"ae97d07f-39eb-46a0-bdc5-96a4dd13bf76\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Exclusion Criteria\\\", \\\"5.2\\\", \\\"2\\\", 866, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The potential participant MUST NOT be included in the study if ANY exclusion criterion applies.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"77ff3fd6-12a3-49d0-bc5c-621079c0f6f0\\\", \\\"childbox\\\": \\\"30676671-5229-4b4d-96cc-5b200e18f226\\\", \\\"subtext\\\": \\\"ae97d07f-39eb-46a0-bdc5-96a4dd13bf76\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Exclusion Criteria\\\", \\\"5.2\\\", \\\"2\\\", 867, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"5.2.1 Medical Conditions\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6b4b6155-c041-430c-9d13-63ba27e763e5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 868, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1. Current or previous, confirmed or suspected disease caused by\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5769206b-c1f6-4717-ad3e-07451bddb945\\\", \\\"childbox\\\": \\\"8ef2dce4-6ede-4841-b3df-94719721449d\\\", \\\"subtext\\\": \\\"ed07c26f-329f-400f-ab78-c5fc724b2cf2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 869, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5769206b-c1f6-4717-ad3e-07451bddb945\\\", \\\"childbox\\\": \\\"8ef2dce4-6ede-4841-b3df-94719721449d\\\", \\\"subtext\\\": \\\"2b6a380b-9da3-4022-9326-8a170c6d0e3e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 870, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5769206b-c1f6-4717-ad3e-07451bddb945\\\", \\\"childbox\\\": \\\"10a1b17e-da40-4411-b2ef-3d6213c03a22\\\", \\\"subtext\\\": \\\"2b6a380b-9da3-4022-9326-8a170c6d0e3e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 871, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\".\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5769206b-c1f6-4717-ad3e-07451bddb945\\\", \\\"childbox\\\": \\\"10a1b17e-da40-4411-b2ef-3d6213c03a22\\\", \\\"subtext\\\": \\\"02019c35-7bc6-4e5b-b8e6-d0812aeb12c2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 872, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2. Household contact with and/or intimate exposure to an individual with laboratory confirmed\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9053ec6d-d1bc-4af5-8e36-95c81a8ba21f\\\", \\\"childbox\\\": \\\"10d162b4-e270-4352-9ffb-9b8685677f5f\\\", \\\"subtext\\\": \\\"c4a8323e-49b3-4fc9-a17c-30870fc6dc89\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 873, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9053ec6d-d1bc-4af5-8e36-95c81a8ba21f\\\", \\\"childbox\\\": \\\"10d162b4-e270-4352-9ffb-9b8685677f5f\\\", \\\"subtext\\\": \\\"ec7a87ad-af8f-4f11-a0ca-4d7ebf4374b4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 874, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9053ec6d-d1bc-4af5-8e36-95c81a8ba21f\\\", \\\"childbox\\\": \\\"8d23f580-8d08-4b7b-bd3f-aeb93186e485\\\", \\\"subtext\\\": \\\"ec7a87ad-af8f-4f11-a0ca-4d7ebf4374b4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 875, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"infection within 60 days of enrollment.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9053ec6d-d1bc-4af5-8e36-95c81a8ba21f\\\", \\\"childbox\\\": \\\"8d23f580-8d08-4b7b-bd3f-aeb93186e485\\\", \\\"subtext\\\": \\\"c33e7eff-8850-4537-9d48-3dc5e8cc22db\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 876, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"3. History of any reaction or hypersensitivity likely to be exacerbated by any component of ~REDACTED~/product.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a36b3fe2-7633-4e2e-856d-278b113b64c8\\\", \\\"childbox\\\": \\\"9343a68d-efd7-49b5-a2b6-60daa9b92c61\\\", \\\"subtext\\\": \\\"e09ccb3d-def1-4653-a0bd-3d1c9d6fc223\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 877, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"4. Hypersensitivity, including allergy, to any component of vaccines, including diphtheria toxoid (CRM 197) and latex medicinal products or medical equipment whose use is foreseen in this study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"734eff71-b70b-4bfb-a6c0-e6cb7477593e\\\", \\\"childbox\\\": \\\"72b71353-c849-4e7d-a518-6f87cf389179\\\", \\\"subtext\\\": \\\"65634185-cd2c-4b92-91b7-2dedad144a74\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 878, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"5. Progressive, unstable or uncontrolled clinical conditions\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3cf81f2b-96ef-4716-9baa-d3dc6db2be09\\\", \\\"childbox\\\": \\\"a6099dec-9b5f-4d5a-b7ac-d4ca0b950044\\\", \\\"subtext\\\": \\\"bd347a5e-1470-45e5-a6e3-7b6bf61c59d6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 879, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6. Clinical conditions representing a contraindication to intramuscular vaccination and blood draws.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8ac81d06-f793-46a0-a68e-6e9ffb4ca1a3\\\", \\\"childbox\\\": \\\"fc2c44c0-7bd4-45f9-a796-ac78907d2f31\\\", \\\"subtext\\\": \\\"7e8df430-6b10-4c51-882b-f5e1df4bd228\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 880, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"7. Abnormal function or modification of the immune system resulting from:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3fc26039-fa52-41d4-9568-0ff0d59d40f4\\\", \\\"childbox\\\": \\\"9bad9e3c-6b4f-4b1e-b539-5387f0288069\\\", \\\"subtext\\\": \\\"8f6db462-8bcc-45c2-976c-ebfa998a1a79\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 881, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d Autoimmune disorders (including, but not limited to: blood, endocrine, hepatic, muscular, nervous system or skin autoimmune disorders; lupus erythematosus and associated conditions; rheumatoid arthritis and associated conditions; scleroderma and associated disorders) or immunodeficiency syndromes (including, but not limited to: acquired immunodeficiency syndromes and primary immunodeficiency syndromes).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"59ccb7af-f4b1-44b0-ba3b-7130c3b80579\\\", \\\"childbox\\\": \\\"7a147032-097d-410f-a68b-eb708bff337d\\\", \\\"subtext\\\": \\\"9252d73c-c315-4c9e-b7ab-62bd33cdf80f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 882, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d Systemic administration of corticosteroids (oral/intravenous/intramuscular) for more than 14 consecutive days within 90 days prior to study vaccination until the following post-vaccination blood sample.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"80b9d4ca-f393-4447-b48c-b978762c7638\\\", \\\"childbox\\\": \\\"b5bb23cd-87d0-43a6-9025-4ea4d0fe3fe7\\\", \\\"subtext\\\": \\\"3e43228f-f1ab-443a-ac5f-a0dc2f4c2b03\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 883, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This will mean prednisone equivalent \\\\u226520 mg/day for adult participants / and \\\\u22650.5 mg/kg/day with maximum \\\\u226520 mg/day for pediatric participants .\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"80b9d4ca-f393-4447-b48c-b978762c7638\\\", \\\"childbox\\\": \\\"a631be39-db02-4674-826c-b3fd4dcbf4b2\\\", \\\"subtext\\\": \\\"b3f041f7-ec3c-40f2-9ffb-b7dbd5b538b8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 884, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Inhaled and topical steroids are allowed.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"80b9d4ca-f393-4447-b48c-b978762c7638\\\", \\\"childbox\\\": \\\"d02e1f16-35e6-463e-8942-73513c124c1c\\\", \\\"subtext\\\": \\\"ed6a8b42-bbe0-4f9f-ad52-f7f76fa6d1a0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 885, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d Administration of antineoplastic and immunomodulating agents or radiotherapy within 90 days prior to study vaccination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4194b937-c881-43f6-88e0-8ec533984a09\\\", \\\"childbox\\\": \\\"cdda33f9-902c-47ca-94a2-51b9ee57f3ec\\\", \\\"subtext\\\": \\\"9f77fbb3-b434-48e9-86fa-c43a7a7fe784\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 886, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d Administration of long-acting immune-modifying drugs at any time during the study period (e.g., infliximab).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4c813527-f9fc-4dc2-9639-66be397d5321\\\", \\\"childbox\\\": \\\"98d017d2-9a42-4988-8a72-7f0ea8a3cd56\\\", \\\"subtext\\\": \\\"509257a9-e067-48a4-93bb-00bbb0710e7e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 887, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1. Any neuroinflammatory (including but not limited to: demyelinating disorders, encephalitis or myelitis of any origin), congenital neurological conditions, encephalopathies, seizures (including all subtypes such as: absence seizures, generalized tonic-clonic seizures, partial complex seizures, partial simple seizures).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cb5c5bcc-c745-4cfe-93e8-cb51a64a3eb3\\\", \\\"childbox\\\": \\\"351c2d70-313d-4ce6-ab01-ee364fd9ded2\\\", \\\"subtext\\\": \\\"a14c66bf-04d6-47e1-b2f5-b0e13b4e9cda\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 888, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"History of febrile convulsions should not lead to exclusion.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cb5c5bcc-c745-4cfe-93e8-cb51a64a3eb3\\\", \\\"childbox\\\": \\\"2b483510-a388-445b-a61f-6bc7b4a00141\\\", \\\"subtext\\\": \\\"c85349b5-f14d-4c05-93e6-4427e35754b2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 889, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9. Any other clinical condition that, in the opinion of the investigator, might pose additional risk to the participant due to participation in the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"962d7737-edd7-4855-a63c-304f0b409eb7\\\", \\\"childbox\\\": \\\"9a4ea017-b3ed-4f1b-97eb-c4e7713f8c3f\\\", \\\"subtext\\\": \\\"0aee9c57-b76e-4b16-8cf5-56f6cd3d45df\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Conditions\\\", \\\"5.2.1\\\", \\\"3\\\", 890, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"5.2.2 Prior/Concomitant Therapy\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e702681d-7454-40ce-8619-95a9ac5ec422\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Prior/Concomitant Therapy\\\", \\\"5.2.2\\\", \\\"3\\\", 891, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1. Use of any investigational or non-registered product (drug, ~REDACTED~, or medical device) other than the study ~REDACTED~(s)/product during the period beginning 30 days before the first dose of study ~REDACTED~(s)/product (Day \\\\u221229 to Day 1), or planned use during the study period.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d59cba58-fc79-46f1-aecf-3c2f485e9235\\\", \\\"childbox\\\": \\\"dea33dc3-f271-4975-8d43-e7579617fc87\\\", \\\"subtext\\\": \\\"6f544759-5e41-4b79-84e7-edc73dc9e7ea\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Prior/Concomitant Therapy\\\", \\\"5.2.2\\\", \\\"3\\\", 892, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"11. Previous vaccination against any group B meningococcal ~REDACTED~ at any time prior to informed consent and assent as applicable (according to the participant\\\\u2019s age).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e69bbecf-4c7c-46d2-b8af-1e81cde4889a\\\", \\\"childbox\\\": \\\"dc22f975-b531-4600-b67c-8c9c18e0c68f\\\", \\\"subtext\\\": \\\"ffb30b7c-b88d-455e-aa0e-d57be9cf2b23\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Prior/Concomitant Therapy\\\", \\\"5.2.2\\\", \\\"3\\\", 893, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"12. Previous vaccination with 2 or more doses of MenACWY ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ce544ed9-e8e3-4c3a-8f5f-250bd47e5afc\\\", \\\"childbox\\\": \\\"e9e53d4c-50b6-410b-9009-325034fddddc\\\", \\\"subtext\\\": \\\"0320e26b-699c-4dc3-bee6-80728c108325\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Prior/Concomitant Therapy\\\", \\\"5.2.2\\\", \\\"3\\\", 894, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"4. Administration/planned administration of immunoglobulins and/or any blood products or plasma derivatives during the period starting 3 months before any dose of study ~REDACTED~/product until the following post-vaccination blood sample.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"024d4ec1-19cf-4633-9809-f7ebaa761b70\\\", \\\"childbox\\\": \\\"d2102bd8-7aec-4fc1-87dd-989c890ff399\\\", \\\"subtext\\\": \\\"50e6fa69-9a73-4582-b96d-dcb06db28e83\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Prior/Concomitant Therapy\\\", \\\"5.2.2\\\", \\\"3\\\", 895, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"5. Chronic administration (defined as more than 14 days in total) of immunosuppressants or other immune-modifying drugs during the period starting 3 months prior to any ~REDACTED~/product dose until the following post-vaccination blood sample.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b58d6d4a-f48b-4ffa-a862-e332e2f90bf4\\\", \\\"childbox\\\": \\\"32582e5e-a137-4445-aa12-8661f0e79d8c\\\", \\\"subtext\\\": \\\"3a865a32-cd75-46f8-853c-c517e820eda0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Prior/Concomitant Therapy\\\", \\\"5.2.2\\\", \\\"3\\\", 896, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For corticosteroids, this will mean prednisone equivalent \\\\u226520 mg/day for adult participants / and \\\\u22650.5 mg/kg/day with maximum \\\\u226520 mg/day for pediatric participants.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b58d6d4a-f48b-4ffa-a862-e332e2f90bf4\\\", \\\"childbox\\\": \\\"aefa8de8-1f89-4b71-b23c-74d9f8c7d81c\\\", \\\"subtext\\\": \\\"7540db0f-86ce-4425-a45d-f1640b265a2e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Prior/Concomitant Therapy\\\", \\\"5.2.2\\\", \\\"3\\\", 897, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Inhaled and topical steroids are allowed.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b58d6d4a-f48b-4ffa-a862-e332e2f90bf4\\\", \\\"childbox\\\": \\\"0dc97a3d-362d-43da-8d7d-33c47f6f0478\\\", \\\"subtext\\\": \\\"df693cef-a565-40f0-9838-1684814e9d75\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Prior/Concomitant Therapy\\\", \\\"5.2.2\\\", \\\"3\\\", 898, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the Appendix 1, Glossary of Terms, for a definition of a study ~REDACTED~/product.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"17d68bfd-bfe1-483d-b74e-88402524bd87\\\", \\\"childbox\\\": \\\"8f1542ea-1cc3-4693-bc11-cf9ba59952bd\\\", \\\"subtext\\\": \\\"41b2ee18-b9ca-43ae-a173-cec54bdd890c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Prior/Concomitant Therapy\\\", \\\"5.2.2\\\", \\\"3\\\", 899, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"5.2.3 Prior/Concurrent Clinical Study Experience\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"19fb4762-db80-4375-a19f-767f32d9382a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Prior/Concurrent Clinical Study Experience\\\", \\\"5.2.3\\\", \\\"3\\\", 900, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"15.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"33630e43-79e8-4163-bc8d-b84d49972e10\\\", \\\"childbox\\\": \\\"d76f51a0-89d9-4abb-8c54-e33f06462fd0\\\", \\\"subtext\\\": \\\"bb30f88c-bc18-43d5-aaf0-0a80636f2d1a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Prior/Concurrent Clinical Study Experience\\\", \\\"5.2.3\\\", \\\"3\\\", 901, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"33630e43-79e8-4163-bc8d-b84d49972e10\\\", \\\"childbox\\\": \\\"d76f51a0-89d9-4abb-8c54-e33f06462fd0\\\", \\\"subtext\\\": \\\"593fde6d-22e6-4eff-acde-b67dffecf8ef\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Arial\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Prior/Concurrent Clinical Study Experience\\\", \\\"5.2.3\\\", \\\"3\\\", 902, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Concurrently participating in another clinical study, at any time during the study period, in which the participant has been or will be exposed to an investigational or a non-investigational ~REDACTED~/product (drug or medical device).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"33630e43-79e8-4163-bc8d-b84d49972e10\\\", \\\"childbox\\\": \\\"d76f51a0-89d9-4abb-8c54-e33f06462fd0\\\", \\\"subtext\\\": \\\"84902242-fb4d-42d4-b97d-7348a6c18c6b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Prior/Concurrent Clinical Study Experience\\\", \\\"5.2.3\\\", \\\"3\\\", 903, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the Appendix 1, Glossary of Terms, for a definition of an investigational ~REDACTED~/product.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6a606cfe-8c15-4dfe-b7ff-ed0e40d8ff9b\\\", \\\"childbox\\\": \\\"135cf433-12f0-49c8-83dd-057e9938f268\\\", \\\"subtext\\\": \\\"3faaeeb5-f216-4995-be66-be49be9fb1ec\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Prior/Concurrent Clinical Study Experience\\\", \\\"5.2.3\\\", \\\"3\\\", 904, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"5.2.4 Other Exclusions\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3db1d896-86d1-435a-a4ac-03a2b66e4873\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Other Exclusions\\\", \\\"5.2.4\\\", \\\"3\\\", 905, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"16. Child in care.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f10d3f22-8a10-455b-bb16-96baf3514023\\\", \\\"childbox\\\": \\\"1e6a0565-9fff-4aff-addd-b85d62b7a32e\\\", \\\"subtext\\\": \\\"83a85ccc-738f-4ebe-8645-53a36e0b0ab4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Other Exclusions\\\", \\\"5.2.4\\\", \\\"3\\\", 906, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Pregnant or lactating female.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b3a044ae-e5cd-4631-9964-17818fcd5446\\\", \\\"childbox\\\": \\\"94e05e63-9dd4-49a1-845f-9cc13c42c10d\\\", \\\"subtext\\\": \\\"a2de8f92-02be-41b1-a7e9-233e63074ebd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Other Exclusions\\\", \\\"5.2.4\\\", \\\"3\\\", 907, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Female planning to become pregnant or planning to discontinue contraceptive precautions (see inclusion criterion #8 for the necessary duration of contraception practice).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"13b34674-6487-47cd-8d75-a9c3cc313597\\\", \\\"childbox\\\": \\\"5bedb4ec-49ca-4436-b3c4-7f44a4e111ba\\\", \\\"subtext\\\": \\\"fb76538d-7548-49f3-ad2c-01a7c0a25f08\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Other Exclusions\\\", \\\"5.2.4\\\", \\\"3\\\", 908, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"19. History of/current chronic alcohol and/or drug abuse.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"857e0986-15b4-40a2-99a3-df9cd69a9049\\\", \\\"childbox\\\": \\\"1f43ca92-e062-4a49-bd46-830e54af012d\\\", \\\"subtext\\\": \\\"46b17d83-5665-4e5f-a78a-1a99b1618ef1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Other Exclusions\\\", \\\"5.2.4\\\", \\\"3\\\", 909, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"20. Involvement in the study as a study staff member or being immediate dependents, family, or household member of a study staff member.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6f50dfd6-9d3a-41ac-b3e1-a3dbae255bca\\\", \\\"childbox\\\": \\\"603c273a-d887-47e2-95e7-abb51bd7a502\\\", \\\"subtext\\\": \\\"80593941-188d-4957-908d-1c571f56ef1b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Other Exclusions\\\", \\\"5.2.4\\\", \\\"3\\\", 910, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the Appendix 1, Glossary of Terms, for a definition of a child in care.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7b4395ee-c4bb-4a3d-bbe0-e97e8f8161ee\\\", \\\"childbox\\\": \\\"7d98ad4f-6958-43a4-ac3e-711aae5ce957\\\", \\\"subtext\\\": \\\"c0b8f4ed-a441-4a69-8a5d-5367a4ef7f75\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Other Exclusions\\\", \\\"5.2.4\\\", \\\"3\\\", 911, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"5.3 Lifestyle Considerations\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"11017447-3516-4f94-ac60-ad273a2806c0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Lifestyle Considerations\\\", \\\"5.3\\\", \\\"2\\\", 912, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"No dietary, caffeine, alcohol, tobacco use, activity, or other lifestyle restrictions are required.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4b13ba66-cc8a-4a2d-8110-06c7b26a6c30\\\", \\\"childbox\\\": \\\"18c141ef-df42-46de-889a-1ee0480bc8d7\\\", \\\"subtext\\\": \\\"bbbcc765-b93d-4063-a695-1c3af5c5ccff\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Lifestyle Considerations\\\", \\\"5.3\\\", \\\"2\\\", 913, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 28, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4b13ba66-cc8a-4a2d-8110-06c7b26a6c30\\\", \\\"childbox\\\": \\\"18c141ef-df42-46de-889a-1ee0480bc8d7\\\", \\\"subtext\\\": \\\"944fac7c-36f7-47a0-8a0f-44b1087029c1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 28, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Lifestyle Considerations\\\", \\\"5.3\\\", \\\"2\\\", 914, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"5.4 Screen Failures\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7d640d82-0b55-42c6-be3d-f393f894e880\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Screen Failures\\\", \\\"5.4\\\", \\\"2\\\", 915, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If the individual is determined ineligible for study participation or has not entered into the study for other reasons following informed consent but before randomization, he/she is considered a screen failure.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d7010df7-588a-47ab-9792-cb598c62dad3\\\", \\\"childbox\\\": \\\"f29705c1-9edd-4b5e-a310-6dce71e922a5\\\", \\\"subtext\\\": \\\"7a53901e-bbd2-4157-a5b4-1c8bef02616b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Screen Failures\\\", \\\"5.4\\\", \\\"2\\\", 916, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The reason for screen failure must be documented in the Screening and Enrollment log.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d7010df7-588a-47ab-9792-cb598c62dad3\\\", \\\"childbox\\\": \\\"1ddad7c7-e015-42d7-ab80-2addc3233f66\\\", \\\"subtext\\\": \\\"58764dff-2ad7-49d8-a397-3a636ca38022\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Screen Failures\\\", \\\"5.4\\\", \\\"2\\\", 917, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d7010df7-588a-47ab-9792-cb598c62dad3\\\", \\\"childbox\\\": \\\"b2e66a8f-1a6c-4e66-be10-34ed73fa82db\\\", \\\"subtext\\\": \\\"2d96b89b-426e-4925-9d52-2f7566208e27\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Screen Failures\\\", \\\"5.4\\\", \\\"2\\\", 918, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.0  STUDY INTERVENTION\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading1\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ab9b513d-c61e-40ab-a55b-04f366c0f3e8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY INTERVENTION\\\", \\\"6.0\\\", \\\"2\\\", 919, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A \\\\u201cstudy intervention\\\\u201d is defined as a set of investigational or marketed product or placebo intended to be administered to a participant during the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"108a7024-63bc-485a-9dc6-fbcda3e45b40\\\", \\\"childbox\\\": \\\"efabe755-a0c7-425f-bdd2-23a680e58e07\\\", \\\"subtext\\\": \\\"def59263-6f54-4bc0-96c8-9d0ec6183c50\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY INTERVENTION\\\", \\\"6.0\\\", \\\"2\\\", 920, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the study reference manual for additional details.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7b944ebb-7acf-4399-96b9-764bce8255e6\\\", \\\"childbox\\\": \\\"8c8d50b6-686c-407a-aa0d-234a3a2f8412\\\", \\\"subtext\\\": \\\"929e183a-bb88-4596-b2da-7a1d32ceada8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY INTERVENTION\\\", \\\"6.0\\\", \\\"2\\\", 921, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.1 Study Interventions Administered\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bb6d09a6-951e-4f78-8830-f11da2efef2f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY INTERVENTION\\\", \\\"6.0\\\", \\\"2\\\", 922, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The study interventions that will be administered in the study are provided in Table 8.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1595c23a-27bf-4159-8257-5c666d5c9f96\\\", \\\"childbox\\\": \\\"bc251ea5-9d83-4889-899a-8b27484fc8cf\\\", \\\"subtext\\\": \\\"44f72546-91ed-4a21-9b68-9daffc986ede\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY INTERVENTION\\\", \\\"6.0\\\", \\\"2\\\", 923, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The participants must be observed closely for at least 30 minutes after the administration of ~REDACTED~/product.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"72c5e74d-74f3-4a31-a999-7e442dbcede6\\\", \\\"childbox\\\": \\\"44ed1a10-4d31-40fd-8155-b4a438010ee8\\\", \\\"subtext\\\": \\\"d62c9a02-c8bf-4919-93e0-cc8d8be20254\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY INTERVENTION\\\", \\\"6.0\\\", \\\"2\\\", 924, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Appropriate medical treatment must be readily available during the observation period in case of anaphylaxis and/or syncope.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"72c5e74d-74f3-4a31-a999-7e442dbcede6\\\", \\\"childbox\\\": \\\"583dcaf7-ad1c-43f3-8e3c-fadab38fb34d\\\", \\\"subtext\\\": \\\"d62c9a02-c8bf-4919-93e0-cc8d8be20254\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY INTERVENTION\\\", \\\"6.0\\\", \\\"2\\\", 925, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9f078f84-1d08-4ab6-ab7d-a048d04db820\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"STUDY INTERVENTION\\\", \\\"6.0\\\", \\\"2\\\", 926, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.1 Table 8 Study Interventions Administered\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"28c92a95-f020-4103-ab23-e10e24016abf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 927, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n      <th>5.0</th>\\\\n      <th>6.0</th>\\\\n      <th>7.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Study Intervention Name</td>\\\\n      <td>MenABCWY <sup>1,2</sup></td>\\\\n      <td>MenABCWY <sup>1,2</sup></td>\\\\n      <td>Menveo 3,2,4</td>\\\\n      <td></td>\\\\n      <td>Bexsero <sup>5</sup></td>\\\\n      <td>Placebo <sup>5,</sup> <sup>6</sup></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/ Product</td>\\\\n      <td>MenACWY lyo</td>\\\\n      <td>rMenB+OMV NZ</td>\\\\n      <td>MenA</td>\\\\n      <td>MenCWY</td>\\\\n      <td>rMenB+OMV NZ</td>\\\\n      <td>NaCl</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Presentation</td>\\\\n      <td>Vial</td>\\\\n      <td>Syringe</td>\\\\n      <td>Vial</td>\\\\n      <td>Vial</td>\\\\n      <td>Syringe</td>\\\\n      <td>Syringe</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Dose form</td>\\\\n      <td>Powder for suspension for injection</td>\\\\n      <td>Suspension for injection</td>\\\\n      <td>Powder for solution for injection</td>\\\\n      <td>Solution for solution for injection</td>\\\\n      <td>Suspension for injection</td>\\\\n      <td>Solution for injection</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>Vaccines(s)/ Product Formulation <sup>7</sup></td>\\\\n      <td>MenA(10 \\\\u00b5g)-CRM \\\\u2081 \\\\u2089 \\\\u2087 ; MenC(5 \\\\u00b5g)-CRM \\\\u2081 \\\\u2089 \\\\u2087 ; MenW135(5 \\\\u00b5g)-CRM \\\\u2081 \\\\u2089 \\\\u2087 ; MenY(5 \\\\u00b5g)-CRM \\\\u2081 \\\\u2089 \\\\u2087</td>\\\\n      <td>Recombinant N. meningitidis serogroup B NHBA fusion protein (50 \\\\u00b5g) adsorbed on aluminum hydroxide; Recombinant N. meningitidis serogroup B NadA protein (50 \\\\u00b5g) adsorbed on aluminum hydroxide; Recombinant N. meningitidis serogroup B fHbp fusion protein (50 \\\\u00b5g) adsorbed on aluminum hydroxide; Outer membrane vesicles from N. meningitidis serogroup B Strain NZ98/254 (25 \\\\u00b5g PorA P1.4)</td>\\\\n      <td>Meningococcal group A oligosaccharides (10 \\\\u00b5g) conjugated to Corynebacterium diphtheriae C7 (\\\\u03b2197) M8 (CRM197) protein (16.7-33.3 \\\\u00b5g); Potassium dihydrogen phosphate; Sucrose</td>\\\\n      <td>Meningococcal group C oligosaccharides (5 \\\\u00b5g) conjugated to Corynebacterium diphtheriae C7 (\\\\u03b2197) M8 (CRM197) protein (7.1-12.5 \\\\u00b5g); Meningococcal group W-135 oligosaccharides (5 \\\\u00b5g) conjugated to Corynebacterium diphtheriae C7 (\\\\u03b2197) M8 (CRM197) protein (3.3-8.3 \\\\u00b5g); Meningococcal group W-135 oligosaccharides (5 \\\\u00b5g) conjugated to Corynebacterium diphtheriae C7</td>\\\\n      <td>Recombinant N. meningitidis serogroup B NHBA fusion protein (50 \\\\u00b5g) adsorbed on aluminum hydroxide; Recombinant N. meningitidis serogroup B NadA protein (50 \\\\u00b5g) adsorbed on aluminum hydroxide; Recombinant N. meningitidis serogroup B fHbp fusion protein (50 \\\\u00b5g) adsorbed on aluminum hydroxide; Outer membrane vesicles from N. meningitidis serogroup B Strain NZ98/254</td>\\\\n      <td>Sodium chloride (NaCl) (0.9%); Water for injections</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"46\\\", \\\"TableIndex\\\": \\\"24\\\", \\\"TableName\\\": \\\"Table 8 Study Interventions Administered\\\", \\\"Header\\\": [0, 1, 2, 3]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"2445ddee-152e-438f-9084-a5d1198f503e\\\", \\\"childbox\\\": \\\"eafccb4c-871b-499e-adb1-28c00268d074\\\", \\\"subtext\\\": \\\"f9c23c80-24ac-4178-bffd-92470ba32945\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 928, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a664e92e-3a0b-4ef9-a470-0a2e91906fe4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 929, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"013a70fe-5f8a-4e4a-bb8e-8342d30f366a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 930, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n      <th>5.0</th>\\\\n      <th>6.0</th>\\\\n      <th>7.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Study Intervention Name</td>\\\\n      <td>MenABCWY <sup>1,2</sup></td>\\\\n      <td>MenABCWY <sup>1,2</sup></td>\\\\n      <td>Menveo 3,2,4</td>\\\\n      <td>Menveo 3,2,4</td>\\\\n      <td>Bexsero <sup>5</sup></td>\\\\n      <td>Placebo <sup>5,</sup> <sup>6</sup></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>adsorbed on aluminum hydroxide; Aluminum hydroxide (0.5 mg Al\\\\u00b3 \\\\u207a ); Sucrose; Histidine; NaCl; Water for injections q.s. 0.5 mL <sup>10</sup></td>\\\\n      <td></td>\\\\n      <td>(\\\\u03b2197) M8 (CRM197) protein (5.6-10 \\\\u00b5g); NaCl; Sodium dihydrogen phosphate monohydrate; Disodium phosphate dihydrate; Water for injections q.s. 0.5 mL</td>\\\\n      <td>(25 \\\\u00b5g PorA P1.4) adsorbed on aluminum hydroxide; Aluminum hydroxide (0.5 mg Al\\\\u00b3 \\\\u207a ); Sucrose; Histidine; NaCl; Water for injections q.s. 0.5 mL</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Product type</td>\\\\n      <td>Combination</td>\\\\n      <td>Combination</td>\\\\n      <td>Biological</td>\\\\n      <td>Biological</td>\\\\n      <td>Combination</td>\\\\n      <td>Combination</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Type</td>\\\\n      <td>Study</td>\\\\n      <td>Study</td>\\\\n      <td>Control</td>\\\\n      <td>Control</td>\\\\n      <td>Additional</td>\\\\n      <td>Additional</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>Route of Administration</td>\\\\n      <td>Intramuscular use</td>\\\\n      <td>Intramuscular use</td>\\\\n      <td>Intramuscular use</td>\\\\n      <td>Intramuscular use</td>\\\\n      <td>Intramuscular use</td>\\\\n      <td>Intramuscular use</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>Administration site:</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td>Location <sup>8</sup></td>\\\\n      <td>Deltoid</td>\\\\n      <td>Deltoid</td>\\\\n      <td>Deltoid</td>\\\\n      <td>Deltoid</td>\\\\n      <td>Deltoid</td>\\\\n      <td>Deltoid</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>7</th>\\\\n      <td>Laterality <sup>8</sup></td>\\\\n      <td>Non-dominant</td>\\\\n      <td>Non-dominant</td>\\\\n      <td>Non-dominant</td>\\\\n      <td>Non-dominant</td>\\\\n      <td>Non-dominant</td>\\\\n      <td>Non-dominant</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>8</th>\\\\n      <td>Number of doses to be administered</td>\\\\n      <td>2</td>\\\\n      <td>2</td>\\\\n      <td>1</td>\\\\n      <td>1</td>\\\\n      <td>2</td>\\\\n      <td>1</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>9</th>\\\\n      <td>Volume to be administered <sup>9</sup></td>\\\\n      <td>0.5 mL</td>\\\\n      <td>0.5 mL</td>\\\\n      <td>0.5 mL</td>\\\\n      <td>0.5 mL</td>\\\\n      <td>0.5 mL</td>\\\\n      <td>0.65 mL <sup>11</sup></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>10</th>\\\\n      <td>Packaging, labelling</td>\\\\n      <td>Refer to study reference manual for details</td>\\\\n      <td>Refer to study reference manual for details</td>\\\\n      <td>Refer to study reference manual for details</td>\\\\n      <td>Refer to study reference manual for details</td>\\\\n      <td>Refer to study reference manual for details</td>\\\\n      <td>Refer to study reference manual for details</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>11</th>\\\\n      <td>Manufacturer</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"46\\\", \\\"TableIndex\\\": \\\"25\\\", \\\"TableName\\\": \\\"Table 8 Study Interventions Administered\\\", \\\"Header\\\": [0, 2, 3]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"f0aea671-8ab3-442e-851b-a04aeaff676a\\\", \\\"childbox\\\": \\\"9601bae5-7e03-4333-91c3-e1d9bb4834a6\\\", \\\"subtext\\\": \\\"fb9bc24e-2d38-49cd-9724-98976e342614\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 931, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b1ccf72f-c172-4fec-b4fd-ec15f3c356e0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 932, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a105fd61-c482-4b5f-b7b5-58f5c1074967\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 933, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"52655c4a-70bc-4d1e-9452-b106e858c5bb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 934, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7e9a1ebd-e5cf-46ad-bbaa-189ad00eb7dc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 935, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8669063a-5ac0-4bd9-ac4f-78ab090f2e4b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 936, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"CRM = cross reacting material; fHbp = factor H binding protein; ~REDACTED~ = ~REDACTED~; NaCl = sodium chloride; NHBA = Neisseria heparin binding antigen;\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c04d601a-0362-4144-87f2-c0819f7f421b\\\", \\\"childbox\\\": \\\"88c2ee03-98cf-4e81-bf38-bd09e040d36a\\\", \\\"subtext\\\": \\\"74add38f-508f-4e93-8a71-49a43492b523\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 937, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"NZ = New Zealand\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bf23d42c-9610-47c6-8682-431cffc7c506\\\", \\\"childbox\\\": \\\"5a5b9689-6b62-469e-a280-aee30f829c32\\\", \\\"subtext\\\": \\\"813abe5e-a625-4bc6-adae-66ec0270941b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 938, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1 MenABCWY formulation consisting of a MenACWY lyo (lyophilized component) and of a rMenB+OMV liquid component, to be reconstituted together before administration (0.5 mL) by qualified health care practitioner (refer to Appendix 1, Glossary of Terms).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"102f3040-6425-47db-976e-ed75be41cc06\\\", \\\"childbox\\\": \\\"b0d75cea-647f-4298-8fd9-bee12d243a0f\\\", \\\"subtext\\\": \\\"d8eb3037-0268-45fd-962c-f3c25192ea66\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 939, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2 Investigational ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"77d6e3c4-8627-4033-8f0b-640f0a063500\\\", \\\"childbox\\\": \\\"d601b7d6-b9a6-4d35-bfda-d56101a7665b\\\", \\\"subtext\\\": \\\"04e6e119-11f2-4ff2-a08f-78f4dd11980d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 940, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"3 ~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65d50069-8084-46ad-8e44-1a7b6f226b60\\\", \\\"childbox\\\": \\\"e53b12f9-6286-4b51-925d-9e2c6c15e761\\\", \\\"subtext\\\": \\\"08f29ee4-25f9-426b-8987-6f344855e316\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 941, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"commercial formulation consisting of a MenA lyophilized component and of a MenCWY liquid component, to be reconstituted together before administration (0.5 mL) by qualified health care practitioner (refer to Appendix 1, Glossary of Terms).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65d50069-8084-46ad-8e44-1a7b6f226b60\\\", \\\"childbox\\\": \\\"e53b12f9-6286-4b51-925d-9e2c6c15e761\\\", \\\"subtext\\\": \\\"5f6fc013-85c0-47b1-9931-f78db84e8793\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 942, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"4 In the US, the approved specifications for\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cec53307-f497-495c-8a61-a443a68f89e0\\\", \\\"childbox\\\": \\\"bdb07bf0-d10a-411e-9aa5-8be0f1ddc895\\\", \\\"subtext\\\": \\\"9483ba85-91b2-44f0-bd1d-fd115009e99f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 943, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cec53307-f497-495c-8a61-a443a68f89e0\\\", \\\"childbox\\\": \\\"bdb07bf0-d10a-411e-9aa5-8be0f1ddc895\\\", \\\"subtext\\\": \\\"9bfe767b-e243-42a3-bab5-b6c91ab36b85\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 944, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"are described as MenA lyo: MenA=10\\\\u00b5g, CRM197=12.5 \\\\u00b5g-33 \\\\u00b5g; Potassium dihydrogen phosphate; sucrose and MenCWY liquid: MenC=5\\\\u00b5g; CRM197=6.25 \\\\u00b5g-12.5 \\\\u00b5g; MenW=5 \\\\u00b5g,CRM197=3.3 \\\\u00b5g-10 \\\\u00b5g; MenY=5\\\\u00b5g,CRM197=3.3 \\\\u00b5g-10 \\\\u00b5g; Sodium chloride; Sodium dihydrogen phosphate monohydrate; Disodium phosphate dihydrate; water for injections q.s.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cec53307-f497-495c-8a61-a443a68f89e0\\\", \\\"childbox\\\": \\\"bdb07bf0-d10a-411e-9aa5-8be0f1ddc895\\\", \\\"subtext\\\": \\\"971b28ad-7ad0-4a32-ad64-035950856f24\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 945, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"0.5 mL.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cec53307-f497-495c-8a61-a443a68f89e0\\\", \\\"childbox\\\": \\\"10dd3a4a-47a6-4a35-b4bb-a2f877b8267d\\\", \\\"subtext\\\": \\\"df7e58af-ce49-4345-9713-da3c6891e4e5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 946, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"5 Non-investigational ~REDACTED~ or placebo.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"513788dc-5529-4dc8-80db-7387d84ff8de\\\", \\\"childbox\\\": \\\"d15b4dd7-e937-4fe5-8fd2-7f8c3e3551c6\\\", \\\"subtext\\\": \\\"4e121395-d4b3-4ca2-8ac2-7a7a06699d38\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 947, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6 Administered in the ABCWY group at ~REDACTED~ 4 to maintain the study observer-blind.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"786d6442-2181-49e0-ac67-f07a9fe971b2\\\", \\\"childbox\\\": \\\"79239ea0-3763-4d3f-9e59-1f18be1cdbb0\\\", \\\"subtext\\\": \\\"a8f3ba89-1d2e-47ee-a9a8-2bd43706de94\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 948, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"7\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"786d6442-2181-49e0-ac67-f07a9fe971b2\\\", \\\"childbox\\\": \\\"bf33a237-f249-4022-949e-1dd6b84040b5\\\", \\\"subtext\\\": \\\"9839fd67-3d30-42c8-af10-6c266f8018c2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"superscript\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 949, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"786d6442-2181-49e0-ac67-f07a9fe971b2\\\", \\\"childbox\\\": \\\"bf33a237-f249-4022-949e-1dd6b84040b5\\\", \\\"subtext\\\": \\\"b0de55f1-6393-4025-a74c-851363eaf58b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Arial\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 950, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The composition per dose is presented here.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"786d6442-2181-49e0-ac67-f07a9fe971b2\\\", \\\"childbox\\\": \\\"bf33a237-f249-4022-949e-1dd6b84040b5\\\", \\\"subtext\\\": \\\"1f3853df-39bc-43a4-8ec4-7376be86aa23\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 951, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1 The non-dominant arm is the preferred arm of injection.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ad80fccf-6d11-4903-8289-35c080b2891b\\\", \\\"childbox\\\": \\\"699ce87f-a4e7-4ece-a200-5ecad08d94ee\\\", \\\"subtext\\\": \\\"856b3721-cd8d-41ea-ad0b-2c5a76512d4d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 952, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In case it is not possible to administer ~REDACTED~ in the non-dominant arm, an injection in the dominant arm may be performed.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ad80fccf-6d11-4903-8289-35c080b2891b\\\", \\\"childbox\\\": \\\"b676b816-8720-4c7d-a862-f081d915faf7\\\", \\\"subtext\\\": \\\"856b3721-cd8d-41ea-ad0b-2c5a76512d4d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 953, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2 Refer to the study reference manual for details.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f64a69d9-2b8e-4e97-b3b5-6abbd3ebf23c\\\", \\\"childbox\\\": \\\"2a796b62-3a5d-4696-85e8-b466b27fc3f7\\\", \\\"subtext\\\": \\\"087f2374-c080-4285-90b7-061472f26ba9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 954, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"3 Both the manufacture and the final composition of the MenB component of the MenABCWY are identical to that of the commercial\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ddbc97b-6175-45f2-85c6-49e9663a4cb3\\\", \\\"childbox\\\": \\\"81d9f415-22c3-46a0-899c-8d6d26e9a99e\\\", \\\"subtext\\\": \\\"f5f6fe1c-e8a3-4e6b-b15a-e07f5ceb2e80\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 955, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Bexsero\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ddbc97b-6175-45f2-85c6-49e9663a4cb3\\\", \\\"childbox\\\": \\\"81d9f415-22c3-46a0-899c-8d6d26e9a99e\\\", \\\"subtext\\\": \\\"d30c0309-6a01-4968-8aa7-b3f5d9312f71\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 956, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\".\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ddbc97b-6175-45f2-85c6-49e9663a4cb3\\\", \\\"childbox\\\": \\\"81d9f415-22c3-46a0-899c-8d6d26e9a99e\\\", \\\"subtext\\\": \\\"00ecc668-a5cd-43c8-8bab-21682108f25f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 957, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"However, to ensure a consistent reconstitution procedure and to reduce the risk of under-dosing the MenB component, the filling weight has been increased from a nominal 0.609 g present in commercial\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ddbc97b-6175-45f2-85c6-49e9663a4cb3\\\", \\\"childbox\\\": \\\"9be6d2a7-cf37-4419-a764-8b03de573d05\\\", \\\"subtext\\\": \\\"00ecc668-a5cd-43c8-8bab-21682108f25f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 958, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Bexsero\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ddbc97b-6175-45f2-85c6-49e9663a4cb3\\\", \\\"childbox\\\": \\\"9be6d2a7-cf37-4419-a764-8b03de573d05\\\", \\\"subtext\\\": \\\"27ba8066-3196-4ef8-b4b1-92aa697bb40e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 959, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"to 0.640 g in the MenB component, used to reconstitute MenABCWY.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ddbc97b-6175-45f2-85c6-49e9663a4cb3\\\", \\\"childbox\\\": \\\"9be6d2a7-cf37-4419-a764-8b03de573d05\\\", \\\"subtext\\\": \\\"1a677bf5-49d8-417b-921e-6d0540ee09f5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 960, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the study reference manual for details.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ddbc97b-6175-45f2-85c6-49e9663a4cb3\\\", \\\"childbox\\\": \\\"e53fe91e-5746-4c34-95dd-f5e0de7bba38\\\", \\\"subtext\\\": \\\"1a677bf5-49d8-417b-921e-6d0540ee09f5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 961, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"4 The volume of the saline PFS may be between 0.6 mL and 0.8 mL.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1d0cc68b-c405-44b2-a3ec-16fc5d30f929\\\", \\\"childbox\\\": \\\"67ef48fb-f973-4ea1-85e9-028ddb33b1fb\\\", \\\"subtext\\\": \\\"137d28b2-2e4a-488b-8c30-bc54c92af107\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 962, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The full volume is to be injected.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1d0cc68b-c405-44b2-a3ec-16fc5d30f929\\\", \\\"childbox\\\": \\\"a663d064-a0c8-4b20-b1ed-095e30c3fe6a\\\", \\\"subtext\\\": \\\"44b66e54-63af-442f-bb65-a20a860f8f6a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 963, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"77af1123-eb74-4aa3-af78-a694b8323aa8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 964, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"46788eb3-9478-44f0-81ac-790336878ae2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Study Interventions Administered\\\", \\\"Table 8\\\", \\\"1\\\", 965, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.2 Preparation/Handling/Storage/Accountability\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8168f83a-fefd-4c7e-861d-32b9e4399310\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Preparation/Handling/Storage/Accountability\\\", \\\"6.2\\\", \\\"2\\\", 966, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The study ~REDACTED~/product must be stored in a safe, locked place at the temperature specified on ~REDACTED~/product label.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9ccf0edb-8b54-4375-9b93-e23c9da4d355\\\", \\\"childbox\\\": \\\"89906f89-e0d8-498e-b263-60f5ae24801e\\\", \\\"subtext\\\": \\\"319f729b-c9d8-4db5-9b93-63805ee63cdc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Preparation/Handling/Storage/Accountability\\\", \\\"6.2\\\", \\\"2\\\", 967, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The storage temperature should be continuously monitored with calibrated (if not validated) temperature monitoring device(s) and recorded.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9ccf0edb-8b54-4375-9b93-e23c9da4d355\\\", \\\"childbox\\\": \\\"b9ba1190-aae0-449a-ba38-a6cfd878ce60\\\", \\\"subtext\\\": \\\"3db57b21-ea11-49b1-b9d5-e0ead546724b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Preparation/Handling/Storage/Accountability\\\", \\\"6.2\\\", \\\"2\\\", 968, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Only authorized study personnel should be allowed access to the study ~REDACTED~/product.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"85f09d96-c1ec-4d74-89ad-c8dd977af2b5\\\", \\\"childbox\\\": \\\"064cbf35-db27-48fd-9656-37a632c00dc6\\\", \\\"subtext\\\": \\\"21af4f17-b127-4c74-a77b-85760d9b8882\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Preparation/Handling/Storage/Accountability\\\", \\\"6.2\\\", \\\"2\\\", 969, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Storage conditions will be assessed by the sponsor\\\\u2019s designee (~REDACTED~, see the study administrative structure in Table 16) during pre-study activities.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"85f09d96-c1ec-4d74-89ad-c8dd977af2b5\\\", \\\"childbox\\\": \\\"f0920dfa-7157-4509-9ca9-4068d058b1f7\\\", \\\"subtext\\\": \\\"7d8f71fd-cf5d-41f2-81be-9064b7ce3e61\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Preparation/Handling/Storage/Accountability\\\", \\\"6.2\\\", \\\"2\\\", 970, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the study reference manual for more details on storage and handling of the study ~REDACTED~/product.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"85f09d96-c1ec-4d74-89ad-c8dd977af2b5\\\", \\\"childbox\\\": \\\"0a812c54-ef78-42a3-bc55-dc5419d1438f\\\", \\\"subtext\\\": \\\"ea8ed4ef-f2d7-4247-9250-a31111d4772a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Preparation/Handling/Storage/Accountability\\\", \\\"6.2\\\", \\\"2\\\", 971, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator, institution, or the head of the medical institution (where applicable) is responsible for the study ~REDACTED~/product accountability, reconciliation, and record maintenance (i.e., receipt, reconciliation, and final disposition records).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9b84ecbb-ba24-4ee9-8c04-420536b83736\\\", \\\"childbox\\\": \\\"1879a2c7-43f7-4c2f-9e6b-e935098fae05\\\", \\\"subtext\\\": \\\"ae1d0af6-1f67-43fe-9d52-ae36a3c67657\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Preparation/Handling/Storage/Accountability\\\", \\\"6.2\\\", \\\"2\\\", 972, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator, a member of the study center staff, or a hospital pharmacist must maintain an adequate record of the receipt and distribution of all study ~REDACTED~/product using the Product Accountability Form.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4cbb71b7-787a-4355-aae8-292f5cc0e005\\\", \\\"childbox\\\": \\\"62b60e01-20e7-423b-b4bc-34a89473f451\\\", \\\"subtext\\\": \\\"35ab1352-06f0-4f51-b8f9-5b86cfd0a2b6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Preparation/Handling/Storage/Accountability\\\", \\\"6.2\\\", \\\"2\\\", 973, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"These forms must be available for inspection at any time.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4cbb71b7-787a-4355-aae8-292f5cc0e005\\\", \\\"childbox\\\": \\\"a545fd57-68f7-490a-93dc-01ced29861db\\\", \\\"subtext\\\": \\\"35ab1352-06f0-4f51-b8f9-5b86cfd0a2b6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Preparation/Handling/Storage/Accountability\\\", \\\"6.2\\\", \\\"2\\\", 974, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.3 Measures to Minimize Bias: Randomization and Blinding\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"058e2b9b-056f-49bd-8def-1e9494f1c247\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Measures to Minimize Bias: Randomization and Blinding\\\", \\\"6.3\\\", \\\"2\\\", 975, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.3.1 Participant Identification\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6e372d21-71a6-4007-abef-55640c5e1d09\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Identification\\\", \\\"6.3.1\\\", \\\"3\\\", 976, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Participant identification numbers (IDs) will be assigned sequentially to the participants who have consented or provided assent with consent from each participant\\\\u2019s parent(s)/LAR(s) to participate in the study, according to the range of Participant IDs allocated to each study center.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4a80957c-eefa-45ae-9326-cdf37c45e30e\\\", \\\"childbox\\\": \\\"1685977e-06ef-46f6-b942-e80c78e1bbb8\\\", \\\"subtext\\\": \\\"cf038035-8e42-48bc-83fc-5b4ae219161f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Identification\\\", \\\"6.3.1\\\", \\\"3\\\", 977, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The Participant IDs will be documented in the Screening and Enrollment log.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4a80957c-eefa-45ae-9326-cdf37c45e30e\\\", \\\"childbox\\\": \\\"b769c5ad-dd50-4b59-a8db-4d8b4225493f\\\", \\\"subtext\\\": \\\"ad87964b-d3bb-4426-9c88-3094e514459b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Identification\\\", \\\"6.3.1\\\", \\\"3\\\", 978, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The eligibility of the participant will be determined based on the inclusion and exclusion criteria listed in Section 5.0.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cf6daf39-7d86-4453-8d79-ba7961cd70cf\\\", \\\"childbox\\\": \\\"8e08085f-dfd9-445d-9beb-360d241086b5\\\", \\\"subtext\\\": \\\"d7a6773b-43d9-4448-b1db-75d3d2bedacf\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Identification\\\", \\\"6.3.1\\\", \\\"3\\\", 979, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The Participant ID will be the participant\\\\u2019s unique identification number for all eCRFs and associated study documentation that will be used for duration of the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cf6daf39-7d86-4453-8d79-ba7961cd70cf\\\", \\\"childbox\\\": \\\"f652af18-53f2-49fe-8e8d-e52fd0c78dc1\\\", \\\"subtext\\\": \\\"8382eeae-8b56-457e-8bfc-2221d7d67ebd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Identification\\\", \\\"6.3.1\\\", \\\"3\\\", 980, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If the participant is terminated from the study, his/her Participant ID cannot be re-assigned.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cf6daf39-7d86-4453-8d79-ba7961cd70cf\\\", \\\"childbox\\\": \\\"0e75727d-6386-4ceb-b185-d5f8f00d328d\\\", \\\"subtext\\\": \\\"8382eeae-8b56-457e-8bfc-2221d7d67ebd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Identification\\\", \\\"6.3.1\\\", \\\"3\\\", 981, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.3.2 Randomization to Study Intervention\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f6a109a1-37fc-48ed-a05e-0663388a771d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Randomization to Study Intervention\\\", \\\"6.3.2\\\", \\\"3\\\", 982, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"All eligible participants will be centrally randomized using Interactive Voice Response System (IVRS) randomization (refer to Appendix 1, Glossary of Terms, for a definition of IVRS).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2ac9fbfd-869e-4542-9d04-d203a6a81d24\\\", \\\"childbox\\\": \\\"9e5a62ed-b8ff-481e-8306-0f440ce11112\\\", \\\"subtext\\\": \\\"90b2cc55-5334-4c83-a939-f8d58e409c91\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Randomization to Study Intervention\\\", \\\"6.3.2\\\", \\\"3\\\", 983, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Before the study is initiated, login information and directions for the IVRS will be provided to each study center.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2ac9fbfd-869e-4542-9d04-d203a6a81d24\\\", \\\"childbox\\\": \\\"ec712f68-07a3-496f-b500-1a58df6f1fb2\\\", \\\"subtext\\\": \\\"9ba516d8-22a3-4c8d-a237-c5718e9f0962\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Randomization to Study Intervention\\\", \\\"6.3.2\\\", \\\"3\\\", 984, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The participants will receive a unique treatment number (refer to Appendix 1, Glossary of Terms, for a definition of a treatment number).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b4362ad9-d80a-4ae3-bdcd-269f908d4830\\\", \\\"childbox\\\": \\\"86485e65-625b-4861-b6cc-05d41cd28a97\\\", \\\"subtext\\\": \\\"4a738b7f-8c5d-4b56-a4ec-e4f92f912400\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Randomization to Study Intervention\\\", \\\"6.3.2\\\", \\\"3\\\", 985, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Once a treatment number has been assigned, it cannot be re-assigned.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b4362ad9-d80a-4ae3-bdcd-269f908d4830\\\", \\\"childbox\\\": \\\"b06435ce-2133-4277-9f71-62e1cdb48dc9\\\", \\\"subtext\\\": \\\"f1bb222e-8b74-4813-8fce-657bc8c8e2e0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Randomization to Study Intervention\\\", \\\"6.3.2\\\", \\\"3\\\", 986, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"To allow the sponsor to take advantage of greater rates of recruitment in this multicenter study and to thus reduce the overall study recruitment period, an over-randomization of supplies will be prepared.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b4362ad9-d80a-4ae3-bdcd-269f908d4830\\\", \\\"childbox\\\": \\\"ff3b7458-b677-4596-9f17-edc19fc689e4\\\", \\\"subtext\\\": \\\"f1bb222e-8b74-4813-8fce-657bc8c8e2e0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Randomization to Study Intervention\\\", \\\"6.3.2\\\", \\\"3\\\", 987, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.3.3 Intervention Allocation to the Participant\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d7295e53-c2af-4c11-9f1a-d43a6e2f0df5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 988, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The target sample size to be enrolled in this study is 1206 participants to be assigned to the 2 study groups in a 1:1 ratio:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d30bc81d-e6ea-4533-98af-e8d0e7e65493\\\", \\\"childbox\\\": \\\"e9928caf-fe33-4d49-b722-4d311cf5b506\\\", \\\"subtext\\\": \\\"798763af-664a-4e6b-a6d7-453c839b3b8e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 989, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ABCWY:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"09eb654b-030a-4f69-ade6-4f7f92186ad7\\\", \\\"childbox\\\": \\\"35a13a0d-228a-4ff1-976e-7bcdfd37d889\\\", \\\"subtext\\\": \\\"d379f563-4d36-4c46-8eed-8b9c5a89308d\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 990, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"603 participants will receive 2 doses of the MenABCWY ~REDACTED~ at ~REDACTED~ 1 (Day 1) and ~REDACTED~ 3 (Day 181) (0,6-month schedule) and 1 dose of placebo at ~REDACTED~ 4 (Day 211).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"09eb654b-030a-4f69-ade6-4f7f92186ad7\\\", \\\"childbox\\\": \\\"35a13a0d-228a-4ff1-976e-7bcdfd37d889\\\", \\\"subtext\\\": \\\"3bbeea95-836d-4111-8f12-db9a3ecba85a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 991, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ACWY:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"882a35ed-96c6-42d4-ae20-e198d1334c24\\\", \\\"childbox\\\": \\\"f9963475-5023-4919-a1d5-1a82fcae17e2\\\", \\\"subtext\\\": \\\"374ef4e8-7959-472a-b51d-6500b0528694\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 992, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"603 participants will receive 1 dose of MenACWY ~REDACTED~ at ~REDACTED~ 1 (Day\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"882a35ed-96c6-42d4-ae20-e198d1334c24\\\", \\\"childbox\\\": \\\"f9963475-5023-4919-a1d5-1a82fcae17e2\\\", \\\"subtext\\\": \\\"f1e1c54f-13bf-4a94-983b-5b026e7a7d73\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 993, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"882a35ed-96c6-42d4-ae20-e198d1334c24\\\", \\\"childbox\\\": \\\"f9963475-5023-4919-a1d5-1a82fcae17e2\\\", \\\"subtext\\\": \\\"73f96bdd-ebea-47ac-ba1d-1596e408634d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"superscript\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 994, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1) (single dose) and 2 doses of MenB ~REDACTED~ at ~REDACTED~ 3 (Day 181) and ~REDACTED~ 4 (Day 211).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"882a35ed-96c6-42d4-ae20-e198d1334c24\\\", \\\"childbox\\\": \\\"f9963475-5023-4919-a1d5-1a82fcae17e2\\\", \\\"subtext\\\": \\\"c7065db0-d59d-4166-9e58-d37a7f7f752d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 995, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Section 9.2 for a detailed description of the criteria used in the estimation of sample size.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5423c2e5-1edf-4f98-8c84-e84e2bffcd51\\\", \\\"childbox\\\": \\\"081537db-9f7e-426b-957a-0deb16bbcbce\\\", \\\"subtext\\\": \\\"36127104-8167-4fb3-950b-284cc8581c5f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 996, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The system\\\\u2019s randomization algorithm will use a minimization procedure accounting for country.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bd54974f-6db7-4389-ba28-b44d7e01b4fb\\\", \\\"childbox\\\": \\\"0395888e-2704-4087-a620-44d8bf26cb12\\\", \\\"subtext\\\": \\\"fcd87946-31a3-4726-a983-69bba2e413f6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 997, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Upon providing the Participant ID, the randomization system will determine the study group and will provide the treatment number to be used for the first vaccination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bd54974f-6db7-4389-ba28-b44d7e01b4fb\\\", \\\"childbox\\\": \\\"54a008a7-665d-4f67-99ae-9755fc8add0f\\\", \\\"subtext\\\": \\\"6e37e0c2-4464-4661-810f-8d9e1776ff92\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 998, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The treatment number(s) to be used for subsequent dose administration(s) will be provided by the same randomization system.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bd54974f-6db7-4389-ba28-b44d7e01b4fb\\\", \\\"childbox\\\": \\\"33e1e59a-76d8-4ccc-8b01-37876b084bbf\\\", \\\"subtext\\\": \\\"6e37e0c2-4464-4661-810f-8d9e1776ff92\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 999, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"See Appendix 1, Glossary of Terms, for a definition of a treatment number.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c793a74a-cd4e-4e41-9e01-d14fbd1e935d\\\", \\\"childbox\\\": \\\"6e2103c4-e428-4035-adc0-235649713302\\\", \\\"subtext\\\": \\\"16dff0df-6ce3-4022-9f52-fedcf00d04f8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 1000, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The number of each administered treatment must be recorded in the eCRF on ~REDACTED~ Administration form/screen.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"caa59d1a-5d9e-493b-a7eb-ed1c6eceb091\\\", \\\"childbox\\\": \\\"d73339d5-47dd-42cc-ab68-5eb209788f5c\\\", \\\"subtext\\\": \\\"5629e890-9402-4c29-aee6-92ca15553b95\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 1001, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"caa59d1a-5d9e-493b-a7eb-ed1c6eceb091\\\", \\\"childbox\\\": \\\"d73339d5-47dd-42cc-ab68-5eb209788f5c\\\", \\\"subtext\\\": \\\"04ee6847-b77b-49a3-a8fc-1eaeb8de39a0\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 1002, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"When the specified randomization system is not available, refer to the randomization system user guide or the study reference manual for specific instructions.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7d03d0d3-8911-45b7-b025-53b73ce90a2f\\\", \\\"childbox\\\": \\\"54e52623-7ca1-4a4d-92b7-6fb59028b1c4\\\", \\\"subtext\\\": \\\"eba1577e-6395-47f7-a506-dd82f479a071\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 1003, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the study reference manual for additional information relative to the treatment number allocation.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3a018043-136e-422f-a84f-6ca5c21ce083\\\", \\\"childbox\\\": \\\"6e870197-a794-4f80-9c5d-e65bb9c4ce62\\\", \\\"subtext\\\": \\\"3698c891-929d-40b8-8740-4aa937f916a9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention Allocation to the Participant\\\", \\\"6.3.3\\\", \\\"3\\\", 1004, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.3.4 Allocation of Participants to Assay Subsets\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"82e93730-0037-4405-b776-60b32a52e471\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Allocation of Participants to Assay Subsets\\\", \\\"6.3.4\\\", \\\"3\\\", 1005, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Immunogenicity assessments are planned as outlined in Section 8.1.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"edf7640c-c3cc-4497-b973-2bbe7da2a455\\\", \\\"childbox\\\": \\\"590d8835-be04-43f0-a703-a5bbd5a0fb34\\\", \\\"subtext\\\": \\\"80bd0035-7d26-4dbd-b6df-3c30883251b2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Allocation of Participants to Assay Subsets\\\", \\\"6.3.4\\\", \\\"3\\\", 1006, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Section 9.3 for descriptions of analysis populations.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d3107ae2-23c5-466c-a043-3308bcfcfb57\\\", \\\"childbox\\\": \\\"6c7669f0-03f3-4d94-87c6-3bd362b3c98a\\\", \\\"subtext\\\": \\\"72250e61-1445-49cb-b5d3-b45227cbd52a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Allocation of Participants to Assay Subsets\\\", \\\"6.3.4\\\", \\\"3\\\", 1007, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.3.5 Blinding and Unblinding\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f1c03903-747c-4e2d-b6ce-d72b6809adc1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Blinding and Unblinding\\\", \\\"6.3.5\\\", \\\"3\\\", 1008, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.3.5.1 Blinding\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c7f1ca9c-5f85-4bec-868d-4125f6a20f46\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Blinding\\\", \\\"6.3.5.1\\\", \\\"4\\\", 1009, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Data will be collected in an observer-blind manner, i.e., participants, investigators, and teams responsible for assessment of any study endpoints will be blinded to the administered ~REDACTED~/product.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"660415db-7c9f-4510-bdf0-a61b2b613280\\\", \\\"childbox\\\": \\\"3999a6db-382b-4768-8042-cfcb3316c22b\\\", \\\"subtext\\\": \\\"96ae9af0-5ea2-4aef-b7a4-eb11e9864e9b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Blinding\\\", \\\"6.3.5.1\\\", \\\"4\\\", 1010, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Study ~REDACTED~/product will be prepared and administered by qualified study personnel who will not participate in data collection, evaluation, review, or the entry of any study endpoint (i.e., reactogenicity, safety, immunogenicity).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"660415db-7c9f-4510-bdf0-a61b2b613280\\\", \\\"childbox\\\": \\\"475ffbe0-056d-4a65-b2bd-981cc2a80f1d\\\", \\\"subtext\\\": \\\"a6c54028-b637-462f-a5db-9c23b1980567\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Blinding\\\", \\\"6.3.5.1\\\", \\\"4\\\", 1011, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The laboratory in charge of the laboratory testing will be blinded to the treatment, subject and ~REDACTED~ number, and codes will be used to link the subject, ~REDACTED~ and study (without any link to the treatment attributed to the subject) to each sample.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b5e05627-3735-4ac0-8c28-8b161f5d2f1d\\\", \\\"childbox\\\": \\\"85385bd3-efa6-486d-be35-2df5da66b594\\\", \\\"subtext\\\": \\\"8ffc1427-3cbb-457d-93cd-5a14f6187aa5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Blinding\\\", \\\"6.3.5.1\\\", \\\"4\\\", 1012, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.3.5.2 Emergency Unblinding\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"455aea43-d873-48dc-b51b-c824fc183009\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Emergency Unblinding\\\", \\\"6.3.5.2\\\", \\\"4\\\", 1013, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Unblinding a participant\\\\u2019s individual intervention number should occur ONLY in case of a medical emergency when knowledge of the intervention is essential for the clinical management or welfare of the participant.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"629cd4ee-cd33-4cbf-9662-47560fc75160\\\", \\\"childbox\\\": \\\"c7a9b58c-0682-4a81-a8b9-c12a4002f16d\\\", \\\"subtext\\\": \\\"7f1a7a0f-d3f7-491e-a484-28f1de902149\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Emergency Unblinding\\\", \\\"6.3.5.2\\\", \\\"4\\\", 1014, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The emergency unblinding process enables the investigator to have unrestricted, immediate and direct access to the participant\\\\u2019s individual study intervention through IVRS.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"286f77bb-0b41-46a3-b389-e1d489cfa134\\\", \\\"childbox\\\": \\\"51bbd315-8aa8-4990-aeef-d38b885758f9\\\", \\\"subtext\\\": \\\"3b4b321a-ceab-4e83-8f85-507f7a6c1d79\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Emergency Unblinding\\\", \\\"6.3.5.2\\\", \\\"4\\\", 1015, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"At study activation, the study centers will be provided instructions and/or other applicable information for emergency unblinding.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"286f77bb-0b41-46a3-b389-e1d489cfa134\\\", \\\"childbox\\\": \\\"7b2802ff-cd48-4f0c-a4b5-b68aace848e4\\\", \\\"subtext\\\": \\\"1bac716d-a3bf-42cb-9d66-1e6a7f158446\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Emergency Unblinding\\\", \\\"6.3.5.2\\\", \\\"4\\\", 1016, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The Interactive Response Technology used by the IVRS provider will be programmed with blind-breaking instructions.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d6aa898a-5833-4dbb-bea9-532fbc6d2555\\\", \\\"childbox\\\": \\\"9d7112b2-f177-4810-a917-dd5eff4bf93c\\\", \\\"subtext\\\": \\\"c3b49a71-a012-4a11-ad61-a3a131e25ba3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Emergency Unblinding\\\", \\\"6.3.5.2\\\", \\\"4\\\", 1017, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In case of an emergency, the investigator has the sole responsibility for determining if unblinding of a participant\\\\u2019s treatment is warranted.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d6aa898a-5833-4dbb-bea9-532fbc6d2555\\\", \\\"childbox\\\": \\\"69ccb674-44bf-463f-aeab-ce666bc5d4e2\\\", \\\"subtext\\\": \\\"e77b724a-c148-4b99-b598-0686c8ae6a3a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Emergency Unblinding\\\", \\\"6.3.5.2\\\", \\\"4\\\", 1018, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Participant safety must always be the first consideration in making such a determination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d6aa898a-5833-4dbb-bea9-532fbc6d2555\\\", \\\"childbox\\\": \\\"158c84c3-d365-448d-9184-1da5a7c633a4\\\", \\\"subtext\\\": \\\"e77b724a-c148-4b99-b598-0686c8ae6a3a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Emergency Unblinding\\\", \\\"6.3.5.2\\\", \\\"4\\\", 1019, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If the investigator decides that unblinding is warranted, the investigator should make every effort to contact the Medical Monitor (see the definition in Appendix 1, Glossary of Terms) prior to unblinding unless this could delay emergency intervention of the participant.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d6aa898a-5833-4dbb-bea9-532fbc6d2555\\\", \\\"childbox\\\": \\\"29f0cd0b-0208-4d08-a60c-0b32223f91ae\\\", \\\"subtext\\\": \\\"538db278-e9dd-4a20-b4dc-07150bac8da6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Emergency Unblinding\\\", \\\"6.3.5.2\\\", \\\"4\\\", 1020, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If a participant\\\\u2019s intervention assignment is unblinded, the ~REDACTED~ Medical Monitor must be notified within 24 hours after breaking the blind.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d6aa898a-5833-4dbb-bea9-532fbc6d2555\\\", \\\"childbox\\\": \\\"e888a581-777a-4a57-b8bc-cdfe7a5a8984\\\", \\\"subtext\\\": \\\"b4bb33b2-8b8e-49e1-8f12-552d35b8141d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Emergency Unblinding\\\", \\\"6.3.5.2\\\", \\\"4\\\", 1021, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The date and reason that the blind was broken must be recorded in the source documentation and eCRF, as applicable.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d6aa898a-5833-4dbb-bea9-532fbc6d2555\\\", \\\"childbox\\\": \\\"3916be1c-61c8-454f-baf3-40f434af17ac\\\", \\\"subtext\\\": \\\"b4bb33b2-8b8e-49e1-8f12-552d35b8141d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Emergency Unblinding\\\", \\\"6.3.5.2\\\", \\\"4\\\", 1022, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A participant may continue in the study if that participant\\\\u2019s intervention assignment is unblinded.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d6aa898a-5833-4dbb-bea9-532fbc6d2555\\\", \\\"childbox\\\": \\\"b0d59c33-b403-4954-a778-3297c51df250\\\", \\\"subtext\\\": \\\"4127a06c-d748-4a32-8e8b-37213f9aa364\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Emergency Unblinding\\\", \\\"6.3.5.2\\\", \\\"4\\\", 1023, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In the event of a Quality Assurance audit, the auditor(s) may be allowed access to unblinded study treatment information records to verify that randomization/study ~REDACTED~/products dispensing has been done accurately.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7f1fdc77-aea4-424a-b23b-b55d0aecb939\\\", \\\"childbox\\\": \\\"b6ede114-a762-458e-8738-e2a55c90127d\\\", \\\"subtext\\\": \\\"50967732-0ce8-4ed5-a2f2-f858703330b3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Emergency Unblinding\\\", \\\"6.3.5.2\\\", \\\"4\\\", 1024, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A non-investigator physician (e.g., physician from emergency room) or participant/caregiver (see Appendix 1, Glossary of Terms, for a definition of a caregiver)/family member may also request emergency unblinding.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"06fe6431-568c-42c8-ba2c-ab329f0fb9ab\\\", \\\"childbox\\\": \\\"50c6a6d5-4e61-40b5-9479-108b3708eb2d\\\", \\\"subtext\\\": \\\"ca0fc6b5-d771-425a-ba6c-435200000545\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Emergency Unblinding\\\", \\\"6.3.5.2\\\", \\\"4\\\", 1025, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Instructions for this will be provided to the participant/participant\\\\u2019s parent(s)/LAR(s) at enrollment.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"06fe6431-568c-42c8-ba2c-ab329f0fb9ab\\\", \\\"childbox\\\": \\\"e9a6cb17-819e-4799-8935-8672cc196ec2\\\", \\\"subtext\\\": \\\"678aa39f-a74d-4f61-81ab-44c0a2d9183f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Emergency Unblinding\\\", \\\"6.3.5.2\\\", \\\"4\\\", 1026, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.4 Study Intervention Compliance\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7faaa39a-515f-4d85-bb76-5761e8df6e48\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Intervention Compliance\\\", \\\"6.4\\\", \\\"2\\\", 1027, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"When participants are dosed at the study center, they will receive study intervention from the authorized qualified study center staff listed on the site log.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d5677b75-39c3-465d-b922-031a2ca9a5eb\\\", \\\"childbox\\\": \\\"697d97ca-3c0f-4cc8-b937-28fc33e42417\\\", \\\"subtext\\\": \\\"5fdacacf-590f-4e95-98c6-c2f17a52ab76\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Intervention Compliance\\\", \\\"6.4\\\", \\\"2\\\", 1028, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This study center staff member will prepare and administer ~REDACTED~/product and will be unblinded to the intervention but will not participate in any post-injection participant assessments.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d5677b75-39c3-465d-b922-031a2ca9a5eb\\\", \\\"childbox\\\": \\\"61016d0f-dd4c-4bf9-a6b3-0837fe1b9c81\\\", \\\"subtext\\\": \\\"5fdacacf-590f-4e95-98c6-c2f17a52ab76\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Intervention Compliance\\\", \\\"6.4\\\", \\\"2\\\", 1029, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A blinded observer will participate in the participant\\\\u2019s post-injection assessments, perform clinical evaluations and record the clinical data.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d5677b75-39c3-465d-b922-031a2ca9a5eb\\\", \\\"childbox\\\": \\\"a2a976a1-9274-4f19-bf79-55345495c268\\\", \\\"subtext\\\": \\\"e16d45cc-1485-4431-a020-a0ccdb8967ad\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Intervention Compliance\\\", \\\"6.4\\\", \\\"2\\\", 1030, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A delegated second-shift or back-up study staff member can be assigned to perform any of these activities.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d5677b75-39c3-465d-b922-031a2ca9a5eb\\\", \\\"childbox\\\": \\\"74900163-5f28-41cb-a5c2-6b27cbd3c98b\\\", \\\"subtext\\\": \\\"e16d45cc-1485-4431-a020-a0ccdb8967ad\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Intervention Compliance\\\", \\\"6.4\\\", \\\"2\\\", 1031, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Only blinded staff can participate in any clinical evaluations and recording of clinical data.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d5677b75-39c3-465d-b922-031a2ca9a5eb\\\", \\\"childbox\\\": \\\"941f5216-b50d-482e-8452-6fc51b2d7a84\\\", \\\"subtext\\\": \\\"317a35bf-b01d-4907-88d2-44829089e1e6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Intervention Compliance\\\", \\\"6.4\\\", \\\"2\\\", 1032, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The date of each dose administered at the study center will be recorded in the source documents and in the eCRF.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d5677b75-39c3-465d-b922-031a2ca9a5eb\\\", \\\"childbox\\\": \\\"4c668632-79f9-4cef-a09a-6257a4f96176\\\", \\\"subtext\\\": \\\"317a35bf-b01d-4907-88d2-44829089e1e6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Intervention Compliance\\\", \\\"6.4\\\", \\\"2\\\", 1033, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The dose of study intervention and Participant ID will be confirmed at the time of dosing by a study staff member other than the person administering the study intervention.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d5677b75-39c3-465d-b922-031a2ca9a5eb\\\", \\\"childbox\\\": \\\"7517f17d-480f-49ff-bba2-68bdfbbf6af4\\\", \\\"subtext\\\": \\\"562e947e-3993-469c-9805-37caa18903e8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Intervention Compliance\\\", \\\"6.4\\\", \\\"2\\\", 1034, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the SoA (Table 3) for the study intervals.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ad6f26d-da18-4116-9486-d886bf217697\\\", \\\"childbox\\\": \\\"0187ace4-88f6-4b04-9f0d-f57863a0e93b\\\", \\\"subtext\\\": \\\"47d6f4c8-2c31-4ca9-be7d-77184656cf51\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Intervention Compliance\\\", \\\"6.4\\\", \\\"2\\\", 1035, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.5 Concomitant Therapy\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"25a7adc1-8036-4860-9e40-a4869ce4a112\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1036, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"At each study ~REDACTED~/contact, the investigator or authorized study center staff member should question the participant and/or the participant\\\\u2019s parent(s)/LAR(s) about any medications/products taken and vaccinations received by the participant.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"97cfbd83-e83b-4a44-8749-8aa23dba760c\\\", \\\"childbox\\\": \\\"ee0888b6-0877-4c77-a5eb-8b772d453fb0\\\", \\\"subtext\\\": \\\"4121ee45-5694-4fb9-8e7c-f12705a7191f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1037, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The following concomitant medications/products/vaccines must be recorded in the eCRF:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3706d98f-2c57-44fe-8e9e-be957e0ac6f9\\\", \\\"childbox\\\": \\\"9389d02b-52d6-4bd8-8fe8-991347480d75\\\", \\\"subtext\\\": \\\"eac285b9-2f77-4ce5-a9f7-1182c7156979\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1038, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Any concomitant medications/products/vaccines administered for the prevention or treatment of a solicited event or AE to be recorded as per the protocol-specified reporting period (see Section 8.3.6.1).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ba02dbdc-3160-4154-864a-3d8e70fe3e07\\\", \\\"childbox\\\": \\\"79fa85fe-7842-4979-95b2-3f01bd5b5739\\\", \\\"subtext\\\": \\\"7bdb90c4-002d-49b2-965b-b50e655eb99f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1039, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Any concomitant medications/products/vaccines leading to the withdrawal or non-eligibility of the participant from the study (refer to the Section 5.2.2 for further details).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ba10a571-bc27-4524-8325-a1b6591c294b\\\", \\\"childbox\\\": \\\"1e129cd8-f3d6-411e-964c-d1459eda7d17\\\", \\\"subtext\\\": \\\"55c0985e-dd52-407e-b383-159aa178956f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1040, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Any concomitant medications/products/vaccines relevant to a serious adverse event (SAE) or an AE of special interest (AESI) (see definitions in Appendix 4) to be reported as per protocol or administered at any time during the study period for the treatment of an SAE/AESI.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"052e1458-08aa-4cca-a717-a267914a1722\\\", \\\"childbox\\\": \\\"04ab319a-323f-439d-b4c9-456c57e5e9a5\\\", \\\"subtext\\\": \\\"f373b8f8-257e-4a18-8d2f-81188e92b5fb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1041, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Concomitant medications relevant to SAEs and AESI must be recorded on the Expedited AE Report.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"052e1458-08aa-4cca-a717-a267914a1722\\\", \\\"childbox\\\": \\\"48d580a3-6ef7-46d7-abfe-d1786588a355\\\", \\\"subtext\\\": \\\"7b5a6fd3-2026-4d1c-ab81-67374c609db0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1042, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Any concomitant vaccination administered in the period starting 14 days before the first dose of study ~REDACTED~ and ending at the last study contact (Day \\\\u221214 to Day 361).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b8099bc7-b08f-4f07-b9c9-85002b784bbd\\\", \\\"childbox\\\": \\\"ae83a7dc-aed9-49a9-82fd-b6cdbcaff8c4\\\", \\\"subtext\\\": \\\"e72f3f89-ec2d-4cdc-9b93-d962872be863\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1043, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The use of antipyretic and/or other medications to prevent (prophylactic use) and/or treat fever during the first 7 days after vaccination to be recorded in the eCRF as well.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3a7824a0-dbfa-43fb-8fde-0a2bfc0d6669\\\", \\\"childbox\\\": \\\"30fa14a5-c88f-4e7c-b6e3-60fce10e940d\\\", \\\"subtext\\\": \\\"46f1f5ef-2ce8-4c45-82b2-c8e6067d3ab0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1044, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Medications taken for prophylaxis are those intended to prevent the onset of symptoms.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3a7824a0-dbfa-43fb-8fde-0a2bfc0d6669\\\", \\\"childbox\\\": \\\"ea35e3ca-1886-40e0-851e-b8626fbb9538\\\", \\\"subtext\\\": \\\"03a5011f-3463-4739-8fc6-2d3325382353\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1045, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Medications taken for treatment are intended to reduce or eliminate the presence of symptoms that are present.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3a7824a0-dbfa-43fb-8fde-0a2bfc0d6669\\\", \\\"childbox\\\": \\\"13650664-0db5-4f42-a75b-d7a5ca33e4c3\\\", \\\"subtext\\\": \\\"03a5011f-3463-4739-8fc6-2d3325382353\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1046, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"An antipyretic is considered to be prophylactic when it is given in the absence of fever and any other symptom, to prevent fever from occurring (fever is defined as temperature \\\\u226538.0\\\\u00b0C/100.4\\\\u00b0F regardless the location of measurement).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3a7824a0-dbfa-43fb-8fde-0a2bfc0d6669\\\", \\\"childbox\\\": \\\"5812341b-8c4c-49a8-ac78-1cb2fe5af8c3\\\", \\\"subtext\\\": \\\"03a5011f-3463-4739-8fc6-2d3325382353\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1047, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The preferred location for measuring temperature in this study is oral.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3a7824a0-dbfa-43fb-8fde-0a2bfc0d6669\\\", \\\"childbox\\\": \\\"31cd2f29-37b6-4a92-8351-f0bbdae2e137\\\", \\\"subtext\\\": \\\"0618d2f3-f747-4bc8-889c-1ca777161458\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1048, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The use of antipyretics and/or analgesic medications within 24 hours prior to vaccination must be identified and the reason for their use (prophylaxis versus treatment) must be described in the source document and Concomitant Medications eCRF.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d8866941-ef48-4118-bd48-65259163f823\\\", \\\"childbox\\\": \\\"c52316b0-b35e-43dc-8980-b93866475980\\\", \\\"subtext\\\": \\\"2b7c3da9-921c-4e2d-9695-74e4c3c1c2f3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1049, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The use of systemic antibiotics within 3 days prior to blood sampling ~REDACTED~ is a reason to delay blood sample withdrawal (see Section 6.7 for criteria for temporary delay of vaccination).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"75f6b60b-026a-454a-a542-b77b68de7b6b\\\", \\\"childbox\\\": \\\"be9f5060-3d3f-4868-812d-5153c567de13\\\", \\\"subtext\\\": \\\"59778de1-3afa-4bda-a9fa-a88410bb6fb0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1050, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Any concomitant medications or products taken during the study 14 days before the first dose of study ~REDACTED~ and ending at the last study contact that don\\\\u2019t fall under the listed conditions, should also be recorded if deemed important per investigator\\\\u2019s judgment.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"58cda3fb-9d64-4c8b-a039-b35b434b4e34\\\", \\\"childbox\\\": \\\"d9413bca-02e6-4916-bd3e-ff70c05ed7e4\\\", \\\"subtext\\\": \\\"48813d51-8e45-4032-a508-c6182f84f93d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1051, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The reason for use, dates of administration (start and end dates) and dosage information (dose and frequency) for medications/products/vaccines will be recorded in the eCRF.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dbcd6f97-6620-4e7f-824e-c7f409e57e9e\\\", \\\"childbox\\\": \\\"8c8c76c9-a024-4639-842f-0706e984b16c\\\", \\\"subtext\\\": \\\"7f0f2bc9-da95-4de3-9c00-3ef71fe0394f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1052, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The Medical Monitor should be contacted if there are any questions regarding concomitant or prior therapy.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4a5dc38e-dd25-4447-ad63-65a8150f1eff\\\", \\\"childbox\\\": \\\"003fbef3-18f5-4cfc-b574-1174e3ba7631\\\", \\\"subtext\\\": \\\"dcebfb2a-7ba5-43b8-8290-bd9fa1b80989\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Concomitant Therapy\\\", \\\"6.5\\\", \\\"2\\\", 1053, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.6 Dose Modification\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4f01b552-e3aa-431e-8f58-9d391827e326\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Dose Modification\\\", \\\"6.6\\\", \\\"2\\\", 1054, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Not applicable.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c0246209-d0e5-40a3-b12e-4c478030f3da\\\", \\\"childbox\\\": \\\"3c9adb36-8382-4799-bd04-305690657205\\\", \\\"subtext\\\": \\\"760515ee-f642-479d-aaa4-88af8357421b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Dose Modification\\\", \\\"6.6\\\", \\\"2\\\", 1055, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.7 Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"02e26e74-4cfa-49ff-9340-a80bfc892291\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1056, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"and/or Blood Sampling\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 28, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"be5f9e3f-7381-4319-8970-a9a54cec4a9d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 28, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1057, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Enrollment and/or vaccination and/or blood sampling may be postponed within the permitted time interval until transient circumstances cited below are resolved:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a316c421-b91c-4081-93fc-69961ccf6852\\\", \\\"childbox\\\": \\\"6b012235-f32a-4cc4-b1df-45d06acbd88d\\\", \\\"subtext\\\": \\\"32a705a4-0093-4f69-b277-07e092f1644a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1058, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Acute disease and/or fever at the time of vaccination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6ec8e803-fa79-4dcf-8027-b0d9414f98c7\\\", \\\"childbox\\\": \\\"fa40420c-f31a-40cb-9613-b429b10c528e\\\", \\\"subtext\\\": \\\"68db5251-0f61-45a0-8f7b-872d7e976388\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1059, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the SoA (Table 3) for fever definition and preferred location for measuring temperature in this study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6ec8e803-fa79-4dcf-8027-b0d9414f98c7\\\", \\\"childbox\\\": \\\"d422391d-a0f4-40ac-8648-914b9e91bd95\\\", \\\"subtext\\\": \\\"68db5251-0f61-45a0-8f7b-872d7e976388\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1060, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Significant acute illness within the previous 7 days.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a7de28a9-ce07-4db7-a8cb-0fbc0144e3c9\\\", \\\"childbox\\\": \\\"38801dfa-0bcf-4c44-9af5-3d12870b10e3\\\", \\\"subtext\\\": \\\"932beeb7-00da-4c4f-a2d7-8ca9c7e5e7a6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1061, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Receipt of systemic antibiotics within 3 days prior to blood sampling ~REDACTED~ (~REDACTED~ 1, ~REDACTED~ 2, and ~REDACTED~ 4) (this will defer the blood draw).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1d7f23ed-f19b-446c-aeb9-a16a82b0ec3d\\\", \\\"childbox\\\": \\\"e2731346-bd67-4837-9a76-f42549ea69c7\\\", \\\"subtext\\\": \\\"06f4cec6-185f-4def-82df-f3d2838fdc1c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1062, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Receipt of a ~REDACTED~ not foreseen by the study protocol administered during the period starting 7\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 23, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68658e41-adb3-4790-99d3-766af6f05f58\\\", \\\"childbox\\\": \\\"bbc1f8ce-4f83-411b-8040-e4f1ab7f026e\\\", \\\"subtext\\\": \\\"6dfc19c9-2b59-4e52-89d1-b8014fe211bf\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 23, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1063, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"days (for inactivated ~REDACTED~) or 14 days (for live ~REDACTED~s)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68658e41-adb3-4790-99d3-766af6f05f58\\\", \\\"childbox\\\": \\\"bbc1f8ce-4f83-411b-8040-e4f1ab7f026e\\\", \\\"subtext\\\": \\\"aac65389-ae04-4983-b280-b32b9d2d11dc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1064, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"days before each dose\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 23, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68658e41-adb3-4790-99d3-766af6f05f58\\\", \\\"childbox\\\": \\\"bbc1f8ce-4f83-411b-8040-e4f1ab7f026e\\\", \\\"subtext\\\": \\\"b5a1f52f-379f-49a1-9e22-98f57404a735\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 23, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1065, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68658e41-adb3-4790-99d3-766af6f05f58\\\", \\\"childbox\\\": \\\"bbc1f8ce-4f83-411b-8040-e4f1ab7f026e\\\", \\\"subtext\\\": \\\"f028eea2-2b5f-4412-94d0-e6b8386fe6cd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Arial\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1066, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"and ending 7 days\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 23, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68658e41-adb3-4790-99d3-766af6f05f58\\\", \\\"childbox\\\": \\\"bbc1f8ce-4f83-411b-8040-e4f1ab7f026e\\\", \\\"subtext\\\": \\\"baa8c9f9-bd87-47eb-9105-921121389ff7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 23, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1067, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(for inactivated ~REDACTED~) or 14 days (for live ~REDACTED~s)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68658e41-adb3-4790-99d3-766af6f05f58\\\", \\\"childbox\\\": \\\"bbc1f8ce-4f83-411b-8040-e4f1ab7f026e\\\", \\\"subtext\\\": \\\"9b5b06d9-20a0-44d8-a95a-49065b9990af\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1068, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"after each dose\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 23, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68658e41-adb3-4790-99d3-766af6f05f58\\\", \\\"childbox\\\": \\\"bbc1f8ce-4f83-411b-8040-e4f1ab7f026e\\\", \\\"subtext\\\": \\\"a5cd3827-c0ed-4c77-908a-3300fd6eef7a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 23, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1069, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68658e41-adb3-4790-99d3-766af6f05f58\\\", \\\"childbox\\\": \\\"bbc1f8ce-4f83-411b-8040-e4f1ab7f026e\\\", \\\"subtext\\\": \\\"cf472fc9-b9db-4cde-b65d-531d0bddb6bb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Arial\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1070, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"of ~REDACTED~(s)/product administration\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 23, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68658e41-adb3-4790-99d3-766af6f05f58\\\", \\\"childbox\\\": \\\"bbc1f8ce-4f83-411b-8040-e4f1ab7f026e\\\", \\\"subtext\\\": \\\"59b75392-57d8-441d-b30f-36dcdcf49768\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 23, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1071, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"*.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68658e41-adb3-4790-99d3-766af6f05f58\\\", \\\"childbox\\\": \\\"bbc1f8ce-4f83-411b-8040-e4f1ab7f026e\\\", \\\"subtext\\\": \\\"39f0e8f9-598a-46f7-8d26-7c4a577238c0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1072, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"*Note: In case an emergency mass vaccination for an unforeseen public health threat (e.g., a pandemic) is organized by the public health authorities, outside the routine immunization program, the time period described above can be reduced if necessary for that ~REDACTED~ provided it is licensed and used according to its Prescribing Information and according to the local governmental recommendations and provided a written approval of ~REDACTED~ is obtained\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0708966d-9fd3-4577-acbf-f32471510422\\\", \\\"childbox\\\": \\\"e1149d3f-303f-413e-a38d-86b5d9edd2cb\\\", \\\"subtext\\\": \\\"62208a91-73f6-428e-9070-77284c40f25e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1073, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\".\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0708966d-9fd3-4577-acbf-f32471510422\\\", \\\"childbox\\\": \\\"e1149d3f-303f-413e-a38d-86b5d9edd2cb\\\", \\\"subtext\\\": \\\"c702de7e-5531-4ca0-bcaf-dbb10ac458ca\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1074, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Under such circumstances, a participant may be considered eligible for study enrollment and/or vaccination after the appropriate window for delay described above, or as defined by local health authorities, has passed and inclusion/exclusion criteria have been rechecked, and if the participant is confirmed to be eligible.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"39c4a61e-c360-4456-8f40-320afec56b62\\\", \\\"childbox\\\": \\\"dca8034c-95c2-4b6e-be00-b731e9462b55\\\", \\\"subtext\\\": \\\"5f272d58-9547-4b9c-971b-9eaca0edc9f3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Temporary Delay for Enrollment and/or Vaccination\\\", \\\"6.7\\\", \\\"2\\\", 1075, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.8 Contraindications to Subsequent ~REDACTED~ Administration\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2e3caba5-4458-4153-8f14-26df02ece549\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraindications to Subsequent Vaccine(s) Administration\\\", \\\"6.8\\\", \\\"2\\\", 1076, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Participants must be evaluated to confirm they are eligible for subsequent vaccination before administering each additional study ~REDACTED~ dose.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4921c97b-902c-4457-b023-f35e2d7a0350\\\", \\\"childbox\\\": \\\"a061bad2-69ab-4f90-8898-fa708734b08c\\\", \\\"subtext\\\": \\\"fc896f70-e4a1-44b8-a88d-cbf6c7630b9a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraindications to Subsequent Vaccine(s) Administration\\\", \\\"6.8\\\", \\\"2\\\", 1077, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Participants who meet any of the criteria listed below or criteria listed in Section 5.2.1 and Section 5.2.2 should not receive additional vaccinations.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ac18fe8f-ebab-4c62-95e1-0bb1afe9e46c\\\", \\\"childbox\\\": \\\"950dd3bb-c324-4eb1-925d-af92d6a8d4fe\\\", \\\"subtext\\\": \\\"2f39235b-2719-45fc-9228-dc55f0eb3be0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraindications to Subsequent Vaccine(s) Administration\\\", \\\"6.8\\\", \\\"2\\\", 1078, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"However, these participants should be encouraged to continue other study procedures at the discretion of the investigator (refer to Appendix 4 for instructions on follow-up of AEs).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ac18fe8f-ebab-4c62-95e1-0bb1afe9e46c\\\", \\\"childbox\\\": \\\"45342e8f-f887-4650-8dd4-3026c40469ec\\\", \\\"subtext\\\": \\\"b28389b1-2341-4953-904a-5dadb9e640e2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraindications to Subsequent Vaccine(s) Administration\\\", \\\"6.8\\\", \\\"2\\\", 1079, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The relevant criteria for discontinuing vaccination must be recorded in the eCRF.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ac18fe8f-ebab-4c62-95e1-0bb1afe9e46c\\\", \\\"childbox\\\": \\\"180d77d8-d9c3-4321-adbe-d0a0076cc8c5\\\", \\\"subtext\\\": \\\"e8990356-acda-4b11-b42f-89c2f21d7458\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraindications to Subsequent Vaccine(s) Administration\\\", \\\"6.8\\\", \\\"2\\\", 1080, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Participants who experience any SAE judged to be possibly or probably related to study ~REDACTED~ or non-study ~REDACTED~s, including hypersensitivity reactions.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a6a8a9ef-4722-4f03-9695-3c1c83ac3c3d\\\", \\\"childbox\\\": \\\"03eb167f-5dbf-494b-b0c0-62b5fda28b67\\\", \\\"subtext\\\": \\\"7108c6e6-acd8-4907-81fa-75aaf4ac08fe\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraindications to Subsequent Vaccine(s) Administration\\\", \\\"6.8\\\", \\\"2\\\", 1081, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Participants who develop any new condition which, in the opinion of the investigator, may pose additional risk to the participant if he/she continues to participate in the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"931833cb-c77e-4262-8f6f-0331ab85fd3f\\\", \\\"childbox\\\": \\\"765a72d9-f911-49f9-9ef8-16ac74cfaad4\\\", \\\"subtext\\\": \\\"e9262ba3-39db-4228-86c6-d4274b15a525\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraindications to Subsequent Vaccine(s) Administration\\\", \\\"6.8\\\", \\\"2\\\", 1082, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Occurrence of a new AESI or the exacerbation of an existing AESI that, in the opinion of the investigator, exposes the participant to unacceptable risk from subsequent vaccination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"96e891f8-8304-4419-b62b-cdcc60cbd25b\\\", \\\"childbox\\\": \\\"3d10eb83-f872-4af3-9603-7c90fd78d2bd\\\", \\\"subtext\\\": \\\"9dcad742-2448-4100-9b39-626f881af65d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraindications to Subsequent Vaccine(s) Administration\\\", \\\"6.8\\\", \\\"2\\\", 1083, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Appendix 1, Glossary of Terms, for the definition of AESIs.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"96e891f8-8304-4419-b62b-cdcc60cbd25b\\\", \\\"childbox\\\": \\\"1ddcfc75-d8bf-446c-b20b-19ec6afc6aa3\\\", \\\"subtext\\\": \\\"9dcad742-2448-4100-9b39-626f881af65d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraindications to Subsequent Vaccine(s) Administration\\\", \\\"6.8\\\", \\\"2\\\", 1084, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Occurrence of a new potential immune-mediated diseases (pIMD) or the exacerbation of an existing pIMD that, in the opinion of the investigator, expose the participant to unacceptable risk from subsequent vaccination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6a323eb0-3535-497c-b4c8-042156b094fd\\\", \\\"childbox\\\": \\\"d1df352f-2dff-44c3-907d-7205d03c6649\\\", \\\"subtext\\\": \\\"fd1f1583-8e10-49e3-b96d-6721e7abe098\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraindications to Subsequent Vaccine(s) Administration\\\", \\\"6.8\\\", \\\"2\\\", 1085, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In such cases, the investigator should use his/her clinical judgment prior to administering the next dose of ~REDACTED~/product.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6a323eb0-3535-497c-b4c8-042156b094fd\\\", \\\"childbox\\\": \\\"a283bfb1-7a5e-42cc-9e27-8ce2fda600bd\\\", \\\"subtext\\\": \\\"fd1f1583-8e10-49e3-b96d-6721e7abe098\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraindications to Subsequent Vaccine(s) Administration\\\", \\\"6.8\\\", \\\"2\\\", 1086, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Appendix 1, Glossary of Terms, for the definition of pIMDs.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6a323eb0-3535-497c-b4c8-042156b094fd\\\", \\\"childbox\\\": \\\"ac6b1a99-f502-4354-b30e-809000ebc9ff\\\", \\\"subtext\\\": \\\"74111f0d-b85f-41a4-b79c-b426cf0b1330\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraindications to Subsequent Vaccine(s) Administration\\\", \\\"6.8\\\", \\\"2\\\", 1087, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Any condition that in the judgment of the investigator would make intramuscular injection unsafe.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2c5ed1da-5063-4d1c-8b8b-da6530bf6122\\\", \\\"childbox\\\": \\\"4f26f47f-183a-4ade-b578-07167cdc98c7\\\", \\\"subtext\\\": \\\"0744a56a-b5af-4443-a5c8-7d69687abde8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraindications to Subsequent Vaccine(s) Administration\\\", \\\"6.8\\\", \\\"2\\\", 1088, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Anaphylaxis following the administration of vaccines.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cd83017f-371d-4c4c-882c-2d5b3073d7d7\\\", \\\"childbox\\\": \\\"543ee4c3-f695-4208-a1b5-fb66ef8c0fea\\\", \\\"subtext\\\": \\\"d2e74224-2458-40a3-a614-34d18357e931\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraindications to Subsequent Vaccine(s) Administration\\\", \\\"6.8\\\", \\\"2\\\", 1089, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Pregnancy.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fde030eb-85db-4b02-9afc-390b1c745443\\\", \\\"childbox\\\": \\\"bf6644a3-e5a4-4cc7-b7bf-37556d6580a5\\\", \\\"subtext\\\": \\\"eda0c39c-4835-4d82-b3a9-f2bac9547e69\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraindications to Subsequent Vaccine(s) Administration\\\", \\\"6.8\\\", \\\"2\\\", 1090, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Any occurrence of an event listed in the exclusion criteria which must be always re-assessed by the investigator before administration of the next dose of study ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9ddfe111-e31b-4357-854c-eb79f3ca1c94\\\", \\\"childbox\\\": \\\"27a10787-a679-45eb-9bba-fd775eb78cc4\\\", \\\"subtext\\\": \\\"e3443b19-36c5-4c68-b276-c8be95c8edc9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraindications to Subsequent Vaccine(s) Administration\\\", \\\"6.8\\\", \\\"2\\\", 1091, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"6.9 Intervention After the End of the Study\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"51b202a1-e66f-4f45-ad07-dacbf26c49bd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention After the End of the Study\\\", \\\"6.9\\\", \\\"2\\\", 1092, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"During the study conclusion contact, the investigator will ask each participant/participant\\\\u2019s parent(s)/LAR(s) if they are interested in participating/allowing the participant to join a booster study/long-term study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cf54962c-0800-488c-a532-fea04c1aa9b0\\\", \\\"childbox\\\": \\\"58fcb3a9-6470-43e1-ad2f-fe2a7c523699\\\", \\\"subtext\\\": \\\"95fa5cf2-9d4f-4a80-b764-cd41d53262c4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention After the End of the Study\\\", \\\"6.9\\\", \\\"2\\\", 1093, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If a participant/participant\\\\u2019s parent(s)/LAR(s) is/are not interested in joining the long-term study the reason for refusal will be documented, when available, in the participant\\\\u2019s eCRF.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cf54962c-0800-488c-a532-fea04c1aa9b0\\\", \\\"childbox\\\": \\\"358b085b-b8d1-4c0c-be4a-0604e853cfc8\\\", \\\"subtext\\\": \\\"2b655943-063f-48a3-b93e-44b7cc6f2b5f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention After the End of the Study\\\", \\\"6.9\\\", \\\"2\\\", 1094, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator is encouraged to share immunological assay results for non-responders with the study participants/participants\\\\u2019 parents/LARs.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"307e086c-a124-45bf-a574-68d67390f9c8\\\", \\\"childbox\\\": \\\"bb0f5157-e7d2-4609-bd53-84a9a558fc76\\\", \\\"subtext\\\": \\\"b8e55876-f2de-4d48-9e4f-b9e3f9c5f7bb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention After the End of the Study\\\", \\\"6.9\\\", \\\"2\\\", 1095, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For participants identified as non-responders, it is the responsibility of the investigator in charge of the participant\\\\u2019s clinical management to determine the medical care needed as per local/regional practices (such as re-vaccination of the participant[s]).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d27632c4-6e2d-46a9-a08e-1cfa428a01c0\\\", \\\"childbox\\\": \\\"4bd73730-c04f-4856-b561-7fdeff67be27\\\", \\\"subtext\\\": \\\"88fd8fe7-753d-4f06-80d1-e28bf3c52d91\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention After the End of the Study\\\", \\\"6.9\\\", \\\"2\\\", 1096, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Section 8.1.5 for information regarding the immunological correlates of protection.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"88b230d7-46ba-4365-b77d-9b2aefe12b2c\\\", \\\"childbox\\\": \\\"497db56d-c015-4014-a4b4-5cd9a0f47cdc\\\", \\\"subtext\\\": \\\"d0efdb84-2f89-4503-86a9-e9c4b445c1a4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention After the End of the Study\\\", \\\"6.9\\\", \\\"2\\\", 1097, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"88b230d7-46ba-4365-b77d-9b2aefe12b2c\\\", \\\"childbox\\\": \\\"1ee177b3-e47e-461c-9375-bcee0e6df5fa\\\", \\\"subtext\\\": \\\"571ebba3-4d01-42e9-bfa7-24de31810037\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention After the End of the Study\\\", \\\"6.9\\\", \\\"2\\\", 1098, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"7.0  DISCONTINUATION OF STUDY INTERVENTION\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading1\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2e5a2885-f179-4bae-a19f-c7b249de30cb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention After the End of the Study\\\", \\\"6.9\\\", \\\"2\\\", 1099, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"AND PARTICIPANT\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 32, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9dd4bf6d-7fd8-449f-b62f-a1bffb51b3d0\\\", \\\"childbox\\\": \\\"928b3402-f166-401d-a394-c26f81d0be6c\\\", \\\"subtext\\\": \\\"b15148f0-ad63-4257-b042-c3a2a2707814\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 32, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention After the End of the Study\\\", \\\"6.9\\\", \\\"2\\\", 1100, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"DISCONTINUATION/WITHDRAWAL\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 32, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"24944928-7f29-4491-b6bc-b5428f3e7fcb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 32, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Intervention After the End of the Study\\\", \\\"6.9\\\", \\\"2\\\", 1101, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"7.1 Reasons for Discontinuation/Withdrawal\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"23fdfc06-d5d5-43b7-b9b0-e8987b1b0a3b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Reasons for Discontinuation/Withdrawal\\\", \\\"7.1\\\", \\\"2\\\", 1102, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The participant may withdraw or participant\\\\u2019s parent(s)/LAR(s) may withdraw a participant from the study at any time on request, or a participant may be withdrawn at any time at the discretion of the investigator for safety, behavioural, compliance, or administrative reasons.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a5fa20bd-6ab1-4517-aa03-bb35e1e3b326\\\", \\\"childbox\\\": \\\"c1e83ace-dd80-4283-a934-f6893b830a04\\\", \\\"subtext\\\": \\\"c7d92a97-a6a0-4213-b5e2-7774572fb1fc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Reasons for Discontinuation/Withdrawal\\\", \\\"7.1\\\", \\\"2\\\", 1103, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 If the participant/participant\\\\u2019s parent(s)/LAR(s) withdraw consent for disclosure of future information, the sponsor may retain and continue to use any data collected before such a withdrawal of consent.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"77fe7bf4-18c9-4072-8266-6c208444da46\\\", \\\"childbox\\\": \\\"43362f2a-e30a-417a-a490-9dacebaab14b\\\", \\\"subtext\\\": \\\"2f446060-1ebb-4d98-8320-53cb44a18d45\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Reasons for Discontinuation/Withdrawal\\\", \\\"7.1\\\", \\\"2\\\", 1104, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 If a participant is withdrawn from the study, the participant/participant\\\\u2019s parent(s)/LAR(s) may request destruction of any samples taken and not tested, and the investigator must document this in the study center study records.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1e55e9c7-2a22-49ec-a447-64a0a11969b6\\\", \\\"childbox\\\": \\\"37739f6a-8b5e-43fb-a456-bedb8d8f3277\\\", \\\"subtext\\\": \\\"f8c3c47b-39fb-4720-8132-2d8587007478\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Reasons for Discontinuation/Withdrawal\\\", \\\"7.1\\\", \\\"2\\\", 1105, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Participants who discontinue study intervention or are withdrawn from the study will not be replaced.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"309f3646-23df-4aac-8736-f314fc1050ed\\\", \\\"childbox\\\": \\\"966252f9-8d77-4e2d-8192-d383f344b45a\\\", \\\"subtext\\\": \\\"518197c9-ea6e-4f53-9f8f-f1d88c183bd9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Reasons for Discontinuation/Withdrawal\\\", \\\"7.1\\\", \\\"2\\\", 1106, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The eCRF should be completed as much as possible.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"309f3646-23df-4aac-8736-f314fc1050ed\\\", \\\"childbox\\\": \\\"4af42974-46e1-4996-92af-59ef678a05cc\\\", \\\"subtext\\\": \\\"518197c9-ea6e-4f53-9f8f-f1d88c183bd9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Reasons for Discontinuation/Withdrawal\\\", \\\"7.1\\\", \\\"2\\\", 1107, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If a participant is withdrawn from the study because he/she/the participant\\\\u2019s parent(s)/LAR(s) have withdrawn consent and provided the reason for its withdrawal, the investigator must document this reason in the eCRF.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9ccac3ca-f847-4680-b526-e6c998976d2c\\\", \\\"childbox\\\": \\\"f0ad38c0-b28c-4da2-9c23-3a94088c2373\\\", \\\"subtext\\\": \\\"6516d4c8-3ba0-4c7f-9bfb-0145580beab0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Reasons for Discontinuation/Withdrawal\\\", \\\"7.1\\\", \\\"2\\\", 1108, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"7.2 Discontinuation of Study Intervention\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1e36c0ec-e709-4f09-950a-5999a329d88d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Discontinuation of Study Intervention\\\", \\\"7.2\\\", \\\"2\\\", 1109, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u201cDiscontinuation\\\\u201d of study intervention (study ~REDACTED~/product) means any participant who has not received all planned doses of ~REDACTED~/product.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3dfbb48b-edbd-48d3-b862-681b36335834\\\", \\\"childbox\\\": \\\"4b0e823e-65f0-4286-9060-b642384bf991\\\", \\\"subtext\\\": \\\"aaeb6a7f-7230-47e8-b5b8-55d2a8305b63\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Discontinuation of Study Intervention\\\", \\\"7.2\\\", \\\"2\\\", 1110, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A participant who discontinued study ~REDACTED~/product may, if deemed appropriate by the investigator, continue other study procedures (e.g., safety or immunogenicity) if planned in the study protocol.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3dfbb48b-edbd-48d3-b862-681b36335834\\\", \\\"childbox\\\": \\\"17a9dcae-0294-4d97-8211-831a84061749\\\", \\\"subtext\\\": \\\"48e841a9-b293-477a-a60c-409a117617ab\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Discontinuation of Study Intervention\\\", \\\"7.2\\\", \\\"2\\\", 1111, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The primary reason for premature discontinuation of the study ~REDACTED~/product will be documented on the eCRF based on the following:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ee816ce3-5a24-4570-9fd0-a018a5db3595\\\", \\\"childbox\\\": \\\"e817f2b0-840e-4960-b428-fec87a983bcc\\\", \\\"subtext\\\": \\\"4e408bb9-7814-4a6f-9d4e-9aa4099b39ec\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Discontinuation of Study Intervention\\\", \\\"7.2\\\", \\\"2\\\", 1112, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 AE requiring expedited reporting to ~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"732e21b3-2021-48ce-b422-61907c359575\\\", \\\"childbox\\\": \\\"05f52902-e014-47a0-b47a-3969aa1e4e6a\\\", \\\"subtext\\\": \\\"2fcdb130-85c0-4324-9cc7-f5797521e922\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Discontinuation of Study Intervention\\\", \\\"7.2\\\", \\\"2\\\", 1113, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Unsolicited non-serious AE\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"baa79ee6-4a21-46a8-ac4b-d65de29ccf2f\\\", \\\"childbox\\\": \\\"2ec05503-1d84-4122-b7a9-341c82ceed7c\\\", \\\"subtext\\\": \\\"22851b4e-b66d-4472-ab72-0b4c3ea9d03e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Discontinuation of Study Intervention\\\", \\\"7.2\\\", \\\"2\\\", 1114, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Solicited AE\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f01c7874-d4d9-480e-8dc0-79dff1b27440\\\", \\\"childbox\\\": \\\"7e9ca166-575b-4a8a-8b49-e650a7df897b\\\", \\\"subtext\\\": \\\"0e513226-8eaa-4ba8-b367-198cadaf0b74\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Discontinuation of Study Intervention\\\", \\\"7.2\\\", \\\"2\\\", 1115, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Protocol deviation\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e1051cf8-4f6f-4d7f-bbcd-16b072d53a94\\\", \\\"childbox\\\": \\\"ac28bfd6-9ee8-470b-aac1-add93a58c61f\\\", \\\"subtext\\\": \\\"b6a463fa-ec3b-4b6a-a4d9-35caead1f989\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Discontinuation of Study Intervention\\\", \\\"7.2\\\", \\\"2\\\", 1116, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Not willing to be vaccinated\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"11f4497b-8c26-43bc-aa31-2123dbe64d37\\\", \\\"childbox\\\": \\\"04008d06-8e2e-4d59-a5ac-9647b2640c6e\\\", \\\"subtext\\\": \\\"01373747-164e-4bde-9bf4-e0964344ac7d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Discontinuation of Study Intervention\\\", \\\"7.2\\\", \\\"2\\\", 1117, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Other (specify)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"06f4c3ed-aaff-4731-8bde-2390b4a41ff4\\\", \\\"childbox\\\": \\\"0718d2ba-dd4a-4484-9794-e8772c9bf974\\\", \\\"subtext\\\": \\\"18ecd904-7c1d-45ba-ae52-33b56c50757b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Discontinuation of Study Intervention\\\", \\\"7.2\\\", \\\"2\\\", 1118, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"7.3 Participant Discontinuation/Withdrawal from the Study\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"180cfefb-e98f-4f01-ad62-32e0ac024fac\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1119, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A participant is considered a \\\\u201cwithdrawal\\\\u201d from the study when no study procedure has occurred, no follow-up has been performed and no further information has been collected for this participant from the date of withdrawal/last contact.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a65e9c7a-0a7a-46ba-bcb4-dccedff34075\\\", \\\"childbox\\\": \\\"4d1c5a2a-4837-48ff-806b-585551c5d912\\\", \\\"subtext\\\": \\\"1285fe05-4af6-479d-a43a-28b2001b33d4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1120, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"From an analysis perspective, a \\\\u201cwithdrawal\\\\u201d from the study refers to any participant who was not available for the concluding contact foreseen in the protocol.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2a462d70-864b-482d-a60d-070beb53c509\\\", \\\"childbox\\\": \\\"7b7d9d4d-8be9-4ee2-a4f9-e020d04f5873\\\", \\\"subtext\\\": \\\"75304d89-1bef-4b85-852c-10ee1a9e1fe8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1121, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Investigators or designated study center personnel will attempt to contact those participants who do not return for scheduled visits or follow-up.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"07087689-f222-4948-ac67-36301ce9d734\\\", \\\"childbox\\\": \\\"105bd1b4-ce8b-4b07-9666-06e34e71cb50\\\", \\\"subtext\\\": \\\"2a168ca6-efd8-4bdd-a2cf-385983b1d230\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1122, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"All data and samples collected until the date of withdrawal/last contact of the participant will be used for the analysis.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"93057488-e7da-40da-aca2-05eec4d9103e\\\", \\\"childbox\\\": \\\"19684b83-f739-4672-a131-13639c5684e1\\\", \\\"subtext\\\": \\\"41155691-d030-4370-a297-d8d76c9278af\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1123, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The primary reason for study withdrawal will be documented in the eCRF based on the list below:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8d8e7066-bedd-49d7-a774-636e17145dda\\\", \\\"childbox\\\": \\\"f80d6218-9d88-45ff-8d6e-45b126e4ac3a\\\", \\\"subtext\\\": \\\"8160edef-952c-4557-bc63-008e3581ed8b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1124, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 AEs requiring expedited reporting to ~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"84760f63-a666-4a28-9f4e-fb8abff89c21\\\", \\\"childbox\\\": \\\"b034c231-6b89-45d9-9bab-25021b16d0e5\\\", \\\"subtext\\\": \\\"5033cdf8-30da-4fd7-a320-48b5d67fa5fd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1125, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Unsolicited non-serious AE\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0417e497-69fd-4dd9-bd97-192c1bca9780\\\", \\\"childbox\\\": \\\"7e75a341-eee1-4150-8bd7-880a35451048\\\", \\\"subtext\\\": \\\"78c7defa-1f87-40fc-9c34-1bc3a197b837\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1126, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Solicited AE\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bad12756-6d80-4afe-8e00-0e8eb3049d22\\\", \\\"childbox\\\": \\\"62c1a2ed-7c60-4e15-8424-37a238a5b44d\\\", \\\"subtext\\\": \\\"73e2c391-0c50-4c37-9928-f05869d26e2b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1127, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Protocol deviation\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cf82ebfc-5aee-41ce-8486-c978a4ad6ac2\\\", \\\"childbox\\\": \\\"17654e80-e003-4141-bff7-c7356700916a\\\", \\\"subtext\\\": \\\"9ad3f592-258c-4548-a7bf-b66a8279b966\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1128, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Withdrawal by participant, not due to an AE (see Section 7.1)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"133cd967-1e8b-4fe1-b522-2f18e883bc69\\\", \\\"childbox\\\": \\\"b383d9ca-e1cb-4f15-8f44-1e6d49c3f8bf\\\", \\\"subtext\\\": \\\"39433c20-9822-4597-9902-6cda93cc7548\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1129, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Migrated/Moved from the study area\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7a1cfe65-176e-47cb-9536-3d2bd3b36504\\\", \\\"childbox\\\": \\\"e05227c5-3884-4d8d-8be9-39eb6b80558b\\\", \\\"subtext\\\": \\\"cb3625ed-9fac-4936-8b86-1715886bad48\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1130, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Lost to follow-up\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d0c2e361-c780-47bf-8c04-9c0788f76764\\\", \\\"childbox\\\": \\\"81f2c0ee-42b3-469f-b6bd-7d631149c73a\\\", \\\"subtext\\\": \\\"236c051d-0937-44c0-a644-e0b522cf39cd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1131, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Sponsor study termination\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dd383478-194e-49cb-a3b6-e1bd440075a8\\\", \\\"childbox\\\": \\\"6d8badf1-7610-4a58-82e0-817648c935a0\\\", \\\"subtext\\\": \\\"dc02128c-ff66-4930-9bf7-3e0cc647f903\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1132, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Other (specify)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fda4703e-6ad2-4077-bd08-e10503e24e51\\\", \\\"childbox\\\": \\\"7f3371fa-ea4e-46a9-aebc-5ed201ab28e6\\\", \\\"subtext\\\": \\\"01e85c45-9f7d-4531-8b07-a90381bf73ce\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1133, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Participants who are withdrawn from the study because of SAEs/AEs must be clearly distinguished from participants who are withdrawn for other reasons.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"51132c68-fd73-475b-b85e-bfc93eb230e1\\\", \\\"childbox\\\": \\\"d7c0b2b3-eb77-4878-ace6-a9c51663acf3\\\", \\\"subtext\\\": \\\"14284adc-159b-43e7-90b0-ec736b2900cd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1134, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Investigators will follow participants who are withdrawn from the study as result of an SAE/AE until the event is resolved (refer to Appendix 4 for instructions on follow-up of AEs).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"51132c68-fd73-475b-b85e-bfc93eb230e1\\\", \\\"childbox\\\": \\\"7f31f53a-0ba2-4ff1-8b02-488c4e6e87c5\\\", \\\"subtext\\\": \\\"14284adc-159b-43e7-90b0-ec736b2900cd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Discontinuation/Withdrawal from the Study\\\", \\\"7.3\\\", \\\"2\\\", 1135, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"7.4 Lost to Follow-up\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"35acd028-0ca4-4fc7-a5bc-5207bd4cd87e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Lost to Follow-up\\\", \\\"7.4\\\", \\\"2\\\", 1136, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A participant will be considered \\\\u201clost to follow-up\\\\u201d if he/she fails to return for scheduled visits and is unable to be contacted by the study center.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"06edb990-d463-45d4-a0c5-bed24bb0ad61\\\", \\\"childbox\\\": \\\"2c897f13-3ba8-478b-8d08-fad4abfa222f\\\", \\\"subtext\\\": \\\"3e3cf735-57b1-40cc-95d0-2d80565a45ae\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Lost to Follow-up\\\", \\\"7.4\\\", \\\"2\\\", 1137, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the study reference manual for a description of the actions to be taken before considering the participant as lost to follow-up.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"08a29dac-8080-459f-8f2c-cd0c66ccdb5c\\\", \\\"childbox\\\": \\\"4e2bd60d-be36-43e4-9e2f-3551d962f7b4\\\", \\\"subtext\\\": \\\"8e85dcdb-0e56-4ded-b485-cf81bd85dd8c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Lost to Follow-up\\\", \\\"7.4\\\", \\\"2\\\", 1138, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.0  STUDY ASSESSMENTS AND PROCEDURES\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading1\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ca8ed93d-d573-4bc7-b9dc-7b8cc3fe7626\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY ASSESSMENTS AND PROCEDURES\\\", \\\"8.0\\\", \\\"2\\\", 1139, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Study procedures and their timing are summarized in the SoA (Table 3).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"727f1d22-0965-4601-aff2-214621d17ec6\\\", \\\"childbox\\\": \\\"8b9d11fa-2cc0-4b76-aa53-f652cdffcfe0\\\", \\\"subtext\\\": \\\"51edd795-9b19-45fa-a61e-00f27c8184aa\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY ASSESSMENTS AND PROCEDURES\\\", \\\"8.0\\\", \\\"2\\\", 1140, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"727f1d22-0965-4601-aff2-214621d17ec6\\\", \\\"childbox\\\": \\\"bb18cab7-bc2a-424c-986d-4a0269e33bdc\\\", \\\"subtext\\\": \\\"73d49e73-bb12-48dc-9b66-aa0e789f06b7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Segoe UI Symbol\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY ASSESSMENTS AND PROCEDURES\\\", \\\"8.0\\\", \\\"2\\\", 1141, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"727f1d22-0965-4601-aff2-214621d17ec6\\\", \\\"childbox\\\": \\\"bb18cab7-bc2a-424c-986d-4a0269e33bdc\\\", \\\"subtext\\\": \\\"a260ec7a-35a0-4d68-9030-63c4685ae253\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Arial\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY ASSESSMENTS AND PROCEDURES\\\", \\\"8.0\\\", \\\"2\\\", 1142, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Adherence to the protocol is required for study conduct.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"727f1d22-0965-4601-aff2-214621d17ec6\\\", \\\"childbox\\\": \\\"bb18cab7-bc2a-424c-986d-4a0269e33bdc\\\", \\\"subtext\\\": \\\"7b88af38-5ba7-4910-af48-75a9535da683\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY ASSESSMENTS AND PROCEDURES\\\", \\\"8.0\\\", \\\"2\\\", 1143, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Protocol waivers or exemptions are not allowed unless necessary for the management of an immediate safety concerns.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a1be7a8b-181b-435a-839f-2224f48e73c1\\\", \\\"childbox\\\": \\\"a85f676f-2a23-46ac-8c10-086c74183cc4\\\", \\\"subtext\\\": \\\"e152b965-0bba-470a-9d53-de9dcee7372a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY ASSESSMENTS AND PROCEDURES\\\", \\\"8.0\\\", \\\"2\\\", 1144, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The investigator is not allowed to do testing on samples outside of what has been agreed upon by the Independent Ethics Committee (IEC)/Institutional Review Board (IRB).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7d75fadd-7260-448e-ac75-b015b3635910\\\", \\\"childbox\\\": \\\"99f2b7a2-e799-4416-a0b9-8f22d100f040\\\", \\\"subtext\\\": \\\"51992eb9-d498-4e0d-8345-82f5d1f3dd5d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY ASSESSMENTS AND PROCEDURES\\\", \\\"8.0\\\", \\\"2\\\", 1145, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Immediate safety concerns should be discussed with ~REDACTED~ as soon as they occur or when the study team is aware of them.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"96b6712b-14a5-47ea-b7f0-ae439dff4cfa\\\", \\\"childbox\\\": \\\"057e02bd-fbdb-4dfe-bc83-fe138487c4ea\\\", \\\"subtext\\\": \\\"11d85aa7-6860-4d64-8cf2-3615afc83279\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY ASSESSMENTS AND PROCEDURES\\\", \\\"8.0\\\", \\\"2\\\", 1146, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The purpose of this communication is to determine if the participant(s) should discontinue the study intervention.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"96b6712b-14a5-47ea-b7f0-ae439dff4cfa\\\", \\\"childbox\\\": \\\"834c3bbd-5072-4993-b3d9-dcaf5cde6b50\\\", \\\"subtext\\\": \\\"11d85aa7-6860-4d64-8cf2-3615afc83279\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY ASSESSMENTS AND PROCEDURES\\\", \\\"8.0\\\", \\\"2\\\", 1147, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 All screening evaluations (i.e., eligibility criteria check) must be completed and the results reviewed before confirming that potential participants meet all eligibility criteria.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"add6e734-3170-4fc6-8f19-1dae637104ec\\\", \\\"childbox\\\": \\\"9a2cc1e6-d1ff-44bc-bd81-406530af79d2\\\", \\\"subtext\\\": \\\"8e397a46-213f-4af0-97b8-673899e40aa9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY ASSESSMENTS AND PROCEDURES\\\", \\\"8.0\\\", \\\"2\\\", 1148, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The investigator will maintain a screening log of all participants screened.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bdd67e69-f5e1-4b27-8bab-ff5ebc8eee0b\\\", \\\"childbox\\\": \\\"ed6ec5f5-37dc-4561-8c2e-fad74f657884\\\", \\\"subtext\\\": \\\"6795567e-a679-4319-ab49-4401066e0d60\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY ASSESSMENTS AND PROCEDURES\\\", \\\"8.0\\\", \\\"2\\\", 1149, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"All relevant information, such as confirmation of eligibility and reasons for screening failure will be mentioned in this screening log.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bdd67e69-f5e1-4b27-8bab-ff5ebc8eee0b\\\", \\\"childbox\\\": \\\"39a42349-a861-4ea6-acf5-b58c1a7f72b6\\\", \\\"subtext\\\": \\\"5a281be2-068f-469c-8c26-0bc1b5818d78\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY ASSESSMENTS AND PROCEDURES\\\", \\\"8.0\\\", \\\"2\\\", 1150, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The study reference manual provides the investigator and study center personnel with administrative and detailed technical information that does not impact participant safety.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cacfcaf3-dc3b-47ce-958b-8204869ad145\\\", \\\"childbox\\\": \\\"0422e22b-e740-4a2a-9c5f-059dd63386ea\\\", \\\"subtext\\\": \\\"e3836559-4a26-4bb5-a8f4-4c6cfbc63b1a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STUDY ASSESSMENTS AND PROCEDURES\\\", \\\"8.0\\\", \\\"2\\\", 1151, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.1 Immunogenicity Assessments\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"781eb6d7-3254-4cbe-baab-2b7f7b51e166\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1152, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Collected biological samples will be used for protocol mandated research and purposes related to the improvement, development and quality assurance of the laboratory tests described in this protocol.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6d88da40-20a1-4895-9ad5-9d581d4a6aa7\\\", \\\"childbox\\\": \\\"3bb9be3e-78ea-4012-a017-f4ba93aa4f00\\\", \\\"subtext\\\": \\\"84ade447-bd37-4ae4-800f-d2363986a8e7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1153, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Future findings may make it desirable to use the samples acquired in this study for future research not described in this protocol.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0a672abf-13e8-4b2d-885e-2f16eb80e3da\\\", \\\"childbox\\\": \\\"64e53c13-3f48-41ee-8f4a-4b963fd62d08\\\", \\\"subtext\\\": \\\"b0cc6094-46f0-4c17-b10a-4f09e45c2e44\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1154, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Therefore, all participants in countries where this is allowed will be asked to give a specific consent to allow the sponsor or a contracted partner to use the samples for future research.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0a672abf-13e8-4b2d-885e-2f16eb80e3da\\\", \\\"childbox\\\": \\\"24846aba-586b-4d77-adca-85e08c496a78\\\", \\\"subtext\\\": \\\"2f10cbf8-c2ad-487a-ac93-3bb2742ebdba\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1155, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Future research will be participant to IEC/IRB approval if required per local legislation.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0a672abf-13e8-4b2d-885e-2f16eb80e3da\\\", \\\"childbox\\\": \\\"313fce31-7d9d-47a7-ae9f-e8d1c6928889\\\", \\\"subtext\\\": \\\"acdda465-ca99-40a5-9fbb-9d0554a97887\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1156, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Additional serological assays may be performed in the future to further characterize the disease and/or the antibody response to the antigens included in the study vaccines or hSBA against an additional panel of strains of\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e07ac646-135a-48d7-a352-760de3d4a72e\\\", \\\"childbox\\\": \\\"2edc79aa-688a-4b43-a1b2-3acbc3ea768b\\\", \\\"subtext\\\": \\\"47e1c80d-867b-479c-89f1-02745e4870bd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1157, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Neisseria\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e07ac646-135a-48d7-a352-760de3d4a72e\\\", \\\"childbox\\\": \\\"2edc79aa-688a-4b43-a1b2-3acbc3ea768b\\\", \\\"subtext\\\": \\\"8db3c016-4ffc-4b11-ab1e-19ef78d5558a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1158, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"species.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e07ac646-135a-48d7-a352-760de3d4a72e\\\", \\\"childbox\\\": \\\"2edc79aa-688a-4b43-a1b2-3acbc3ea768b\\\", \\\"subtext\\\": \\\"da37b344-856f-48e4-81c6-7f6e135179d8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1159, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"These assays may not be represented in the objectives/endpoints of the study protocol.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e07ac646-135a-48d7-a352-760de3d4a72e\\\", \\\"childbox\\\": \\\"ca614a1d-69b5-460a-9659-1fb1acc2ceab\\\", \\\"subtext\\\": \\\"da37b344-856f-48e4-81c6-7f6e135179d8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1160, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Information on further investigations and their rationale can be obtained from ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74decc22-135b-4524-93aa-ad550b3dfab3\\\", \\\"childbox\\\": \\\"7fa21ca9-dd9b-4fc1-8e4f-5a9ea452390f\\\", \\\"subtext\\\": \\\"63946690-bbc9-4bd9-a884-593ad2787bba\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1161, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Sample testing will be done in accordance with the recorded consent of the individual participant/participant\\\\u2019s parent(s)/LAR(s).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0f25d21f-3a48-4673-ad8f-7e06f8685129\\\", \\\"childbox\\\": \\\"565e8524-3dfa-43e9-8561-6fc666ce6bb5\\\", \\\"subtext\\\": \\\"eb4e004e-f34c-4050-afb2-bc91dd52be6f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1162, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If additional testing is performed, the marker priority ranking given in the Section 8.1.3 may be changed.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"63e05263-7382-4fb1-8e24-488de42218b7\\\", \\\"childbox\\\": \\\"277dae50-5a1d-4ada-9878-ecb17501afeb\\\", \\\"subtext\\\": \\\"4d1ca7d2-7e03-4316-814a-7f4da881c171\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1163, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Collected samples will be stored for a maximum of 20 years.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e1d421a3-bca2-477e-a7b9-612f4a37913c\\\", \\\"childbox\\\": \\\"ab55c201-208f-42cc-9bcb-c0e14ebe677f\\\", \\\"subtext\\\": \\\"d96cb4c5-563e-4327-bdf4-25561ecd55b2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1164, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This storage period begins when the last participant performed the last study ~REDACTED~, unless local rules, regulations or guidelines require different timeframes or procedures, which would then be in line with participant consent.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e1d421a3-bca2-477e-a7b9-612f4a37913c\\\", \\\"childbox\\\": \\\"f0d8294a-7af6-4e69-9a34-7ca26d6c6fe8\\\", \\\"subtext\\\": \\\"b47695ce-1f44-499b-8f5f-6af45d8c6297\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1165, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"These extra requirements need to be communicated formally to and discussed and agreed with the sponsor.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e1d421a3-bca2-477e-a7b9-612f4a37913c\\\", \\\"childbox\\\": \\\"0d5891cf-04cc-473b-9440-4130e6951296\\\", \\\"subtext\\\": \\\"947c7abe-9e25-4abf-a335-c23196878572\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1166, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.1.1 Biological Samples\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74684a90-bde7-4f27-8baf-d76696c45b04\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1167, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"An overall volume of approximately 60 mL of blood per participant will be collected during the entire study period.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e62dcf1e-d9e1-4a6e-be2e-832e12c28903\\\", \\\"childbox\\\": \\\"271feb43-32e8-440e-b1d8-487c33ca519a\\\", \\\"subtext\\\": \\\"5e385120-6a91-4adb-b08b-073a202f9f0a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1168, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Table 9 and the SoA (Table 3) for details of blood volumes collected for different assessments.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"712aa3d5-950f-4f80-bca3-411da9924cd9\\\", \\\"childbox\\\": \\\"2df701ef-56d6-46f1-9206-b88d79701126\\\", \\\"subtext\\\": \\\"a8f3ad18-49a5-4a85-b6e4-61f9c90eda83\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunogenicity Assessments\\\", \\\"8.1\\\", \\\"2\\\", 1169, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.1.1 Table 9 Biological Samples\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d7220da3-100b-4f5d-827d-2e01efe123dc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1170, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Sample Type</td>\\\\n      <td>Quantity</td>\\\\n      <td>Time Point</td>\\\\n      <td>Subset Name <sup>1</sup></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Blood</td>\\\\n      <td>Approximately 20 mL <sup>2</sup></td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 1 (Day 1)</td>\\\\n      <td>Not applicable</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Blood</td>\\\\n      <td>Approximately 20 mL <sup>2</sup></td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 2 (Day 31)</td>\\\\n      <td>Not applicable</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Blood</td>\\\\n      <td>Approximately 20 mL <sup>2</sup></td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 4 (Day 211)</td>\\\\n      <td>Not applicable</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"59\\\", \\\"TableIndex\\\": \\\"26\\\", \\\"TableName\\\": \\\"Table 9 Biological Samples\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"9fce7267-83fe-43bf-9dc6-8961686b4e44\\\", \\\"childbox\\\": \\\"4e17b1c0-e699-4729-8f1c-53d90359ab7e\\\", \\\"subtext\\\": \\\"1bb3b739-71f6-4fdb-b8ab-ee54a94eeb9a\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1171, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1 Refer to Section 6.3.4 and Section 8.1 for information regarding assay subsets.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74217792-6963-4cee-b4ef-8bbf4f8e246b\\\", \\\"childbox\\\": \\\"030f7872-11f4-4caf-9cfd-ec4d9b017273\\\", \\\"subtext\\\": \\\"32be9bf5-2c45-4317-b47f-6ca93b053463\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1172, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2 Insufficient blood volume may lead to test cancellation and jeopardize the statistical power.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6905a0ed-5b69-429c-99e4-ffb3240e2371\\\", \\\"childbox\\\": \\\"35c56efe-c4c8-46a0-9294-a61b553ec7c6\\\", \\\"subtext\\\": \\\"41ee5b49-13fa-47c8-bcff-b98aa686e5ab\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1173, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Hence, every effort must be done to collect blood volume as per protocol requirements.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6905a0ed-5b69-429c-99e4-ffb3240e2371\\\", \\\"childbox\\\": \\\"0ec44ba4-4635-4377-939f-bf48ed8f56b9\\\", \\\"subtext\\\": \\\"41ee5b49-13fa-47c8-bcff-b98aa686e5ab\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1174, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.1.2 Laboratory Assays\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fa52d33c-4a4f-4bc8-bc25-22299ca3c1df\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1175, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"All laboratory testing will be performed at ~REDACTED~ laboratory or in a laboratory designated by ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"167a3160-3da6-44b0-9d59-1b9e0790d7ed\\\", \\\"childbox\\\": \\\"2bc8fc66-01cb-4b24-b4bc-5b1cde486917\\\", \\\"subtext\\\": \\\"e3abe6fd-97ee-4510-8c8b-6d5677400289\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1176, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Serum bactericidal activity which is a functional measure of the ability of antibodies, in conjunction with human complement, to kill meningococci, is widely accepted and generally recognized as the serological surrogate marker for protection.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2eb0f3d7-a355-4b5f-bb82-f1dfc1665958\\\", \\\"childbox\\\": \\\"df838240-0477-43b1-80aa-15f1597679ff\\\", \\\"subtext\\\": \\\"d0a7a1a7-9c41-4771-a9b3-f69b239ab20c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1177, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Immunogenicity of ~REDACTED~ against serogroups A, B, C, W, and Y will be evaluated with the serum bactericidal assay using exogenous source of human complement (hSBA).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cf6c3440-79e5-4770-8ed8-f1c544f31674\\\", \\\"childbox\\\": \\\"f6cbdb51-3c9f-42a8-a8b0-032572454e79\\\", \\\"subtext\\\": \\\"ed4d8c31-fade-4137-9dcd-e4adc83d71e7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1178, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The 4 indicator strains representing serogroups Men A, C, W, and Y will be tested in the hSBA using the agar-overlay technology, while the 4 indicator strains representing serogroup MenB will be tested in the hSBA using the manual (tilt) technology.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cf6c3440-79e5-4770-8ed8-f1c544f31674\\\", \\\"childbox\\\": \\\"59e0ead9-7460-4e7a-b81a-7d1958f542f4\\\", \\\"subtext\\\": \\\"ed4d8c31-fade-4137-9dcd-e4adc83d71e7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1179, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The induction of anti-polysaccharide antibodies directed against serogroup A, C, W, and\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"17fa6fd2-f1a0-4ef5-b83a-20aad29826b8\\\", \\\"childbox\\\": \\\"efe2cf7c-94c8-4aca-bc51-dd898e3066ba\\\", \\\"subtext\\\": \\\"2ab9ade5-9bca-4219-9860-2c3705e4009a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1180, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Y meningococci following MenACWY vaccination may be measured by Enzyme-Linked\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"348963b6-6de3-4144-b20a-91268a25f37f\\\", \\\"childbox\\\": \\\"94bdb000-505e-486e-98eb-736668ea0a08\\\", \\\"subtext\\\": \\\"4671de3b-f993-4485-8135-7694f6c1b23a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1181, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Immunosorbent Assay (ELISA).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"09017a08-9ba9-4a39-8e8b-34148880e74b\\\", \\\"childbox\\\": \\\"c57fec4e-d163-40df-bb59-51b08cfb1d75\\\", \\\"subtext\\\": \\\"3b8327dc-26c4-45a1-a270-9e5b168fbeda\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1182, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The ELISA procedure is used to detect the amount of serum immunoglobulin G (IgG) antibodies in response to specific\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"09017a08-9ba9-4a39-8e8b-34148880e74b\\\", \\\"childbox\\\": \\\"ae6d2720-95d9-4a8b-b8da-9e00dd93aedb\\\", \\\"subtext\\\": \\\"3b8327dc-26c4-45a1-a270-9e5b168fbeda\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1183, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"09017a08-9ba9-4a39-8e8b-34148880e74b\\\", \\\"childbox\\\": \\\"ae6d2720-95d9-4a8b-b8da-9e00dd93aedb\\\", \\\"subtext\\\": \\\"84e4ad3d-d63b-4408-996b-d0de711d42ae\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1184, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"09017a08-9ba9-4a39-8e8b-34148880e74b\\\", \\\"childbox\\\": \\\"40ecdbe6-4791-4fe2-bd67-e6c260ca9441\\\", \\\"subtext\\\": \\\"84e4ad3d-d63b-4408-996b-d0de711d42ae\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1185, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"polysaccharide antigens.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"09017a08-9ba9-4a39-8e8b-34148880e74b\\\", \\\"childbox\\\": \\\"40ecdbe6-4791-4fe2-bd67-e6c260ca9441\\\", \\\"subtext\\\": \\\"6340c1b6-e559-4130-84ae-da92d0472eee\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1186, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"See Table 10 for details.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"09017a08-9ba9-4a39-8e8b-34148880e74b\\\", \\\"childbox\\\": \\\"15a24162-8015-4bf6-9e01-3d4cce861c58\\\", \\\"subtext\\\": \\\"6340c1b6-e559-4130-84ae-da92d0472eee\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biological Samples\\\", \\\"Table 9\\\", \\\"1\\\", 1187, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.1.2 Table 10 Laboratory Assays\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d2e929d5-c400-4eb9-a126-0519135d233b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1188, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>System</td>\\\\n      <td>Component <sup>1</sup></td>\\\\n      <td>Method</td>\\\\n      <td>Laboratory</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Serum</td>\\\\n      <td>N men A (3125) Ab</td>\\\\n      <td>hSBA</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> <sup>2</sup> or laboratory designated by <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> Biologicals</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td></td>\\\\n      <td>N men C (C11) Ab</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td></td>\\\\n      <td>N men W (240070) Ab</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td></td>\\\\n      <td>N men Y (860800) Ab</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>Serum</td>\\\\n      <td>N men B fHbp (M14459) Ab</td>\\\\n      <td>hSBA</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td></td>\\\\n      <td>N men B NadA (96217) Ab</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>7</th>\\\\n      <td></td>\\\\n      <td>N men B PorA (NZ98/254) Ab</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>8</th>\\\\n      <td></td>\\\\n      <td>N men B NHBA (M07-0241084) <sup>1</sup> Ab</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>9</th>\\\\n      <td>Serum</td>\\\\n      <td>N men A Ab IgG</td>\\\\n      <td>ELISA <sup>3</sup></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>10</th>\\\\n      <td></td>\\\\n      <td>N. men C Ab IgG</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>11</th>\\\\n      <td></td>\\\\n      <td>N men W Ab IgG</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>12</th>\\\\n      <td></td>\\\\n      <td>N men Y Ab IgG</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"60\\\", \\\"TableIndex\\\": \\\"27\\\", \\\"TableName\\\": \\\"Table 10 Laboratory Assays\\\", \\\"Header\\\": [0, 1]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"7737c0f6-9863-405b-b43b-f33a0ff5b45b\\\", \\\"childbox\\\": \\\"a20564f5-f3f1-4192-97f4-5f827bb9336e\\\", \\\"subtext\\\": \\\"76a45b35-b04d-4add-b992-2869a7f4cc47\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1189, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"041db845-842d-4610-8c5f-e9e9e71f74d2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1190, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"40e0091c-d7b0-4f42-9587-10dcd8634c2e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1191, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5c317fdf-a8b5-478e-9fa5-1723f45a818f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1192, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e1a8c152-647a-4dac-bcb1-1381c15483a8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1193, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"58330d44-93a5-48c3-be8c-c58430f13cba\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1194, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a0eef217-b306-4ace-93df-70e3d9647c67\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1195, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"277d1216-64ab-4ab2-808b-fa9d83bfaeb7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1196, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9a2265a7-2490-4256-b53e-337d59e3f493\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1197, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c69d94d0-4b15-414d-97e3-71ef08056085\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1198, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"334345ee-7e77-4cc2-94fd-1796e713a64a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1199, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4b067399-6548-4809-a4dd-0937868a0ead\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1200, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d35d8864-e1db-462b-b091-f2917009504b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1201, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d17e8dd0-facd-4adb-a99d-a729d7352409\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1202, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e19b279a-05d3-4151-bf2f-18068936afb1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1203, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6eb6e789-0cf6-4ccc-836b-62d0c376b0c9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1204, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"faf12a64-48c5-46b9-a4eb-e3f04e76103a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1205, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b34c5f68-af51-493c-921f-4efbe9921d6d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1206, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7edc02d4-fc6f-4dff-baae-11d5e60d6bb9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1207, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5219bb8a-742b-4c55-bd66-0d6a857f1438\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1208, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0c96c364-f059-4073-91ce-ae1a09a86d50\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1209, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5f9df82f-5929-498d-9092-f999ed3af07f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1210, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"58db0323-c1e3-4611-8d98-40cf42ca4f44\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1211, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c8088680-7014-47d6-afbd-9496c5287500\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1212, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"be4b79aa-33cc-4d77-a69c-07ce67868292\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1213, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"407dea23-e5e7-4800-965e-538e71e9dd58\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1214, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a1bcd094-4226-451c-856b-5fc997ad9670\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1215, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"39012544-b280-424a-b95e-4c32c9c3dd2b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1216, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8164f7a6-bd8a-4f40-b208-313a0d69aa08\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1217, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7c61a79d-ff7b-496c-b2d5-f2d2cd78d9e2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1218, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Ab = Antibody; ELISA = enzyme-linked immunosorbent assay; fHbp = factor H binding protein; hSBA = serum bactericidal assay using human complement; IgG = Immunoglobin G;\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cd039ec7-00fc-4b9f-91c6-618590b88ebc\\\", \\\"childbox\\\": \\\"3cae58c5-31c0-4d3f-8f3c-9f8031841e54\\\", \\\"subtext\\\": \\\"ba6a1cef-81f8-4826-b242-e813697247d9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1219, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N men =\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"04b7e284-50a2-4849-ad69-71d88a445ef0\\\", \\\"childbox\\\": \\\"6352af0e-66d8-4456-8e93-d33a38778e30\\\", \\\"subtext\\\": \\\"9130b121-7857-4fa1-9455-57cb718e8bc6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1220, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Neisseria meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"04b7e284-50a2-4849-ad69-71d88a445ef0\\\", \\\"childbox\\\": \\\"6352af0e-66d8-4456-8e93-d33a38778e30\\\", \\\"subtext\\\": \\\"712862d4-527a-43fa-a6a3-dc6bb68796e7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1221, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"; NadA = Neisserial adhesin A; NHBA = Neisseria Heparin Binding Antigen; PorA = Porin A\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"04b7e284-50a2-4849-ad69-71d88a445ef0\\\", \\\"childbox\\\": \\\"6352af0e-66d8-4456-8e93-d33a38778e30\\\", \\\"subtext\\\": \\\"69be4585-deff-4d9f-b30c-12e3aa3ea896\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1222, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1 Strain(s) and unit(s) might be participant to change during the study (e.g., in case of requalification, revalidation or standardization).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"556c4059-071a-442c-95df-3f57895f48eb\\\", \\\"childbox\\\": \\\"60aae6b2-7874-4636-944f-a7af9d3bd7f9\\\", \\\"subtext\\\": \\\"915298c5-993a-40d0-880c-72db50b34b6e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1223, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In this case, this will be documented either in a protocol amendment or in the clinical report.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"556c4059-071a-442c-95df-3f57895f48eb\\\", \\\"childbox\\\": \\\"deb44cbb-e99b-4aa4-a46d-86773b6c52e9\\\", \\\"subtext\\\": \\\"4e762695-eeef-4a5c-8ff2-16002cf6c8a6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1224, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2 ~REDACTED~ Biologicals laboratory refers to the ~REDACTED~ Sciences (CLS) in Rixensart or Wavre, Belgium.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"88999251-7d7f-4806-9a2d-703f122ba12f\\\", \\\"childbox\\\": \\\"9f748d1f-4994-4788-89b3-a6f7ec4ab19b\\\", \\\"subtext\\\": \\\"080531e6-3e21-491c-8c79-fc2070444de2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1225, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"CLS may delegate testing to ~REDACTED~ Research laboratories in Siena, Italy, or to Nexelis in Marburg, Germany, or other external laboratories.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"88999251-7d7f-4806-9a2d-703f122ba12f\\\", \\\"childbox\\\": \\\"0539cd6d-6b6e-4ba6-af52-9efa734085b0\\\", \\\"subtext\\\": \\\"080531e6-3e21-491c-8c79-fc2070444de2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1226, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"3 ELISA assay characteristics (e.g., validated assay cut-offs and units) for each of the serogroup will be determined at the time of the generation of validation data.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"33df9e74-e166-46a2-9ff6-6d44fff57840\\\", \\\"childbox\\\": \\\"15ae4165-6eae-48f0-a0c7-51d91408298c\\\", \\\"subtext\\\": \\\"99788717-6829-44df-8623-9a2ce6440392\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1227, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Any change, including the change of the format of the assay, will be documented in a protocol amendment or in the clinical study report.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"33df9e74-e166-46a2-9ff6-6d44fff57840\\\", \\\"childbox\\\": \\\"da48b56e-3020-499e-83ad-019f34b6b896\\\", \\\"subtext\\\": \\\"99788717-6829-44df-8623-9a2ce6440392\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1228, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Appendix 3 for a detailed description of the assays performed in the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a96c3b6e-3b45-4ac0-bd25-804dc51d6824\\\", \\\"childbox\\\": \\\"4c0baae0-676f-4b57-8036-0975480ccee3\\\", \\\"subtext\\\": \\\"1f45c7e2-789b-414d-967b-8a167356d440\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1229, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The addresses of clinical laboratories used for sample analysis will be provided in a separate document.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a96c3b6e-3b45-4ac0-bd25-804dc51d6824\\\", \\\"childbox\\\": \\\"a7b567cb-ff9f-4720-9f9b-81319a720497\\\", \\\"subtext\\\": \\\"fdb37a72-bc35-433b-9138-3a568127c7c0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1230, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~ clinical laboratories and designated laboratories have established a Quality System supported by procedures.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"962753d2-890d-42cc-8dda-91d3f941b67c\\\", \\\"childbox\\\": \\\"551f5844-7722-4b14-8a07-416f5561d38b\\\", \\\"subtext\\\": \\\"b941fb4f-6b33-4599-98fb-e6fb68f694c0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1231, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The activities of ~REDACTED~ clinical and designated laboratories are audited regularly for quality assessment by an internal (sponsor-dependent) but laboratory-independent ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"962753d2-890d-42cc-8dda-91d3f941b67c\\\", \\\"childbox\\\": \\\"571a196b-5441-462e-a445-56d1bbbdc017\\\", \\\"subtext\\\": \\\"f8f43f40-3636-4ade-85c0-66942784039b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1232, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Laboratory/analyte results that could unblind the study will not be reported to study centers or other blinded personnel until the study has been unblinded.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8e8c8f18-e23b-497b-a2da-565fd1ba8cfc\\\", \\\"childbox\\\": \\\"68da2cb3-f609-4408-9041-bf5a13c7fd2f\\\", \\\"subtext\\\": \\\"1e047ed0-5cbf-4841-9660-d6683095c7ae\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1233, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.1.3 Immunological Read-outs\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c5b281cd-4c20-4f5a-b125-5907b51b6e01\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1234, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In case of insufficient blood sample volume to perform assays for all antibodies, the samples will be analyzed according to priority ranking provided in Table 11.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b0355ec6-1d41-4224-9cb2-db7168fd01ff\\\", \\\"childbox\\\": \\\"139abd86-4fba-4c3f-8f0e-0c31bd8b20c7\\\", \\\"subtext\\\": \\\"6863a733-2f1b-44ac-a10f-794fefa98083\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1235, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The subsets for immunological read-outs will be randomly selected from the pool of blood draws and will be described in separate randomization list(s) and handed over to the laboratory.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b0355ec6-1d41-4224-9cb2-db7168fd01ff\\\", \\\"childbox\\\": \\\"6712e0f6-10d1-4491-9de2-1553cbe85f5b\\\", \\\"subtext\\\": \\\"181cd8a7-98ee-46d1-8ff4-d1c54b31522a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1236, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The trigger for the randomization list(s) will be completion of blood draws for a given ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b0355ec6-1d41-4224-9cb2-db7168fd01ff\\\", \\\"childbox\\\": \\\"9d2facb7-b6e8-44f5-b128-7d6f4784ed98\\\", \\\"subtext\\\": \\\"f6728e7a-b073-4c0d-accd-4c4d12d303c4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"Table 10\\\", \\\"1\\\", 1237, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Table 11 Immunological Read-outs\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d64ed08f-0d6d-45e0-8848-6b9d6cbba41e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1238, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n      <th>5.0</th>\\\\n      <th>6.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Blood Sampling Time Point</td>\\\\n      <td>Blood Sampling Time Point</td>\\\\n      <td>No. Planned Participa nts <sup>1</sup> <sup></sup></td>\\\\n      <td>Method <sup>2</sup></td>\\\\n      <td>Component</td>\\\\n      <td>Components Priority Rank <sup>3</sup></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Type of Contact and Time Point</td>\\\\n      <td>Sampling Time Point</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 1 (Day 1)</td>\\\\n      <td>Pre-Vacc 1</td>\\\\n      <td>1206 <sup>4</sup></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men A (3125) Ab</td>\\\\n      <td>1</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men C (C11) Ab</td>\\\\n      <td>1</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men W (240070) Ab</td>\\\\n      <td>1</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men Y (860800) Ab</td>\\\\n      <td>1</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>209 <sup>4</sup></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men B (M14459) Ab</td>\\\\n      <td>2</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>7</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men B (M07-0241084) Ab <sup>5</sup></td>\\\\n      <td>2</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>8</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men B (96217) Ab</td>\\\\n      <td>2</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>9</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men B (NZ98/254) Ab</td>\\\\n      <td>2</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>10</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 2 (Day 31)</td>\\\\n      <td>Post-Vacc 1</td>\\\\n      <td>1206 <sup>4</sup></td>\\\\n      <td>hSBA hSBA</td>\\\\n      <td>N men A (3125) Ab N men C (C11) Ab</td>\\\\n      <td>1 1</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>11</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men W (240070) Ab</td>\\\\n      <td>1</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>12</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men Y (860800) Ab</td>\\\\n      <td>1</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>13</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>209 <sup>4</sup></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men B (M14459) Ab</td>\\\\n      <td>2</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>14</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men B (M07-0241084) Ab <sup>5</sup></td>\\\\n      <td>2</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>15</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men B (96217) Ab</td>\\\\n      <td>2</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>16</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men B (NZ98/254) Ab</td>\\\\n      <td>2</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>17</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> 4 (Day 211)</td>\\\\n      <td>Post-Vacc 2</td>\\\\n      <td>270 <sup>4</sup></td>\\\\n      <td>hSBA hSBA</td>\\\\n      <td>N men A (3125) Ab N men C (C11) Ab</td>\\\\n      <td>1 1</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>18</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men W (240070) Ab</td>\\\\n      <td>1</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>19</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men Y (860800) Ab</td>\\\\n      <td>1</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>20</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>209 <sup>4</sup></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men B (M14459) Ab</td>\\\\n      <td>2</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>21</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men B (M07-0241084) Ab <sup>5</sup></td>\\\\n      <td>2</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>22</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men B (96217) Ab</td>\\\\n      <td>2</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>23</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>hSBA</td>\\\\n      <td>N men B (NZ98/254) Ab</td>\\\\n      <td>2</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"61\\\", \\\"TableIndex\\\": \\\"28\\\", \\\"TableName\\\": \\\"Table 11 Immunological Read-outs\\\", \\\"Header\\\": [0, 1]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"1e70a787-4b1f-4608-a247-aace04b1a7bc\\\", \\\"childbox\\\": \\\"e80dd46c-674c-461c-bd74-d8aa4185e287\\\", \\\"subtext\\\": \\\"69530e81-4a99-4b74-8f1e-ad9fbbeb467f\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1239, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2c44c66a-8ca2-4f51-8eb8-677585accf41\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1240, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c92f998b-6f09-481f-8e72-fab3261e64e7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1241, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"da9e61fa-d28e-4190-9210-a896b85edf2d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1242, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1e3aa2a6-3357-4097-ab39-0a4f997c516a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1243, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2d03f72e-264f-4617-866a-5b3f4925e668\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1244, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"da7f5110-70c2-4214-82c2-2030be2064b4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1245, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cdd07afd-d38b-48d6-b7b3-7fb5fdad8671\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1246, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5e579f26-f996-4ca6-b9cc-3afef4d8b888\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1247, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"128c8ab3-c67d-4dcc-8863-71de4e8dbd17\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1248, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fb761dda-7ec8-46e6-be7e-86793520ff15\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1249, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5b807a6b-09ce-4f41-aa8f-f385767de35f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1250, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ab3b42f6-9f76-43cc-85a4-a0ff28638b45\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1251, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"01811ccc-8b80-4b7e-9a43-e5cce111b8e5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1252, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"548cea01-793e-49eb-9b66-a8c7bbc8f8be\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1253, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0b53aab7-4342-4e3a-80b1-e7d0c2a3050b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1254, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9f9c7a9b-1b61-4cd5-a0c1-116d91c899aa\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1255, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"34baf958-da27-4985-8560-6c7fdbb4e6e8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1256, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0d014c52-e9a2-4db7-a3df-5a789f8d5663\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1257, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e983ba98-4833-4b07-9c8f-a19cf454dccf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1258, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"27315f5f-6000-433a-a04d-0958dffa299b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1259, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6340b613-45a0-4f8c-a105-7e4ee9f70d89\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1260, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b87c67a3-75bc-416e-a7ac-ff0c1fa271c8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1261, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f16a9d44-741d-4c4f-b926-adecbaf9cf77\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1262, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"96cf1e8a-d04c-4b5b-a76a-94413456325f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1263, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"05fb06fe-1e2e-49b5-9726-d80d6552cf6d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1264, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7bcc9f8a-06ff-4e7f-9a8d-2c46f6c614c3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1265, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5dc3bc2c-68aa-4b4c-8f40-f98369f8f1bc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1266, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"45d79105-22c5-431b-bc6b-d35356486b7c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1267, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b1ac95ca-3c59-4326-b84d-a2eadbbe1f8b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1268, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ed12f3f9-134c-4bf4-bb8b-5c31c743b22a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1269, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3118b56b-efb8-42e7-9c63-aede76f05b77\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1270, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"605db4c0-bbe1-4d0b-9611-713a6fefdbbc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1271, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"58021558-e80d-4b2a-a8bd-22807c8e396b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1272, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7748a269-5ac4-4749-8e7b-d9039f0ae32e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1273, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1871bc1c-729f-4894-bce3-6bc367b3f489\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1274, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"295c234b-02d6-4925-98ba-c231c5e0f1b0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1275, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"026a2d8b-a80c-43d5-9e62-ae4d2f812f2f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1276, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1bb2ee03-f4c2-40aa-aed0-01e87c4cb713\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1277, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7638dcf5-7aa1-491d-b59e-9f16c60f7e11\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1278, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0c63e839-579f-448d-926d-e1a2421b7ae3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1279, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cefadd96-533c-423f-945e-3e3a5f30b3f3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1280, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3844f8b9-ca25-4ca1-a378-a350e551c69a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1281, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f037003c-0b7b-469b-a5c0-749fbdf7b2a5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1282, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"41f5023c-1d7e-41cc-bb84-631726917c6d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1283, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6251109b-d32a-4687-82c5-278482690908\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1284, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"13a03e80-17d9-4b8a-bd0f-7089a2009c9e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1285, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c7754745-5add-44f0-9a85-e772a228ed56\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1286, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"63046544-602f-44db-a119-8d3645abb313\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1287, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"894c3079-a4f9-4610-aa9b-57d1a66e9862\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1288, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ceb2d844-123c-4bb1-abdd-b7d20026a663\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1289, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"83df5ca7-ddfa-4214-9b93-89a556ae93d2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1290, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e49ab7a2-8836-4185-b493-495780e5bf1a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1291, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"393d0eeb-659d-47ab-9c64-0c37e62d48c5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1292, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bf5e21a3-732e-45db-9498-b7a54cbb1ca4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1293, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"716e7409-92cf-46bd-b13e-4bfd7c4dbfc1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1294, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5a82a28a-2e9f-4689-89a6-b08c311d2555\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1295, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"52a8d0e5-d5dd-4cc5-a02a-914172756613\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1296, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"db5552b2-d938-4a18-8440-a6fe7c339b87\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1297, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Ab = antibody; hSBA = serum bactericidal assay using human complement; IgG = Immunoglobin G;\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9d553d08-5419-4f53-808d-1bfe6c18bc53\\\", \\\"childbox\\\": \\\"92ae6b13-2fd9-41e6-ad42-07d78a2dd2d6\\\", \\\"subtext\\\": \\\"85ffb171-18bf-4cd1-ac44-61daa7f47935\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1298, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N men =\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"379d2377-2705-4f5f-9ab6-52f5aac9b977\\\", \\\"childbox\\\": \\\"3b6af49d-e1e4-4d82-88f5-a900f9d9ff90\\\", \\\"subtext\\\": \\\"99ea9e1f-2398-4230-9255-24f7192fcbe7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1299, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Neisseria meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"379d2377-2705-4f5f-9ab6-52f5aac9b977\\\", \\\"childbox\\\": \\\"3b6af49d-e1e4-4d82-88f5-a900f9d9ff90\\\", \\\"subtext\\\": \\\"b6bbbe5b-3f6c-499d-a35e-48b41d22f0e8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1300, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"; Pre-Vacc = pre-vaccination; Post-Vacc = post-vaccination\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"379d2377-2705-4f5f-9ab6-52f5aac9b977\\\", \\\"childbox\\\": \\\"3b6af49d-e1e4-4d82-88f5-a900f9d9ff90\\\", \\\"subtext\\\": \\\"a2e5d278-11fc-4329-955d-a1304572529d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1301, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"379d2377-2705-4f5f-9ab6-52f5aac9b977\\\", \\\"childbox\\\": \\\"3b6af49d-e1e4-4d82-88f5-a900f9d9ff90\\\", \\\"subtext\\\": \\\"7c870ece-14cc-415c-83e1-36b594c21ac6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"superscript\\\"}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1302, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Approximate number of participant samples tested.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fa4f72a6-eb7f-4441-90e2-6cf5976ce97a\\\", \\\"childbox\\\": \\\"01c83efd-1c81-438a-9756-14708ee30419\\\", \\\"subtext\\\": \\\"b6c4e8d9-2b71-4bf9-9148-b2a394dd9338\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1303, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For details regarding the method refer to Table 10.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d9549978-7d81-4ca2-9456-9a3e52ced1c3\\\", \\\"childbox\\\": \\\"745eb17b-9eb5-4f94-b7fe-428d43db193f\\\", \\\"subtext\\\": \\\"45853202-fab2-49ac-9014-5e1ba9520dec\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1304, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"3 Priority ranking for the serum bactericidal assay using human complement (hSBA) testing using the 8 indicator strains may be participant to change during the study (e.g., in case of requalification, revalidation or standardization).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8177397d-5c50-4ed2-a583-063894ee6aad\\\", \\\"childbox\\\": \\\"1e72bc2e-e314-43e8-83ef-3be87db16c22\\\", \\\"subtext\\\": \\\"42ba1cdc-6ff4-4644-b896-a7ff5f780795\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1305, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This will be documented in a protocol amendment or the clinical study report.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8177397d-5c50-4ed2-a583-063894ee6aad\\\", \\\"childbox\\\": \\\"d4f6e3af-3241-441c-b1b7-dd8abe6f3e7e\\\", \\\"subtext\\\": \\\"c11b40f4-ab2e-4f9d-9bf0-94035f8d840a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1306, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"4 For the N Men B test strains: samples from 189 participants in the ABCWY group and 20 participants in the control group to maintain the study blinding at all time points (Day 1, Day 31, and Day 211).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ed4bd7c5-2848-4d1f-b9b2-9943731d99ba\\\", \\\"childbox\\\": \\\"68a270aa-479b-430c-b6f3-aa639d3da7a6\\\", \\\"subtext\\\": \\\"d4010e41-75dd-4eae-953c-46c8514329e6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1307, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For the N Men A, C, W, Y serogroups: samples from all study participants will be tested at Day 1 and Day 31, and samples from 250 participants in the ABCWY group and 20 participants in the control group to maintain the study blinding will be tested at Day 211.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ed4bd7c5-2848-4d1f-b9b2-9943731d99ba\\\", \\\"childbox\\\": \\\"37b83c88-689a-4fba-b91a-8bc44f452578\\\", \\\"subtext\\\": \\\"d9de883e-4983-4378-8352-7c36b3f137ff\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1308, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Evaluation of the tertiary objective is participant to the availability of samples and may or not be performed.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ed4bd7c5-2848-4d1f-b9b2-9943731d99ba\\\", \\\"childbox\\\": \\\"c6d0282b-b804-408d-b2c2-13cb83be3ee7\\\", \\\"subtext\\\": \\\"33573e6e-e06e-4363-baaf-8d4dd5543580\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1309, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"5 Strain(s) and unit(s) might be participant to change during the study (e.g., in case of requalification, revalidation or standardization).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9cdc212b-2e71-4102-a31a-f47d4f5fc947\\\", \\\"childbox\\\": \\\"89eec958-a6cf-4f96-bbd6-fdcfe177311f\\\", \\\"subtext\\\": \\\"ae1237ea-ef34-4c14-8e3e-f8af1b43b6c7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1310, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In this case, this will be documented either in a protocol amendment or in the clinical study report.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9cdc212b-2e71-4102-a31a-f47d4f5fc947\\\", \\\"childbox\\\": \\\"12456165-be41-4a18-9880-452955f5799a\\\", \\\"subtext\\\": \\\"e181df29-cfec-462e-b67e-dd63e2d1b3c0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Read-outs\\\", \\\"Table 11\\\", \\\"1\\\", 1311, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.1.4 Clinical Safety Laboratory Assessments\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b3e0d121-f491-410f-94d6-709a8e14a75d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Clinical Safety Laboratory Assessments\\\", \\\"8.1.4\\\", \\\"3\\\", 1312, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A urine pregnancy test will be conducted as needed for women of childbearing potential (refer to Section 8.3.3).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"656f7640-4fba-47b8-b595-7aba133a167c\\\", \\\"childbox\\\": \\\"b6fe8d20-06b9-4d8b-b2b6-8959a29512f8\\\", \\\"subtext\\\": \\\"1d91847c-e8b9-4ac2-bff1-9385910c62eb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Clinical Safety Laboratory Assessments\\\", \\\"8.1.4\\\", \\\"3\\\", 1313, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The test will be conducted locally according to the clinical laboratory manual and the SoA (Table 3).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"656f7640-4fba-47b8-b595-7aba133a167c\\\", \\\"childbox\\\": \\\"6ef84405-dd30-4548-a37f-0dfd75e6c55a\\\", \\\"subtext\\\": \\\"51e25ce0-72d5-46d9-a7be-6ef1f63d3a6e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Clinical Safety Laboratory Assessments\\\", \\\"8.1.4\\\", \\\"3\\\", 1314, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.1.5 Immunological Correlates of Protection\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0bfc46a7-f072-46ca-a35c-4c7a002dabba\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Correlates of Protection\\\", \\\"8.1.5\\\", \\\"3\\\", 1315, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"No generally accepted immunological correlate (see Appendix 1, Glossary of Terms, for a definition of immunological correlate) of protection has been demonstrated so far against\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"97dcfd04-f45e-4fd3-90a5-b3d3a2b07193\\\", \\\"childbox\\\": \\\"cf7ae7eb-58cb-41a0-a2ed-906ad6074efe\\\", \\\"subtext\\\": \\\"6a105228-f7d0-42d6-ad6a-6a25ecedcf12\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Correlates of Protection\\\", \\\"8.1.5\\\", \\\"3\\\", 1316, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"97dcfd04-f45e-4fd3-90a5-b3d3a2b07193\\\", \\\"childbox\\\": \\\"cf7ae7eb-58cb-41a0-a2ed-906ad6074efe\\\", \\\"subtext\\\": \\\"259c2200-10a1-47bf-bbd8-c59ed76214d3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Correlates of Protection\\\", \\\"8.1.5\\\", \\\"3\\\", 1317, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"97dcfd04-f45e-4fd3-90a5-b3d3a2b07193\\\", \\\"childbox\\\": \\\"3be5d3db-c1ce-4ef4-8add-98fae833d9f9\\\", \\\"subtext\\\": \\\"259c2200-10a1-47bf-bbd8-c59ed76214d3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Correlates of Protection\\\", \\\"8.1.5\\\", \\\"3\\\", 1318, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"serogroups A, B, W-135, and Y.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"97dcfd04-f45e-4fd3-90a5-b3d3a2b07193\\\", \\\"childbox\\\": \\\"3be5d3db-c1ce-4ef4-8add-98fae833d9f9\\\", \\\"subtext\\\": \\\"e23ffec2-bf13-4a7a-975d-48011e0c068c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Correlates of Protection\\\", \\\"8.1.5\\\", \\\"3\\\", 1319, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"An hSBA titer \\\\u22654 is a generally accepted correlate of protection against invasive meningococcal disease caused by\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"13c72aab-e147-4642-950a-24608f259a18\\\", \\\"childbox\\\": \\\"2ba598a8-fb02-4113-b2b7-affdd84710a7\\\", \\\"subtext\\\": \\\"d03c40c0-fe85-4809-9f0e-b844f6b751a7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Correlates of Protection\\\", \\\"8.1.5\\\", \\\"3\\\", 1320, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"13c72aab-e147-4642-950a-24608f259a18\\\", \\\"childbox\\\": \\\"2ba598a8-fb02-4113-b2b7-affdd84710a7\\\", \\\"subtext\\\": \\\"55e1a9f5-90cc-4077-8a10-720bebfb8a3e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Correlates of Protection\\\", \\\"8.1.5\\\", \\\"3\\\", 1321, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"13c72aab-e147-4642-950a-24608f259a18\\\", \\\"childbox\\\": \\\"a6975a9a-f6f4-487a-ae50-1dde78bec012\\\", \\\"subtext\\\": \\\"55e1a9f5-90cc-4077-8a10-720bebfb8a3e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Correlates of Protection\\\", \\\"8.1.5\\\", \\\"3\\\", 1322, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"serogroup C.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"13c72aab-e147-4642-950a-24608f259a18\\\", \\\"childbox\\\": \\\"a6975a9a-f6f4-487a-ae50-1dde78bec012\\\", \\\"subtext\\\": \\\"126749ed-cc2e-415f-a45c-e74b26253afe\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Correlates of Protection\\\", \\\"8.1.5\\\", \\\"3\\\", 1323, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The immunological assay results will be communicated to the investigator.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"13c72aab-e147-4642-950a-24608f259a18\\\", \\\"childbox\\\": \\\"f53b2143-7005-4513-8427-b7ba7dbd363f\\\", \\\"subtext\\\": \\\"126749ed-cc2e-415f-a45c-e74b26253afe\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Correlates of Protection\\\", \\\"8.1.5\\\", \\\"3\\\", 1324, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Section 6.9 for details regarding treatment for non-responders.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a3b3e8c1-43b2-49ab-9b98-3ae3ea99ada3\\\", \\\"childbox\\\": \\\"58ea734a-1488-4122-b563-f55340b8d74a\\\", \\\"subtext\\\": \\\"19f77917-8133-4315-b310-9a168a237a2a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Correlates of Protection\\\", \\\"8.1.5\\\", \\\"3\\\", 1325, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.2 Collection of Demographic Data and Other Baseline\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f7a0478d-8196-45af-b025-a995af8bc372\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Collection of Demographic Data and Other Baseline\\\", \\\"8.2\\\", \\\"2\\\", 1326, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Characteristics\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 28, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"592d4fac-f62d-480a-9d76-dd634394b1a5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 28, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Collection of Demographic Data and Other Baseline\\\", \\\"8.2\\\", \\\"2\\\", 1327, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"At ~REDACTED~ 1, demographic data such as date of birth (month and year), gender, race, and ethnic origin will be recorded in the participant\\\\u2019s eCRF.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a50b7bd9-5065-4c39-92d7-dea3ac0c5364\\\", \\\"childbox\\\": \\\"2a8e06ae-0e12-4be7-a455-6e9e00e49d46\\\", \\\"subtext\\\": \\\"7790bc81-5dc0-4c49-9d53-e0facbc21067\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Collection of Demographic Data and Other Baseline\\\", \\\"8.2\\\", \\\"2\\\", 1328, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Height and weight will be measured using calibrated equipment, and the body mass index will be derived.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a50b7bd9-5065-4c39-92d7-dea3ac0c5364\\\", \\\"childbox\\\": \\\"0d967086-7aae-4348-ae5f-5c3867220b5c\\\", \\\"subtext\\\": \\\"b038f29d-7fa8-49f7-970d-a80338e51e0f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Collection of Demographic Data and Other Baseline\\\", \\\"8.2\\\", \\\"2\\\", 1329, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3 Safety Assessments\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"13f126b9-302f-4e61-bb07-885593c219e8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Safety Assessments\\\", \\\"8.3\\\", \\\"2\\\", 1330, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator and investigator\\\\u2019s designee(s) are responsible for detecting, documenting, and reporting events that meet the definition of an AE or SAE.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"438a2d1f-83e5-4908-b88f-ed73b3247be2\\\", \\\"childbox\\\": \\\"c148dd90-88ca-4ec2-93f0-ed023008cb24\\\", \\\"subtext\\\": \\\"368957ce-bc53-49ee-8040-f6bd0802772f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Safety Assessments\\\", \\\"8.3\\\", \\\"2\\\", 1331, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator and investigator\\\\u2019s designee(s) remain responsible for following up AEs that are serious, considered related to the study intervention or the study, or that caused the participant to discontinue the study treatment or study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"438a2d1f-83e5-4908-b88f-ed73b3247be2\\\", \\\"childbox\\\": \\\"89bb6ce9-72b9-4d44-bf1c-951b9a7d06fc\\\", \\\"subtext\\\": \\\"f9838d54-1d36-47c9-a104-bc426eaa9802\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Safety Assessments\\\", \\\"8.3\\\", \\\"2\\\", 1332, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Data will be collected in an observer-blind manner, i.e., participants, investigators, and teams responsible for assessment of any study endpoints will be blinded to the administered ~REDACTED~/product.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a0dbfb95-e40c-448c-9e94-a409e252eb80\\\", \\\"childbox\\\": \\\"e0a0ae74-e87a-44f5-95da-e69ad9584033\\\", \\\"subtext\\\": \\\"f7382fb1-5317-4cd0-aeb5-9779f28d4d99\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Safety Assessments\\\", \\\"8.3\\\", \\\"2\\\", 1333, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Safety follow-up calls are calls made to the participant by a qualified health care professional designated on the Study Site Responsibility Delegation Log.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5d26e974-3798-41e5-b2ed-d56f80c948b8\\\", \\\"childbox\\\": \\\"bf04df6f-5829-41fe-802d-2132e6b21fb7\\\", \\\"subtext\\\": \\\"e6f87740-5f4f-4f42-8bef-4585747e204a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Safety Assessments\\\", \\\"8.3\\\", \\\"2\\\", 1334, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"These calls will follow a script which will facilitate the collection of relevant safety information.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5d26e974-3798-41e5-b2ed-d56f80c948b8\\\", \\\"childbox\\\": \\\"6fd68c7d-22f9-4ef7-8aa4-66954af3caea\\\", \\\"subtext\\\": \\\"e9124824-dd5b-4947-b8aa-664633d71bbd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Safety Assessments\\\", \\\"8.3\\\", \\\"2\\\", 1335, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.1 Medical History\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8d0b576e-2ce7-449f-b1e0-8236d934702f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical History\\\", \\\"8.3.1\\\", \\\"3\\\", 1336, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Participant\\\\u2019s vaccination history will be obtained by interviewing the participant/participant\\\\u2019s parent(s)/LAR(s) and/or review of the participant\\\\u2019s medical records.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f5f6148e-839e-4ef5-beb0-e0e359d8a9e6\\\", \\\"childbox\\\": \\\"c0c06607-fd97-4905-85eb-a0baa341c1fe\\\", \\\"subtext\\\": \\\"67e8615d-a8b3-48f9-a876-b3ff4d7f5b0b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical History\\\", \\\"8.3.1\\\", \\\"3\\\", 1337, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The appropriate written documentation of the identity of the primary MenACWY vaccination and vaccination date should to be provided prior to enrollment.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f5f6148e-839e-4ef5-beb0-e0e359d8a9e6\\\", \\\"childbox\\\": \\\"e204d509-4b25-467b-b9d0-f68a1acef957\\\", \\\"subtext\\\": \\\"67e8615d-a8b3-48f9-a876-b3ff4d7f5b0b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical History\\\", \\\"8.3.1\\\", \\\"3\\\", 1338, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Individuals for whom written documentation is not available may still be enrolled into the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f5f6148e-839e-4ef5-beb0-e0e359d8a9e6\\\", \\\"childbox\\\": \\\"0b24395c-6578-434f-901d-234a9705905e\\\", \\\"subtext\\\": \\\"eed87cc8-af1d-46f7-957e-020788298eff\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical History\\\", \\\"8.3.1\\\", \\\"3\\\", 1339, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Any pre-existing participant conditions, signs and/or symptoms present prior to the first vaccination will be recorded in the eCRF.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f5f6148e-839e-4ef5-beb0-e0e359d8a9e6\\\", \\\"childbox\\\": \\\"7633ccf4-b864-4d43-b351-4d3f5030ce40\\\", \\\"subtext\\\": \\\"eed87cc8-af1d-46f7-957e-020788298eff\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical History\\\", \\\"8.3.1\\\", \\\"3\\\", 1340, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Medical history will be collected at ~REDACTED~ 1, including but not limited to any medical history that may be relevant to participant eligibility for study participation such as prior vaccinations, concomitant medications (refer to Section 5.2.2), and previous and ongoing illnesses or injuries.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fba8733a-cd26-4928-a33f-d0c641105fe9\\\", \\\"childbox\\\": \\\"25d9f64f-f16e-4c49-9ac8-9ca19ac2db7f\\\", \\\"subtext\\\": \\\"103bf65d-d77b-41da-8478-d9194e18e8d9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical History\\\", \\\"8.3.1\\\", \\\"3\\\", 1341, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Relevant medical history can also include any medical history that contributes to the understanding of an AE that occurs during study participation, if it represents an exacerbation of an underlying disease/pre-existing problem.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fba8733a-cd26-4928-a33f-d0c641105fe9\\\", \\\"childbox\\\": \\\"58f1f3f1-5cec-4cba-a32e-c4874e0de2cd\\\", \\\"subtext\\\": \\\"3f83140a-b696-4165-a856-cb513888ec09\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical History\\\", \\\"8.3.1\\\", \\\"3\\\", 1342, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.2 Physical Examination\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ce1f574a-8695-43b5-97ac-608f4054e99b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Physical Examination\\\", \\\"8.3.2\\\", \\\"3\\\", 1343, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"At ~REDACTED~ 1, a general physical examination will be performed by a qualified health care professional.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8cab390c-6a84-4af8-a047-a61c65f7acf8\\\", \\\"childbox\\\": \\\"dd0933b8-ca26-4220-87bd-9ef9dc5ad3ba\\\", \\\"subtext\\\": \\\"137441ca-7940-43a7-b020-29feb0fcf776\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Physical Examination\\\", \\\"8.3.2\\\", \\\"3\\\", 1344, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u201cQualified health care professional\\\\u201d refers to any licensed or certified\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8cab390c-6a84-4af8-a047-a61c65f7acf8\\\", \\\"childbox\\\": \\\"a3bb2a33-4f44-438c-ba1a-e31892fc0028\\\", \\\"subtext\\\": \\\"137441ca-7940-43a7-b020-29feb0fcf776\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Physical Examination\\\", \\\"8.3.2\\\", \\\"3\\\", 1345, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8cab390c-6a84-4af8-a047-a61c65f7acf8\\\", \\\"childbox\\\": \\\"a3bb2a33-4f44-438c-ba1a-e31892fc0028\\\", \\\"subtext\\\": \\\"1be0a029-8235-48f6-869e-7afccac94374\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Physical Examination\\\", \\\"8.3.2\\\", \\\"3\\\", 1346, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"health care practitioner who is permitted by institutional policy to perform protocol-required procedures and who is identified within the Study Staff Signature Log.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8cab390c-6a84-4af8-a047-a61c65f7acf8\\\", \\\"childbox\\\": \\\"a3bb2a33-4f44-438c-ba1a-e31892fc0028\\\", \\\"subtext\\\": \\\"94a18592-305e-4214-bfd1-8d32fdaa1d64\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Physical Examination\\\", \\\"8.3.2\\\", \\\"3\\\", 1347, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The physical examination may include examination of organ systems that are relevant to the investigation based on medical history and review of systems (e.g., measurement of heart rate, blood pressure, height and weight, body temperature).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"92e78e79-589e-437b-a5b0-ae96e94f8090\\\", \\\"childbox\\\": \\\"810bc27e-fabc-400a-98e4-9a81e3c6c46d\\\", \\\"subtext\\\": \\\"a85c841c-c335-4786-b109-f26557df5544\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Physical Examination\\\", \\\"8.3.2\\\", \\\"3\\\", 1348, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Review of systems is a structured interview that queries the participant and/or parent(s)/LAR(s) as to any complaints the participant has experienced across each organ system.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"77bd1654-642e-46a4-bf26-3f44d3bcb6e0\\\", \\\"childbox\\\": \\\"a2c707de-b7f8-4fb3-a33e-e0597a633fea\\\", \\\"subtext\\\": \\\"770e6e47-4220-48e0-96e2-5463c0ad2395\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Physical Examination\\\", \\\"8.3.2\\\", \\\"3\\\", 1349, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"At Visits 2 through 4, a brief symptom-directed physical examination is to be performed if necessary according to symptoms the participant/participant\\\\u2019s parent(s)/LAR(s) has either recorded in the eDiary or reported.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b51d94f0-442a-49ce-9fef-49a26f06097d\\\", \\\"childbox\\\": \\\"e8a38982-a8ec-4549-944e-e0c5caf3254f\\\", \\\"subtext\\\": \\\"208dd621-efcc-464d-84f2-08f509e361eb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Physical Examination\\\", \\\"8.3.2\\\", \\\"3\\\", 1350, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This is a physical examination that will include an examination of organ systems that are relevant to the investigator based only on review of the participant\\\\u2019s reported AEs and concomitant medication use.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b51d94f0-442a-49ce-9fef-49a26f06097d\\\", \\\"childbox\\\": \\\"7dd7d39e-e251-4d78-a3fd-b796bc722c19\\\", \\\"subtext\\\": \\\"3224b244-0183-4f67-a8d7-869ccbdc9acb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Physical Examination\\\", \\\"8.3.2\\\", \\\"3\\\", 1351, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This assessment may include measurement of heart rate and temperature.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b51d94f0-442a-49ce-9fef-49a26f06097d\\\", \\\"childbox\\\": \\\"094c87f4-1dc9-496f-9758-dd0a6e365843\\\", \\\"subtext\\\": \\\"3224b244-0183-4f67-a8d7-869ccbdc9acb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Physical Examination\\\", \\\"8.3.2\\\", \\\"3\\\", 1352, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"It should be performed prior to the administration of study ~REDACTED~/product and should be documented in source documents.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b51d94f0-442a-49ce-9fef-49a26f06097d\\\", \\\"childbox\\\": \\\"10739af7-45f5-4a75-9f3c-44454d524b3d\\\", \\\"subtext\\\": \\\"2d9c81f0-c220-4cec-978e-43e9ce50c235\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Physical Examination\\\", \\\"8.3.2\\\", \\\"3\\\", 1353, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Should the physical assessment reveal any abnormal values or events, these must be documented in the eCRF AE Form.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b7f1ff91-519e-4cb4-b3d1-08f21ab0a2d2\\\", \\\"childbox\\\": \\\"7ff889cb-bb5e-4b51-b99f-3c9655818dac\\\", \\\"subtext\\\": \\\"77b71abc-5e69-4b06-a259-956dd6c60beb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Physical Examination\\\", \\\"8.3.2\\\", \\\"3\\\", 1354, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If the investigator determines that the participant\\\\u2019s health on the day of vaccination temporarily precludes vaccination, the ~REDACTED~ will be rescheduled within the allowed interval between study ~REDACTED~s (Table 4) (refer to Section 6.7).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9433e7b5-f772-4dcd-a5cc-1fff71f60859\\\", \\\"childbox\\\": \\\"793700e5-8676-4d33-99bb-6994aba50de6\\\", \\\"subtext\\\": \\\"e44abf73-ccb9-4413-9344-d126809bc886\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Physical Examination\\\", \\\"8.3.2\\\", \\\"3\\\", 1355, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Treatment of any abnormality observed during this examination should be performed according to local medical practice outside this study or by referral to an appropriate health care provider.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"46c1da40-479c-4b96-8c3d-8c92bfbf8676\\\", \\\"childbox\\\": \\\"5db7f701-505b-42bf-abc6-0f4d4105f133\\\", \\\"subtext\\\": \\\"86f808c0-ab69-4065-bc21-a3bc7bb5d09f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Physical Examination\\\", \\\"8.3.2\\\", \\\"3\\\", 1356, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Concomitant medications should be documented in the eCRF.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"46c1da40-479c-4b96-8c3d-8c92bfbf8676\\\", \\\"childbox\\\": \\\"1b58b7bb-8f25-4769-9877-9698f750cd36\\\", \\\"subtext\\\": \\\"86f808c0-ab69-4065-bc21-a3bc7bb5d09f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Physical Examination\\\", \\\"8.3.2\\\", \\\"3\\\", 1357, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.3 Pregnancy Test\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9135ca39-3c83-4079-b6fa-d536efcf7bbb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Pregnancy Test\\\", \\\"8.3.3\\\", \\\"3\\\", 1358, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Female participants of childbearing potential must perform a urine pregnancy test prior to any study ~REDACTED~ administration.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"41d489c1-5346-4412-b078-9ff2e0343626\\\", \\\"childbox\\\": \\\"01c0613d-e908-425b-a651-e0b641dc8962\\\", \\\"subtext\\\": \\\"cc78ab48-1d28-414e-a89b-61ed71dcdd13\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Pregnancy Test\\\", \\\"8.3.3\\\", \\\"3\\\", 1359, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Pregnancy testing must be performed even if the participant is menstruating at the time of the study ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"41d489c1-5346-4412-b078-9ff2e0343626\\\", \\\"childbox\\\": \\\"ca5b3d4b-bd07-4dca-ade6-2b264aa2cc7a\\\", \\\"subtext\\\": \\\"cc78ab48-1d28-414e-a89b-61ed71dcdd13\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Pregnancy Test\\\", \\\"8.3.3\\\", \\\"3\\\", 1360, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The study ~REDACTED~/product may only be administered if the pregnancy test is negative.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"41d489c1-5346-4412-b078-9ff2e0343626\\\", \\\"childbox\\\": \\\"0cc5a9f1-19b4-4006-a8eb-50e96d5b772c\\\", \\\"subtext\\\": \\\"1b60b700-ba07-488f-84ad-e35e436cff5c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Pregnancy Test\\\", \\\"8.3.3\\\", \\\"3\\\", 1361, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the Appendix 5 for the contraceptive guidance and information on study continuation for a participant who becomes pregnant during the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6bd8bd40-38a6-45e6-9c83-9f68436a6cca\\\", \\\"childbox\\\": \\\"c23424dd-ef46-47f5-8f08-efeeea83915d\\\", \\\"subtext\\\": \\\"9f521956-b60e-4b6f-b4c4-279a61c4e013\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Pregnancy Test\\\", \\\"8.3.3\\\", \\\"3\\\", 1362, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.4 Warnings and Precautions to Vaccination\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"75897ffe-55ee-46ec-b2ef-7d0bf207f077\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Warnings and Precautions to Vaccination\\\", \\\"8.3.4\\\", \\\"3\\\", 1363, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Warnings and precautions to vaccination must be checked at the beginning of each vaccination ~REDACTED~ prior to any study ~REDACTED~/product administration.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fb3349e5-52ec-41c2-bf5c-e8362dc3c8b1\\\", \\\"childbox\\\": \\\"693bad62-5183-4c1b-b215-1e2b24280104\\\", \\\"subtext\\\": \\\"5944a0c5-7900-456a-b874-a6aea8dcb788\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Warnings and Precautions to Vaccination\\\", \\\"8.3.4\\\", \\\"3\\\", 1364, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Please refer to the IB for MenABCWY and to the approved product label/package insert for the commercial\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d2206d96-96d7-49a0-bf62-20142de15e71\\\", \\\"childbox\\\": \\\"1c8213f7-0ff6-4c47-bc27-c9d4504b568c\\\", \\\"subtext\\\": \\\"df58f848-c7f6-4369-a498-faee59fd428e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Warnings and Precautions to Vaccination\\\", \\\"8.3.4\\\", \\\"3\\\", 1365, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Bexsero\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d2206d96-96d7-49a0-bf62-20142de15e71\\\", \\\"childbox\\\": \\\"1c8213f7-0ff6-4c47-bc27-c9d4504b568c\\\", \\\"subtext\\\": \\\"62949a0f-299c-4436-b196-4e2d87d5f565\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Warnings and Precautions to Vaccination\\\", \\\"8.3.4\\\", \\\"3\\\", 1366, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"and\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d2206d96-96d7-49a0-bf62-20142de15e71\\\", \\\"childbox\\\": \\\"1c8213f7-0ff6-4c47-bc27-c9d4504b568c\\\", \\\"subtext\\\": \\\"64c08ea3-65db-4933-9f97-5f8c596c1357\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Warnings and Precautions to Vaccination\\\", \\\"8.3.4\\\", \\\"3\\\", 1367, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d2206d96-96d7-49a0-bf62-20142de15e71\\\", \\\"childbox\\\": \\\"1c8213f7-0ff6-4c47-bc27-c9d4504b568c\\\", \\\"subtext\\\": \\\"84743045-9ea8-4e1e-9dfc-b43f579e3ec8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Warnings and Precautions to Vaccination\\\", \\\"8.3.4\\\", \\\"3\\\", 1368, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"vaccines.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d2206d96-96d7-49a0-bf62-20142de15e71\\\", \\\"childbox\\\": \\\"1c8213f7-0ff6-4c47-bc27-c9d4504b568c\\\", \\\"subtext\\\": \\\"29517095-85af-4ca5-9f89-f7cd7dfdb586\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Warnings and Precautions to Vaccination\\\", \\\"8.3.4\\\", \\\"3\\\", 1369, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.5 Pre-vaccination Body Temperature\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1c3cf394-ed09-4bd9-842e-ddc28c9b6e15\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Pre-vaccination Body Temperature\\\", \\\"8.3.5\\\", \\\"3\\\", 1370, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The body temperature (preferably oral*) of each participant needs to be measured prior to any study vaccines administration.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1e77ec9e-b6c0-43cd-badf-d8ec26735a81\\\", \\\"childbox\\\": \\\"827dbdf8-5c82-4c65-bcda-467d88f7b083\\\", \\\"subtext\\\": \\\"9896d80d-20a4-4b5e-aba7-20ef77c78d91\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Pre-vaccination Body Temperature\\\", \\\"8.3.5\\\", \\\"3\\\", 1371, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If the participant has fever, defined as body temperature\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1e77ec9e-b6c0-43cd-badf-d8ec26735a81\\\", \\\"childbox\\\": \\\"cbcf7d74-f6a4-4153-9306-74a746c6f4b4\\\", \\\"subtext\\\": \\\"fcd1c350-4f95-491b-a317-28b2881560fd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Pre-vaccination Body Temperature\\\", \\\"8.3.5\\\", \\\"3\\\", 1372, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1e77ec9e-b6c0-43cd-badf-d8ec26735a81\\\", \\\"childbox\\\": \\\"cbcf7d74-f6a4-4153-9306-74a746c6f4b4\\\", \\\"subtext\\\": \\\"c2ed90bd-e488-4594-8807-c7556d8addfc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Segoe UI Symbol\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Pre-vaccination Body Temperature\\\", \\\"8.3.5\\\", \\\"3\\\", 1373, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"38.0\\\\u00b0C/100.4\\\\u00b0F regardless the location of measurement, on the day of vaccination, the vaccination ~REDACTED~ will be rescheduled within the allowed interval for this ~REDACTED~ (refer to Section 6.7).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1e77ec9e-b6c0-43cd-badf-d8ec26735a81\\\", \\\"childbox\\\": \\\"cbcf7d74-f6a4-4153-9306-74a746c6f4b4\\\", \\\"subtext\\\": \\\"6d325aac-e025-4364-b38e-d99395d5ec64\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Pre-vaccination Body Temperature\\\", \\\"8.3.5\\\", \\\"3\\\", 1374, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"*Note: If the body temperature is measured by any other route (other than oral), this needs to be recorded in the participant\\\\u2019s eCRF.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"81eb6fd3-0788-43a3-a8a1-7a3541a56182\\\", \\\"childbox\\\": \\\"3ba6c477-a17f-4294-8723-6395b5dc73d1\\\", \\\"subtext\\\": \\\"30dd3a3e-514f-4af5-b1fd-7d28f8c10738\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Pre-vaccination Body Temperature\\\", \\\"8.3.5\\\", \\\"3\\\", 1375, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.6 Adverse Events\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2bbcde4a-1a36-43a2-9b61-51c1c8a86c33\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Adverse Events\\\", \\\"8.3.6\\\", \\\"3\\\", 1376, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.6.1 Time Period and Frequency for Collecting AE and SAE Information\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3553092b-af06-46b6-a3c5-c67b4b0a38de\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1377, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Solicited administration site and systemic events occurring during the 7 days (including the day of vaccination) following vaccination at Day 1 and Day 181, will be collected using a pre-defined participant eDiary (refer to the SoA [Table 3]).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"045160b5-8278-4f44-a27f-130c15bf9fd7\\\", \\\"childbox\\\": \\\"dbe65745-f505-43cb-a37a-76743533c319\\\", \\\"subtext\\\": \\\"47d8b375-383b-48a2-8b5f-9703c20f0f15\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1378, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"See Appendix 1, Glossary of Terms, for definitions of various types of AEs and to Appendix 4 for further details on solicited AEs.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"045160b5-8278-4f44-a27f-130c15bf9fd7\\\", \\\"childbox\\\": \\\"52fbb322-1ef8-4906-8060-089fac5d1422\\\", \\\"subtext\\\": \\\"0810568d-cceb-4582-b0dd-fb8a7c0de581\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1379, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Solicited administration site and systemic events that are ongoing after the 7-day reporting period will continue to be recorded in the eDiary until resolution or up to 30 days post-vaccination (i.e., recording period for unsolicited AEs) whichever occurs first and do not need to be entered as an AE in the AE eCRF or the participant\\\\u2019s source document.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"045160b5-8278-4f44-a27f-130c15bf9fd7\\\", \\\"childbox\\\": \\\"2b439fd0-1afb-489e-97a1-3fa03be51c08\\\", \\\"subtext\\\": \\\"e88f16f7-cde6-440d-a61d-938402bd1ecb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1380, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Any solicited AE that has not resolved within 30 days post-vaccination and is reported during clinic visits or safety follow-up calls will be entered into the subject\\\\u2019s eCRF as an unsolicited AE.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"59afe794-12d3-405a-8e18-15574cb384f9\\\", \\\"childbox\\\": \\\"70e28a6d-a5a7-47f9-91a0-b4f44d50f053\\\", \\\"subtext\\\": \\\"ada86ee6-b4c2-461b-a7db-8074b9a19460\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1381, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"It will also be included in the subject\\\\u2019s source documents at the site by the investigator/site staff as a verbally reported event.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"59afe794-12d3-405a-8e18-15574cb384f9\\\", \\\"childbox\\\": \\\"7e8fe69e-c2ee-4095-b0ee-13616f290e30\\\", \\\"subtext\\\": \\\"ada86ee6-b4c2-461b-a7db-8074b9a19460\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1382, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"It will not be included in the Subject eDiary.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"59afe794-12d3-405a-8e18-15574cb384f9\\\", \\\"childbox\\\": \\\"d2eda0c9-bd2f-4ee2-a179-487ce1ec3c89\\\", \\\"subtext\\\": \\\"431a5c19-2b91-4d78-a660-a684e0428973\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1383, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"These AEs will be analyzed as unsolicited AEs (i.e., in the Unsolicited Safety Set).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"59afe794-12d3-405a-8e18-15574cb384f9\\\", \\\"childbox\\\": \\\"54773f01-f28c-45e7-b10c-4cf1541c63a9\\\", \\\"subtext\\\": \\\"431a5c19-2b91-4d78-a660-a684e0428973\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1384, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Unsolicited AEs are AEs that are not solicited using a participant eDiary occurring during the 30 days (including the day of vaccination) following vaccination at Day 1 and Day 181 (refer to the SoA [Table 3]), and must be recorded in the appropriate section of the eCRF, irrespective of intensity or whether or not they are considered vaccinationrelated.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"df4e18c6-d77e-4a33-81c7-8597b4ef6ff8\\\", \\\"childbox\\\": \\\"2d348363-aa62-43e5-b063-74bbc84569db\\\", \\\"subtext\\\": \\\"c746fdb7-b1c9-4517-beb5-259bc68f9dbb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1385, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The time period for collecting and recording AEs leading to ~REDACTED~/study withdrawal, medically attended AEs, SAEs, pregnancies, and AESIs will begin at Day 1 (i.e., the first receipt of study ~REDACTED~s) and will end 6 months following administration of the last dose of investigational ~REDACTED~ for each participant (i.e., study end).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4ea37016-a666-44c0-94bb-fbdcf8ad30a6\\\", \\\"childbox\\\": \\\"43860233-94e3-491b-96f1-9a01e945d0b2\\\", \\\"subtext\\\": \\\"a2eea27e-b1ad-4a2e-943e-31ab76acb664\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1386, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Section 8.3.6.4 for instructions on reporting of SAEs, pregnancies, and AESIs.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4ea37016-a666-44c0-94bb-fbdcf8ad30a6\\\", \\\"childbox\\\": \\\"e77f1fc5-dec0-42c7-8a7e-d38ceca372ae\\\", \\\"subtext\\\": \\\"1a2a8e3e-2b4d-4075-8404-9c6add38fd1b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1387, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In addition to the above-mentioned reporting requirements and in order to fulfill international reporting obligations, SAEs that are related to study participation (i.e., protocol-mandated procedures, invasive tests, a change from existing therapy) or are related to a concurrent ~REDACTED~ medication/~REDACTED~ will be collected and recorded from consent until the participant is discharged from the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"30a18585-037d-4f6a-88e6-def805e2ec0e\\\", \\\"childbox\\\": \\\"5aaf41d8-6737-47de-a2d3-b4cb2c6af1e4\\\", \\\"subtext\\\": \\\"26dbdea3-f4c7-40ba-8657-796c51a7ba85\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1388, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Details regarding follow-up of AEs, SAEs, and AESIs are provided in Appendix 4.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"30a18585-037d-4f6a-88e6-def805e2ec0e\\\", \\\"childbox\\\": \\\"de0ea4e5-06d4-41b4-a89d-cb44cc9defd2\\\", \\\"subtext\\\": \\\"101e0e73-5720-4cf3-a0bc-b872157d235e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1389, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"An overview of the protocol-required reporting periods for solicited administration site and systemic events, unsolicited AEs, medically attended AEs, AEs leading to ~REDACTED~/study withdrawal, SAEs, AESIs, SAEs related to study participation or concurrent ~REDACTED~ medication/~REDACTED~ and pregnancy is provided in Table 12.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fd350e5d-fb86-41d8-9f33-4c06ee0ea4c9\\\", \\\"childbox\\\": \\\"3429bcae-f62e-45ae-8882-ada49a0333af\\\", \\\"subtext\\\": \\\"b61c98b5-8c22-486b-95cc-4717d65a3e99\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1390, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aa2f5b88-48da-4941-9662-55207b58035f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1391, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"CONFIDENTIAL\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7f6b2434-1fb7-4b99-ae83-230b74799816\\\", \\\"childbox\\\": \\\"4868887a-9e85-4857-a702-ffe0a6c41230\\\", \\\"subtext\\\": \\\"63f87734-5e48-46c5-bf78-422e38fb9137\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1392, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7f6b2434-1fb7-4b99-ae83-230b74799816\\\", \\\"childbox\\\": \\\"48be1984-0432-4ecd-a299-6dd1459f0ae6\\\", \\\"subtext\\\": \\\"32d87ef1-e10c-4950-930d-a794b090a296\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1393, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Protocol 213171 (MENABCWY-019) \\\\u2013 Amendment 2\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7f6b2434-1fb7-4b99-ae83-230b74799816\\\", \\\"childbox\\\": \\\"8a1b96e2-7ae0-4546-bc0c-9031e32b38d9\\\", \\\"subtext\\\": \\\"32d87ef1-e10c-4950-930d-a794b090a296\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Time Period and Frequency for Collecting AE and SAE Information\\\", \\\"8.3.6.1\\\", \\\"4\\\", 1394, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Table 12 Timeframes for Collecting and Reporting of Safety Information\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d941020c-a612-43fc-af57-f6608a9abc25\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1395, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n      <th>5.0</th>\\\\n      <th>6.0</th>\\\\n      <th>7.0</th>\\\\n      <th>8.0</th>\\\\n      <th>9.0</th>\\\\n      <th>10.0</th>\\\\n      <th>11.0</th>\\\\n      <th>12.0</th>\\\\n      <th>13.0</th>\\\\n      <th>14.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Time Points</td>\\\\n      <td>Pre- Vacc <sup>1</sup></td>\\\\n      <td>Vacc 1</td>\\\\n      <td>Post- Vacc 1</td>\\\\n      <td>PC</td>\\\\n      <td>Post- Vacc 1</td>\\\\n      <td>PC</td>\\\\n      <td></td>\\\\n      <td>Vacc 2</td>\\\\n      <td>Post- Vacc 2</td>\\\\n      <td>PC</td>\\\\n      <td>Post- Vacc 2</td>\\\\n      <td>PC</td>\\\\n      <td>PC</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n      <td>-</td>\\\\n      <td>V1</td>\\\\n      <td></td>\\\\n      <td>T1</td>\\\\n      <td>V2</td>\\\\n      <td>T2</td>\\\\n      <td></td>\\\\n      <td>V3</td>\\\\n      <td></td>\\\\n      <td>T3</td>\\\\n      <td>V4</td>\\\\n      <td>T4</td>\\\\n      <td>T5 ESFU</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Day</td>\\\\n      <td>-</td>\\\\n      <td>D1</td>\\\\n      <td>D7 <sup>2</sup></td>\\\\n      <td>D15</td>\\\\n      <td>D31 <sup>3</sup></td>\\\\n      <td>D91</td>\\\\n      <td></td>\\\\n      <td>D181</td>\\\\n      <td>D187 <sup>2</sup></td>\\\\n      <td>D195</td>\\\\n      <td>D211 <sup>3</sup></td>\\\\n      <td>D271</td>\\\\n      <td>D361</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Month</td>\\\\n      <td>-</td>\\\\n      <td>M0</td>\\\\n      <td>M0</td>\\\\n      <td></td>\\\\n      <td>M1</td>\\\\n      <td>M3</td>\\\\n      <td>-</td>\\\\n      <td>M6</td>\\\\n      <td>M6</td>\\\\n      <td></td>\\\\n      <td>M7</td>\\\\n      <td>M9</td>\\\\n      <td>M12</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>Solicited administration site and systemic events <sup>4,5</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>All unsolicited AEs 4,6</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td>AEs leading to intervention/study withdrawal <sup>4,6</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>7</th>\\\\n      <td>Medically attended AEs <sup>4,6</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>8</th>\\\\n      <td>SAEs 4,6</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>9</th>\\\\n      <td>AESIs <sup>4</sup></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>10</th>\\\\n      <td>SAEs related to study participation or concurrent <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> medication/vaccin e 4,6</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>11</th>\\\\n      <td>Pregnancy</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"66\\\", \\\"TableIndex\\\": \\\"29\\\", \\\"TableName\\\": \\\"Table 12 Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Header\\\": [0, 1, 2, 3]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"1e9743e9-34ca-4441-aa10-40e9c058fc15\\\", \\\"childbox\\\": \\\"573ba004-7652-4fe3-a723-165aad968933\\\", \\\"subtext\\\": \\\"356fc5e2-1f96-4964-9b93-119231b925d3\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1396, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6a2ea628-fc78-4c05-bf4b-8c36e5e868a0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1397, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2e136471-44c8-47f5-88a9-67c1cde8dc31\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1398, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"08621a1d-8e2f-4059-9b48-00cbec15cc18\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1399, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ea130594-2a84-438c-b791-57d5374e1a1d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1400, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"97e43381-7bb2-4b1a-9615-e303c19b4d86\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1401, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a98641f3-b65a-4a8a-9431-88f475ea6b5c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1402, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b0c295f9-99c1-4db3-8cca-f4b670e142bf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1403, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d349ce9d-9341-41d2-a1d4-c595f495d6d3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1404, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"38d3c80a-a883-4c0f-b0d7-4ad4742d508c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1405, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"02087de9-ffe5-4921-bafc-09f717e765d3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1406, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5264d345-7d31-4b55-95da-edf2dbf55e4e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1407, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e4b566f4-06ff-4f7e-88ff-20fe65b190ee\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1408, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3b565d6d-4362-4822-83d5-a358fd722fe9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1409, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f1ea2b86-1469-409b-baa3-d4572a630b58\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1410, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b460555e-8e89-4f44-8fe3-fd6ff4ece927\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1411, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ac748cea-07f4-49d7-9a85-04cd123adae1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1412, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c7e75b61-22d9-454f-b99b-dd5e597f5feb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1413, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d3feba7f-82c2-4a51-899c-4cbaafc63d90\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1414, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9e351c63-d0de-42bf-9400-68c706a16838\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1415, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f9456e77-3d59-4666-bfdd-0de24b83074d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1416, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f0b9408f-a5cf-4ff1-9c3e-26826b8b03ba\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1417, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"44334937-c919-4b67-82a7-64109a1ceaa1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1418, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a565d143-95b8-433a-aaa0-2b361fce5267\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1419, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b307d79e-3350-40fe-892b-a042054e15dd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1420, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bd503af5-d2ad-4049-8a9e-03d48efed728\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1421, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"64d0337b-4312-44f7-b672-55257d3f33cd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1422, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d168180c-c66a-47f7-aa55-80ea20850f37\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1423, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5083014d-ca8e-4219-ac39-68e6e8bce8c7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1424, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f2531135-6381-461e-954c-eef8a7501471\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1425, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6d97c7de-d85a-4721-ae83-b50a684dced7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1426, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"22b11a16-c17b-4c1d-bf7f-e32485a5b088\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1427, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"806243fe-0f7a-4590-91a7-077b0b110782\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1428, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"155b2ea5-1e84-4081-a6dc-2757050cd8c0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1429, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e9d06185-8a07-45b4-a70d-0f1d9213deb4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1430, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dc4d0afa-53ad-475b-bf73-fa3b06512b86\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1431, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3cef654d-63ac-49b7-b31e-c9d5fa8c5eb7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1432, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6efb15fb-2fbe-415a-8916-222b7ca94d78\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1433, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d57211f8-6e9c-4133-86ab-3e33f41b6dd6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1434, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2fc36db9-e25b-4ad5-9842-13085b4c9173\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1435, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bc702e99-c2a5-4fc5-b370-4686ad7bbb9c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1436, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68fca15d-f819-4344-aa7f-47944d506390\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1437, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"922619b3-c0a4-40c4-be3d-dc7e4342336c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1438, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"45281965-f45f-4f04-ab71-80c804461221\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1439, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a16ca2dc-d98c-4d2c-a555-8745dfaef045\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1440, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0cdd5423-9b77-47c0-84f3-9d945efc4ac8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1441, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"12678ecf-fff6-4ce2-b6a8-e5f30fbb0806\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1442, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9f226a7c-519a-4a01-bc36-e5305cecf9e4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1443, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e24d76a3-45de-45f0-9b7f-07fff4684deb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1444, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"386337f9-59d4-4044-8de1-618bd8938a38\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1445, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bbe38b99-265e-4f87-aed3-8fcce6a69405\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1446, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3b2bb1c1-638f-490a-8d61-1f0192b83249\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1447, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"254dd897-0af9-468a-9d67-e4d200c7f8ff\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1448, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4060fbd7-a8b0-44a1-a135-b173b0fb0786\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1449, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a5a092b3-ca40-41da-b59d-ad48b4d9553d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1450, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"feff06bb-71d2-4518-a7b4-ceac619d94ba\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1451, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dacb5e3e-bb73-4cc5-b18c-6fead196466b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1452, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4211ac51-a5da-4e0a-8dfb-4bf2675648b1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1453, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"23868186-9dd2-477c-bbaa-11c52ce5d555\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1454, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"519c0c34-8655-44eb-a81c-893d4ed8960e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1455, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ad5adf81-9864-4a7f-aaef-7bb8504a6066\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1456, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0263d9be-80f7-4657-b414-8def5713c6dc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1457, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3e0abe78-a7f2-418a-bce8-6334ee80f530\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1458, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"51a68229-3a89-45f0-9952-814ceb26460b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1459, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"18e7db3d-b499-4875-849a-3d3b4779d66a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1460, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fafbf1d1-d5e3-47a3-b1c6-0da3aa039e15\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1461, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ba823a9a-73df-44aa-bac7-a28cc0769ced\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1462, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0c730281-b18b-468a-ae70-868bf0de8850\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1463, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2afb6656-e6cc-42f0-8fed-8ca339b22755\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1464, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"722c2b3d-a64c-4fc3-9d5d-5c5371b86adb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1465, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8e7ee984-174d-4d5f-93f2-5ba0ea843540\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1466, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c0a281a2-5a44-4dea-861e-dcfa74696a62\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1467, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dbc1b141-e80c-4043-9331-161c21647c98\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1468, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d1cc0044-f9de-4027-8891-4c72e308e6f3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1469, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1ab71b76-8cbf-465c-b9f3-4d96676a5d26\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1470, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0f79b4a6-5bd0-4180-929e-40623b11c837\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1471, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f7a298bd-90e7-423d-8ed6-3399bae4f512\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1472, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c0e80b69-9df6-4b61-80b6-5b220cbd516a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1473, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ded2512e-202b-4f22-9364-7a46176007cc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1474, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9400a4d7-99ac-4b7b-a556-d6b498fd71ec\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1475, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a6326d3c-40ad-4105-8fab-19439753c19e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1476, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eab1b46b-81de-4609-a9df-857eb5db40db\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1477, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4c9bdcff-a766-4ccd-b9eb-46f4b9c3aa11\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1478, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0bbe4242-b999-40de-a456-5dcd445c7511\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1479, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"47200c69-a0f5-464d-8868-a7e94d9a2503\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1480, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d93423d4-8e2c-43e8-b890-4984fec724cd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1481, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8bbfbadc-5439-433e-9939-c4e7113e3e16\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1482, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2d38b66e-e793-4102-9d75-268e7995b6fb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1483, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2f75b98b-8353-4f54-b86b-bbacf38989b2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1484, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ee40bfba-dd6a-480e-bb66-b8b1f81b4c4d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1485, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f474d8ad-de33-41ff-93f8-046b0bea66ca\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1486, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"58f024b1-3449-4bd7-9a5c-c0cc958e2fab\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1487, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9c7ef696-9579-4c4e-b8cd-2663a22395e0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1488, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ac0249fd-1d0b-4ac6-9b02-bebea255d311\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1489, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"de3467a7-46ae-421b-8600-5b24df54b2a0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1490, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"72e156e7-209b-41c4-a456-26b4d982049b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1491, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b47c7d38-325f-4556-9ee4-5fcd55119eb9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1492, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c34a48e0-c6b3-4a97-bad2-8eda0f201de4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1493, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"721ba402-a75c-4ab9-8de3-b2d5f80fa7f1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1494, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3942e020-cb63-416e-9e9d-babadb65bc02\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1495, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ec3e889a-669c-4df7-a6be-c668dab5803c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1496, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cd63f560-4ff1-4715-854a-136a93509dc6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1497, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c4d44833-db6c-4860-b3f0-3a6c468706c9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1498, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b965af76-bf25-40a5-ac0d-0be4841d0114\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1499, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f7ccfe2d-39db-4982-8f45-a4edf87a6817\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1500, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c4ebd536-f48f-433f-9568-89eec13b1c51\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1501, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"13dab0a0-9a68-4fde-9462-76afc4051bdb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1502, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"21d72036-ef6f-403d-99ef-388e6a0f6686\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1503, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ed71385a-df46-47de-8b59-e9b932d40d9d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1504, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0b782b07-3eba-461c-9929-e79cee37621b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1505, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d59da77b-4c38-467d-812f-6523790c22b2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1506, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6f1e1ffb-a65f-4dff-9433-8e3dd2b8030d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1507, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c3aa8520-dcb1-4058-987e-f1b1e67f9094\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1508, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6a878ea6-aad0-49c7-9543-2d87fb65be95\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1509, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f6aec461-2a02-4b1a-b029-ea5d64b13f32\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1510, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6f96d1c1-eb9d-4343-b210-74efcb7295fd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1511, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3fa4bce7-0dcb-49c1-bbff-db1405062805\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1512, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ab4983ce-7acb-4f91-9eaf-d49625422549\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1513, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a8326943-7850-46d1-b3bb-c77bd1240bdb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1514, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5cb5ce8e-da0c-4658-ab9b-b61edbb3e05b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1515, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"31165326-6d7b-4473-91eb-33c4f1b2e3ad\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1516, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"372cc93b-fafa-4bc7-bca6-6371705583b4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1517, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2803510b-9f6d-47ee-97bf-53762fe27630\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1518, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1277e71b-0fa5-4a6e-8a2d-db402e99581c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1519, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"144f3c70-fdff-419d-9051-e40dc1d6c357\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1520, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dcf64cff-4f8e-4512-92ae-cb5e124a51b2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1521, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"84f44f35-40de-4405-bce1-67f3e72d60f6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1522, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"34c966a6-6e1d-4771-986e-a7421f5c2aa5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1523, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"19de0204-bf71-4c0e-a8f3-e92957439c92\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1524, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9aa71b39-8432-4a07-ae17-bf2a2e4dfbfc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1525, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"258e970e-db50-4a03-9d37-4bf6a2484d3d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1526, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7b290ae5-804a-4fb9-b2c2-6a87f21c37bf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1527, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"08392bc9-ceae-48f2-8005-8475c31b930d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1528, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b647e81c-4058-488c-92b0-7d6526eca093\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1529, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"25246d92-45a5-4eed-b0c0-99baf35b2879\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1530, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"12e59989-093a-48e1-ba50-9a94b64b1b54\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1531, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"692443d9-5add-4b63-8e59-3ece650c9d78\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1532, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dd9f81c1-969d-42bf-9b14-4aaeb548b887\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1533, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"510fc2f4-5ddf-44c9-b0dd-ef0b66e4acb0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1534, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4867ee6d-4830-4b8a-b12b-2a405f725938\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1535, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f74ce314-a313-463a-9895-b3a9ab0f1356\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1536, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ad87548e-84db-41ca-b9e5-85dd2cfd0de4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1537, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7e112bfa-3819-40dd-b3e1-b0944a776f2f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1538, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"156af418-98c1-466b-acdb-fdc2af015329\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1539, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f2d577d4-23b5-49ec-a25e-89a42b7fffa5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1540, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1bdbbb13-b7d0-44ce-8797-c1e4e38a3b0c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1541, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"04fd9d68-ad2e-452b-8274-d60b388b015d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1542, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"849c96b2-62ed-4134-b7c6-d0e9a92d9234\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1543, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"36efbcdf-9ecb-42f6-962e-a4307ba82c3c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1544, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9c38e529-96e2-4360-8d10-f125c990cca7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1545, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bad6aa13-d04b-4bbd-8d1f-68829410b752\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1546, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0eff78fa-229f-4093-82eb-77cc5626a44e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1547, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb53c43a-b484-476b-8ce4-f703defe9206\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1548, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"79ada6e4-9d4c-454c-8707-4dbddc203704\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1549, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"12e16918-7754-4d51-96c3-b1155c615bfc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1550, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6362d250-9ffa-44ac-aeae-a72867492a46\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1551, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ed92d3c5-46a4-4263-954a-028f2f7376df\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1552, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f38b9182-fe50-4ad4-a119-ff174baf6b84\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1553, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8abf5ab1-2a6c-47c1-9b23-82bad8d45f8f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1554, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2f6e5535-a400-4bdb-aa75-e949f8a7fad4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1555, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"240c094b-d416-4fd3-b5ee-58e5c9b2d783\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1556, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"54982ea1-10ca-43f2-9481-21143ec77759\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1557, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"077fdc13-06e9-4c39-9574-954364707655\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1558, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e4bbc826-9e25-476c-90a5-81be87ab68ae\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1559, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"999c2e2d-e5d9-4e89-a378-6a15f03791dd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1560, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8aebb3e1-96b8-49da-9458-216982897225\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1561, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"185c8287-583b-4efc-be29-371cb16f4b63\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1562, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"608930c6-29f2-4447-901b-c801b8232798\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1563, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3fa839de-d293-480a-bf4f-ed7a6bee6d58\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1564, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2b67a78c-e744-4fa7-9411-305224b9a79c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1565, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"954a842b-a46f-4bcc-96da-6f729b329f1a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1566, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d327d1ea-ef5c-477b-a852-585347ec5caf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1567, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a7d9df14-6d53-40ea-ac9d-76821d60fb20\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1568, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ff63d387-dc5c-4a70-8e27-1d970e26a10b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1569, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"71502586-d36f-441a-925f-658898aa8861\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1570, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e4cd2165-1922-48c5-9684-568160eed20f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1571, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2b0805b0-0c32-4ce9-94cc-1d45af1b9cd6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1572, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"02b4e477-c307-4d34-ad18-8ac0abf9ab08\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1573, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b0fd15b6-dc04-4291-a647-d2a57bb12c58\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1574, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"94bf16e1-a774-43bb-b486-2f3871a72fc4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1575, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"99c3bf59-2a81-46cb-bce7-f87c54605adf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1576, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"72e1fa9e-d7ee-4e64-9e7b-46137f8857b4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1577, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3a824c25-68d5-43a7-9293-ad3ac9b14217\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1578, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"60afc139-34ef-40bb-8516-a2cae8a83e55\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1579, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"867cdb36-38bd-43c6-9e32-3968196a374b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1580, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9ede3b02-75d5-4d81-9ac3-ba327700ec82\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1581, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"45f27006-394d-4cc0-b2b3-d6feb89266ab\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1582, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"35f91b0f-1aab-443b-abc3-0f053063b76f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1583, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"df099dd7-cc1e-406b-8f01-18e294abb048\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1584, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"24b01f86-5bd0-426a-bd8f-e05018f8724d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1585, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e8ff905b-c432-474d-ad70-54f3b9e809ff\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1586, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"56746343-fc74-43f4-9fc8-cd3df49fe7bd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1587, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"489aee43-cd7f-4597-be83-a049a99d60f4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1588, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dff880ad-ff0d-4a49-9b69-eaf6e7b12d3d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1589, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3cf84bc4-7618-43fb-a6af-4faef4269582\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1590, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"280a6bf0-bebf-47b6-9f88-8bedde7de29d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1591, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ed31920-8cec-4c9f-adf5-900d6aa098c0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1592, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ba73097a-19c6-4b2b-9796-57f67fc02550\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1593, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e3b30f61-8173-4917-908b-4f0f46112904\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1594, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a8ffadd4-9903-4c5b-9c8e-0e2d23c6b628\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1595, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"24e57531-dac4-44be-9dfe-1212bab08db6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1596, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e065bcab-1687-41a3-829e-20bed8ec9db8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1597, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6609f8ea-84dd-4f43-be45-c1c059081df4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1598, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9ce7bcd0-407e-43de-8ffd-a378e6faed5f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1599, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b823d077-2506-4588-8a07-89c1b6a3a31b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1600, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1faf74ce-e13d-40fc-8214-77841242824f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1601, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f0b292a4-be65-4487-9db1-b48b86f01ed8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1602, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6c5db84e-56ca-46d2-873e-b235275dca40\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1603, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2ae2117b-1c01-40a7-a077-e10ddfc1e8c5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1604, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4b0c09a8-181e-4e7c-8a71-8c3dfc233ff6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1605, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"be029870-13bd-4e95-abf4-99f321f4504e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1606, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4714f854-3e2a-4630-a439-470ec97ab4ca\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1607, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb828740-0d83-45d9-9828-a84652e18150\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1608, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5d6bcee1-9b39-4b4a-9ce6-30fb74c5e1df\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1609, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ed108aa9-a046-4e0a-8adf-5cedf41366af\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1610, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5667ab3f-1d00-47ed-a803-3062b77cf899\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1611, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0ecf2c32-1d4e-4a83-80ee-f97a0c0bf68d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1612, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1a8a16cc-d358-4fbf-b0de-a98573a390e6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1613, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"944d2df6-a120-4471-9282-9643ce893016\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1614, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"516c8c84-a7b9-42db-9d93-9ed5a55a2038\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1615, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c74b1b81-48ff-4c4d-941b-aa14143d8885\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1616, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"98710410-e5b5-4746-980d-52c8ab75be96\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1617, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a212273a-d9fb-475f-9939-e0f3603fbbd4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1618, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"49785f14-9d90-40a1-a443-629a9c618696\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1619, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"772b25b5-994d-47f0-aeaf-1c2081b82dc0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1620, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8c28e5dc-2c47-44c4-958b-90ea24b66136\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1621, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6e1bf02b-e1a7-41ec-a76e-2746ca8c0100\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1622, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8597f9c5-cbf3-41da-a8fa-8a3dcca53e37\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1623, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"647f66a5-dc64-4e25-a4fc-4d7698858045\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1624, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"83d4b60a-45de-41f5-8180-d4ee5663d274\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1625, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b83bba38-10ee-49da-a152-be181fd49155\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1626, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ca262c1-ee64-4a17-a68b-e0f79d45b050\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1627, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3e57a50f-af38-49a9-9512-3e95b0cd0e7b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1628, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7b34f3cb-2ff3-4bd9-a679-a76dd4d87210\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1629, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4d378dff-9879-42cb-a24f-21967f8d6b47\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1630, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"499c7c2e-0716-4b91-b8a6-9b357558d85b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1631, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"14990b43-f41b-4f83-8259-b4c48f45cefe\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1632, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4a03ea19-3336-4f6c-9e52-9dad31004394\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1633, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e82cb0d5-6859-4860-ac7e-ed0570e36846\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1634, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"401bfdc3-a512-43eb-87b0-64a8df4c1846\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1635, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"84fe748d-271d-4f01-a887-01bdd88f9beb\\\", \\\"childbox\\\": \\\"5f6c2c3e-b9fb-4ec9-8de4-2d1c426b86d2\\\", \\\"subtext\\\": \\\"223a9bb5-c973-4d66-a602-8a594073576c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1636, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"67\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"84fe748d-271d-4f01-a887-01bdd88f9beb\\\", \\\"childbox\\\": \\\"9acc8f7f-cc8f-4c03-8ca2-05ff85ca0143\\\", \\\"subtext\\\": \\\"223a9bb5-c973-4d66-a602-8a594073576c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1637, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"CONFIDENTIAL\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a7512904-8f9a-4702-87cb-580bff2cae1b\\\", \\\"childbox\\\": \\\"aa5bacc4-d6fa-4f82-a72b-e03f432bed9d\\\", \\\"subtext\\\": \\\"c36424a8-b017-4dc8-ab00-48a58ae02042\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1638, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a7512904-8f9a-4702-87cb-580bff2cae1b\\\", \\\"childbox\\\": \\\"a8111dc1-e21a-4a0a-9dad-fe9f21267b46\\\", \\\"subtext\\\": \\\"5224638b-4788-434e-a2a6-383a9a49384a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1639, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Protocol 213171 (MENABCWY-019) \\\\u2013 Amendment 2\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a7512904-8f9a-4702-87cb-580bff2cae1b\\\", \\\"childbox\\\": \\\"e5908d87-6d95-4600-95b3-7ecd61fb9226\\\", \\\"subtext\\\": \\\"5224638b-4788-434e-a2a6-383a9a49384a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1640, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"a615c621-7edb-4f5a-9d1f-4e15c551d78d\\\", \\\"childbox\\\": \\\"d0183e4c-fc11-4703-8830-ef558c1cc654\\\", \\\"subtext\\\": \\\"8e297666-2b59-46b8-8c5d-c06112b94251\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1641, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fc57f722-3b3d-4bb9-8bc8-53cefab1b0b1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1642, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"42070833-e9b3-438e-9ba4-6cfb519e1cff\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1643, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3d33b2eb-b7ae-4e7b-b4a0-ce64cebbe126\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1644, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"99114eba-2c0e-4781-bf25-36efad506d99\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1645, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"342802ce-9ad2-4d28-9612-a57baaa511da\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1646, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"864f445c-c745-47c5-96e4-42754fe6b6f9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1647, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e7fe2f74-4e12-4590-9cc9-d7543e7f33b6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1648, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5bf64027-88f1-4508-854e-c73f0c999fb2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1649, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7087cfbe-570d-413a-bc52-5ec160f6b61f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1650, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8d84e238-9272-41a4-8289-a94b4e58b256\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1651, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a5d59233-4d3b-413d-ac05-a7bb1d9cac9f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1652, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0b9f50b6-663c-4029-a263-f60e19f1c8fb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1653, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bf5daebf-de86-4eae-9b4c-d93e6c9791f4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1654, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"03d6e866-1719-4fb5-b89a-893b4693b218\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1655, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"01a33700-e72b-4e73-902e-b5747ec2174f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1656, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ac37ce04-861f-4cc5-b177-d2eac8008d7d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1657, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2efe3514-4b11-43fc-8662-e9b818cb07e5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1658, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"26c9088f-2285-4c43-b0b8-36dd11777179\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1659, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5b45a443-9a27-41f7-a308-29139da284cb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1660, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"94a9a965-f710-49a5-a120-ecff07609ce7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1661, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"71026840-3448-4c40-aadd-b1c9d8d1bd87\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1662, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f41ca053-eb51-40d4-b94f-37f1880b055f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1663, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ec735917-b34e-4d9b-b51c-7852fd8fc4e3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1664, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"12d8136b-e67b-4f24-b8ca-b468d0069948\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1665, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ea5857ed-0fc4-4f1e-8b76-5e74d9cbb5c8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1666, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1f5f5502-10c0-487d-9a72-1082b2cae7de\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1667, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"16176ac3-35d9-436b-ab64-5137b92eaee5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1668, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e2871dfa-bcac-4100-9df0-6fe6a7b2c537\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1669, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fe4cdccb-4b7f-452a-b029-4268538ac332\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1670, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68274464-1fce-45be-ab1f-b1db6030f63b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1671, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"01a73f5a-667a-4938-9444-06b2d66465ef\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1672, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"677ac348-bb5d-43db-a5f7-7cee36de9950\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1673, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ead3f9fb-ec73-4d50-b53e-7b11eabd1aef\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1674, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7c57d50d-8a0d-4442-82f6-d379c10824b2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1675, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6c5e94e2-8769-46d5-bbde-6cd5c19a9c00\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1676, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"22a34ba5-4f48-4831-8647-70391e3465e7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1677, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"776c8a6a-1b62-4e6a-b115-884aa4b55874\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1678, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c8df2741-c9bf-4535-b0bd-e50095898fa7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1679, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9939b955-9f0e-4c65-8bac-ae18c919110d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1680, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d5a10149-522b-40ae-b5d1-21a3fc6a4a56\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1681, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8c333897-256c-4c57-a29b-a2bb735baf7b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1682, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e87de3c6-853a-4a50-a9d9-3916e0541e7b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1683, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5f9afaeb-0fbc-4611-8bbe-ff42ee5cb2a5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1684, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6f0cbe90-2529-4e62-88bd-3c6b9b3967ec\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1685, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"91a79f9d-5124-42ed-b101-b2fe0ecfb2cd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1686, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a1f9d4bd-0828-4014-b341-a620bc576cdb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1687, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b392218f-7e75-4cd0-a515-6fcd29dff53b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1688, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6550fd1d-1eba-4ea5-8fd1-b2fdb497a139\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1689, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"569cf2e4-b40b-44fa-b156-a52304cb41be\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1690, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cb90c298-e731-4c32-b01e-9a1fe96eb593\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1691, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dcb03af7-5891-4511-bd81-e8d5f2b32d46\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1692, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"52a7ea32-4245-400e-b7d5-92ad89c863be\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1693, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aa7be7a4-d45c-44f1-9ddd-e3cdbabb31bd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1694, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4e7e4ea1-3960-4780-b068-3299133c5b2a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1695, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7601b7bb-9879-4862-b49c-bd7e5fa1af50\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1696, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"930678fd-3a32-43dd-8f1d-580bec9d7f4b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1697, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9c457cdd-e453-40b7-bbae-b7b3794dfad2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1698, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e3a697c2-d648-4e4c-9173-6359467f1f2d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1699, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"35d48089-e0cc-481f-8ab1-0e333a935ff5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1700, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"646fa433-e917-4db1-9d8e-7a04a280aed1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1701, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b01d2435-72f0-4b35-921c-257f4f67dd20\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1702, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6ea5a90d-a4f8-4e6c-b826-63eab6f7dbaf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1703, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"66ded930-f08f-4bfa-a555-7ce063d2d65c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1704, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5458a066-cca1-494f-b19d-41499c0af391\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1705, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e6aa6f72-894a-43e7-8501-9c486dd376c3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1706, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6d8e1840-5e79-404f-a94b-399ea1716aff\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1707, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1a973eb7-902b-4584-aa27-369d5caa0e79\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1708, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1bfdfabb-5da7-45e3-ad0d-0b99d54bf031\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1709, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"07b9f794-53ae-445e-ab6e-4ee0fc6a433b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1710, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f488acfb-fc4d-4079-8655-2cb191ba19cc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1711, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b14a30c9-179d-4fef-8bbc-1e7f6e3ad57d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1712, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4322ab60-c33c-4a12-829b-4c7dae63cf56\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1713, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"441958ff-943e-4e59-a717-335cd7100d34\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1714, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d6994df3-df2b-49a6-92ab-521fe80941e8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1715, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c2424f74-47be-499a-b499-abda35851c46\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1716, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"52b43883-e45a-4f5d-98d5-065f0027c080\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1717, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"80930a17-a6e9-4eed-ba34-4630ff28c727\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1718, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fbbe8f43-f718-46e0-991e-f3cdc457f8ea\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1719, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bc871edd-9eb5-491d-9fda-e1d33d41394f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1720, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4baae040-562c-460f-99ef-745b91b45aa9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1721, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8ece21e3-ccb7-4476-82c7-209248228ddf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1722, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b558aa06-7761-4340-b45b-24b2fb1049a6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1723, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7a777b8c-52ca-4601-b93e-37ff091654f1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1724, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"281889ea-a519-4c7f-abf6-fef3c0c58fea\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1725, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"21ae3319-84cf-47e5-885e-ea65293586bc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1726, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"83caa204-0841-42a1-83b9-d1a7343754e7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1727, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"95c51c3e-347b-4fd5-96cf-38b8114db47a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1728, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dcfbde0d-46a9-403e-9bd5-53f7dbb24dcc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1729, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a0f2499e-6e8c-45f4-9022-5e8e42bce447\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1730, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5029e422-307f-47f6-9e0c-33f182c843f4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1731, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9a374183-2f99-4929-ac37-bb9ac2214dda\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1732, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"94b7de95-e54d-4cdc-9277-07696947e77a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1733, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7f48404a-dbff-4bfe-a2ea-6594952651a9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1734, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d301925a-220d-440e-ab02-2d7b6bd7f107\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1735, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"665fb8f5-87b1-47ee-846c-7a389be83f15\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1736, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"56d3e8bf-1f20-4a3f-9df9-aa0a2d5eab97\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1737, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"590f1c83-6363-44c1-afc8-e063fe26bc86\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1738, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c4b17d98-79c1-4663-a65c-44bd46f9e787\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1739, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1d6582ac-a5d5-4201-a4a8-dbb34773149e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1740, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"48c5591a-d4ba-46b2-8a58-4b00b4fe1099\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1741, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7bc7d875-bbc4-46cd-9c1e-2de56d249f06\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1742, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fd37737f-9abc-4ed2-8238-2786ffb11044\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1743, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b9e3929b-528d-4b24-8fad-68f3575239c3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1744, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"AEs = adverse events; AESIs = adverse events of special interest; D = day; ESFU = extended safety follow-up; M = month; PC = phone contact; SAE = serious adverse event; T = telephone call; V = ~REDACTED~; Vacc = vaccination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ebaadf4-e1a9-4fd7-88d9-c1ce9e408049\\\", \\\"childbox\\\": \\\"1db40b39-f246-4a63-b962-ca77182b2056\\\", \\\"subtext\\\": \\\"84f4c1fa-c888-40f2-bff7-953a0029bcf5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1745, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1 Consent obtained.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ec13b36d-8857-46e5-a3d0-79a8dc725129\\\", \\\"childbox\\\": \\\"09243b39-7d72-40f5-9151-ed5daf334e90\\\", \\\"subtext\\\": \\\"05f5832b-4c83-4cf3-a8a5-a5eea87231a5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1746, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2 Seven consecutive days post-vaccination (including the day of vaccination).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f0806098-a6eb-479f-8d02-0e40a6261196\\\", \\\"childbox\\\": \\\"c6bb6b49-d20c-4f54-9bf8-95c785c6451e\\\", \\\"subtext\\\": \\\"a253378c-6cb8-4241-9a87-2e6254db08b1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1747, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"3 Thirty consecutive days post-vaccination (including the day of vaccination).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"529de628-0a98-47d8-b854-fefa8f793c10\\\", \\\"childbox\\\": \\\"0343f775-7990-4f73-9e5c-8e2bec7207e8\\\", \\\"subtext\\\": \\\"18ba28e3-2ab3-41f0-894c-b0778c23c129\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1748, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"4 All concomitant medications/products, except vitamins and dietary supplements, administered to treat an AE/SAE, occurred during the entire study period (Day 1 to Day 361), should be recorded in the eCRF and participant\\\\u2019s medical records.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"baa54d1c-322f-4f3c-a1bb-d6aeaca726a7\\\", \\\"childbox\\\": \\\"5e50be65-944f-4d35-b4fc-1f152e5912c3\\\", \\\"subtext\\\": \\\"8f48ab03-4ab6-4a31-855a-7b9c3ce2fafc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1749, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"5 All solicited administration site and systemic events that occur during the 7 days following administration of study ~REDACTED~ at ~REDACTED~ 1 (Day 1) and ~REDACTED~ 3 (Day 181).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d824b056-4575-4fe2-9bd7-496e335d206a\\\", \\\"childbox\\\": \\\"8d021782-a7fc-4cf9-9f8f-4461e35bff68\\\", \\\"subtext\\\": \\\"3823f489-b915-429d-93ac-dcfff32f2ad5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1750, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"6 For coronavirus disease 2019 (COVID-19) related AEs/SAEs, follow routine AE/SAE collection and reporting processes as outlined in the protocol.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8c5e463e-31b6-496c-94ce-1d64b04dcfac\\\", \\\"childbox\\\": \\\"04872c75-a6ed-4cdc-ae5f-49ec60d80204\\\", \\\"subtext\\\": \\\"bb6c78b3-e5cc-48e8-a56c-a173ea4031e4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1751, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e552f440-2974-4463-980b-e5fac9adb733\\\", \\\"childbox\\\": \\\"c189220f-8500-46a1-aba0-472a421e2a5d\\\", \\\"subtext\\\": \\\"d500b06a-7b14-42e0-b086-a3850b5adc3f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1752, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"68\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e552f440-2974-4463-980b-e5fac9adb733\\\", \\\"childbox\\\": \\\"75b7e1da-5602-4bd5-b230-f6e5b7903621\\\", \\\"subtext\\\": \\\"d500b06a-7b14-42e0-b086-a3850b5adc3f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1753, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"732fb0ee-c054-4366-b407-b945f22f412d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1754, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator or investigator\\\\u2019s designee will record and immediately report all SAEs to ~REDACTED~ via the Expedited AE Reporting Form.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b9fa821b-26cb-40ca-9a85-78444462162c\\\", \\\"childbox\\\": \\\"ffe16130-dbc1-4c64-a3bc-0fb1d5a7f182\\\", \\\"subtext\\\": \\\"ab43f9c5-d155-4172-b09f-f653094b6e47\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1755, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This reporting should, under no circumstances, occur later than 24 hours after the investigator becomes aware of an SAE, as indicated in Appendix 4.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b9fa821b-26cb-40ca-9a85-78444462162c\\\", \\\"childbox\\\": \\\"4fc276dd-764c-4b4b-ad78-43ff7901a8eb\\\", \\\"subtext\\\": \\\"ab43f9c5-d155-4172-b09f-f653094b6e47\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1756, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator will submit any updated SAE data to ~REDACTED~ within 24 hours of it being available.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b9fa821b-26cb-40ca-9a85-78444462162c\\\", \\\"childbox\\\": \\\"4d163a41-24d3-4b1c-8d1f-066f729871f5\\\", \\\"subtext\\\": \\\"a09eb16c-c4de-4115-846b-c539abfb670c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1757, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A post-study AE/SAE is defined as any event that occurs outside of the AE/SAE reporting periods defined in Table 12.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b30ead3d-33e5-43fb-a5a6-28cd6040ace7\\\", \\\"childbox\\\": \\\"759dbdde-38fc-4fc9-8acb-f6522bd0bd89\\\", \\\"subtext\\\": \\\"39d6c309-c000-4e0b-8a84-18c3146dc32b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1758, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Investigators are not obligated to actively seek AEs or SAEs in former study participants.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b30ead3d-33e5-43fb-a5a6-28cd6040ace7\\\", \\\"childbox\\\": \\\"4a491b45-bb76-4acd-8e1e-272ca0cec00e\\\", \\\"subtext\\\": \\\"8e9aa3dc-1249-4862-8515-3f84f092636b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1759, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"However, if the investigator learns of any SAE, including a death, at any time after a participant has been discharged from the study, and he/she considers the event to be reasonably related to the study ~REDACTED~/product, the investigator will promptly notify ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b30ead3d-33e5-43fb-a5a6-28cd6040ace7\\\", \\\"childbox\\\": \\\"046d0743-031c-4f97-8755-f744beeb792d\\\", \\\"subtext\\\": \\\"8e9aa3dc-1249-4862-8515-3f84f092636b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1760, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The method of recording, evaluating, and assessing causality of AE and SAE and the procedures for completing and transmitting SAE reports are provided in Appendix 4.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"80a0580e-77ea-4932-afb2-1873e787e1ff\\\", \\\"childbox\\\": \\\"d86193a6-bcfa-4989-96f3-3481952c8ebe\\\", \\\"subtext\\\": \\\"a96851d7-570a-4aca-a3ed-995d30d9d6cd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Collecting and Reporting of Safety Information\\\", \\\"Table 12\\\", \\\"1\\\", 1761, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.6.2 Method of Detecting AEs and SAEs\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"93fd0225-2169-4f36-a299-3a2ddfa041cc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Method of Detecting AEs and SAEs\\\", \\\"8.3.6.2\\\", \\\"4\\\", 1762, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Methods of detecting and recording AE/SAE/AESI/pregnancies, and the assessment of AE/SAE intensity, causality and outcome are provided in Appendix 4.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aa502e21-93de-46c0-a570-9d7524c85d55\\\", \\\"childbox\\\": \\\"f3262170-ab24-44b8-8d3f-ef5749e1f9ef\\\", \\\"subtext\\\": \\\"ec0a7976-6c73-47a3-9803-6854658d5ebb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Method of Detecting AEs and SAEs\\\", \\\"8.3.6.2\\\", \\\"4\\\", 1763, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Open-ended and non-leading verbal questioning of the participants/participants\\\\u2019 parents/LARs is the preferred method of acquiring information related to an AE/SAE/AESI/pregnancy.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"abb97fb1-51da-4b98-85a9-0c09ae6c10bb\\\", \\\"childbox\\\": \\\"66771989-2024-4482-b705-c96dde5337ac\\\", \\\"subtext\\\": \\\"feedce08-93ef-4e62-9f12-f7822611b566\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Method of Detecting AEs and SAEs\\\", \\\"8.3.6.2\\\", \\\"4\\\", 1764, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"8.3.6.3\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9ab532b3-3a6c-45f1-a87f-dd6cdd11e5a3\\\", \\\"childbox\\\": \\\"d18fcc05-8a6b-4a4a-a58a-990dc2d08b11\\\", \\\"subtext\\\": \\\"b2c01266-04ba-48fa-88bf-a61a913b0fef\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Follow-up of AEs and SAEs\\\", \\\"8.3.6.3\\\", \\\"4\\\", 1765, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9ab532b3-3a6c-45f1-a87f-dd6cdd11e5a3\\\", \\\"childbox\\\": \\\"d18fcc05-8a6b-4a4a-a58a-990dc2d08b11\\\", \\\"subtext\\\": \\\"05e7a4ff-0ff5-447f-bc15-1c0c62146639\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Arial\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Follow-up of AEs and SAEs\\\", \\\"8.3.6.3\\\", \\\"4\\\", 1766, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9ab532b3-3a6c-45f1-a87f-dd6cdd11e5a3\\\", \\\"childbox\\\": \\\"8c9de10c-81d4-45f5-ba20-d30bd571f0a5\\\", \\\"subtext\\\": \\\"5b61cafc-a72c-493e-bc50-e19e8a11615e\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Arial\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Follow-up of AEs and SAEs\\\", \\\"8.3.6.3\\\", \\\"4\\\", 1767, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Follow-up of AEs and SAEs\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9ab532b3-3a6c-45f1-a87f-dd6cdd11e5a3\\\", \\\"childbox\\\": \\\"227716ee-f31d-445b-ae66-6a11cbce8e3a\\\", \\\"subtext\\\": \\\"2eb14141-0e5b-494c-86dc-c1444e86fa28\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Follow-up of AEs and SAEs\\\", \\\"8.3.6.3\\\", \\\"4\\\", 1768, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Instructions on follow-up of AEs and SAEs are provided in Appendix 4.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"19d41655-5b75-4979-9f01-1958d337e92a\\\", \\\"childbox\\\": \\\"c5a9e3a7-85cc-4ead-afad-6c3af9af80b3\\\", \\\"subtext\\\": \\\"af506579-4b44-40e2-8aa3-0be2f73b5af3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Follow-up of AEs and SAEs\\\", \\\"8.3.6.3\\\", \\\"4\\\", 1769, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.6.4 Regulatory Reporting Requirements for SAEs\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c7470edd-3c0a-47e8-9356-cde3ca389b14\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory Reporting Requirements for SAEs\\\", \\\"8.3.6.4\\\", \\\"4\\\", 1770, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Once an investigator becomes aware that a study participant has experienced an\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3dd567fe-b017-46a7-a10f-c46cf7ce6a52\\\", \\\"childbox\\\": \\\"7c2494ea-4e7e-40bd-aa9b-2ca9eb288254\\\", \\\"subtext\\\": \\\"5954ff0e-4186-4ed8-92e9-de59e8ad44af\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory Reporting Requirements for SAEs\\\", \\\"8.3.6.4\\\", \\\"4\\\", 1771, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"SAE/AESI/pregnancy, he/she must report it to ~REDACTED~ within the timeframes provided in Table 13.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"088bc2f4-c3a2-4fa5-ba11-493e70ba9356\\\", \\\"childbox\\\": \\\"5bda5bd1-48a5-48bc-b0b9-3623667a491e\\\", \\\"subtext\\\": \\\"c27af473-5f60-41ba-a8bd-302f55228f37\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory Reporting Requirements for SAEs\\\", \\\"8.3.6.4\\\", \\\"4\\\", 1772, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This is essential for meeting legal obligations and ethical responsibilities for participant safety and the safety of a study intervention under clinical investigation.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"088bc2f4-c3a2-4fa5-ba11-493e70ba9356\\\", \\\"childbox\\\": \\\"4e908f90-b266-4c09-acfa-ecd85980daf0\\\", \\\"subtext\\\": \\\"d74f7e6f-bfa7-4d35-98e3-d10a79bbef4f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory Reporting Requirements for SAEs\\\", \\\"8.3.6.4\\\", \\\"4\\\", 1773, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For SAEs/AESIs, the investigator will always provide an assessment of causality at the time of the initial report, as defined in the Appendix 4.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1e63783c-3d71-487f-8dc5-700bd15ad0c5\\\", \\\"childbox\\\": \\\"764f1305-b223-4052-b3d3-df5e7753c65a\\\", \\\"subtext\\\": \\\"9e5da2fb-424e-4c09-bec7-fd4324becee2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory Reporting Requirements for SAEs\\\", \\\"8.3.6.4\\\", \\\"4\\\", 1774, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Local regulatory requirements and sponsor\\\\u2019s policy for the preparation of an investigator safety report for suspected unexpected serious adverse reactions (SUSARs) must be followed.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3ceb469b-be46-4ab4-bfb3-3247fb398555\\\", \\\"childbox\\\": \\\"25825136-39c2-472e-bafd-a1851da78f30\\\", \\\"subtext\\\": \\\"d56844d3-7413-43f5-9b7d-24446febdf59\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory Reporting Requirements for SAEs\\\", \\\"8.3.6.4\\\", \\\"4\\\", 1775, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"These reports will be forwarded to investigators as necessary.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3ceb469b-be46-4ab4-bfb3-3247fb398555\\\", \\\"childbox\\\": \\\"d8980ab7-3523-434f-b056-dcf25c748661\\\", \\\"subtext\\\": \\\"d17260c5-32b1-4d6c-8091-a2cd6e230979\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory Reporting Requirements for SAEs\\\", \\\"8.3.6.4\\\", \\\"4\\\", 1776, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The sponsor has a legal responsibility to notify local authorities and other regulatory agencies about the safety of a study intervention under clinical investigation.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3feec772-5682-43cf-8555-eb23f511444f\\\", \\\"childbox\\\": \\\"29574e60-4af0-4ea0-ac11-16f98cfca3fd\\\", \\\"subtext\\\": \\\"24b3f66a-b7a6-4934-8728-311aab534feb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory Reporting Requirements for SAEs\\\", \\\"8.3.6.4\\\", \\\"4\\\", 1777, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The sponsor will comply with country-specific regulatory requirements related to safety reporting to the regulatory authority, IRB/IEC, and investigators.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3feec772-5682-43cf-8555-eb23f511444f\\\", \\\"childbox\\\": \\\"1c67c0b5-0e0b-43d9-a520-2d9b12a6c10a\\\", \\\"subtext\\\": \\\"d182d9ee-61fd-4810-84f2-cf3a012aecba\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory Reporting Requirements for SAEs\\\", \\\"8.3.6.4\\\", \\\"4\\\", 1778, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Appendix 4 for further details regarding the reporting of SAEs/AESIs/pregnancies.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cf832447-edc5-4135-a41b-77a6b6a458fe\\\", \\\"childbox\\\": \\\"08586de0-8d27-4541-a9a4-6a2b0fc5f5c5\\\", \\\"subtext\\\": \\\"94c85ea2-d07e-4875-9fd6-8ee0d96cfda5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory Reporting Requirements for SAEs\\\", \\\"8.3.6.4\\\", \\\"4\\\", 1779, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Table 13 Timeframes for Submitting SAEs, Pregnancies, and AESIs\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c9cca78e-6898-49f7-93ba-9e2d46bc5e88\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Submitting SAEs, Pregnancies, and AESIs\\\", \\\"Table 13\\\", \\\"1\\\", 1780, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n      <th>5.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Type of Event</td>\\\\n      <td>Initial Reports</td>\\\\n      <td>Initial Reports</td>\\\\n      <td>Follow-up of Relevant Information on a Previous Report</td>\\\\n      <td>Follow-up of Relevant Information on a Previous Report</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td></td>\\\\n      <td>Timeframe</td>\\\\n      <td>Documents</td>\\\\n      <td>Timeframe</td>\\\\n      <td>Documents</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>SAE</td>\\\\n      <td>24 hours 1,2,3</td>\\\\n      <td>electronic Expedited AE Report</td>\\\\n      <td>24 hours <sup>1</sup></td>\\\\n      <td>electronic Expedited AE Report</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Pregnancy</td>\\\\n      <td>2 weeks <sup>1</sup></td>\\\\n      <td>electronic Pregnancy Report</td>\\\\n      <td>2 weeks <sup>1</sup></td>\\\\n      <td>electronic Pregnancy Report</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>AESI</td>\\\\n      <td>24 hours <sup>2,4</sup></td>\\\\n      <td>electronic Expedited AE Report</td>\\\\n      <td>24 hours <sup>1</sup></td>\\\\n      <td>electronic Expedited AE Report</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"69\\\", \\\"TableIndex\\\": \\\"31\\\", \\\"TableName\\\": \\\"Table 13 Timeframes for Submitting SAEs, Pregnancies, and AESIs\\\", \\\"Header\\\": [0, 1]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"4baf44b1-992f-4780-87b0-24fc8089dbe2\\\", \\\"childbox\\\": \\\"2349e4a1-cf9e-4770-ac9e-8fd8286a7328\\\", \\\"subtext\\\": \\\"a56e981c-b24e-48f0-bcf9-851d4a281155\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Submitting SAEs, Pregnancies, and AESIs\\\", \\\"Table 13\\\", \\\"1\\\", 1781, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8e599cf3-d10b-4f5e-afef-06e346201d44\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Timeframes for Submitting SAEs, Pregnancies, and AESIs\\\", \\\"Table 13\\\", \\\"1\\\", 1782, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"AE = adverse event; AESI = adverse event of special interest; SAE = serious adverse event\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"24acecf1-2a0b-4ba8-ac41-d6a0fae16b54\\\", \\\"childbox\\\": \\\"00a10e07-eef7-417b-9518-4846ed407ecb\\\", \\\"subtext\\\": \\\"afce6616-3c90-43b1-9ecf-d74945ff4add\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Submitting SAEs, Pregnancies, and AESIs\\\", \\\"Table 13\\\", \\\"1\\\", 1783, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d2b9e745-73cc-44f7-bf6d-01017cba6e3e\\\", \\\"childbox\\\": \\\"5128f0d0-2ea4-4bd5-8857-8d476a8ddf24\\\", \\\"subtext\\\": \\\"44231479-1327-4945-9803-ee44908a7e74\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"superscript\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Submitting SAEs, Pregnancies, and AESIs\\\", \\\"Table 13\\\", \\\"1\\\", 1784, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d2b9e745-73cc-44f7-bf6d-01017cba6e3e\\\", \\\"childbox\\\": \\\"5128f0d0-2ea4-4bd5-8857-8d476a8ddf24\\\", \\\"subtext\\\": \\\"5c28c052-3e8e-4330-a4bb-629e59388b4e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Arial\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Submitting SAEs, Pregnancies, and AESIs\\\", \\\"Table 13\\\", \\\"1\\\", 1785, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Timeframe allowed after receipt or awareness of the information by the investigator/study center staff.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d2b9e745-73cc-44f7-bf6d-01017cba6e3e\\\", \\\"childbox\\\": \\\"5128f0d0-2ea4-4bd5-8857-8d476a8ddf24\\\", \\\"subtext\\\": \\\"ddb61b28-4748-4bd1-94c4-ab5ecb49e4ef\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Submitting SAEs, Pregnancies, and AESIs\\\", \\\"Table 13\\\", \\\"1\\\", 1786, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d2b9e745-73cc-44f7-bf6d-01017cba6e3e\\\", \\\"childbox\\\": \\\"5128f0d0-2ea4-4bd5-8857-8d476a8ddf24\\\", \\\"subtext\\\": \\\"8a49cf01-6795-4d1f-83cd-cbe7ee226872\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"superscript\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Submitting SAEs, Pregnancies, and AESIs\\\", \\\"Table 13\\\", \\\"1\\\", 1787, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d2b9e745-73cc-44f7-bf6d-01017cba6e3e\\\", \\\"childbox\\\": \\\"5128f0d0-2ea4-4bd5-8857-8d476a8ddf24\\\", \\\"subtext\\\": \\\"3c1bf66d-131b-45b1-83f8-608b3b029638\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Arial\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Submitting SAEs, Pregnancies, and AESIs\\\", \\\"Table 13\\\", \\\"1\\\", 1788, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator will be required to confirm review of the SAE/AESI causality by ticking the \\\\u201creviewed\\\\u201d box in the electronic Expedited AE Report within 72 hours of submission of the SAE/AESI.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d2b9e745-73cc-44f7-bf6d-01017cba6e3e\\\", \\\"childbox\\\": \\\"5128f0d0-2ea4-4bd5-8857-8d476a8ddf24\\\", \\\"subtext\\\": \\\"c301fd98-a5ef-4d21-8637-301a1286d793\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Submitting SAEs, Pregnancies, and AESIs\\\", \\\"Table 13\\\", \\\"1\\\", 1789, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1 For coronavirus disease 2019 (COVID-19) related SAEs, reports should be submitted following routine procedures for SAEs.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"87f61b03-01db-40eb-a69e-0c0c7a71d6d6\\\", \\\"childbox\\\": \\\"2aeaf583-d339-4be1-bf06-e4393334b4be\\\", \\\"subtext\\\": \\\"1a31edc1-ca54-4e8c-baf0-76082bd5df15\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Submitting SAEs, Pregnancies, and AESIs\\\", \\\"Table 13\\\", \\\"1\\\", 1790, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2 Timeframe allowed once the investigator determines that the event meets the protocol definition of an AESI.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5d2762e5-1d31-4328-9ed9-c9fda25dfe51\\\", \\\"childbox\\\": \\\"daade338-a177-4284-b771-9fb80ce0faf8\\\", \\\"subtext\\\": \\\"3ed28c72-1405-4aee-8a75-a2c063f165dc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Timeframes for Submitting SAEs, Pregnancies, and AESIs\\\", \\\"Table 13\\\", \\\"1\\\", 1791, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.6.5 Treatment of Adverse Events\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e82e3f25-c2b1-4acf-ab90-ec4498f561ba\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Treatment of Adverse Events\\\", \\\"8.3.6.5\\\", \\\"4\\\", 1792, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Any medication administered for the treatment of an SAE/AESI should be recorded in the Expedited AE Report of the participant\\\\u2019s eCRF screen (refer to Appendix 4).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"31c3768e-8093-4d70-ad11-e31f0dc4256c\\\", \\\"childbox\\\": \\\"b0649576-3a6f-43fd-88d0-77c51f351304\\\", \\\"subtext\\\": \\\"51f2c8bb-7fab-4764-b714-aa6146169bea\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Treatment of Adverse Events\\\", \\\"8.3.6.5\\\", \\\"4\\\", 1793, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.6.6 Participant Card\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a4508c36-b9a7-432d-8ae3-30915fb2e00e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Card\\\", \\\"8.3.6.6\\\", \\\"4\\\", 1794, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator or investigator\\\\u2019s designee must provide the participant/participant\\\\u2019s parent(s)/LAR(s) with a \\\\u201cparticipant card\\\\u201d containing information about the clinical study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"199775df-5334-429b-85d8-cd86ddf1158c\\\", \\\"childbox\\\": \\\"d4bd1ddb-4cf9-43ff-8750-e11b7c9d7266\\\", \\\"subtext\\\": \\\"ed502ec8-f956-4961-b787-4711e0969ba3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Card\\\", \\\"8.3.6.6\\\", \\\"4\\\", 1795, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The participant/participant\\\\u2019s parent(s)/LAR(s) must be instructed to keep the participant card in his/her/their possession at all times throughout the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"199775df-5334-429b-85d8-cd86ddf1158c\\\", \\\"childbox\\\": \\\"d713b861-2e19-46c7-919d-fc6ae9e18c31\\\", \\\"subtext\\\": \\\"ed502ec8-f956-4961-b787-4711e0969ba3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Card\\\", \\\"8.3.6.6\\\", \\\"4\\\", 1796, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In an emergency, this card serves to inform the responsible attending physician/LAR/caregiver/family member that the participant is in a clinical study and that relevant information may be obtained by contacting the investigator.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"199775df-5334-429b-85d8-cd86ddf1158c\\\", \\\"childbox\\\": \\\"5814c381-1616-4ede-a068-0e1854fa890f\\\", \\\"subtext\\\": \\\"b79df8ed-141d-449d-b609-0c763d1ba67e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participant Card\\\", \\\"8.3.6.6\\\", \\\"4\\\", 1797, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.7 Treatment of Overdose\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a2ba04c1-cf6e-4f6c-b223-e17db5797e8b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Treatment of Overdose\\\", \\\"8.3.7\\\", \\\"3\\\", 1798, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.7.1 ~REDACTED~ Administration Error\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading6\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"87ff4a3c-8088-40b9-a4a7-8ec57b00a25f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Vaccine Administration Error\\\", \\\"8.3.7.1\\\", \\\"4\\\", 1799, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~ administration error is defined as receiving a dose of study ~REDACTED~ that was not reconstituted as instructed or administered by a different route from the intended route of administration.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"810138b9-d8d5-404f-98d2-d49aa1fbddbc\\\", \\\"childbox\\\": \\\"0ae65b06-ac4a-488c-adcd-f42134fcf8db\\\", \\\"subtext\\\": \\\"96381a94-d37b-4837-a249-056a78428ab8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Vaccine Administration Error\\\", \\\"8.3.7.1\\\", \\\"4\\\", 1800, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Any ~REDACTED~ administration error detailed in this protocol must be reported as an AE, and if overdose is associated with an SAE, it must be reported as such within 24 hours to ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"746f8bef-d4c6-45eb-b155-b901f0a06b6b\\\", \\\"childbox\\\": \\\"fe4fe150-f1ee-4877-aa48-d5ed9b9745ce\\\", \\\"subtext\\\": \\\"b0ab907d-3eea-4eec-bc30-5a205622facf\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Vaccine Administration Error\\\", \\\"8.3.7.1\\\", \\\"4\\\", 1801, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.7.2 Overdose of Study ~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading6\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ed165701-5e66-4b75-8e95-dc41f3665173\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Overdose of Study Vaccine\\\", \\\"8.3.7.2\\\", \\\"4\\\", 1802, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"An overdose of study ~REDACTED~ (whether accidental or intentional) is defined when a dosage higher than the recommended dosage is administered in 1 dose of study ~REDACTED~ MenABCWY and/or MenB and/or MenACWY.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"468ce568-2a1d-447e-aee6-54e5a0cf5a7d\\\", \\\"childbox\\\": \\\"43f9b02d-2304-4782-9014-5af4de4d760e\\\", \\\"subtext\\\": \\\"c153c95a-712e-4e35-91ef-ba08c61bfe25\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Overdose of Study Vaccine\\\", \\\"8.3.7.2\\\", \\\"4\\\", 1803, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"An overdose would also occur if 2 doses of the study ~REDACTED~ are administered within 2 weeks of the recommended interval between doses.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4fa89358-60f8-4132-a2dc-63536bffc545\\\", \\\"childbox\\\": \\\"dd1d93a0-6d25-4571-9662-4dc29fc9cbb4\\\", \\\"subtext\\\": \\\"d752e607-b4bf-44c5-9097-20c783dc4507\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Overdose of Study Vaccine\\\", \\\"8.3.7.2\\\", \\\"4\\\", 1804, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Any overdose of study ~REDACTED~ detailed in this protocol must be reported as an AE, and if overdose is associated with an SAE, it must be reported as such within 24 hours to the sponsor\\\\u2019s designee.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"25736b48-aad5-4306-b2ae-35eb88fa4d1e\\\", \\\"childbox\\\": \\\"7d1ea62c-09df-4787-b7a0-cc7ae28593a9\\\", \\\"subtext\\\": \\\"cb8466dc-3a26-4575-8f8f-b4116099e618\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Overdose of Study Vaccine\\\", \\\"8.3.7.2\\\", \\\"4\\\", 1805, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.8 Medical Device Deficiencies\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"729a19c0-92fe-4165-b262-8b5cafb227ee\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Device Deficiencies\\\", \\\"8.3.8\\\", \\\"3\\\", 1806, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The study interventions (MenABCWY and\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"844e3f88-9354-4d6c-ba05-69a1f999e5b5\\\", \\\"childbox\\\": \\\"dc1e8ea4-3232-4be1-80e3-e8996359535f\\\", \\\"subtext\\\": \\\"97dd6b5e-8718-4b9b-b1e5-7ece35dfc7f4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Device Deficiencies\\\", \\\"8.3.8\\\", \\\"3\\\", 1807, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Bexsero\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"844e3f88-9354-4d6c-ba05-69a1f999e5b5\\\", \\\"childbox\\\": \\\"dc1e8ea4-3232-4be1-80e3-e8996359535f\\\", \\\"subtext\\\": \\\"10c1bce3-58ce-4e41-8d89-3037b443a777\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Device Deficiencies\\\", \\\"8.3.8\\\", \\\"3\\\", 1808, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\") are combination products constituted of a device and biologic product (e.g., pre-filled syringes).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"844e3f88-9354-4d6c-ba05-69a1f999e5b5\\\", \\\"childbox\\\": \\\"dc1e8ea4-3232-4be1-80e3-e8996359535f\\\", \\\"subtext\\\": \\\"a42d04d0-fb70-4b44-994b-39d8c80844ca\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Device Deficiencies\\\", \\\"8.3.8\\\", \\\"3\\\", 1809, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Appendix 1 for the definition of a combination product and a medical device deficiency.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"844e3f88-9354-4d6c-ba05-69a1f999e5b5\\\", \\\"childbox\\\": \\\"736b8d5e-fbf1-44c6-8a6d-40e6ff521e9d\\\", \\\"subtext\\\": \\\"a42d04d0-fb70-4b44-994b-39d8c80844ca\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Device Deficiencies\\\", \\\"8.3.8\\\", \\\"3\\\", 1810, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.8.1 Detection, Follow-up and Prompt Reporting of Medical Device Deficiency\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading6\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"69ff338f-bda9-4736-b40c-6e1fb0a82c70\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Detection, Follow-up and Prompt Reporting of Medical Device Deficiency\\\", \\\"8.3.8.1\\\", \\\"4\\\", 1811, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator is responsible for the detection, documentation and prompt reporting of any medical device deficiency occurring during the study to the sponsor\\\\u2019s designee.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"46f90510-3e37-4e29-8ad2-4cb994b0a576\\\", \\\"childbox\\\": \\\"3062e176-0023-4395-82ed-15a249b71b66\\\", \\\"subtext\\\": \\\"e1fb7e83-b318-4201-af1d-cdba3812550c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Detection, Follow-up and Prompt Reporting of Medical Device Deficiency\\\", \\\"8.3.8.1\\\", \\\"4\\\", 1812, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This applies to any medical device provided for the conduct of the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"46f90510-3e37-4e29-8ad2-4cb994b0a576\\\", \\\"childbox\\\": \\\"989e19be-9801-4130-94a5-da1c92ba7710\\\", \\\"subtext\\\": \\\"4287db67-41ff-447b-bd46-177d675a7d2c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Detection, Follow-up and Prompt Reporting of Medical Device Deficiency\\\", \\\"8.3.8.1\\\", \\\"4\\\", 1813, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Device deficiencies will be reported to the sponsor\\\\u2019s designee within 24 hours after the investigator determines that the event meets the protocol definition of a device deficiency.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bb402081-94c5-4ab8-affa-e02f8ed9672f\\\", \\\"childbox\\\": \\\"635be09d-81de-4d27-ac09-bda54f2f26ec\\\", \\\"subtext\\\": \\\"29298b5f-1985-4a5c-9253-d44e9b33a9f8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Detection, Follow-up and Prompt Reporting of Medical Device Deficiency\\\", \\\"8.3.8.1\\\", \\\"4\\\", 1814, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Appendix 4 for definitions and details on recording and reporting of these events.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bb402081-94c5-4ab8-affa-e02f8ed9672f\\\", \\\"childbox\\\": \\\"98600911-ffcc-4957-9be9-b481e5029213\\\", \\\"subtext\\\": \\\"9fdd30e3-208a-428d-a4e9-73f24b0102d0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Detection, Follow-up and Prompt Reporting of Medical Device Deficiency\\\", \\\"8.3.8.1\\\", \\\"4\\\", 1815, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator will ensure that follow-up includes any additional investigations to elucidate the nature and/or causality of the deficiency.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bc1043a5-91db-4932-afb4-623423749124\\\", \\\"childbox\\\": \\\"13a7ab7b-b2fd-4df2-a1f1-ee3a23c8160b\\\", \\\"subtext\\\": \\\"d8b729d2-08c7-4be0-aa48-53ab14219e5d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Detection, Follow-up and Prompt Reporting of Medical Device Deficiency\\\", \\\"8.3.8.1\\\", \\\"4\\\", 1816, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Follow-up applies to all participants, including those who discontinue study intervention or the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bc1043a5-91db-4932-afb4-623423749124\\\", \\\"childbox\\\": \\\"00e7dc1b-a322-43f6-88ca-652c21c572cf\\\", \\\"subtext\\\": \\\"524599b4-131c-4851-a619-7b513d77299f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Detection, Follow-up and Prompt Reporting of Medical Device Deficiency\\\", \\\"8.3.8.1\\\", \\\"4\\\", 1817, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"New or updated information will be recorded on the originally completed form with all changes signed and dated by the investigator and reported to the sponsor\\\\u2019s designee within 24 hours.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b8fe3298-2db0-4273-a853-bde0337e2124\\\", \\\"childbox\\\": \\\"9c909e1e-8e1c-44b0-a967-9bccd3731a19\\\", \\\"subtext\\\": \\\"d2024f80-0f62-443f-9471-ca0511b3a17c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Detection, Follow-up and Prompt Reporting of Medical Device Deficiency\\\", \\\"8.3.8.1\\\", \\\"4\\\", 1818, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.3.8.2 Regulatory Reporting of Medical Device Deficiency When Used as Combination Product\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading6\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d8d928a4-967e-488e-976c-08617d8fcae3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory Reporting of Medical Device Deficiency When Used as Combination Product\\\", \\\"8.3.8.2\\\", \\\"4\\\", 1819, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator will promptly report all device deficiencies occurring with any medical device provided for use in the study in order for the sponsor to fulfill the legal responsibility to notify appropriate regulatory authorities and other entities about certain safety information relating to medical devices being used in clinical studies.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0899e90c-2b15-4eca-9d23-44afe2aced47\\\", \\\"childbox\\\": \\\"da25358b-4dcf-4a3e-b01b-af6286c5a1d6\\\", \\\"subtext\\\": \\\"e7d3f3ae-0d25-4ed9-ac28-64fbe22d3aa9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory Reporting of Medical Device Deficiency When Used as Combination Product\\\", \\\"8.3.8.2\\\", \\\"4\\\", 1820, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Appendix 4 for details of reporting.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0899e90c-2b15-4eca-9d23-44afe2aced47\\\", \\\"childbox\\\": \\\"6af74963-6463-4444-a276-e78198a97bfb\\\", \\\"subtext\\\": \\\"59cd94f8-39d0-4af0-bccc-3fdfc8470755\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory Reporting of Medical Device Deficiency When Used as Combination Product\\\", \\\"8.3.8.2\\\", \\\"4\\\", 1821, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator, or responsible person according to local requirements (e.g., the head of the medical institution), will comply with the applicable local regulatory requirements relating to the reporting of device deficiencies to the IRB/IEC.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e0a031ee-38dc-4966-ad2f-6982c67d0a00\\\", \\\"childbox\\\": \\\"bc019776-7a60-41c4-a39f-ec9ca2c9e1aa\\\", \\\"subtext\\\": \\\"e2af9e84-7c16-4fae-a5d1-3e27c79d65a8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory Reporting of Medical Device Deficiency When Used as Combination Product\\\", \\\"8.3.8.2\\\", \\\"4\\\", 1822, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.4 Pharmacokinetics\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e73e9bbb-60ae-4d05-a1a3-7ccc8ea18665\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Pharmacokinetics\\\", \\\"8.4\\\", \\\"2\\\", 1823, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Pharmacokinetic parameters will not be evaluated in this study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9e1dda41-c0fc-4526-92e6-1c4ce503f777\\\", \\\"childbox\\\": \\\"8ca71698-53e7-438d-abb5-21f8f5296401\\\", \\\"subtext\\\": \\\"ee5c4191-8e6c-4bdd-ae2a-0b458190a0b4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Pharmacokinetics\\\", \\\"8.4\\\", \\\"2\\\", 1824, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.5 Pharmacodynamics\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d346f8c6-d578-4a11-8631-98966eb70ff3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Pharmacodynamics\\\", \\\"8.5\\\", \\\"2\\\", 1825, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Pharmacodynamic parameters will not be evaluated in this study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"de197d6b-51d8-4e9a-9602-c8f437761da7\\\", \\\"childbox\\\": \\\"c1e742ea-4ca5-4c70-b35c-2f1cfae254dd\\\", \\\"subtext\\\": \\\"de4a4277-e093-4ef6-9e53-f2a2f29bc3de\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Pharmacodynamics\\\", \\\"8.5\\\", \\\"2\\\", 1826, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.6 Genetics\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a5228a84-d8f4-4586-89c9-ab1e511abf42\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Genetics\\\", \\\"8.6\\\", \\\"2\\\", 1827, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"No samples will be collected during this study for genetic or pharmacogenetic research.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c001b736-39b8-4a6f-8cb4-a60b1a3bbdf5\\\", \\\"childbox\\\": \\\"fd74a38b-482e-4ca4-be68-d3321062bef0\\\", \\\"subtext\\\": \\\"d0d3ce42-d118-4917-8260-5faa6bd138a5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Genetics\\\", \\\"8.6\\\", \\\"2\\\", 1828, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.7 Biomarkers\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bfa1d2d3-d6ac-47af-a18b-948dedb05a67\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biomarkers\\\", \\\"8.7\\\", \\\"2\\\", 1829, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"No biomarkers will be collected for pharmacogenetic research in this study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f527391b-3b4b-4b4c-8902-f8a9471a8e0e\\\", \\\"childbox\\\": \\\"654d9034-621b-47d7-87d4-1f120959637c\\\", \\\"subtext\\\": \\\"16cc9a9b-213c-47eb-bcd0-aa8b28a52e51\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Biomarkers\\\", \\\"8.7\\\", \\\"2\\\", 1830, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.8 Health Outcomes\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c424802b-8feb-4dd0-b50e-a923cfcfe786\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Health Outcomes\\\", \\\"8.8\\\", \\\"2\\\", 1831, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"No economic health outcome measures will be collected in this study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e24d7eef-6913-4200-ad8c-32ff7a9f124a\\\", \\\"childbox\\\": \\\"dd6a0104-c479-446c-bef8-22b3eafe3772\\\", \\\"subtext\\\": \\\"7736718c-1e20-4a0a-a789-1a55802fa69b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Health Outcomes\\\", \\\"8.8\\\", \\\"2\\\", 1832, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"8.9 Study Procedures During Special Circumstances\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2ad0490c-5702-4c2e-adee-5abef8c8dea0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1833, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"During special circumstances (e.g., coronavirus disease 2019 [COVID-19] pandemic), the specific guidance from local public health and other competent authorities regarding the protection of individuals\\\\u2019 welfare must be applied.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0c1f367f-47e9-4749-a9b6-ac089280b35a\\\", \\\"childbox\\\": \\\"02f9ed6b-be49-4f24-a3eb-8c8d0fbdbb0a\\\", \\\"subtext\\\": \\\"eaa9b9d3-b78a-46e2-ac64-66ce68a19d94\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1834, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For the duration of such special circumstances, the following measures may be implemented for enrolled participants:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0c1f367f-47e9-4749-a9b6-ac089280b35a\\\", \\\"childbox\\\": \\\"059e85b6-9767-474c-bc88-b583e0c2d00e\\\", \\\"subtext\\\": \\\"eaa9b9d3-b78a-46e2-ac64-66ce68a19d94\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1835, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Safety follow-up may be made by a telephone call, other means of virtual contact or home ~REDACTED~, if appropriate.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1e41675e-a14d-425f-9d15-d217b51696d9\\\", \\\"childbox\\\": \\\"3acf06c6-34a0-440a-8a32-ca09f34cefd2\\\", \\\"subtext\\\": \\\"c11f5e45-61e0-4d43-9651-53d78c2b5cb4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1836, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 If an eDiary device was provided to the participant, it may be returned to the study center by conventional mail after the end of the relevant data collection period.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d8654a03-8a40-4c12-815d-a4c339f760e7\\\", \\\"childbox\\\": \\\"7c25e5cb-0a4a-40e6-9d04-49e3a85304af\\\", \\\"subtext\\\": \\\"7bf5001f-fb8d-47ca-a821-a4239c9265ba\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1837, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Visits for suspected AEs may take place in a different location\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fc493680-c503-48d9-9954-2ad543de47f9\\\", \\\"childbox\\\": \\\"d7297fdb-700f-406f-adcd-ca7326b23766\\\", \\\"subtext\\\": \\\"4a8680e4-e12c-433a-8d3d-cc009af93367\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1838, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"*\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fc493680-c503-48d9-9954-2ad543de47f9\\\", \\\"childbox\\\": \\\"d7297fdb-700f-406f-adcd-ca7326b23766\\\", \\\"subtext\\\": \\\"b6906fc4-06b6-4776-bb2d-e4a2decb0f37\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"superscript\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1839, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"other than the study center or at participant\\\\u2019s home.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fc493680-c503-48d9-9954-2ad543de47f9\\\", \\\"childbox\\\": \\\"d7297fdb-700f-406f-adcd-ca7326b23766\\\", \\\"subtext\\\": \\\"4047377d-c3b4-4f54-a13f-465b24aac1d8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1840, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If this is not feasible, then the medical evaluation of AEs may take place virtually with documentation of symptoms by other means of communication (e.g., phone call or videoconference), if possible.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fc493680-c503-48d9-9954-2ad543de47f9\\\", \\\"childbox\\\": \\\"93c3b102-17d7-4cc0-8409-62d3354ec2f3\\\", \\\"subtext\\\": \\\"4047377d-c3b4-4f54-a13f-465b24aac1d8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1841, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Biological samples may be collected at a different location\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b26a2540-8b48-4082-8fcc-3193d83bf7ae\\\", \\\"childbox\\\": \\\"51cf2dc1-fd00-4919-ba08-47a76a50c4ea\\\", \\\"subtext\\\": \\\"ead97ac4-4f64-4db0-8d51-1928ab5977f4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1842, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"*\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b26a2540-8b48-4082-8fcc-3193d83bf7ae\\\", \\\"childbox\\\": \\\"51cf2dc1-fd00-4919-ba08-47a76a50c4ea\\\", \\\"subtext\\\": \\\"0e751d36-3fda-44b6-b981-e41871ac1c4f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"superscript\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1843, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"other than the study center or at participant\\\\u2019s home.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b26a2540-8b48-4082-8fcc-3193d83bf7ae\\\", \\\"childbox\\\": \\\"51cf2dc1-fd00-4919-ba08-47a76a50c4ea\\\", \\\"subtext\\\": \\\"df7d7938-081f-476c-a254-e1de3f8044db\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1844, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Biological samples should not be collected if they cannot be processed in a timely manner or appropriately stored until the intended use.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b26a2540-8b48-4082-8fcc-3193d83bf7ae\\\", \\\"childbox\\\": \\\"89878423-1b06-47a9-80ac-8264eb94f5f5\\\", \\\"subtext\\\": \\\"6e4cfb9b-fe62-4730-97ce-241f4b6c7af3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1845, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"*\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b3a4ac34-1284-4033-95d6-17a0786bd92c\\\", \\\"childbox\\\": \\\"2093b95e-cab7-4e04-8cfd-74195bbf22cb\\\", \\\"subtext\\\": \\\"7b33fa0e-df8d-40f6-9465-ac1b01b3ca3f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1846, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Note:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b3a4ac34-1284-4033-95d6-17a0786bd92c\\\", \\\"childbox\\\": \\\"2093b95e-cab7-4e04-8cfd-74195bbf22cb\\\", \\\"subtext\\\": \\\"ec15efae-8957-4397-8092-6c74254c63cc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1847, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b3a4ac34-1284-4033-95d6-17a0786bd92c\\\", \\\"childbox\\\": \\\"2093b95e-cab7-4e04-8cfd-74195bbf22cb\\\", \\\"subtext\\\": \\\"c8e587d2-cf2a-4cc7-98d2-60ab2f070d1f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1848, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"It is the investigator\\\\u2019s responsibility to identify an alternate location.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b3a4ac34-1284-4033-95d6-17a0786bd92c\\\", \\\"childbox\\\": \\\"2093b95e-cab7-4e04-8cfd-74195bbf22cb\\\", \\\"subtext\\\": \\\"77a88083-562c-4d76-91d6-a43a8fc76935\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1849, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator should ensure that this alternate location meets ICH Good Clinical Practice\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b3a4ac34-1284-4033-95d6-17a0786bd92c\\\", \\\"childbox\\\": \\\"b68f47ce-fa1b-4f80-b391-4886251ff8a8\\\", \\\"subtext\\\": \\\"33136e2f-a666-4516-b15a-cd4d22173998\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1850, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(GCP) requirements, such as adequate facilities to perform study procedures, appropriate training of the staff and documented delegation of responsibilities in this location.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f28457ff-47ac-4b51-8390-53994b525e68\\\", \\\"childbox\\\": \\\"0a27dfc3-46b1-48ab-99dc-bb10f12b6d09\\\", \\\"subtext\\\": \\\"1b8341c3-a988-4e6e-8595-c858d2d487b2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1851, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This alternate location should be covered by proper insurance for the conduct of study on participants by investigator and study center staff other than the designated study center.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f28457ff-47ac-4b51-8390-53994b525e68\\\", \\\"childbox\\\": \\\"043dfac1-fb31-488d-b4c9-b765d9eea181\\\", \\\"subtext\\\": \\\"0df6d410-bea3-4703-916d-3d2312278b25\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1852, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to EMA Guidance on the Management of Clinical Trials during the COVID-19 pandemic (version 2, 27 March, 2020) for more details.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f28457ff-47ac-4b51-8390-53994b525e68\\\", \\\"childbox\\\": \\\"7f4f295e-693a-44b0-82d2-2d2f79365ed0\\\", \\\"subtext\\\": \\\"0df6d410-bea3-4703-916d-3d2312278b25\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1853, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f28457ff-47ac-4b51-8390-53994b525e68\\\", \\\"childbox\\\": \\\"7f4f295e-693a-44b0-82d2-2d2f79365ed0\\\", \\\"subtext\\\": \\\"fff1465e-239f-4c47-a7d0-5357985b1215\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1854, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Impact on the per protocol set (PPS) for immunogenicity will be determined on a case by case basis.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8688f6ec-d7f6-484e-9fd6-4ef5022a7c70\\\", \\\"childbox\\\": \\\"c5ebf619-58cb-440d-87f8-e7fb4bb20404\\\", \\\"subtext\\\": \\\"0fb7ef09-53e3-4af8-9419-f37ef7f4f09b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Procedures During Special Circumstances\\\", \\\"8.9\\\", \\\"2\\\", 1855, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.0  STATISTICAL CONSIDERATIONS\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading1\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fa025f52-27b4-4613-9047-aa64ac1e595e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"STATISTICAL CONSIDERATIONS\\\", \\\"9.0\\\", \\\"2\\\", 1856, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.1 Statistical Hypotheses\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f2ad525d-0e6a-41c0-85af-db3529b3aae1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1857, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"~REDACTED~ Immunogenicity Objective (Family 1)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"088d24ef-c220-4b2d-b10a-5bf65e9161e1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1858, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The first co-primary immunogenicity objective is to demonstrate the immunological non-inferiority (NI) of the antibody response to MenABCWY ~REDACTED~, compared to MenACWY ~REDACTED~ given to healthy participants, previously primed with MenACWY, as measured by percentage of participants with 4-fold rise in hSBA titer against each of the\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"18ff7237-e4ce-4bae-8532-8f6b8e7b3f99\\\", \\\"childbox\\\": \\\"b6cd2a05-68c9-4df9-b195-59543920cd9c\\\", \\\"subtext\\\": \\\"43d362fc-ceb0-4296-b4e2-a1ba24b5f87e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1859, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"18ff7237-e4ce-4bae-8532-8f6b8e7b3f99\\\", \\\"childbox\\\": \\\"b6cd2a05-68c9-4df9-b195-59543920cd9c\\\", \\\"subtext\\\": \\\"02cee150-57a3-4a0b-b263-fe16280fd564\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1860, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"18ff7237-e4ce-4bae-8532-8f6b8e7b3f99\\\", \\\"childbox\\\": \\\"ee0dcfc6-2057-494c-b83f-11bbb9671f02\\\", \\\"subtext\\\": \\\"02cee150-57a3-4a0b-b263-fe16280fd564\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1861, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"serogroups A, C, W, and Y, at 1 month after the second MenABCWY vaccination and 1 month after the MenACWY vaccination (single dose).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"18ff7237-e4ce-4bae-8532-8f6b8e7b3f99\\\", \\\"childbox\\\": \\\"ee0dcfc6-2057-494c-b83f-11bbb9671f02\\\", \\\"subtext\\\": \\\"7dbeb5bc-de74-4d18-b9fe-15e6443df113\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1862, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This translates to the following hypotheses:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"18ff7237-e4ce-4bae-8532-8f6b8e7b3f99\\\", \\\"childbox\\\": \\\"210e0aa6-fe9d-45b4-a698-e8e6f79a7a90\\\", \\\"subtext\\\": \\\"7dbeb5bc-de74-4d18-b9fe-15e6443df113\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1863, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"H\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c887c79c-731b-42c8-9ff4-a16a58cc350d\\\", \\\"childbox\\\": \\\"108a7d90-09a0-47a2-afea-08be5858d68e\\\", \\\"subtext\\\": \\\"87f15347-38f1-459f-92d3-d7927b864571\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1864, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"0\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c887c79c-731b-42c8-9ff4-a16a58cc350d\\\", \\\"childbox\\\": \\\"108a7d90-09a0-47a2-afea-08be5858d68e\\\", \\\"subtext\\\": \\\"040b5f77-f39c-43c1-a105-f2efab2c0236\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"subscript\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1865, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\":\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c887c79c-731b-42c8-9ff4-a16a58cc350d\\\", \\\"childbox\\\": \\\"108a7d90-09a0-47a2-afea-08be5858d68e\\\", \\\"subtext\\\": \\\"b458ac45-9a05-4ce5-83c8-107c1db9504b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1866, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c887c79c-731b-42c8-9ff4-a16a58cc350d\\\", \\\"childbox\\\": \\\"2495fa53-8a31-41d2-aa4e-28527db20bdb\\\", \\\"subtext\\\": \\\"b5ae5931-77ca-4c4a-8ccc-23a045a67c21\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1867, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(p1_MenABCWY\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c887c79c-731b-42c8-9ff4-a16a58cc350d\\\", \\\"childbox\\\": \\\"2651f27d-b5fe-43bf-86d4-493da3cff6e8\\\", \\\"subtext\\\": \\\"b5ae5931-77ca-4c4a-8ccc-23a045a67c21\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1868, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(i)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c887c79c-731b-42c8-9ff4-a16a58cc350d\\\", \\\"childbox\\\": \\\"2651f27d-b5fe-43bf-86d4-493da3cff6e8\\\", \\\"subtext\\\": \\\"69db19aa-4035-4a3d-9e04-686ac51c79bd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"subscript\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1869, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2013 p1_MenACWY\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c887c79c-731b-42c8-9ff4-a16a58cc350d\\\", \\\"childbox\\\": \\\"2651f27d-b5fe-43bf-86d4-493da3cff6e8\\\", \\\"subtext\\\": \\\"44adbe37-0ee0-4b5a-99e5-a3832b165fd5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1870, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(i)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c887c79c-731b-42c8-9ff4-a16a58cc350d\\\", \\\"childbox\\\": \\\"2651f27d-b5fe-43bf-86d4-493da3cff6e8\\\", \\\"subtext\\\": \\\"ad093c28-8ac3-423a-b1e8-b49bc958cf72\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"subscript\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1871, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2264\\\\u221210%\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c887c79c-731b-42c8-9ff4-a16a58cc350d\\\", \\\"childbox\\\": \\\"2651f27d-b5fe-43bf-86d4-493da3cff6e8\\\", \\\"subtext\\\": \\\"8ac51b1c-b5d8-4ca0-981e-0cea672a4b5f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1872, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"vs.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1cf7d389-5caf-4dba-a53b-8ef54d5bb0e6\\\", \\\"childbox\\\": \\\"a539a7e4-8add-46c4-8cb4-88b8a7d59280\\\", \\\"subtext\\\": \\\"7e70f01b-d061-4ab0-ac2e-47b7b3ba9e85\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1873, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"H1:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e61fd6b3-9918-4b71-aca3-7c40909a4b23\\\", \\\"childbox\\\": \\\"a10c5039-9511-4a81-b1b7-9978feff7ed7\\\", \\\"subtext\\\": \\\"c580ea41-7304-4d5b-873e-6c1e6f43d318\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1874, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e61fd6b3-9918-4b71-aca3-7c40909a4b23\\\", \\\"childbox\\\": \\\"777cbe81-a766-44b9-b8d2-590f419902fd\\\", \\\"subtext\\\": \\\"ddedc5f5-5ff9-4b96-8fe5-81005ce94625\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1875, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(p1_MenABCWY(i) \\\\u2013 p1_MenACWY(i) >\\\\u221210%\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e61fd6b3-9918-4b71-aca3-7c40909a4b23\\\", \\\"childbox\\\": \\\"5f4c2d95-328b-45c2-a995-ef887e87b93c\\\", \\\"subtext\\\": \\\"ddedc5f5-5ff9-4b96-8fe5-81005ce94625\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1876, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Where\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1f3d4426-4e5a-4d5f-816b-3cac75cebb84\\\", \\\"childbox\\\": \\\"5a5b9e4e-5389-41e7-9448-43c6f597ec9e\\\", \\\"subtext\\\": \\\"f00cd741-8365-4755-9090-56af0634185f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1877, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1f3d4426-4e5a-4d5f-816b-3cac75cebb84\\\", \\\"childbox\\\": \\\"5a5b9e4e-5389-41e7-9448-43c6f597ec9e\\\", \\\"subtext\\\": \\\"e555662c-de71-427d-9f18-05ca44a23cab\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"subscript\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1878, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"p1_MenABCWY\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1f3d4426-4e5a-4d5f-816b-3cac75cebb84\\\", \\\"childbox\\\": \\\"5a5b9e4e-5389-41e7-9448-43c6f597ec9e\\\", \\\"subtext\\\": \\\"630de5cd-c25a-4496-b7a3-220911e2993f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1879, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(i)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1f3d4426-4e5a-4d5f-816b-3cac75cebb84\\\", \\\"childbox\\\": \\\"5a5b9e4e-5389-41e7-9448-43c6f597ec9e\\\", \\\"subtext\\\": \\\"f25114ce-257f-4997-9cc6-647e0d05be95\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"subscript\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1880, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the second vaccination of MenABCWY group and p1_MenACWY\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1f3d4426-4e5a-4d5f-816b-3cac75cebb84\\\", \\\"childbox\\\": \\\"5a5b9e4e-5389-41e7-9448-43c6f597ec9e\\\", \\\"subtext\\\": \\\"f429e653-3266-46d0-af74-6c626f4eba49\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1881, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(i)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1f3d4426-4e5a-4d5f-816b-3cac75cebb84\\\", \\\"childbox\\\": \\\"5a5b9e4e-5389-41e7-9448-43c6f597ec9e\\\", \\\"subtext\\\": \\\"64662a88-debe-4abf-8a71-ad84bdac6798\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"subscript\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1882, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1f3d4426-4e5a-4d5f-816b-3cac75cebb84\\\", \\\"childbox\\\": \\\"5a5b9e4e-5389-41e7-9448-43c6f597ec9e\\\", \\\"subtext\\\": \\\"7cb27ec1-ad4e-46e0-b795-803b6f372d9f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1883, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b48522e7-17e1-4a95-8e4f-d276310bc20c\\\", \\\"childbox\\\": \\\"ea631e11-2856-4365-9487-b53967da1b6e\\\", \\\"subtext\\\": \\\"190af295-a009-4614-b624-bfae1e3c98f3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1884, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"~REDACTED~ Immunogenicity Objective (Family 2)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"56dc1b51-a9f5-4a6a-8f98-7868782c7efb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1885, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The second co-primary immunogenicity objective is to demonstrate the immunological NI of the antibody response to MenABCWY ~REDACTED~, compared to MenACWY ~REDACTED~ given to healthy participants, previously primed with MenACWY, as measured by percentage of participants with 4-fold rise in hSBA titer against each of the\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5bee046e-57a0-43fb-8884-df7ebd2c76d1\\\", \\\"childbox\\\": \\\"38fb0efb-e647-404f-99b5-2e00956fcd11\\\", \\\"subtext\\\": \\\"c8f44442-3468-4359-9a25-de5655238219\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1886, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5bee046e-57a0-43fb-8884-df7ebd2c76d1\\\", \\\"childbox\\\": \\\"38fb0efb-e647-404f-99b5-2e00956fcd11\\\", \\\"subtext\\\": \\\"fe9838c2-3f99-47ad-bbf3-b49d46761935\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1887, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5bee046e-57a0-43fb-8884-df7ebd2c76d1\\\", \\\"childbox\\\": \\\"cc1274cb-d51c-4fba-a6c0-f82d4871950e\\\", \\\"subtext\\\": \\\"fe9838c2-3f99-47ad-bbf3-b49d46761935\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1888, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"serogroups A, C, W, and Y, at 1 month after the first MenABCWY vaccination and 1 month after the MenACWY vaccination (single dose).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5bee046e-57a0-43fb-8884-df7ebd2c76d1\\\", \\\"childbox\\\": \\\"cc1274cb-d51c-4fba-a6c0-f82d4871950e\\\", \\\"subtext\\\": \\\"22ca9132-69bb-4391-9c68-951de45132fe\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1889, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This translates to the following hypotheses:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5bee046e-57a0-43fb-8884-df7ebd2c76d1\\\", \\\"childbox\\\": \\\"74697b5f-4697-4e1e-ba90-c7d1a3ec7492\\\", \\\"subtext\\\": \\\"22ca9132-69bb-4391-9c68-951de45132fe\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1890, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"H\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb5e667e-4ff7-412e-94b3-d9c2e6c5407f\\\", \\\"childbox\\\": \\\"98423393-514a-4720-84c6-ff0b66ffcca7\\\", \\\"subtext\\\": \\\"89459abf-5609-4343-b06e-e007b9fdaf89\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1891, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"0\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb5e667e-4ff7-412e-94b3-d9c2e6c5407f\\\", \\\"childbox\\\": \\\"98423393-514a-4720-84c6-ff0b66ffcca7\\\", \\\"subtext\\\": \\\"be4d4a43-6508-407a-8280-fd3241ea2c1f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"subscript\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1892, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\":\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb5e667e-4ff7-412e-94b3-d9c2e6c5407f\\\", \\\"childbox\\\": \\\"98423393-514a-4720-84c6-ff0b66ffcca7\\\", \\\"subtext\\\": \\\"595c47f4-0c3c-4f1a-b415-b421887b35cc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1893, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb5e667e-4ff7-412e-94b3-d9c2e6c5407f\\\", \\\"childbox\\\": \\\"ab59950d-c039-4970-87de-78a5069a2d2b\\\", \\\"subtext\\\": \\\"82e4a770-ed45-4881-a3b8-9cb8247f93c2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1894, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(p2_MenABCWY\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb5e667e-4ff7-412e-94b3-d9c2e6c5407f\\\", \\\"childbox\\\": \\\"2642c316-64c1-423a-a3ed-dc4b3ee950d8\\\", \\\"subtext\\\": \\\"82e4a770-ed45-4881-a3b8-9cb8247f93c2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1895, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(i)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb5e667e-4ff7-412e-94b3-d9c2e6c5407f\\\", \\\"childbox\\\": \\\"2642c316-64c1-423a-a3ed-dc4b3ee950d8\\\", \\\"subtext\\\": \\\"4e068163-4063-4eac-b59d-1dec63799b1d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"subscript\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1896, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2013 p2_MenACWY\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb5e667e-4ff7-412e-94b3-d9c2e6c5407f\\\", \\\"childbox\\\": \\\"2642c316-64c1-423a-a3ed-dc4b3ee950d8\\\", \\\"subtext\\\": \\\"f0443340-295c-457b-8071-8b2758b4d798\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1897, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(i)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb5e667e-4ff7-412e-94b3-d9c2e6c5407f\\\", \\\"childbox\\\": \\\"2642c316-64c1-423a-a3ed-dc4b3ee950d8\\\", \\\"subtext\\\": \\\"f2e195a9-587b-491f-98d1-ea7cfe665e57\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"subscript\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1898, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2264\\\\u221210%\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb5e667e-4ff7-412e-94b3-d9c2e6c5407f\\\", \\\"childbox\\\": \\\"2642c316-64c1-423a-a3ed-dc4b3ee950d8\\\", \\\"subtext\\\": \\\"cfc74a70-c001-4a23-88a5-72e00c9aecdb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1899, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"vs.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"17c39a11-4dd1-4475-82eb-cddbc111aca9\\\", \\\"childbox\\\": \\\"09200bed-c3e3-4fda-b53a-720fdf37d108\\\", \\\"subtext\\\": \\\"3e038d16-b5e9-4396-a10e-534efa8a348e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1900, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"H1:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d8316ba6-d012-46b8-ac4a-94911a0a17f1\\\", \\\"childbox\\\": \\\"05a8736c-35b2-401e-91a8-9c640e7c8187\\\", \\\"subtext\\\": \\\"654ecdda-4b2a-4fa8-893a-ce69e1d06863\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1901, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d8316ba6-d012-46b8-ac4a-94911a0a17f1\\\", \\\"childbox\\\": \\\"cab1ef57-75f5-4cb1-89a3-a9427f91bed4\\\", \\\"subtext\\\": \\\"056ac941-8054-46d9-87c4-81e63ef5fd32\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1902, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(p2_MenABCWY(i) \\\\u2013 p2_MenACWY(i) >\\\\u221210%\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d8316ba6-d012-46b8-ac4a-94911a0a17f1\\\", \\\"childbox\\\": \\\"a15e2344-b157-479a-9114-953e04a45204\\\", \\\"subtext\\\": \\\"056ac941-8054-46d9-87c4-81e63ef5fd32\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1903, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Where\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e31ce2c0-6c31-4c42-a4b2-ab3669e1ee92\\\", \\\"childbox\\\": \\\"486e7c86-5862-447f-b148-c0f41a58e26a\\\", \\\"subtext\\\": \\\"07cfedeb-33a5-41a9-82c1-47c07c4710ea\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1904, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e31ce2c0-6c31-4c42-a4b2-ab3669e1ee92\\\", \\\"childbox\\\": \\\"486e7c86-5862-447f-b148-c0f41a58e26a\\\", \\\"subtext\\\": \\\"ce4a89db-005e-4955-a50f-431a68d0620a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"subscript\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1905, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"p2_MenABCWY\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e31ce2c0-6c31-4c42-a4b2-ab3669e1ee92\\\", \\\"childbox\\\": \\\"486e7c86-5862-447f-b148-c0f41a58e26a\\\", \\\"subtext\\\": \\\"b9bdd848-2e68-4683-a59d-cbf847eac457\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1906, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(i)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e31ce2c0-6c31-4c42-a4b2-ab3669e1ee92\\\", \\\"childbox\\\": \\\"486e7c86-5862-447f-b148-c0f41a58e26a\\\", \\\"subtext\\\": \\\"591e924d-95c6-4810-96fc-6eab229be406\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"subscript\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1907, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the first vaccination of MenABCWY group and p2_MenACWY\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e31ce2c0-6c31-4c42-a4b2-ab3669e1ee92\\\", \\\"childbox\\\": \\\"486e7c86-5862-447f-b148-c0f41a58e26a\\\", \\\"subtext\\\": \\\"e4e37170-01fa-4c67-895c-d066d8bafe48\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1908, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(i)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e31ce2c0-6c31-4c42-a4b2-ab3669e1ee92\\\", \\\"childbox\\\": \\\"486e7c86-5862-447f-b148-c0f41a58e26a\\\", \\\"subtext\\\": \\\"dcb6528c-3b00-4e75-a747-991edd63f806\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"subscript\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1909, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"denotes the percentages of participants with 4-fold rise in hSBA titers for serogroups i=A, C, W, and Y, 1 month after the single vaccination of MenACWY group.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e31ce2c0-6c31-4c42-a4b2-ab3669e1ee92\\\", \\\"childbox\\\": \\\"486e7c86-5862-447f-b148-c0f41a58e26a\\\", \\\"subtext\\\": \\\"55fffd68-68a5-4f47-a354-684bf2a0e4ef\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1910, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"NI criterion: Non-inferiority will be demonstrated if the lower limit of the two-sided 95% CI for the percent difference in the 4-fold rise in hSBA titers (p_MenABCWY\\\\u2013 p_MenACWY) is above \\\\u221210% for each serogroup A, C, W, and Y.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"22857a0b-d5e8-46b4-9561-8f38fe4b8ad0\\\", \\\"childbox\\\": \\\"bbe37521-70fb-46a0-b4ec-0f4b1e100457\\\", \\\"subtext\\\": \\\"830001b9-620a-4d0e-8d76-3a0fd99f0bbd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Hypotheses\\\", \\\"9.1\\\", \\\"2\\\", 1911, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.2 Sample Size Determination\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ec454c2e-661e-4672-954d-3bf4eb05babb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sample Size Determination\\\", \\\"9.2\\\", \\\"2\\\", 1912, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The sample size calculation was based on data from the MenABCWY, V102_03E1 study after adjusting for the variabilities due to different settings of the study (e.g., differences in population, differences in antibody assays, and different strain for serogroup A) (Table 14).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5fd4ca38-3c8d-4678-ae04-dec42a58bc02\\\", \\\"childbox\\\": \\\"fabc9ef7-a538-46c8-929e-ceeae1aadb5d\\\", \\\"subtext\\\": \\\"019d3bf6-4966-4f6b-8473-558da3ac9c3b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sample Size Determination\\\", \\\"9.2\\\", \\\"2\\\", 1913, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Assuming that MenACWY group will induce a 4-fold rise in about 95% of the participants for each of the 4 serogroups; MenABCWY will induce a 4-fold rise in about 91% of the participants for A and W serogroups, and 93% of the participants for C and Y serogroups; and using a 1-sided score test (~REDACTED~, 1985), non-inferiority margin of \\\\u221210% and actual margins as given in Table 14, an estimated number of evaluable participants (n=542) and individual powers of 96.00%, 99.95%, 96.00%, and 99.95% for each A, C, W, and Y serogroup test, will give a global power of 90% to demonstrate NI of MenABCWY vs MenACWY.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a6252a81-1a3c-4adc-8fb5-f75deafbacbe\\\", \\\"childbox\\\": \\\"10adc5ed-5484-439c-a6f1-1b58eb8483e5\\\", \\\"subtext\\\": \\\"e91dac8c-101b-47d2-a70b-b72eacb2b58c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sample Size Determination\\\", \\\"9.2\\\", \\\"2\\\", 1914, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Family 1:  Assuming that MenABCWY and MenACWY groups will induce a 4-fold rise in about 95% of the participants for each of the 4 serogroups (Table 14), and using a 1-sided score test (~REDACTED~, 1985), non-inferiority margin of \\\\u221210% and actual margin of\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f7276a1b-ada4-422a-9fd0-3f02293693a5\\\", \\\"childbox\\\": \\\"658bb8e6-39cd-4e31-883a-c54501a92e83\\\", \\\"subtext\\\": \\\"9a3c2fb3-392b-4fc0-ad6e-2ff5b422fdc5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sample Size Determination\\\", \\\"9.2\\\", \\\"2\\\", 1915, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"0%, an estimated number of evaluable participants (n = 225) and individual powers of 99.87% for each A, C, W, and Y serogroup test, will give a global power of 99.48% to demonstrate non-inferiority of MenABCWY versus MenACWY.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b3eb9b12-ea61-4cf7-af0d-09deaeaf6778\\\", \\\"childbox\\\": \\\"1d45ee0c-b27e-4db1-8936-c8b5d72ee3f4\\\", \\\"subtext\\\": \\\"53172af4-3dcb-4b3b-abb1-41825fdb5a2d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sample Size Determination\\\", \\\"9.2\\\", \\\"2\\\", 1916, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Family 2: Assuming that MenACWY group will induce a 4-fold rise in about 95% of the participants for each of the 4 serogroups; MenABCWY will induce a 4-fold rise in about 91% of the participants for A and W serogroups, and 93% of the participants for C and Y serogroups; and, using a 1-sided score test (~REDACTED~, 1985), non-inferiority margin of \\\\u221210% and actual margins as given in Table 14, an estimated evaluable participants\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"26d45117-d42d-4307-b331-638cfde23ada\\\", \\\"childbox\\\": \\\"5d80c5ed-c54a-4418-b77a-fb37f62d9a5b\\\", \\\"subtext\\\": \\\"3664c501-b353-4392-b70c-a9b03725bb15\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sample Size Determination\\\", \\\"9.2\\\", \\\"2\\\", 1917, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(n=542) and individual powers of 96.00%, 99.95%, 96.00%, and 99.95% for each A, C, W, and Y serogroup test, will give a global power of 91% to demonstrate NI of\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ef25a869-9232-407a-bd95-490768c07389\\\", \\\"childbox\\\": \\\"01e13ff1-21fb-43a2-b7ce-d98ece850c12\\\", \\\"subtext\\\": \\\"e26b19b9-55c6-44e2-983a-992032f90d12\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sample Size Determination\\\", \\\"9.2\\\", \\\"2\\\", 1918, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"MenABCWY versus MenACWY.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9a29416c-80fa-41bc-bb51-6ddb46c07227\\\", \\\"childbox\\\": \\\"2c9a3232-8429-439d-9505-a51ee43759b9\\\", \\\"subtext\\\": \\\"ba5d6895-aa4c-4e12-82d7-0c6c507e5665\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sample Size Determination\\\", \\\"9.2\\\", \\\"2\\\", 1919, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For the multiplicity adjustment, all hypotheses will be ranked into two families according to the following power of test:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f9797fa8-2a15-47e8-80c7-af4c35361a18\\\", \\\"childbox\\\": \\\"ce7a354c-2740-4600-8c75-fe529b238cd5\\\", \\\"subtext\\\": \\\"e685da80-5974-4432-9fc6-11ac5f9ae264\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sample Size Determination\\\", \\\"9.2\\\", \\\"2\\\", 1920, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"87daf4a0-d2c3-44be-98fd-2867afdd32fe\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Sample Size Determination\\\", \\\"9.2\\\", \\\"2\\\", 1921, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Table 14 Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"526116e4-65d9-443a-a9cb-9c974827fc3c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1922, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n      <th>5.0</th>\\\\n      <th>6.0</th>\\\\n      <th>7.0</th>\\\\n      <th>8.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Serogroup</td>\\\\n      <td>4-fold rate</td>\\\\n      <td>4-fold rate MenABCWY</td>\\\\n      <td>NI margin</td>\\\\n      <td>Actual margin</td>\\\\n      <td>Power</td>\\\\n      <td>N</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td></td>\\\\n      <td>MenACWY</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>ABCWY/</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>ACWY</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Family 1: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 1: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 1: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 1: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 1: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>A</td>\\\\n      <td>95%</td>\\\\n      <td>95%</td>\\\\n      <td>\\\\u221210%</td>\\\\n      <td>0%</td>\\\\n      <td>99.87%</td>\\\\n      <td></td>\\\\n      <td>225</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>C</td>\\\\n      <td>95%</td>\\\\n      <td>95%</td>\\\\n      <td>\\\\u221210%</td>\\\\n      <td>0%</td>\\\\n      <td>99.87%</td>\\\\n      <td></td>\\\\n      <td>225</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td>W</td>\\\\n      <td>95%</td>\\\\n      <td>95%</td>\\\\n      <td>\\\\u221210%</td>\\\\n      <td>0%</td>\\\\n      <td>99.87%</td>\\\\n      <td></td>\\\\n      <td>225</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>7</th>\\\\n      <td>Y</td>\\\\n      <td>95%</td>\\\\n      <td>95%</td>\\\\n      <td>\\\\u221210%</td>\\\\n      <td>0%</td>\\\\n      <td>99.87%</td>\\\\n      <td></td>\\\\n      <td>225</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>8</th>\\\\n      <td>Global Power</td>\\\\n      <td>Global Power</td>\\\\n      <td>Global Power</td>\\\\n      <td>Global Power</td>\\\\n      <td>Global Power</td>\\\\n      <td>99.48%</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>9</th>\\\\n      <td>Family 2: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 2: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 2: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 2: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td>Family 2: NI, 2-sided score test (<span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> and <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, 1985)</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>10</th>\\\\n      <td>A</td>\\\\n      <td>95%</td>\\\\n      <td>91%</td>\\\\n      <td>\\\\u221210%</td>\\\\n      <td>\\\\u22124%</td>\\\\n      <td>96.00%</td>\\\\n      <td></td>\\\\n      <td>542</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>11</th>\\\\n      <td>C</td>\\\\n      <td>95%</td>\\\\n      <td>93%</td>\\\\n      <td>\\\\u221210%</td>\\\\n      <td>\\\\u22122%</td>\\\\n      <td>99.95%</td>\\\\n      <td></td>\\\\n      <td>542</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>12</th>\\\\n      <td>W</td>\\\\n      <td>95%</td>\\\\n      <td>91%</td>\\\\n      <td>\\\\u221210%</td>\\\\n      <td>\\\\u22124%</td>\\\\n      <td>96.00%</td>\\\\n      <td></td>\\\\n      <td>542</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>13</th>\\\\n      <td>Y</td>\\\\n      <td>95%</td>\\\\n      <td>93%</td>\\\\n      <td>\\\\u221210%</td>\\\\n      <td>\\\\u22122%</td>\\\\n      <td>99.95%</td>\\\\n      <td></td>\\\\n      <td>542</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>14</th>\\\\n      <td>Global Power</td>\\\\n      <td>Global Power</td>\\\\n      <td>Global Power</td>\\\\n      <td>Global Power</td>\\\\n      <td>Global Power</td>\\\\n      <td>91.00%</td>\\\\n      <td></td>\\\\n      <td></td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"75\\\", \\\"TableIndex\\\": \\\"32\\\", \\\"TableName\\\": \\\"Table 14 Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Header\\\": [0, 1, 2]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"100a1e97-0df8-4c3f-a6cc-59c4dac62ed7\\\", \\\"childbox\\\": \\\"1943137f-0008-4773-bf98-9e0578d5a60a\\\", \\\"subtext\\\": \\\"46db3326-807c-46bf-89e2-62b16ba47d6b\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1923, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9a8276b9-f166-41ff-b10a-c3ebc46cc672\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1924, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7b9e832e-cb6d-4892-a72e-44b51ed2ddb0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1925, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"453f6756-f548-4122-b913-8568a0ed5a7d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1926, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3e7da8a0-e8c6-4d43-a5dc-15d784a6b34a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1927, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ebe9bd1d-d6f4-44ed-94b2-f3d7af0186b4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1928, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a853d4e2-87d9-4777-989e-10c68bae8941\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1929, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f055324d-b871-43dd-aeaf-79e99fcd3656\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1930, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e91f5511-c167-45be-a386-e871dc5616cc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1931, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1d816821-0a9b-4437-80d5-3f42b5ee3821\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1932, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"98fb17dc-0c02-48b6-a21e-4ab946def610\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1933, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f547f835-b566-485c-bbc2-42411283bccb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1934, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dc4bac03-d8a5-41e3-9355-9592082e40cb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1935, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5301da29-6c53-4369-9581-acc08dd2dd0b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1936, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d2df5637-8b39-4d58-853a-42f655b28888\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1937, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b0e57f15-6674-4f21-b787-f89ff79ea745\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1938, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bda009eb-addf-4ba8-8a65-71b7bab1833d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1939, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7d92d0ed-9f08-43c6-a2aa-94623dd8119c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1940, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"82527d1e-17f3-4927-8ecf-315c6ea30251\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1941, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f4a1f8a3-dc9b-4bc1-ac41-a075ac794400\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1942, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6c66854c-950b-44f6-beba-49fed5c1df15\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1943, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8695109a-704e-4ed6-a0d5-83b637d984ee\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1944, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65435b13-1d41-4315-9520-6f9212d6bf72\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1945, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eeeadcb6-0eee-442b-8dfb-54b9bf0c92a4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1946, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0ac3a34f-8f2c-49f0-8072-339eaad84521\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1947, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"acd37cb4-ff13-4ad8-a18b-a3668f567484\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1948, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"490c0738-e30e-4aee-982a-d1be85c64db9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1949, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"242d00d1-a4cf-4568-9e83-2285c8a9212c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1950, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dcc43d6d-5354-4049-ba92-f5e3c6cee8b8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1951, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"236cb791-447d-47be-ac03-900c26815dba\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1952, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5c4b29ca-2402-4ad0-bb72-c4cca6fdc5ad\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1953, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"n = number of participants; NI = non-inferiority\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"71c32015-82f4-4950-8e6f-a82446bcd843\\\", \\\"childbox\\\": \\\"13677e3b-a6bd-49d0-ad5a-0981b4f72147\\\", \\\"subtext\\\": \\\"334714e8-0952-459a-bde4-758797e3d2c6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1954, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Considering that approximately 10% of the selected participants might withdraw or not be evaluable for the immunogenicity objectives, the target sample size to be analyzed will be 270 participants per group and 603 participants per group for the first co-primary and the second co-primary objectives, respectively.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1bb43ea6-de39-45d1-8f08-84d06552aa6a\\\", \\\"childbox\\\": \\\"c0474d13-4299-4567-b806-5c1f50821f60\\\", \\\"subtext\\\": \\\"f7f535c9-bb70-42cb-89d4-790745235e72\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1955, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Evaluable means all participants included in the set for the statistical analysis defined in Section 9.3.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ad1b647a-09ca-4b8d-a9f3-e954a8696c04\\\", \\\"childbox\\\": \\\"cfb6cbd5-264a-4614-8f04-95f999f01b0c\\\", \\\"subtext\\\": \\\"65455117-1b83-4f12-8b63-b20ebc921cb9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1956, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The sample size calculation was performed in PASS 12 (~REDACTED~, 2013).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ad1b647a-09ca-4b8d-a9f3-e954a8696c04\\\", \\\"childbox\\\": \\\"545f41a8-3315-41a1-aba6-65f6cc8d4a11\\\", \\\"subtext\\\": \\\"65455117-1b83-4f12-8b63-b20ebc921cb9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1957, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The global power for all 4 strains across Family 1 and Family 2 is the product of individual powers.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ad1b647a-09ca-4b8d-a9f3-e954a8696c04\\\", \\\"childbox\\\": \\\"84b0dd16-7322-4f7c-a371-3b034b6f54c1\\\", \\\"subtext\\\": \\\"9e35201c-094d-4696-b45e-4dcd7499af5d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1958, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Approximately 1206 participants will be randomized in a 1:1 ratio to achieve 1084 evaluable participants (542 per group).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8750c833-be2e-42af-a3e0-7617dcc71917\\\", \\\"childbox\\\": \\\"c7589ef8-fc04-4e38-aaa4-6be58bfb3306\\\", \\\"subtext\\\": \\\"f4594f89-7ec1-4423-87da-2500a9fe6701\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1959, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Withdrawals will not be replaced.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"49effd88-5c9a-4793-a421-392fc9976027\\\", \\\"childbox\\\": \\\"3e2f038f-d572-4b60-96ea-a116eca10500\\\", \\\"subtext\\\": \\\"5d8b15fd-a96c-4c42-9539-0257fd66c6ee\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1960, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.3 Populations for Analyses\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"995e319b-5f92-4a31-890e-fb80b88b66ae\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1961, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Populations for analyses in this study are defined in Table 15.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7d0b08fe-3d56-4c6e-a422-1231a7751eac\\\", \\\"childbox\\\": \\\"a6879d3d-0e5e-4683-a0ed-9b3b2b42d3b4\\\", \\\"subtext\\\": \\\"a3b14bfa-a77a-4b24-a532-d135e134345e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Power to Demonstrate Immunological Non-inferiority for Serogroups A, C, W, and Y of MenABCWY Compared to MenACWY (Primary)\\\", \\\"Table 14\\\", \\\"1\\\", 1962, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.3 Table 15 Populations for Analyses\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d8c16f04-1176-4326-9201-c6c5b056aa46\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Populations for Analyses\\\", \\\"Table 15\\\", \\\"1\\\", 1963, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Analysis set</td>\\\\n      <td>Description</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Enrolled Set (Enr)</td>\\\\n      <td>Participant who agreed/participant for whom parent(s)/LAR(s) agreed to participate in a clinical study after completion of the informed consent process and randomized or received study intervention or undergone an invasive procedure.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Exposed Set (ES)</td>\\\\n      <td>All participants who received at least 1 dose of the study intervention. The allocation in a group is done in function of all administered interventions.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Full Analysis Set (FAS)</td>\\\\n      <td>All participant who received at least 1 dose of the study intervention and have post-vaccination immunogenicity data</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>Per Protocol Set (PPS)</td>\\\\n      <td>All participants who received at least 1 dose of the study intervention to which they are randomized and have post-vaccination data (FAS) minus participants with protocol deviations that lead to exclusion from the PPS.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>Unsolicited Safety Set (USS)</td>\\\\n      <td>All participants who received at least 1 dose of the study intervention (ES) that report unsolicited AEs/report not having unsolicited AEs</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td>Solicited Safety Set (SSS)</td>\\\\n      <td>All participants who received at least 1 dose of the study intervention (ES) that report solicited safety data</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"76\\\", \\\"TableIndex\\\": \\\"33\\\", \\\"TableName\\\": \\\"Table 15 Populations for Analyses\\\", \\\"Header\\\": [0, 1, 2, 3]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"286107db-f886-47a8-89fb-42b1bb23ede4\\\", \\\"childbox\\\": \\\"06dc7b87-9933-4b25-be18-e357aa197991\\\", \\\"subtext\\\": \\\"1cdfba59-788b-4088-8023-dcd8d9cffb2a\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Populations for Analyses\\\", \\\"Table 15\\\", \\\"1\\\", 1964, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"AE = adverse event; LAR = legally acceptable representative\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f3dd4793-7a17-4e78-80de-81ebd7b6ef57\\\", \\\"childbox\\\": \\\"c73edc45-5b4d-4930-8f13-4c6066cc620e\\\", \\\"subtext\\\": \\\"b09747eb-eca5-4de9-b535-cde5ae5ebb6a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Populations for Analyses\\\", \\\"Table 15\\\", \\\"1\\\", 1965, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.3.1 Criteria for Elimination from Analysis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c57ee9b6-5e2d-493c-b28b-c4189381ef3f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Elimination from Analysis\\\", \\\"9.3.1\\\", \\\"3\\\", 1966, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If the participant meets 1 of the criteria mentioned in the Section 6.8, he/she may be eliminated from per protocol analysis.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"994ad021-3929-49fe-8913-79b56492514c\\\", \\\"childbox\\\": \\\"ff04e3bc-3854-4967-8b8c-6667d0a8eef2\\\", \\\"subtext\\\": \\\"fbdf7cfe-c579-4442-afe7-cebe91d2d75f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Criteria for Elimination from Analysis\\\", \\\"9.3.1\\\", \\\"3\\\", 1967, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.4 Statistical Analyses\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b8aff07e-d645-416a-9d4e-44a5de0dabbf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Analyses\\\", \\\"9.4\\\", \\\"2\\\", 1968, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The statistical analysis plan (SAP) will be finalized prior to First Participant First ~REDACTED~; the SAP will include a more technical and detailed description of the statistical analyses described in this section.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b78bbfba-c44a-453e-88a6-747070ec02c0\\\", \\\"childbox\\\": \\\"9bad1d23-a49d-4ffd-9312-157abbac874b\\\", \\\"subtext\\\": \\\"ebe395df-b51b-4834-b96d-fa370507942f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Analyses\\\", \\\"9.4\\\", \\\"2\\\", 1969, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This section is a summary of the planned statistical analyses of endpoints.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b78bbfba-c44a-453e-88a6-747070ec02c0\\\", \\\"childbox\\\": \\\"b66e0530-00b6-4d6f-ae41-aca54c28b9a7\\\", \\\"subtext\\\": \\\"02db819f-10b1-4fa8-aa54-a2c25e00edc5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Analyses\\\", \\\"9.4\\\", \\\"2\\\", 1970, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.4.1 General Considerations\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"59fe398b-6c77-4c01-8451-3a92baf222a1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1971, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Immunogenicity:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"654e9453-5cd7-4a0c-90f1-2d0a3790e40c\\\", \\\"childbox\\\": \\\"0cacf3c8-a446-43ed-bcce-29e353976940\\\", \\\"subtext\\\": \\\"9e68343d-bbcb-43f3-b6f1-bba6f4be7d81\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1972, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Non-inferiority criterion: NI will be demonstrated if, the lower limit of 2-sided 95% confidence interval (CI) for the percent difference in 4-fold rise in hSBA titers (p_MenABCWY \\\\u2212 p_MenACWY) is above \\\\u221210%, for each\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9a47a1ab-2fa3-40fb-a954-e92136558e4e\\\", \\\"childbox\\\": \\\"a9c1eba9-a5a9-4626-8051-30a4375dd0ad\\\", \\\"subtext\\\": \\\"eaef5521-7df2-431d-a74e-891ae984b4b9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1973, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9a47a1ab-2fa3-40fb-a954-e92136558e4e\\\", \\\"childbox\\\": \\\"a9c1eba9-a5a9-4626-8051-30a4375dd0ad\\\", \\\"subtext\\\": \\\"678a97c3-41dd-4c02-965b-60e0788a98ac\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1974, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9a47a1ab-2fa3-40fb-a954-e92136558e4e\\\", \\\"childbox\\\": \\\"bec947fd-4007-4919-a04f-b5e66463ffcb\\\", \\\"subtext\\\": \\\"678a97c3-41dd-4c02-965b-60e0788a98ac\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1975, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A, C, W, and Y serogroup.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9a47a1ab-2fa3-40fb-a954-e92136558e4e\\\", \\\"childbox\\\": \\\"bec947fd-4007-4919-a04f-b5e66463ffcb\\\", \\\"subtext\\\": \\\"ed5f6b2f-b633-4d41-97e3-e8c97c46e3c9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1976, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Fixed sequential testing with full alpha propagation in pre-ordered hypotheses families (Family 1 and Family 2, as defined in Section 9.1) will be applied.The assay cut-off values will be defined by the laboratory before analysis and will be documented in a protocol amendment or in the clinical study report.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e6aabf1c-83c2-42c4-a87c-b2f9710abe17\\\", \\\"childbox\\\": \\\"17ce7e16-095e-4cca-b8ae-71e5ab68eddc\\\", \\\"subtext\\\": \\\"145bb741-12e4-4f55-b18d-8ee43120d01d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1977, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 For the primary and secondary endpoints, the percentages of participants with hSBA titers \\\\u2265Lower Limit of Quantitation (LLOQ) and with a 4-fold rise in hSBA titers against each of the\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65707ce8-8c0c-4cad-80dd-3cf7a438473c\\\", \\\"childbox\\\": \\\"a51badb1-8691-4bd9-8f05-dda5e77f90c8\\\", \\\"subtext\\\": \\\"b494a299-f833-4bff-b57a-5770f10f8bca\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1978, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65707ce8-8c0c-4cad-80dd-3cf7a438473c\\\", \\\"childbox\\\": \\\"a51badb1-8691-4bd9-8f05-dda5e77f90c8\\\", \\\"subtext\\\": \\\"01ee246f-1d3e-4696-b49e-962839d71b2b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1979, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65707ce8-8c0c-4cad-80dd-3cf7a438473c\\\", \\\"childbox\\\": \\\"0c006882-d9e8-45ee-b050-10d5db01245d\\\", \\\"subtext\\\": \\\"01ee246f-1d3e-4696-b49e-962839d71b2b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1980, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"serogroup B test strains and against\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65707ce8-8c0c-4cad-80dd-3cf7a438473c\\\", \\\"childbox\\\": \\\"0c006882-d9e8-45ee-b050-10d5db01245d\\\", \\\"subtext\\\": \\\"36009a09-f62e-4096-a573-6cf18fc0f663\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1981, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65707ce8-8c0c-4cad-80dd-3cf7a438473c\\\", \\\"childbox\\\": \\\"0c006882-d9e8-45ee-b050-10d5db01245d\\\", \\\"subtext\\\": \\\"8318e79a-007a-4274-b56b-3f0159e4795b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1982, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65707ce8-8c0c-4cad-80dd-3cf7a438473c\\\", \\\"childbox\\\": \\\"3fce1cc1-b002-47c8-9564-7ceaa3476492\\\", \\\"subtext\\\": \\\"8318e79a-007a-4274-b56b-3f0159e4795b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1983, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"serogroups A, C, W, and Y will be determined.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65707ce8-8c0c-4cad-80dd-3cf7a438473c\\\", \\\"childbox\\\": \\\"3fce1cc1-b002-47c8-9564-7ceaa3476492\\\", \\\"subtext\\\": \\\"d629975f-db53-47de-94a6-012d1c64ee8d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1984, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 For the serogroups A, C, W, Y and for each of the serogroup B indicator strains evaluation the 4-fold rise is defined as:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5713337b-4297-4a75-a4bd-ff7ead880361\\\", \\\"childbox\\\": \\\"8ea27863-7a45-41c2-a6a2-931fbe6cfdd5\\\", \\\"subtext\\\": \\\"47a6ff49-b9b3-4d11-861e-e09162383b10\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1985, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d a post-vaccination hSBA titer \\\\u226516 for participants with a pre-vaccination hSBA titer <4;\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e29e7e53-d48e-45fa-8d31-dabc9ffbee9c\\\", \\\"childbox\\\": \\\"ebd34e60-8211-40f1-91dd-426535d5c488\\\", \\\"subtext\\\": \\\"09baaeb9-9403-4fbc-9c37-e7b4298b30d3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1986, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d a post-vaccination hSBA titer \\\\u22654 times the LLOQ for participants with a pre-vaccination hSBA titer \\\\u2265limit of detection (LOD) but <LLOQ; and,\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7c48cedc-c90e-400c-82fd-2868a86e37c5\\\", \\\"childbox\\\": \\\"d9825397-b552-4981-a0a3-72117185190c\\\", \\\"subtext\\\": \\\"97378f5d-49d8-42db-857e-5ff648e8dece\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1987, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d a post-vaccination hSBA titer \\\\u22654 times the pre-vaccination titer for participants with a pre-vaccination hSBA titer \\\\u2265LLOQ.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6e3c8d32-7dfc-417a-a0f6-c4a4369a9aed\\\", \\\"childbox\\\": \\\"67a49153-822f-46ba-9166-28ef9df8b117\\\", \\\"subtext\\\": \\\"3f3420df-e2ff-402c-8b8c-a32f407d4b63\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1988, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The geometric mean titers (GMTs)/geometric mean concentrations (GMCs) calculations are performed by taking the anti-log of the mean of the log titer transformations.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"622a34ad-78c1-4bc4-99d7-ede8f3699b5d\\\", \\\"childbox\\\": \\\"b2fb7cb2-91c3-4e4b-8f52-a85665637ba3\\\", \\\"subtext\\\": \\\"9437f57d-6c9f-41ec-901f-11de6f52120b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1989, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Values to be used for the antibody concentrations/titers below the assay cut-off will be described in the SAP.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"622a34ad-78c1-4bc4-99d7-ede8f3699b5d\\\", \\\"childbox\\\": \\\"29ba0438-e995-489a-83b2-9c3bc2c8ccbf\\\", \\\"subtext\\\": \\\"9437f57d-6c9f-41ec-901f-11de6f52120b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1990, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Handling of missing data will be discussed in the SAP.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8f3b5598-5fcb-4b3d-9960-b5ed62dfc988\\\", \\\"childbox\\\": \\\"8281d2bf-f415-4bd3-ace0-7d77fe95c476\\\", \\\"subtext\\\": \\\"b623ac97-2be0-4888-a347-77d096373f68\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1991, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"During special circumstances (e.g., COVID-19 pandemic), the specific guidance from local public health and other competent authorities regarding the protection of individuals\\\\u2019 welfare will be applied.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"017edca3-2bf0-457c-b9db-f72be08a241b\\\", \\\"childbox\\\": \\\"50facce6-9b0e-4618-95ab-4373c19c1b1c\\\", \\\"subtext\\\": \\\"5ef83e5e-03ed-49d9-b36a-b0e3d8af89ca\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1992, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For the duration of such special circumstances, some measures may impact the data and analysis (e.g., missing visits, early study discontinuation, see Section 8.9).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"017edca3-2bf0-457c-b9db-f72be08a241b\\\", \\\"childbox\\\": \\\"dda7ae89-8054-41b2-a6e4-a120a0a7f3be\\\", \\\"subtext\\\": \\\"d0c6cc70-3475-4b70-8ff7-892a6bcc34c4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1993, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The impact will be determined on a case by case basis and the analysis methodology described in the SAP will account for such cases, if any.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"017edca3-2bf0-457c-b9db-f72be08a241b\\\", \\\"childbox\\\": \\\"2be00555-de67-4013-acf9-fc39307bc6f1\\\", \\\"subtext\\\": \\\"1d6286e2-0e36-487f-96d7-afacc41886ad\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"General Considerations\\\", \\\"9.4.1\\\", \\\"3\\\", 1994, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.4.2 Participants Disposition\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7ce48b0e-10ac-4acf-9880-354b0ac938da\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participants Disposition\\\", \\\"9.4.2\\\", \\\"3\\\", 1995, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The number of enrolled, vaccinated (at least 1 vaccination, full vaccination course), completed participants, screening failures, reason for withdrawal, and reason for elimination from analysis sets, as well as number of participants in FAS and PPS will be reported by group for the enrolled analysis population.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"38bd9b53-245b-423f-b6fd-fd93f3e4a65b\\\", \\\"childbox\\\": \\\"0c08d8ff-c69f-40cd-8740-80ec1ff2237b\\\", \\\"subtext\\\": \\\"64c55323-78f5-4e6e-a63c-d6fb3fcc79c1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Participants Disposition\\\", \\\"9.4.2\\\", \\\"3\\\", 1996, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.4.3 Primary Endpoint(s)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0c312e52-62bd-49a3-a0b6-28364cd54284\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Primary Endpoint(s)\\\", \\\"9.4.3\\\", \\\"3\\\", 1997, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.4.3.1 Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0821a76a-527c-44ef-832c-e528778eb217\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 1998, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Analysis set:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6a0e0392-a704-40bd-b639-8315c61cca36\\\", \\\"childbox\\\": \\\"b5f768a6-acd0-4f13-b532-9beffa05ec82\\\", \\\"subtext\\\": \\\"48d9bf14-73f0-4ca4-96a7-10134db532be\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 1999, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The analysis of NI will be based on the PPS.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6a0e0392-a704-40bd-b639-8315c61cca36\\\", \\\"childbox\\\": \\\"b5f768a6-acd0-4f13-b532-9beffa05ec82\\\", \\\"subtext\\\": \\\"06fdf941-4e23-41b3-838c-40c618729a98\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2000, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Statistical method (Family 1):\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c9b088f8-58fa-492a-84be-1c0880c76eb9\\\", \\\"childbox\\\": \\\"ec1756dd-64b9-4183-928c-48d1ee27475f\\\", \\\"subtext\\\": \\\"ca1d39bc-2587-405e-aa95-7c6efe7b995a\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2001, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For each of the\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c9b088f8-58fa-492a-84be-1c0880c76eb9\\\", \\\"childbox\\\": \\\"ec1756dd-64b9-4183-928c-48d1ee27475f\\\", \\\"subtext\\\": \\\"a6cb9f9a-f3c4-41f5-8b23-824dbfb896c6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2002, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c9b088f8-58fa-492a-84be-1c0880c76eb9\\\", \\\"childbox\\\": \\\"ec1756dd-64b9-4183-928c-48d1ee27475f\\\", \\\"subtext\\\": \\\"854847d5-4a74-4d87-94dd-5c6ea60aa846\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2003, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"serogroups A, C, W, and Y, the percentages of participants with 4-fold rise (refer to Section 9.4.1), and the corresponding exact 2-sided 95% CIs based on Clopper-Pearson method (Clopper and Pearson, 1934) will be calculated for each study group at 1 month after the second vaccination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c9b088f8-58fa-492a-84be-1c0880c76eb9\\\", \\\"childbox\\\": \\\"ec1756dd-64b9-4183-928c-48d1ee27475f\\\", \\\"subtext\\\": \\\"39daea65-2e9f-479a-acd5-277209f7408f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2004, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The standardized asymptotic CIs between group differences in percentages will be derived using the method of ~REDACTED~ and ~REDACTED~ (~REDACTED~, 1985).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c9b088f8-58fa-492a-84be-1c0880c76eb9\\\", \\\"childbox\\\": \\\"e2ea358a-d65c-4bdc-a72e-a0b9df0cacbf\\\", \\\"subtext\\\": \\\"b4d1bfff-7e28-40e9-ae7b-bb009dfb1cd0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2005, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"NI criterion:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8bebb7cd-95b8-4445-946a-690001dece41\\\", \\\"childbox\\\": \\\"ab3904c4-690d-4328-a2a9-28b35b74aca7\\\", \\\"subtext\\\": \\\"97316d9a-9f4f-43ca-8e83-dd376c885a15\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2006, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Non-inferiority will be demonstrated if, the lower limit of 2-sided 95% CI for the percent difference in 4-fold rise in hSBA titers\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8bebb7cd-95b8-4445-946a-690001dece41\\\", \\\"childbox\\\": \\\"ab3904c4-690d-4328-a2a9-28b35b74aca7\\\", \\\"subtext\\\": \\\"8984bacd-2c9b-4d4f-824b-5d8a85dba41c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2007, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(p1_MenABCWY \\\\u2212 p1_MenACWY) is above \\\\u221210%, for each serogroup A, C, W, and Y.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1dac09d6-f998-4987-9561-51e8a592dada\\\", \\\"childbox\\\": \\\"d2a55d27-28aa-47de-a109-191fef691020\\\", \\\"subtext\\\": \\\"4035ec0e-8121-4b92-9689-fc97e1e68332\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2008, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Statistical method (Family 2):\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68e05b97-fd03-4edf-bbf3-34e235776b98\\\", \\\"childbox\\\": \\\"57bbf894-e566-4186-9dce-a91d0a6b57f2\\\", \\\"subtext\\\": \\\"96e4dd03-3857-420e-b1a6-e89dc60e2aea\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2009, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For each of the\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68e05b97-fd03-4edf-bbf3-34e235776b98\\\", \\\"childbox\\\": \\\"57bbf894-e566-4186-9dce-a91d0a6b57f2\\\", \\\"subtext\\\": \\\"d4cf84d4-d5a4-4c7d-b162-85ec2e23b655\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2010, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68e05b97-fd03-4edf-bbf3-34e235776b98\\\", \\\"childbox\\\": \\\"57bbf894-e566-4186-9dce-a91d0a6b57f2\\\", \\\"subtext\\\": \\\"3e8eaa17-1670-49e3-bea2-e1ab17292b73\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2011, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"serogroups A, C, W, and Y, the percentages of participants with 4-fold rise (refer to Section 9.4.1), and the corresponding exact 2-sided 95% CIs based on Clopper-Pearson method (Clopper and Pearson, 1934) will be calculated for each study group at 1 month after the first vaccination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68e05b97-fd03-4edf-bbf3-34e235776b98\\\", \\\"childbox\\\": \\\"57bbf894-e566-4186-9dce-a91d0a6b57f2\\\", \\\"subtext\\\": \\\"4df9341d-e7ce-47e0-aae1-370f1f613e01\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2012, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The standardized asymptotic CIs between group differences in percentages will be derived using the method of ~REDACTED~ and ~REDACTED~ (~REDACTED~, 1985).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68e05b97-fd03-4edf-bbf3-34e235776b98\\\", \\\"childbox\\\": \\\"fcbecfa8-7ab4-4b37-9bdb-1cb8eb2fb865\\\", \\\"subtext\\\": \\\"148150e5-889e-4f3d-984a-be3cdcf52414\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2013, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"NI criterion:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cebdeba6-4ed0-4794-b309-65506ffd6b10\\\", \\\"childbox\\\": \\\"88eaf924-7677-4312-b3b9-1e449520a856\\\", \\\"subtext\\\": \\\"f0aa9fd3-6be7-4297-825a-15ff93ae0187\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2014, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Non-inferiority will be demonstrated if, the lower limit of 2-sided 95% CI for the percent difference in 4-fold rise in hSBA titers\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cebdeba6-4ed0-4794-b309-65506ffd6b10\\\", \\\"childbox\\\": \\\"88eaf924-7677-4312-b3b9-1e449520a856\\\", \\\"subtext\\\": \\\"a2be562a-12f3-40a9-a1da-4d59bba9185a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2015, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(p1_MenABCWY \\\\u2212 p1_MenACWY) is above \\\\u221210%, for each serogroup A, C, W, and Y.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dd765475-5c08-42b6-a311-d307b869230a\\\", \\\"childbox\\\": \\\"c1a7e4bd-a6cc-4ed6-8950-7425de63bfd2\\\", \\\"subtext\\\": \\\"e52e5c41-e2d2-414a-be47-3472eabb611d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immunological Non-inferiority of MenABCWY vs. MenACWY\\\", \\\"9.4.3.1\\\", \\\"4\\\", 2016, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.4.3.2 Safety Analysis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2fddff86-8608-4814-b5c4-46ba99d09e0c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Safety Analysis\\\", \\\"9.4.3.2\\\", \\\"4\\\", 2017, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Distribution of participants by vaccinations will be summarized by ~REDACTED~ group for the exposed set.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"812d9616-c2c1-4ce3-b306-58f996689613\\\", \\\"childbox\\\": \\\"707f7f06-08a8-44b5-ba73-06b4d2f532f5\\\", \\\"subtext\\\": \\\"58d18841-6b24-4ec8-a41d-f4efdf9bf77d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Safety Analysis\\\", \\\"9.4.3.2\\\", \\\"4\\\", 2018, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In case of vaccination error, participants will be analyzed \\\\u201cas treated\\\\u201d (according to ~REDACTED~ the participant actually received).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"812d9616-c2c1-4ce3-b306-58f996689613\\\", \\\"childbox\\\": \\\"b3be2353-ec66-4cd3-ab5d-6b389448156e\\\", \\\"subtext\\\": \\\"58d18841-6b24-4ec8-a41d-f4efdf9bf77d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Safety Analysis\\\", \\\"9.4.3.2\\\", \\\"4\\\", 2019, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The standard coding for medical history, AE, SAE, and concomitant medications data will be done by ~REDACTED~ Clinical Dictionary.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7112758d-396f-45c0-894a-05e838e4c6d2\\\", \\\"childbox\\\": \\\"0c74832e-3edc-4348-a9fb-2d57827298e3\\\", \\\"subtext\\\": \\\"f8c5b497-6ecb-4628-a6be-48f194fc3884\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Safety Analysis\\\", \\\"9.4.3.2\\\", \\\"4\\\", 2020, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The coded terms received from the sponsor will be merged into the appropriate datasets before the transfer to ~REDACTED~ for statistical analyses.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7112758d-396f-45c0-894a-05e838e4c6d2\\\", \\\"childbox\\\": \\\"c595c9cf-0f76-474d-a34e-4f101a99557b\\\", \\\"subtext\\\": \\\"ab5e60f0-1dc1-4af5-a424-bb9af6355f7b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Safety Analysis\\\", \\\"9.4.3.2\\\", \\\"4\\\", 2021, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.4.3.2.1 Solicited Events\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading6\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1f669894-d48d-4cc0-ab3e-bc23540c82bc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Solicited Events\\\", \\\"9.4.3.2.1\\\", \\\"5\\\", 2022, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"These analyses will be performed on the solicited safety set.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0a72defc-1fa7-4293-bf58-f3f6ad169c50\\\", \\\"childbox\\\": \\\"e059bafb-3965-4e4e-91e9-233bc4470a89\\\", \\\"subtext\\\": \\\"daf93f01-a69b-470d-9c62-85b9cbe6bed8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Solicited Events\\\", \\\"9.4.3.2.1\\\", \\\"5\\\", 2023, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The frequencies and percentages of participants with solicited administration site (i.e., injection site pain, erythema, swelling, induration) and systemic (i.e., fever [temperature\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"061a6089-a3dd-4e67-bdea-d387ab85d9ee\\\", \\\"childbox\\\": \\\"df63c1cc-6ab9-4111-9fd6-867241faa4f6\\\", \\\"subtext\\\": \\\"d0953ede-d5ed-4687-9f93-518f7effe86d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Solicited Events\\\", \\\"9.4.3.2.1\\\", \\\"5\\\", 2024, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u226538.0\\\\u00b0C/100.4\\\\u00b0F], nausea, fatigue, myalgia, arthralgia, headache) events during the 7 days (including the day of vaccination) following each vaccination at Day 1 and Day 181 will be presented.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a4c2cbec-89a6-4e37-9718-923059450873\\\", \\\"childbox\\\": \\\"e3e7982e-c331-463a-b427-7f8df5a76a01\\\", \\\"subtext\\\": \\\"a41a18ef-e46b-4f80-96dc-b4614c551119\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Solicited Events\\\", \\\"9.4.3.2.1\\\", \\\"5\\\", 2025, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"All solicited administration site and systemic events will be summarized according to defined severity grading scales (Appendix 4).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3c795639-b21c-46ed-8996-af6bb8cedf92\\\", \\\"childbox\\\": \\\"421d0d5c-6eac-4832-aa41-636a3a8c7034\\\", \\\"subtext\\\": \\\"11e33dc9-edd9-4c1c-8968-c1a0e5a58fb2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Solicited Events\\\", \\\"9.4.3.2.1\\\", \\\"5\\\", 2026, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Frequencies and percentages of participants experiencing each solicited administration site and systemic events will be presented for each symptom severity.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3c795639-b21c-46ed-8996-af6bb8cedf92\\\", \\\"childbox\\\": \\\"e8fb536e-e165-4859-a38e-fa78814d5071\\\", \\\"subtext\\\": \\\"6fbffabe-8238-4f6a-81c5-465bd169cb5a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Solicited Events\\\", \\\"9.4.3.2.1\\\", \\\"5\\\", 2027, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Summary tables showing the occurrence of any solicited administration site or systemic event overall and at each time point will also be presented.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3c795639-b21c-46ed-8996-af6bb8cedf92\\\", \\\"childbox\\\": \\\"883da6b3-67b3-4ad1-bf3f-ae1fe1afbbd8\\\", \\\"subtext\\\": \\\"6fbffabe-8238-4f6a-81c5-465bd169cb5a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Solicited Events\\\", \\\"9.4.3.2.1\\\", \\\"5\\\", 2028, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"9.4.3.2.2 Post-vaccination solicited AEs reported from Day 1 to Day 7 will be summarized for the intervals Day 1-3, Day 4-7, and Day 1-7 by maximal severity and by ~REDACTED~ group, excluding the 30-minute measurement, which will be summarized separately.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0567d95d-4914-4ed4-bd04-a886627e21da\\\", \\\"childbox\\\": \\\"44752f7c-6b9e-4db6-a481-d241c76e49b0\\\", \\\"subtext\\\": \\\"1bd0c42f-9631-4aa0-8d29-83f037990587\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Solicited Events\\\", \\\"9.4.3.2.1\\\", \\\"5\\\", 2029, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The severity of solicited administration events, including redness at injection site, swelling of skin at injection site, and hardness of skin at injection site will be summarized according to categories described in Appendix 4.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0567d95d-4914-4ed4-bd04-a886627e21da\\\", \\\"childbox\\\": \\\"936bd91f-7330-477d-aafa-7c11047f3a03\\\", \\\"subtext\\\": \\\"280f77a2-7b7a-4672-889b-63c771fada13\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Solicited Events\\\", \\\"9.4.3.2.1\\\", \\\"5\\\", 2030, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Injection site and systemic reactions (except fever) occurring up to 7 days after each study vaccination (Day 1 and Day 181), will be summarized according to \\\\u201cmild\\\\u201d, \\\\u201cmoderate\\\\u201d or \\\\u201csevere\\\\u201d as described in Appendix 4.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"853da77d-d2ec-4fe6-9cff-4c834ac7fbff\\\", \\\"childbox\\\": \\\"efaa657c-1c7e-4e1a-a3f9-9678a2f9b4d5\\\", \\\"subtext\\\": \\\"f58698f5-9888-462c-ae44-7556f949fb6a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Solicited Events\\\", \\\"9.4.3.2.1\\\", \\\"5\\\", 2031, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Each solicited administration site and systemic event will also be further summarized as \\\\u201cnone\\\\u201d versus \\\\u201cany\\\\u201d (for fever the latter will be \\\\u226538.0\\\\u00b0C/100.4\\\\u00b0F).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"47ec5bb5-4a14-4176-af60-4fc4126a4091\\\", \\\"childbox\\\": \\\"4bca5b43-8f29-4033-8fa4-3daeb2b70af8\\\", \\\"subtext\\\": \\\"3fdd981c-ae26-4663-9982-dbf5aa480e6a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Solicited Events\\\", \\\"9.4.3.2.1\\\", \\\"5\\\", 2032, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Use of antipyretics and analgesics will be summarized by frequency by type of use (prophylactic versus treatment) and percentage of participants reporting use.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b6da020e-4025-4de1-a3ec-6b0edab52f5f\\\", \\\"childbox\\\": \\\"7811bab9-ba42-42ff-bd5b-28f462f85411\\\", \\\"subtext\\\": \\\"fde5f26d-2bf9-434f-9c0c-5320c1610ce7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Solicited Events\\\", \\\"9.4.3.2.1\\\", \\\"5\\\", 2033, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Body temperature will be summarized by 0.5\\\\u00b0C/32.9\\\\u00b0F increments from 36.0\\\\u00b0C/96.8\\\\u00b0F up to \\\\u226540\\\\u00b0C/104\\\\u00b0F and will be broken down according by route of measurement, if applicable.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"50a3ceaf-3db5-4a14-bf67-e9e8dc6397b6\\\", \\\"childbox\\\": \\\"04186dd6-72d8-4f56-924a-4dc77dd3f6ab\\\", \\\"subtext\\\": \\\"b180395a-3644-4852-8f95-8c530e853fdd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Solicited Events\\\", \\\"9.4.3.2.1\\\", \\\"5\\\", 2034, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Frequencies and percentages of participants with temperatures \\\\u226538.0\\\\u00b0C/100.4\\\\u00b0F and temperatures \\\\u226540.0\\\\u00b0C/104\\\\u00b0F will also be presented.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"50a3ceaf-3db5-4a14-bf67-e9e8dc6397b6\\\", \\\"childbox\\\": \\\"f3974da8-b669-40dc-b953-5cf1248baef6\\\", \\\"subtext\\\": \\\"8440ef8f-8d91-48e9-a141-12ac3cef28cf\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Solicited Events\\\", \\\"9.4.3.2.1\\\", \\\"5\\\", 2035, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.4.3.2.2 Unsolicited AEs\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading6\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"29e43faa-c446-4010-b2dc-43c41c665347\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2036, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"These analyses will be performed on the unsolicited safety set.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b74ac751-a690-4d6c-b4e6-032fa028c1d7\\\", \\\"childbox\\\": \\\"e4b146df-d65b-4b93-aa4d-d94f1971d704\\\", \\\"subtext\\\": \\\"481a0770-a720-4a10-a579-6664f2498717\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2037, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The frequencies and percentages of participants with any unsolicited AEs (including all\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e6ade9b2-abda-4a32-8e14-dbe1fe94fdfc\\\", \\\"childbox\\\": \\\"232bf4bc-7bd6-4647-9855-ae7c53cd3b49\\\", \\\"subtext\\\": \\\"d7d579eb-62f8-4b7f-b7b9-8b646bca4c0e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2038, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"SAEs, AEs leading to withdrawal, AESIs and medically attended AEs [see all relevant AE definitions in Appendix 1, Glossary of Terms]) during the 7 and the 30 days (including the day of vaccination) following vaccination at Day 1 and Day 181 will be presented.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"44c238f8-e5a5-4cfd-adcf-4e71685b016f\\\", \\\"childbox\\\": \\\"fedd8359-30d9-4e6a-bd18-0cb5c5e3478d\\\", \\\"subtext\\\": \\\"9c5b6092-51c8-4686-8ed9-143067e0585a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2039, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The frequencies and percentages of participants with SAEs, AEs leading to withdrawal, AESIs and medically attended AEs throughout the study period will be presented.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4cbbeb24-105d-4430-af14-e295696f2432\\\", \\\"childbox\\\": \\\"606f6809-2ac2-4ba2-833e-15212cd5ae66\\\", \\\"subtext\\\": \\\"9c33ee31-6876-4826-abd6-ff72a8493d45\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2040, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This analysis applies to all AEs occurring during the study, judged either as probably related, possibly related or not related to vaccination by the investigator, recorded in AE eCRF, with a start date on or after the date of first vaccination (Table 12).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"be9226c7-bb2e-41db-be24-1911e2f3235d\\\", \\\"childbox\\\": \\\"254d58c8-97db-4166-b0dd-a10527a474ac\\\", \\\"subtext\\\": \\\"742af857-b13d-4dfe-abd1-e2a24bf1a689\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2041, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"AE starting prior to the first vaccination will only be listed.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"be9226c7-bb2e-41db-be24-1911e2f3235d\\\", \\\"childbox\\\": \\\"a240d3ef-8a05-47ff-ac31-c427dfcc338a\\\", \\\"subtext\\\": \\\"3e2ee439-3754-4d79-8e01-19f9944a4533\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2042, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The original verbatim terms used by investigators to identify AEs in the eCRFs will be mapped to preferred terms (PTs) using the Medical Dictionary for Regulatory Activities (MedDRA) dictionary.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"be9226c7-bb2e-41db-be24-1911e2f3235d\\\", \\\"childbox\\\": \\\"7453acaa-4c1f-43cf-add0-77412823a842\\\", \\\"subtext\\\": \\\"3e2ee439-3754-4d79-8e01-19f9944a4533\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2043, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The AEs will then be grouped by MedDRA PTs into frequency tables according to system organ class (SOC).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"be9226c7-bb2e-41db-be24-1911e2f3235d\\\", \\\"childbox\\\": \\\"c3c67e8b-1c9b-48a7-97cc-32a7ec18c820\\\", \\\"subtext\\\": \\\"f372d27a-f14a-4066-b602-1ef3e418b934\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2044, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"All reported AEs, as well as AEs judged by the investigator as related to study ~REDACTED~, will be summarized according to SOC and PT within SOC. These summaries will be presented by ~REDACTED~ group and by interval of study observation.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f9b4e6d5-922e-4e32-b43f-21d6f09a8560\\\", \\\"childbox\\\": \\\"f22ee7af-95a6-4a2c-98cf-60667601aec8\\\", \\\"subtext\\\": \\\"4f23c2bd-f124-43d4-bf09-0bb662f07828\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2045, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"When an AE occurs more than once for a participant, the maximal severity and strongest relationship to ~REDACTED~ group will be counted.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f9b4e6d5-922e-4e32-b43f-21d6f09a8560\\\", \\\"childbox\\\": \\\"04fb7255-0528-4d74-ad66-07914145197c\\\", \\\"subtext\\\": \\\"803822f3-d470-461c-a649-af58ef300344\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2046, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Separate summaries will be produced for the following categories:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4edf095a-12f7-42d4-8aa1-bd3b6ca72923\\\", \\\"childbox\\\": \\\"2878d859-0831-4422-bc83-262381d9793c\\\", \\\"subtext\\\": \\\"f18f13d2-c00b-4594-9162-fde6005d254d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2047, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 SAE\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"76a03a40-4f3b-436b-a873-139333893c99\\\", \\\"childbox\\\": \\\"2be18503-b9b5-4ef6-b3e2-fec18bf307f6\\\", \\\"subtext\\\": \\\"7c1081c3-fd32-4e65-8173-f242c3a4b245\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2048, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 AE related to ~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c8026141-9144-42b9-863e-81fcc5dcf6b3\\\", \\\"childbox\\\": \\\"b5670303-34d5-436e-8750-fdb7ada4faad\\\", \\\"subtext\\\": \\\"e4594ed1-2abb-451a-bc80-1d2d2757c46c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2049, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 AESI\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e0d2aca1-68bb-4dfd-b759-96d86b8398d5\\\", \\\"childbox\\\": \\\"bbf618bd-0939-424d-80d8-54495b080c6e\\\", \\\"subtext\\\": \\\"08a82237-1bcb-4026-962e-0bc8a5caa28d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2050, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 AE leading to withdrawal\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"991225b4-33b1-403d-9cb4-376ce0514109\\\", \\\"childbox\\\": \\\"37e39fc3-d925-40cb-bdea-7bd2e5459b7c\\\", \\\"subtext\\\": \\\"c108c416-84d6-4d6a-abbd-75228e46e0f5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2051, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 AE leading to a medically attended ~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eb630a6d-c25d-4489-a627-92f4a4e742c5\\\", \\\"childbox\\\": \\\"0f7b8aec-0823-4775-973b-2c915227613e\\\", \\\"subtext\\\": \\\"15f0a329-53e4-4f02-a254-f383bbf38b73\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2052, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Data listings of all AEs will be provided by participant.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6cf90207-35b8-43ea-820f-3b23e0d61491\\\", \\\"childbox\\\": \\\"ff30047d-b4e7-49c9-9593-0904d7d9a62f\\\", \\\"subtext\\\": \\\"54041351-4b10-42be-9c38-b1bc95d1891e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2053, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In addition, AEs in the categories above will be provided as listed data.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6cf90207-35b8-43ea-820f-3b23e0d61491\\\", \\\"childbox\\\": \\\"e253f709-2955-4f60-b8cc-4e2ea6457578\\\", \\\"subtext\\\": \\\"54041351-4b10-42be-9c38-b1bc95d1891e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"9.4.3.2.2\\\", \\\"5\\\", 2054, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.4.4 Secondary Endpoints\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3cb92713-2f96-4b7f-b7d7-cf09ea6c7758\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Secondary Endpoints\\\", \\\"9.4.4\\\", \\\"3\\\", 2055, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.4.4.1 Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dea08f47-7775-40e1-bbe5-e9fb15d63ee8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2056, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Analysis set:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"91c84fa4-7865-443c-a644-84c28f143e1c\\\", \\\"childbox\\\": \\\"36419654-cd25-42c6-98b9-5e2d4a7a4766\\\", \\\"subtext\\\": \\\"7dcdd90b-a9b0-4b25-841c-b72c5c751ed2\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2057, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The analysis will be based on the FAS.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"91c84fa4-7865-443c-a644-84c28f143e1c\\\", \\\"childbox\\\": \\\"36419654-cd25-42c6-98b9-5e2d4a7a4766\\\", \\\"subtext\\\": \\\"8a2b3577-dc1c-414f-bd28-453e240663b3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2058, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Statistical method:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1813da36-313f-4145-b4a5-bb313bb2cb36\\\", \\\"childbox\\\": \\\"8db43733-c0f3-4cea-b7d5-1b3af01afee9\\\", \\\"subtext\\\": \\\"a30286c1-5b9a-4197-a423-cbb1351b719d\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2059, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For each of the 4\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1813da36-313f-4145-b4a5-bb313bb2cb36\\\", \\\"childbox\\\": \\\"8db43733-c0f3-4cea-b7d5-1b3af01afee9\\\", \\\"subtext\\\": \\\"b8250cc4-b4d0-4695-8bdf-5733449438d6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2060, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1813da36-313f-4145-b4a5-bb313bb2cb36\\\", \\\"childbox\\\": \\\"8db43733-c0f3-4cea-b7d5-1b3af01afee9\\\", \\\"subtext\\\": \\\"78693101-b057-4a85-af3d-9c97c5066004\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2061, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1813da36-313f-4145-b4a5-bb313bb2cb36\\\", \\\"childbox\\\": \\\"97f3166c-2e58-4072-a61e-30dd5154b586\\\", \\\"subtext\\\": \\\"78693101-b057-4a85-af3d-9c97c5066004\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2062, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"serogroups A, C, W, and Y the percentages of participants with hSBA titers \\\\u2265LLOQ and the corresponding exact 2-sided 95% CIs based on Clopper-Pearson method (Clopper and Pearson, 1934) will be calculated for ABCWY and ACWY study groups.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1813da36-313f-4145-b4a5-bb313bb2cb36\\\", \\\"childbox\\\": \\\"97f3166c-2e58-4072-a61e-30dd5154b586\\\", \\\"subtext\\\": \\\"3975c01a-5a1c-4755-a5b9-0208acbe55c4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2063, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to Section 9.4.3.1 for the definition of 4-fold rise for the Men A, C, W, and Y evaluation.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1813da36-313f-4145-b4a5-bb313bb2cb36\\\", \\\"childbox\\\": \\\"e7230714-c58b-4da4-b93f-fab3fd37e478\\\", \\\"subtext\\\": \\\"cbf33cf1-f453-4ffd-84c8-3930a983aca1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2064, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Geometric mean titers and associated 2-sided 95% CIs will be computed for each group and for each strain at each ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f00407e9-83ea-4da3-86e5-ea65dd200e6d\\\", \\\"childbox\\\": \\\"5d421bd8-545a-4882-a7f7-2942649bb74e\\\", \\\"subtext\\\": \\\"19f4db3b-52d6-4a74-9064-8663abd95ee0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2065, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The titers at baseline (Day 1, Month 0), at 1 month after the first (Day 31, Month 1) and the last vaccination (Day 211, Month 7) for the ABCWY group, and at 1 month after the single MenACWY vaccination (Day 31, Month 1) in the ACWY group, will be logarithmically transformed (base10) to fulfill the normal distribution assumption.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f00407e9-83ea-4da3-86e5-ea65dd200e6d\\\", \\\"childbox\\\": \\\"4f321f5e-95b0-4f7e-8e84-aae3d2fcc146\\\", \\\"subtext\\\": \\\"12750d2a-d976-409d-831a-5d1d0ce636f9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2066, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Geometric mean titers and 95% CIs will be calculated by exponentiating (base 10) the least squares means and the lower and upper limits of the 95% CIs of the log-transformed titers (base10) obtained from a 2-way Analysis of covariance (ANCOVA) with factors for ~REDACTED~ group and country.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"69163eb8-2251-41f5-b6a8-b803a595aea4\\\", \\\"childbox\\\": \\\"0f3f2cbf-61e4-4961-8459-63af51a9877f\\\", \\\"subtext\\\": \\\"2edafd05-f538-46ac-8378-6542cd21c9d8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2067, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The ANCOVA will include baseline titers as covariate, and it will be performed to take into consideration the possible effect of these on the post-vaccination titers.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"69163eb8-2251-41f5-b6a8-b803a595aea4\\\", \\\"childbox\\\": \\\"a53c0c9f-555f-4917-9196-4f1fcb34d6f5\\\", \\\"subtext\\\": \\\"3d0c89d2-3e87-4529-9a5f-74863c609501\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2068, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Geometric mean ratios (GMRs) (post-vaccination/baseline titer) and associated 2-sided\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"50adca9e-a566-4630-b43f-976a56670389\\\", \\\"childbox\\\": \\\"df456efe-03e6-4e36-bd50-21bec3f8df5b\\\", \\\"subtext\\\": \\\"a2efe7c9-3c1e-4bf3-8729-68a9d509db47\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2069, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"95% CIs will be computed for each group and for each strain at each ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"406d9798-2cd8-44bb-8071-3167d0b38197\\\", \\\"childbox\\\": \\\"8b11359b-79f0-4db5-9118-5548e86c6a80\\\", \\\"subtext\\\": \\\"e44fae24-490e-4e71-b709-07b9a1a3e5b6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2070, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Geometric mean ratios will be calculated by exponentiating (base10) the least squares means and the lower and upper limits of the 95% CIs of the log-transformed titers (base10) obtained from a 2-way ANOVA with factors for ~REDACTED~ group and country.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"406d9798-2cd8-44bb-8071-3167d0b38197\\\", \\\"childbox\\\": \\\"c389ee84-81bc-419a-9a5c-77df82a9bebf\\\", \\\"subtext\\\": \\\"e44fae24-490e-4e71-b709-07b9a1a3e5b6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2071, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Additionally, GMTs and GMRs group ratios between the 2 intervention groups and their respective 95% CIs will be computed by exponentiating the difference of the least square means of the log-transformed titers and the lower and upper limits of the 95% CIs on the difference obtained from the ANCOVA/ANOVA model above.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"59bfef0d-0ad7-4459-a287-48806ff58a52\\\", \\\"childbox\\\": \\\"8d1c681b-ba41-41bb-bc48-74ae387fbb11\\\", \\\"subtext\\\": \\\"62061360-5b7d-48b1-b71b-a17437f07e7b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2072, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.4.4.2 Immune Response \\\\u2013 N meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"860f1251-2cad-4f67-81cd-1f96f9862d3d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2073, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Analysis set:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e42348f0-b4de-4e71-bd66-cb0f72199743\\\", \\\"childbox\\\": \\\"bbbe2402-3e1d-4de8-9ae3-f658564cd2b7\\\", \\\"subtext\\\": \\\"eb976616-8c63-4d72-83b5-19606d12dfb9\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2074, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The analysis will be based on the FAS.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e42348f0-b4de-4e71-bd66-cb0f72199743\\\", \\\"childbox\\\": \\\"bbbe2402-3e1d-4de8-9ae3-f658564cd2b7\\\", \\\"subtext\\\": \\\"58bf4f01-6a53-4e76-a5db-a38c58721156\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2075, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Statistical method:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ef7e1c77-1777-43b3-abf7-202abe28fceb\\\", \\\"childbox\\\": \\\"e91f05b9-f7aa-4251-8943-fc1abecb47bd\\\", \\\"subtext\\\": \\\"13348d8b-8479-4ff0-8f3e-dc46a638e818\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2076, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For each of\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ef7e1c77-1777-43b3-abf7-202abe28fceb\\\", \\\"childbox\\\": \\\"e91f05b9-f7aa-4251-8943-fc1abecb47bd\\\", \\\"subtext\\\": \\\"0f01d456-6dee-4bfb-9655-55fbbc6cc13d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2077, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ef7e1c77-1777-43b3-abf7-202abe28fceb\\\", \\\"childbox\\\": \\\"e91f05b9-f7aa-4251-8943-fc1abecb47bd\\\", \\\"subtext\\\": \\\"4e4a007e-cfa9-42f8-a86f-c7a406d6ad96\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2078, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ef7e1c77-1777-43b3-abf7-202abe28fceb\\\", \\\"childbox\\\": \\\"ffc1e52b-ff7c-4f8b-8082-bd485cdf8db4\\\", \\\"subtext\\\": \\\"4e4a007e-cfa9-42f8-a86f-c7a406d6ad96\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2079, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"B indicator strain (M14459 for factor H binding protein [fHbp] antigen, M07-0241084 [or alternative strain]* for Neisseria Heparin Binding Antigen (NHBA) antigen, 96217 for Neisseria adhesin A (NadA) antigen and NZ98/254 for PorA P1.4 antigen) the percentages of participants with hSBA titers \\\\u2265LLOQ and of participants with 4-fold rise (refer to Section 9.4.1), and the corresponding exact 2-sided 95% CIs based on Clopper-Pearson method will be calculated for MenABCWY study group at 1 month after the last MenABCWY vaccination .\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ef7e1c77-1777-43b3-abf7-202abe28fceb\\\", \\\"childbox\\\": \\\"ffc1e52b-ff7c-4f8b-8082-bd485cdf8db4\\\", \\\"subtext\\\": \\\"e6db2761-cb86-4666-af6e-950fbaf5a653\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2080, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A composite endpoint defined as the percentage of participants with hSBA titers \\\\u2265LLOQ for all (4)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"147b509d-1ad1-4223-baca-a5ef53799677\\\", \\\"childbox\\\": \\\"2f4d3e56-5dcc-4c30-8984-f88f9270967f\\\", \\\"subtext\\\": \\\"12a1db29-c35f-44cb-b00d-5538b7ce2a58\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2081, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"147b509d-1ad1-4223-baca-a5ef53799677\\\", \\\"childbox\\\": \\\"2f4d3e56-5dcc-4c30-8984-f88f9270967f\\\", \\\"subtext\\\": \\\"0a0ad776-c32d-4ae6-b2e6-4eb03ed321a7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2082, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"147b509d-1ad1-4223-baca-a5ef53799677\\\", \\\"childbox\\\": \\\"13930139-4a0c-4c56-b0ef-8e068e199ac1\\\", \\\"subtext\\\": \\\"0a0ad776-c32d-4ae6-b2e6-4eb03ed321a7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2083, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"B indicator strains will be derived.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"147b509d-1ad1-4223-baca-a5ef53799677\\\", \\\"childbox\\\": \\\"13930139-4a0c-4c56-b0ef-8e068e199ac1\\\", \\\"subtext\\\": \\\"1e75fa2c-353f-4281-8108-803d1289c1e6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2084, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For this composite endpoint, the percentage of participants with hSBA titers \\\\u2265LLOQ for all (4) B indicator strains and the corresponding exact 2-sided 95% CIs based on Clopper-Pearson method will be calculated for MenABCWY study group at 1 month after the last MenABCWY vaccination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"147b509d-1ad1-4223-baca-a5ef53799677\\\", \\\"childbox\\\": \\\"5eedc913-38d9-488d-8490-819684a81644\\\", \\\"subtext\\\": \\\"1e75fa2c-353f-4281-8108-803d1289c1e6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2085, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Geometric mean titers and GMRs, and associated 2-sided 95% CIs will be computed for each strain at each ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"549af97d-5050-4cd9-9fd3-3f70ceb232a4\\\", \\\"childbox\\\": \\\"8a4d473b-d579-4a4d-9f95-1412cccfb2ae\\\", \\\"subtext\\\": \\\"b7f3ce93-475a-4c94-a37f-4270597616de\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2086, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The hSBA titers at baseline (Day 1, Month 0), and the hSBA titers at 1 month after the last vaccination (Day 211, Month 7) for the ABCWY group, will be logarithmically transformed (base10) to fulfill the normal distribution assumption.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"549af97d-5050-4cd9-9fd3-3f70ceb232a4\\\", \\\"childbox\\\": \\\"9b96986e-6e60-4b9a-a8c3-d483997fb0fe\\\", \\\"subtext\\\": \\\"e30e57a7-b00c-4440-b601-8f9c26498632\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2087, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"*Note: Strains and unit(s) might be participant to change during the study (e.g., in case of requalification, revalidation or standardization).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7caca1e4-eb8e-4051-a994-e8fc38cdbb63\\\", \\\"childbox\\\": \\\"0e06539d-2e10-4227-a4e3-9bbbabe615dd\\\", \\\"subtext\\\": \\\"383318dd-7fba-41a7-b5fb-26b86fae8849\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2088, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In this case, this will be documented either in a protocol amendment or in the CSR.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7caca1e4-eb8e-4051-a994-e8fc38cdbb63\\\", \\\"childbox\\\": \\\"06b935d4-a3fe-40e6-9d5a-c63d0d8d7f44\\\", \\\"subtext\\\": \\\"383318dd-7fba-41a7-b5fb-26b86fae8849\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response N. Meningitidis Serogroups A, C, W, and Y (Measured by hSBA)\\\", \\\"9.4.4.1\\\", \\\"4\\\", 2089, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.4.5 Tertiary Endpoints\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"69b3b47c-90b1-4e64-9c91-07431f760b4f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Tertiary Endpoints\\\", \\\"9.4.5\\\", \\\"3\\\", 2090, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.4.5.1 Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3bbe7599-13a0-4c29-9705-615c7fa2d52a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2091, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Analysis set:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3b5308a3-986d-430f-903e-82d870473956\\\", \\\"childbox\\\": \\\"f134c032-d4b7-42d9-94a9-b86049fea99d\\\", \\\"subtext\\\": \\\"e230d750-9b5e-4cb4-8898-1dd89cff6b9b\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2092, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The analysis of tertiary objectives will be based on the FAS.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3b5308a3-986d-430f-903e-82d870473956\\\", \\\"childbox\\\": \\\"f134c032-d4b7-42d9-94a9-b86049fea99d\\\", \\\"subtext\\\": \\\"1d7f4bef-f531-4170-9f56-776b8772fd7c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2093, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Statistical method:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1e3b4b5e-fe6a-4915-881f-e1d96d36f812\\\", \\\"childbox\\\": \\\"20a8d580-9185-4218-a813-d7d36321ab1b\\\", \\\"subtext\\\": \\\"96c48fdf-442f-46bd-a0ed-84c0172ed712\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2094, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For each of\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1e3b4b5e-fe6a-4915-881f-e1d96d36f812\\\", \\\"childbox\\\": \\\"20a8d580-9185-4218-a813-d7d36321ab1b\\\", \\\"subtext\\\": \\\"15a6e68d-845d-472d-a783-4a37ac6ed2b6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2095, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1e3b4b5e-fe6a-4915-881f-e1d96d36f812\\\", \\\"childbox\\\": \\\"20a8d580-9185-4218-a813-d7d36321ab1b\\\", \\\"subtext\\\": \\\"534013e8-b1c7-45fc-966e-c7c937f5e1d7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2096, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1e3b4b5e-fe6a-4915-881f-e1d96d36f812\\\", \\\"childbox\\\": \\\"91726077-dcc2-4768-88d7-5e308801519c\\\", \\\"subtext\\\": \\\"534013e8-b1c7-45fc-966e-c7c937f5e1d7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2097, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"B indicator strain (M14459,\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1e3b4b5e-fe6a-4915-881f-e1d96d36f812\\\", \\\"childbox\\\": \\\"91726077-dcc2-4768-88d7-5e308801519c\\\", \\\"subtext\\\": \\\"e0516019-3ddd-4dba-84e5-fcf9d360f8cc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2098, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"M07-0241084, 96217 and NZ98/254) the percentages of participants with hSBA titers\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2680cef7-26a2-48c1-af09-8643e214a14c\\\", \\\"childbox\\\": \\\"36502dfe-c9be-436b-8987-6b976ec76e8e\\\", \\\"subtext\\\": \\\"153bc616-3552-423e-93e1-9a7c4f955a37\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2099, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2265LLOQ and of participants with 4-fold rise (refer to Section 9.4.1), and the corresponding exact 2-sided 95% CIs based on Clopper-Pearson method\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c799d922-a16d-4172-8c9f-e3d2df4bcba3\\\", \\\"childbox\\\": \\\"8e46ced3-5ebc-4665-aa38-a9e307e464fd\\\", \\\"subtext\\\": \\\"86accf4e-e465-433f-9dd9-3842b012c217\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2100, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(Clopper and Pearson, 1934) will be calculated for MenABCWY study group at 1 month after the first MenABCWY vaccination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4c773b3c-4c46-448e-824a-8f6fc11fbc08\\\", \\\"childbox\\\": \\\"8726f667-c605-47c3-ab99-d9f9d79e561e\\\", \\\"subtext\\\": \\\"981c22a1-fd6d-4c07-a9b3-1a867300f121\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2101, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A composite endpoint defined as the percentage of participants with hSBA titers \\\\u2265LLOQ for all (4)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2377e896-9f36-453a-8f54-0cd830aaee5d\\\", \\\"childbox\\\": \\\"467c8212-13df-450f-8ce6-82b2838096bf\\\", \\\"subtext\\\": \\\"e173cb5e-55ec-43f1-b7f9-9acc51cecc81\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2102, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2377e896-9f36-453a-8f54-0cd830aaee5d\\\", \\\"childbox\\\": \\\"467c8212-13df-450f-8ce6-82b2838096bf\\\", \\\"subtext\\\": \\\"745b19a0-97c8-4893-82c5-14f291539cf6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2103, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2377e896-9f36-453a-8f54-0cd830aaee5d\\\", \\\"childbox\\\": \\\"23993af9-1fc2-4de2-861c-23b4bad0a841\\\", \\\"subtext\\\": \\\"745b19a0-97c8-4893-82c5-14f291539cf6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2104, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"B indicator strains will be derived.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2377e896-9f36-453a-8f54-0cd830aaee5d\\\", \\\"childbox\\\": \\\"23993af9-1fc2-4de2-861c-23b4bad0a841\\\", \\\"subtext\\\": \\\"79e20419-bb3f-4824-ba9c-edfb078fd27c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2105, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For this composite endpoint, the percentage of participants with hSBA titers \\\\u2265LLOQ for all (4) B indicator strains and the corresponding exact 2-sided 95% CIs based on Clopper-Pearson method will be calculated for MenABCWY study group at 1 month after the first MenABCWY vaccination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2377e896-9f36-453a-8f54-0cd830aaee5d\\\", \\\"childbox\\\": \\\"1dd2130b-bf1f-4b47-9137-b1517783d5c6\\\", \\\"subtext\\\": \\\"79e20419-bb3f-4824-ba9c-edfb078fd27c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2106, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Geometric mean titers and GMRs, and associated 2-sided 95% CIs will be computed for each strain at 1 month after the first MenABCWY vaccination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fbf35a10-457c-41b3-94f2-f010aa4d8f1b\\\", \\\"childbox\\\": \\\"83bc5162-d6ed-4743-97b1-473aee36064e\\\", \\\"subtext\\\": \\\"5f018635-1271-4202-8da9-7f8ae61b4542\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2107, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The hSBA titers at baseline (Day 1, Month 0), and the hSBA titers at 1 month after the first vaccination (Day 31, Month 1) for the ABCWY group, will be logarithmically transformed (base10) to fulfill the normal distribution assumption.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fbf35a10-457c-41b3-94f2-f010aa4d8f1b\\\", \\\"childbox\\\": \\\"1c40fa4d-e5b0-4ecb-9b26-558dd67059e6\\\", \\\"subtext\\\": \\\"5f018635-1271-4202-8da9-7f8ae61b4542\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2108, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"*Note: Strains and unit(s) might be participant to change during the study (e.g., in case of requalification, revalidation or standardization).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d82a4574-217f-4671-bc7b-df08fda6a0d3\\\", \\\"childbox\\\": \\\"556ad4ce-d0b2-4737-8965-f2c0e1d8864d\\\", \\\"subtext\\\": \\\"14266687-3ada-40f1-9f38-147b43dd3c67\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2109, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In this case, this will be documented either in a protocol amendment (see a definition in Appendix 1, Glossary of Terms) or in the clinical report\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d82a4574-217f-4671-bc7b-df08fda6a0d3\\\", \\\"childbox\\\": \\\"6bbba142-9033-4498-98a7-e3690570a535\\\", \\\"subtext\\\": \\\"a5456f95-5d64-4bf2-aaec-c231ce777bc9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2110, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\".\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d82a4574-217f-4671-bc7b-df08fda6a0d3\\\", \\\"childbox\\\": \\\"6bbba142-9033-4498-98a7-e3690570a535\\\", \\\"subtext\\\": \\\"7f72233a-afd2-4e4b-843f-30f4d111ee92\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroup B Indicator Strains (Measured by hSBA)\\\", \\\"9.4.5.1\\\", \\\"4\\\", 2111, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.4.5.2 Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"26d2cda1-6b23-4007-bff1-9056a178f3bf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2112, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Analysis set:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bb6cbeb7-dd47-40c9-af76-7c5b6fcc6ee3\\\", \\\"childbox\\\": \\\"31c2d9f2-d31d-4b45-9021-0f61a5806a4d\\\", \\\"subtext\\\": \\\"6558d8e4-2aa0-4b66-99de-57af86fdc7d3\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2113, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The analysis of tertiary objectives will be based on the FAS.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bb6cbeb7-dd47-40c9-af76-7c5b6fcc6ee3\\\", \\\"childbox\\\": \\\"31c2d9f2-d31d-4b45-9021-0f61a5806a4d\\\", \\\"subtext\\\": \\\"8cfe72f1-cc27-4ee8-8b47-f3b8184e6161\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2114, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Statistical method:\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9449d284-5a29-43a0-8840-a12eac0a88a8\\\", \\\"childbox\\\": \\\"139adea2-c797-4b4d-9fa2-b473e3711ef2\\\", \\\"subtext\\\": \\\"c775c3f9-d92f-4d98-8aa2-d97e03a6210e\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2115, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"GMCs and associated 2-sided 95% CIs will be computed for each group and for each strain at each ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9449d284-5a29-43a0-8840-a12eac0a88a8\\\", \\\"childbox\\\": \\\"139adea2-c797-4b4d-9fa2-b473e3711ef2\\\", \\\"subtext\\\": \\\"6288a0eb-b602-4d41-bbe8-668bd02d90be\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2116, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"GMCs at baseline (Day 1, Month 0), at 1 month after the first (Day 31, Month 1) and the last vaccinations (Day 211, Month 7) for the ABCWY group, and 1 month after the single MenACWY vaccination (Day 31, Month 1) in the ACWY group, will be logarithmically transformed (base10) to fulfill the normal distribution assumption.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9449d284-5a29-43a0-8840-a12eac0a88a8\\\", \\\"childbox\\\": \\\"7eb977af-b602-4b9c-a56f-6e8cb25c96d8\\\", \\\"subtext\\\": \\\"98142445-3e05-4599-a734-e863d090002a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2117, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For each of the 4\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9449d284-5a29-43a0-8840-a12eac0a88a8\\\", \\\"childbox\\\": \\\"7e32755a-2677-4e1a-96a9-7f9d1bca89be\\\", \\\"subtext\\\": \\\"62a63b6b-63fb-4c58-b016-bd0d936541c9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2118, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9449d284-5a29-43a0-8840-a12eac0a88a8\\\", \\\"childbox\\\": \\\"7e32755a-2677-4e1a-96a9-7f9d1bca89be\\\", \\\"subtext\\\": \\\"7a586c86-bd5a-4f95-9810-2544717ca47c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2119, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9449d284-5a29-43a0-8840-a12eac0a88a8\\\", \\\"childbox\\\": \\\"296077bc-d822-4229-a55b-28283ba08cd0\\\", \\\"subtext\\\": \\\"7a586c86-bd5a-4f95-9810-2544717ca47c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2120, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"serogroups A, C, W, and Y, the GMCs will be calculated with their associated 2-sided 95% CIs by exponentiating (base 10) the least squares means and the lower and upper limits of the 95% CIs of the log-transformed titers (base10) obtained from a 2-way ANCOVA with factors for ~REDACTED~ group and country.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9449d284-5a29-43a0-8840-a12eac0a88a8\\\", \\\"childbox\\\": \\\"296077bc-d822-4229-a55b-28283ba08cd0\\\", \\\"subtext\\\": \\\"9164a470-1368-4b48-9749-2a5c9c7cb0d1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2121, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The ANCOVA will include baseline titers as covariate, and it will be performed to take into consideration the possible effect of these on the post-vaccination titers.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9449d284-5a29-43a0-8840-a12eac0a88a8\\\", \\\"childbox\\\": \\\"b76b2234-ace0-4b5d-8097-5939f2726c96\\\", \\\"subtext\\\": \\\"13df82b7-4483-4dae-9563-b073db329b9c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2122, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Geometric mean ratios (post-vaccination / baseline concentration) and associated 2-sided\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a9955393-bf8e-4474-b536-a9dcee625125\\\", \\\"childbox\\\": \\\"8783373b-1985-4665-a152-80296695c6cd\\\", \\\"subtext\\\": \\\"67cc20c6-b54c-426a-a963-906c608be544\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2123, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"95% CIs will be computed for each strain at each ~REDACTED~, by exponentiating the corresponding log-transformed means and their 95% CIs obtained from a 2-way ANOVA with factors for ~REDACTED~ group and country\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5bd0e01f-8196-4047-8e1f-1a6a64b9069d\\\", \\\"childbox\\\": \\\"f5160154-b154-4efe-8a87-9ae3f292f8c6\\\", \\\"subtext\\\": \\\"effb0fee-92f2-47ca-88c5-4433e26efb2a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2124, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"GMC/GMR group ratios and their 95% CIs will be calculated by exponentiating\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f1d07773-2610-4915-ab95-d7144205b263\\\", \\\"childbox\\\": \\\"5afb0b34-16c1-4538-b534-31787450ab90\\\", \\\"subtext\\\": \\\"877c48c3-2e4c-493f-810f-8582c1f80796\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2125, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(base 10) the difference of the least squares means and the lower and upper limits of the\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bec8e485-7a18-4637-b72d-d303fd05ec85\\\", \\\"childbox\\\": \\\"19b81652-e3fa-4fd3-8815-0ca5ed987d39\\\", \\\"subtext\\\": \\\"53f24c93-9f13-4c33-80a6-c373d482cedb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2126, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"95% CIs of the log-transformed titers (base 10) obtained from a 2-way\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"943cb2b9-c7f6-43cd-8190-1448e7bb7fec\\\", \\\"childbox\\\": \\\"f9bdcd5d-d402-4473-abc4-0f554b81b9d0\\\", \\\"subtext\\\": \\\"d7bebdc8-0fe9-401e-b493-a2489a967a96\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2127, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"ANCOVA/ANOVA.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d6daba57-9d8e-4e34-b786-347db3d880a0\\\", \\\"childbox\\\": \\\"044bfa46-ab06-4a81-bce6-826e7f66c488\\\", \\\"subtext\\\": \\\"150f29d2-73cb-41d5-b1b9-11fedfb9a569\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Immune Response \\\\u2013 N Meningitidis Serogroups A, C, W, and Y (Measured by ELISA)\\\", \\\"9.4.5.2\\\", \\\"4\\\", 2128, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.4.6 Other Analyses\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0c2b5a94-c20e-43f1-bdf8-97490bb32492\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Other Analyses\\\", \\\"9.4.6\\\", \\\"3\\\", 2129, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"No other analyses are planned.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"086eaf7c-5678-4db5-89d6-cda26b39a7fb\\\", \\\"childbox\\\": \\\"29531339-6999-48b1-9e9b-d7066783b996\\\", \\\"subtext\\\": \\\"c7f5e501-be06-4ed8-a922-7f0aab71abf9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Other Analyses\\\", \\\"9.4.6\\\", \\\"3\\\", 2130, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.4.6.1 Demography and Baseline Characteristics Analyses\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0748cf1e-4a04-44c1-9c68-3ab962b49f3c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Demography and Baseline Characteristics Analyses\\\", \\\"9.4.6.1\\\", \\\"4\\\", 2131, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Descriptive statistics (mean, standard deviation [SD], median, minimum and maximum) for age, height, weight, and body mass index will be calculated overall and by ~REDACTED~ group.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"40dc3eb0-a268-402b-894d-9bac5e5ee4c6\\\", \\\"childbox\\\": \\\"9730dbf5-acf4-4877-93a7-038854443471\\\", \\\"subtext\\\": \\\"0731fd3c-8758-4175-afa6-bd7adf2d7ab9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Demography and Baseline Characteristics Analyses\\\", \\\"9.4.6.1\\\", \\\"4\\\", 2132, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Distributions of participants by sex, race, and ethnic origin will be summarized overall and by ~REDACTED~ group.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ddca09ab-e64d-4922-956d-2ebeb8234330\\\", \\\"childbox\\\": \\\"1b455d38-7bae-4651-9de9-acf4e4b98808\\\", \\\"subtext\\\": \\\"329a38d6-31d7-45f0-8e6e-1d1f888296cd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Demography and Baseline Characteristics Analyses\\\", \\\"9.4.6.1\\\", \\\"4\\\", 2133, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Demography will be done for the FAS and PPS.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"645bd548-e0c8-45b6-956c-6081591810ea\\\", \\\"childbox\\\": \\\"57a66b70-43e7-4120-8667-99c759244e9b\\\", \\\"subtext\\\": \\\"af069035-7db3-4b11-bab1-cf90a4667311\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Demography and Baseline Characteristics Analyses\\\", \\\"9.4.6.1\\\", \\\"4\\\", 2134, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.5 Interim Analyses\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"094ac81a-c89c-4831-9aa6-571a417396ea\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Interim Analyses\\\", \\\"9.5\\\", \\\"2\\\", 2135, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"All analyses will be conducted on final data and therefore no statistical adjustment for interim analyses is required.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e57e8975-2e87-4191-8aaf-427457070d00\\\", \\\"childbox\\\": \\\"649f326b-40fd-45de-bd56-e4335304f153\\\", \\\"subtext\\\": \\\"5b27697b-acb9-4d53-a429-2c8024274547\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Interim Analyses\\\", \\\"9.5\\\", \\\"2\\\", 2136, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The final study report will contain the final analyses of all primary and secondary endpoints and made available to the investigators.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d37509d4-461e-4561-ac86-d7deb355febc\\\", \\\"childbox\\\": \\\"78883bd2-f586-427d-9675-faa9b8961c74\\\", \\\"subtext\\\": \\\"a1315db6-2471-4425-bf25-7ae97ab23593\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Interim Analyses\\\", \\\"9.5\\\", \\\"2\\\", 2137, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.5.1 Sequence of Analyses\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4409e9d8-5f8d-4834-8ec9-119469d1138c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sequence of Analyses\\\", \\\"9.5.1\\\", \\\"3\\\", 2138, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Not applicable.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6911d93c-8cd8-47da-9fa9-6c179df78881\\\", \\\"childbox\\\": \\\"0f5f7634-e4f7-4bd4-ac29-56574ef1bf53\\\", \\\"subtext\\\": \\\"6a5b6522-1aca-4f6a-8b7a-997c90965f1c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Sequence of Analyses\\\", \\\"9.5.1\\\", \\\"3\\\", 2139, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.5.2 Statistical Consideration for Interim Analysis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d3eb4cbe-bf39-41f5-9637-a710c0e7a5f0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Consideration for Interim Analysis\\\", \\\"9.5.2\\\", \\\"3\\\", 2140, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Not applicable.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a2fa1dc3-948d-4293-a76d-feb239e3b2f6\\\", \\\"childbox\\\": \\\"7e1642f2-9bc8-477c-98d7-16649f428e55\\\", \\\"subtext\\\": \\\"0e0d0944-b36a-42fb-ac40-c5fad902c4ca\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Statistical Consideration for Interim Analysis\\\", \\\"9.5.2\\\", \\\"3\\\", 2141, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"9.6 Data Monitoring Committee\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ada24b5-eaa4-4ded-9f5b-59ed4afcfc6b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Monitoring Committee\\\", \\\"9.6\\\", \\\"2\\\", 2142, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Not applicable.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8d127a5d-67a3-45fc-91e4-77048b4e3482\\\", \\\"childbox\\\": \\\"870d2e88-f04c-45b8-b7ef-14d62b9936fa\\\", \\\"subtext\\\": \\\"263f8fc0-ef1d-4831-b9a1-fcb56a820bcb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Monitoring Committee\\\", \\\"9.6\\\", \\\"2\\\", 2143, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"10.0  REFERENCES\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading1\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d2c004c8-1cfa-4c41-839e-646fc84654f3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2144, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ~REDACTED~ (CDC).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3c5cc636-8c80-4ff3-a7df-ba10cedcc917\\\", \\\"childbox\\\": \\\"93343d73-4dc0-45d2-8806-9e81386535de\\\", \\\"subtext\\\": \\\"c11826b1-5c3a-43ac-aca5-e11d09aeae52\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2145, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Enhanced meningococcal disease surveillance report,\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3c5cc636-8c80-4ff3-a7df-ba10cedcc917\\\", \\\"childbox\\\": \\\"9760ad13-9074-4900-be05-759c5f237aee\\\", \\\"subtext\\\": \\\"c11826b1-5c3a-43ac-aca5-e11d09aeae52\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2146, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2018. CDC; 2018 [cited 20-DEC-2019].\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f904e093-15d5-4601-9e67-e51fe6306615\\\", \\\"childbox\\\": \\\"a92e8df1-0094-45f2-bc1b-6e1e17cf9104\\\", \\\"subtext\\\": \\\"8c7ee8e7-4211-4abb-8283-50c5da49bfdb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2147, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Available from\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f904e093-15d5-4601-9e67-e51fe6306615\\\", \\\"childbox\\\": \\\"4a0ebc90-9335-4562-bdc8-9f26e648630f\\\", \\\"subtext\\\": \\\"8c7ee8e7-4211-4abb-8283-50c5da49bfdb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2148, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report-2018.pdf\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cd20e5b0-8f54-406f-aa3b-e01c50c9c474\\\", \\\"childbox\\\": \\\"6d772eca-f470-4751-8c45-bbcd7c6dd7c7\\\", \\\"subtext\\\": \\\"2a35d17e-d089-45d4-94e6-0c9973131f83\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2149, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Clopper CJ, Pearson ES.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aee88dd0-ee01-4dd3-9baf-45752b87a932\\\", \\\"childbox\\\": \\\"1cc23738-8233-4058-af93-a0b0f3f877a1\\\", \\\"subtext\\\": \\\"cfe2dd58-29b4-4028-85cf-d66b36a5ec89\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2150, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The use of confidence or fiducial limits illustrated in the case of binomial.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aee88dd0-ee01-4dd3-9baf-45752b87a932\\\", \\\"childbox\\\": \\\"622559a7-07e4-4232-91df-d4efb3eabfec\\\", \\\"subtext\\\": \\\"cfe2dd58-29b4-4028-85cf-d66b36a5ec89\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2151, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Biometrika\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aee88dd0-ee01-4dd3-9baf-45752b87a932\\\", \\\"childbox\\\": \\\"7fc92d0e-0453-42c0-a924-cfaf26c2305a\\\", \\\"subtext\\\": \\\"0de21a76-fc91-431e-a1a0-2366e740cc9a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2152, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\". 1934; 26:404-413.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aee88dd0-ee01-4dd3-9baf-45752b87a932\\\", \\\"childbox\\\": \\\"7fc92d0e-0453-42c0-a924-cfaf26c2305a\\\", \\\"subtext\\\": \\\"53abac55-b314-4566-ae04-8b6132b93b06\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2153, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ~REDACTED~, ~REDACTED~, ~REDACTED~, et al.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c2933b62-fbbf-4179-8db3-ea12cec4c0c8\\\", \\\"childbox\\\": \\\"111532bd-75fd-4684-9258-8eccd577e849\\\", \\\"subtext\\\": \\\"d47bfd49-5b94-4456-9711-206f5651a0c1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2154, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Prevention and control of meningococcal disease:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c2933b62-fbbf-4179-8db3-ea12cec4c0c8\\\", \\\"childbox\\\": \\\"1aa1249e-ad02-40db-8f11-1fa62a376173\\\", \\\"subtext\\\": \\\"d47bfd49-5b94-4456-9711-206f5651a0c1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2155, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"recommendations of the Advisory Committee on Immunization Practices (ACIP).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cc8ca830-d0c7-4b32-8379-08156be31752\\\", \\\"childbox\\\": \\\"482fa3bc-5e86-4cd1-a470-132e4b415c20\\\", \\\"subtext\\\": \\\"5194ae94-5e4f-4093-9e6d-b33970eb677a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2156, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"MMWR Recomm Rep.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cc8ca830-d0c7-4b32-8379-08156be31752\\\", \\\"childbox\\\": \\\"110cbd26-eb97-40c3-84b4-0706bae39ed5\\\", \\\"subtext\\\": \\\"190e0bb0-bc6c-4d57-9141-8bad2243de5f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2157, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2013;62, 1-28.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cc8ca830-d0c7-4b32-8379-08156be31752\\\", \\\"childbox\\\": \\\"110cbd26-eb97-40c3-84b4-0706bae39ed5\\\", \\\"subtext\\\": \\\"075db27a-af3a-40bb-84c4-bf39b20b2d34\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2158, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Cohn A and Macneil J.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"98284ef5-4ccd-4e1d-9f71-920ab4a4e2fc\\\", \\\"childbox\\\": \\\"ea94a5aa-9efc-4576-a6d1-05eb56fec0a8\\\", \\\"subtext\\\": \\\"05fc15ce-eb6a-4b75-bc44-e3d5574c058d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2159, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The Changing Epidemiology of Meningococcal Disease.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"98284ef5-4ccd-4e1d-9f71-920ab4a4e2fc\\\", \\\"childbox\\\": \\\"e140967a-0d2a-4603-ae2a-fa290c5bdb16\\\", \\\"subtext\\\": \\\"05fc15ce-eb6a-4b75-bc44-e3d5574c058d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2160, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Infectious Disease Clinics of North America\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"98284ef5-4ccd-4e1d-9f71-920ab4a4e2fc\\\", \\\"childbox\\\": \\\"01c88882-8b94-4b99-aaa8-6df07cc410c6\\\", \\\"subtext\\\": \\\"d306922d-d278-4f42-ab53-733dae7cd9ec\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2161, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\".\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"98284ef5-4ccd-4e1d-9f71-920ab4a4e2fc\\\", \\\"childbox\\\": \\\"01c88882-8b94-4b99-aaa8-6df07cc410c6\\\", \\\"subtext\\\": \\\"a35c1d56-8b52-4c76-aabd-6e62c74716dd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2162, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2015; 29, 667-677.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"98284ef5-4ccd-4e1d-9f71-920ab4a4e2fc\\\", \\\"childbox\\\": \\\"cc9677a4-d135-4071-946a-ee19a49dbcac\\\", \\\"subtext\\\": \\\"a35c1d56-8b52-4c76-aabd-6e62c74716dd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2163, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Crum-Cianflone N, Sullivan E.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"71897f3d-0110-4d4f-b58c-190c57ed62f9\\\", \\\"childbox\\\": \\\"6e312651-b407-4d76-bdfa-bc99a77ddb22\\\", \\\"subtext\\\": \\\"acc2f738-11f2-43f2-b1e8-986d7b52bf38\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2164, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Meningococcal Vaccinations.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"71897f3d-0110-4d4f-b58c-190c57ed62f9\\\", \\\"childbox\\\": \\\"813b9987-e0b9-4430-9d5a-820c823e64af\\\", \\\"subtext\\\": \\\"acc2f738-11f2-43f2-b1e8-986d7b52bf38\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2165, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Infect Dis Ther.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"71897f3d-0110-4d4f-b58c-190c57ed62f9\\\", \\\"childbox\\\": \\\"c8cb7627-7db1-4d4b-8696-f6bead53ec89\\\", \\\"subtext\\\": \\\"c186d30b-b9f9-49f7-a579-f83f3a47ef6c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2166, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2016;5(2):89\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"71897f3d-0110-4d4f-b58c-190c57ed62f9\\\", \\\"childbox\\\": \\\"c8cb7627-7db1-4d4b-8696-f6bead53ec89\\\", \\\"subtext\\\": \\\"a284406f-cc56-4854-bc42-03ee2a9f430a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2167, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2010\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"71897f3d-0110-4d4f-b58c-190c57ed62f9\\\", \\\"childbox\\\": \\\"c8cb7627-7db1-4d4b-8696-f6bead53ec89\\\", \\\"subtext\\\": \\\"4dfb9f9b-24ed-4b16-af5d-81b208c533be\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Cambria Math\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2168, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"112.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"71897f3d-0110-4d4f-b58c-190c57ed62f9\\\", \\\"childbox\\\": \\\"c8cb7627-7db1-4d4b-8696-f6bead53ec89\\\", \\\"subtext\\\": \\\"74d06e7f-621e-4df9-9664-1e5eda8b17bf\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2169, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ~REDACTED~ (ECDC).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0112f7b7-5075-433a-b174-0e5269631f23\\\", \\\"childbox\\\": \\\"50a8a233-ba27-44e6-9149-82ef8b6a4740\\\", \\\"subtext\\\": \\\"d4af582b-3846-433c-8bb5-96c7f3e57b57\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2170, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Annual Epidemiological\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0112f7b7-5075-433a-b174-0e5269631f23\\\", \\\"childbox\\\": \\\"71cc0f00-1cd2-4c69-bd5a-798b15d50f82\\\", \\\"subtext\\\": \\\"d4af582b-3846-433c-8bb5-96c7f3e57b57\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2171, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Report 2016 \\\\u2013 Invasive meningococcal disease.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"701f2037-3e02-4dd4-8983-0d17896fbc25\\\", \\\"childbox\\\": \\\"09a1870d-3524-40e7-9297-4f5b05e0672e\\\", \\\"subtext\\\": \\\"decd3754-091f-411e-9f54-ebc1c1321166\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2172, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"[Internet]. Stockholm: ECDC; 2016\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"701f2037-3e02-4dd4-8983-0d17896fbc25\\\", \\\"childbox\\\": \\\"f03073d9-e549-4723-b8f2-1bd58489a83d\\\", \\\"subtext\\\": \\\"decd3754-091f-411e-9f54-ebc1c1321166\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2173, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"[cited 09-DEC-2019].\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"48f1095f-d1c2-415e-a9c2-1c3a04d49489\\\", \\\"childbox\\\": \\\"d3ec1e54-001e-425a-ac5a-62634ff105c8\\\", \\\"subtext\\\": \\\"863423c1-ac6e-4289-ae05-8702c326ded7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2174, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Available from\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"48f1095f-d1c2-415e-a9c2-1c3a04d49489\\\", \\\"childbox\\\": \\\"3e882996-3a5c-430c-8c53-0919ee675846\\\", \\\"subtext\\\": \\\"863423c1-ac6e-4289-ae05-8702c326ded7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2175, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"https://ecdc.europa.eu/sites/portal/files/documents/Invasive%20meningococcal%20diseas e%20AER.pdf\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"25a6afe3-c446-48ad-8d4a-3a9b4e160034\\\", \\\"childbox\\\": \\\"39d569d9-ab87-4ea5-bcf2-67d24e082579\\\", \\\"subtext\\\": \\\"2115d1de-d69a-446e-867b-e5abb4f2588d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2176, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ~REDACTED~, ~REDACTED~, ~REDACTED~ et al.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"77cd3735-9b27-48d2-b726-7b0c840f36f0\\\", \\\"childbox\\\": \\\"52038a26-b325-4ce9-9453-e3fd211a211d\\\", \\\"subtext\\\": \\\"c18b5586-24f2-4c03-87ca-6956f66246ea\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2177, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Immunogenicity and tolerability of recombinant serogroup B meningococcal ~REDACTED~ administered with or without routine infant vaccinations according to different immunization schedules.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"77cd3735-9b27-48d2-b726-7b0c840f36f0\\\", \\\"childbox\\\": \\\"ddef6f5e-425a-4f09-9ad9-1794d5778646\\\", \\\"subtext\\\": \\\"c18b5586-24f2-4c03-87ca-6956f66246ea\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2178, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"JAMA: The Journal of the ~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"77cd3735-9b27-48d2-b726-7b0c840f36f0\\\", \\\"childbox\\\": \\\"60fb4b00-29f8-404e-9aac-887cb0fdb9a9\\\", \\\"subtext\\\": \\\"4c6944ce-fc6d-46b4-bac4-73b90d1b961c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2179, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2012;307(6):573\\\\u201382.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"77cd3735-9b27-48d2-b726-7b0c840f36f0\\\", \\\"childbox\\\": \\\"60fb4b00-29f8-404e-9aac-887cb0fdb9a9\\\", \\\"subtext\\\": \\\"3466fc7a-c4c9-4c89-8662-c260ddb9568c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2180, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Hintze, J. (2013).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0dffb4ce-5c8f-4f42-af08-1ec1d46f517c\\\", \\\"childbox\\\": \\\"3f93818a-5e1d-4507-86bb-b8fe4adf3f08\\\", \\\"subtext\\\": \\\"c6db519a-d56f-4dc6-a15d-8e92e394ce8c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2181, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"PASS 12. ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0dffb4ce-5c8f-4f42-af08-1ec1d46f517c\\\", \\\"childbox\\\": \\\"04084e8d-ecd6-4d95-90b3-9f51abbf09d5\\\", \\\"subtext\\\": \\\"c6db519a-d56f-4dc6-a15d-8e92e394ce8c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2182, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Kaysville, Utah, USA.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0dffb4ce-5c8f-4f42-af08-1ec1d46f517c\\\", \\\"childbox\\\": \\\"32454aa7-f550-4f57-bfb7-8fa16d628141\\\", \\\"subtext\\\": \\\"c6db519a-d56f-4dc6-a15d-8e92e394ce8c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2183, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"www.ncss.com.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0dffb4ce-5c8f-4f42-af08-1ec1d46f517c\\\", \\\"childbox\\\": \\\"b7667c8d-e773-4e76-9f3b-b0b5681440dc\\\", \\\"subtext\\\": \\\"c6db519a-d56f-4dc6-a15d-8e92e394ce8c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2184, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ICH Harmonised Tripartite ICH Guideline for Good Clinical Practices E6 (R1).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"727288ff-66bd-4a06-8bfb-4e6407ef4b1f\\\", \\\"childbox\\\": \\\"f288e99b-a043-4ffd-bb45-550ca0c389ca\\\", \\\"subtext\\\": \\\"0cf7b2fb-a318-40db-8b89-a84838c3d7ef\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2185, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1997 Federal Register, 62 (90):25691-25709\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"727288ff-66bd-4a06-8bfb-4e6407ef4b1f\\\", \\\"childbox\\\": \\\"15672298-44c9-405e-b386-2a1b5a584eaa\\\", \\\"subtext\\\": \\\"0cf7b2fb-a318-40db-8b89-a84838c3d7ef\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2186, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Miettinen O., Nurminen M.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65821c68-0d59-4587-8012-5c857a9b923f\\\", \\\"childbox\\\": \\\"36e3af77-a4c0-4726-8cda-15488041536f\\\", \\\"subtext\\\": \\\"eb938a3f-6e9e-4592-b943-2f5532231012\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2187, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Comparative analysis of 2 rates.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65821c68-0d59-4587-8012-5c857a9b923f\\\", \\\"childbox\\\": \\\"fb2ccbb5-3b37-4d85-b142-fe9265d15aec\\\", \\\"subtext\\\": \\\"eb938a3f-6e9e-4592-b943-2f5532231012\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2188, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Statistics in Medicine\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65821c68-0d59-4587-8012-5c857a9b923f\\\", \\\"childbox\\\": \\\"596679a1-4505-4cbe-9708-32db4f80c1da\\\", \\\"subtext\\\": \\\"aaf9753b-7cb5-4781-b539-7182dcbd73d4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2189, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1985; 4(2):213-26.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65821c68-0d59-4587-8012-5c857a9b923f\\\", \\\"childbox\\\": \\\"596679a1-4505-4cbe-9708-32db4f80c1da\\\", \\\"subtext\\\": \\\"db164fec-6c4f-4e7e-b435-dcb033663e23\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2190, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ~REDACTED~, ~REDACTED~, ~REDACTED~, et al.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"996f74d7-b427-47c1-b672-3f6f6f1be5e7\\\", \\\"childbox\\\": \\\"1e304da9-09b1-4fa7-b148-3ddf0aeb16e9\\\", \\\"subtext\\\": \\\"57666d9c-1c48-401a-957f-4d7d0b16b6df\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2191, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Meningococcal disease.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"996f74d7-b427-47c1-b672-3f6f6f1be5e7\\\", \\\"childbox\\\": \\\"93c281da-0f3e-4453-8d73-573b653ecf70\\\", \\\"subtext\\\": \\\"57666d9c-1c48-401a-957f-4d7d0b16b6df\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2192, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N Engl J Med\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"996f74d7-b427-47c1-b672-3f6f6f1be5e7\\\", \\\"childbox\\\": \\\"3689bf36-c125-4c87-a62b-b92d80ae4842\\\", \\\"subtext\\\": \\\"4a9ed690-57c1-4ee4-aa1f-4cdf375d59c5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2193, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\". 2001; 344: 1378-88.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"996f74d7-b427-47c1-b672-3f6f6f1be5e7\\\", \\\"childbox\\\": \\\"3689bf36-c125-4c87-a62b-b92d80ae4842\\\", \\\"subtext\\\": \\\"fd21f1e4-af86-4669-bb08-fd7312098c7d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2194, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ~REDACTED~ et al.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5128bac5-58ff-4aa1-a857-eac23a389725\\\", \\\"childbox\\\": \\\"db1ae9c2-07c1-43b3-860b-ec07189bf418\\\", \\\"subtext\\\": \\\"870b316e-67d3-4f2e-8d31-2adc6ae3c6eb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2195, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY ~REDACTED~ administered to healthy adolescents and young adults.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5128bac5-58ff-4aa1-a857-eac23a389725\\\", \\\"childbox\\\": \\\"b9e234fe-5364-48aa-8e6b-96e48903a757\\\", \\\"subtext\\\": \\\"870b316e-67d3-4f2e-8d31-2adc6ae3c6eb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2196, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Hum Vaccin Immunother.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5128bac5-58ff-4aa1-a857-eac23a389725\\\", \\\"childbox\\\": \\\"bda29140-d908-4d24-8d68-c8b941b9d649\\\", \\\"subtext\\\": \\\"1eeff28d-6836-4310-9b69-41e1a891e802\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2197, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5128bac5-58ff-4aa1-a857-eac23a389725\\\", \\\"childbox\\\": \\\"bda29140-d908-4d24-8d68-c8b941b9d649\\\", \\\"subtext\\\": \\\"3f856ca8-beb9-4769-a8f0-9b1c2a8101d5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2198, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2018;14(5):1161-74.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5128bac5-58ff-4aa1-a857-eac23a389725\\\", \\\"childbox\\\": \\\"2431ebb7-903b-4bcc-be27-022305fa07cd\\\", \\\"subtext\\\": \\\"3f856ca8-beb9-4769-a8f0-9b1c2a8101d5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2199, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ~REDACTED~, ~REDACTED~, ~REDACTED~ et al.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7d811a41-6ac1-4b39-9396-519e8edaa85c\\\", \\\"childbox\\\": \\\"25094e5b-ea15-4c72-8440-7cf1f18470a9\\\", \\\"subtext\\\": \\\"f3002076-0c47-4882-9bd5-92eb3bad398b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2200, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Immune responses to booster vaccination with meningococcal ABCWY ~REDACTED~ after primary vaccination with either investigational or licensed ~REDACTED~s\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7d811a41-6ac1-4b39-9396-519e8edaa85c\\\", \\\"childbox\\\": \\\"ff5cfd85-9b74-48e2-b9e2-a32b358d99af\\\", \\\"subtext\\\": \\\"f3002076-0c47-4882-9bd5-92eb3bad398b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2201, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\".\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7d811a41-6ac1-4b39-9396-519e8edaa85c\\\", \\\"childbox\\\": \\\"ff5cfd85-9b74-48e2-b9e2-a32b358d99af\\\", \\\"subtext\\\": \\\"baa35570-0231-4c64-9e35-26c82abc3bcb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2202, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Pediatr Infect Dis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7d811a41-6ac1-4b39-9396-519e8edaa85c\\\", \\\"childbox\\\": \\\"1fb47cb1-a4c1-4943-8eb7-8464bdaf6c3a\\\", \\\"subtext\\\": \\\"baa35570-0231-4c64-9e35-26c82abc3bcb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2203, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"J 2018;37:475\\\\u201382.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 22, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7d811a41-6ac1-4b39-9396-519e8edaa85c\\\", \\\"childbox\\\": \\\"1fb47cb1-a4c1-4943-8eb7-8464bdaf6c3a\\\", \\\"subtext\\\": \\\"f6f34643-bb86-47ea-bfcf-fc9e221560ac\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 22, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"REFERENCES\\\", \\\"10.0\\\", \\\"2\\\", 2204, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"11.0  APPENDICES\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading1\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0b5f9bd9-8e3c-4ec7-bce5-a59697fc5647\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"APPENDICES\\\", \\\"11.0\\\", \\\"2\\\", 2205, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Appendix 1 Abbreviations and Glossary of Terms\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6b1ea075-aff4-4966-8a58-147ee9e6d341\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 1  Abbreviations and Glossary of Terms\\\", \\\"\\\", \\\"1\\\", 2206, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Abbreviations\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"576c3d48-539e-4395-b9df-3f7e382156ff\\\", \\\"childbox\\\": \\\"ff2610b7-b28a-4cc0-94f6-f8b6d162ae57\\\", \\\"subtext\\\": \\\"a2a61ad4-fe5c-4e4d-927b-6734d561e4af\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2207, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Abbreviation Definition\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ab821d41-5d7e-4747-8978-0be21cd2cde0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2208, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"ACIP\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5700d39b-1af7-49da-9b20-cba9ba3d2b31\\\", \\\"childbox\\\": \\\"6e7fe6c8-5623-4707-bb9a-cd44a9faf62a\\\", \\\"subtext\\\": \\\"d68ccb4b-635c-49b8-ad65-227c2035d529\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2209, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5700d39b-1af7-49da-9b20-cba9ba3d2b31\\\", \\\"childbox\\\": \\\"4398e778-030a-429e-9942-99d59df129e3\\\", \\\"subtext\\\": \\\"10051eac-927e-4a57-8aa2-3f9133b45190\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2210, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Advisory Committee on Immunization Practices\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5700d39b-1af7-49da-9b20-cba9ba3d2b31\\\", \\\"childbox\\\": \\\"9c7964d1-224e-4355-a3a1-91f76a6adf66\\\", \\\"subtext\\\": \\\"10051eac-927e-4a57-8aa2-3f9133b45190\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2211, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"AE\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"983c77e2-2935-4f9a-a630-75c41ee12872\\\", \\\"childbox\\\": \\\"f0e4ef2e-5edf-48f0-9b63-ab124e3a56cc\\\", \\\"subtext\\\": \\\"97823011-fe3f-493a-bdf1-ce9ff2c9d880\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2212, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"983c77e2-2935-4f9a-a630-75c41ee12872\\\", \\\"childbox\\\": \\\"11849de5-cea4-442a-b2ab-4cf20fc75ca3\\\", \\\"subtext\\\": \\\"9e278eef-0cb1-45a4-97b1-b6f10d206327\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2213, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Adverse event\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"983c77e2-2935-4f9a-a630-75c41ee12872\\\", \\\"childbox\\\": \\\"e53cf2d5-9a34-4fd7-9dd3-d5f874f680e2\\\", \\\"subtext\\\": \\\"e9c270e1-d778-4474-bb75-8b28d1a5fd57\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2214, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"ADE\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ea54280a-d7b2-4cd4-8331-3954d258a285\\\", \\\"childbox\\\": \\\"667bc672-b10d-4101-8039-75ec84d984a8\\\", \\\"subtext\\\": \\\"6daf37e5-043e-4c99-b296-e02ff3200bb4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2215, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ea54280a-d7b2-4cd4-8331-3954d258a285\\\", \\\"childbox\\\": \\\"d6ad05e5-2f30-42a2-b0b9-1d46faaf157c\\\", \\\"subtext\\\": \\\"6f75ef9d-4e03-466b-9496-40f2457ea147\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2216, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Adverse device effect\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ea54280a-d7b2-4cd4-8331-3954d258a285\\\", \\\"childbox\\\": \\\"f5bb37c1-c4f9-4eb2-a82c-140e822ec972\\\", \\\"subtext\\\": \\\"6f75ef9d-4e03-466b-9496-40f2457ea147\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2217, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"AESI\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e721446e-a4e3-4b63-994e-6c06bb33ac2e\\\", \\\"childbox\\\": \\\"e7069977-e19b-4ad8-9af7-11693c7051fa\\\", \\\"subtext\\\": \\\"c6daf450-f7a3-480a-a309-367b6a6a6835\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2218, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e721446e-a4e3-4b63-994e-6c06bb33ac2e\\\", \\\"childbox\\\": \\\"cfe5f85b-9330-4270-a403-8916038ed4ff\\\", \\\"subtext\\\": \\\"84246ef6-a622-40c5-99eb-2beb2fe9efb4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2219, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Adverse event of special interest\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e721446e-a4e3-4b63-994e-6c06bb33ac2e\\\", \\\"childbox\\\": \\\"5c8b25f1-4f84-4fbc-bfa3-4d201fbea410\\\", \\\"subtext\\\": \\\"84246ef6-a622-40c5-99eb-2beb2fe9efb4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2220, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"ANCOVA\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"938ea246-ef35-479e-93b5-4f689c80ed43\\\", \\\"childbox\\\": \\\"b7b22cb1-3c4c-4115-95f8-1b5711878578\\\", \\\"subtext\\\": \\\"bee66580-b87d-49b6-92fa-844989823f1d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2221, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"938ea246-ef35-479e-93b5-4f689c80ed43\\\", \\\"childbox\\\": \\\"8a2eb55e-4bdc-44de-aeb7-04eeb9236379\\\", \\\"subtext\\\": \\\"51e66209-353f-4037-8841-2e7c9de4f8fb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2222, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Analysis of covariance\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"938ea246-ef35-479e-93b5-4f689c80ed43\\\", \\\"childbox\\\": \\\"3012f571-5a47-4773-8a58-81dd440bf8b0\\\", \\\"subtext\\\": \\\"51e66209-353f-4037-8841-2e7c9de4f8fb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2223, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"ANOVA\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"90cbc511-1be4-429d-b26c-f7df94f8c9ea\\\", \\\"childbox\\\": \\\"c2def276-e735-4bb9-a195-fb89beca50c8\\\", \\\"subtext\\\": \\\"d2fa38f5-6375-4f47-9eb9-74286ea5eb91\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2224, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"90cbc511-1be4-429d-b26c-f7df94f8c9ea\\\", \\\"childbox\\\": \\\"dffcb61c-8f9f-46ba-a1e5-edb1908a8bef\\\", \\\"subtext\\\": \\\"1a5a828c-81f6-4d9e-aced-eaf48d6f4249\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2225, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Analysis of variance\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"90cbc511-1be4-429d-b26c-f7df94f8c9ea\\\", \\\"childbox\\\": \\\"635695e2-12f3-44cb-aa05-57700a46a2e6\\\", \\\"subtext\\\": \\\"1a5a828c-81f6-4d9e-aced-eaf48d6f4249\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2226, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"CFR\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7da5b9fa-1a58-43d7-8124-b8a431b21642\\\", \\\"childbox\\\": \\\"bbaa92f1-5565-45c0-8fd6-988d9f0a4091\\\", \\\"subtext\\\": \\\"ae2a8652-e285-4c0b-b90f-8a0c2ab1c348\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2227, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7da5b9fa-1a58-43d7-8124-b8a431b21642\\\", \\\"childbox\\\": \\\"22e7a21d-5105-47e1-a5b3-20b27a1353d5\\\", \\\"subtext\\\": \\\"53a5cbfe-8807-4c0b-8332-bb2517b0eef0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2228, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Code of Federal Regulations\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7da5b9fa-1a58-43d7-8124-b8a431b21642\\\", \\\"childbox\\\": \\\"27eae2dc-bd20-4a19-a20d-e2f5a1d70f76\\\", \\\"subtext\\\": \\\"53a5cbfe-8807-4c0b-8332-bb2517b0eef0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2229, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"CI\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"85520758-2e17-430b-bacd-c546ab6ba32f\\\", \\\"childbox\\\": \\\"1f0d7a8d-0953-455a-8121-4d9cca02a43b\\\", \\\"subtext\\\": \\\"17b05fae-ad56-46c2-a2a1-99576be730dc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2230, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"85520758-2e17-430b-bacd-c546ab6ba32f\\\", \\\"childbox\\\": \\\"6e4d8aee-1209-42b2-b3cb-7932f58c9e6f\\\", \\\"subtext\\\": \\\"28a06acd-9b8b-4c2c-a944-5400e6ed6fb5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2231, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Confidence Interval\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"85520758-2e17-430b-bacd-c546ab6ba32f\\\", \\\"childbox\\\": \\\"a73486df-2b4c-4fac-bfdf-409940a75244\\\", \\\"subtext\\\": \\\"28a06acd-9b8b-4c2c-a944-5400e6ed6fb5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2232, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"CLS\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"075d1cc3-b5f9-49a7-8409-b49727a25e7c\\\", \\\"childbox\\\": \\\"fd65e4ca-a8b1-4cec-ad71-35357580fe81\\\", \\\"subtext\\\": \\\"4e57f024-f457-4504-979b-182b9edfdd5e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2233, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"075d1cc3-b5f9-49a7-8409-b49727a25e7c\\\", \\\"childbox\\\": \\\"8e76af08-8d99-482e-ae8f-8e875e3dfd2b\\\", \\\"subtext\\\": \\\"7bff783e-6023-483e-82ae-9dfad86e29b1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2234, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Clinical Laboratory Sciences\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"075d1cc3-b5f9-49a7-8409-b49727a25e7c\\\", \\\"childbox\\\": \\\"7f0329c8-8204-4517-bb99-85521d399ad6\\\", \\\"subtext\\\": \\\"7bff783e-6023-483e-82ae-9dfad86e29b1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2235, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"COVID-19\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d1c0e826-9ca7-4fe5-b978-976f35f08e10\\\", \\\"childbox\\\": \\\"f5698efe-5fcd-4a7d-91c5-81de6df6b7bd\\\", \\\"subtext\\\": \\\"8e112e71-1ad3-487d-8ca0-227fe6bd169c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2236, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d1c0e826-9ca7-4fe5-b978-976f35f08e10\\\", \\\"childbox\\\": \\\"907a901a-ff8f-4577-af3f-bdf01bf992ee\\\", \\\"subtext\\\": \\\"b885ebcc-3181-4bf4-abff-f6393232582e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2237, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Coronavirus disease 2019\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d1c0e826-9ca7-4fe5-b978-976f35f08e10\\\", \\\"childbox\\\": \\\"bd0700b2-7de0-4fd8-8fdb-6a9e0c63b2d4\\\", \\\"subtext\\\": \\\"bd48479f-85f5-49c1-9fc4-dacb5d5c9383\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2238, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"CRM\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4c9430b9-7a04-4b3b-9fde-21fef63235ce\\\", \\\"childbox\\\": \\\"eeb83669-fb84-41d2-8c1f-0f218358e71d\\\", \\\"subtext\\\": \\\"7cec5e4b-1c01-4f0b-9479-b75b48f7637c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2239, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4c9430b9-7a04-4b3b-9fde-21fef63235ce\\\", \\\"childbox\\\": \\\"e905d3d7-431f-425b-9f0c-063bccae8ad6\\\", \\\"subtext\\\": \\\"6362f2ac-6da6-4b4d-bcb2-eb1e9e59e7d2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2240, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Cross-reacting Material CSR\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4c9430b9-7a04-4b3b-9fde-21fef63235ce\\\", \\\"childbox\\\": \\\"fe87cdac-135d-4b63-9011-54b24256fc54\\\", \\\"subtext\\\": \\\"6362f2ac-6da6-4b4d-bcb2-eb1e9e59e7d2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2241, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4c9430b9-7a04-4b3b-9fde-21fef63235ce\\\", \\\"childbox\\\": \\\"93a39cbb-ce39-43e3-87f2-3c3ba71afd39\\\", \\\"subtext\\\": \\\"b8f01af6-4f95-442f-9ca4-0c4dee8028eb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2242, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Clinical Study Report eCRF\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4c9430b9-7a04-4b3b-9fde-21fef63235ce\\\", \\\"childbox\\\": \\\"f8f0c7b6-f0b0-46e5-b72a-88b0509b4471\\\", \\\"subtext\\\": \\\"b8f01af6-4f95-442f-9ca4-0c4dee8028eb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2243, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4c9430b9-7a04-4b3b-9fde-21fef63235ce\\\", \\\"childbox\\\": \\\"04219ff4-68d6-4cfd-b45a-b0e081464c50\\\", \\\"subtext\\\": \\\"9448409e-151d-40c7-853d-b1735093bec7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2244, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Electronic Case Report Form EDC\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4c9430b9-7a04-4b3b-9fde-21fef63235ce\\\", \\\"childbox\\\": \\\"eb7d94cd-3ab5-4d66-bb0c-13d079f0e1a3\\\", \\\"subtext\\\": \\\"9448409e-151d-40c7-853d-b1735093bec7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2245, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4c9430b9-7a04-4b3b-9fde-21fef63235ce\\\", \\\"childbox\\\": \\\"2cc16bec-0fe3-47f1-8dce-2362710ad44b\\\", \\\"subtext\\\": \\\"3851af96-dc1d-49a0-b6c0-0cd0e82a29b8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2246, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Electronic Data Capture System eDiary\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4c9430b9-7a04-4b3b-9fde-21fef63235ce\\\", \\\"childbox\\\": \\\"85902d29-a63b-4aee-9862-151c521b068e\\\", \\\"subtext\\\": \\\"3851af96-dc1d-49a0-b6c0-0cd0e82a29b8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2247, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4c9430b9-7a04-4b3b-9fde-21fef63235ce\\\", \\\"childbox\\\": \\\"b5891a36-7d83-4688-85d2-a298b2489b8e\\\", \\\"subtext\\\": \\\"5afd090d-3816-432e-a3c7-543da5167ea8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2248, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Participant Diary (Electronic Diary)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4c9430b9-7a04-4b3b-9fde-21fef63235ce\\\", \\\"childbox\\\": \\\"c973394d-b834-49c5-99fa-5c80d0b266d3\\\", \\\"subtext\\\": \\\"5afd090d-3816-432e-a3c7-543da5167ea8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2249, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"ES\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f808acdd-90b9-449f-a51b-153a2b86c196\\\", \\\"childbox\\\": \\\"2644488a-4b9b-4f8b-8cb4-4664b4a7d735\\\", \\\"subtext\\\": \\\"4addc3b9-8782-4c76-97f6-c0eb56c8c25f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2250, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f808acdd-90b9-449f-a51b-153a2b86c196\\\", \\\"childbox\\\": \\\"a31ccc52-23f7-4f68-a4db-5a475da93fcc\\\", \\\"subtext\\\": \\\"b7001a11-b7c1-4dd5-88fd-b114cf138f95\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2251, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Exposed Set\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f808acdd-90b9-449f-a51b-153a2b86c196\\\", \\\"childbox\\\": \\\"b8967c16-379d-464a-af7a-b660933243e8\\\", \\\"subtext\\\": \\\"b7001a11-b7c1-4dd5-88fd-b114cf138f95\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2252, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"ELISA\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2ecfc59c-f311-41e5-b5f3-8ad9faaaf8ed\\\", \\\"childbox\\\": \\\"11aa24d6-1379-444b-81ff-015d0c0975d3\\\", \\\"subtext\\\": \\\"f5de6fab-5d1b-4762-9c09-fa7c8f78d93a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2253, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2ecfc59c-f311-41e5-b5f3-8ad9faaaf8ed\\\", \\\"childbox\\\": \\\"368b10f6-dbdf-40ea-b3a9-dfc4f6ec5aca\\\", \\\"subtext\\\": \\\"81cb6b04-379a-4646-897e-25eaaa3a6212\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2254, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Enzyme-linked immunosorbent assay\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2ecfc59c-f311-41e5-b5f3-8ad9faaaf8ed\\\", \\\"childbox\\\": \\\"9143b7ae-9360-4244-ab27-98a250d77f75\\\", \\\"subtext\\\": \\\"81cb6b04-379a-4646-897e-25eaaa3a6212\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2255, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Enr\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d7916aef-391e-479b-93a0-3c1cc02dbcac\\\", \\\"childbox\\\": \\\"76ebaae6-f8de-4404-8bf9-45464ecbdbf7\\\", \\\"subtext\\\": \\\"a5f1df21-7bc8-4934-8fba-55e3c70e1339\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2256, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d7916aef-391e-479b-93a0-3c1cc02dbcac\\\", \\\"childbox\\\": \\\"bb1aec7f-7c6d-49c8-bce9-1d3687533124\\\", \\\"subtext\\\": \\\"d162c73a-fbf6-49a1-b564-d6c08ed2fd6f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2257, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Enrolled Set\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d7916aef-391e-479b-93a0-3c1cc02dbcac\\\", \\\"childbox\\\": \\\"b046e5c6-8135-4803-b987-91becaab0a01\\\", \\\"subtext\\\": \\\"d162c73a-fbf6-49a1-b564-d6c08ed2fd6f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2258, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"EoS\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"24022d79-c216-4eae-a17c-9ddc5220cee3\\\", \\\"childbox\\\": \\\"4e51cb00-5b3f-400c-bdb1-4c7dcb36905b\\\", \\\"subtext\\\": \\\"b896609a-2aaf-4b14-a33e-40419946eee9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2259, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"24022d79-c216-4eae-a17c-9ddc5220cee3\\\", \\\"childbox\\\": \\\"b3c03a39-e51a-44b5-a4a2-eb32295e3d08\\\", \\\"subtext\\\": \\\"11bd72b1-3e56-42d2-aea0-0f82ca1df360\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2260, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"End of Study\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"24022d79-c216-4eae-a17c-9ddc5220cee3\\\", \\\"childbox\\\": \\\"8946df52-63b0-4b49-b8fd-c592e11ec718\\\", \\\"subtext\\\": \\\"11bd72b1-3e56-42d2-aea0-0f82ca1df360\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2261, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"EU\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f74f9e9d-9c14-43f8-a5fe-cc4e872c8901\\\", \\\"childbox\\\": \\\"6fb3c33a-2bc4-432e-99f2-beb8b25d73cf\\\", \\\"subtext\\\": \\\"a80505b1-42ed-4695-aa93-66f7abd9fa55\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2262, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f74f9e9d-9c14-43f8-a5fe-cc4e872c8901\\\", \\\"childbox\\\": \\\"f9b3600b-3aee-448b-b9a8-101f85c85fed\\\", \\\"subtext\\\": \\\"b6f6c435-c4eb-4c9a-84f2-4fea5b9efc87\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2263, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"European Union\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f74f9e9d-9c14-43f8-a5fe-cc4e872c8901\\\", \\\"childbox\\\": \\\"b48ce803-59f1-4490-9aeb-91079fd3cbfd\\\", \\\"subtext\\\": \\\"b6f6c435-c4eb-4c9a-84f2-4fea5b9efc87\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2264, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"FAS\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"77b35c27-81bd-402c-90ac-9ad51697f3a9\\\", \\\"childbox\\\": \\\"37765cd6-e34b-4ff5-8b3b-8ba41893ca8d\\\", \\\"subtext\\\": \\\"5ee2c145-7310-49d1-b149-5cb0f7476169\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2265, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"77b35c27-81bd-402c-90ac-9ad51697f3a9\\\", \\\"childbox\\\": \\\"8ad009f6-9714-4460-92d4-5deb708b85dc\\\", \\\"subtext\\\": \\\"767983ab-9559-4941-a3b0-cda4df967a2f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2266, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Full Analysis Set\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"77b35c27-81bd-402c-90ac-9ad51697f3a9\\\", \\\"childbox\\\": \\\"a6176528-0ffb-407f-ac09-2d082ef19b8c\\\", \\\"subtext\\\": \\\"767983ab-9559-4941-a3b0-cda4df967a2f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2267, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"683d64ab-af55-4e27-8f4a-cb3c483fa372\\\", \\\"childbox\\\": \\\"0077e869-7dec-4f2d-a6e8-bf616eb47e81\\\", \\\"subtext\\\": \\\"c62f0665-c9be-4bd3-a59e-9d955bc903f0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2268, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"683d64ab-af55-4e27-8f4a-cb3c483fa372\\\", \\\"childbox\\\": \\\"8369db61-d219-4986-9293-051d1709cd12\\\", \\\"subtext\\\": \\\"2e76a839-6e7b-4ae9-bc31-e3afd75b9ced\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2269, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Food and Drug Administration fHbp\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"683d64ab-af55-4e27-8f4a-cb3c483fa372\\\", \\\"childbox\\\": \\\"2054330e-8ce2-4ec0-9600-20536ff89b1b\\\", \\\"subtext\\\": \\\"2e76a839-6e7b-4ae9-bc31-e3afd75b9ced\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2270, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"683d64ab-af55-4e27-8f4a-cb3c483fa372\\\", \\\"childbox\\\": \\\"35c00b28-7ddc-48b7-9f48-44c970e6684d\\\", \\\"subtext\\\": \\\"e04a1245-8b44-4f8c-9ee2-4119eaca379d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2271, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Factor H binding protein GCP\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"683d64ab-af55-4e27-8f4a-cb3c483fa372\\\", \\\"childbox\\\": \\\"6fb346e9-040f-477e-9ca6-d19e0ef10afa\\\", \\\"subtext\\\": \\\"e04a1245-8b44-4f8c-9ee2-4119eaca379d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2272, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"683d64ab-af55-4e27-8f4a-cb3c483fa372\\\", \\\"childbox\\\": \\\"0bf8a3b3-268c-4ca6-bdfb-c64aa7e0e4ed\\\", \\\"subtext\\\": \\\"8f57324f-7b00-4f2a-b812-a2f64b1e3053\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2273, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Good Clinical Practice\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"683d64ab-af55-4e27-8f4a-cb3c483fa372\\\", \\\"childbox\\\": \\\"ecff6860-a93f-4809-9d73-747e7426d725\\\", \\\"subtext\\\": \\\"8f57324f-7b00-4f2a-b812-a2f64b1e3053\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2274, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"GMC\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c88919cf-89b9-4b28-b736-8ebaa90c9d16\\\", \\\"childbox\\\": \\\"541cd2f4-e36f-43e9-9192-07dd8c6adb5c\\\", \\\"subtext\\\": \\\"d00bf1a6-77d4-4808-b365-8e67d0af0470\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2275, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c88919cf-89b9-4b28-b736-8ebaa90c9d16\\\", \\\"childbox\\\": \\\"05d1bfe1-cbd5-4d2b-9ce1-8ee3029977d2\\\", \\\"subtext\\\": \\\"45d511e9-e0f1-437a-9c9f-02c8183e3908\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2276, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Geometric mean concentration\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c88919cf-89b9-4b28-b736-8ebaa90c9d16\\\", \\\"childbox\\\": \\\"3de1662e-999a-49c1-9bc3-a6144ffa22b3\\\", \\\"subtext\\\": \\\"45d511e9-e0f1-437a-9c9f-02c8183e3908\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2277, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"GMR\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e3768726-7a21-42b0-8192-e2cf485b81a2\\\", \\\"childbox\\\": \\\"ef9de3d9-b3aa-46f5-a168-0780f86e54aa\\\", \\\"subtext\\\": \\\"abca99af-8fbd-450b-bd82-0e3b7876daa5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2278, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e3768726-7a21-42b0-8192-e2cf485b81a2\\\", \\\"childbox\\\": \\\"8d5e80c7-3128-42a8-b348-32fa7113016f\\\", \\\"subtext\\\": \\\"74b0d311-833a-4540-a55c-ed5f0f0042d4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2279, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Geometric mean ratio\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e3768726-7a21-42b0-8192-e2cf485b81a2\\\", \\\"childbox\\\": \\\"8ff28583-03fc-4812-90e4-64b72120c7ef\\\", \\\"subtext\\\": \\\"74b0d311-833a-4540-a55c-ed5f0f0042d4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2280, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"GMT\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1fd5c8ff-36c3-44a2-89f9-e7d278c0a431\\\", \\\"childbox\\\": \\\"141fff74-028c-4aaf-93b0-6699aa8ea1db\\\", \\\"subtext\\\": \\\"5fb35685-1cf3-4c44-9df0-5b2f807b8938\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2281, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1fd5c8ff-36c3-44a2-89f9-e7d278c0a431\\\", \\\"childbox\\\": \\\"749317f0-0ea1-48a7-bde4-5b13a4d70b6a\\\", \\\"subtext\\\": \\\"69b94453-19c8-4481-96f7-c7fbb7afe326\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2282, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Geometric mean titer\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1fd5c8ff-36c3-44a2-89f9-e7d278c0a431\\\", \\\"childbox\\\": \\\"42d3e4a6-8e01-4691-a5d4-666e3090b6bc\\\", \\\"subtext\\\": \\\"e8bdcb9d-460f-471a-8da8-ebb97d27c341\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2283, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aafcee1d-07fb-4e44-85c3-0ef2e09e7be1\\\", \\\"childbox\\\": \\\"22d222e4-0b95-4ef1-94bf-3ef2d826a9bf\\\", \\\"subtext\\\": \\\"1a565302-f239-4adf-ba0e-a7317d20a958\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2284, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aafcee1d-07fb-4e44-85c3-0ef2e09e7be1\\\", \\\"childbox\\\": \\\"bb761f6a-f7dc-42dc-839c-ff0f179f57fd\\\", \\\"subtext\\\": \\\"9d007337-d1bc-4eb2-84c7-06ae869a3fc9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2285, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"aafcee1d-07fb-4e44-85c3-0ef2e09e7be1\\\", \\\"childbox\\\": \\\"ef00f1ec-9ac0-44e4-994e-7baa0d593b97\\\", \\\"subtext\\\": \\\"9d007337-d1bc-4eb2-84c7-06ae869a3fc9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2286, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"HRT\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"28b5e953-d513-47ba-859a-b81203ece0a5\\\", \\\"childbox\\\": \\\"bab010f0-d5cb-4177-9287-5200040f82a8\\\", \\\"subtext\\\": \\\"68601115-4e1e-4d54-836d-a030e698bd81\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2287, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"28b5e953-d513-47ba-859a-b81203ece0a5\\\", \\\"childbox\\\": \\\"6787b628-f303-4cd3-ac18-3752067971cf\\\", \\\"subtext\\\": \\\"5850e6f6-2837-4956-88b1-bcc238748e6b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2288, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Hormone replacement therapy hSBA\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"28b5e953-d513-47ba-859a-b81203ece0a5\\\", \\\"childbox\\\": \\\"9583143d-6246-4d60-976b-d54886962fed\\\", \\\"subtext\\\": \\\"5850e6f6-2837-4956-88b1-bcc238748e6b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2289, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"28b5e953-d513-47ba-859a-b81203ece0a5\\\", \\\"childbox\\\": \\\"393c7456-708c-4951-a355-dfe4848523dc\\\", \\\"subtext\\\": \\\"3f48abdb-e567-4b91-8d3f-537abc6b9fd4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2290, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Human Serum Bactericidal Assay IB\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"28b5e953-d513-47ba-859a-b81203ece0a5\\\", \\\"childbox\\\": \\\"7e8b9a32-aeba-4ffa-96c3-bd8294cf5a3a\\\", \\\"subtext\\\": \\\"3f48abdb-e567-4b91-8d3f-537abc6b9fd4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2291, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"28b5e953-d513-47ba-859a-b81203ece0a5\\\", \\\"childbox\\\": \\\"fc64080f-fd88-4b44-9bc6-75e3a78ffcfe\\\", \\\"subtext\\\": \\\"72b129f3-0f69-4977-a29e-c11009dbf9a3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2292, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Investigator\\\\u2019s Brochure\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"28b5e953-d513-47ba-859a-b81203ece0a5\\\", \\\"childbox\\\": \\\"e2a4e370-27c1-4f1a-9c58-764b54f9cb02\\\", \\\"subtext\\\": \\\"72b129f3-0f69-4977-a29e-c11009dbf9a3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2293, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"415a07b7-bb1b-4190-a294-61c2d1d82c4d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2294, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Abbreviation</td>\\\\n      <td>Definition</td>\\\\n      <td>Definition</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>IAF</td>\\\\n      <td>Informed Assent Form</td>\\\\n      <td>Informed Assent Form</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>ICF</td>\\\\n      <td>Informed Consent Form</td>\\\\n      <td>Informed Consent Form</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>ICH</td>\\\\n      <td>International Council on Harmonisation</td>\\\\n      <td>International Council on Harmonisation</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>IEC</td>\\\\n      <td>Independent Ethics Committee</td>\\\\n      <td>Independent Ethics Committee</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>IMD</td>\\\\n      <td>Invasive meningococcal disease</td>\\\\n      <td>Invasive meningococcal disease</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td>IND</td>\\\\n      <td>Investigational New Drug</td>\\\\n      <td>Investigational New Drug</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>7</th>\\\\n      <td>IRB</td>\\\\n      <td>Institutional Review Board</td>\\\\n      <td>Institutional Review Board</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>8</th>\\\\n      <td>IVRS</td>\\\\n      <td>Interactive Voice Response System</td>\\\\n      <td>Interactive Voice Response System</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>9</th>\\\\n      <td>LAR</td>\\\\n      <td>Legally acceptable representative</td>\\\\n      <td>Legally acceptable representative</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>10</th>\\\\n      <td>LLOQ</td>\\\\n      <td>Lower limit of quantitation</td>\\\\n      <td>Lower limit of quantitation</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>11</th>\\\\n      <td>LOD</td>\\\\n      <td>Limit of detection</td>\\\\n      <td>Limit of detection</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>12</th>\\\\n      <td>LSLV</td>\\\\n      <td>Last Participant Last <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n      <td>Last Participant Last <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>13</th>\\\\n      <td>M</td>\\\\n      <td>Month</td>\\\\n      <td>Month</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>14</th>\\\\n      <td>MedDRA</td>\\\\n      <td>Medical Dictionary for Regulatory Activities</td>\\\\n      <td>Medical Dictionary for Regulatory Activities</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>15</th>\\\\n      <td>MenABCWY</td>\\\\n      <td>Meningococcal serogroups A, B, C, W, and Y investigational <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n      <td>Meningococcal serogroups A, B, C, W, and Y investigational <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>16</th>\\\\n      <td>MenACWY</td>\\\\n      <td>Meningococcal serogroups A, C, W, and Y conjugate <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n      <td>Meningococcal serogroups A, C, W, and Y conjugate <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>17</th>\\\\n      <td>MenB</td>\\\\n      <td>Meningitis B</td>\\\\n      <td>Meningitis B</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>18</th>\\\\n      <td>NadA</td>\\\\n      <td>Neisseria adhesin A</td>\\\\n      <td>Neisseria adhesin A</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>19</th>\\\\n      <td>NHBA</td>\\\\n      <td>Neisseria Heparin Binding Antigen</td>\\\\n      <td>Neisseria Heparin Binding Antigen</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>20</th>\\\\n      <td>NI</td>\\\\n      <td>Non-inferiority</td>\\\\n      <td>Non-inferiority</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>21</th>\\\\n      <td>NZ</td>\\\\n      <td>New Zealand</td>\\\\n      <td>New Zealand</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>22</th>\\\\n      <td>OMV</td>\\\\n      <td>Outer membrane vesicles</td>\\\\n      <td>Outer membrane vesicles</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>23</th>\\\\n      <td>PCD</td>\\\\n      <td>Primary completion date</td>\\\\n      <td>Primary completion date</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>24</th>\\\\n      <td>pIMD</td>\\\\n      <td>Potential immune-mediated disease</td>\\\\n      <td>Potential immune-mediated disease</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>25</th>\\\\n      <td>PT</td>\\\\n      <td>Preferred term</td>\\\\n      <td>Preferred term</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>26</th>\\\\n      <td>PorA</td>\\\\n      <td>Porin A</td>\\\\n      <td>Porin A</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>27</th>\\\\n      <td>PPS</td>\\\\n      <td>Per Protocol Set</td>\\\\n      <td>Per Protocol Set</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>28</th>\\\\n      <td>SADE</td>\\\\n      <td>Serious adverse device effect</td>\\\\n      <td>Serious adverse device effect</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>29</th>\\\\n      <td>SAE</td>\\\\n      <td>Serious adverse event</td>\\\\n      <td>Serious adverse event</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>30</th>\\\\n      <td>SoA</td>\\\\n      <td>Schedule of Activities</td>\\\\n      <td>Schedule of Activities</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>31</th>\\\\n      <td>SOC</td>\\\\n      <td>System organ class</td>\\\\n      <td>System organ class</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>32</th>\\\\n      <td>SSS</td>\\\\n      <td>Solicited Safety Set</td>\\\\n      <td>Solicited Safety Set</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>33</th>\\\\n      <td>SUSAR</td>\\\\n      <td>Suspected unexpected serious adverse reaction</td>\\\\n      <td>Suspected unexpected serious adverse reaction</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>34</th>\\\\n      <td>T</td>\\\\n      <td>T</td>\\\\n      <td>Telephone contact</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>35</th>\\\\n      <td>USADE</td>\\\\n      <td>USADE</td>\\\\n      <td>Unexpected serious adverse device effect</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>36</th>\\\\n      <td>US</td>\\\\n      <td>US</td>\\\\n      <td>United States (of America)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>37</th>\\\\n      <td>USS</td>\\\\n      <td>USS</td>\\\\n      <td>Unsolicited Safety Set</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>38</th>\\\\n      <td>V Glossary of Terms</td>\\\\n      <td>V Glossary of Terms</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>39</th>\\\\n      <td>Term</td>\\\\n      <td>Term</td>\\\\n      <td>Definition</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>40</th>\\\\n      <td>Blinding</td>\\\\n      <td>Blinding</td>\\\\n      <td>A procedure in which 1 or more parties to the study are kept unaware of the intervention assignment in order to reduce the risk of biased study outcomes. The level of blinding is maintained throughout the conduct of the study, and only when the data are cleaned to an acceptable level of quality will appropriate personnel be unblinded or when required in case of a serious adverse event. In an observer-blind study, the participant, the study center and sponsor or sponsor\\\\u2019s designee\\\\u2019s personnel involved in the clinical evaluation of the participants are blinded while other study personnel may be aware of the treatment assignment.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>41</th>\\\\n      <td>Caregiver</td>\\\\n      <td>Caregiver</td>\\\\n      <td>A \\\\u201ccaregiver\\\\u201d is someone who lives in the close surroundings of a participant and has a continuous caring role or has substantial periods of contact with a participant and is engaged in his/her daily health care (e.g., a relative of the participant, a nurse who helps with daily activities in case of residence in a nursing home). In the context of a clinical study, a caregiver could include an individual appointed to oversee and support the participant's compliance with protocol specified procedures.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>42</th>\\\\n      <td>Child in care</td>\\\\n      <td>Child in care</td>\\\\n      <td>A child who has been placed under the control or</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"86\\\", \\\"TableIndex\\\": \\\"34\\\", \\\"TableName\\\": \\\"Abbreviations\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"51de92e8-288e-473e-94ee-a5c651cb1e4d\\\", \\\"childbox\\\": \\\"bc370a0b-00b0-44a6-a0e1-2bc6eb9e36ab\\\", \\\"subtext\\\": \\\"b1579b16-0073-4fd4-b8b8-0bf1050ddaba\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2295, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"protection of an agency, organization, institution or entity by the courts, the government or a government body, acting in accordance with powers conferred on them by law or regulation.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"170f3a07-4a4d-4637-867b-b074d1c6d07d\\\", \\\"childbox\\\": \\\"5e189ef2-d5ff-4949-9a3a-93c0cc5367c6\\\", \\\"subtext\\\": \\\"e16b842e-92c1-4776-9185-3949d00898f9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2296, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The definition of a child in care can include a child cared for by foster parents or living in a care home or institution, provided that the arrangement falls within the definition above.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"170f3a07-4a4d-4637-867b-b074d1c6d07d\\\", \\\"childbox\\\": \\\"286f4e46-811a-4d12-ac2b-9151713d1a07\\\", \\\"subtext\\\": \\\"65bcdb45-3ca7-452d-997f-d09415d4b540\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2297, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The definition of a child in care does not include a child who is adopted.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"170f3a07-4a4d-4637-867b-b074d1c6d07d\\\", \\\"childbox\\\": \\\"1184d127-3ef3-42fc-b6aa-cd25d78ad05c\\\", \\\"subtext\\\": \\\"65aea3e6-8ebc-4760-b00a-dcb16dc9651d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2298, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Combination product</td>\\\\n      <td>Combination product comprises any combination of drug device biological product Each drug, device, and biological product included in a combination product is a constituent part.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Eligible (participant)</td>\\\\n      <td>Qualified for enrollment into the study based upon strict adherence to inclusion/exclusion criteria.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Enrolled (participant)</td>\\\\n      <td>\\\\u201cEnrolled\\\\u201d means a participant\\\\u2019s/participant\\\\u2019s parent(s)\\\\u2019/LAR(s)\\\\u2019 agreement to participate in a clinical study following completion of the informed consent process. Potential participants who are screened for the purpose of determining eligibility for the study, but do not participate in the study, are not considered enrolled, unless otherwise specified by the protocol. Refer to the Section 9.3 for the definition of \\\\u201cenrolled\\\\u201d applicable to the study.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Essential documents</td>\\\\n      <td>Documents which individually and collectively permit evaluation of the conduct of a study and the quality of the data produced.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>Evaluable (participant)</td>\\\\n      <td>Meeting all eligibility criteria, complying with the procedures defined in the protocol, and, therefore, included in the per-protocol analysis. Refer to Section 9.3 for details on criteria for evaluability.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>Immunological correlate of protection</td>\\\\n      <td>A correlate of risk that has been validated to predict a certain level of protection from the targeted endpoint.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td>Intervention</td>\\\\n      <td>Term used throughout the clinical study to denote a set of investigational product or marketed product or placebo intended to be administered to a participant.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>7</th>\\\\n      <td>Investigational <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product</td>\\\\n      <td>A pharmaceutical form of an active ingredient being tested in a clinical study, including a product with a marketing authorization when used in a way different from the approved form, or when used for an unapproved indication, or when used to gain further information about an approved use.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>8</th>\\\\n      <td>Investigator</td>\\\\n      <td>A person responsible for the conduct of the clinical study</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"86\\\", \\\"TableIndex\\\": \\\"35\\\", \\\"TableName\\\": \\\"Abbreviations\\\", \\\"Header\\\": []}, {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"d1094949-741c-4c95-b01d-0b1ba62c54b3\\\", \\\"childbox\\\": \\\"e74cbc48-293c-4a27-8cb4-bc41dd8b057f\\\", \\\"subtext\\\": \\\"69c8dacf-fdeb-4f18-a065-f93ac3c06b3f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2299, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4a853737-9aab-433b-b21e-93ea36da02c9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2300, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"at a study center.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a25b3874-050a-4dc5-a7b5-73f4c5fb218c\\\", \\\"childbox\\\": \\\"1ee324f9-41c8-4584-9169-84f218d22e7c\\\", \\\"subtext\\\": \\\"fa580aeb-444e-4b90-9105-cd03e3501d57\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2301, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If a study is conducted by a team of\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a25b3874-050a-4dc5-a7b5-73f4c5fb218c\\\", \\\"childbox\\\": \\\"859064f2-7a1e-418d-88c7-4b168a8394bd\\\", \\\"subtext\\\": \\\"fa580aeb-444e-4b90-9105-cd03e3501d57\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2302, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"individuals at a study center, the investigator is the responsible ~REDACTED~ of the team and may be called the principal investigator.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1807b43c-ad05-41be-969e-746e4031c87c\\\", \\\"childbox\\\": \\\"3a59a4be-0a5a-4b23-a036-416cb828e541\\\", \\\"subtext\\\": \\\"d0564142-504b-491a-87f3-e2a98dcd8bf5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2303, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator can delegate study-related duties and functions conducted at the study center to qualified individual or party to perform those study-related duties and functions.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a7cf9ec5-cb90-4d98-b5aa-c249c8a3fb41\\\", \\\"childbox\\\": \\\"de18b097-2ffa-4235-af4c-136b5f2f8576\\\", \\\"subtext\\\": \\\"98ffdbac-a763-4af9-9dc6-f82489d83160\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2304, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Interactive voice response system (IVRS)</td>\\\\n      <td>The software that enables the randomizing of participants into clinical trials and allocation of the study product to them in a blinded fashion. This technology allows study centers to interact with a database by pressing keypad buttons on a phone and following voice prompts in order to enter in information.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Legally acceptable representative</td>\\\\n      <td>An individual or juridical or other body authorized under applicable law to consent, on behalf of a prospective participant, to the participant's participation in the clinical study. The terms legal representative, legally authorized representative are used in some settings.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Medical device deficiency:</td>\\\\n      <td>A device deficiency is an inadequacy of a medical device with respect to its identity, quality, durability, reliability, safety, or performance. Device deficiencies include malfunctions, use errors and information supplied by the manufacturer.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Medically attended AEs</td>\\\\n      <td>Symptoms or illnesses requiring hospitalization, or emergency room <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, or <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to/by a health care provider.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>Study/Site Monitor</td>\\\\n      <td>An individual assigned by the sponsor or sponsor\\\\u2019s designee and responsible for assuring proper conduct of clinical studies at 1 or more study centers. The terms Clinical Research Monitor and Clinical Research Associate are used in some settings.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>Participant</td>\\\\n      <td>Term used throughout the protocol to denote an individual who has been contacted to participate or participates in the clinical study, either as a recipient of <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product or as a control. Synonym: participant</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td>Participant number</td>\\\\n      <td>A unique identification number assigned to each</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"86\\\", \\\"TableIndex\\\": \\\"36\\\", \\\"TableName\\\": \\\"Abbreviations\\\", \\\"Header\\\": []}, {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"5bc020ed-9191-4107-94b4-603a02647894\\\", \\\"childbox\\\": \\\"83304639-b0ae-4990-9f2a-059419de7b3f\\\", \\\"subtext\\\": \\\"9b782015-3d31-43c8-ad39-14bf1c68591a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2305, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"participant who consents to participate in the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cfdfe145-e96c-4a3d-8c16-18d92e3082e0\\\", \\\"childbox\\\": \\\"0d131c1d-6aac-4f91-b22c-34619a38831b\\\", \\\"subtext\\\": \\\"a95e52f2-bf30-4435-a337-b67e586196a1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2306, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Primary completion date (PCD)</td>\\\\n      <td>The date that the final participant was examined or received an intervention for the purpose of final collection of data for all primary outcomes, whether the clinical study was concluded according to the pre-specified protocol or was terminated.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Protocol amendment</td>\\\\n      <td>The International Council on Harmonisation (ICH) defines a protocol amendment as \\\\u201cA written description of a change(s) to or formal clarification of a protocol.\\\\u201d <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> further details this to include a change to an approved protocol that affects the safety of participants, scope of the investigation, study design, or scientific integrity of the study.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Qualified health care professional</td>\\\\n      <td>Term used to refer to any licensed or certified health care professional who is permitted by institutional policy to perform protocol required procedures, and who is identified within the Study Staff Signature Log.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Randomization</td>\\\\n      <td>Process of random attribution of intervention to participants to reduce selection bias.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>Self-contained study</td>\\\\n      <td>Study with objectives not linked to the data of another study.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>Solicited event</td>\\\\n      <td>Events to be recorded as endpoints in the clinical study. The presence/occurrence/intensity of these events is actively solicited from the participant or an observer during a specified post-vaccination follow-up period.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td>Source data</td>\\\\n      <td>All information in original records and certified copies of original records of clinical findings, observations, or other activities in a clinical study necessary for the reconstruction and evaluation of the study. Source data are contained in source documents (original records or certified copies). A certified copy is a copy (irrespective of the type of media used) of the original record that has been verified (i.e., by a dated signature or by generation through a validated process) to have the same information, including data that describe the context, content, and structure, as the original.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>7</th>\\\\n      <td>Source documents</td>\\\\n      <td>Original legible documents, data, and records (e.g.,</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"86\\\", \\\"TableIndex\\\": \\\"37\\\", \\\"TableName\\\": \\\"Abbreviations\\\", \\\"Header\\\": []}, {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"75989888-b147-4d80-b04e-e5d9faa61205\\\", \\\"childbox\\\": \\\"e7c20bc4-eacd-4db2-a690-0c2e6b79fb48\\\", \\\"subtext\\\": \\\"5f88aad7-0901-4f6c-bde3-dc569dc9575f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2307, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"hospital records, clinical and office charts, laboratory notes, memoranda, participants' diaries or evaluation checklists, pharmacy dispensing records, recorded data from automated instruments, copies or transcriptions certified after verification as being accurate copies, microfiches, photographic negatives, microfilm or magnetic media, X-rays, participant files, and records kept at the pharmacy, at the laboratories and at medicotechnical departments involved in the clinical study).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"07f52359-d502-46f7-a727-7ee36a212b56\\\", \\\"childbox\\\": \\\"bcd03706-9bea-4c82-a994-b7f6775af620\\\", \\\"subtext\\\": \\\"201dadf8-3baa-4c61-8388-70939a9943f4\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2308, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Study <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product</td>\\\\n      <td>Any investigational <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product being tested and/or any authorized use of a <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product/placebo as a reference or administered concomitantly, in a clinical study that evaluates the use of an investigational <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Treatment</td>\\\\n      <td>Term used throughout the clinical study to denote a set of investigational product or marketed product or placebo intended to be administered to a participant.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Treatment number</td>\\\\n      <td>A number identifying intervention given to a participant, according to intervention allocation.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Unsolicited adverse event</td>\\\\n      <td>Any AE reported in addition to those solicited during the clinical study. Also, any \\\\u201csolicited\\\\u201d symptom with onset outside the specified period of follow-up for solicited symptoms will be reported as an unsolicited AE.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>Witness (impartial witness)</td>\\\\n      <td>The witness is an individual independent of the study, whose role is to attend the informed consent process if the</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"86\\\", \\\"TableIndex\\\": \\\"38\\\", \\\"TableName\\\": \\\"Abbreviations\\\", \\\"Header\\\": []}, {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [{\\\"start_idx\\\": 6, \\\"end_idx\\\": 12, \\\"standard_entity_name\\\": \\\"Molecule\\\", \\\"subcategory\\\": \\\"Molecule\\\", \\\"confidence\\\": 75.0, \\\"text\\\": \\\"vaccine\\\"}], \\\"roi_id\\\": {\\\"para\\\": \\\"e816517a-b97c-435d-9948-f18f5889c928\\\", \\\"childbox\\\": \\\"6340f5c1-3b64-415f-88a9-8c6884b79dd6\\\", \\\"subtext\\\": \\\"ef662235-5c9b-443b-bad2-fe94143078a0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2309, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"participant/participant\\\\u2019s parent(s)/LAR(s) cannot read.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"49e96d2a-a17a-4f30-ab3a-13fed1daa3ca\\\", \\\"childbox\\\": \\\"99917bc3-52ae-463d-9d6a-162818fa8e3f\\\", \\\"subtext\\\": \\\"95be5e99-feca-44de-80f4-287b55eda70f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2310, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The witness reads the documents supplied to the participant/participant\\\\u2019s parent(s)/LAR(s) and signs them after the participant/participant\\\\u2019s parent(s)/LAR(s) sign/thumb print the applicable documents.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"49e96d2a-a17a-4f30-ab3a-13fed1daa3ca\\\", \\\"childbox\\\": \\\"c1479001-d59c-45f1-8744-409d657353f8\\\", \\\"subtext\\\": \\\"aa23b8ad-9fe8-4c61-bd5f-a3099a604426\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2311, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The witness cannot in any way influence participant\\\\u2019s/participant\\\\u2019s parent(s)\\\\u2019/LAR(s)\\\\u2019 decision to participate in the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"49e96d2a-a17a-4f30-ab3a-13fed1daa3ca\\\", \\\"childbox\\\": \\\"1a11d3c3-6dc5-4bf6-b116-a2494630313c\\\", \\\"subtext\\\": \\\"aa23b8ad-9fe8-4c61-bd5f-a3099a604426\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2312, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"360a7ff8-0481-4532-b3a6-cb55220a8628\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Abbreviations\\\", \\\"\\\", \\\"3\\\", 2313, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Appendix 2 Regulatory, Ethical, and Study Oversight Considerations\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c7b43b6f-720a-4f60-988f-bd4baa147e49\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 2  Regulatory, Ethical, and Study Oversight Considerations\\\", \\\"\\\", \\\"1\\\", 2314, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Regulatory and Ethical Considerations\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d8f7ba54-68cf-4130-9e24-79c49a17579e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory and Ethical Considerations\\\", \\\"\\\", \\\"1\\\", 2315, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 This study will be conducted in accordance with the protocol and with:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"dd44f0ac-7541-4593-96ac-23bbe3d4c23b\\\", \\\"childbox\\\": \\\"e8ef7ea5-4b0a-4257-b6f1-3b79c017f599\\\", \\\"subtext\\\": \\\"a1140429-0920-43e9-ba95-2f2cb7e2c8f5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory and Ethical Considerations\\\", \\\"\\\", \\\"1\\\", 2316, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d Consensus ethical principles derived from international guidelines including the Declaration of Helsinki and Council for International Organisations of\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b2e10a32-ee57-443a-ad50-8e3673649a70\\\", \\\"childbox\\\": \\\"91b684ad-ad33-46be-bff0-24868109cd1a\\\", \\\"subtext\\\": \\\"db481792-3dc5-43f5-9fc5-caf6cbf00546\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory and Ethical Considerations\\\", \\\"\\\", \\\"1\\\", 2317, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Medical Sciences (CIOMS) International Ethical Guidelines\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"959e281e-0741-4a75-8083-07c0be686e7d\\\", \\\"childbox\\\": \\\"aca3fddf-5a9b-42e3-8c7d-8509a261af4e\\\", \\\"subtext\\\": \\\"39b36214-09d3-4fb9-8c0d-1426d0951def\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory and Ethical Considerations\\\", \\\"\\\", \\\"1\\\", 2318, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d Applicable ICH GCP Guidelines\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"07184c65-3ccb-4ded-b177-4cc1c0d3fa89\\\", \\\"childbox\\\": \\\"bf03ac7e-a10f-4a05-bf94-f43a8679f8c2\\\", \\\"subtext\\\": \\\"074cd9c3-f969-4388-8aa0-2a87afe1ec0d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory and Ethical Considerations\\\", \\\"\\\", \\\"1\\\", 2319, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d Applicable laws and regulations\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2c0c563c-d54f-4ef2-8c55-be8e9983e751\\\", \\\"childbox\\\": \\\"0f0ed357-30b5-4eba-9d31-3e36815a2d4d\\\", \\\"subtext\\\": \\\"14d3aa74-af4f-44e1-ae18-04eeb6298b57\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory and Ethical Considerations\\\", \\\"\\\", \\\"1\\\", 2320, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The protocol, protocol amendments, ICF and Informed Assent Form (IAF) if applicable, IB, and other relevant documents (e.g., advertisements) must be submitted to an IRB/IEC by the investigator for review and approval.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ff2d3d3a-aa46-49a8-b14a-1256a0033728\\\", \\\"childbox\\\": \\\"0dd1a12b-141e-40aa-b787-8040e2ff09aa\\\", \\\"subtext\\\": \\\"5774a343-c84f-40c8-85e0-89de44c39b39\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory and Ethical Considerations\\\", \\\"\\\", \\\"1\\\", 2321, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"These documents will be signed and dated by the investigator before the study is initiated.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ff2d3d3a-aa46-49a8-b14a-1256a0033728\\\", \\\"childbox\\\": \\\"1baddc76-7d8f-4186-be7a-66077fbcba1e\\\", \\\"subtext\\\": \\\"6339b8d4-d85d-4696-a86e-5ed2b3641035\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory and Ethical Considerations\\\", \\\"\\\", \\\"1\\\", 2322, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Any protocol amendments will require IEC/IRB approval before implementation of changes made to the study design, except for changes necessary to eliminate an immediate hazard to study participants.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"97fb2e79-ed75-449a-a5b8-3af57e31f667\\\", \\\"childbox\\\": \\\"950d0afb-bc04-4af2-8a53-2d3f4a128100\\\", \\\"subtext\\\": \\\"ed76e0ed-3a10-47f7-93d2-3db9bf73250f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory and Ethical Considerations\\\", \\\"\\\", \\\"1\\\", 2323, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ~REDACTED~ will provide full details of the above procedures to the investigator, either verbally, in writing, or both.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"840baa31-e6ed-4b7b-a251-d2fe90677942\\\", \\\"childbox\\\": \\\"f0d1308b-b394-4c37-8150-4908a6a5d7aa\\\", \\\"subtext\\\": \\\"b11c9849-e145-4fc7-9ea9-ad2e3ab4db87\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory and Ethical Considerations\\\", \\\"\\\", \\\"1\\\", 2324, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The investigator will be responsible for the following:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e3fcb0f9-e4fc-4062-b8d2-b69c257784ab\\\", \\\"childbox\\\": \\\"e387bdb7-1791-440e-ad27-c7b8ad5b63a8\\\", \\\"subtext\\\": \\\"4a1d13fe-e302-48a4-9317-92f98781de6b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory and Ethical Considerations\\\", \\\"\\\", \\\"1\\\", 2325, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d Providing written summaries of the status of the study to the IRB/IEC annually or more frequently in accordance with the requirements, policies, and procedures established by the IRB/IEC.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"de1c29a6-0fab-45a9-97f5-8183ed39c2a7\\\", \\\"childbox\\\": \\\"6181a58a-e6bf-4fbd-8669-9e39773f7b01\\\", \\\"subtext\\\": \\\"076731d1-bf47-4840-a49d-af31e371df28\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory and Ethical Considerations\\\", \\\"\\\", \\\"1\\\", 2326, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d Notifying the IRB/IEC of SAE(s) or other significant safety findings as required by IRB/IEC procedures.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c7333105-092b-498d-83c0-4c891d67f0a7\\\", \\\"childbox\\\": \\\"1ab1064c-2ac2-4bb0-b58d-db4fc16bb1aa\\\", \\\"subtext\\\": \\\"0ed82984-2aeb-4fe3-952d-514928f7231d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory and Ethical Considerations\\\", \\\"\\\", \\\"1\\\", 2327, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\uf02d Providing oversight of the conduct of the study at the study center and adherence to requirements of Code of Federal Regulations Title 21 (21 CFR), ICH guidelines, the IRB/IEC, European regulation 536/2014 for clinical studies (if applicable), and all other applicable local regulations.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"76644fea-3608-4e8c-b1e9-032e4d9bc177\\\", \\\"childbox\\\": \\\"93ff752b-95d0-4687-8cb5-685d8b250a8a\\\", \\\"subtext\\\": \\\"bf94ad17-a1dd-4dcb-81d3-80743c1474fc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory and Ethical Considerations\\\", \\\"\\\", \\\"1\\\", 2328, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 After reading the protocol, each investigator will sign the protocol signature page (Appendix 7) and send a copy of the signed page to ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"78cb24f6-7921-4c49-8f67-5a924bba14f7\\\", \\\"childbox\\\": \\\"f2af6f63-b9ef-42bc-b728-ef26cce88651\\\", \\\"subtext\\\": \\\"2d985f17-294e-4fa6-a6c5-2fe41072c9c0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory and Ethical Considerations\\\", \\\"\\\", \\\"1\\\", 2329, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The study will not start at any study center at which the investigator has not signed the protocol.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"78cb24f6-7921-4c49-8f67-5a924bba14f7\\\", \\\"childbox\\\": \\\"59edfaf2-1d12-45c2-af89-1cc9820462b2\\\", \\\"subtext\\\": \\\"ea769059-e803-49fd-8780-5e8c81afa8e5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Regulatory and Ethical Considerations\\\", \\\"\\\", \\\"1\\\", 2330, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Financial Disclosure\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7f062431-e9ef-4955-ad32-eb5103f9fd5c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Financial Disclosure\\\", \\\"\\\", \\\"1\\\", 2331, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Investigators and sub-investigators will provide ~REDACTED~ with sufficient, accurate financial information as requested to allow the sponsor or ~REDACTED~ to submit complete and accurate financial certification or disclosure statements to the appropriate regulatory authorities.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7b140bbb-3c2b-413e-b29f-c44ea1a37764\\\", \\\"childbox\\\": \\\"b5598588-ffcb-4c30-b020-b6a1dd2d427a\\\", \\\"subtext\\\": \\\"d269bcc3-f502-4397-8864-199d4ac42096\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Financial Disclosure\\\", \\\"\\\", \\\"1\\\", 2332, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Investigators are responsible for providing financial interest information prior to initiation of the study center.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7b140bbb-3c2b-413e-b29f-c44ea1a37764\\\", \\\"childbox\\\": \\\"915573c2-7c62-443f-926f-baa31f5ecaff\\\", \\\"subtext\\\": \\\"85ba473d-df34-41fb-a9fe-6e5b676aae39\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Financial Disclosure\\\", \\\"\\\", \\\"1\\\", 2333, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Investigators are responsible for providing the financial information update if their financial interests change at any point during their participation in a study and for 1 year after completion of the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7b140bbb-3c2b-413e-b29f-c44ea1a37764\\\", \\\"childbox\\\": \\\"712f48e9-14b5-4333-8d2d-cd8ae166f7bf\\\", \\\"subtext\\\": \\\"85ba473d-df34-41fb-a9fe-6e5b676aae39\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Financial Disclosure\\\", \\\"\\\", \\\"1\\\", 2334, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Insurance\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"eba56f06-e9c4-4d19-938b-6322d6d74e84\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Insurance\\\", \\\"\\\", \\\"3\\\", 2335, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Sponsor will provide insurance in accordance with local guidelines and requirements as a minimum for the participants in this study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"40c1b5d6-e9ce-4cfe-abd8-c5acf2afbcce\\\", \\\"childbox\\\": \\\"575f9bc0-f9c1-4ca0-96b8-0012aa38e21e\\\", \\\"subtext\\\": \\\"479c9b34-0c2b-47dc-a45d-d293300887ff\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Insurance\\\", \\\"\\\", \\\"3\\\", 2336, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The terms of the insurance will be kept in the study files.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"40c1b5d6-e9ce-4cfe-abd8-c5acf2afbcce\\\", \\\"childbox\\\": \\\"577f13e1-a782-45fb-8acd-665909c2856f\\\", \\\"subtext\\\": \\\"479c9b34-0c2b-47dc-a45d-d293300887ff\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Insurance\\\", \\\"\\\", \\\"3\\\", 2337, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Informed Consent and Assent Process\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"429d5751-b3b2-4f65-9dd3-ee5dcef42bab\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Informed Consent and Assent Process\\\", \\\"\\\", \\\"1\\\", 2338, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The investigator or his/her representative will explain the nature of the study to the participant/participant\\\\u2019s parent(s)/LAR(s) and answer all questions regarding the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4c73b709-b47f-4e08-bedc-7328ccc3c86a\\\", \\\"childbox\\\": \\\"91142fe2-ab83-4fc6-b404-c0e1f6ff463b\\\", \\\"subtext\\\": \\\"eb60a7f7-ffe5-40a3-bfb3-b25a598247a1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Informed Consent and Assent Process\\\", \\\"\\\", \\\"1\\\", 2339, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Participant/participant/s parent(s)/LAR(s) must be informed that their participation is voluntary.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c51b13ca-d9a9-4921-8c2f-2671f558c0e6\\\", \\\"childbox\\\": \\\"400fd56b-9ca9-4c16-9af6-23e5579151a6\\\", \\\"subtext\\\": \\\"34e7e9e4-5658-4410-8062-5d36e2fe0c89\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Informed Consent and Assent Process\\\", \\\"\\\", \\\"1\\\", 2340, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Participants/participants\\\\u2019 parents/LARs will be required to sign a statement of informed consent or assent (if applicable) that meets the requirements of 21 CFR 50, local regulations, ICH guidelines, Health Insurance Portability and Accountability Act (HIPAA) requirements, where applicable, and the IRB/IEC.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c51b13ca-d9a9-4921-8c2f-2671f558c0e6\\\", \\\"childbox\\\": \\\"ad5573d8-c4ee-43e5-b0d0-748bf1c9d52d\\\", \\\"subtext\\\": \\\"4b5d3aa6-2545-46e2-9e8c-adf55a76e353\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Informed Consent and Assent Process\\\", \\\"\\\", \\\"1\\\", 2341, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The medical record must include a statement that informed consent and assent (if applicable) was obtained before the participant was enrolled in the study and the date the written consent and assent (if applicable) was obtained.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8238ae74-efde-46b4-a68f-b246182d61df\\\", \\\"childbox\\\": \\\"a41b23f0-a299-416d-a8b8-7acc768639f9\\\", \\\"subtext\\\": \\\"a960557d-5424-43cc-8ebe-7a196ebefa27\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Informed Consent and Assent Process\\\", \\\"\\\", \\\"1\\\", 2342, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The authorized person obtaining the informed consent and assent (if applicable) must also sign the ICF.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8238ae74-efde-46b4-a68f-b246182d61df\\\", \\\"childbox\\\": \\\"fda83f77-aeee-42b3-b140-643c81ff093d\\\", \\\"subtext\\\": \\\"acd61f45-bade-48fe-aa60-35656344478e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Informed Consent and Assent Process\\\", \\\"\\\", \\\"1\\\", 2343, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Participants must be re-consented to the most current version of the ICF(s) and assent form(s) during their participation in the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"663a6c87-c96e-4008-b016-db4aafd68712\\\", \\\"childbox\\\": \\\"bf38b727-ad27-4089-8838-3de9534d9394\\\", \\\"subtext\\\": \\\"cb9858ae-887e-4657-9072-838ae78eebe1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Informed Consent and Assent Process\\\", \\\"\\\", \\\"1\\\", 2344, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 A copy of the ICF(s) and assent form(s) (if applicable) must be provided to the participant participants\\\\u2019 parent(s)/LAR(s).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8e491b20-fc4d-4b61-812b-29562df29b48\\\", \\\"childbox\\\": \\\"7a5b7d24-e3d3-47bb-b93a-5bf79dd5ae03\\\", \\\"subtext\\\": \\\"164947cd-bda0-414d-80e1-fc3b02a440d2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Informed Consent and Assent Process\\\", \\\"\\\", \\\"1\\\", 2345, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Re-consent must be obtained in accordance with local laws and regulations for participants who become legally emancipated during the study, i.e.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ed4dde8-2060-43c4-8ab9-212715946c55\\\", \\\"childbox\\\": \\\"7b36d660-4b78-4a4a-ba09-1fa54d8385c9\\\", \\\"subtext\\\": \\\"22a26514-e993-40a3-9a25-f64e9a86fc1e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Informed Consent and Assent Process\\\", \\\"\\\", \\\"1\\\", 2346, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"reach the legal age of consent.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ed4dde8-2060-43c4-8ab9-212715946c55\\\", \\\"childbox\\\": \\\"d63d3c41-19de-44b6-884e-2fc27bd10705\\\", \\\"subtext\\\": \\\"fa10f91b-a0f0-486e-ab30-a9ab9e9afdcf\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Informed Consent and Assent Process\\\", \\\"\\\", \\\"1\\\", 2347, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The participant can provide consent by signing/witnessing/thumb printing an ICF, similar to that provided to the parent(s)/LAR(s) at study start, which summarizes the study and includes a consent statement and documents that the participant agrees to continue participating in the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ed4dde8-2060-43c4-8ab9-212715946c55\\\", \\\"childbox\\\": \\\"2abbcc46-7a10-41ca-bed8-e0cf3201bfc1\\\", \\\"subtext\\\": \\\"fa10f91b-a0f0-486e-ab30-a9ab9e9afdcf\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Informed Consent and Assent Process\\\", \\\"\\\", \\\"1\\\", 2348, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d3c9ddcd-7696-4dbc-a854-d29dd88e99c6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2349, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The protocol and the proposed informed consent form must be reviewed and approved by a properly constituted IRB/EC before study start.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74f68d79-6763-4eae-83ad-b4d5182b4ef5\\\", \\\"childbox\\\": \\\"e96a4d96-c161-4eed-b38e-d792816590cd\\\", \\\"subtext\\\": \\\"b3d08c9e-b165-474f-a043-7897901ea33f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2350, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Properly constituted IRB/EC is defined in ICH Guideline for GCP E6 (R1), Section 3 (ICH, 1997).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74f68d79-6763-4eae-83ad-b4d5182b4ef5\\\", \\\"childbox\\\": \\\"d69a6262-6d14-41e2-b082-65802d8addc8\\\", \\\"subtext\\\": \\\"a6ad9bfe-90ef-45a9-9793-07d3444db888\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2351, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A signed and dated statement that the protocol and informed consent have been approved by the IEC/IRB must be given to ~REDACTED~ before study initiation.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74f68d79-6763-4eae-83ad-b4d5182b4ef5\\\", \\\"childbox\\\": \\\"46cdde32-53bc-4bbb-8b37-fed239b97ee0\\\", \\\"subtext\\\": \\\"4b840c69-fc2f-444d-a4e6-4380d587ef42\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2352, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Prior to study start and at any time the protocol is amended during study conduct, the investigator is required to sign a protocol signature page confirming his/her agreement to conduct the study in accordance with these documents and all of the instructions and procedures found in this protocol and to give access to all relevant data and records to the Medical Monitor, auditors, ~REDACTED~ Clinical Quality Assurance representatives, designated agents of ~REDACTED~, IEC/IRB, and regulatory authorities as required.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74f68d79-6763-4eae-83ad-b4d5182b4ef5\\\", \\\"childbox\\\": \\\"3c7cb1a7-84dc-4b6f-8d86-7ba5273ebe2c\\\", \\\"subtext\\\": \\\"5e1f82b0-5615-4698-9612-5ef135ffaab9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2353, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If an inspection of the study center is requested by a regulatory authority, the investigator must inform ~REDACTED~ immediately that this request has been made.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74f68d79-6763-4eae-83ad-b4d5182b4ef5\\\", \\\"childbox\\\": \\\"58d0b443-75e3-44c7-875d-cb07a95d8cda\\\", \\\"subtext\\\": \\\"7f3f8d41-b7cf-4551-981a-1ba49e9def6d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2354, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator also responsible for the following:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"11ad5a87-c756-4abb-8a89-2b37db94f8ab\\\", \\\"childbox\\\": \\\"89510354-6b49-4d2d-b2ec-861e6eef7bfe\\\", \\\"subtext\\\": \\\"5f51e96e-93bf-42cb-9413-1cf8423ac4c7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2355, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Maintaining a list of appropriately qualified persons to whom the investigator has delegated significant study-related duties.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b187cd05-d071-4325-87a2-698d683e3e21\\\", \\\"childbox\\\": \\\"95e89d49-efbe-4af5-ab48-6a453b7786e4\\\", \\\"subtext\\\": \\\"e8a108b0-1df6-4637-bed0-729f5dfca659\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2356, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Demonstrating the capability of recruiting the required number of suitable participants within the recruitment period.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0557510f-bd36-4433-8876-756e87426b9f\\\", \\\"childbox\\\": \\\"1b6a364b-6610-4ff0-a2a8-48a227c44b62\\\", \\\"subtext\\\": \\\"e82a2578-063b-4ad6-8a20-ab3327271088\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2357, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Demonstrating sufficient time and staffing to properly conduct and complete the study within the agreed study period.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c1ab1578-7fd3-45ad-9aac-e2da7ebb8053\\\", \\\"childbox\\\": \\\"aec5e4a7-f77b-4621-ba69-dd7721b96fbd\\\", \\\"subtext\\\": \\\"4bdc1934-1131-4c25-8c91-6aa781a70678\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2358, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Ensuring that all persons assisting with the study are adequately informed about the protocol, the investigational product, and their study-related duties and functions\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d772d62d-be61-4e01-8e66-029776d10acc\\\", \\\"childbox\\\": \\\"69cdabda-b58f-4e97-8d26-213b59e0b639\\\", \\\"subtext\\\": \\\"ea525b6b-96a0-458f-865d-dbc44fb1eef0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2359, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Ensuring that appropriately trained health care professionals are responsible for all study-related medical decisions and for ensuring appropriate medical care of participants experiencing any adverse event related to the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1ecab0e2-ca07-42d2-9778-e6848914f5bd\\\", \\\"childbox\\\": \\\"fed17043-cda9-439c-812b-f0c5f4909e0d\\\", \\\"subtext\\\": \\\"38e40ec9-796e-494d-8994-977dc1b181bc\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2360, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 If permission to do so is given by the participant and/or participant\\\\u2019s parent(s)/LAR(s), ensuring that the participant\\\\u2019s primary health care provider is informed of the participant\\\\u2019s participation in the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"308dc194-bf0c-423e-879c-04878fca5796\\\", \\\"childbox\\\": \\\"017595d6-92c6-4ec0-aaa7-957ae6657640\\\", \\\"subtext\\\": \\\"8bb747e6-c243-4552-9e2c-ed9c5d0057f9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2361, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator should not implement any deviation from, or changes of the protocol without agreement by the sponsor and prior review and documented approval/favorable opinion from the IEC/IRB of an amendment, except where necessary to eliminate an immediate hazard to study participants, or when the change involves only logistical or administrative aspects.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9d086cea-b9c4-4688-abec-c5511dd654ea\\\", \\\"childbox\\\": \\\"82021d67-9743-47f8-87c7-16baac432591\\\", \\\"subtext\\\": \\\"cb44f449-3529-4240-9fcf-a4155f8d26ae\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2362, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In addition, the investigator, or person designated by the investigator, should document and explain any deviation from the approved protocol.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9d086cea-b9c4-4688-abec-c5511dd654ea\\\", \\\"childbox\\\": \\\"3b176f7a-1002-4139-8c6d-1f2bafb7022f\\\", \\\"subtext\\\": \\\"a1e3aae7-2dbc-416a-8e5e-ff3118312766\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2363, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator may implement a deviation from, or a change of, the protocol to eliminate an immediate hazard(s) to study participants without prior IEC/IRB approval/favorable opinion.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0e99475f-24c1-4c49-963d-85e4d0d79285\\\", \\\"childbox\\\": \\\"a70b9f7f-aba0-4074-a184-15a5f943d94e\\\", \\\"subtext\\\": \\\"f6c82250-85fa-4309-89e1-f7a762bf91d2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2364, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"As soon as possible, the implemented deviation or change, the reasons for it, and, if appropriate, the proposed protocol amendment(s) should be submitted:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0e99475f-24c1-4c49-963d-85e4d0d79285\\\", \\\"childbox\\\": \\\"ff1c6a00-a97e-4c25-b95e-8d523cdba273\\\", \\\"subtext\\\": \\\"eeb2eea1-01ca-46ab-8767-38069c6b0680\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2365, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 to the IEC/IRB for review and approval/favorable opinion,\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2a4e30a4-7ed3-4fc5-a15b-581774303474\\\", \\\"childbox\\\": \\\"a88ea4e3-1b4e-4a0f-ab56-0e6b47bce470\\\", \\\"subtext\\\": \\\"bdba9683-fd76-4c6d-a7a9-7f34d53484ec\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2366, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2a4e30a4-7ed3-4fc5-a15b-581774303474\\\", \\\"childbox\\\": \\\"a88ea4e3-1b4e-4a0f-ab56-0e6b47bce470\\\", \\\"subtext\\\": \\\"f75e142d-c90f-4264-8bdd-98814b295a03\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Segoe UI Symbol\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2367, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2a4e30a4-7ed3-4fc5-a15b-581774303474\\\", \\\"childbox\\\": \\\"a88ea4e3-1b4e-4a0f-ab56-0e6b47bce470\\\", \\\"subtext\\\": \\\"78e42a92-2e7f-4842-ab8a-517ab4fd75a1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Arial\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2368, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"to the sponsor for agreement and, if required,\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2a4e30a4-7ed3-4fc5-a15b-581774303474\\\", \\\"childbox\\\": \\\"a88ea4e3-1b4e-4a0f-ab56-0e6b47bce470\\\", \\\"subtext\\\": \\\"f34ee849-cd74-47ee-bdf0-ae80a1fa6397\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2369, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2a4e30a4-7ed3-4fc5-a15b-581774303474\\\", \\\"childbox\\\": \\\"a88ea4e3-1b4e-4a0f-ab56-0e6b47bce470\\\", \\\"subtext\\\": \\\"d341eb4d-3108-4b9f-950d-23e4e2687bff\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Segoe UI Symbol\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2370, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2a4e30a4-7ed3-4fc5-a15b-581774303474\\\", \\\"childbox\\\": \\\"a88ea4e3-1b4e-4a0f-ab56-0e6b47bce470\\\", \\\"subtext\\\": \\\"1f71f5b7-19cd-456c-a099-7c0c73aaab8a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Arial\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2371, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"to the regulatory authority(ies).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2a4e30a4-7ed3-4fc5-a15b-581774303474\\\", \\\"childbox\\\": \\\"a88ea4e3-1b4e-4a0f-ab56-0e6b47bce470\\\", \\\"subtext\\\": \\\"dce1517b-7637-470e-93de-a4df181ae238\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Responsibilities of the Investigator and IRB/EC\\\", \\\"\\\", \\\"1\\\", 2372, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Table 16 Administrative Structure\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e3c82502-c886-4b0d-9d55-a614e4369151\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Administrative Structure\\\", \\\"\\\", \\\"1\\\", 2373, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Table 16 Study Administrative Structure\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"77b4ad50-f9be-4aff-a384-8ff2676c5bdd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Administrative Structure\\\", \\\"Table 16\\\", \\\"1\\\", 2374, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Function</td>\\\\n      <td>Responsible Organization</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Study Operations Management Medical Monitoring, Study Master File</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Randomization, Blinding, Unblinding</td>\\\\n      <td>Cenduit</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Clinical Supply Management, Quality Assurance Auditing</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>Biostatistics, Medical Writing</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>Laboratory Assessments</td>\\\\n      <td><span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"96\\\", \\\"TableIndex\\\": \\\"39\\\", \\\"TableName\\\": \\\"Table 16 Study Administrative Structure\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"4baa690e-1ff3-4b6e-8b4f-bd86fd1dce71\\\", \\\"childbox\\\": \\\"6ae3fbe8-8aba-46b5-973b-6cb7ce25e735\\\", \\\"subtext\\\": \\\"df3519f2-4942-437b-93b4-29ae7979009f\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study Administrative Structure\\\", \\\"Table 16\\\", \\\"1\\\", 2375, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Medical Monitor\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"69f9ec32-4650-4e6f-934d-440b0dd470ce\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Monitor\\\", \\\"\\\", \\\"1\\\", 2376, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the study reference manual.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bf9d9d02-0621-478e-892f-1499f54db7bc\\\", \\\"childbox\\\": \\\"a6e1a8de-20c2-4637-88ca-6129fd3c93f7\\\", \\\"subtext\\\": \\\"867d5445-79c6-44dc-b20b-651818318316\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Medical Monitor\\\", \\\"\\\", \\\"1\\\", 2377, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Dissemination of Clinical Study Data\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0c5eb801-a197-4788-b936-882896d3ecce\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Dissemination of Clinical Study Data\\\", \\\"\\\", \\\"1\\\", 2378, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The key design elements of this protocol and results summaries will be posted on www.ClinicalTrials.gov and/or ~REDACTED~ Clinical Study register in compliance with the applicable regulations/~REDACTED~ policy.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"72137fa4-c7e0-4736-9c0d-8b916fef793e\\\", \\\"childbox\\\": \\\"27643807-5bab-4fe2-a256-f1f9de12261b\\\", \\\"subtext\\\": \\\"2d4038dd-cc7c-4124-adca-a18e34942e2c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Dissemination of Clinical Study Data\\\", \\\"\\\", \\\"1\\\", 2379, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The sponsor will aim to register protocols summaries prior to study start and target results summaries submission within 12 months of primary completion date.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"72137fa4-c7e0-4736-9c0d-8b916fef793e\\\", \\\"childbox\\\": \\\"8e70a895-8bea-4c84-a94e-b2edd75460e0\\\", \\\"subtext\\\": \\\"2d4038dd-cc7c-4124-adca-a18e34942e2c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Dissemination of Clinical Study Data\\\", \\\"\\\", \\\"1\\\", 2380, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Where external regulations require earlier disclosure, the sponsor will follow those timelines.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"72137fa4-c7e0-4736-9c0d-8b916fef793e\\\", \\\"childbox\\\": \\\"eecfdefe-0807-4ee1-842d-2e01c7bb71d3\\\", \\\"subtext\\\": \\\"30ed54d3-66fb-4bd9-8161-eafa6ea596ed\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Dissemination of Clinical Study Data\\\", \\\"\\\", \\\"1\\\", 2381, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Where required by regulation, summaries will also be posted on applicable national or regional clinical study registers.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a1ae52fa-21d9-4d02-9d8e-c222bdfdfe5e\\\", \\\"childbox\\\": \\\"ea296357-1f51-49a5-86f2-51e88496962c\\\", \\\"subtext\\\": \\\"f8d080b3-cb71-447e-a20d-094e7f488f64\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Dissemination of Clinical Study Data\\\", \\\"\\\", \\\"1\\\", 2382, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Where required by applicable regulatory requirements, an investigator signatory will be identified for the approval of the study report, and provided reasonable access to statistical tables, figures, and relevant reports.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a60cf3b8-a446-4106-b4de-52dfa6e83e22\\\", \\\"childbox\\\": \\\"fffdffeb-f1ff-4d99-b49e-f46662a34a9e\\\", \\\"subtext\\\": \\\"ca9e466a-09db-4245-85bc-d0a12e5a58e8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Dissemination of Clinical Study Data\\\", \\\"\\\", \\\"1\\\", 2383, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~ will also provide the investigator with the full summary of the study results.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a60cf3b8-a446-4106-b4de-52dfa6e83e22\\\", \\\"childbox\\\": \\\"85baf031-592a-4fd9-859f-129ceb56ca6e\\\", \\\"subtext\\\": \\\"e4d2336e-8167-4050-9e64-39a93ce9ac4d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Dissemination of Clinical Study Data\\\", \\\"\\\", \\\"1\\\", 2384, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator is encouraged to share the summary results with the study participants, as appropriate.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a60cf3b8-a446-4106-b4de-52dfa6e83e22\\\", \\\"childbox\\\": \\\"0115ece6-1c8b-4b99-948e-29c371dd6ea3\\\", \\\"subtext\\\": \\\"e4d2336e-8167-4050-9e64-39a93ce9ac4d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Dissemination of Clinical Study Data\\\", \\\"\\\", \\\"1\\\", 2385, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ~REDACTED~ will provide the investigator with the randomization codes for their study center only after completion of the full statistical analysis.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7cd72f1a-4c45-4b84-86b7-cb05a4b6d4d7\\\", \\\"childbox\\\": \\\"6132a4c8-0a31-4049-a5d9-2cf105c97ae8\\\", \\\"subtext\\\": \\\"585e84a1-85d8-472a-a2b6-0bb6b362aba1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Dissemination of Clinical Study Data\\\", \\\"\\\", \\\"1\\\", 2386, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The sponsor intends to make anonymized patient-level data from this study available to external researchers for scientific analyses or to conduct further research that can help advance medical science or improve patient care.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"22c34424-0c29-405d-9376-531f004dbd57\\\", \\\"childbox\\\": \\\"11095360-9ffe-4700-921c-ffcd663309fe\\\", \\\"subtext\\\": \\\"3016294c-b4cd-4525-9ccc-dc2012333fad\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Dissemination of Clinical Study Data\\\", \\\"\\\", \\\"1\\\", 2387, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This helps ensure the data provided by study participants are used to maximum effect in the creation of knowledge and understanding.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"22c34424-0c29-405d-9376-531f004dbd57\\\", \\\"childbox\\\": \\\"30929b9f-898e-4964-a06e-73d7d27a2528\\\", \\\"subtext\\\": \\\"3016294c-b4cd-4525-9ccc-dc2012333fad\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Dissemination of Clinical Study Data\\\", \\\"\\\", \\\"1\\\", 2388, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Data Quality Assurance\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6499e655-e783-4987-aba0-b71c62810d06\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2389, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The investigator should maintain a record of the location(s) of their respective essential documents including source documents (see Appendix 1, Glossary of Terms, for definitions of essential documents and source documents).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f9212a97-8a5a-4cdb-bdf4-2ae6f1717167\\\", \\\"childbox\\\": \\\"8d0618f6-3734-41f0-9558-9a06c601ba66\\\", \\\"subtext\\\": \\\"7333e69e-e8c8-4f1b-9dc5-ebd231efa17e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2390, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The storage system used during the study and for archiving (irrespective of the type of media used) should provide for document identification, version history, search, and retrieval.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f9212a97-8a5a-4cdb-bdf4-2ae6f1717167\\\", \\\"childbox\\\": \\\"fca6833b-e374-4f1a-a366-a24966161086\\\", \\\"subtext\\\": \\\"e42db030-4db5-4333-85bb-14e7b35e92f5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2391, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Essential study documents may be added or removed where justified (in advance of study initiation) based on their importance and relevance to the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1feff2bd-dfbc-4f17-b8b2-666ebc1c88d6\\\", \\\"childbox\\\": \\\"db9c6da8-8715-4857-a437-1b9e519fefd2\\\", \\\"subtext\\\": \\\"78155dac-f34d-4a98-84eb-70e0a55e686e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2392, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"When a copy is used to replace an original document (e.g., source documents, eCRF), the copy should fulfill the requirements for certified copies.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1feff2bd-dfbc-4f17-b8b2-666ebc1c88d6\\\", \\\"childbox\\\": \\\"a6d9ac59-e162-4a06-85e6-dc625b4a8e76\\\", \\\"subtext\\\": \\\"78155dac-f34d-4a98-84eb-70e0a55e686e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2393, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 All participant data relating to the study will be recorded on eCRF (or printed CRF in case of an electronic data capture system [EDC] failure) unless transmitted to the sponsor or ~REDACTED~ electronically (e.g., laboratory data).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d4898007-1691-450e-8b4f-53946e3fec07\\\", \\\"childbox\\\": \\\"d8360eca-0491-4bdb-a4ad-22ea3cf7d393\\\", \\\"subtext\\\": \\\"08aecc71-4802-4a12-9c3c-8ad65eadf4f7\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2394, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator is responsible for verifying that data entries are accurate and correct by physically or electronically signing the eCRF.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d4898007-1691-450e-8b4f-53946e3fec07\\\", \\\"childbox\\\": \\\"d8eb9653-4bd7-4ab2-8095-ad0ec6a003c9\\\", \\\"subtext\\\": \\\"6aa1baab-178f-4a63-a158-1f9b6eb41e23\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2395, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The investigator must maintain adequate and accurate source documents and study records that include all pertinent observations on each of the study center\\\\u2019s participants that supports information entered in the eCRF.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d44fc9cf-97c6-4085-821a-0d1abb71ca92\\\", \\\"childbox\\\": \\\"a3b61798-fae7-437b-9c7f-bf3164722287\\\", \\\"subtext\\\": \\\"81d34f2f-4831-47ac-a482-aa7ec2e7e11f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2396, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The investigator must permit study-related monitoring, audits, IRB/IEC review, and regulatory agency inspections and provide direct access to source documents or certified copies.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a2f18061-06fb-42c1-879f-b2e0b613fdd8\\\", \\\"childbox\\\": \\\"1e053b0c-9859-4b06-b95b-f38e475f4a53\\\", \\\"subtext\\\": \\\"d59e9093-b5fe-44fe-b145-e406c5ce3696\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2397, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 ~REDACTED~ is responsible for the data management of this study including quality checking of the source data.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a6145f72-0a14-4492-85b5-8ff3df3fb2b9\\\", \\\"childbox\\\": \\\"cec6337f-31b9-4c79-bca7-93ea96151dfd\\\", \\\"subtext\\\": \\\"85aec265-cb69-4e2d-9b71-7a9084cd2f10\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2398, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Study/Site Monitors (see a definition in Appendix 1, Glossary of Terms) will perform ongoing source data verification to confirm that data entered into the eCRF by authorized study center personnel are attributable, legible, contemporaneous, original, accurate, and complete.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74c83f38-b186-47ee-aeb3-1113c2699569\\\", \\\"childbox\\\": \\\"dc6dbf3a-2642-4356-9079-d10e5abc34e4\\\", \\\"subtext\\\": \\\"87554eee-ef2d-4f1f-af48-9dd4dbdc3e73\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2399, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Changes to source data should be traceable, should not obscure the original entry, and should be explained if necessary (e.g., via an audit trail).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74c83f38-b186-47ee-aeb3-1113c2699569\\\", \\\"childbox\\\": \\\"fb8f86ea-df63-4561-bcf8-0ff45b48e1f8\\\", \\\"subtext\\\": \\\"e75591b8-b707-4792-bbaf-c30ef4794365\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2400, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The safety and rights of participants must be protected and study be conducted in accordance with the currently approved protocol and any other study agreements, ICH GCP, and all applicable regulatory requirements.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74c83f38-b186-47ee-aeb3-1113c2699569\\\", \\\"childbox\\\": \\\"2d45c248-3a78-4d65-8ad0-532f7bd916db\\\", \\\"subtext\\\": \\\"9f7bd5e9-4376-4bc9-8ee4-54987b98d7b6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2401, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Study records and source documents, including signed ICF/IAF (as applicable), pertaining to the conduct of this study must be retained by the investigator for 25 years from the issue of the final CSR/equivalent summary unless local regulations or institutional policies require a longer retention period.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6be41c95-7808-4cce-8ca8-45b3894eec14\\\", \\\"childbox\\\": \\\"c66b92e5-53f4-4b08-8146-b6ecab63c34c\\\", \\\"subtext\\\": \\\"cde98660-6f99-40e6-85a5-de27f5dc6c17\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2402, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"No records may be destroyed during the retention period without the written approval from the sponsor.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6be41c95-7808-4cce-8ca8-45b3894eec14\\\", \\\"childbox\\\": \\\"18c89095-3ee3-4cbd-b3af-5a8bfe6debc9\\\", \\\"subtext\\\": \\\"0e710199-d274-4828-ae45-a7d4f758b30e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2403, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"No records may be transferred to another location or party without written notification to the sponsor or ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6be41c95-7808-4cce-8ca8-45b3894eec14\\\", \\\"childbox\\\": \\\"a66e5c80-1588-437e-b65d-8f875b826967\\\", \\\"subtext\\\": \\\"0e710199-d274-4828-ae45-a7d4f758b30e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2404, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Source Documents\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b7c96808-ae47-4432-8642-48646ccc4de5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Data Quality Assurance\\\", \\\"\\\", \\\"1\\\", 2405, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Source documents provide evidence for the existence of the participant and substantiate the integrity of the data collected.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1edade62-b265-4e9a-bad2-8dae2ff5de2d\\\", \\\"childbox\\\": \\\"d9497627-a785-4f21-b9a8-d7aeaf7c07f5\\\", \\\"subtext\\\": \\\"577e0fcf-2d19-4637-ad4c-e7ec470073e5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Source documents provide evidence for the existence of the participant and substantiate the integrity of the data collected. Investigator should maintain a record of the location(s) of their source documents.\\\", \\\"\\\", \\\"1\\\", 2406, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Investigator should maintain a record of the location(s) of their source documents.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1edade62-b265-4e9a-bad2-8dae2ff5de2d\\\", \\\"childbox\\\": \\\"5f59d8cd-2c4f-492e-8de6-179ffea0abc3\\\", \\\"subtext\\\": \\\"577e0fcf-2d19-4637-ad4c-e7ec470073e5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Source documents provide evidence for the existence of the participant and substantiate the integrity of the data collected. Investigator should maintain a record of the location(s) of their source documents.\\\", \\\"\\\", \\\"1\\\", 2407, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Data entered in the eCRF that are transcribed from source documents must be consistent with the source documents or the discrepancies must be explained.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6a939c20-7576-4b6d-88e0-58bbd601a1b0\\\", \\\"childbox\\\": \\\"1b0c6ad8-515d-46ee-8e5a-d42ecc342748\\\", \\\"subtext\\\": \\\"f6cdfcdc-bd2f-4f4e-9ef5-126d0500caea\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Source documents provide evidence for the existence of the participant and substantiate the integrity of the data collected. Investigator should maintain a record of the location(s) of their source documents.\\\", \\\"\\\", \\\"1\\\", 2408, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator may need to request previous medical records or transfer records, depending on the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6a939c20-7576-4b6d-88e0-58bbd601a1b0\\\", \\\"childbox\\\": \\\"089eca27-760f-41dc-95e9-f3ef7d3e8ee6\\\", \\\"subtext\\\": \\\"f6cdfcdc-bd2f-4f4e-9ef5-126d0500caea\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Source documents provide evidence for the existence of the participant and substantiate the integrity of the data collected. Investigator should maintain a record of the location(s) of their source documents.\\\", \\\"\\\", \\\"1\\\", 2409, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Also, current medical records must be available.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6a939c20-7576-4b6d-88e0-58bbd601a1b0\\\", \\\"childbox\\\": \\\"49270a2e-6ed9-4ded-904b-42439ff0cc70\\\", \\\"subtext\\\": \\\"6c844fc3-d70e-4a11-b5f0-e5604a47f6a1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Source documents provide evidence for the existence of the participant and substantiate the integrity of the data collected. Investigator should maintain a record of the location(s) of their source documents.\\\", \\\"\\\", \\\"1\\\", 2410, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Definition of what constitutes source data and source documents can be found in the Appendix 1, Glossary of Terms.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"293d6072-4927-4adf-b32f-196b4b31bdd4\\\", \\\"childbox\\\": \\\"671fe002-ecb8-42fc-992a-a9d1e46a8011\\\", \\\"subtext\\\": \\\"b03f237e-79e1-44e2-8353-2e163c871183\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Source documents provide evidence for the existence of the participant and substantiate the integrity of the data collected. Investigator should maintain a record of the location(s) of their source documents.\\\", \\\"\\\", \\\"1\\\", 2411, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"~REDACTED~ Closure\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fc0ce1df-0a35-4968-9044-51040c5682d1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study and Study Center Closure\\\", \\\"\\\", \\\"1\\\", 2412, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"~REDACTED~ reserves the right to close the study center or terminate the study at any time for any reason at the sole discretion of the sponsor, provided there is sufficient notice given to account for participant\\\\u2019s safe exit from study participation.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"332871b6-eecf-408f-a00e-a3cea70c871d\\\", \\\"childbox\\\": \\\"cf761e78-4973-444d-889b-9714c864f675\\\", \\\"subtext\\\": \\\"b2272b75-41b8-4d1a-bbff-fee63ad5319c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study and Study Center Closure\\\", \\\"\\\", \\\"1\\\", 2413, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Study center regular closure will occur upon study completion.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"332871b6-eecf-408f-a00e-a3cea70c871d\\\", \\\"childbox\\\": \\\"c8082b21-c00f-4961-aac5-51a2df686c1e\\\", \\\"subtext\\\": \\\"b2272b75-41b8-4d1a-bbff-fee63ad5319c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study and Study Center Closure\\\", \\\"\\\", \\\"1\\\", 2414, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A study center is considered closed when all required data/documents and study supplies have been collected and a study center closure ~REDACTED~ has been performed.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"332871b6-eecf-408f-a00e-a3cea70c871d\\\", \\\"childbox\\\": \\\"9913eeee-7423-45bb-aa72-df63d1352e4b\\\", \\\"subtext\\\": \\\"a798de22-06ef-4703-8f86-4b91392ac13e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study and Study Center Closure\\\", \\\"\\\", \\\"1\\\", 2415, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator may initiate study center closure at any time, provided there is reasonable cause and sufficient notice is given in advance of the intended termination.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5eec0a34-4282-4221-9f5e-a63a7f4530b0\\\", \\\"childbox\\\": \\\"29849166-5636-4b7c-9a62-d0446d1908a4\\\", \\\"subtext\\\": \\\"aa15b09b-fbb6-4d26-83af-7a831a13a951\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study and Study Center Closure\\\", \\\"\\\", \\\"1\\\", 2416, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Reasons for the early closure of a study center by ~REDACTED~/sponsor or investigator may include but are not limited to:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4fe218c6-e763-4392-a216-82d2fb49b9e9\\\", \\\"childbox\\\": \\\"d7621ab5-d9bf-477e-a09d-e92b05cbe32c\\\", \\\"subtext\\\": \\\"fef8a04b-86e6-402a-8447-73de443a5c9c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study and Study Center Closure\\\", \\\"\\\", \\\"1\\\", 2417, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Failure of the investigator to comply with the protocol, the requirements of the\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"edba4305-a5db-424c-ae08-a98baf9244d1\\\", \\\"childbox\\\": \\\"c3d9ef45-4598-4f8f-ad78-6ff5159233e7\\\", \\\"subtext\\\": \\\"3775ef12-0cc7-408e-b94e-0d4d5b5a3287\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study and Study Center Closure\\\", \\\"\\\", \\\"1\\\", 2418, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"IRB/IEC or local health authorities, the sponsor's procedures, or GCP guidelines\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"be908828-ef18-4be3-955a-00b623373068\\\", \\\"childbox\\\": \\\"e9f7d549-89e7-4aa4-8f7a-d8dfa9ee02fb\\\", \\\"subtext\\\": \\\"2a15533e-35ee-43f7-aebe-c345dccf1eab\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study and Study Center Closure\\\", \\\"\\\", \\\"1\\\", 2419, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Inadequate recruitment of participants by the investigator\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"15dce6e3-d145-41e7-a1c1-3fa88e5d7fcf\\\", \\\"childbox\\\": \\\"19e6786b-3b96-4b5c-80f9-28828194c895\\\", \\\"subtext\\\": \\\"97649b9d-694d-4d7a-b8c6-52b6bf792c07\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study and Study Center Closure\\\", \\\"\\\", \\\"1\\\", 2420, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Discontinuation of further study intervention development\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a84cc5bc-474a-4d90-bca8-b32d5f417f68\\\", \\\"childbox\\\": \\\"a2b2cf02-0d1d-49b2-ba54-ab1b71772c25\\\", \\\"subtext\\\": \\\"9b94bd78-2823-43fe-bc57-d1b6e6addc88\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study and Study Center Closure\\\", \\\"\\\", \\\"1\\\", 2421, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Total number of participants included earlier than expected\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"248a5b08-3350-464a-a769-303d2d027535\\\", \\\"childbox\\\": \\\"e59b0424-0dc7-4d7c-8e73-cf25a5a603d8\\\", \\\"subtext\\\": \\\"1282fac1-c20f-4de1-b984-fd94fcc66679\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study and Study Center Closure\\\", \\\"\\\", \\\"1\\\", 2422, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If the study is prematurely terminated or suspended, ~REDACTED~ shall promptly inform the investigators, the IECs/IRBs, the regulatory authorities, for the reason for termination or suspension, as specified by the applicable regulatory requirements.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ac6a3964-bd49-4677-8b48-6188da6eee49\\\", \\\"childbox\\\": \\\"3149a412-f1ca-4dcf-99f6-7f35ad7de1ff\\\", \\\"subtext\\\": \\\"9329daba-a30c-4f53-a999-e7214be12762\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study and Study Center Closure\\\", \\\"\\\", \\\"1\\\", 2423, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator shall promptly inform the participants and should assure appropriate participant therapy and/or follow-up.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ac6a3964-bd49-4677-8b48-6188da6eee49\\\", \\\"childbox\\\": \\\"f3710b6c-e1c2-413d-a5e8-8c2c9c1fdfcb\\\", \\\"subtext\\\": \\\"e314dd99-83ab-4042-9a86-46f3cd12367b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Study and Study Center Closure\\\", \\\"\\\", \\\"1\\\", 2424, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Publication Policy\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f2dbb944-12d7-4c1a-8fab-be213ce5eaff\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Publication Policy\\\", \\\"\\\", \\\"1\\\", 2425, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The sponsor aims to submit for publication the results of the study in searchable, peer reviewed scientific literature within 18 months from LSLV for interventional studies and follows authorship and other guidance from the International Committee of Medical Journal Editors.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1c2afd5e-d74a-48b2-b0d7-b23d92231796\\\", \\\"childbox\\\": \\\"a01b1e45-ba7b-4a66-a5a5-a7719f518c7d\\\", \\\"subtext\\\": \\\"ff8b4d6e-9e91-46da-a5d6-aecc0fa83a1c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Publication Policy\\\", \\\"\\\", \\\"1\\\", 2426, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Appendix 3 Clinical Laboratory Tests\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2629f602-f312-401c-b887-4a427fd89850\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 3  Clinical Laboratory Tests\\\", \\\"\\\", \\\"1\\\", 2427, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"~REDACTED~ Assessments\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1f0bb628-e626-4701-8afb-11233f055bf9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Protocol-required Safety Laboratory Assessments\\\", \\\"\\\", \\\"1\\\", 2428, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A urine pregnancy test will be conducted as needed for women of childbearing potential.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"83fe2f1c-063f-43c3-9d13-6e0db6c2d353\\\", \\\"childbox\\\": \\\"1f99166a-cbb0-467d-a4c8-b94a95d6e00b\\\", \\\"subtext\\\": \\\"3357f181-5641-4208-9692-d5f827dcac27\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Protocol-required Safety Laboratory Assessments\\\", \\\"\\\", \\\"1\\\", 2429, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"83fe2f1c-063f-43c3-9d13-6e0db6c2d353\\\", \\\"childbox\\\": \\\"1f99166a-cbb0-467d-a4c8-b94a95d6e00b\\\", \\\"subtext\\\": \\\"971b53c3-6021-4750-bdf5-7dca37379f78\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Protocol-required Safety Laboratory Assessments\\\", \\\"\\\", \\\"1\\\", 2430, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Laboratory Assays\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cedfffe0-fdd1-403e-af14-106322c18c70\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2431, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"MenACWY Serum Bactericidal Assays Using Human Complement (hSBA)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2c2f4d58-9504-49c8-919d-e37519ee52c4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2432, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The induction of functional anti-meningococcal activity by bactericidal antibodies directed against\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3ccd6baf-9763-427b-b292-babc642a3d38\\\", \\\"childbox\\\": \\\"f8a574fe-b528-4b43-b21c-0a9889371fe5\\\", \\\"subtext\\\": \\\"185ab7c0-322e-42ea-b9b8-abc4ec7485c8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2433, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"N.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3ccd6baf-9763-427b-b292-babc642a3d38\\\", \\\"childbox\\\": \\\"f8a574fe-b528-4b43-b21c-0a9889371fe5\\\", \\\"subtext\\\": \\\"2db38b04-ebf5-43de-8964-19cc37f9d9a8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2434, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"meningitidis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3ccd6baf-9763-427b-b292-babc642a3d38\\\", \\\"childbox\\\": \\\"c38df9f9-4dad-4fd8-b739-872c64bac2e8\\\", \\\"subtext\\\": \\\"2db38b04-ebf5-43de-8964-19cc37f9d9a8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2435, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"serogroups A, C, W, and Y will be also determined by hSBA using a new format, so-called agar overlay hSBA, using a higher throughput colony counting method compared to the manual hSBA based on the Tilt method.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3ccd6baf-9763-427b-b292-babc642a3d38\\\", \\\"childbox\\\": \\\"c38df9f9-4dad-4fd8-b739-872c64bac2e8\\\", \\\"subtext\\\": \\\"f9e822ad-fca2-46ab-9c9f-825e4eefa262\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2436, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This new hSBA is also based on the measurement of human complement-dependent bactericidal killing of meningococci.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4262064b-7885-40a7-ba14-b14bec3303b8\\\", \\\"childbox\\\": \\\"85f3162c-e980-4535-bbc0-e1a040b13013\\\", \\\"subtext\\\": \\\"04e80db5-033f-4c9f-8451-5932aefa6b7b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2437, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"As with all functional hSBAs, the assay includes a first step of heat inactivation of the human serum samples to inactivate the endogenous complement, followed by serial dilution of the serum samples in which a fixed amount of bacteria and of human exogenous complement are added.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4262064b-7885-40a7-ba14-b14bec3303b8\\\", \\\"childbox\\\": \\\"142e0452-d31d-43d7-80cd-7208812ea978\\\", \\\"subtext\\\": \\\"38aad3fc-ef2a-4e02-be35-c24b1cb03e1a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2438, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The reactions are incubated to allow the association of meningococcal specific antibodies and their target antigen.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4262064b-7885-40a7-ba14-b14bec3303b8\\\", \\\"childbox\\\": \\\"e7f0ce01-8fa5-4822-84fe-9695040895f7\\\", \\\"subtext\\\": \\\"c2e3ad34-8582-467d-b590-521c71acc916\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2439, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The antibody-antigen complex activates the classical pathway of complement which ultimately results in bacterial lysis.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4262064b-7885-40a7-ba14-b14bec3303b8\\\", \\\"childbox\\\": \\\"3452badf-e33c-4c08-8e19-4dc675d1c791\\\", \\\"subtext\\\": \\\"d23178aa-ee6f-4039-a6bb-ccfa0ab36a85\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2440, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"As a measure of the meningococcal specific antibody titer of each serum sample, the MenACWY agar-overlay hSBA follows the principle of detecting and counting the surviving meningococcal bacteria after bacterial growth within solid agar media, using an automatic colony counter (AxioLab Image Analysis System \\\\u2013 detection of colony-forming units).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6bc82d86-f26c-4b4f-bdd4-0482d3c7d201\\\", \\\"childbox\\\": \\\"486dcfa3-6e18-408c-9b79-063f0ab5f034\\\", \\\"subtext\\\": \\\"353b9032-5f1a-41a1-a903-f382c42b1178\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2441, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"MenACWY IgG ELISA\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fee254a1-a2eb-42c4-9307-750ae952b259\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2442, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The anti-MenACWY total IgG antibody concentrations will be measured by using an Enzyme-Linked Immunosorbent Assay (ELISA) or equivalent to evaluate the immunogenicity of the capsular polysaccharides of serogroups A, C, W, and Y in MenACWY ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ebed1db8-1fdf-4635-b9a9-5d98c1004ab7\\\", \\\"childbox\\\": \\\"c2569122-6433-4a99-a766-eafc563b0823\\\", \\\"subtext\\\": \\\"d5ba0ef7-8be5-4eb6-96aa-48f06fe121f2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2443, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 The assay characteristics (e.g., validated assay cut-offs and units) for each of the serogroup will be determined at the time of the generation of validation data.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9552a55a-dc47-498c-9be0-7b1c499119d4\\\", \\\"childbox\\\": \\\"c3913d42-9f51-4d86-b8cd-a450713d733d\\\", \\\"subtext\\\": \\\"5e1f303c-3bcf-46b0-8802-ea855d53829e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2444, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Any change, including the change of the format of the assay, will be documented in a protocol amendment or in the clinical study report.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9552a55a-dc47-498c-9be0-7b1c499119d4\\\", \\\"childbox\\\": \\\"d660a925-e260-4ce1-8cde-1217103aa066\\\", \\\"subtext\\\": \\\"5e1f303c-3bcf-46b0-8802-ea855d53829e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2445, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"MenB Serum Bactericidal Assays Using Human Complement (hSBA)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5d03614a-d36d-4443-b924-23de55dca599\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2446, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Serum bactericidal activity against MenB will be determined by using a validated manual\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3dfa71d3-e565-4ba3-988a-7281022c2ca8\\\", \\\"childbox\\\": \\\"34fa2d93-e8fa-4139-ac52-94df140c737d\\\", \\\"subtext\\\": \\\"c70d8a68-d1e9-49f8-b50a-079cf116f3bf\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2447, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"(Tilt-based) hSBA against a standard panel consisting of 4 meningococcal B indicator strains M14459, 96217, NZ98/254 and M07-0241084.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"40b1a224-dff0-45af-9c56-c73279767a71\\\", \\\"childbox\\\": \\\"9229e450-2ba0-4784-84fa-a8afaa9393a0\\\", \\\"subtext\\\": \\\"892cb275-36f7-4fff-beeb-f4ef06bd6032\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2448, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Each of these strains measures bactericidal activity primarily directed against one of the major bactericidal antigens included in ~REDACTED~: strain M14459 measures hSBA against the 741 part of the 936-741 antigen, also known as fHbp variant 1.1; strain 96217 measures hSBA against antigen 961c, also known as NadA; strain NZ98/254 measures hSBA against PorA P1.4, the immunodominant antigen in the OMV NZ ~REDACTED~ component; strain M07-0241084 measures hSBA against the 287 part of the 287-953 antigen, also known as NHBA.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"40b1a224-dff0-45af-9c56-c73279767a71\\\", \\\"childbox\\\": \\\"afc98c66-042d-4887-b002-0f4a1101d099\\\", \\\"subtext\\\": \\\"6b3ee294-aa04-470f-bd3e-55a484654c67\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2449, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The NHBA M07-0241084 indicator strain may be participant to change to an alternative NHBA indicator strain (e.g., strain M13520) during the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f7ba8528-03a7-4f55-a30a-5be528e2f36c\\\", \\\"childbox\\\": \\\"c1d39098-17d8-4be5-8bc2-76dfacda3a97\\\", \\\"subtext\\\": \\\"06d9c1c6-fc11-4679-b52d-8aa16352aaca\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2450, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In this case, this change will be documented either in a protocol amendment or in the CSR.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f7ba8528-03a7-4f55-a30a-5be528e2f36c\\\", \\\"childbox\\\": \\\"6182dad6-0741-4e3e-ae9c-cd7980a33cc4\\\", \\\"subtext\\\": \\\"4b64142a-6b96-4a1c-ba1b-0c51669406ad\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2451, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Serum bactericidal activity against MenB will be determined by performing serum bactericidal assays using hSBA against an additional panel of\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b86058f8-bf4c-483f-bd58-a21f5acc6903\\\", \\\"childbox\\\": \\\"14c5e0d6-a9bd-43fd-81d4-c93022650ac1\\\", \\\"subtext\\\": \\\"8a2b8503-370f-44d6-9b01-d775eba4d08c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2452, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Neisseria\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b86058f8-bf4c-483f-bd58-a21f5acc6903\\\", \\\"childbox\\\": \\\"14c5e0d6-a9bd-43fd-81d4-c93022650ac1\\\", \\\"subtext\\\": \\\"4ab4d086-7497-4f3b-896b-f83743a22f0e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2453, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"indicator strains for exploratory objective if necessary.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b86058f8-bf4c-483f-bd58-a21f5acc6903\\\", \\\"childbox\\\": \\\"14c5e0d6-a9bd-43fd-81d4-c93022650ac1\\\", \\\"subtext\\\": \\\"d70d4699-de93-411a-86d5-064737e8061c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2454, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b86058f8-bf4c-483f-bd58-a21f5acc6903\\\", \\\"childbox\\\": \\\"8be27a41-030e-4aec-a688-16079fcc02f3\\\", \\\"subtext\\\": \\\"4773eacf-84dc-408b-9750-d086a63f8c5d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Laboratory Assays\\\", \\\"\\\", \\\"1\\\", 2455, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Appendix 4 Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8b347fa3-cb61-4451-922e-1db4a89672d0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 4  Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting\\\", \\\"\\\", \\\"1\\\", 2456, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Definitions of AEs\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6caf39ca-96b4-4736-8e76-4d818943d283\\\", \\\"childbox\\\": \\\"3c44f73c-56ff-4b4a-b1c0-e2bea838a435\\\", \\\"subtext\\\": \\\"5f363665-762c-4a5c-afaf-a50888403b8b\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions of AEs\\\", \\\"\\\", \\\"3\\\", 2457, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Adverse Events\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1245e205-2958-46c3-8cc0-1211133bc88c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Adverse Events\\\", \\\"\\\", \\\"3\\\", 2458, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>AE Definition</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>An AE is any untoward medical occurrence in a patient or clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. Note: An AE can therefore be any unfavourable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of study intervention.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"101\\\", \\\"TableIndex\\\": \\\"40\\\", \\\"TableName\\\": \\\"Adverse Events\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"c8fb2b5a-6d9d-4631-ad15-f39a022b025f\\\", \\\"childbox\\\": \\\"00b0fd98-122b-4534-8864-02618ce013b5\\\", \\\"subtext\\\": \\\"eccd54df-3395-4634-be48-d291a8c090e2\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Adverse Events\\\", \\\"\\\", \\\"3\\\", 2459, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"45e45898-9a3b-4096-ac43-28ceabd082d2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Adverse Events\\\", \\\"\\\", \\\"3\\\", 2460, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Events Meeting the AE Definition</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Significant or unexpected worsening or exacerbation of the condition/indication under study. Exacerbation of a chronic or intermittent pre-existing condition including either an increase in frequency and/or intensity of the condition. New conditions detected or diagnosed after study <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product administration even though they may have been present prior to the start of the study. Signs, symptoms, or the clinical sequelae of a suspected interaction. Signs, symptoms, or the clinical sequelae of a suspected overdose of either study <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product or a concurrent medication (overdose per se should not be reported as an AE/SAE). Signs or symptoms temporally associated with study <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product administration. Signs, symptoms that require medical attention (e.g., hospital stays, physician visits and emergency room visits). Significant failure of an expected pharmacologic or biological action. Pre- or post-intervention events that occur as a result of protocol-mandated procedures (i.e., invasive procedures, modification of participant\\\\u2019s previous therapeutic regimen). Clinically significant abnormal laboratory findings or other abnormal assessments that are present at baseline and significantly worsen following the start of the study will also be reported as AEs or SAEs. AEs will be recorded as solicited AEs if they do not meet the definition of unsolicited AEs. The signs, symptoms, and/or clinical sequelae resulting from lack of efficacy will be reported as AE or SAE if they fulfill the definition of an AE or SAE.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"101\\\", \\\"TableIndex\\\": \\\"41\\\", \\\"TableName\\\": \\\"Adverse Events\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"7a2d006e-ed7a-4d34-905e-9ea52672d069\\\", \\\"childbox\\\": \\\"0cff3069-84d7-43bf-9302-a95da6a96048\\\", \\\"subtext\\\": \\\"581a3819-53c9-4bc4-85e4-66a56f71aa9d\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Adverse Events\\\", \\\"\\\", \\\"3\\\", 2461, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"217acf48-1216-437f-b64d-67f85897d551\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Adverse Events\\\", \\\"\\\", \\\"3\\\", 2462, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Events NOT Meeting the AE Definition</td>\\\\n      <td>Events NOT Meeting the AE Definition</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Situations where an untoward medical occurrence did not occur (e.g., social and/or convenience admission to a hospital, admission for routine examination). Anticipated day-to-day fluctuations of pre-existing disease(s) or condition(s) present or detected at the start of the study that do not worsen. Pre-existing conditions or signs and/or symptoms present in a participant prior to the first study vaccination. These events will be recorded in the medical history section of the eCRF. Hospitalization for elective treatment of a pre-existing condition (known or diagnosed prior to</td>\\\\n      <td>Situations where an untoward medical occurrence did not occur (e.g., social and/or convenience admission to a hospital, admission for routine examination). Anticipated day-to-day fluctuations of pre-existing disease(s) or condition(s) present or detected at the start of the study that do not worsen. Pre-existing conditions or signs and/or symptoms present in a participant prior to the first study vaccination. These events will be recorded in the medical history section of the eCRF. Hospitalization for elective treatment of a pre-existing condition (known or diagnosed prior to</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td></td>\\\\n      <td>informed consent signature) that did not worsen from baseline.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td></td>\\\\n      <td>Clinically significant abnormal laboratory findings or other abnormal assessments that are present or detected at the start of the study and do not worsen.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"101\\\", \\\"TableIndex\\\": \\\"42\\\", \\\"TableName\\\": \\\"Adverse Events\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"27b6f295-1f92-4888-98f2-c00630cfdfbc\\\", \\\"childbox\\\": \\\"485472f6-b9a6-4c5a-a705-4abf635d5c32\\\", \\\"subtext\\\": \\\"2e90b25d-f84c-4e8b-ace5-caf5cc7e6f3f\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Adverse Events\\\", \\\"\\\", \\\"3\\\", 2463, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ccd5a18a-4347-4f83-af39-a423c8a16046\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Adverse Events\\\", \\\"\\\", \\\"3\\\", 2464, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ef1e7590-7545-4750-b25a-232d86166acd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Adverse Events\\\", \\\"\\\", \\\"3\\\", 2465, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Serious Adverse Events\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bae987e7-99d4-4c38-9373-0df735b2b57b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Serious Adverse Events\\\", \\\"\\\", \\\"3\\\", 2466, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>An SAE is any untoward medical occurrence that:</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>a)  Results in death</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>b)  Is life-threatening Note: The term \\\\u201clife-threatening\\\\u201d in the definition of \\\\u201cserious\\\\u201d refers to an event in which the participant was at risk of death at the time of the event. It does not refer to an event, which hypothetically might have caused death, had it been more severe.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>c)  Requires inpatient hospitalization or prolongation of existing hospitalization Note: In general, hospitalization signifies that the participant has been admitted at the hospital or emergency ward for observation and/or treatment that would not have been appropriate in the physician\\\\u2019s office or in an outpatient setting. Complications that occur during hospitalization are also considered as AEs. If a complication prolongs hospitalization or fulfills any other serious criteria, the event will also be considered serious. When in doubt as to whether \\\\u201chospitalization\\\\u201d occurred, or was necessary, the AE should be considered serious.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>d)  Results in disability/incapacity Note: The term disability means a substantial disruption of a person\\\\u2019s ability to conduct normal life functions. This definition is not intended to include experiences of relatively minor medical significance such as uncomplicated headache, nausea, vomiting, diarrhea, influenza like illness, and accidental trauma (e.g., sprained ankle) which may interfere or prevent everyday life functions but do not constitute a substantial disruption.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>e)  Is a congenital anomaly/birth defect in the offspring of a study participant</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td>f)   Abnormal pregnancy outcomes (e.g., spontaneous abortion, fetal death, stillbirth, congenital anomalies, ectopic pregnancy).</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>7</th>\\\\n      <td>g)  Other situations Medical or scientific judgment should be exercised in deciding whether reporting is appropriate in other situations, such as important medical events that may not be immediately life-threatening or result in death or hospitalization but may jeopardize the participant or may require medical or surgical intervention to prevent 1 of the other outcomes listed in the above definition. These should also be considered serious. Examples of such events are invasive or malignant cancers, intensive treatment in an emergency room or at home for allergic bronchospasm, blood dyscrasias or convulsions that do not result in hospitalization.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"102\\\", \\\"TableIndex\\\": \\\"43\\\", \\\"TableName\\\": \\\"Serious Adverse Events\\\", \\\"Header\\\": [0, 1, 2, 3]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"9c09610c-8704-4ba4-aa23-1c3e634b0038\\\", \\\"childbox\\\": \\\"37dfb57b-05ca-41b2-a8b2-e9b652a8db76\\\", \\\"subtext\\\": \\\"21615c45-8bf7-486f-afd7-a91ec0ce45dd\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Serious Adverse Events\\\", \\\"\\\", \\\"3\\\", 2467, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Solicited Events\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"121e7b86-bb00-4e54-a6d2-bfebec66a3ec\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Solicited Events\\\", \\\"\\\", \\\"3\\\", 2468, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Solicited Events will include the following:</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>a)  Solicited administration site events The following administration site events will be solicited for all age groups : Pain Redness Swelling Induration</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Solicited Events will include the following:</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Note: participants/participants\\\\u2019 parents/LARs will be instructed to measure \\\\u201cSolicited administration site events\\\\u201d using the ruler provided by the site. Should multiple measurements be performed during the day, participants/participants\\\\u2019 parent(s)/LAR(s) will be instructed to record the highest grading in the eDiary.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>b)  Solicited systemic events The following systemic events will be solicited for adults 15 to 25 years : Fever Fatigue Nausea Headache Arthralgia Myalgia Note: participants/participants\\\\u2019 parents/LARs will be instructed to measure and record the preferably oral body temperature in the evening using the thermometer provided by the site. Should additional temperature measurements be performed at other times of day, participants/participants\\\\u2019 parents/LARs will be instructed to record the highest temperature in the eDiary. Note: Any solicited event that meets any of the following criteria must be entered into the participant\\\\u2019s source documents and eCRF: Solicited administration site or systemic event that leads to a <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to a health care provider (medically attended AE). Solicited administration site or systemic event leading to the participant withdrawing from the study or the participant being withdrawn from the study by the investigator (AE leading to withdrawal). Solicited administration site or systemic event that otherwise meets the definition of an SAE.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"102\\\", \\\"TableIndex\\\": \\\"44\\\", \\\"TableName\\\": \\\"Solicited Events\\\", \\\"Header\\\": [0, 1, 2]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"e1a2adaa-56c0-43b0-8973-fc0349e3ec50\\\", \\\"childbox\\\": \\\"dbb12d1f-6175-407d-a9b9-cbeaa3ea6835\\\", \\\"subtext\\\": \\\"77ad3242-5f1e-41d4-a77b-2c8746431b46\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Solicited Events\\\", \\\"\\\", \\\"3\\\", 2469, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Unsolicited AEs\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8bc8da8c-ab5e-4cbd-bb17-67ab559b1a12\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"\\\", \\\"3\\\", 2470, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Definition of an Unsolicited AE:</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>An unsolicited AE is an AE that was not solicited using an eDiary and that was spontaneously communicated by a participant/participant\\\\u2019s parent(s)/LAR(s) who has signed the informed consent. Unsolicited AEs include serious and non-serious AEs. Potential unsolicited AEs may be medically attended (i.e., symptoms or illnesses requiring a hospitalization, or emergency room <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>, or <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to/by a health care provider). The participants/participants\\\\u2019 parents/LARs will be instructed to contact the study center as soon as possible to report medically attended events, as well as any events that, though not medically attended, are of participant/parental/LAR\\\\u2019s concern. Detailed information about reported unsolicited AEs will be collected by qualified study center personnel and documented in the participant\\\\u2019s records. Unsolicited AEs that are not medically attended nor perceived as a concern by participant/participant\\\\u2019s parent(s)/LAR(s) will be collected during interview with the participants/participant\\\\u2019s parent(s)/LAR(s) and by review of available medical records at the next <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"103\\\", \\\"TableIndex\\\": \\\"45\\\", \\\"TableName\\\": \\\"Unsolicited AEs\\\", \\\"Header\\\": []}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"aa305ba7-a6cf-4456-8bf6-29c087ecbfd4\\\", \\\"childbox\\\": \\\"56194083-8ca8-4f1c-b151-75913bbf988e\\\", \\\"subtext\\\": \\\"73115ed8-998e-4f03-9985-dbed506ea1bd\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Unsolicited AEs\\\", \\\"\\\", \\\"3\\\", 2471, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"COVID-19 Cases\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"14681b84-7c7c-4e70-a0e6-9ca13a1b703d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"COVID-19 Cases\\\", \\\"\\\", \\\"3\\\", 2472, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Diagnosis of COVID-19 should be made in accordance with the WHO case definition.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e6c66e4b-9f6e-4e94-a80f-6ff655c1f5d6\\\", \\\"childbox\\\": \\\"01a4dd09-e22e-4ada-8db5-0df85288f29f\\\", \\\"subtext\\\": \\\"dccf1bec-5e3b-422b-820c-cb3d3febea59\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"COVID-19 Cases\\\", \\\"\\\", \\\"3\\\", 2473, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Cases should be categorized as AEs or SAEs, and routine procedures for recording, evaluation, follow-up, and reporting of AEs, and SAEs should be followed in accordance with the time period set out in the protocol (Table 12, Table 13).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0a02594d-848a-46af-b48c-1622fca8943f\\\", \\\"childbox\\\": \\\"4fe24db0-93bf-4b7c-a3db-a28aa7013402\\\", \\\"subtext\\\": \\\"4b2747be-19dd-46d0-854b-c226c0c5040f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"COVID-19 Cases\\\", \\\"\\\", \\\"3\\\", 2474, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Adverse Events of Special Interest (AESIs)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0463e06e-d212-41a1-b37d-4d9e2bba24b3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"COVID-19 Cases\\\", \\\"\\\", \\\"3\\\", 2475, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Definition of an AESI</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Adverse events of special interest (AESIs) are predefined (serious or non-serious) AEs of scientific and medical concern specific to the product or program, for which ongoing monitoring and rapid communication by the investigator to the sponsor can be appropriate, because such an event might warrant further investigation in order to characterize and understand it.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"103\\\", \\\"TableIndex\\\": \\\"46\\\", \\\"TableName\\\": \\\"COVID-19 Cases\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"184e5ead-99c3-4eae-88fe-6427e5101243\\\", \\\"childbox\\\": \\\"c460e99f-c249-442a-b30c-249e479aaad9\\\", \\\"subtext\\\": \\\"955808b4-eea1-484f-842a-f4fa423f6adc\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"COVID-19 Cases\\\", \\\"\\\", \\\"3\\\", 2476, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Potential Immune-Mediated Diseases (pIMDs)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a62daffd-1660-449d-9177-0ab853239f57\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"\\\", \\\"3\\\", 2477, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Potential immune-mediated diseases are a subset of AESIs that include autoimmune diseases and other inflammatory and/or neurologic disorders of interest which may or may not have an autoimmune etiology.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a51c803c-fdaf-4d6c-b57f-dd7bcd45640d\\\", \\\"childbox\\\": \\\"c71c159e-df20-4ad4-8bc1-3e5d9c25d7bd\\\", \\\"subtext\\\": \\\"ef1c56c4-8f5f-4a50-befc-775300d35df2\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"\\\", \\\"3\\\", 2478, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Adverse events that need to be recorded and reported as pIMDs include those listed in the Table 17.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a51c803c-fdaf-4d6c-b57f-dd7bcd45640d\\\", \\\"childbox\\\": \\\"01a4b57f-e2c4-447e-918b-46b090513b59\\\", \\\"subtext\\\": \\\"dfc28192-7fcd-49b4-ba5c-e3780d97df00\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"\\\", \\\"3\\\", 2479, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"However, the investigator will exercise his/her medical and scientific judgment to determine whether other diseases have an autoimmune origin (i.e., pathophysiology involving systemic or organ-specific pathogenic autoantibodies) and should also be recorded as a pIMD.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"53cffd31-3fe5-4223-8ad0-d1e0c8bc2dcf\\\", \\\"childbox\\\": \\\"a96350be-dd08-4c5e-859c-78176db60ac9\\\", \\\"subtext\\\": \\\"81cf6a68-3d30-4e8b-9a85-a5ff38bc2c6b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"\\\", \\\"3\\\", 2480, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In order to facilitate the documentation of pIMDs in the eCRF, a pIMD standard questionnaire and a list of MedDRA PTs and PT codes corresponding to the above diagnoses will be available to investigators at study start.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bbc4c223-5b0a-4b85-b6fe-ed68038b1d45\\\", \\\"childbox\\\": \\\"d015fdbd-8f4b-4424-bcfe-961c18f588c0\\\", \\\"subtext\\\": \\\"d717f583-4a2e-4796-a2d2-5a3177da814f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"\\\", \\\"3\\\", 2481, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1f38f364-26aa-4b6f-adce-2a69b6cb43a8\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"\\\", \\\"3\\\", 2482, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"CONFIDENTIAL\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0a747c82-6f79-4d53-a22b-ed86f4395a3f\\\", \\\"childbox\\\": \\\"c5ae0eff-639c-4ff2-87d2-b49545422356\\\", \\\"subtext\\\": \\\"95e52d88-0c34-444a-a471-3050e3c28754\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"\\\", \\\"3\\\", 2483, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0a747c82-6f79-4d53-a22b-ed86f4395a3f\\\", \\\"childbox\\\": \\\"d326a722-2903-4214-b69b-09f7b1618971\\\", \\\"subtext\\\": \\\"73568863-03df-48a2-a4d1-6028c53c606a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"\\\", \\\"3\\\", 2484, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Protocol 213171 (MENABCWY-019) \\\\u2013 Amendment 2\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0a747c82-6f79-4d53-a22b-ed86f4395a3f\\\", \\\"childbox\\\": \\\"0352f331-4754-4e2f-99ff-7bb00dc1f1d8\\\", \\\"subtext\\\": \\\"73568863-03df-48a2-a4d1-6028c53c606a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"\\\", \\\"3\\\", 2485, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"29769437-5064-434f-b6c3-0f7c90e68805\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2486, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Neuroinflammatory Disorders</td>\\\\n      <td>Musculoskeletal Disorders</td>\\\\n      <td>Skin Disorders</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Cranial nerve neuropathy, including paralysis and paresis (e.g., Bell\\\\u2019s palsy). Optic neuritis. Multiple sclerosis. Transverse myelitis. Guillain-Barr\\\\u00e9 syndrome, including Miller Fisher syndrome and other variants. Acute disseminated encephalomyelitis, including site specific variants such as non-infectious encephalitis, encephalomyelitis, myelitis, myeloradiculoneuritis. Myasthenia gravis, including Lambert-Eaton myasthenic syndrome. Demyelinating peripheral neuropathies including: Chronic inflammatory demyelinating polyneuropathy, Multifocal motor neuropathy,   Polyneuropathies associated with monoclonal gammopathy. Narcolepsy.</td>\\\\n      <td>Systemic lupus erythematosus and associated conditions. Systemic scleroderma (Systemic sclerosis), including: Diffuse scleroderma, CREST syndrome. Idiopathic inflammatory myopathies, including: Dermatomyositis, Polymyositis, Anti-synthetase syndrome. Rheumatoid arthritis and associated conditions including: Juvenile idiopathic arthritis, Still\\\\u2019s disease,   Polymyalgia rheumatica. Spondyloarthropathies, including: Ankylosing spondylitis, Reactive arthritis (Reiter's Syndrome), Undifferentiated spondyloarthritis, Psoriatic arthritis,   Enteropathic arthritis. Relapsing Polychondritis. Mixed connective tissue disorder. Gout.</td>\\\\n      <td>Psoriasis. Vitiligo. Erythema nodosum. Autoimmune bullous skin diseases including: Pemphigus, Pemphigoid, Dermatitis herpetiformis. Lichen planus. Sweet\\\\u2019s syndrome. Localised scleroderma (morphoea).</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Vasculitis</td>\\\\n      <td>Blood Disorders</td>\\\\n      <td>Others</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Large vessels vasculitis including:   Giant cell arteritis (temporal arteritis),</td>\\\\n      <td>Autoimmune haemolytic anemia. Autoimmune thrombocytopenia.</td>\\\\n      <td>Autoimmune glomerulonephritis including:   IgA nephropathy,</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"105\\\", \\\"TableIndex\\\": \\\"47\\\", \\\"TableName\\\": \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Header\\\": [0, 2]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"82d944b9-c709-4a15-9e30-37831c6e10f2\\\", \\\"childbox\\\": \\\"f4578093-3b10-4b37-ad0c-fe3c69fbac40\\\", \\\"subtext\\\": \\\"efb54e8b-d9f3-4d95-ae1c-a0fd057e8dfb\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2487, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0c0997af-00a5-47f4-8581-322e279cca3a\\\", \\\"childbox\\\": \\\"dc8a7f82-a099-46bf-8e88-72b6bb4fcb45\\\", \\\"subtext\\\": \\\"5b9aa6a8-ccd1-47b7-8bc2-46dbb8f9d7cd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2488, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"106\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0c0997af-00a5-47f4-8581-322e279cca3a\\\", \\\"childbox\\\": \\\"0de609ab-057a-4d85-8a9b-a211c7517c97\\\", \\\"subtext\\\": \\\"5b9aa6a8-ccd1-47b7-8bc2-46dbb8f9d7cd\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2489, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"CONFIDENTIAL\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3554b6de-2537-413d-8e9a-81e57b5e316f\\\", \\\"childbox\\\": \\\"530e765f-6cff-4e75-b6b9-6b13c0275a49\\\", \\\"subtext\\\": \\\"1825f680-1f24-47b3-aa5b-69f18d715878\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2490, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3554b6de-2537-413d-8e9a-81e57b5e316f\\\", \\\"childbox\\\": \\\"fce3fa2b-0f8d-4c09-8bb8-9ee11aa7f075\\\", \\\"subtext\\\": \\\"e79d159f-47a7-41b5-815d-d2f40a7f0710\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2491, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Protocol 213171 (MENABCWY-019) \\\\u2013 Amendment 2\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3554b6de-2537-413d-8e9a-81e57b5e316f\\\", \\\"childbox\\\": \\\"083e175b-dd62-4417-83e7-3668e17ac2c7\\\", \\\"subtext\\\": \\\"e79d159f-47a7-41b5-815d-d2f40a7f0710\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2492, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Takayasu's arteritis.  Medium sized and/or small vessels vasculitis including: Polyarteritis nodosa, Kawasaki's disease, Microscopic polyangiitis, Wegener's granulomatosis (granulomatosis with polyangiitis), Churg\\\\u2013Strauss syndrome (allergic granulomatous angiitis or eosinophilic granulomatosis with polyangiitis), Buerger\\\\u2019s disease (thromboangiitis obliterans),   Necrotising vasculitis (cutaneous or systemic), Anti-neutrophil cytoplasmic antibody (ANCA) positive vasculitis (type unspecified), Henoch-Schonlein purpura (IgA vasculitis), Behcet's syndrome, Leukocytoclastic vasculitis.</td>\\\\n      <td>Antiphospholipid syndrome. Pernicious anemia. Autoimmune aplastic anemia. Autoimmune neutropenia. Autoimmune pancytopenia.</td>\\\\n      <td>Glomerulonephritis rapidly progressive, Membranous glomerulonephritis, Membranoproliferative glomerulonephritis,   Mesangioproliferative glomerulonephritis. Tubulointerstitial nephritis and uveitis syndrome. Ocular autoimmune diseases including:   Autoimmune uveitis,   Autoimmune retinitis. Autoimmune myocarditis. Sarcoidosis. Stevens-Johnson syndrome. Sj\\\\u00f6gren\\\\u2019s syndrome. Alopecia areata. Idiopathic pulmonary fibrosis. Goodpasture syndrome. Raynaud\\\\u2019s phenomenon.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Liver Disorders</td>\\\\n      <td>Gastrointestinal Disorders</td>\\\\n      <td>Endocrine Disorders</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Autoimmune hepatitis. Primary biliary cirrhosis. Primary sclerosing cholangitis. Autoimmune cholangitis.</td>\\\\n      <td>Inflammatory bowel disease, including: Crohn\\\\u2019s disease, Ulcerative colitis, Microscopic colitis,   Ulcerative proctitis. Celiac disease. Autoimmune pancreatitis.</td>\\\\n      <td>Autoimmune thyroiditis (Hashimoto thyroiditis). Grave's or Basedow\\\\u2019s disease. Diabetes mellitus type I. Addison\\\\u2019s disease. Polyglandular autoimmune syndrome. Autoimmune hypophysitis.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"105\\\", \\\"TableIndex\\\": \\\"48\\\", \\\"TableName\\\": \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Header\\\": [1]}, {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"83402a21-add3-4484-8039-d194e13c3318\\\", \\\"childbox\\\": \\\"cafc99e5-fc38-44fd-b636-50b9bd0597f8\\\", \\\"subtext\\\": \\\"d045fa38-ecce-4c6e-81ff-6f19c1c4ca41\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"Segoe UI Symbol\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2493, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9fe4a817-3dad-4676-85d6-6eb4aad61ebf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2494, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"313b59b7-2c8c-4404-9f1e-8ae5c99dd5d0\\\", \\\"childbox\\\": \\\"4e149b3e-3961-4bea-b18d-281a1f2555b3\\\", \\\"subtext\\\": \\\"28427af0-cb17-4774-86c1-2ce4162f333b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2495, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"107\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"313b59b7-2c8c-4404-9f1e-8ae5c99dd5d0\\\", \\\"childbox\\\": \\\"db713b23-a922-468c-8876-8c6e6f6f7fda\\\", \\\"subtext\\\": \\\"28427af0-cb17-4774-86c1-2ce4162f333b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2496, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c1a8c2f0-b1f4-42c8-b9b6-098cfec9b3ef\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2497, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Other AEs of Special Interest\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1b273161-dab0-4a67-bd7c-b4ac3902e5cc\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2498, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"When there is enough evidence to make any of the above diagnoses, the AE must be reported as AESI.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f6c2fc15-043d-476f-b370-18a6575eac71\\\", \\\"childbox\\\": \\\"f46f1638-2c66-4d5b-87d4-7031df120f29\\\", \\\"subtext\\\": \\\"a9cec8ad-895b-447f-955e-e38e656046d8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2499, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Symptoms, signs or conditions which might (or might not) represent the above diagnoses, should be recorded and reported as AEs but not as AESI until the final or definitive diagnosis has been determined, and alternative diagnoses have been eliminated or shown to be less likely.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f6c2fc15-043d-476f-b370-18a6575eac71\\\", \\\"childbox\\\": \\\"c093e953-01b2-4424-852b-04bccc861002\\\", \\\"subtext\\\": \\\"a9cec8ad-895b-447f-955e-e38e656046d8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2500, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Arthritis\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1bcf8aca-6463-4a4b-a123-b5d2c4dd60ae\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2501, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Cases of arthritis are defined according to the following ad-hoc definition:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"be0e72d6-eef7-4b1c-8608-a1182b0d5b0a\\\", \\\"childbox\\\": \\\"81fd6cd9-afb4-4dd5-83c1-26ad933f4b0b\\\", \\\"subtext\\\": \\\"f4425f92-0bdd-45da-981e-d9064ff706fb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2502, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Presence of physical examination findings of swelling, redness, heat, or limitation in range of motion and/or\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fddf5e54-976f-4033-966a-7449b244071d\\\", \\\"childbox\\\": \\\"0b1b63ff-56c6-4773-bded-701d90e28f79\\\", \\\"subtext\\\": \\\"7b6f8e7c-707a-44d1-a24c-d18b4590f21b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2503, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\\u2022 Presence of diagnostic imaging studies interpreted by a health care provider as demonstrating evidence of joint inflammation and/or arthrocentesis results evidencing inflammation\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6646b5c0-d138-4641-9281-829a6acc6da3\\\", \\\"childbox\\\": \\\"2992b9fa-c374-4719-9d64-354a4aabf096\\\", \\\"subtext\\\": \\\"25cca427-bc9a-4b73-98c9-371b32617842\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2504, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Due to the heterogeneity of the presentation of arthritis, which can be either acute or chronic, the threshold of duration of 6 weeks is to be considered.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c48b0ff4-9ffe-496c-9f01-65914779fa61\\\", \\\"childbox\\\": \\\"4b4bb048-9d32-4dc8-b1da-fbce8042474d\\\", \\\"subtext\\\": \\\"4fd68340-d79f-4c4e-9073-88776edf2831\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2505, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The list of PTs corresponding to the diagnosis of arthritis are those included in the Standardized MedDRA Queries (SMQ) Narrow \\\\u201cArthritis\\\\u201d.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65e70584-20aa-413c-8195-902fd28696b0\\\", \\\"childbox\\\": \\\"77e7ca8b-83cf-47d2-907a-3fdf654faa2c\\\", \\\"subtext\\\": \\\"aab9ab08-fbb1-4029-ab97-b413ca21a720\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2506, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For any new diagnosis of arthritis (serious or non-serious) in a study participant, the investigator (or designate) must complete an electronic Expedited Adverse Events Report and an ad-hoc eCRF page on arthritis to further characterize this AESI.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65e70584-20aa-413c-8195-902fd28696b0\\\", \\\"childbox\\\": \\\"8a9e097b-44fc-452f-bcb0-8f76c014556b\\\", \\\"subtext\\\": \\\"aab9ab08-fbb1-4029-ab97-b413ca21a720\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2507, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"~REDACTED~ Parameters and Other Abnormal Assessments Qualifying as AEs or SAEs\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9c6ca839-781a-45ed-b642-131b7f9754d6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2508, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"In the absence of a diagnosis, abnormal laboratory findings (e.g., clinical chemistry, hematology, urinalysis) or other abnormal assessments the investigator considers clinically significant will be recorded as an AE or SAE if they meet the definition of an AE or SAE.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"88faf27c-9919-4700-833d-ffd23189fd8e\\\", \\\"childbox\\\": \\\"08b1738b-eebf-484f-a556-0a1ab7374a2e\\\", \\\"subtext\\\": \\\"7b401d3d-9a11-453a-9537-fa6fa2e98430\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2509, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"The investigator will exercise his or her medical and scientific judgment in deciding whether an abnormal laboratory finding or other abnormal assessment is clinically significant.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a275134b-3d96-445a-b0de-7857ce9027de\\\", \\\"childbox\\\": \\\"ccaf8fc7-4946-4754-86a6-a543b58e24e5\\\", \\\"subtext\\\": \\\"3f746a42-6b96-4c1e-8d03-cc5a401e5cee\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2510, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cc513094-8a5a-404d-a744-e722d314f8ac\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2511, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Events or Outcomes Not Qualifying as AEs or SAEs\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"82635258-ab03-4b3c-9f9d-62920128a8d4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2512, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Pregnancy\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a5a81394-5b08-46fa-a7ea-1dd1667f96d1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2513, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Female participants who become pregnant after the first vaccination must not receive subsequent doses of the study ~REDACTED~/product, but may continue other study procedures at the discretion of the investigator.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"886b73de-42ca-4164-b51d-cc1553a17cfc\\\", \\\"childbox\\\": \\\"722357d9-c038-4ccc-bc6f-1714d139a89b\\\", \\\"subtext\\\": \\\"22ac9683-ae37-4eee-8af9-753741f82163\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2514, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"While pregnancy itself is not considered an AE or SAE, any abnormal pregnancy outcome or complication or elective termination of a pregnancy for medical reasons will be recorded and reported as an SAE.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"33caa1e8-e273-4421-b33c-c0512da2fc73\\\", \\\"childbox\\\": \\\"7fa6f981-bd00-4744-93d2-ad6e32d11c79\\\", \\\"subtext\\\": \\\"32be005b-81cc-4817-ad70-abe6fab22d52\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2515, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Recording and Follow-up of AEs, SAEs, AESIs, and Pregnancies\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f6613ce4-3386-4e71-96f6-9151d50da220\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2516, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>AE and SAE Recording</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>The participants/participants\\\\u2019 parents/LARs will be instructed to contact the investigator immediately should the participants manifest any signs or symptoms they perceive as serious. When an AE/SAE occurs, it is the responsibility of the investigator to review all documentation (e.g., hospital progress notes, laboratory and diagnostics reports) relative to the event. The investigator will then record all relevant information regarding an AE/SAE in the eCRF. The investigator is not allowed to send photocopies of the participant\\\\u2019s medical records to neither the sponsor nor <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> instead of appropriately completing the eCRF. However, there may be instances when copies of medical records for certain cases are requested by the sponsor or <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>. In this instance, all participant identifiers will be blinded on the copies of the medical records prior to submission to the sponsor or <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>. The investigator will attempt to establish a diagnosis pertaining to the event based on signs, symptoms, and/or other clinical information. In such cases, the diagnosis should be documented as the AE/SAE and not the individual signs/symptoms. An eDiary will be used in this study to capture solicited administration site or systemic events. The participant should be trained on how and when to complete each field of the eDiary. Any individual(s) who perform the measurements of administration site or systemic events and who will enter the information into the eDiary should be trained on the use of the eDiary. This training must be documented in the participant\\\\u2019s source record. If any other individual other than the participant/participant\\\\u2019s parent(s)/LAR(s) is making entries in the eDiary, their identity should be documented in the participant\\\\u2019s source record. Refer to the study reference manual for more information regarding the use of eDiary.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"105\\\", \\\"TableIndex\\\": \\\"49\\\", \\\"TableName\\\": \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"01f011ed-d6fa-488c-a6f3-439bf6f2b24e\\\", \\\"childbox\\\": \\\"b6251093-2b2a-4dc0-add2-2bed4b6ea485\\\", \\\"subtext\\\": \\\"a1684355-1fa8-469a-aa7d-d7d523d03198\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2517, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d3d8320a-30f5-4c37-ad6d-5ec5eb7fdc59\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2518, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Time Period for Collecting and Recording AEs, SAEs, AESIs, and Pregnancies</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>All solicited events that occur during 7 days following administration of each dose of study <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product (including the day of vaccination) (Day 1 and Day 181) must be recorded into the eDiary, irrespective of intensity. All other AEs occurring within the time frame described in Table 12 should be recorded into the appropriate section of the eCRF, irrespective of intensity or whether or not they are considered vaccination-related. Refer to Section 8.3.6.1 for collecting and reporting of safety information.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"105\\\", \\\"TableIndex\\\": \\\"50\\\", \\\"TableName\\\": \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"9db49692-b0b7-412a-a125-f2bf6d2e900f\\\", \\\"childbox\\\": \\\"97afb02f-c486-42e9-a9e0-48a72f051133\\\", \\\"subtext\\\": \\\"1b29a401-8a36-4913-8d58-f6a7a033bb3d\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2519, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ace5dbf8-315f-45c5-9403-f4421643a3ad\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2520, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Follow-up of AEs, SAEs, AESIs, Pregnancies, or any Other Events of Interest</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>After the initial AE/SAE/AESI/pregnancy or any other event of interest for the study, the investigator is required to proactively follow each participant at subsequent <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>s/contacts. All SAEs, and non-serious AEs of special interest, will be followed until the event is resolved, stabilized, otherwise explained, or the participant is lost to follow-up. Other non-serious AEs must be followed until the last contact or until the participant is lost to follow-up. Follow-up During the Study AEs/AESIs documented at a previous <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/contact and defined as not recovered/not resolved or recovering/resolving will be reviewed at subsequent <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>s/contacts until the last <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/contact of the participant. If the participant dies during participation in the study or during a recognized follow-up period, <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> will be provided with any available post-mortem findings, including histopathology. Follow-up After the Participant is Discharged From the Study The investigator will provide any new or updated relevant information on previously reported SAE/AESI to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> using electronic Expedited Adverse Events Report and/or pregnancy report as applicable. The investigator is obliged to perform or arrange for the conduct of supplemental clinical examinations/tests and/or evaluations to elucidate the nature and/or causality of the AE or SAE as fully as possible. Follow-up of Pregnancies Pregnant participants will be followed to determine the outcome of the pregnancy. At the end of the pregnancy, whether full-term or premature, information on the status of the mother and child will be forwarded to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> using the electronic pregnancy report and the Expedited Adverse Events Report if applicable. Generally, the follow-up period doesn\\\\u2019t need to be longer than 6 to 8 weeks after the estimated date of delivery. Regardless of the reporting period for SAEs for this study, if the pregnancy outcome is an SAE, it should always be reported as SAE. Furthermore, in case if the investigator becomes aware of any SAE occurring as a result of a post-study pregnancy AND considered by the investigator to be reasonably related to the study <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product, he/she has to report this information to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> as described in Section 8.3.6.4. Updating of SAE, AESI, and Pregnancy Information After Removal of Write Access to the Participant\\\\u2019s eCRF When additional SAE, AESI, or pregnancy information is received after removal of write access to the participant\\\\u2019s eCRF, new or updated information should be recorded on the appropriate paper report, with all changes signed and dated by the investigator. The updated report should be faxed to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> as described in the relevant section within the timeframes specified in Table 13).</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"105\\\", \\\"TableIndex\\\": \\\"51\\\", \\\"TableName\\\": \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Header\\\": [0, 1]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"4c7875cd-57b2-410d-8d17-938c7d7d5580\\\", \\\"childbox\\\": \\\"059aebac-aeca-427c-a67c-5a2da37add7f\\\", \\\"subtext\\\": \\\"461e8f47-1990-461b-ae75-68479146cabd\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2521, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Assessment of Intensity\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"97cf7ffd-fe58-4327-b897-aa7666a3bbe4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2522, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n      <th>5.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Maximum Intensity for Solicited Events</td>\\\\n      <td>Maximum Intensity for Solicited Events</td>\\\\n      <td>Maximum Intensity for Solicited Events</td>\\\\n      <td>Maximum Intensity for Solicited Events</td>\\\\n      <td>Maximum Intensity for Solicited Events</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>The intensity of the following solicited AEs will be assessed as described in the table below. Intensity Scales for Solicited Events in Adults and Children of 6 Years of Age or Older Adults/Child (  10 years)</td>\\\\n      <td>The intensity of the following solicited AEs will be assessed as described in the table below. Intensity Scales for Solicited Events in Adults and Children of 6 Years of Age or Older Adults/Child (  10 years)</td>\\\\n      <td>The intensity of the following solicited AEs will be assessed as described in the table below. Intensity Scales for Solicited Events in Adults and Children of 6 Years of Age or Older Adults/Child (  10 years)</td>\\\\n      <td>The intensity of the following solicited AEs will be assessed as described in the table below. Intensity Scales for Solicited Events in Adults and Children of 6 Years of Age or Older Adults/Child (  10 years)</td>\\\\n      <td>The intensity of the following solicited AEs will be assessed as described in the table below. Intensity Scales for Solicited Events in Adults and Children of 6 Years of Age or Older Adults/Child (  10 years)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td></td>\\\\n      <td>Event</td>\\\\n      <td>Intensity Grade</td>\\\\n      <td>Parameter</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td></td>\\\\n      <td>Pain at administration site</td>\\\\n      <td>0</td>\\\\n      <td>None</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>1</td>\\\\n      <td>Mild: Any pain neither interfering with nor preventing normal everyday activities.</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>2</td>\\\\n      <td>Moderate: Painful when limb is moved and interferes with everyday activities.</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>3</td>\\\\n      <td>Severe: Significant pain at rest. Prevents normal everyday</td>\\\\n      <td></td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"105\\\", \\\"TableIndex\\\": \\\"52\\\", \\\"TableName\\\": \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Header\\\": [0, 1, 2]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"edb05027-0a55-4d3a-8328-f60a34223a26\\\", \\\"childbox\\\": \\\"fac87e22-2767-4196-bcb9-1bca71e2ddc1\\\", \\\"subtext\\\": \\\"68cf8822-882c-4373-90f1-e4c9fef0ddbc\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2523, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"12dc8134-172e-480f-8755-1243f1e9b224\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2524, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e63da5c6-9dee-44f3-b911-763a9c1266aa\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2525, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d940b90a-fab6-4f92-88de-fb44c2573a01\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2526, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e109b880-5261-4549-af76-c568cde92b8c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2527, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"027e1607-fd1a-49ab-8437-f78e0ddf3836\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2528, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"22bde82a-7280-44a6-b20a-05c92b7234eb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2529, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"852c9a04-ed37-440e-8bca-45bbe6294f43\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2530, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"09a86fa2-1ddc-4232-9567-725de7c48fb9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2531, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2c766f8c-c7de-493d-b06b-e88619f0c573\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2532, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"735896ae-831d-4056-9b2a-73a995269931\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2533, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"98871edd-237b-4b6e-a877-1fc514e680b6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2534, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8905162b-840b-4285-b807-829e2426540d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2535, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"37a5057d-ee84-4ac5-bb8b-34fb4bf8766a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2536, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"75407356-5dec-4557-a5f4-86e30d216e83\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2537, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a27ff62e-d7dd-4ecb-b42b-4eb2263db862\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2538, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7ca32a28-6d7d-4618-aed9-669187a3d195\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2539, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8a3d07d2-7ed9-47c8-bb0f-064b79741a56\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2540, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"91d73df0-f292-464e-94cf-c93238d16d42\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2541, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n      <th>2.0</th>\\\\n      <th>3.0</th>\\\\n      <th>4.0</th>\\\\n      <th>5.0</th>\\\\n      <th>6.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>activities.</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td></td>\\\\n      <td>Redness at administration site</td>\\\\n      <td>Redness at administration site</td>\\\\n      <td>Redness at administration site</td>\\\\n      <td>Record greatest surface diameter in mm</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td></td>\\\\n      <td>Swelling at administration site</td>\\\\n      <td>Swelling at administration site</td>\\\\n      <td>Swelling at administration site</td>\\\\n      <td>Record greatest surface diameter in mm</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td></td>\\\\n      <td>Induration at administration site</td>\\\\n      <td>Induration at administration site</td>\\\\n      <td>Induration at administration site</td>\\\\n      <td>Record greatest surface diameter in mm</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td></td>\\\\n      <td>Temperature*</td>\\\\n      <td>Temperature*</td>\\\\n      <td></td>\\\\n      <td>Record temperature in \\\\u00b0C/\\\\u00b0F (with 1 decimal)</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td></td>\\\\n      <td>Nausea</td>\\\\n      <td>Nausea</td>\\\\n      <td>0</td>\\\\n      <td>Normal</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>1</td>\\\\n      <td>Mild: Nausea that is easily tolerated</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>7</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>2</td>\\\\n      <td>Moderate: Nausea that interferes with normal activity</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>8</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>3</td>\\\\n      <td>Severe: Nausea that prevents normal activity</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>9</th>\\\\n      <td></td>\\\\n      <td>Headache</td>\\\\n      <td>Headache</td>\\\\n      <td>0</td>\\\\n      <td>Normal</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>10</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>1</td>\\\\n      <td>Mild: Headache that is easily tolerated</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>11</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>2</td>\\\\n      <td>Moderate: Headache that interferes with normal activity</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>12</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>3</td>\\\\n      <td>Severe: Headache that prevents normal activity</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>13</th>\\\\n      <td></td>\\\\n      <td>Fatigue</td>\\\\n      <td>Fatigue</td>\\\\n      <td>0</td>\\\\n      <td>Normal</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>14</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>1</td>\\\\n      <td>Mild: Fatigue that is easily tolerated</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>15</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>2</td>\\\\n      <td>Moderate: Fatigue that interferes with normal activity</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>16</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>3</td>\\\\n      <td>Severe: Fatigue that prevents normal activity</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>17</th>\\\\n      <td></td>\\\\n      <td>Myalgia</td>\\\\n      <td>Myalgia</td>\\\\n      <td>0</td>\\\\n      <td>None</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>18</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>1</td>\\\\n      <td>Mild: Myalgia present but does not interfere with activity</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>19</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>2</td>\\\\n      <td>Moderate: Myalgia that interferes with normal activity</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>20</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>3</td>\\\\n      <td>Severe: Myalgia that prevents normal activity</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>21</th>\\\\n      <td></td>\\\\n      <td>Arthralgia *Refer to the SoA (Table 3)</td>\\\\n      <td>Arthralgia *Refer to the SoA (Table 3)</td>\\\\n      <td>0</td>\\\\n      <td>None</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>22</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>1</td>\\\\n      <td>Mild: Arthralgia present but does not interfere with activity</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>23</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>2</td>\\\\n      <td>Moderate: Arthralgia that interferes with normal activity</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>24</th>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td></td>\\\\n      <td>3  Severe: Arthralgia that prevents normal activity for the definition of fever and the preferred location for temperature measurement</td>\\\\n      <td>3  Severe: Arthralgia that prevents normal activity for the definition of fever and the preferred location for temperature measurement</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>25</th>\\\\n      <td>Maximum Intensity of Local Injection Site Redness/Swelling/Induration</td>\\\\n      <td>Maximum Intensity of Local Injection Site Redness/Swelling/Induration</td>\\\\n      <td>Maximum Intensity of Local Injection Site Redness/Swelling/Induration</td>\\\\n      <td>Maximum Intensity of Local Injection Site Redness/Swelling/Induration</td>\\\\n      <td>Maximum Intensity of Local Injection Site Redness/Swelling/Induration</td>\\\\n      <td>Maximum Intensity of Local Injection Site Redness/Swelling/Induration</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>26</th>\\\\n      <td>The maximum intensity of local injection site redness/swelling/induration and fever will be scored as follows:   Redness/swelling/ induration   Fever</td>\\\\n      <td>The maximum intensity of local injection site redness/swelling/induration and fever will be scored as follows:   Redness/swelling/ induration   Fever</td>\\\\n      <td>The maximum intensity of local injection site redness/swelling/induration and fever will be scored as follows:   Redness/swelling/ induration   Fever</td>\\\\n      <td>The maximum intensity of local injection site redness/swelling/induration and fever will be scored as follows:   Redness/swelling/ induration   Fever</td>\\\\n      <td>The maximum intensity of local injection site redness/swelling/induration and fever will be scored as follows:   Redness/swelling/ induration   Fever</td>\\\\n      <td>The maximum intensity of local injection site redness/swelling/induration and fever will be scored as follows:   Redness/swelling/ induration   Fever</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>27</th>\\\\n      <td></td>\\\\n      <td>0:</td>\\\\n      <td>1 to 24 mm</td>\\\\n      <td>1 to 24 mm</td>\\\\n      <td><38.0\\\\u00b0C (100.4\\\\u00b0F)</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>28</th>\\\\n      <td></td>\\\\n      <td>1:</td>\\\\n      <td>25 to 50 mm</td>\\\\n      <td>25 to 50 mm</td>\\\\n      <td>\\\\u226538.0\\\\u00b0C (100.4\\\\u00b0F) to  38.9\\\\u00b0C (102.1\\\\u00b0F)</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>29</th>\\\\n      <td></td>\\\\n      <td>2:</td>\\\\n      <td>51 to 100 mm</td>\\\\n      <td>51 to 100 mm</td>\\\\n      <td>>39.0\\\\u00b0C (102.2\\\\u00b0F) to  39.9\\\\u00b0C (103.9\\\\u00b0F)</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>30</th>\\\\n      <td></td>\\\\n      <td>3:</td>\\\\n      <td>>100 mm</td>\\\\n      <td>>100 mm</td>\\\\n      <td>>40.0\\\\u00b0C (104\\\\u00b0F)</td>\\\\n      <td></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>31</th>\\\\n      <td>Maximum Intensity for Unsolicited AEs and SAEs</td>\\\\n      <td>Maximum Intensity for Unsolicited AEs and SAEs</td>\\\\n      <td>Maximum Intensity for Unsolicited AEs and SAEs</td>\\\\n      <td>Maximum Intensity for Unsolicited AEs and SAEs</td>\\\\n      <td>Maximum Intensity for Unsolicited AEs and SAEs</td>\\\\n      <td>Maximum Intensity for Unsolicited AEs and SAEs</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>32</th>\\\\n      <td>The investigator will assess the maximum intensity that occurred over the duration of the event for all unsolicited AEs (including SAEs) recorded during the study. The assessment will be based on the investigator\\\\u2019s clinical</td>\\\\n      <td>The investigator will assess the maximum intensity that occurred over the duration of the event for all unsolicited AEs (including SAEs) recorded during the study. The assessment will be based on the investigator\\\\u2019s clinical</td>\\\\n      <td>The investigator will assess the maximum intensity that occurred over the duration of the event for all unsolicited AEs (including SAEs) recorded during the study. The assessment will be based on the investigator\\\\u2019s clinical</td>\\\\n      <td>The investigator will assess the maximum intensity that occurred over the duration of the event for all unsolicited AEs (including SAEs) recorded during the study. The assessment will be based on the investigator\\\\u2019s clinical</td>\\\\n      <td>The investigator will assess the maximum intensity that occurred over the duration of the event for all unsolicited AEs (including SAEs) recorded during the study. The assessment will be based on the investigator\\\\u2019s clinical</td>\\\\n      <td>The investigator will assess the maximum intensity that occurred over the duration of the event for all unsolicited AEs (including SAEs) recorded during the study. The assessment will be based on the investigator\\\\u2019s clinical</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>33</th>\\\\n      <td>judgment. The intensity should be assigned to 1 of the following categories: 1 (mild): An AE which is easily tolerated by the participant, causing minimal discomfort and not interfering with everyday activities. 2 (moderate): An AE which is sufficiently discomforting to interfere with normal everyday activities. 3 (severe): An AE which prevents normal, everyday activities (in a young child, such an AE would, for example, prevent attendance at school/kindergarten/daycare and would cause the parent(s)/LAR(s) to seek medical advice. In adults/adolescents, such an AE would, for example, prevent attendance at work/school and would necessitate the administration of corrective therapy. An AE that is assessed as Grade 3 (severe) should not be confused with an SAE. Grade 3 is a category used for rating the intensity of an event; and both AEs and SAEs can be assessed as Grade 3. An event is defined as \\\\u201cserious\\\\u201d when it meets 1 of the outcomes that define an SAE.</td>\\\\n      <td>judgment. The intensity should be assigned to 1 of the following categories: 1 (mild): An AE which is easily tolerated by the participant, causing minimal discomfort and not interfering with everyday activities. 2 (moderate): An AE which is sufficiently discomforting to interfere with normal everyday activities. 3 (severe): An AE which prevents normal, everyday activities (in a young child, such an AE would, for example, prevent attendance at school/kindergarten/daycare and would cause the parent(s)/LAR(s) to seek medical advice. In adults/adolescents, such an AE would, for example, prevent attendance at work/school and would necessitate the administration of corrective therapy. An AE that is assessed as Grade 3 (severe) should not be confused with an SAE. Grade 3 is a category used for rating the intensity of an event; and both AEs and SAEs can be assessed as Grade 3. An event is defined as \\\\u201cserious\\\\u201d when it meets 1 of the outcomes that define an SAE.</td>\\\\n      <td>judgment. The intensity should be assigned to 1 of the following categories: 1 (mild): An AE which is easily tolerated by the participant, causing minimal discomfort and not interfering with everyday activities. 2 (moderate): An AE which is sufficiently discomforting to interfere with normal everyday activities. 3 (severe): An AE which prevents normal, everyday activities (in a young child, such an AE would, for example, prevent attendance at school/kindergarten/daycare and would cause the parent(s)/LAR(s) to seek medical advice. In adults/adolescents, such an AE would, for example, prevent attendance at work/school and would necessitate the administration of corrective therapy. An AE that is assessed as Grade 3 (severe) should not be confused with an SAE. Grade 3 is a category used for rating the intensity of an event; and both AEs and SAEs can be assessed as Grade 3. An event is defined as \\\\u201cserious\\\\u201d when it meets 1 of the outcomes that define an SAE.</td>\\\\n      <td>judgment. The intensity should be assigned to 1 of the following categories: 1 (mild): An AE which is easily tolerated by the participant, causing minimal discomfort and not interfering with everyday activities. 2 (moderate): An AE which is sufficiently discomforting to interfere with normal everyday activities. 3 (severe): An AE which prevents normal, everyday activities (in a young child, such an AE would, for example, prevent attendance at school/kindergarten/daycare and would cause the parent(s)/LAR(s) to seek medical advice. In adults/adolescents, such an AE would, for example, prevent attendance at work/school and would necessitate the administration of corrective therapy. An AE that is assessed as Grade 3 (severe) should not be confused with an SAE. Grade 3 is a category used for rating the intensity of an event; and both AEs and SAEs can be assessed as Grade 3. An event is defined as \\\\u201cserious\\\\u201d when it meets 1 of the outcomes that define an SAE.</td>\\\\n      <td>judgment. The intensity should be assigned to 1 of the following categories: 1 (mild): An AE which is easily tolerated by the participant, causing minimal discomfort and not interfering with everyday activities. 2 (moderate): An AE which is sufficiently discomforting to interfere with normal everyday activities. 3 (severe): An AE which prevents normal, everyday activities (in a young child, such an AE would, for example, prevent attendance at school/kindergarten/daycare and would cause the parent(s)/LAR(s) to seek medical advice. In adults/adolescents, such an AE would, for example, prevent attendance at work/school and would necessitate the administration of corrective therapy. An AE that is assessed as Grade 3 (severe) should not be confused with an SAE. Grade 3 is a category used for rating the intensity of an event; and both AEs and SAEs can be assessed as Grade 3. An event is defined as \\\\u201cserious\\\\u201d when it meets 1 of the outcomes that define an SAE.</td>\\\\n      <td>judgment. The intensity should be assigned to 1 of the following categories: 1 (mild): An AE which is easily tolerated by the participant, causing minimal discomfort and not interfering with everyday activities. 2 (moderate): An AE which is sufficiently discomforting to interfere with normal everyday activities. 3 (severe): An AE which prevents normal, everyday activities (in a young child, such an AE would, for example, prevent attendance at school/kindergarten/daycare and would cause the parent(s)/LAR(s) to seek medical advice. In adults/adolescents, such an AE would, for example, prevent attendance at work/school and would necessitate the administration of corrective therapy. An AE that is assessed as Grade 3 (severe) should not be confused with an SAE. Grade 3 is a category used for rating the intensity of an event; and both AEs and SAEs can be assessed as Grade 3. An event is defined as \\\\u201cserious\\\\u201d when it meets 1 of the outcomes that define an SAE.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"105\\\", \\\"TableIndex\\\": \\\"53\\\", \\\"TableName\\\": \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Header\\\": []}, {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"13417c03-12ae-4d2f-9be6-df58cef1b3c1\\\", \\\"childbox\\\": \\\"a8b15dc2-edc8-45e1-a090-a46efd48547f\\\", \\\"subtext\\\": \\\"e985ae09-a4e1-4c3e-8039-e2277eee0f1a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2542, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7b5c9b3f-ea2c-4c66-8951-775378e28ec7\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2543, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"30ad5672-3a0b-4e82-9c4e-8b0eb6d7a3e1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2544, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"785ca062-117d-4bdc-b2bc-5d8098c50559\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2545, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"71065ca6-98c7-49f5-b53f-e006e6e5d116\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2546, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f7b86a25-982e-4ff7-a66b-52da7b7399d9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2547, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b3d55185-9af3-4731-9a0c-6968c1fd402f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2548, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e47c93cf-5c18-4423-8842-38901d1a0fbd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2549, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ae919bdc-10ef-4cc4-aa0b-184f4fdad0df\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2550, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"66ef1dbc-5c78-4a11-8fb5-a5b2350257fd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2551, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7cf9c4d1-afae-4061-a445-85428d29bfe6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2552, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"31a4fc24-bdde-43a0-9027-8c34917ee4cf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2553, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fd8b85f5-6abc-4cae-91b7-cbfd753f8ae3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2554, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"05f75ee8-53d3-4226-9fca-86be6b1295ec\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2555, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"65261e20-573e-48ff-9a73-be5d87608c05\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2556, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"70a8b47c-ff6e-4708-b271-ab9deb3b0096\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2557, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"7a77683a-0788-4fef-960c-f9c4da541e9b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2558, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c52ea259-df5f-477b-98b1-194600e1ef8b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2559, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3a85068e-01d5-4e6f-af28-8f1999bb0f80\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2560, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cc0cc30a-c867-4043-8a50-17a18c32c7b2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2561, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0b45fadd-0c64-4801-9bb6-1d252149db94\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2562, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"283502d9-2716-493d-a802-73202a3714f4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2563, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f8640a1a-ca7c-42f6-88b7-3719d8ad392f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2564, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d18faf60-10cb-4eb0-8714-86d940bf6295\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2565, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3cab7783-185e-4799-bfd2-dc1182fee433\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2566, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fc121384-1880-4130-90cd-4f33b27c69f4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2567, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"32433229-587a-4559-a012-9053b26cf849\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2568, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"82fae25b-c7aa-4fd6-82ae-c551bc45847d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2569, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f787f7bf-a2c3-4b85-9ec9-74adf5ab16be\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2570, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b3ecc4e8-240f-453f-81c2-0f6e1c399683\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2571, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2d77abf1-d178-41cd-ae59-4329091ea0cd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2572, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ac270e2e-7e14-4d17-bc9f-d124f15b7931\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2573, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b72764fb-1114-47ff-a747-243b25b410b4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2574, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3f0cc35c-a6a9-4bad-9da3-3abcb301cb08\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2575, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5a1c4fa5-ff4b-4ab6-8d2c-4f692647ee3a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2576, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"67e10604-c0ea-49cb-9e2c-ccb663dec4f1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2577, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0c7ba522-0307-4428-b6d6-388101c6cc0a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2578, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"509df728-5d9d-405c-af9c-39dfbe1d71a2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2579, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"89816e74-3ea7-49d6-a1f7-41bd81d2ffac\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2580, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2b8ef1ca-481b-4552-88a2-78dc40b70cf9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2581, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1c0d2b7c-1cd0-464b-9410-899a826386a4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2582, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4dd6f7b3-8ec4-4e80-b674-fe09525d08e3\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2583, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6c7ed9b5-7ad5-4361-91ce-bec509dfa78e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2584, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c20a1f53-f9fb-4f20-a2bc-41e3b7f22114\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2585, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3a73eeaa-e8db-434d-8436-0931c8dfd8af\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2586, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3e7c9461-f1e1-4c84-be36-2427534f856c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2587, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5bfafb95-0cf9-4543-b1ad-20e726620eaf\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2588, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5a8e8d03-367a-452a-9318-7e81e61ec94c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2589, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"24df8dc2-987a-4aff-86b7-f5606fa7940b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2590, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"15455ffd-ff92-4675-9f5e-f7a9d151b877\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2591, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2ce57bbb-35b9-4626-9540-cc1b1a94d74f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2592, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fea9c377-0949-4686-8a7d-3cee7d3ef3d2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2593, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6304aa93-d590-4483-a342-40c195e03bc5\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2594, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e4bc3248-902a-4a5e-b571-12fe6bbed5cb\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2595, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b3b2da22-a07b-4e3e-a6fc-984578b61eb9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2596, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"6cf575bf-36c8-4870-ac38-eff029d8fa45\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2597, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b7556a22-5c60-44c3-ac7d-c73ccda31553\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2598, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"790f42c5-e398-4b40-9be8-9af488a1e462\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2599, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"85b6743f-9560-4b1c-8196-ec6192c413ec\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2600, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ced9b6dd-dc26-4a25-ba93-6d868349d167\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2601, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fe5ff515-b163-4d39-8cdc-3ebc375c102a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2602, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0cab1a70-7126-42d2-bf4d-7684c7345692\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2603, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"beb61405-fd35-4369-a33d-d060ac91d437\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2604, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"efd0b1e1-0387-4455-a3d9-8652a65eaf9b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2605, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d78b5975-938b-4b4a-be4e-e133e263ce41\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2606, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8a8cb746-0529-427d-825b-12262ca9fdd9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2607, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"fc6af906-0875-4d9b-8c64-46359de8ad79\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2608, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3d892fc7-63ef-420b-8b1e-bf1d0719b549\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2609, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e0842686-566e-4b51-8aff-846bef2a6d17\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2610, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"08bea4fc-51c2-4dd6-aab5-b1dd2999b425\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2611, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5f379e39-d028-4e22-a395-e7f4ee0f9429\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2612, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e36edf17-90c3-4c1e-a428-5b7c7793986a\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2613, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"bfa61323-757d-46f6-8d3f-bc03a3cf326c\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2614, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8c9cf1ea-770c-4764-9896-de09239ec954\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2615, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"03b57052-b63a-4cc7-8c42-6fea3cbc6fba\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2616, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e91f9ab5-a7be-4c30-83b2-75dab94bc912\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2617, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f2a55581-2f00-43da-b0c5-d20a7052327b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2618, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5ddfcdbf-0b51-473e-b09d-604dcea026db\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2619, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Assessment of Causality</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>All solicited administration-site and systemic events will be considered causally related to vaccination. The investigator must assess the relationship between study <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>s and the occurrence of each unsolicited AE/SAE using clinical judgment. Where several different <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>s/products were administered, the investigator should specify, when possible, if the unsolicited AE/SAE could be causally related to a specific <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>/product (ie investigational, control/placebo or co-administered <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>). When causal relationship to a specific <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> cannot be determined, the investigator should indicate the unsolicited AE/SAE to be related to all products. Alternative plausible causes, such as natural history of the underlying diseases, concomitant therapy, other risk factors, and the temporal relationship of the event to the study <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>(s)/product will be considered and investigated. The investigator will also consult the IB and/or Summary of Product Characteristics and/or Prescribing Information for marketed products to determine his/her assessment. Causality should be assessed by the investigator using the following question: Is there a reasonable possibility that the unsolicited AE may have been caused by the study <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>? YES: There is a reasonable possibility that the study <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>(s)/product contributed to the AE. NO: There is no reasonable possibility that the AE is causally related to the administration of the study <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>(s)/product. There are other, more likely causes and administration of the study <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>(s)/product is not suspected to have contributed to the AE. If an event meets the criteria to be determined as \\\\u201cserious\\\\u201d, additional examinations/tests will be performed by the investigator to determine ALL possible contributing factors for each SAE. Possible contributing factors include: Medical history. Other medication. Protocol required procedure. Other procedure not required by the protocol. Lack of efficacy of the <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>(s)/product, if applicable. Erroneous administration. Other cause (specify). There may be situations when an SAE has occurred and the investigator has minimal information to include in the initial report to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>. However, it is very important to record an assessment of causality for every event before submitting the Expedited Adverse Events Report to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>. The causality assessment is 1 of the criteria used when determining regulatory reporting requirements. The investigator may change his/her opinion of causality after receiving additional information and update the SAE information accordingly.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"105\\\", \\\"TableIndex\\\": \\\"54\\\", \\\"TableName\\\": \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Header\\\": [0, 1]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"10e7ac60-7adf-4dab-ae1a-76b74e89c3a5\\\", \\\"childbox\\\": \\\"adb539d6-f928-4ccb-89bc-a7e78400dbd2\\\", \\\"subtext\\\": \\\"6424b425-0709-4301-903c-84d3e4a85aec\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2620, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"006b94e1-5eab-464c-b0d0-8388e91267be\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2621, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Medically Attended Visits</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>For each solicited and unsolicited symptom the participant experiences, the participant/participant\\\\u2019s parent(s)/LAR(s) will be asked if he/she/the participant received medical attention defined as hospitalization, or an otherwise unscheduled <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> to or from medical personnel for any reason, including emergency room <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>s. This information will be recorded in the eCRF.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"105\\\", \\\"TableIndex\\\": \\\"55\\\", \\\"TableName\\\": \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"3be36572-e08e-488f-9f3a-8d181588786b\\\", \\\"childbox\\\": \\\"27ca0159-2cb0-4026-922f-f607f0e2a5ca\\\", \\\"subtext\\\": \\\"c147bd96-0960-4e88-b6ef-c388cd72a564\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2622, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ab5d1c34-d0b1-4ea1-831b-9a03b08cba20\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2623, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Assessment of Outcomes</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>The investigator will assess the outcome of all unsolicited AEs (including SAEs) recorded during the study as: Recovered/resolved. Recovering/resolving. Not recovered/not resolved. Recovered with sequelae/resolved with sequelae. Fatal (SAEs only).</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"105\\\", \\\"TableIndex\\\": \\\"56\\\", \\\"TableName\\\": \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"2b78b468-5e6b-4a82-9455-b992d196ae73\\\", \\\"childbox\\\": \\\"ccbd2b91-6ddb-45da-807b-f72ef0c35f02\\\", \\\"subtext\\\": \\\"ecfab039-5acd-432a-bddb-832111bc7c6c\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2624, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Reporting of SAEs, AESIs, Pregnancies, and Other Events\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2dcc099a-cbe6-4152-966d-a98496375e15\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2625, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Events Requiring Expedited Reporting to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Once an investigator becomes aware that an SAE/AESI has occurred in a study participant, the investigator or investigator\\\\u2019s designee must complete information in the electronic Expedited AE Report WITHIN 24 HOURS. The report will always be completed as thoroughly as possible with all available details of the event. The report allows to specify that the event is an AESI and whether it is serious or non-serious. Even if the investigator does not have all information regarding an SAE/AESI, the report should still be completed within 24 hours. Once additional relevant information is received, the report should be updated WITHIN 24 HOURS. The investigator will always provide an assessment of causality at the time of the initial report. The investigator will be required to confirm the review of the SAE/AESI causality by ticking the \\\\u201creviewed\\\\u201d box in the electronic Expedited AE Report within 72 hours of submission of the SAE/AESI. Refer to Table 13 for the details on timeframes for reporting of SAEs/AESIs.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"105\\\", \\\"TableIndex\\\": \\\"57\\\", \\\"TableName\\\": \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [{\\\"start_idx\\\": 40, \\\"end_idx\\\": 44, \\\"standard_entity_name\\\": \\\"ANY: Organization\\\", \\\"subcategory\\\": \\\"ANY: Organization\\\", \\\"confidence\\\": 75.0, \\\"text\\\": \\\"IQVIA\\\"}], \\\"roi_id\\\": {\\\"para\\\": \\\"3dad498c-de09-490e-8974-cef1d9322199\\\", \\\"childbox\\\": \\\"f8c16304-4865-42b8-b013-e456bbbd6b3a\\\", \\\"subtext\\\": \\\"12b972fb-7c7c-4795-be23-c4866c8e76eb\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2626, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"0c9f5a1a-32ce-4ca9-bd4c-6df78221dee0\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2627, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>SAE/AESI/Pregnancy Reporting to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> via an Electronic Data Collection Tool</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>The primary mechanism for reporting an SAE/AESI/Pregnancy to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> will be an EDC. If the EDC is unavailable for more than 24 hours, then the study center will use the paper Expedited AE/Pregnancy Report (see details in the next section). The study center will enter the SAE/AESI/pregnancy data into the EDC as soon as it become available. After the study is completed at a given study center, the EDC will be taken offline to prevent the entry of new data or changes to existing data. If a study center receives a report of a new SAE/AESI/pregnancy from a participant or receives updated data on a previously reported SAE/AESI/pregnancy after the EDC has been taken offline, then the study center can report this information on a paper Expedited AE/Pregnancy Report (see the next section) or to the Medical Monitor by telephone. Contacts of the Medical Monitor for SAE/AESI/pregnancy reporting can be found in the study reference manual.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"105\\\", \\\"TableIndex\\\": \\\"58\\\", \\\"TableName\\\": \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [{\\\"start_idx\\\": 32, \\\"end_idx\\\": 36, \\\"standard_entity_name\\\": \\\"ANY: Organization\\\", \\\"subcategory\\\": \\\"ANY: Organization\\\", \\\"confidence\\\": 75.0, \\\"text\\\": \\\"IQVIA\\\"}], \\\"roi_id\\\": {\\\"para\\\": \\\"6c8c1caf-1869-48bc-b8fa-3a1096fa1785\\\", \\\"childbox\\\": \\\"4069432f-5f00-4902-9676-00150cd76b6b\\\", \\\"subtext\\\": \\\"86ec8dd7-4b37-40c2-8017-f90d359190f8\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2628, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8b0bef72-b816-499f-afdb-52280a3b7e1d\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2629, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Back-up SAE/AESI/Pregnancy Reporting to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> via Paper (in Case of EDC Failure)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Facsimile transmission (fax) of the SAE/AESI/pregnancy paper Expedited AE/Pregnancy Report in case of EDC failure is the preferred method to transmit this information to the Medical Monitor. In rare circumstances and in the absence of a fax equipment, notification by telephone is acceptable with a copy of the paper Expedited AE/Pregnancy Report sent by overnight mail or courier service. Initial notification via telephone does not replace the need for the investigator to complete and sign the Expedited AE/Pregnancy Report within the designated reporting timeframes. Contacts of the Medical Monitor for SAE/AESI/pregnancy reporting can be found in the study reference manual.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"105\\\", \\\"TableIndex\\\": \\\"59\\\", \\\"TableName\\\": \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [{\\\"start_idx\\\": 40, \\\"end_idx\\\": 44, \\\"standard_entity_name\\\": \\\"ANY: Organization\\\", \\\"subcategory\\\": \\\"ANY: Organization\\\", \\\"confidence\\\": 75.0, \\\"text\\\": \\\"IQVIA\\\"}], \\\"roi_id\\\": {\\\"para\\\": \\\"cbb77513-77e9-43e9-a748-784fbaeef01a\\\", \\\"childbox\\\": \\\"eca68c77-36f8-44ac-a6b6-237a9d472722\\\", \\\"subtext\\\": \\\"9c9b6103-e263-4c9f-b2eb-b878091b4a2a\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2630, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Definitions of Medical Device Adverse Events and Adverse Device Effects\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cf6136c4-771d-4f17-8272-d24354c5e84e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2631, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>A Medical Device AE  is:</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>is any untoward medical occurrence, in a clinical study participant, users, or other persons, temporally associated with the use of study intervention whether or not considered related to a medical device. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a medical device. This definition includes events related to the medical device or comparator and events related to the procedures involved.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>An Adverse Device Effect (ADE)  is:</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Any AE related to the use of a medical device. This definition includes any AE resulting from: insufficient or inadequate instructions for use (i.e., user error), or any malfunction of a medical device, or intentional misuse of the medical device.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"105\\\", \\\"TableIndex\\\": \\\"60\\\", \\\"TableName\\\": \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Header\\\": []}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"64f17d27-72e5-49c9-aee3-9f58f45dcbce\\\", \\\"childbox\\\": \\\"73228b50-09a1-4f7b-9f49-221bc68cab9b\\\", \\\"subtext\\\": \\\"20bf4e60-cd93-4d7e-8225-68c826516ded\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2632, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Definitions of a Medical Device SAE, Serious Adverse Device Effect, and Unexpected Serious Adverse Device Effect\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"59f7ef71-7b64-430e-a577-210623211023\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2633, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>A Medical Device SAE is Any SAE that:</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Led to death   Led to serious deterioration in the health of the participant, that either resulted in: A life-threatening illness or injury. The term \\\\u201clife-threatening\\\\u201d in the definition of \\\\u201cserious\\\\u201d refers to an event in which the participant was at risk of death at the time of the event. It does not refer to an event, which hypothetically might have caused death, if it were more severe. A permanent impairment of a body structure or a body function. Inpatient or prolonged hospitalization. Planned hospitalization for a pre-existing condition, or a procedure required by the protocol, without serious deterioration in health, is not considered an SAE. Medical or surgical intervention to prevent life-threatening illness or injury or permanent impairment to a body structure or a body function   Led to fetal distress, fetal death or a congenital abnormality or birth defect   Is a suspected transmission of any infectious agent via a medicinal product</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>A Serious Adverse Device Effect (SADE) is:</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>A SADE is defined as an ADE that has resulted in any of the consequences characteristic of a serious adverse event. Any device deficiency that might have led to an SAE if appropriate action had not been taken, intervention had not occurred, or circumstances had been less fortunate.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>An Unanticipated SADE (USADE) is:</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>An USADE (also identified as UADE in US Regulations 21 CFR 813.3), is a SADE that by its nature, incidence, severity or outcome has not been identified in the current version of the IB.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"105\\\", \\\"TableIndex\\\": \\\"61\\\", \\\"TableName\\\": \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Header\\\": [0, 2]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"37719493-8dfb-4848-9074-0f7c27373664\\\", \\\"childbox\\\": \\\"a3e99e91-b835-4225-91d2-08facf66547b\\\", \\\"subtext\\\": \\\"00355df3-472a-425c-a5a0-aa7160a19a93\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2634, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"233f48c9-fad1-4fec-85e6-6f639911a6da\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2635, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Recording and Reporting of Medical Device AE, ADEs, SADEs and USADE</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Any device deficiency must be reported to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> within 24 hours after the investigator determines that the event meets the definition of a device deficiency. E-mail/fax transmission of the paper \\\\u201cMedical device or combination product with device deficiency/incident report form\\\\u201d is the preferred method to transmit this information to <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span>. In rare circumstances and in the absence of facsimile equipment, notification by telephone is acceptable with a copy of \\\\u201cMedical device or combination product with device deficiency/incident report form\\\\u2019 sent by overnight mail or courier service.\\\\u201d Contacts of the Medical Monitor for medical device safety events reporting can be found in the study reference manual. <span class=\\\\\\\"redact\\\\\\\">~REDACTED~</span> will review all device deficiencies and determine and document in writing whether they could have led to an SAE. These device deficiencies will be reported to the regulatory authorities and IRBs/IECs as required by national regulations.</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"105\\\", \\\"TableIndex\\\": \\\"62\\\", \\\"TableName\\\": \\\"Table 17 List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Header\\\": [0]}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"fad9775b-8604-4abf-bfbd-5fa5a68974af\\\", \\\"childbox\\\": \\\"3fc2738b-f9e9-421c-b55e-d479e7cfab54\\\", \\\"subtext\\\": \\\"dea057c9-de23-45ff-b1c4-1abeefd16d4e\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2636, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"cee8db2d-ba11-4e22-87c9-4390f3937fec\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2637, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"71b01e98-57b5-4f8c-9a48-56f47a62a88b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"List of Potential Immune-Mediated Diseases (pIMDs)\\\", \\\"Table 17\\\", \\\"1\\\", 2638, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Appendix 5 Contraceptive Guidance and Collection of Pregnancy\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8c0697b6-f5a0-4e05-ac7a-8dc08362c054\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 5  Contraceptive Guidance and Collection of Pregnancy\\\", \\\"\\\", \\\"1\\\", 2639, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Information\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 28, \\\"font_style\\\": \\\"Heading3\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"efe63a00-c2a3-4e8a-9146-fec461c0066e\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 28, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 5  Contraceptive Guidance and Collection of Pregnancy\\\", \\\"\\\", \\\"1\\\", 2640, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Definitions\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8d359a3d-e9ca-4c89-9b0b-3de92677aeaa\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2641, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Woman of Childbearing Potential\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"799b1960-b33d-405c-9361-56712a5f6162\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2642, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A woman is considered fertile following menarche and until becoming post-menopausal unless permanently sterile (see below).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f532da27-99fe-4aed-855b-bc3bf62d872f\\\", \\\"childbox\\\": \\\"f80831e8-8243-4d3d-b6e2-fe1650be6ac7\\\", \\\"subtext\\\": \\\"485b0d03-c651-43be-af91-8fdeabaf575d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2643, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Women NOT Considered as Women of Childbearing Potential\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading5\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d0bb4b75-013c-4ee0-ad4c-de0df7630dfd\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2644, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"1. Premenarchal female*:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"328c6033-fab2-449b-bc0a-0bd53182b3f8\\\", \\\"childbox\\\": \\\"32ce07cd-5ea9-4ca4-a1e5-e3eba05a03d1\\\", \\\"subtext\\\": \\\"f5528036-40e8-4aad-a1ef-fd81caaa0027\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2645, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"a) Menarche is defined as an onset of menses for the first time in a young female and is preceded by several changes associated with puberty including breast development and pubic hair growth.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"954e9399-6801-4bd3-9b44-8b51191fb86c\\\", \\\"childbox\\\": \\\"0fa9e807-0710-4ae2-a9b1-34e790d15ae6\\\", \\\"subtext\\\": \\\"1968b435-897d-4402-a47a-d4f9ecaaa50c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2646, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"b) If fertility is unclear (e.g., amenorrhea in adolescents or athletes) and a menstrual cycle cannot be confirmed before first dose of study intervention, additional evaluation should be considered.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d9a5fb77-20b8-4def-ac8b-cc3fd1361e8b\\\", \\\"childbox\\\": \\\"cc01049f-82cf-4dd8-a928-e9d8fd7d72a4\\\", \\\"subtext\\\": \\\"f90aea25-868d-4cfc-b842-8bfd2aa4c882\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2647, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"2. Premenopausal female with 1 of the following:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"68b0b6d6-6b04-4ec6-9c9f-c9fbfc57c262\\\", \\\"childbox\\\": \\\"f6021d03-dd5f-4a2e-a65f-53ab0264029a\\\", \\\"subtext\\\": \\\"3cb7ec32-ddc6-4109-a974-86c26baac43e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2648, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"a) Documented hysterectomy\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d749587b-0cfd-46bc-8d6d-5a370437a08a\\\", \\\"childbox\\\": \\\"32c0bd75-a6d2-4f1a-8f85-72d5b351f62c\\\", \\\"subtext\\\": \\\"8a199f53-d690-47d9-ba6d-d60e95808977\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2649, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"b) Documented bilateral salpingectomy\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"d1b16bb6-0b28-40b9-8c77-4781741dcf54\\\", \\\"childbox\\\": \\\"8dc326f5-c211-4ee2-ab1e-b015a9e6a43d\\\", \\\"subtext\\\": \\\"dc754ce9-df73-4272-bc25-77a69161ce87\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2650, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"c) Documented bilateral oophorectomy\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"49871181-34a5-4856-bfc1-fba3ef7b3b54\\\", \\\"childbox\\\": \\\"703daf17-e148-4ac8-bb42-d593229b63a4\\\", \\\"subtext\\\": \\\"5d53b09f-37c5-49fe-a781-4bd09da4f421\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2651, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Note: Documentation can come from the study center staff: review of participant\\\\u2019s medical records, medical examination, or medical history interview.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f9647eb9-b1e3-4506-ad4d-c1319ce902af\\\", \\\"childbox\\\": \\\"bdaa41b0-6ecf-4d75-bc11-f1a658571407\\\", \\\"subtext\\\": \\\"3023b992-601a-4b2a-8fe5-2a22ede0b770\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2652, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"3. Postmenopausal female:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3047a045-bd39-46bc-b158-240a8355ff8f\\\", \\\"childbox\\\": \\\"f7d7d606-7780-4a1c-9230-e8dfd13466cf\\\", \\\"subtext\\\": \\\"4a1623e9-0eea-4d33-a430-97d5e544ecb1\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2653, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"a) A postmenopausal state is defined as no menses for 12 months without an alternative medical cause.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2f0487a4-d245-459f-acfa-28db6f4d09f6\\\", \\\"childbox\\\": \\\"18c76d18-8b65-4f27-8260-0263c72a1504\\\", \\\"subtext\\\": \\\"f182c8de-98c7-479f-9b95-85700da8c3bf\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2654, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"A high follicle stimulating hormone level in the postmenopausal range may be used to confirm a postmenopausal state in women not using hormonal contraception or hormone replacement therapy (HRT).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2f0487a4-d245-459f-acfa-28db6f4d09f6\\\", \\\"childbox\\\": \\\"67348a3d-113c-4f9d-993d-4430a6b878a8\\\", \\\"subtext\\\": \\\"265f2c5b-1b85-41e2-bf95-3f93fcb8c334\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2655, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"However, in the absence of 12 months of amenorrhea, a single follicle stimulating hormone measurement is insufficient.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2f0487a4-d245-459f-acfa-28db6f4d09f6\\\", \\\"childbox\\\": \\\"89eef07f-2c42-4053-97b2-71e1f0d05b4a\\\", \\\"subtext\\\": \\\"265f2c5b-1b85-41e2-bf95-3f93fcb8c334\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2656, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"b) Females on HRT and whose menopausal status is in doubt will be required to use 1 of the non-hormonal highly effective contraception methods if they wish to continue their HRT during the study.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e2935117-f438-4876-b7cd-42ef38c70a9e\\\", \\\"childbox\\\": \\\"8c916992-5cf5-4f98-9643-c0e94e2f17f8\\\", \\\"subtext\\\": \\\"0ba44704-fe53-49a5-a9dc-7bd11c279f12\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2657, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Otherwise, they must discontinue HRT to allow confirmation of postmenopausal status before study enrollment.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e2935117-f438-4876-b7cd-42ef38c70a9e\\\", \\\"childbox\\\": \\\"3b41c7da-d1d4-40ad-8e57-317bfcb1de88\\\", \\\"subtext\\\": \\\"352a70b6-bb30-4a2f-a354-e3746f97a4e5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2658, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"*Note: If the childbearing potential changes after start of the study (e.g., a premenarchal female participant experiences menarche) or the risk of pregnancy changes (e.g., a female participant who is not heterosexually active becomes active), the participant must discuss this with the investigator, who should determine a highly effective method of contraception.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"26fcb17f-83cf-4252-83ee-2d89902a790a\\\", \\\"childbox\\\": \\\"3aaf7d6d-30e1-4011-8927-95950a85e222\\\", \\\"subtext\\\": \\\"26b6b53c-8e55-413a-ba0f-d83182221365\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2659, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"If reproductive status is questionable, additional evaluation should be considered.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"26fcb17f-83cf-4252-83ee-2d89902a790a\\\", \\\"childbox\\\": \\\"6f741907-0871-4a32-80c0-e1a8c336a10d\\\", \\\"subtext\\\": \\\"b4c5db39-5ff5-412c-aa38-ea38d21dded8\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": true, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Definitions\\\", \\\"\\\", \\\"3\\\", 2660, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Contraception Guidance\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b851ea2d-338f-4ffb-976f-f89ebf9b06d1\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Contraception Guidance\\\", \\\"\\\", \\\"3\\\", 2661, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Female participants of childbearing potential are eligible to participate if they\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e9a783cd-203f-40bb-8b31-2a1dc0839595\\\", \\\"childbox\\\": \\\"048fa82d-b369-40a0-b83b-33ce8a7a1f6f\\\", \\\"subtext\\\": \\\"10837bc4-b5ca-406a-b9e9-176a5f15030b\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Female participants of childbearing potential are eligible to participate if they agree to use an adequate contraception consistently and correctly according to the methods listed in the sponsor\\\\u2019s list of highly effective contraceptive methods provided in the table below.\\\", \\\"\\\", \\\"3\\\", 2662, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e9a783cd-203f-40bb-8b31-2a1dc0839595\\\", \\\"childbox\\\": \\\"048fa82d-b369-40a0-b83b-33ce8a7a1f6f\\\", \\\"subtext\\\": \\\"e2773690-584d-4fc7-914b-0a6da4b332b7\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Female participants of childbearing potential are eligible to participate if they agree to use an adequate contraception consistently and correctly according to the methods listed in the sponsor\\\\u2019s list of highly effective contraceptive methods provided in the table below.\\\", \\\"\\\", \\\"3\\\", 2663, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"agree to use an adequate contraception consistently and correctly according to the methods listed in the sponsor\\\\u2019s list of highly effective contraceptive methods provided in the table below.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e9a783cd-203f-40bb-8b31-2a1dc0839595\\\", \\\"childbox\\\": \\\"048fa82d-b369-40a0-b83b-33ce8a7a1f6f\\\", \\\"subtext\\\": \\\"e14746ba-a1cb-45c5-8501-b1f5c9bcfbcb\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Female participants of childbearing potential are eligible to participate if they agree to use an adequate contraception consistently and correctly according to the methods listed in the sponsor\\\\u2019s list of highly effective contraceptive methods provided in the table below.\\\", \\\"\\\", \\\"3\\\", 2664, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": true, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"e9a783cd-203f-40bb-8b31-2a1dc0839595\\\", \\\"childbox\\\": \\\"048fa82d-b369-40a0-b83b-33ce8a7a1f6f\\\", \\\"subtext\\\": \\\"ad1e04cb-35b9-4f64-b060-7aa7cc28197e\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Female participants of childbearing potential are eligible to participate if they agree to use an adequate contraception consistently and correctly according to the methods listed in the sponsor\\\\u2019s list of highly effective contraceptive methods provided in the table below.\\\", \\\"\\\", \\\"3\\\", 2665, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Highly Effective Contraceptive Methods\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"b78b8a1e-ce15-427b-82a8-1579629a561f\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Female participants of childbearing potential are eligible to participate if they agree to use an adequate contraception consistently and correctly according to the methods listed in the sponsor\\\\u2019s list of highly effective contraceptive methods provided in the table below.\\\", \\\"\\\", \\\"3\\\", 2666, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"table\\\", {\\\"Table\\\": \\\"<table border=\\\\\\\"1\\\\\\\" class=\\\\\\\"dataframe\\\\\\\">\\\\n  <thead>\\\\n    <tr style=\\\\\\\"text-align: right;\\\\\\\">\\\\n      <th></th>\\\\n      <th>1.0</th>\\\\n    </tr>\\\\n  </thead>\\\\n  <tbody>\\\\n    <tr>\\\\n      <th>0</th>\\\\n      <td>Highly Effective Contraceptive Methods That Are User Dependent <sup>*</sup>  Failure rate of <1% per year when used consistently and correctly.</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>1</th>\\\\n      <td>Combined (oestrogen- and progestogen-containing) hormonal contraception associated with inhibition of ovulation Oral Intravaginal Transdermal</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>2</th>\\\\n      <td>Progestogen-only hormonal contraception associated with inhibition of ovulation Oral Injectable</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>3</th>\\\\n      <td>Highly Effective Methods That Are User Independent <sup>*</sup></td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>4</th>\\\\n      <td>Implantable progestogen-only hormonal contraception associated with inhibition of ovulation    Intrauterine device Intrauterine hormone-releasing system Bilateral tubal occlusion</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>5</th>\\\\n      <td>Vasectomized partner (A vasectomized partner is a highly effective contraception method provided that the partner is the sole male sexual partner of the woman of childbearing potential and the absence of sperm has been confirmed. If not, an additional highly effective method of contraception should be used.)</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>6</th>\\\\n      <td>Male partner sterilization prior to the female participant\\\\u2019s entry into the study, and this male is the sole partner for that participant, (The information on the male sterility can come from the study center personnel\\\\u2019s review of the participant\\\\u2019s medical records; medical examination and/or semen analysis, or medical history interview provided by her or her partner).</td>\\\\n    </tr>\\\\n    <tr>\\\\n      <th>7</th>\\\\n      <td>Sexual abstinence (Sexual abstinence is considered a highly effective method only if defined as refraining from heterosexual intercourse during the entire period of risk associated with the study drug. The reliability of sexual abstinence needs to be evaluated in relation to the duration of the study and the preferred and usual lifestyle of the participant.)</td>\\\\n    </tr>\\\\n  </tbody>\\\\n</table>\\\", \\\"SectionHeaderPrintPage\\\": \\\"116\\\", \\\"TableIndex\\\": \\\"63\\\", \\\"TableName\\\": \\\"Highly Effective Contraceptive Methods\\\", \\\"Header\\\": []}, {\\\"IsBold\\\": true, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"entity\\\": [], \\\"roi_id\\\": {\\\"para\\\": \\\"9d72a4cb-eb0f-4031-abb7-419e7ac32bf9\\\", \\\"childbox\\\": \\\"f8cec5c3-eb70-4bfb-a68e-70b1a82fe71a\\\", \\\"subtext\\\": \\\"87aebd96-3ea4-4914-9452-ad6190c00a7d\\\"}, \\\"Bold\\\": true, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Female participants of childbearing potential are eligible to participate if they agree to use an adequate contraception consistently and correctly according to the methods listed in the sponsor\\\\u2019s list of highly effective contraceptive methods provided in the table below.\\\", \\\"\\\", \\\"3\\\", 2667, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"* Typical use failure rates may differ from those when used consistently and correctly.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"32239215-60a9-48ab-af3c-57d9e87ff45f\\\", \\\"childbox\\\": \\\"a0c9175b-b6a4-4989-873d-bc4b0508c050\\\", \\\"subtext\\\": \\\"788e7446-c5b6-47eb-a45e-4b9396c13c1f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Female participants of childbearing potential are eligible to participate if they agree to use an adequate contraception consistently and correctly according to the methods listed in the sponsor\\\\u2019s list of highly effective contraceptive methods provided in the table below.\\\", \\\"\\\", \\\"3\\\", 2668, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Use should be consistent with local regulations regarding the use of contraceptive methods for participants in clinical studies.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 20, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"32239215-60a9-48ab-af3c-57d9e87ff45f\\\", \\\"childbox\\\": \\\"6daf844d-4d60-43de-b5fc-721e0ffcd4ad\\\", \\\"subtext\\\": \\\"788e7446-c5b6-47eb-a45e-4b9396c13c1f\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 20, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Female participants of childbearing potential are eligible to participate if they agree to use an adequate contraception consistently and correctly according to the methods listed in the sponsor\\\\u2019s list of highly effective contraceptive methods provided in the table below.\\\", \\\"\\\", \\\"3\\\", 2669, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Female participants must practice adequate contraception for 30 days prior to vaccination, have a negative pregnancy test on the day of vaccination, and agree to continue adequate contraception during the entire intervention period and for 30 days after completion of the vaccination series.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"1b2f139b-db17-4271-bad1-4aa7a810221a\\\", \\\"childbox\\\": \\\"913d1745-b772-41fb-990f-8c6f1d9ec34d\\\", \\\"subtext\\\": \\\"e9747a07-57fa-40af-8ac7-0da280eeb8ba\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Female participants of childbearing potential are eligible to participate if they agree to use an adequate contraception consistently and correctly according to the methods listed in the sponsor\\\\u2019s list of highly effective contraceptive methods provided in the table below.\\\", \\\"\\\", \\\"3\\\", 2670, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Female Participants Who Become Pregnant\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading4\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f8ad7426-99ea-46f1-8112-6103bb4ee0af\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Female Participants Who Become Pregnant\\\", \\\"\\\", \\\"3\\\", 2671, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Refer to the Sections 8.3.6 for information on detection, recording, reporting and follow-up of pregnancies.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9073dce0-96b6-464b-88ac-3a690e5e640d\\\", \\\"childbox\\\": \\\"e2155b6f-f6dc-46b6-9605-de9516d758b8\\\", \\\"subtext\\\": \\\"f906c90f-2ed4-4ddc-b35b-5c1f2b01b0df\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Female Participants Who Become Pregnant\\\", \\\"\\\", \\\"3\\\", 2672, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Any female participant who becomes pregnant during the study will discontinue study intervention.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9073dce0-96b6-464b-88ac-3a690e5e640d\\\", \\\"childbox\\\": \\\"347fd88f-da86-41d5-b319-66657089fbef\\\", \\\"subtext\\\": \\\"5f4cab2b-f2b7-42b4-87ed-5b6d58fd9183\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Female Participants Who Become Pregnant\\\", \\\"\\\", \\\"3\\\", 2673, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"For a participant who becomes pregnant during the study, this information will be shared with the participant\\\\u2019s parent(s)/LAR(s) depending on the participant\\\\u2019s age as required by local regulations.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9073dce0-96b6-464b-88ac-3a690e5e640d\\\", \\\"childbox\\\": \\\"9c2b612f-ea65-4bec-b9d1-76451b4511a7\\\", \\\"subtext\\\": \\\"5f4cab2b-f2b7-42b4-87ed-5b6d58fd9183\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Female Participants Who Become Pregnant\\\", \\\"\\\", \\\"3\\\", 2674, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9073dce0-96b6-464b-88ac-3a690e5e640d\\\", \\\"childbox\\\": \\\"64134e63-cd9f-43cd-956a-797ddfd74f74\\\", \\\"subtext\\\": \\\"c9075641-39de-4aa1-8bed-7d2af555d3ac\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Female Participants Who Become Pregnant\\\", \\\"\\\", \\\"3\\\", 2675, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Appendix 6 Country-specific Requirements\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"356f6692-a050-4eb2-a9e4-60c1ebd1a8c6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 6  Country-specific Requirements\\\", \\\"\\\", \\\"1\\\", 2676, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"To be confirmed.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"72b38925-61a1-4229-98d4-1bec20ec6502\\\", \\\"childbox\\\": \\\"ac922bda-706e-4b3c-a93b-c1a4c04d2868\\\", \\\"subtext\\\": \\\"d491dae6-2053-43b1-bdcd-efeeb24b5d0e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 6  Country-specific Requirements\\\", \\\"\\\", \\\"1\\\", 2677, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"72b38925-61a1-4229-98d4-1bec20ec6502\\\", \\\"childbox\\\": \\\"e551f6a6-8c07-4c50-9663-06c1170817e2\\\", \\\"subtext\\\": \\\"7af1a4d6-1065-42e1-ad6e-0375b9b1754c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 6  Country-specific Requirements\\\", \\\"\\\", \\\"1\\\", 2678, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"header\\\", \\\"Appendix 7 Signature of Investigator\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"Heading2\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2562ec18-2680-4194-932b-07445785fcf4\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2679, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"PROTOCOL TITLE:  A phase IIIB, randomized, controlled, observer-blind study to evaluate safety and immunogenicity of ~REDACTED~ Meningococcal ABCWY ~REDACTED~ when administered in healthy adolescents and adults, previously primed with MenACWY ~REDACTED~\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"9896fd18-d389-4554-9257-94880778b20c\\\", \\\"childbox\\\": \\\"ba845441-d992-40b6-ad8a-6ca449e38b66\\\", \\\"subtext\\\": \\\"dc3a77df-ffea-46df-a660-5fc3caaad440\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2680, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"PROTOCOL NO:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"016567ca-ec98-4002-bc6d-a0da83dbf38a\\\", \\\"childbox\\\": \\\"542176d2-6023-4a90-82b2-14372451a0d5\\\", \\\"subtext\\\": \\\"39953ca1-b307-491c-b852-30172147b7e6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2681, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"016567ca-ec98-4002-bc6d-a0da83dbf38a\\\", \\\"childbox\\\": \\\"bf1c8d9b-6c40-48c5-9ccd-7e49a7d57090\\\", \\\"subtext\\\": \\\"69914a2c-cf9a-454f-b84c-f7b33f29152d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2682, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"213171 (MENABCWY-019)\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"016567ca-ec98-4002-bc6d-a0da83dbf38a\\\", \\\"childbox\\\": \\\"a80fa009-7622-4dc9-bb68-b948a236aab0\\\", \\\"subtext\\\": \\\"69914a2c-cf9a-454f-b84c-f7b33f29152d\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2683, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"VERSION:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4b02ddd2-b1dc-43da-a319-096fdd139ac9\\\", \\\"childbox\\\": \\\"d1af1448-bbce-429b-aa10-e540803700c6\\\", \\\"subtext\\\": \\\"41a017da-41dd-47b7-9b6a-8035d8ad5886\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2684, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4b02ddd2-b1dc-43da-a319-096fdd139ac9\\\", \\\"childbox\\\": \\\"19f4b649-6d54-4dfa-952f-b23c0860dc12\\\", \\\"subtext\\\": \\\"e7b17c7b-cc97-4bb1-8047-d89a1f34f9db\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2685, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4b02ddd2-b1dc-43da-a319-096fdd139ac9\\\", \\\"childbox\\\": \\\"e78d0544-8bf4-43ae-9506-5452b494fa5b\\\", \\\"subtext\\\": \\\"363141c9-10a0-419c-b120-b69c5b8b884c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2686, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Amendment 2\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"4b02ddd2-b1dc-43da-a319-096fdd139ac9\\\", \\\"childbox\\\": \\\"09761dea-5aba-410b-a9e1-e485c48c9f0b\\\", \\\"subtext\\\": \\\"363141c9-10a0-419c-b120-b69c5b8b884c\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2687, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"This protocol is a confidential communication of ~REDACTED~ (~REDACTED~).\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8e64097b-3402-46a7-8815-386537e6060e\\\", \\\"childbox\\\": \\\"8345e7b4-7ea4-410f-a77f-f4fde813e03b\\\", \\\"subtext\\\": \\\"4d878a09-d647-43aa-98d4-459836eeabf6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2688, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"I confirm that I have read this protocol, I understand it, and I will work according to this protocol.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8e64097b-3402-46a7-8815-386537e6060e\\\", \\\"childbox\\\": \\\"48f3a771-7643-4904-9b9f-6f9359ce1ecb\\\", \\\"subtext\\\": \\\"4d878a09-d647-43aa-98d4-459836eeabf6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2689, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"I will also work consistently with the ethical principles that have their origin in the Declaration of Helsinki and that are consistent with Good Clinical Practices and the applicable laws and regulations.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8e64097b-3402-46a7-8815-386537e6060e\\\", \\\"childbox\\\": \\\"8461dca3-d21e-4363-a8b9-e35c4a334d9f\\\", \\\"subtext\\\": \\\"4d878a09-d647-43aa-98d4-459836eeabf6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2690, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Acceptance of this document constitutes my agreement that no unpublished information contained herein will be published or disclosed without prior written approval from ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8e64097b-3402-46a7-8815-386537e6060e\\\", \\\"childbox\\\": \\\"4ceaa536-9e3b-4fb6-a243-5ed478cb7959\\\", \\\"subtext\\\": \\\"07a70ad3-e9fe-4976-bd75-44cd72c2b287\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2691, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Instructions to the Investigator:  Please SIGN and DATE this signature page.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"00fb3d3d-e232-4bbf-bf5c-67a253e6b14f\\\", \\\"childbox\\\": \\\"75b92ca3-0e09-48f5-96f6-a1b09f9668b1\\\", \\\"subtext\\\": \\\"00c274e5-780a-448d-b12c-7c0941974d10\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2692, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"PRINT your name, title, and the name of the study center in which the study will be conducted.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"00fb3d3d-e232-4bbf-bf5c-67a253e6b14f\\\", \\\"childbox\\\": \\\"4ab596cc-dc17-4d8b-9dc5-623a5dce498e\\\", \\\"subtext\\\": \\\"00c274e5-780a-448d-b12c-7c0941974d10\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2693, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Return the signed copy to ~REDACTED~.\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": 18, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"00fb3d3d-e232-4bbf-bf5c-67a253e6b14f\\\", \\\"childbox\\\": \\\"3db46fe9-23df-42f4-884e-9cff6b88aec7\\\", \\\"subtext\\\": \\\"00c274e5-780a-448d-b12c-7c0941974d10\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": 18, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2694, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"I have read this protocol in its entirety and agree to conduct the study accordingly:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"2537fdb4-9d5d-40d5-883e-4124927b0422\\\", \\\"childbox\\\": \\\"546dec6e-35f7-4693-b596-1f5b390260da\\\", \\\"subtext\\\": \\\"e723279a-c955-4420-a120-3bcde9b2a4d3\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2695, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"c98d20b4-0994-418b-afb7-b6ce3a2a9fd2\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2696, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5a8fb9f7-cd79-44c3-acc9-4e27900b75de\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2697, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"ffa6ca76-a692-4c0c-9593-48bbd665fca6\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2698, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"8d10b0ff-1e38-4f51-94d4-5448bff9226b\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2699, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Signature of Investigator:      __________________________            Date:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"a729bfa1-936c-4adf-93e1-b06756d5f267\\\", \\\"childbox\\\": \\\"91b942d8-4352-4f14-a4fc-e4e1e81e0a96\\\", \\\"subtext\\\": \\\"fec297e6-d956-4f62-961c-9c68522f65a5\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2700, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Printed Name:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"3bca1013-c5ab-43ad-b615-447bb42cf91f\\\", \\\"childbox\\\": \\\"cd9db642-7b59-44f0-b235-167ab7e5524d\\\", \\\"subtext\\\": \\\"2ea44f76-d66b-4547-8667-1682c364c543\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2701, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Investigator Title:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f4d08cf0-1e75-4c8a-b210-adcbff9880be\\\", \\\"childbox\\\": \\\"f490b5a8-905f-4593-9013-e9ba37e2ea24\\\", \\\"subtext\\\": \\\"7225c1c0-e166-44b5-af31-cc36fcfe13f9\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2702, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"5353ffa1-6af0-4bc2-a4d6-3e5e702047d9\\\", \\\"childbox\\\": \\\"\\\", \\\"subtext\\\": \\\"\\\"}}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2703, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"Name/Address of Center:\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"f8454eae-d225-401e-bec2-018f33389804\\\", \\\"childbox\\\": \\\"cbd50d3c-ab8b-4d72-8a73-de0c8c4c8d0f\\\", \\\"subtext\\\": \\\"700bf29f-f3d5-43f6-af3c-c8e93fab6f1e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2704, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74313c97-ae13-4455-922d-0d230e713f9b\\\", \\\"childbox\\\": \\\"ae2776fc-2a6d-4b63-949e-8c7ffef65ec2\\\", \\\"subtext\\\": \\\"d9216676-7d23-4557-a6f5-d8c914c11e5e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2705, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74313c97-ae13-4455-922d-0d230e713f9b\\\", \\\"childbox\\\": \\\"45c03933-710f-4744-9b90-2cdec498f1bd\\\", \\\"subtext\\\": \\\"ad8883e2-f0ee-458d-b56f-4ed4bec2b0e6\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2706, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74313c97-ae13-4455-922d-0d230e713f9b\\\", \\\"childbox\\\": \\\"5d9cfc67-4f5b-435a-9893-a8f26e96c7b8\\\", \\\"subtext\\\": \\\"d125083d-786e-4158-a6b4-34bd482b510a\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2707, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"74313c97-ae13-4455-922d-0d230e713f9b\\\", \\\"childbox\\\": \\\"ae98daef-555f-4531-9f7f-bdb5d00095a1\\\", \\\"subtext\\\": \\\"779ae166-f7e8-4186-a938-4cb5ee0cc380\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2708, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"48eff9ab-1025-461c-9ef3-9c99329682bb\\\", \\\"childbox\\\": \\\"c6ff557c-485f-424f-999a-ece617b59982\\\", \\\"subtext\\\": \\\"23fc82cc-0f55-48e7-a3e5-a37fb170e921\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2709, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"48eff9ab-1025-461c-9ef3-9c99329682bb\\\", \\\"childbox\\\": \\\"0cf01fbf-48ce-48e4-8ea3-54b75cb4e2e3\\\", \\\"subtext\\\": \\\"88ca76e8-d0cc-4f09-8876-4216a115477e\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2710, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"48eff9ab-1025-461c-9ef3-9c99329682bb\\\", \\\"childbox\\\": \\\"10ccdf67-62da-44b7-96fe-fecdf90ef22c\\\", \\\"subtext\\\": \\\"57687a75-d5f3-49d1-a033-3de264ded865\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2711, \\\"\\\"], [\\\"\\\", \\\"Unmapped\\\", \\\"text\\\", \\\"\\\", {\\\"IsBold\\\": false, \\\"font_size\\\": -1, \\\"font_style\\\": \\\"\\\", \\\"roi_id\\\": {\\\"para\\\": \\\"48eff9ab-1025-461c-9ef3-9c99329682bb\\\", \\\"childbox\\\": \\\"c37dacf0-5134-4428-b8ab-a2779044b697\\\", \\\"subtext\\\": \\\"7a7a63ab-5aac-4db7-a69f-90d3b2badea0\\\"}, \\\"Bold\\\": false, \\\"Caps\\\": false, \\\"ColorRGB\\\": 0, \\\"DStrike\\\": false, \\\"Emboss\\\": false, \\\"Highlight\\\": \\\"\\\", \\\"Imprint\\\": false, \\\"Italics\\\": false, \\\"Outline\\\": false, \\\"rFonts\\\": \\\"\\\", \\\"rStyle\\\": \\\"\\\", \\\"Shadow\\\": false, \\\"Size\\\": -1, \\\"SmallCaps\\\": false, \\\"Strike\\\": false, \\\"Underline\\\": \\\"\\\", \\\"Vanish\\\": false, \\\"VertAlign\\\": \\\"\\\"}, \\\"Unmapped\\\", \\\"Appendix 7  Signature of Investigator\\\", \\\"\\\", \\\"1\\\", 2712, \\\"\\\"]], \\\"metadata\\\": {\\\"protocol_title\\\": \\\"Protocol Title: A phase IIIB, randomized, controlled, observer-blind study to evaluate safety and immunogenicity of ~REDACTED~ meningococcal ABCWY ~REDACTED~ when administered in healthy adolescents and adults, previously primed with meningococcal ACWY ~REDACTED~\\\", \\\"protocol_title_short\\\": \\\"Immunogenicity and safety study of GSK\\\\u2019s MenABCWY vaccine in healthy adolescents and adults previously primed with MenACWY vaccine\\\", \\\"amendment_number\\\": \\\"\\\\u2013 Amendment 2\\\", \\\"is_amendment\\\": \\\"N\\\", \\\"trial_phase\\\": \\\"IIIb\\\", \\\"sponsor\\\": \\\"Pfizer\\\", \\\"sponsor_address\\\": \\\"\\\", \\\"drug\\\": \\\"\\\", \\\"approval_date\\\": \\\"20210212\\\", \\\"version_number\\\": \\\"4\\\", \\\"version_date\\\": \\\"\\\", \\\"blinded\\\": \\\"\\\", \\\"compound_number\\\": \\\"\\\", \\\"control\\\": \\\"\\\", \\\"investigator\\\": \\\"\\\", \\\"study_id\\\": \\\"EudraCT\\\", \\\"number_of_subjects\\\": \\\"1206\\\", \\\"participant_age\\\": \\\"[10y, inf]\\\", \\\"participant_sex\\\": \\\"FEMALE\\\", \\\"exclusion_criteria\\\": \\\"Refer to the Appendix 1, Glossary of Terms, for a definition of a child in care.\\\", \\\"inclusion_criteria\\\": \\\"Refer to Appendix 1, Glossary of Terms, for definitions of the investigator, eligible participants, enrolled participants, and witness.\\\", \\\"indication\\\": \\\"Multiple sclerosis\\\", \\\"objectives_section\\\": \\\"2 Evaluation of the tertiary objective is participant to availability of samples and may or not be performed. If the tertiary objective is evaluated, it may be assessed in a subset of participants using remaining serum after the primary and secondary analyses have been completed; no additional blood samples will be collected from participants. Any outcome of exploratory testing in respect of the tertiary objective will be reported in an annex/addendum to the final clinical study report.\\\", \\\"study_population\\\": \\\"entity: basic\\\", \\\"entities_in_assessments\\\": \\\"\\\", \\\"soa_epochs\\\": \\\"\\\", \\\"assessment_footnote\\\": \\\"\\\", \\\"upload_date\\\": \\\"20220103095527\\\", \\\"protocol_number\\\": \\\"213171 (MENABCWY-019)_DEC30\\\", \\\"study_status\\\": \\\"phase 1\\\", \\\"molecule_device\\\": \\\"test13\\\", \\\"secondary_objectives\\\": \\\"\\\", \\\"protocol_name\\\": \\\"\\\", \\\"endpoints\\\": \\\"\\\", \\\"trial_type_randomized\\\": \\\"\\\", \\\"accuracy\\\": \\\"\\\", \\\"ProtocolTitle\\\": \\\"\\\", \\\"protocolTitle\\\": \\\"\\\", \\\"primary_objectives\\\": \\\"\\\"}}\""